[go: up one dir, main page]

TW202236965A - Novel agrochemical composition comprising piperidine thiazole compounds - Google Patents

Novel agrochemical composition comprising piperidine thiazole compounds Download PDF

Info

Publication number
TW202236965A
TW202236965A TW110146642A TW110146642A TW202236965A TW 202236965 A TW202236965 A TW 202236965A TW 110146642 A TW110146642 A TW 110146642A TW 110146642 A TW110146642 A TW 110146642A TW 202236965 A TW202236965 A TW 202236965A
Authority
TW
Taiwan
Prior art keywords
iii
methyl
phenyl
trifluoromethyl
oxadiazol
Prior art date
Application number
TW110146642A
Other languages
Chinese (zh)
Inventor
桑陶許 斯里達 奧卡爾
蓋加拿 桑博格
拉維庫瑪 蘇雅娜拉雅娜 薩拉古爾
哈佳拉瓦迪M 凡卡泰沙
Original Assignee
印度商皮埃企業有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 印度商皮埃企業有限公司 filed Critical 印度商皮埃企業有限公司
Publication of TW202236965A publication Critical patent/TW202236965A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01PBIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
    • A01P3/00Fungicides
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/72Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
    • A01N43/80Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,2
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01PBIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
    • A01P7/00Arthropodicides

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Pest Control & Pesticides (AREA)
  • Environmental Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Dentistry (AREA)
  • Microbiology (AREA)
  • Agronomy & Crop Science (AREA)
  • Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • General Health & Medical Sciences (AREA)
  • Insects & Arthropods (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention discloses a novel agrochemical composition comprising (1) at least one compound of formula (I) wherein, A, G, R1, R2 and n are as defined in the detailed description and (2) at least one active compound. The present invention further discloses a method for controlling the microorganisms such as phytopathogenic fungi and bacteria of plants, and/or insect pests and mites using the agrochemical composition according to the invention.

Description

包含哌啶噻唑化合物之新穎農業化學組成物Novel agrochemical compositions comprising piperidinethiazole compounds

本案係關於一種新穎之農業化學組成物。更具體地,本案係關於一種新穎農業化學組成物,其包含一種或多種如式 (I)所示之哌啶噻唑 (piperidine thiazole)化合物作為組分 (1)以及一種或多種殺真菌活性化合物 (II)及/或一種或多種殺蟲或殺線蟲活性化合物 (III)作為組分 (2)。進一步地,本案關於一種控制例如植物病原性真菌 (phytopathogenic fungi)與細菌等微生物及/或害蟲 (insect pests)與蟎蟲 (mites)的方法、一種使用本案所述之新穎農業化學組成物於處理一或多個種子的用途、一種保護一或多個種子的方法、以及其對應之經過處理的種子。This case concerns a novel agricultural chemical composition. More specifically, this case relates to a novel agricultural chemical composition, which comprises one or more piperidine thiazole compounds represented by formula (I) as component (1) and one or more fungicidally active compounds ( II) and/or one or more insecticidally or nematicidally active compounds (III) as component (2). Further, the present application relates to a method for controlling microorganisms such as phytopathogenic fungi and bacteria and/or insect pests and mites, and a method of using the novel agricultural chemical composition described in the present application to treat a Use of one or more seeds, a method of protecting one or more seeds, and the corresponding treated seeds.

從下列先前技術文件中可知,使用吡啶噻唑化合物作為殺真菌劑為已知:The use of pyridinethiazole compounds as fungicides is known from the following prior art documents:

PCT專利公開號WO 2008013622、WO 2008013925、WO 2009094407、WO 2009094445、WO 2011076699、WO 2013037768、WO 2018/193387、WO 2019048988、WO 2019048989以及WO 2021094905揭露了此類衍生物作為殺真菌劑。PCT Patent Publication Nos. WO 2008013622, WO 2008013925, WO 2009094407, WO 2009094445, WO 2011076699, WO 2013037768, WO 2018/193387, WO 2019048988, WO 21 21 and WO 2020 have disclosed such derivatives as fungicides.

WO 2017138069、WO 2013127704、WO 200955514揭露了多種包含至少一種哌啶噻唑衍生物以及另外選擇的已知殺真菌劑之殺真菌劑混合物。WO 2017138069, WO 2013127704, WO 200955514 disclose various fungicide mixtures comprising at least one piperidinethiazole derivative and additionally selected known fungicides.

殺真菌劑的組合通常用於幫助疾病控制和延緩抗性發展。期望藉由使用可提供予植物病原體具治療性、系統性以及預防性控制的活性成分混合物來擴展活性譜 (spectrum of activity)並提高疾病控制的功效。可提供更持久的控制以允許延長噴霧間隔的組合物亦有其需求。另亦有需求的是,將用於抑制真菌病原體中不同生化途徑的殺真菌劑結合起來,以防止或延緩對任何一種特定植物病害控制劑的抗性產生。Combinations of fungicides are often used to aid disease control and delay resistance development. It would be desirable to broaden the spectrum of activity and increase the efficacy of disease control through the use of mixtures of active ingredients that can provide therapeutic, systemic and preventive control of plant pathogens. There is also a need for compositions that provide more permanent control to allow for extended spray intervals. There is also a need for combinations of fungicides that inhibit different biochemical pathways in fungal pathogens to prevent or delay the development of resistance to any one particular plant disease control agent.

能有效控制植物病原性真菌,同時減少釋放至環境中之化學製劑量的殺真菌劑也一直是有其需求的。此外,關於擴展殺真菌劑之活性譜、降低其毒性以及降低其施用率 (application rate)方面也有持續的需求。本案提供至少在某些方面實現前述目的之農業化學組成物。There is also a continuing need for fungicides that are effective in controlling phytopathogenic fungi while reducing the amount of chemical released into the environment. In addition, there is a continuing need to expand the spectrum of activity of fungicides, reduce their toxicity, and reduce their application rates. The present application provides an agricultural chemical composition that achieves the foregoing objectives at least in some aspects.

令人驚訝的是,申請人發現使用本案之新穎農業化學組成物不僅對欲控制的植物病原體的活性譜 (spectrum of action)具有原則上可以預期的額外增強效果 (additive enhancement),且還進一步產生了協同作用 (synergistic effect)。本案之新穎農業化學組成物的協同作用有助於在保持有效性的前提下,減少組分 (1)和組分 (2)的施用率,即便是此兩種化合物在如此低的施用率下單獨使用時其有效性將降低或甚至無效。此外,本案之新穎農業化學組成物亦實質地拓寬了可被控制的植物病原體譜 (spectrum of phytopathogens),且同時提高了使用的安全性。Surprisingly, the applicant found that the use of the novel agricultural chemical composition of the present application not only has an expected additional enhancement effect (additive enhancement) on the spectrum of action of the phytopathogen to be controlled in principle, but also further produces synergistic effect. The synergistic effect of the novel agrochemical composition of this case helps to reduce the application rate of components (1) and (2) while maintaining effectiveness, even when the two compounds are applied at such low rates It will be less effective or even ineffective when used alone. In addition, the novel agricultural chemical composition of this case also substantially broadens the spectrum of phytopathogens that can be controlled, and at the same time improves the safety of use.

除了殺真菌及/或殺線蟲及/或殺昆蟲的協同活性外,本案的農業化學組成物還具有其他令人驚訝的特性,在更廣泛的意義上,這些特性也可以稱為協同作用,舉例而言如:擴大活性譜至其他昆蟲、線蟲及/或植物病原體,例如植物病害之抗性菌株;減少活性化合物的施用率;藉由本案之農業化學組成物,即使在單個化合物會顯示出低活性或幾乎沒有活性的施用率下也能充分控制害蟲;在配製或使用的過程中,例如在研磨、篩分、乳化、溶解或分散的過程中,具有較佳的行為;改善其儲存穩定性以及光穩定性;形成有益殘餘物;改善其毒理學上或生態毒理學上之行為;改善所謂植物生理效應 (plant physiological effect)的特性,例如更好的生長、產量的增加、具有更發達的根系、更大的葉面積、更綠的葉子、更強壯的枝條、更少的種子需求量、更好的植物相容性以及可啟動植物之防禦系統。In addition to the synergistic fungicidal and/or nematicidal and/or insecticidal activity, the agrochemical composition of the present case has other surprising properties which may also be termed synergistic in a wider sense, e.g. For example: expanding the activity spectrum to other insects, nematodes and/or plant pathogens, such as resistant strains of plant diseases; reducing the application rate of active compounds; Adequate pest control at active or barely active application rates; better behavior during formulation or use, e.g. grinding, sieving, emulsifying, dissolving or dispersing; improved storage stability and photostability; formation of beneficial residues; improvement of its toxicological or ecotoxicological behavior; improvement of characteristics of so-called plant physiological effects, such as better growth, increased yield, more Developed root system, larger leaf area, greener leaves, stronger shoots, less seed requirement, better plant compatibility and activated plant defense system.

因此,使用本案之新穎農業化學組成物顯著地有助於保持穀物幼苗的健康,這增加了,舉例而言,經處理過的穀物種子的冬季存活率 (winter survival)並且還保證了其品質以及產量。Therefore, the use of the novel agrochemical composition of the present case contributes significantly to maintaining the health of cereal seedlings, which increases, for example, the winter survival rate (winter survival) of treated cereal seeds and also ensures their quality and Yield.

再者,本案之新穎農業化學組成物可有助於增強內吸作用 (systemic action)。即使組合物中的單個化合物不具有足夠的內吸性,本案之新穎農業化學組成物仍可具有該特性。以類似的方式,本案之新穎農業化學組成物可使其殺真菌及/或殺昆蟲及/或殺線蟲的作用具有更持久的效力。Furthermore, the novel agricultural chemical composition of this case can help to enhance systemic action. Even if the individual compounds in the composition do not have sufficient systemic properties, the novel agrochemical compositions of the present invention can still have this property. In a similar manner, the novel agrochemical compositions of the present invention allow their fungicidal and/or insecticidal and/or nematicidal effects to be more durable.

據此,本案提供了一種新的農業化學組成物,其包含:Accordingly, this case provides a new agricultural chemical composition comprising:

至少一種如式 (I)所示之化合物作為組分 (1),

Figure 02_image001
式 (I) 其中, R 1選自鹵素、腈基、C 1-C 6烷基、C 1-C 6鹵烷基、C 1-C 6烷氧基、C 1-C 6烷硫基以及C 3-C 6環烷基; A係C或N,但不超過兩個A同時為N; G係C(R ) 2或O; 其中R 選自氫、鹵素以及C 1-C 3烷基; R 2選自氫、鹵素、腈基、C 1-C 6烷基、C 1-C 6鹵烷基、C 1-C 6烷氧基、C 3-C 6環烷基以及C 1-C 6烷基磺醯氧基 (alkylsulfonyloxy); n係0-3的整數; 及其鹽類、N-氧化物、金屬錯合物或立體異構物; 以及至少一種殺真菌活性化合物 (II)以及/或至少一種殺蟲或殺線蟲活性化合物 (III)作為組分 (2);其中 該至少一種殺真菌活性化合物 (II)選自以下組合: (II-A) 甾醇生物合成的抑制劑; (II-B) 呼吸鏈複合物I (complex I)或複合物II (complex II)的抑制劑; (II-C) 呼吸鏈複合物III (complex III)的抑制劑; (II-D) 有絲分裂和細胞分裂的抑制劑; (II-E) 可具有多位點作用 (multisite action)的化合物; (II-F) 可誘發宿主防禦之化合物; (II-G) 胺基酸及/或蛋白質生物合成之抑制劑; (II-H) 三磷酸腺苷 (adenosine triphosphate, ATP)產生之抑制劑; (II-I) 細胞壁合成之抑制劑; (II-J) 脂質和膜合成之抑制劑; (II-K) 黑色素 (melanine)生物合成的抑制劑; (II-L) 核酸合成之抑制劑; (II-M) 訊息傳遞之抑制劑; (II-N) 可作為去耦合劑 (uncoupler)之化合物; (II-O) 其他殺真菌劑; (II-P) 組織蛋白去乙醯酶 (Histone deacetylase, HDAC)抑制劑; (II-Q) 可作為保護劑 (safener)的化合物;或 (II-R) 生物殺真菌劑;及/或 該至少一種殺蟲或殺線蟲活性化合物 (III)選自以下組合: (III-A) 乙醯膽鹼酯酶 (Acetylcholinesterase, AChE)抑制劑; (III-B) γ-胺基丁酸閘控氯離子通道阻斷劑 (GABA-gated chloride channel blocker); (III-C) 鈉通道調節劑; (III-D) 菸鹼乙醯膽鹼受體 (Nicotinic acetylcholine receptor, nAChR)競爭性調節劑; (III-E) 菸鹼乙醯膽鹼受體異位調節劑 (allosteric modulator)-位點I; (III-F) 麩胺酸閘控氯通道 (Glutamate-gated chloride channel, GluCl)異位調節劑; (III-G) 青春激素模擬物 (Juvenile hormone mimics); (III-H) 多重非特異性(多位點)抑制劑 (Miscellaneous non-specific (multi-site) inhibitors); (III-I) 弦音器官 (chordotonal organ) TRPV (transient receptor potential)通道調節劑; (III-J) 影響幾丁質合成酶 (chitin synthase 1, CHS1)的蟎生長抑制劑; (III-K) 昆蟲中腸 (midgut)膜的微生物干擾劑; (III-L) 粒線體ATP合成酶之抑制劑; (III-M) 藉由干擾質子梯度而作用之氧化磷酸化 (oxidative phosphorylation)去耦合劑; (III-N) 菸鹼乙醯膽鹼受體 (nAChR)通道阻斷劑; (III-O) 影響CHS1的幾丁質生物合成抑制劑; (III-P) 第1型之幾丁質生物合成抑制劑; (III-Q) 蛻皮干擾劑 (moulting disruptor); (III-R) 蛻皮素 (ecdysone)受體促效劑 (agonists); (III-S) 奧克巴胺 (octopamine)受體促效劑; (III-T) 粒線體複合物III電子傳遞抑制劑; (III-U) 粒線體複合物I電子傳遞抑制劑; (III-V) 電壓依賴性之鈉通道阻斷劑; (III-W) 乙醯輔酶A羧化酶 (acetyl CoA carboxylase)抑制劑; (III-X) 粒線體複合物IV電子傳遞抑制劑; (III-Y) 粒線體複合物II電子傳遞抑制劑; (III-Z) 雷若丁 (Ryanodine)受體調節劑; (III-AA) 弦音器官調節劑; (III-BB) γ-胺基丁酸閘控 (GABA-gated)氯離子通道異位調節劑; (III-CC) 桿狀病毒 (baculoviruses); (III-DD) 菸鹼乙醯膽鹼受體異位調節劑-位點II; (III-EE) 作用方式未知或不確定之殺蟲活性化合物; (III-FF) 生物性殺蟲劑;或 (III-GG) 具有殺蟲、殺蟎、殺軟體動物 (molluscidal)、費洛蒙 (pheromone)及/或殺線蟲活性的生化殺害蟲劑。 At least one compound shown in formula (I) as component (1),
Figure 02_image001
Formula (I) wherein, R 1 is selected from halogen, nitrile, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 alkoxy, C 1 -C 6 alkylthio and C 3 -C 6 cycloalkyl; A is C or N, but no more than two A are N at the same time; G is C(R ' ) 2 or O; wherein R ' is selected from hydrogen, halogen and C 1 -C 3 Alkyl; R 2 is selected from hydrogen, halogen, nitrile, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 alkoxy, C 3 -C 6 cycloalkyl and C 1 -C 6 alkylsulfonyloxy (alkylsulfonyloxy); n is an integer of 0-3; and its salts, N-oxides, metal complexes or stereoisomers; and at least one fungicidally active compound ( II) and/or at least one insecticidally or nematicidally active compound (III) as component (2); wherein the at least one fungicidally active compound (II) is selected from the following combinations: (II-A) Inhibition of sterol biosynthesis (II-B) inhibitor of respiratory chain complex I (complex I) or complex II (complex II); (II-C) inhibitor of respiratory chain complex III (complex III); (II-D ) inhibitors of mitosis and cell division; (II-E) compounds capable of multisite action; (II-F) compounds capable of inducing host defense; (II-G) amino acids and/or Inhibitors of protein biosynthesis; (II-H) inhibitors of adenosine triphosphate (ATP) production; (II-I) inhibitors of cell wall synthesis; (II-J) inhibitors of lipid and membrane synthesis; -K) Inhibitors of melanine biosynthesis; (II-L) Inhibitors of nucleic acid synthesis; (II-M) Inhibitors of message transmission; (II-N) Compounds that can be used as uncouplers (II-O) other fungicides; (II-P) tissue protein deacetylase (Histone deacetylase, HDAC) inhibitors; (II-Q) compounds that can be used as protective agents (safener); or (II- R) biological fungicides; and/or the at least one insecticidal or nematicidal active compound (III) is selected from the following combinations: (III-A) acetylcholinesterase (Acetylcholinesterase, AChE) inhibitors; (III- B) GABA-gated chloride channel blocker; (III-C) Sodium channel modulator (III-D) Nicotinic acetylcholine receptor (nAChR) competitive modulator; (III-E) Nicotinic acetylcholine receptor allosteric modulator (allosteric modulator)-site I; (III-F) Glutamate-gated chloride channel (GluCl) ectopic modulator; (III-G) Juvenile hormone mimics; (III-H) Multiple non- Specific (multi-site) inhibitors (Miscellaneous non-specific (multi-site) inhibitors); (III-I) TRPV (transient receptor potential) channel modulator of chordotonal organ; (III-J) affect several Mite growth inhibitor of chitin synthase 1 (CHS1); (III-K) Microbial disruptor of insect midgut membrane; (III-L) Inhibitor of mitochondrial ATP synthase; ( III-M) oxidative phosphorylation (oxidative phosphorylation) decouplers acting by interfering with the proton gradient; (III-N) nicotinic acetylcholine receptor (nAChR) channel blockers; (III-O) effects Chitin biosynthesis inhibitor of CHS1; (III-P) chitin biosynthesis inhibitor of type 1; (III-Q) moulting disruptor; (III-R) ecdysone Receptor agonists; (III-S) octopamine receptor agonists; (III-T) mitochondrial complex III electron transport inhibitors; (III-U) mitochondria (III-V) voltage-dependent sodium channel blocker; (III-W) acetyl CoA carboxylase (acetyl CoA carboxylase) inhibitor; (III-X) particle Mitochondrial Complex IV Electron Transport Inhibitor; (III-Y) Mitochondrial Complex II Electron Transport Inhibitor; (III-Z) Rianodine Receptor Modulator; (III-AA) Chord Organ Regulation (III-BB) GABA-gated chloride channel ectopic modulator; (III-CC) baculoviruses ); (III-DD) Nicotinic acetylcholine receptor ectopic modulator-site II; (III-EE) Insecticidally active compounds with unknown or uncertain mode of action; (III-FF) Biological insecticides or (III-GG) A biochemical insecticide having insecticidal, acaricidal, molluscidal, pheromone and/or nematicidal activity.

在一實施例中,本案提供了一種控制非所欲(或有害)之微生物的方法,例如非所欲之真菌和細菌及/或害蟲和蟎蟲,其包括將至少一種本案之新穎農業化學組成物施用於微生物及/或其棲息地(施用於植物、植物的部分、種子、果實或植物生長的土壤)的步驟。In one embodiment, the present invention provides a method of controlling unwanted (or harmful) microorganisms, such as unwanted fungi and bacteria and/or pests and mites, comprising at least one novel agricultural chemical composition of the present invention Step of application to microorganisms and/or their habitat (application to plants, plant parts, seeds, fruits or soil in which plants grow).

定義:definition:

在上式給出之符號的定義中,使用了通常代表以下取代基的集合術語 (collective terms):In the definitions of the symbols given in the above formulas, collective terms are used which generally represent the following substituents:

氫:較佳地,氫的定義還包括氫的同位素,較佳為氘和氚,更佳地為氘。Hydrogen: Preferably, the definition of hydrogen also includes isotopes of hydrogen, preferably deuterium and tritium, more preferably deuterium.

鹵素:(亦可以存在於例如鹵烷基、鹵代烷氧基等組合中之鹵素)氟、氯、溴以及碘,較佳為氟、氯、溴,更佳為氟、氯;Halogen: (halogen that can also exist in combinations such as haloalkyl, haloalkoxy, etc.) fluorine, chlorine, bromine and iodine, preferably fluorine, chlorine, bromine, more preferably fluorine, chlorine;

烷基:(包括存在於如烷硫基、烷氧基等中之烷基)具有1至6個碳原子的飽和、直鏈或支鏈烴基,例如C 1-C 6烷基,例如甲基、乙基、丙基、1-甲基乙基、丁基、1-甲基丙基、2-甲基丙基、1,1-二甲基乙基、戊基、1-甲基丁基、2-甲基丁基、3-甲基丁基、2,2-二甲基丙基、1-乙基丙基、己基、1,1-二甲基丙基、1,2-二甲基丙基、1-甲基戊基、2-甲基戊基、3-甲基戊基、4-甲基戊基、1,1-二甲基丁基、1,2-二甲基丁基、1,3-二甲基丁基、2,2-二甲基丁基、2,3-二甲基丁基、3,3-二甲基丁基、1-乙基丁基、2-乙基丁基、1,1,2-三甲基丙基、1,2,2-三甲基丙基、l-乙基-1-甲基丙基、1乙基-2-甲基丙基、庚基和辛基。如果烷基在複合取代基的末端,例如在烷基環烷基中,則複合取代基的起始部分,例如環烷基,可以被單一烷基取代或是被多個相同或不同且獨立的烷基進行多取代。 Alkyl: (including those present in e.g. alkylthio, alkoxy, etc.) saturated, straight-chain or branched hydrocarbon groups having 1 to 6 carbon atoms, e.g. C 1 -C 6 alkyl, e.g. methyl , ethyl, propyl, 1-methylethyl, butyl, 1-methylpropyl, 2-methylpropyl, 1,1-dimethylethyl, pentyl, 1-methylbutyl , 2-methylbutyl, 3-methylbutyl, 2,2-dimethylpropyl, 1-ethylpropyl, hexyl, 1,1-dimethylpropyl, 1,2-dimethyl propyl, 1-methylpentyl, 2-methylpentyl, 3-methylpentyl, 4-methylpentyl, 1,1-dimethylbutyl, 1,2-dimethylbutyl base, 1,3-dimethylbutyl, 2,2-dimethylbutyl, 2,3-dimethylbutyl, 3,3-dimethylbutyl, 1-ethylbutyl, 2 -Ethylbutyl, 1,1,2-trimethylpropyl, 1,2,2-trimethylpropyl, l-ethyl-1-methylpropyl, 1ethyl-2-methyl Propyl, Heptyl and Octyl. If the alkyl group is at the end of a composite substituent, such as in an alkylcycloalkyl group, the initial part of the composite substituent, such as a cycloalkyl group, may be substituted by a single alkyl group or by multiple identical or different independent Alkyl groups undergo multiple substitutions.

鹵烷基:(包括存在於如鹵代烷硫基 (haloalkylthio)、鹵代烷氧基 (haloalkoxy)等中之鹵烷基)具有1至6個碳原子的直鏈或支鏈烷基(如上所述),其中這些基團中的一些或全部氫原子可以被前述的鹵原子取代。舉例而言,C 1-C 3鹵烷基可例如為氯甲基、溴甲基、二氯甲基、三氯甲基、氟甲基、二氟甲基、三氟甲基、氯氟甲基、二氯氟甲基、氯二氟甲基、1-氯乙基、1-溴乙基、1-氟乙基、2-氟乙基、2,2-二氟乙基、2,2,2-三氟乙基、2-氯-2-氟乙基、2-氯-2-二氟乙基、2,2-二氯-2-氟乙基、2,2,2-三氯乙基、五氟乙基以及1,1,1-三氟丙-2-基。 Haloalkyl: (including those present in e.g. haloalkylthio, haloalkoxy, etc.) straight-chain or branched-chain alkyl groups (as described above) having 1 to 6 carbon atoms, Some or all of the hydrogen atoms in these groups may be replaced by the aforementioned halogen atoms. For example, C 1 -C 3 haloalkyl can be, for example, chloromethyl, bromomethyl, dichloromethyl, trichloromethyl, fluoromethyl, difluoromethyl, trifluoromethyl, chlorofluoromethyl base, dichlorofluoromethyl, chlorodifluoromethyl, 1-chloroethyl, 1-bromoethyl, 1-fluoroethyl, 2-fluoroethyl, 2,2-difluoroethyl, 2,2 ,2-trifluoroethyl, 2-chloro-2-fluoroethyl, 2-chloro-2-difluoroethyl, 2,2-dichloro-2-fluoroethyl, 2,2,2-trichloro Ethyl, pentafluoroethyl and 1,1,1-trifluoropropan-2-yl.

鹵甲基:在一甲基中的部分或全部氫原子可以被前述的鹵原子取代,例如(但不限於)氯甲基、溴甲基、二氯甲基、三氯甲基、氟甲基、二氟甲基、三氟甲基、氯氟甲基、二氯氟甲基、氯二氟甲基;且較佳為三氟甲基。Halomethyl: some or all of the hydrogen atoms in a methyl group can be replaced by the aforementioned halogen atoms, such as (but not limited to) chloromethyl, bromomethyl, dichloromethyl, trichloromethyl, fluoromethyl , difluoromethyl, trifluoromethyl, chlorofluoromethyl, dichlorofluoromethyl, chlorodifluoromethyl; and preferably trifluoromethyl.

術語「環烷基」是指閉合形成環的烷基。非限制性的實例包括但不限於環丙基、環戊基和環己基。該定義也適用於作為複合取代基的一部分的環烷基,例如環烷基烷基等,除非在別處有其他具體的定義。The term "cycloalkyl" refers to an alkyl group which is closed to form a ring. Non-limiting examples include, but are not limited to, cyclopropyl, cyclopentyl, and cyclohexyl. This definition also applies to cycloalkyl as part of a composite substituent, eg cycloalkylalkyl etc., unless specifically defined elsewhere.

單獨或在複合詞中使用的術語「烷氧基」包括C 1-C 6烷氧基。烷氧基的例子可包括甲氧基、乙氧基、丙氧基、1-甲基乙氧基、丁氧基、1-甲基丙氧基、2-甲基丙氧基、1,1-二甲基乙氧基、戊氧基、1-甲基丁氧基、2-甲基丁氧基、3-甲基丁氧基、2,2-二甲基丙氧基、1-乙基丙氧基、己氧基、1,1-二甲基丙氧基、1,2-二甲基丙氧基、1-甲基戊氧基、2-甲基戊氧基、3-甲基戊氧基、4-甲基戊氧基、1,1-二甲基丁氧基、1,2-二甲基丁氧基、1,3-二甲基丁氧基、2,2-二甲基丁氧基、2,3-二甲基丁氧基、3,3-二甲基丁氧基、1-乙基丁氧基、2-乙基丁氧基、1,1,2-三甲基丙氧基、1,2,2-三甲基丙氧基、1-乙基-1-甲基丙氧基以及1-乙基-2-甲基丙氧基及前述之不同的異構物。 The term "alkoxy" used alone or in compound words includes C 1 -C 6 alkoxy. Examples of alkoxy may include methoxy, ethoxy, propoxy, 1-methylethoxy, butoxy, 1-methylpropoxy, 2-methylpropoxy, 1,1 -Dimethylethoxy, pentyloxy, 1-methylbutoxy, 2-methylbutoxy, 3-methylbutoxy, 2,2-dimethylpropoxy, 1-ethyl Propyloxy, Hexyloxy, 1,1-Dimethylpropoxy, 1,2-Dimethylpropoxy, 1-Methylpentyloxy, 2-Methylpentyloxy, 3-Methylpropoxy Amylpentyloxy, 4-methylpentyloxy, 1,1-dimethylbutoxy, 1,2-dimethylbutoxy, 1,3-dimethylbutoxy, 2,2- Dimethylbutoxy, 2,3-dimethylbutoxy, 3,3-dimethylbutoxy, 1-ethylbutoxy, 2-ethylbutoxy, 1,1,2 -Trimethylpropoxy, 1,2,2-trimethylpropoxy, 1-ethyl-1-methylpropoxy and 1-ethyl-2-methylpropoxy and the differences isomers.

取決於取代基的性質,式 (I)所示之化合物可以各種可能的異構物形式的混合物存在,特別是立體異構物,例如E型和Z型異構物、蘇式 (threo)和赤式 (erythro)異構物、以及光學異構物,並且如果合適,還含有其互變異構物。如果適用,式 (I)所示之化合物同時包含E型和Z型異構物、蘇式和赤式異構物、以及光學異構物、前述此些異構物的任何混合物以及其可能的互變異構物形式。Depending on the nature of the substituents, the compounds represented by formula (I) may exist as a mixture of various possible isomeric forms, especially stereoisomers, such as E and Z isomers, threo and Erythro isomers, as well as optical isomers and, if appropriate, tautomers thereof. If applicable, the compound shown in formula (I) includes both E and Z isomers, threo and erythro isomers, and optical isomers, any mixture of the aforementioned isomers and possible combinations thereof Tautomeric forms.

取決於化合物中不對稱中心的數目,本發明的任何化合物可以一種或多種光學、幾何或掌性異構物的形式存在。因此,本發明同樣涉及所有光學異構物以及其外消旋或其非外消旋混合物(術語「非外消旋 (scalemic)」表示以不同比例的鏡像異構物所形成的混合物),以及所有可能的立體異構物之以任意比例所形成的混合物。非鏡像異構物及/或光學異構物可根據本發明所屬技術領域中具有通常知識者本身已知的方法進行分離。Any compound of the invention may exist as one or more optical, geometric or chiral isomers, depending on the number of asymmetric centers in the compound. Accordingly, the present invention also relates to all optical isomers as well as their racemic or non-racemic mixtures (the term "scalemic" means a mixture of mirror-image isomers in different proportions), and Mixtures of all possible stereoisomers in any ratio. Diastereomers and/or optical isomers can be separated according to methods known per se to those skilled in the art to which the present invention pertains.

取決於化合物中雙鍵的數目,本發明的任何化合物可以一種或多種幾何異構物的形式存在。因此,本發明也關於所有幾何異構物和所有可能的幾何異構物以任意比例所形成的混合物。立體異構物可以根據本發明所屬技術領域中具有通常知識者已知的通常方法進行分離。Any compound of the invention may exist as one or more geometric isomers, depending on the number of double bonds in the compound. The invention therefore also relates to all geometric isomers and mixtures of all possible geometric isomers in any ratio. Stereoisomers can be separated according to common methods known to those skilled in the art to which the present invention pertains.

取決於取代基的性質,式 (I)所示之化合物也可以一種或多種幾何異構物之形式存在,這取決於環B之取代基之間的相對位置(syn/anti或cis/trans)。因此,本發明同樣涉及所有的順反異構物(syn/anti或cis/trans)以及所有可能的順反異構物以任意比例所形成之混合物。順反異構物可根據本發明所屬技術領域中具有通常知識者本身已知的通常方法進行分離。Depending on the nature of the substituents, the compound represented by formula (I) can also exist in the form of one or more geometric isomers, depending on the relative position between the substituents of ring B (syn/anti or cis/trans) . Therefore, the present invention also relates to all cis-trans isomers (syn/anti or cis/trans) and mixtures of all possible cis-trans isomers in any ratio. The cis-trans isomers can be separated according to the usual methods known per se by those skilled in the art to which the present invention pertains.

無機酸的例子可以是氫鹵酸(例如氟化氫、氯化氫、溴化氫和碘化氫)、硫酸、磷酸、硝酸以及酸性鹽(例如NaHSO 4和KHSO 4)。 Examples of inorganic acids may be hydrohalic acids (such as hydrogen fluoride, hydrogen chloride, hydrogen bromide, and hydrogen iodide), sulfuric acid, phosphoric acid, nitric acid, and acidic salts (such as NaHSO 4 and KHSO 4 ).

合適的有機酸舉例而言可為甲酸、碳酸和烷酸 (alkanoic acid)(例如醋酸、三氟乙酸、三氯乙酸和丙酸),以及乙醇酸 (glycolic acid)、硫氰酸 (thiocyanic acid)、乳酸、琥珀酸 (succinic acid)、檸檬酸、苯甲酸、肉桂酸 (cinnamic acid)、草酸、烷基磺酸(alkylsulfonic acids,具有1至20個碳原子的直鏈或支鏈烷基的磺酸)、芳基磺酸 (arylsulfonic acids) 或芳基二磺酸(芳基(如苯基和萘基)上帶有一或兩個磺酸基團)、烷基膦酸(alkylphosphonic acids,具有1至20個碳原子的直鏈或支鏈烷基的膦酸)、芳基膦酸 (arylphosphonic acids)或芳基二膦酸(芳基(例如苯基和萘基)上帶有一個或兩個膦酸基團),其中烷基和芳基可帶有進一步的取代基,例如對甲苯磺酸 (p-toluenesulfonic acid)、水楊酸 (salicylic acid)、對胺基水楊酸 (p-aminosalicylic acid)、2-苯氧基苯甲酸、2-乙醯氧基苯甲酸等。Suitable organic acids may be exemplified by formic, carbonic and alkanoic acids such as acetic, trifluoroacetic, trichloroacetic and propionic acids, as well as glycolic acid, thiocyanic acid , lactic acid, succinic acid (succinic acid), citric acid, benzoic acid, cinnamic acid (cinnamic acid), oxalic acid, alkylsulfonic acids (alkylsulfonic acids, with 1 to 20 carbon atoms straight-chain or branched-chain alkyl sulfonate acids), arylsulfonic acids or aryldisulfonic acids (aryl groups such as phenyl and naphthyl with one or two sulfonic acid groups), alkylphosphonic acids (with 1 straight-chain or branched-chain alkyl phosphonic acids of up to 20 carbon atoms), arylphosphonic acids, or aryldiphosphonic acids (aryl (such as phenyl and naphthyl) with one or two phosphonic acid groups), where the alkyl and aryl groups may carry further substituents, such as p-toluenesulfonic acid, salicylic acid, p-aminosalicylic acid acid), 2-phenoxybenzoic acid, 2-acetyloxybenzoic acid, etc.

然而,以上以概括性術語所給出或在較佳範圍內陳述的基本定義和解釋也可以根據需要彼此組合,亦即包含在特定給出的範圍以及較佳範圍之間的組合。此些定義既適用於最終產物,也適用於前趨物 (precursors)和中間產物 (intermediates)。此外,個別定義可能不適用。However, the basic definitions and explanations given above in general terms or stated within preferred ranges can also be combined with each other as desired, ie combinations between specifically stated ranges and preferred ranges are included. These definitions apply both to final products and to precursors and intermediates. Furthermore, individual definitions may not apply.

在一個實施例中,本案提供了一種新的農業化學組成物,其包含組分 (1)作為至少一種如式 (I)所示的化合物,

Figure 02_image001
式 (I) 其中, R 1選自鹵素、腈基、C 1-C 6烷基、C 1-C 6鹵烷基、C 1-C 6烷氧基、C 1-C 6烷硫基以及C 3-C 6環烷基; A係C或N,但不超過兩個A同時為N; G係C(R ) 2或O; 其中R 選自氫、鹵素以及C 1-C 3烷基; R 2選自氫、鹵素、腈基、C 1-C 6烷基、C 1-C 6鹵烷基、C 1-C 6烷氧基、C 3-C 6環烷基以及C 1-C 6烷基磺醯氧基 (alkylsulfonyloxy); n是0-3的整數; 及其鹽類、N-氧化物、金屬錯合物或立體異構物;以及 至少一種殺真菌活性化合物 (II)及/或至少一種殺蟲或殺線蟲活性化合物 (III)作為組分 (2);其中 該至少一種殺真菌活性化合物 (II)選自以下組合: (II-A) 甾醇合成的抑制劑; (II-B) 呼吸鏈複合物I (complex I)或複合物II (complex II)的抑制劑; (II-C) 呼吸鏈複合物III (complex III)的抑制劑; (II-D) 有絲分裂和細胞分裂的抑制劑; (II-E) 可具有多位點作用 (multisite action)的化合物; (II-F) 可誘發宿主防禦之化合物; (II-G) 胺基酸及/或蛋白質生物合成之抑制劑; (II-H) 三磷酸腺苷 (adenosine triphosphate, ATP)產生之抑制劑; (II-I) 細胞壁合成之抑制劑; (II-J) 脂質和膜合成之抑制劑; (II-K) 黑色素 (melanine)生物合成的抑制劑; (II-L) 核酸合成之抑制劑; (II-M) 訊息傳遞之抑制劑; (II-N) 可作為去耦合劑 (uncoupler)之化合物; (II-O) 其他殺真菌劑; (II-P) 組織蛋白去乙醯酶 (Histone deacetylase, HDAC)抑制劑; (II-Q) 可作為保護劑 (safener)的化合物;或 (II-R) 生物殺真菌劑;及/或 該至少一種殺蟲或殺線蟲活性化合物 (III)選自以下組合: (III-A) 乙醯膽鹼酯酶 (Acetylcholinesterase, AChE)抑制劑; (III-B) γ-胺基丁酸閘控氯離子通道阻斷劑 (GABA-gated chloride channel blocker); (III-C) 鈉通道調節劑; (III-D) 菸鹼乙醯膽鹼受體 (Nicotinic acetylcholine receptor, nAChR)競爭性調節劑; (III-E) 菸鹼乙醯膽鹼受體異位調節劑 (allosteric modulator)-位點I; (III-F) 麩胺酸閘控氯通道 (Glutamate-gated chloride channel, GluCl)異位調節劑; (III-G) 青春激素模擬物 (Juvenile hormone mimics); (III-H) 多重非特異性(多位點)抑制劑 (Miscellaneous non-specific (multi-site) inhibitors); (III-I) 弦音器官 (chordotonal organ) TRPV通道調節劑; (III-J) 影響幾丁質合成酶 (chitin synthase 1, CHS1)的蟎生長抑制劑; (III-K) 昆蟲中腸 (midgut)膜的微生物干擾劑; (III-L) 粒線體ATP合成酶之抑制劑; (III-M) 藉由干擾質子梯度而作用之氧化磷酸化 (oxidative phosphorylation)去耦合劑; (III-N) 菸鹼乙醯膽鹼受體 (nAChR)通道阻斷劑; (III-O) 影響CHS1的幾丁質生物合成抑制劑; (III-P) 第1型之幾丁質生物合成抑制劑; (III-Q) 蛻皮干擾劑 (moulting disruptor); (III-R) 蛻皮素 (ecdysone)受體促效劑 (agonists); (III-S) 奧克巴胺 (octopamine)受體促效劑; (III-T) 粒線體複合物III電子傳遞抑制劑; (III-U) 粒線體複合物I電子傳遞抑制劑; (III-V) 電壓依賴性之鈉通道阻斷劑; (III-W) 乙醯輔酶A羧化酶 (acetyl CoA carboxylase)抑制劑; (III-X) 粒線體複合物IV電子傳遞抑制劑; (III-Y) 粒線體複合物II電子傳遞抑制劑; (III-Z) 雷若丁 (Ryanodine)受體調節劑; (III-AA) 弦音器官調節劑-未定義的目標位點 (undefined target site); (III-BB) γ-胺基丁酸閘控氯離子通道異位調節劑; (III-CC) 桿狀病毒 (baculoviruses); (III-DD) 菸鹼乙醯膽鹼受體異位調節劑-位點II; (III-EE) 作用方式未知或不確定之殺蟲活性化合物; (III-FF) 生物性殺蟲劑;或 (III-GG) 具有殺蟲、殺蟎、殺軟體動物 (molluscidal)、費洛蒙 (pheromone)及/或殺線蟲活性的生化殺害蟲劑。 In one embodiment, the present application provides a novel agricultural chemical composition comprising component (1) as at least one compound represented by formula (I),
Figure 02_image001
Formula (I) wherein, R 1 is selected from halogen, nitrile, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 alkoxy, C 1 -C 6 alkylthio and C 3 -C 6 cycloalkyl; A is C or N, but no more than two A are N at the same time; G is C(R ' ) 2 or O; wherein R ' is selected from hydrogen, halogen and C 1 -C 3 Alkyl; R 2 is selected from hydrogen, halogen, nitrile, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 alkoxy, C 3 -C 6 cycloalkyl and C 1 -C 6 alkylsulfonyloxy (alkylsulfonyloxy); n is an integer of 0-3; and its salts, N-oxides, metal complexes or stereoisomers; and at least one fungicidally active compound ( II) and/or at least one insecticidally or nematicidally active compound (III) as component (2); wherein the at least one fungicidally active compound (II) is selected from the following combinations: (II-A) Inhibitors of sterol synthesis (II-B) inhibitors of respiratory chain complex I (complex I) or complex II (complex II); (II-C) inhibitors of respiratory chain complex III (complex III); (II-D) Inhibitors of mitosis and cell division; (II-E) Compounds capable of multisite action; (II-F) Compounds capable of inducing host defense; (II-G) Amino acids and/or proteins Inhibitors of biosynthesis; (II-H) Inhibitors of adenosine triphosphate (ATP) production; (II-I) Inhibitors of cell wall synthesis; (II-J) Inhibitors of lipid and membrane synthesis; (II- K) Inhibitors of melanine biosynthesis; (II-L) Inhibitors of nucleic acid synthesis; (II-M) Inhibitors of message transmission; (II-N) Compounds that can be used as uncouplers; (II-O) Other fungicides; (II-P) Histone deacetylase (HDAC) inhibitors; (II-Q) Compounds that can act as safeners; or (II-R ) biological fungicides; and/or the at least one insecticidal or nematicide active compound (III) is selected from the following combinations: (III-A) acetylcholinesterase (Acetylcholinesterase, AChE) inhibitors; (III-B ) gamma-aminobutyric acid gated chloride channel blocker (GABA-gated chloride channel blocker); (III-C) sodium channel modulator; (I II-D) Nicotinic acetylcholine receptor (nAChR) competitive modulator; (III-E) Nicotinic acetylcholine receptor allosteric modulator (allosteric modulator) - site I; (III-F) Glutamate-gated chloride channel (GluCl) ectopic modulator; (III-G) Juvenile hormone mimics; (III-H) Multiple nonspecific (Multi-site) inhibitors (Miscellaneous non-specific (multi-site) inhibitors); (III-I) TRPV channel modulator of chordotonal organ; (III-J) Affect chitin synthase (chitin synthase 1, mite growth inhibitor of CHS1); (III-K) microbial disruptor of insect midgut membrane; (III-L) inhibitor of mitochondrial ATP synthase; (III-M) by interference Oxidative phosphorylation decoupler acting on proton gradient; (III-N) nicotinic acetylcholine receptor (nAChR) channel blocker; (III-O) affecting chitin biosynthesis of CHS1 Inhibitors; (III-P) type 1 chitin biosynthesis inhibitors; (III-Q) moulting disruptors; (III-R) ecdysone receptor agonists ); (III-S) octopamine receptor agonist; (III-T) mitochondrial complex III electron transport inhibitor; (III-U) mitochondrial complex I electron transport inhibitor (III-V) voltage-dependent sodium channel blockers; (III-W) acetyl CoA carboxylase inhibitors; (III-X) mitochondrial complex IV electron transport Inhibitor; (III-Y) Mitochondrial Complex II Electron Transport Inhibitor; (III-Z) Ryanodine Receptor Modulator; (III-AA) Chord Organ Modulator - Undefined Target Site (undefined target site); (III-BB) gamma-aminobutyric acid-gated chloride channel ectopic modulator; (III-CC) baculoviruses; (III-DD) nicotine B Acylcholine receptor ectopic modulator-site II; (III-EE) insecticidally active compound with unknown or uncertain mode of action; (III-FF) biological insecticide; or (III-GG) Biochemical insecticides with insecticidal, acaricidal, molluscidal, pheromone and/or nematicidal activity.

在一實施例中,本案的農業化學組成物包含至少一種選自下述各組的殺真菌活性化合物 (II)作為一組分 (2): (II-A) 甾醇生物合成的抑制劑; (II-B) 呼吸鏈複合物I (complex I)或複合物II (complex II)的抑制劑; (II-C) 呼吸鏈複合物III (complex III)的抑制劑; (II-D) 有絲分裂和細胞分裂的抑制劑; (II-E) 可具有多位點作用的化合物; (II-I) 細胞壁合成之抑制劑; (II-J) 脂質和膜合成之抑制劑; (II-L) 核酸合成抑制劑; (II-N) 能夠作為去耦合劑的化合物,(II-O) 其他殺真菌劑; (II-P) 組織蛋白去乙醯酶 (HDAC)抑制劑; (II-Q) 可作為保護劑的化合物;或 (II-R) 生物殺真菌劑。 In one embodiment, the agricultural chemical composition of the present invention comprises at least one fungicidally active compound (II) selected from the following groups as a component (2): (II-A) Inhibitors of sterol biosynthesis; (II-B) Inhibitors of respiratory chain complex I (complex I) or complex II (complex II); (II-C) Inhibitors of respiratory chain complex III (complex III); (II-D) Inhibitors of mitosis and cell division; (II-E) Compounds that may have multiple sites of action; (II-I) Inhibitors of cell wall synthesis; (II-J) Inhibitors of lipid and membrane synthesis; (II-L) Nucleic acid synthesis inhibitors; (II-N) compounds capable of acting as decoupling agents, (II-O) other fungicides; (II-P) Histone deacetylase (HDAC) inhibitors; (II-Q) Compounds that can act as protective agents; or (II-R) Biofungicides.

在一較佳實施例中,本案的農業化學組成物包含至少一種選自下述各組的殺真菌活性化合物 (II) 作為一組分 (2): (II-A) 甾醇生物合成的抑制劑; (II-B) 呼吸鏈複合物I (complex I)或複合物II (complex II)的抑制劑; (II-C) 呼吸鏈複合物III (complex III)的抑制劑; (II-D) 有絲分裂和細胞分裂的抑制劑; (II-E) 可具有多位點作用的化合物; (II-I) 細胞壁合成之抑制劑; (II-J) 脂質和膜合成之抑制劑; (II-L) 核酸合成之抑制劑; (II-N) 可作為去耦合劑之化合物; (II-O) 其他殺真菌劑; (II-P) 組織蛋白去乙醯酶 (HDAC)抑制劑;或 (II-R) 生物殺真菌劑。 In a preferred embodiment, the agricultural chemical composition of the present invention comprises at least one fungicidally active compound (II) selected from the following groups as a component (2): (II-A) Inhibitors of sterol biosynthesis; (II-B) Inhibitors of respiratory chain complex I (complex I) or complex II (complex II); (II-C) Inhibitors of respiratory chain complex III (complex III); (II-D) Inhibitors of mitosis and cell division; (II-E) Compounds that may have multiple sites of action; (II-I) Inhibitors of cell wall synthesis; (II-J) Inhibitors of lipid and membrane synthesis; (II-L) Inhibitors of nucleic acid synthesis; (II-N) Compounds that can be used as decoupling agents; (II-O) Other fungicides; (II-P) Histone deacetylase (HDAC) inhibitors; or (II-R) Biofungicides.

在一較佳實施例中,本案的農業化學組成物包含至少一種選自下述各組的殺真菌活性化合物 (II)作為一組分 (2): (II-A) 甾醇生物合成的抑制劑; (II-B) 呼吸鏈複合物I (complex I)或複合物II (complex II)的抑制劑; (II-C) 呼吸鏈複合物III (complex III)的抑制劑; (II-D) 有絲分裂和細胞分裂的抑制劑; (II-E) 可具有多位點作用的化合物; (II-I) 細胞壁合成之抑制劑; (II-J) 脂質和膜合成之抑制劑; (II-L) 核酸合成之抑制劑; (II-N) 可作為去耦合劑之化合物;或 (II-O) 其他殺真菌劑。 In a preferred embodiment, the agricultural chemical composition of the present case comprises at least one fungicidally active compound (II) selected from the following groups as a component (2): (II-A) Inhibitors of sterol biosynthesis; (II-B) Inhibitors of respiratory chain complex I (complex I) or complex II (complex II); (II-C) Inhibitors of respiratory chain complex III (complex III); (II-D) Inhibitors of mitosis and cell division; (II-E) Compounds that may have multiple sites of action; (II-I) Inhibitors of cell wall synthesis; (II-J) Inhibitors of lipid and membrane synthesis; (II-L) Inhibitors of nucleic acid synthesis; (II-N) Compounds that can act as decoupling agents; or (II-O) Other fungicides.

在一較佳實施例中,本案的農業化學組成物包含至少一種選自下述各組的殺真菌活性化合物 (III)作為一組分 (2): (III-B) γ-胺基丁酸閘控氯離子通道阻斷劑; (III-C) 鈉通道調節劑; (III-D) 菸鹼乙醯膽鹼受體 (nAChR)競爭性調節劑; (III-E) 菸鹼乙醯膽鹼受體異位調節劑-位點I; (III-F) 麩胺酸閘控氯通道 (GluCl)異位調節劑; (III-G) 青春激素模擬物; (III-I) 弦音器官TRPV通道調節劑; (III-K) 昆蟲中腸膜的微生物干擾劑; (III-M) 藉由干擾質子梯度而作用之氧化磷酸化去耦合劑; (III-V) 電壓依賴性之鈉通道阻斷劑; (III-Z) 雷若丁 (Ryanodine)受體調節劑; (III-BB) γ-胺基丁酸閘控氯離子通道異位調節劑;或 (III-EE) 作用方式未知或不確定之殺蟲活性化合物。 In a preferred embodiment, the agricultural chemical composition of the present case comprises at least one fungicidally active compound (III) selected from the following groups as a component (2): (III-B) GABA-gated chloride channel blockers; (III-C) Sodium channel modulators; (III-D) Nicotinic acetylcholine receptor (nAChR) competitive modulators; (III-E) Nicotinic acetylcholine receptor ectopic modulator-site I; (III-F) Glutamine-gated chloride channel (GluCl) ectopic modulator; (III-G) Mimetics of youth hormones; (III-I) string organ TRPV channel modulator; (III-K) Microbial disruptors of insect midgut membranes; (III-M) Oxidative phosphorylation decouplers that act by interfering with the proton gradient; (III-V) Voltage-dependent sodium channel blockers; (III-Z) Ryanodine receptor modulators; (III-BB) GABA-gated chloride channel ectopic modulators; or (III-EE) Pesticidally active compounds with unknown or uncertain mode of action.

在一更佳實施例中,本案的新穎農業化學組成物包含至少一種選自以下組的殺蟲或殺線蟲活性化合物 (III)作為一組分 (2): (III-B) γ-胺基丁酸閘控氯離子通道阻斷劑; (III-D) 菸鹼乙醯膽鹼受體 (nAChR)競爭性調節劑;以及 (III-Z) 雷若丁受體調節劑。 In a more preferred embodiment, the novel agricultural chemical composition of the present case comprises at least one insecticidal or nematicidal active compound (III) selected from the following group as a component (2): (III-B) GABA-gated chloride channel blockers; (III-D) Nicotinic acetylcholine receptor (nAChR) competitive modulators; and (III-Z) Rajodine Receptor Modulators.

具體地,本案的新穎農業化學組成物包含式 (I)所示之化合物作為組分 (1),

Figure 02_image001
式 (I) 其中, R 1選自鹵素、腈基、C 1-C 6烷基、C 1-C 6鹵烷基、C 1-C 6烷氧基、C 1-C 6烷硫基以及C 3-C 6環烷基; A係C或N,但不超過兩個A同時為N; G係C(R ) 2或O; 其中R 選自氫、鹵素以及C 1-C 3烷基; R 2選自氫、鹵素、腈基、C 1-C 6烷基、C 1-C 6鹵烷基、C 1-C 6烷氧基、C 3-C 6環烷基以及C 1-C 6烷基磺醯氧基; 及其鹽類、N-氧化物、金屬錯合物或立體異構物。 Specifically, the novel agricultural chemical composition of the present case comprises the compound represented by formula (I) as component (1),
Figure 02_image001
Formula (I) wherein, R 1 is selected from halogen, nitrile, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 alkoxy, C 1 -C 6 alkylthio and C 3 -C 6 cycloalkyl; A is C or N, but no more than two A are N at the same time; G is C(R ' ) 2 or O; wherein R ' is selected from hydrogen, halogen and C 1 -C 3 Alkyl; R 2 is selected from hydrogen, halogen, nitrile, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 alkoxy, C 3 -C 6 cycloalkyl and C 1 -C 6 alkylsulfonyloxy; and salts, N-oxides, metal complexes or stereoisomers thereof.

更具體地,式 (I)所示之化合物選自由以下各組所組成的群組: (I-1) 1-(4-(4-(5-(2,6-二氯苯基)-4,5-二氫異噁唑-3-基)噻唑-2-基)哌啶-1-基)-2-((3-(三氟甲基)吡嗪-2-基)氧)乙-1-酮 (1-(4-(4-(5-(2, 6-dichlorophenyl)-4,5-dihydroisoxazol-3-yl)thiazol-2-yl)piperidin-1-yl)-2-((3-(trifluoromethyl) pyrazin-2-yl) oxy)ethan-1-one); (I-2) 1-(4-(4-(5-(2-氯-6-氟苯基)-4,5-二氫異噁唑-3-基)噻唑-2-基)哌啶-1-基)-2-((3-(三氟甲基)吡啶-2-基)氧基)乙-1-酮 (1-(4-(4-(5-(2-chloro-6-fluorophenyl)-4,5-dihydroisoxazol-3-yl)thiazol-2-yl)piperidin-1-yl)-2-((3-(trifluoromethyl) pyridin-2-yl) oxy) ethan-1-one); (I-3) 4-(4-(5-(2-溴-6-氟苯基)-4,5-二氫異噁唑-3-基)噻唑-2-基)哌啶-1-羧酸叔丁酯 (tert-butyl 4-(4-(5-(2-bromo-6-fluorophenyl) -4,5-dihydroisoxazol-3-yl)thiazol-2-yl)piperidine-1-carboxylate)。 More specifically, the compound represented by formula (I) is selected from the group consisting of the following groups: (I-1) 1-(4-(4-(5-(2,6-dichlorophenyl)-4,5-dihydroisoxazol-3-yl)thiazol-2-yl)piperidine- 1-yl)-2-((3-(trifluoromethyl)pyrazin-2-yl)oxy)ethan-1-one (1-(4-(4-(5-(2, 6-dichlorophenyl) -4,5-dihydroisoxazol-3-yl)thiazol-2-yl)piperidin-1-yl)-2-((3-(trifluoromethyl)pyrazin-2-yl)oxy)ethan-1-one); (I-2) 1-(4-(4-(5-(2-chloro-6-fluorophenyl)-4,5-dihydroisoxazol-3-yl)thiazol-2-yl)piperidine -1-yl)-2-((3-(trifluoromethyl)pyridin-2-yl)oxy)ethan-1-one (1-(4-(4-(5-(2-chloro-6 -fluorophenyl)-4,5-dihydroisoxazol-3-yl)thiazol-2-yl)piperidin-1-yl)-2-((3-(trifluoromethyl)pyridin-2-yl)oxy)ethan-1-one) ; (I-3) 4-(4-(5-(2-bromo-6-fluorophenyl)-4,5-dihydroisoxazol-3-yl)thiazol-2-yl)piperidine-1- Tert-butyl carboxylate (tert-butyl 4-(4-(5-(2-bromo-6-fluorophenyl) -4,5-dihydroisoxazol-3-yl) thiazol-2-yl) piperidine-1-carboxylate.

在一較佳實施例中,本案的農業化學組成物包含至少一種選自以下各組的殺真菌活性化合物 (II) 作為一組分 (2):In a preferred embodiment, the agricultural chemical composition of the present invention comprises at least one fungicidally active compound (II) selected from the following groups as a component (2):

(II-A) 甾醇生物合成的抑制劑,舉例而言,可為(II-A001) 環克座 (cyproconazole)、(II-A002) 待克利 (difenoconazole)、(II-A003) 依普座 (epoxiconazole)、(II-A004) 環醯菌胺 (fenhexamid)、(II-A005) 苯鏽啶 (fenpropidin)、(II-A006) 芬普福 (fenpropimorph)、(II-A007) 胺苯吡菌酮 (fenpyrazamine)、(II-A008) 氟喹唑 (fluquinconazole)、(II-A009) 護汰芬 (flutriafol)、(II-A010) 依滅列 (imazalil)、(II-A011) 依滅列硫酸鹽 (imazalil sulfate)、(II-A012) 種菌唑 (ipconazole)、(II-A013) 滅特座 (metconazole)、(II-A014) 邁克尼 (myclobutanil)、(II-A015) 巴克素 (paclobutrazol)、(II-A016) 撲克拉 (prochloraz)、(II-A017) 普克利 (propiconazole)、(II-A018) 丙硫菌唑 (prothioconazole)、(II-A019) 啶菌㗁唑 (pyrisoxazole)、(II-A020) 葚孢菌素 (spiroxamine)、(II-A021) 得克利 (tebuconazole)、(II-A022) 四克利 (tetraconazole)、(II-A023) 三泰隆 (triadimenol)、(II-A024) 三得芬 (tridemorph)、(II-A025) 滅菌唑 (triticonazole)、(II-A026) (1R,2S,5S)-5-(4-氯苄基)-2-(氯甲基)-2-甲基-1-(1H-1,2,4-三唑-1-基甲基)環戊醇 ((1R,2S,5S)-5-(4-chlorobenzyl)-2-(chloromethyl)-2-methyl-l-(1H-1,2,4-triazol-1­ylmethyl)cyclopentanol、(II-A027) (1S,2R,5R)-5-(4-氯苄基)-2-(氯甲基)-2-甲基-1-(1H-1,2,4-三唑-1-基甲基)環戊醇 ((1S,2R,5R)-5-(4-chlorobenzyl)-2-(chloromethyl)-2-methyl-1-(1H-1,2,4-triazol-l-ylmethyl)cyclopentanol)、(II-A028) (2R)-2-(1-氯環丙基)-4-[(1R)-2,2-二氯環丙基]-1-(1H-1,2,4-三唑-1-基)丁-2-醇 ((2R)-2-(1-chlorocyclopropyl)-4-[(1R)-2,2-dichlorocyclopropyl]-1-(1H-1,2,4-triazol-1-yl)butan-2-ol)、(II-A029) (2R)-2-(1-氯環丙基)-4-[(1S)-2,2-二氯環丙基]-1-(1H-1,2,4-三唑-1-基)丁-2-醇 ((2R)-2-(1-chlorocyclopropyl)-4-[(1S)-2,2-dichlorocyclopropyl]-1-(1H-1,2,4-triazol-1-yl)butan-2-ol)、(II-A030) (2R)-2-[4-(4-氯苯氧基)-2-(三氟甲基)苯基]-1-(1H-1,2,4-三唑-1-基)丙-2-醇 ((2R)-2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1H-1,2,4-triazol-1-yl)propan-2-ol)、(II-A031) (2S)-2-(1-氯環丙基)-4-[(1R)-2,2-二氯環丙基]-1-(1H-1,2,4-三唑-1-基)丁-2-醇 ((2S)-2-(1-chlorocyclopropyl)-4-[(1R)-2,2-dichlorocyclopropyl]-1-(1H-l,2,4-triazol-1-yl)butan-2-ol)、(II-A032) (2S)-2-(1-氯環丙基)-4-[(1S)-2,2-二氯環丙基]-1-(1H-1,2,4-三唑-1-基)丁-2-醇 ((2S)-2-(1-chlorocyclopropyl)-4-[(1S)-2,2-dichlorocyclopropyl]-1-(1H-1,2,4-triazol-1-yl)butan-2-ol)、(II-A033) (2S)-2-[4-(4-氯苯氧基)-2-(三氟甲基)苯基]-1-(1H-1,2,4-三唑-1-基)丙-2-醇 ((2S)-2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1H-1,2,4-triazol-1-yl)propan-2-ol)、(II-A034) (R)-[3-(4-氯-2-氟苯基)-5-(2,4-二氟苯基)-1,2-噁唑-4-基](吡啶-3-基)甲醇 ((R)-[3-(4-chloro-2-fluorophenyl)-5-(2,4-difluorophenyl)-1,2-oxazol-4-yl](pyridin-3-yl)methanol)、(II-A035) (S)[3-(4-氯-2-氟苯基)-5-(2,4-二氟苯基)-1,2-噁唑-4-基](吡啶-3-基)甲醇 ((S)­[3-(4-chloro-2-fluorophenyl)-5-(2,4-difluorophenyl)-1,2-oxazol-4-yl](pyridin-3-yl)methanol)、(II-A036) [3-(4-氯-2-氟苯基)-5-(2,4-二氟苯基)-1,2-噁唑-4-基](吡啶-3-基)甲醇 ([3-(4-chloro-2-fluorophenyl)-5-(2,4-difluorophenyl)-1,2-oxazol-4-yl](pyridin-3-yl)methanol)、(II-A037) 1-({(2R,4S)-2-[2-氯-4-(4-氯苯氧基)苯基]-4-甲基-1,3-二氧戊環-2-基}甲基)-1H-1,2,4-三唑 (1-({(2R,4S)-2-[2-chloro-4-(4-chlorophenoxy)phenyl]-4-methyl-1,3-dioxolan-2-yl}methyl)-1H-1,2,4-triazole)、(II-A038) 1-({(2S,4S)-2-[2-氯-4-(4-氯苯氧基)苯基]-4-甲基-1,3-二氧戊環-2-基}甲基)-1H-1,2,4-三唑 (1-({(2S,4S)-2-[2-chloro-4-(4-chlorophenoxy)phenyl]-4-methyl-l,3-dioxolan-2-yl}methyl)-1H-1,2,4-triazole)、(II-A039) 1-{[3-(2-氯苯基)-2-(2,4-二氟苯基)環氧乙烷-2-基]甲基}-1H-1,2,4-三唑-5-基硫氰酸酯 (1-{[3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-1H-1,2,4-triazol-5-yl thiocyanate)、(II-A040) 1-{[rel(2R,3R)-3-(2-氯苯基)-2-(2,4-二氟苯基)環氧乙烷-2-基]甲基}-1H-1,2,4-三唑-5-基硫氰酸酯 (1-{[rel(2R,3R)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-1H-1,2,4-triazol-5-yl thiocyanate)、(II-A041) 1-{[rel(2R,3S)-3-(2-氯苯基)-2-(2,4-二氟苯基)環氧乙烷-2-基]甲基}-1H-1,2,4-三唑-5-基硫氰酸酯 (1-{[rel(2R,3S)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-1H-1,2,4-triazol-5-yl thiocyanate)、(II-A042) 2-[(2R,4R,5R)-1-(2,4-二氯苯基)-5-羥基-2,6,6-三甲基庚烷-4-基]-2,4-二氫-3H-1,2,4-三唑-3-硫酮 (2-[(2R,4R,5R)-1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione)、(II-A043) 2-[(2R,4R,5S)-1-(2,4-二氯苯基)-5-羥基-2,6,6-三甲基庚烷-4-基]-2,4-二氫-3H-1,2,4-三唑-3-硫酮 (2-[(2R,4R,5S)-1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione)、(II-A044) 2-[(2R,4S,5R)-1-(2,4-二氯苯基)-5-羥基-2,6,6-三甲基庚烷-4-基]-2,4-二氫-3H-1,2,4-三唑-3-硫酮 (2-[(2R,4S,5R)-l-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione)、(II-A045) 2-[(2R,4S,5S)-1-(2,4-二氯苯基)-5-羥基-2,6,6-三甲基庚烷-4-基]-2,4-二氫-3H-1,2,4-三唑-3-硫酮 (2-[(2R,4S,5S)-l-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione)、(II-A046) 2-[(2S,4R,5R)-1-(2,4-二氯苯基)-5-羥基-2,6,6-三甲基庚烷-4-基]-2,4-二氫-3H-1,2,4-三唑-3-硫酮 (2-[(2S,4R,5R)-1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione)、(II-A047) 2-[(2S,4R,5S)-1-(2,4-二氯苯基)-5-羥基-2,6,6-三甲基庚烷-4-基]-2,4-二氫-3H-1,2,4-三唑-3-硫酮 (2-[(2S,4R,5S)-1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione)、(II-A048) 2-[(2S,4S,5R)-1-(2,4-二氯苯基)-5-羥基-2,6,6-三甲基庚烷-4-基]-2,4-二氫-3H-1,2,4-三唑-3-硫酮 (2-[(2S,4S,5R)-1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione)、(II-A049) 2-[(2S,4S,5S)-1-(2,4-二氯苯基)-5-羥基-2,6,6-三甲基庚烷-4-基]-2,4-二氫-3H-1,2,4-三唑-3-硫酮 (2-[(2S,4S,5S)-l-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione)、(II-A050) 2-[1-(2,4-二氯苯基)-5-羥基-2,6,6-三甲基庚烷-4-基]-2,4-二氫-3H-1,2,4-三唑-3-硫酮 (2-[1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione)、(II-A051)     2-[2-氯-4-(2,4-二氯苯氧基)苯基]-l-(1H-1,2,4-三唑-1-基)丙-2-醇 (2-[2-chloro-4-(2,4-dichlorophenoxy)phenyl]-l-(1H-1,2,4-triazol-1-yl) propan-2-ol)、(II-A052) 2-[2-氯-4-(4-氯苯氧基)苯基]-1-(1H-1,2,4-三唑-1-基)丁-2-醇 (2-[2-chloro-4-(4-chlorophenoxy)phenyl]-1-(1H-1,2,4-triazol-1-yl)butan-2-ol)、(II-A053) 2-[4-(4-氯苯氧基)-2-(三氟甲基)苯基]-1-(1H-1,2,4-三唑-1-基)丁-2-醇 (2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1H-1,2,4-triazol-1-yl)butan-2-ol)、(II-A054) 2-[4-(4-氯苯氧基)-2-(三氟甲基)苯基]-1-(1H-1,2,4-三唑-1-基)戊-2-醇 (2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1H-1,2,4-triazol-l-yl)pentan-2-ol)、(II-A055) 2-[4-(4-氯苯氧基)-2-(三氟甲基)苯基]-1-(1H-1,2,4-三唑-1-基)丙-2-醇 (2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1H-1,2,4-triazol-1-yl)propan-2-ol)、(II-A056) 2-{[3-(2-氯苯基)-2-(2,4-二氟苯基)環氧乙烷-2-基]甲基}-2,4-二氫-3H-1,2,4-三唑-3-硫酮 (2-{[3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-2,4-dihydro-3H-l,2,4-triazole-3-thione)、(II-A057) 2-{[rel(2R,3R)-3-(2-氯苯基)-2-(2,4-二氟苯基)環氧乙烷-2-基]甲基}-2,4-二氫-3H-1,2,4-三唑-3-硫酮 (2-{[rel(2R,3R)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-2,4-dihydro-3H-1,2,4-triazole-3-thione)、(II-A058) 2-{[rel(2R,3S)-3-(2-氯苯基)-2-(2,4-二氟苯基)環氧乙烷-2-基]甲基}-2,4-二氫-3H-l,2,4-三唑-3-硫酮 (2-{[rel(2R,3S)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-2,4-dihydro-3H-l,2,4-triazole-3-thione)、(II-A059) 5-(4-氯芐基)-2-(氯甲基)-2-甲基-1-(1H-1,2,4-三唑-1-基甲基)環戊醇 (5-(4-chlorobenzyl)-2-(chloromethyl)-2-methyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol)、(II-A060) 5-(烯丙基硫基)-1-{[3-(2-氯苯基)-2-(2,4-二氟苯基)環氧乙烷-2-基]甲基}-1H-1,2,4-三唑 (5-(allylsulfanyl)-1-{[3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-1H-1,2,4-triazole)、(II-A061) 5-(烯丙基硫烷基)-1-{[rel(2R,3R)-3-2-氯苯基)-2-(2,4-二氟苯基)環氧乙烷-2-基]甲基}-1H-1,2,4-三唑 (5-(allylsulfanyl)-1-{[rel(2R,3R)-3-2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-1H-1,2,4-triazole)、(II-A062) 5-(烯丙基硫烷基)-1-{[rel(2R,3S)-3-(2-氯苯基)-2-(2,4-二氟苯基)環氧乙烷-2-基]甲基}-1H-1,2,4-三唑 (5-(allylsulfanyl)-1-{[rel(2R,3S)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-1H-1,2,4-triazole)、(II-A063) N’-(2,5-二甲基-4-{[3-(1,1,2,2-四氟乙氧基)苯基]硫基}苯基)-N-乙基-N-甲基亞胺基甲醯胺 (N’-(2,5-dimethyl-4-{[3-(1,1,2,2-tetrafluoroethoxy)phenyl]sulfanyl}phenyl)-N-ethyl-N­methylimidoformamide)、(II-A064) N’-(2,5-二甲基-4-{[3-(2,2,2-三氟乙氧基)苯基]硫基}苯基)N-乙基-N-甲基亞胺基甲醯胺 (N’-(2,5-dimethyl-4-{[3-(2,2,2-trifluoroethoxy)phenyl]sulfanyl}phenyl)­N-ethyl-N-methylimidoformamide)、(II-A065) N’-(2,5-二甲基-4-{[3-(2,2,3,3-四氟丙氧基)苯基]硫基}苯基)-N-乙基-N-甲基亞胺基甲醯胺(N’-(2,5-dimethyl-4-{[3-(2,2,3,3-tetrafluoropropoxy)phenyl]sulfanyl}phenyl)-N-ethyl-N-methylimidoformamide)、(II-A066) N’-(2,5-二甲基-4-{[3-(五氟乙氧基)苯基]硫基}苯基)-N-乙基-N-甲基亞胺基甲醯胺 (N’-(2,5-dimethyl-4-{[3-(pentafluoroethoxy)phenyl]sulfanyl}phenyl)-N-ethyl-N-methylimidoformamide)、(II-A067) N’-(2,5-二甲基)-4-{3-[(1,1,2,2-四氟乙基)硫烷基]苯氧基}苯基)-N-乙基-N-甲基亞胺基甲醯胺 (N’-(2,5-dimethyl-4-{3-[(1,l,2,2-tetrafluoroethyl)sulfanyl]phenoxy}phenyl)-N-ethyl-N­methylimidoformamide)、(II-A068) N’-(2,5-二甲基-4-{3-[(2,2,2-三氟乙基)硫烷基]苯氧基}苯基)N-乙基-N-甲基亞胺基甲醯胺 (N’-(2,5-dimethyl-4-{3-[(2,2,2-trifluoroethyl)sulfanyl]phenoxy}phenyl)­N-ethyl-N-methylimidoformamide)、(II-A069) N’-(2,5-二甲基-4-{3-[(2,2) ,3,3-四氟丙基)硫烷基]苯氧基}苯基)-N-乙基-N-甲基亞胺基甲醯胺 (N’-(2,5-dimethyl-4-{3-[(2,2,3,3-tetrafluoropropyl)sulfanyl]phenoxy}phenyl)-N-ethyl-N-methylimidoformamide、(II-A070) N’-(2,5-二甲基-4-{3-[(五氟乙基)硫烷基]苯氧基}苯基)-N-乙基-N-甲基亞胺基甲醯胺 (N’-(2,5- dimethyl-4-{3-[(pentafluoroethyl)sulfanyl]phenoxy}phenyl)-N-ethyl-N-methylimidoformamide)、(II-A071) N’-(2,5-二甲基-4-苯氧基苯基)-N-乙基-N-甲基亞胺基甲醯胺 (N’-(2,5-dimethyl-4-phenoxyphenyl)-N-ethyl-N-methylimidoformamide)、(II-A072) N’-(4-{[3-(二氟甲氧基)苯基]硫烷基}-2,5-二甲基苯基)-N-乙基-N-甲基亞胺基甲醯胺 (N’-(4-{[3-(difluoromethoxy)phenyl]sulfanyl}-2,5-dimethylphenyl)-N-ethyl-N-methylimidoformamide)、(II-A073) N’(4-{3-[(二氟甲基)硫烷基]苯氧基}-2,5-二甲基苯基)-N-乙基-N-甲基亞胺基甲醯胺 (N’­(4-{3-[(difluoromethyl)sulfanyl]phenoxy}-2,5-dimethylphenyl)-N-ethyl-N-methylimidoformamide)、(II-A074) N’-[5-溴-6-(2,3-二氫-1H-茚-2-氧基)-2-甲基吡啶-3-基]-N-乙基-N-甲基亞胺基甲醯胺 (N’-[5-bromo-6-(2,3-dihydro-1H-inden-2-yloxy)-2-methylpyridin-3-yl]-N-ethyl-N­methylimidoformamide)、(II-A075) N’-{4-[(4,5-二氯-1,3-噻唑-2-基)氧]-2,5-二甲基苯基}-N-乙基-N-甲基亞胺基甲醯胺 (N’-{4-[(4,5-dichloro-1,3-thiazol-2-yl)oxy]-2,5-dimethylphenyl}-N­ethyl-N-methylimidoformamide)、(II-A076) N’-{5-溴-6-[(1R)-1-(3,5-二氟苯基)乙氧基]-2-甲基吡啶-3-基}-N-乙基-N-甲基亞胺基甲醯胺 (N’-{5-bromo-6-[(1R)-1-(3,5-difluorophenyl)ethoxy]-2-methylpyridin-3-yl}-N-ethyl-N-methylimidofonnamide)、(II-A077) N’-{5-溴-6-[(1S)-1-(3,5-二氟苯基)乙氧基]-2-甲基吡啶-3-基}-N-乙基-N-甲基亞胺基甲醯胺 (N’-{5-bromo-6-[(1S)-1-(3,5-difluorophenyl)ethoxy]-2-methylpyridin-3-yl}-N-ethyl-N-methylimidoformamide)、(II-A078) N’-{5-溴-6-[(順式-4-異丙基環己基)氧]-2-甲基吡啶-3-基}-N-乙基-N-甲基亞胺基甲醯胺 (N’-{5-bromo-6-[(cis-4-isopropylcyclohexyl)oxy]-2-methylpyridin-3-yl}-N-ethyl-N-methylimidofornamide)、(II-A079) N’-{5-溴-6-[(反式-4-異丙基環己基)氧]-2-甲基吡啶-3-基}-N-乙基-N-甲基亞胺基甲醯胺 N’-{5-bromo-6-[(trans-4-isopropylcyclohexyl)oxy]-2-methylpyridin-3-yl}-N-ethyl-N­methylimidoformamide)、(II-A080) N’-{5-溴-6-[1-(3,5-二氟苯基)乙氧基]-2-甲基吡啶-3-基}-N-乙基-N-甲基亞胺基甲醯胺 (N’-{5-bromo-6-[1-(3,5-difluorophenyl)ethoxy]-2-methylpyridin-3-yl}­N-ethyl-N-methylimidoformamide)、(II-A081) 滅芬座 (mefentrifluconazole)、(II-A082) 異芬三氟康唑 (ipfentrifluconazole)、(II-A083) 1-(2,4-二氟苯基)-2-(1H-1,2,4-三唑-1-基)-1-[1-(2,6-二氟-4-氯苯氧基)環丙基]乙醇 (1-(2,4-difluorophenyl)-2-(1H-1,2,4-triazol-1-yl)-1-[1-(2,6-difluoro-4-chlorophenoxy)cyclopropyl]ethanol)、(II-A084) 1-[2-(1-氯環丙基)-3-(2-氟苯基)-2-羥丙基]-1H-咪唑-5-腈 (1-[2-(l-chlorocyclopropyl)-3-(2-fluorophenyl)-2-hydroxypropyl]-1H- imidazole-5-carbonitrile)、(II-A085) 特比萘芬 (terbinafine)、(II-A086) 丁硫菌酸鹽 (buthiobate)、(II-A087) 比芬諾 (pyrifenox)、(II-A088) 芬瑞莫 (fenarimol)、(II-A089) 尼瑞莫 (nuarimol)、(II-A090) 嘧菌醇 (triarimol)、(II-A091) 賽福寧 (triforine)、(II-A092) 克黴唑 (clotrimazole)、(II-A093) 益康唑 (econazole)、(II-A094) 異康唑 (isoconazole)、(II-A095) 咪康唑 (miconazole)、(II-A096) 氧唑菌 (oxpoconazole)、(II-A097) 披扶座 (pefurazoate)、(II-A098) 氟蟲唑 (triflumizole)、(II-A099) 氮唑康唑 (azaconazole)、(II-A100) 雙苯三唑醇 (bitertanol)、(II-A101) 溴康唑 (bromuconazole)、(II-A102) 達克利 (diniconazole)、(II-A103) 達克利-M (diniconazole-M)、(II-A104) 乙環唑 (etaconazole)、(II-A105) 芬克座 (fenbuconazole)、(II-A106) 菲克利 (hexaconazole)、(II-A107) 易胺座 (imibenconazole)、(II-A108) 平克座 (penconazole)、(II-A109) 西咪康唑 (simeconazole)、(II-A110) 三泰芬 (triadimefon)、(II-A111) 單克素 (uniconazole)、(II-A112) 稗草畏 (pyributicarb)、(II-A113) 十二嗎啉 (dodemorph)、(II-A114) 歐地莫 (aldimorph)、(II-A115) 三芬醯胺 (trimorphamide)、(II-A116) 粉病靈 (piperalin)、(II-A117) 萘替芬 (naftifine);(II-A) Inhibitors of sterol biosynthesis, for example, may be (II-A001) cyproconazole, (II-A002) difenoconazole, (II-A003) iptr ( epoxiconazole), (II-A004) fenhexamid, (II-A005) fenpropidin, (II-A006) fenpropimorph, (II-A007) fenpropidin (fenpyrazamine), (II-A008) fluquinconazole, (II-A009) flutriafol, (II-A010) imazalil, (II-A011) imazalil sulfate (imazalil sulfate), (II-A012) ipconazole, (II-A013) metconazole, (II-A014) myclobutanil, (II-A015) paclobutrazol, (II-A016) Prochloraz, (II-A017) Propiconazole, (II-A018) Prothioconazole, (II-A019) Pyrisoxazole, (II -A020) spiroxamine, (II-A021) tebuconazole, (II-A022) tetraconazole, (II-A023) triadimenol, (II-A024) three Tridemorph, (II-A025) triticonazole, (II-A026) (1R,2S,5S)-5-(4-chlorobenzyl)-2-(chloromethyl)-2- Methyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol ((1R,2S,5S)-5-(4-chlorobenzyl)-2-(chloromethyl)-2 -methyl-l-(1H-1,2,4-triazol-1ylmethyl)cyclopentanol, (II-A027) (1S,2R,5R)-5-(4-chlorobenzyl)-2-(chloromethyl )-2-methyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol ((1S,2R,5R)-5-(4-chlorobenzyl)-2-(chloromethyl)-2-methyl-1-(1H-1,2,4-triazol-l-ylmethyl)cyclopentanol), (II- A028) (2R)-2-(1-chlorocyclopropyl)-4-[(1R)-2,2-dichlorocyclopropyl]-1-(1H-1,2,4-triazole-1 -yl)butan-2-ol ((2R)-2-(1-chlorocyclopropyl)-4-[(1R)-2,2-dichlorocyclopropyl]-1-(1H-1,2,4-triazol-1- yl)butan-2-ol), (II-A029) (2R)-2-(1-chlorocyclopropyl)-4-[(1S)-2,2-dichlorocyclopropyl]-1-( 1H-1,2,4-triazol-1-yl)butan-2-ol ((2R)-2-(1-chlorocyclopropyl)-4-[(1S)-2,2-dichlorocyclopropyl]-1-( 1H-1,2,4-triazol-1-yl)butan-2-ol), (II-A030) (2R)-2-[4-(4-chlorophenoxy)-2-(trifluoromethane Base)phenyl]-1-(1H-1,2,4-triazol-1-yl)propan-2-alcohol ((2R)-2-[4-(4-chlorophenoxy)-2-(trifluoromethyl) phenyl]-1-(1H-1,2,4-triazol-1-yl)propan-2-ol), (II-A031) (2S)-2-(1-chlorocyclopropyl)-4-[ (1R)-2,2-dichlorocyclopropyl]-1-(1H-1,2,4-triazol-1-yl)butan-2-ol ((2S)-2-(1-chlorocyclopropyl) -4-[(1R)-2,2-dichlorocyclopropyl]-1-(1H-l,2,4-triazol-1-yl)butan-2-ol), (II-A032) (2S)-2- (1-Chlorocyclopropyl)-4-[(1S)-2,2-dichlorocyclopropyl]-1-(1H-1,2,4-triazol-1-yl)butan-2-ol ((2S)-2-(1-chlorocyclopropyl)-4-[(1S)-2,2-dichlorocyclopropyl]-1-(1H-1,2,4-triazol-1-yl)butan-2-ol) 、(II-A033) (2S)-2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1H-1,2,4-triazole- 1-yl)propan-2-ol ((2S)-2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1H-1,2,4-triazol-1-yl) propan-2-ol), (II-A034) (R)-[3-(4-chloro-2-fluorophenyl)-5-(2,4-difluorophenyl)-1,2-oxazole -4-yl](pyridin-3-yl)methanol ((R)-[3-(4-chloro-2-fluorophenyl)-5-(2,4-difluorophenyl)-1,2-oxazol-4-yl ](pyridin-3-yl)methanol), (II-A035) (S)[3-(4-chloro-2-fluorophenyl)-5-(2,4-difluorophenyl)-1,2 -Oxazol-4-yl](pyridin-3-yl)methanol ((S)[3-(4-chloro-2-fluorophenyl)-5-(2,4-difluorophenyl)-1,2-oxazol-4 -yl](pyridin-3-yl)methanol), (II-A036) [3-(4-chloro-2-fluorophenyl)-5-(2,4-difluorophenyl)-1,2- Oxazol-4-yl](pyridin-3-yl)methanol ([3-(4-chloro-2-fluorophenyl)-5-(2,4-difluorophenyl)-1,2-oxazol-4-yl]( pyridin-3-yl)methanol), (II-A037) 1-({(2R,4S)-2-[2-chloro-4-(4-chlorophenoxy)phenyl]-4-methyl- 1,3-dioxolan-2-yl}methyl)-1H-1,2,4-triazole (1-({(2R,4S)-2-[2-chloro-4-(4- chlorophenoxy)phenyl]-4-methyl-1,3-dioxolan-2-yl}methyl)-1H-1,2,4-triazole), (II-A038) 1-({(2S,4S)-2- [2-Chloro-4-(4-chlorophenoxy)phenyl]-4-methyl-1,3-dioxolan-2-yl}methyl)-1H-1,2,4-tri Azole (1-({(2S,4S)-2-[2-chloro-4-(4-chlorophenoxy)phenyl]-4-methyl-l,3-dioxolan-2-yl}methyl)-1H-1, 2,4-triazole), (II-A039) 1-{[3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl} -1H-1,2, 4-triazol-5-ylthiocyanate (1-{[3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-1H-1,2,4 -triazol-5-yl thiocyanate), (II-A040) 1-{[rel(2R,3R)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxirane Alk-2-yl]methyl}-1H-1,2,4-triazol-5-ylthiocyanate (1-{[rel(2R,3R)-3-(2-chlorophenyl)-2- (2,4-difluorophenyl)oxiran-2-yl]methyl}-1H-1,2,4-triazol-5-yl thiocyanate), (II-A041) 1-{[rel(2R,3S)-3- (2-Chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-1H-1,2,4-triazol-5-ylthiocyanate Esters (1-{[rel(2R,3S)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-1H-1,2,4-triazol-5 -yl thiocyanate), (II-A042) 2-[(2R,4R,5R)-1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptane- 4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione (2-[(2R,4R,5R)-1-(2,4-dichlorophenyl)-5 -hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione), (II-A043) 2-[(2R,4R, 5S)-1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2, 4-triazole-3-thione (2-[(2R,4R,5S)-1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2, 4-dihydro-3H-1,2,4-triazole-3-thione), (II-A044) 2-[(2R,4S,5R)-1-(2,4-dichlorophenyl)-5- Hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione (2-[(2R,4S, 5R)-l-(2,4 -dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione), (II-A045) 2-[ (2R,4S,5S)-1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H -1,2,4-triazole-3-thione (2-[(2R,4S,5S)-l-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4- yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione), (II-A046) 2-[(2S,4R,5R)-1-(2,4-dichlorobenzene Base)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione (2-[ (2S,4R,5R)-1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazole -3-thione), (II-A047) 2-[(2S,4R,5S)-1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptane -4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione (2-[(2S,4R,5S)-1-(2,4-dichlorophenyl)- 5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione), (II-A048) 2-[(2S,4S ,5R)-1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2 ,4-triazole-3-thione (2-[(2S,4S,5R)-1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2 ,4-dihydro-3H-1,2,4-triazole-3-thione), (II-A049) 2-[(2S,4S,5S)-1-(2,4-dichlorophenyl)-5 -Hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione (2-[(2S,4S ,5S)-l-(2,4-dich lorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione), (II-A050) 2-[1 -(2,4-Dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazole -3-Thione (2-[1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4- triazole-3-thione), (II-A051) 2-[2-chloro-4-(2,4-dichlorophenoxy)phenyl]-l-(1H-1,2,4-triazole- 1-yl) propan-2-ol (2-[2-chloro-4-(2,4-dichlorophenoxy)phenyl]-l-(1H-1,2,4-triazol-1-yl) propan-2- ol), (II-A052) 2-[2-chloro-4-(4-chlorophenoxy)phenyl]-1-(1H-1,2,4-triazol-1-yl)butan-2 -Alcohol (2-[2-chloro-4-(4-chlorophenoxy)phenyl]-1-(1H-1,2,4-triazol-1-yl)butan-2-ol), (II-A053) 2 -[4-(4-Chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1H-1,2,4-triazol-1-yl)butan-2-ol (2 -[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1H-1,2,4-triazol-1-yl)butan-2-ol), (II-A054) 2-[ 4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1H-1,2,4-triazol-1-yl)pentan-2-ol (2-[ 4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1H-1,2,4-triazol-l-yl)pentan-2-ol), (II-A055) 2-[4- (4-Chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1H-1,2,4-triazol-1-yl)propan-2-ol (2-[4- (4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1H-1,2,4-triazol-1-yl)propan-2-ol), (II-A 056) 2-{[3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxirane-2-yl]methyl}-2,4-dihydro-3H- 1,2,4-Triazole-3-thione (2-{[3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-2,4-dihydro- 3H-l,2,4-triazole-3-thione), (II-A057) 2-{[rel(2R,3R)-3-(2-chlorophenyl)-2-(2,4-difluoro Phenyl)oxirane-2-yl]methyl}-2,4-dihydro-3H-1,2,4-triazole-3-thione (2-{[rel(2R,3R)- 3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-2,4-dihydro-3H-1,2,4-triazole-3-thione), (II- A058) 2-{[rel(2R,3S)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxirane-2-yl]methyl}-2, 4-Dihydro-3H-l,2,4-triazole-3-thione (2-{[rel(2R,3S)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran -2-yl]methyl}-2,4-dihydro-3H-l,2,4-triazole-3-thione), (II-A059) 5-(4-chlorobenzyl)-2-(chloromethyl )-2-Methyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol (5-(4-chlorobenzyl)-2-(chloromethyl)-2-methyl-1 -(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol), (II-A060) 5-(allylthio)-1-{[3-(2-chlorophenyl)-2- (2,4-Difluorophenyl)oxiran-2-yl]methyl}-1H-1,2,4-triazole(5-(allylsulfanyl)-1-{[3-(2-chlorophenyl )-2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-1H-1,2,4-triazole), (II-A061) 5-(allylsulfanyl)-1-{ [rel(2R,3R)-3-2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-1H-1,2,4- Triazole (5-(allylsulfanyl) -1-{[rel(2R,3R)-3-2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-1H-1,2,4-triazole), (II -A062) 5-(allylsulfanyl)-1-{[rel(2R,3S)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxirane Alk-2-yl]methyl}-1H-1,2,4-triazole(5-(allylsulfanyl)-1-{[rel(2R,3S)-3-(2-chlorophenyl)-2-(2 ,4-difluorophenyl)oxiran-2-yl]methyl}-1H-1,2,4-triazole), (II-A063) N'-(2,5-dimethyl-4-{[3-(1 ,1,2,2-tetrafluoroethoxy)phenyl]thio}phenyl)-N-ethyl-N-methyliminoformamide (N'-(2,5-dimethyl-4 -{[3-(1,1,2,2-tetrafluoroethoxy)phenyl]sulfanyl}phenyl)-N-ethyl-Nmethylimidoformamide), (II-A064) N'-(2,5-dimethyl-4-{ [3-(2,2,2-Trifluoroethoxy)phenyl]thio}phenyl)N-ethyl-N-methyliminoformamide (N'-(2,5-dimethyl -4-{[3-(2,2,2-trifluoroethoxy)phenyl]sulfanyl}phenyl)N-ethyl-N-methylimidoformamide), (II-A065) N'-(2,5-dimethyl-4- {[3-(2,2,3,3-tetrafluoropropoxy)phenyl]thio}phenyl)-N-ethyl-N-methyliminoformamide (N'-(2 ,5-dimethyl-4-{[3-(2,2,3,3-tetrafluoropropoxy)phenyl]sulfanyl}phenyl)-N-ethyl-N-methylimidoformamide), (II-A066) N'-(2,5 -Dimethyl-4-{[3-(pentafluoroethoxy)phenyl]thio}phenyl)-N-ethyl-N-methyliminoformamide (N'-(2, 5-dimethyl-4-{[3-(pentafluoroethoxy)phenyl]sulfanyl}phenyl)-N-ethyl-N-methylimidoformamide), (II-A067) N'-(2,5-dimethyl)-4-{ 3 -[(1,1,2,2-tetrafluoroethyl)sulfanyl]phenoxy}phenyl)-N-ethyl-N-methyliminoformamide (N'-(2, 5-dimethyl-4-{3-[(1,l,2,2-tetrafluoroethyl)sulfanyl]phenoxy}phenyl)-N-ethyl-Nmethylimidoformamide), (II-A068) N'-(2,5-dimethyl Base-4-{3-[(2,2,2-trifluoroethyl)sulfanyl]phenoxy}phenyl)N-ethyl-N-methyliminoformamide (N'- (2,5-dimethyl-4-{3-[(2,2,2-trifluoroethyl)sulfanyl]phenoxy}phenyl)N-ethyl-N-methylimidoformamide), (II-A069) N'-(2,5- Dimethyl-4-{3-[(2,2),3,3-tetrafluoropropyl)sulfanyl]phenoxy}phenyl)-N-ethyl-N-methyliminomethyl Amide (N'-(2,5-dimethyl-4-{3-[(2,2,3,3-tetrafluoropropyl)sulfanyl]phenoxy}phenyl)-N-ethyl-N-methylimidoformamide, (II-A070) N'-(2,5-Dimethyl-4-{3-[(pentafluoroethyl)sulfanyl]phenoxy}phenyl)-N-ethyl-N-methyliminoformyl Amine (N'-(2,5-dimethyl-4-{3-[(pentafluoroethyl)sulfanyl]phenoxy}phenyl)-N-ethyl-N-methylimidoformamide), (II-A071) N'-(2,5- Dimethyl-4-phenoxyphenyl)-N-ethyl-N-methyliminoformamide (N'-(2,5-dimethyl-4-phenoxyphenyl)-N-ethyl-N- methylimidoformamide), (II-A072) N'-(4-{[3-(difluoromethoxy)phenyl]sulfanyl}-2,5-dimethylphenyl)-N-ethyl-N -Methylimidoformamide (N'-(4-{[3-(difluoromethoxy)phenyl]sulfanyl}-2,5-dimethylphenyl)-N-ethyl-N-methylimidoformamide), (II-A073) N '(4-{3-[(difluoromethyl)sulfanyl]phenoxy}-2,5-dimethylphenyl)-N-ethyl-N-methyliminoformamide ( N' (4-{3-[(difluoromethyl)sulfanyl]phenoxy}-2,5-dimethylphenyl)-N-ethyl-N-methylimidoformamide), (II-A074) N'-[5-bromo-6-(2,3 -Dihydro-1H-indene-2-oxyl)-2-methylpyridin-3-yl]-N-ethyl-N-methyliminoformamide (N'-[5-bromo-6 -(2,3-dihydro-1H-inden-2-yloxy)-2-methylpyridin-3-yl]-N-ethyl-Nmethylimidoformamide), (II-A075) N'-{4-[(4,5- Dichloro-1,3-thiazol-2-yl)oxy]-2,5-dimethylphenyl}-N-ethyl-N-methyliminoformamide (N'-{4-[ (4,5-dichloro-1,3-thiazol-2-yl)oxy]-2,5-dimethylphenyl}-Nethyl-N-methylimidoformamide), (II-A076) N'-{5-bromo-6-[ (1R)-1-(3,5-difluorophenyl)ethoxy]-2-methylpyridin-3-yl}-N-ethyl-N-methyliminoformamide (N' -{5-bromo-6-[(1R)-1-(3,5-difluorophenyl)ethoxy]-2-methylpyridin-3-yl}-N-ethyl-N-methylimidofonnamide), (II-A077) N' -{5-bromo-6-[(1S)-1-(3,5-difluorophenyl)ethoxy]-2-methylpyridin-3-yl}-N-ethyl-N-methyl Iminoformamide (N'-{5-bromo-6-[(1S)-1-(3,5-difluorophenyl)ethoxy]-2-methylpyridin-3-yl}-N-ethyl-N-methylimidoformamide ), (II-A078) N'-{5-bromo-6-[(cis-4-isopropylcyclohexyl)oxy]-2-methylpyridin-3-yl}-N-ethyl-N -methyliminoformamide (N'-{5-bromo-6-[(cis-4-isopropylcyclohexyl)oxy]-2-methylpyridin-3-yl}-N-ethyl-N-methylimidofornamide), ( II-A079) N'-{5-bromo-6-[(trans-4-isopropylcyclohexyl)oxy]-2-methylpyridin-3-yl}-N-ethyl-N-methyl Asia Aminoformamide N'-{5-bromo-6-[(trans-4-isopropylcyclohexyl)oxy]-2-methylpyridin-3-yl}-N-ethyl-Nmethylimidoformamide), (II-A080) N'- {5-Bromo-6-[1-(3,5-difluorophenyl)ethoxy]-2-methylpyridin-3-yl}-N-ethyl-N-methyliminoformyl Amine (N'-{5-bromo-6-[1-(3,5-difluorophenyl)ethoxy]-2-methylpyridin-3-yl}N-ethyl-N-methylimidoformamide), (II-A081) (mefentrifluconazole), (II-A082) ipfentrifluconazole, (II-A083) 1-(2,4-difluorophenyl)-2-(1H-1,2,4-triazole -1-yl)-1-[1-(2,6-difluoro-4-chlorophenoxy)cyclopropyl]ethanol (1-(2,4-difluorophenyl)-2-(1H-1,2 ,4-triazol-1-yl)-1-[1-(2,6-difluoro-4-chlorophenoxy)cyclopropyl]ethanol), (II-A084) 1-[2-(1-chlorocyclopropyl)- 3-(2-fluorophenyl)-2-hydroxypropyl]-1H-imidazole-5-carbonitrile (1-[2-(l-chlorocyclopropyl)-3-(2-fluorophenyl)-2-hydroxypropyl]-1H - imidazole-5-carbonitrile), (II-A085) terbinafine, (II-A086) buthiobate, (II-A087) bifenol (pyrifenox), (II- A088) Fenarimol, (II-A089) Nuarimol, (II-A090) Triarimol, (II-A091) Triforine, (II-A092) Clotrimazole, (II-A093) econazole, (II-A094) isoconazole, (II-A095) miconazole, (II-A096) oxazole Bacteria (oxpoconazole), (II -A097) Pefurazoate, (II-A098) Triflumizole, (II-A099) Azaconazole, (II-A100) Bitertanol, ( II-A101) bromuconazole (bromuconazole), (II-A102) diniconazole, (II-A103) diniconazole-M (diniconazole-M), (II-A104) etaconazole, ( II-A105) Fenke (fenbuconazole), (II-A106) Fickley (hexaconazole), (II-A107) Yimin (imibenconazole), (II-A108) Pink (penconazole), (II-A109 ) simeconazole, (II-A110) triadimefon, (II-A111) uniconazole, (II-A112) pyributicarb, (II-A113) Dodemorph, (II-A114) Aldimorph, (II-A115) Trimorphamide, (II-A116) Piperalin, (II-A117) Naftifine (naftifine);

(II-B) 關於呼吸鏈複合物I (complex I)或複合物II (complex II)的抑制劑,可例如 (II-B001) 苯索伏比 (benzovindiflupyr)、(II-B002) 拜沙芬 (bixafen)、(II-B003) 白克列 (boscalid)、(II-B004) 萎鏽靈 (carboxin)、(II-B005) 氟派瑞 (fluopyram)、(II-B006) 福多寧 (flutolanil)、(II-B007) 氟克殺 (fluxapyroxad)、(II-B008) 福拉比 (furametpyr)、(II-B009) 抑吩滅 (isofetamid)、(II-B010) 亞派占 (isopyrazam)(反差向鏡像異構物 (anti-epimeric enantiomer) 1R,4S,9S)、(II-B011) 亞派占(反差向對映異構物1S,4R,9R)(isopyrazam (anti-epimeric enantiomer 1S,4R,9R))、(II-B012) 亞派占(反差向異構消旋物1RS,4SR,9SR)(isopyrazam (anti-epimeric racemate 1RS,4SR,9SR))、(II-B013) 亞派占(同差向異構消旋物1RS,4SR,9RS與反差向異構消旋物1RS,4SR,9SR之混合物)(isopyrazam (mixture of syn-epimeric racemate 1RS,4SR,9RS and anti-epimeric racemate 1RS,4SR,9SR))、(II-B014) 亞派占(同差向異構消旋物1R,4S,9R) (isopyrazam (syn-epimeric enantiomer 1R,4S,9R))、(II-B015) 亞派占(同差向異構消旋物1S,4R,9S) (isopyrazam (syn-epimeric enantiomer 1S,4R,9S))、(II-B016) 亞派占(同差向異構消旋物1RS,4SR,9RS)(isopyrazam (syn-epimeric racemate 1RS,4SR,9RS))、(II-B017) 本福吩 (penflufen)、(II-B018) 本賽能 (penthiopyrad)、(II-B019) 派滅芬 (pydiflumetofen)、(II-B020) 必福滅 (pyraziflumid)、(II-B021) 速達散 (sedaxane)、(II-B022) 1,3-二甲基-N-(1,1,3-三甲基-2,3-二氫-1H-茚-4-基)-1H-吡唑-4-羧醯胺 (1,3-dimethyl-N-(1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl)-1H-pyrazole-4-carboxamide)、(II-B023) 1,3-二甲基-N-[(3R)-1,1,3-三甲基-2,3-二氫 -1H-茚-4-基]-1H-吡唑-4-羧醯胺 (1,3-dimethyl-N-[(3R)-1,l,3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1H- pyrazole-4- carboxamide)、(II-B024) 1,3-二甲基-N-[(3S)-1,1,3-三甲基-2,3-二氫-1H-茚-4-基]-1H-吡唑-4-羧醯胺 (1,3-dimethyl-N-[(3S)-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1H-pyrazole-4-carboxamide)、(II-B025) 1-甲基-3-(三氟甲基)-N-[2’-(三氟甲基)聯苯-2-基]-1H-吡唑-4-羧醯胺 (1-methyl-3-(trifluoromethyl)-N-[2’-(trifluoromethyl)biphenyl-2-yl]-1H-pyrazole-4-carboxamide)、(II-B026) 2-氟-6-(三氟甲基)-N-(1,1,3-三甲基-2,3-二氫-1H-茚-4-基)苯醯胺 (2-fluoro-6-(trifluoromethyl)-N-(1,1,3-trimethyl-2,3-dihydro-1H-inden-4- yl)benzamide)、(II-B027) 3-(二氟甲基)-1-甲基-N-(1,1,3-三甲基-2,3-二氫-1H-茚-4-基)-1H-吡唑-4-羧醯胺 (3-(difluoromethyl)-1-methyl-N-(1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl)-1H­pyrazole-4-carboxamide)、(II-B028) 3-(二氟甲基)-1-甲基-N-[(3R)-1,1,3-三甲基-2,3-二氫-1H-茚-4-基]-1H-吡唑-4-羧醯胺 (3-(difluoromethyl)-1-methyl-N-[(3R)-1,1,3-trimethyl-2,3-dihydro-1H­inden-4-yl]-1H-pyrazole-4-carboxamide)(因吡氟沙,inpyrfluxam)、(II-B029) 3-(二氟甲基)-1-甲基-N-[(3S)-1,1,3-三甲基-2,3-二氫-1H-茚-4-基]-1H-吡唑-4-羧醯胺 (3-(difluoromethyl)-1-methyl-N-[(3S)-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1H-pyrazole-4-carboxamide)、(II-B030) 3-(二氟甲基)-N-(7-氟-1,1,3-三甲基-2,3-二氫-1H-茚-4-基)-1-甲基-1H-吡唑-4-羧醯胺 (3-(difluoromethyl)-N-(7-fluoro-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl)-1-methyl-1H-pyrazole-4- carboxamide)(氟茚唑菌胺,Fluindapyr)、(II-B031) 3-(二氟甲基)-N-[(3R)-7-氟-1,1,3-三甲基-2,3-二氫-1H-茚-4-基]-1-甲基-1H-吡唑-4-羧醯胺 (3-(difluoromethyl)-N-[(3R)-7-fluoro-l,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1-methyl-1H-pyrazole-4-carboxamide)、(II-B032) 3-(二氟甲基)-N-[(3S)-7-氟-1,1,3-三甲基-2,3-二氫-1H-茚-4-基]-1-甲基-1H-吡唑-4-羧醯胺 (3-(difluoromethyl)-N-[(3S)-7-fluoro-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1-methyl-1H-pyrazole-4-carboxamide)、(II-B033) 5,8-二氟-N-[2-(2-氟-4-{[4-(三氟甲基)吡啶-2-基]氧}苯基)乙基]喹唑啉-4-胺 (5,8-difluoro-N-[2-(2-fluoro-4-{[4-(trifluoromethyl)pyridin-2-yl]oxy}phenyl)ethyl]quinazolin-4-amine)、(II-B034) N-(2-環戊基-5-氟苯甲基)-N-環丙基-3-(二氟甲基)-5-氟-1-甲基-1H-吡唑-4-羧醯胺 (N-(2-cyclopentyl-5-fluorobenzyl)-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1-H-pyrazole-4-carboxamide)、(II-B035) N-(2-第三丁基-5-甲基苯甲基)-N-環丙基-3-(二氟甲基)-5-氟-1-甲基-1H-吡唑-4-羧醯胺 (N-(2-tert-butyl-5-methylbenzyl)-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H­pyrazole-4-carboxamide)、(II-B036) N-(2-第三丁基苯甲基)-N-環丙基-3-(二氟甲基)-5-氟-1-甲基-1H-吡唑-4-羧醯胺 (N-(2-tert-butylbenzyl)-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide)、(II-B037) N-(5-氯-2-乙基苯甲基)-N-環丙基-3-(二氟甲基)-5-氟-1-甲基-1H-吡唑-4-羧醯胺 (N-(5-chloro-2-ethylbenzyl)-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide)、(II-B038) N-(5-氯-2-異丙基苯甲基)-N-環丙基-3-(二氟甲基)-5-氟-1-甲基-1H-吡唑-4-羧醯胺 (N-(5-chloro-2-isopropylbenzyl)-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide)(異氟丙啶,isoflucypram)、(II-B039) N-[(1R,4S)-9-(二氯亞甲基)-1,2,3,4-四氫-1,4-甲撐基萘-5-基]-3-(二氟甲基)-1-甲基-1H-吡唑-4-羧醯胺 (N-[(1R,4S)-9-(dichloromethylene)-1,2,3,4-tetrahydro-1,4-methanonaphthalen-5-yl]-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide)、(II-B040) N-[(1S,4R)-9-(二氯亞甲基)-1,2,3,4-四氫-1,4-甲撐基萘-5-基]-3-(二氟甲基)-1-甲基-1H-吡唑-4-羧醯胺 (N-[(1S,4R)-9-(dichloromethylene)-1,2,3,4-tetrahydro-1,4-methanonaphthalen-5-yl]-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide)、(II-B041) N-[1-(2,4-二氯苯基)-1-甲氧基丙-2-基]-3-(二氟甲基)-1-甲基-1H-吡唑-4-羧醯胺 (N-[1-(2,4-dichlorophenyl)-l-methoxypropan-2-yl]-3-(difluoromethyl)-1-methyl­1H-pyrazole-4-carboxamide)、(II-B042) N-[2-氯-6-(三氟甲基)苯甲基]-N-環丙基-3-(二氟甲基)-5-氟-1-甲基-1H-吡唑-4-羧醯胺 (N-[2-chloro-6-(trifluoromethyl)benzyl]-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide)、(II-B043) N-[3-氯-2-氟-6-(三氟甲基)苯甲基]-N-環丙基-3-(二氟甲基)-5-氟-1-甲基-1H-吡唑-4-羧醯胺 (N-[3-chloro-2-fluoro-6-(trifluoromethyl)benzyl]-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4- carboxamide)、(II-B044) N-[5-氯 -2-(三氟甲基)苯甲基]-N-環丙基-3-(二氟甲基)-5-氟-1-甲基-1H-吡唑-4-羧醯胺 (N-[5-chloro-2-(trifluoromethyl)benzyl]-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide)、(II-B045) N-環丙基-3-(二氟甲基)-5-氟-1-甲基-N-[5-甲基-2-(三氟甲基)苯甲基]-1H-吡唑-4-羧醯胺 (N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-N-[5-methyl-2-(trifluoromethyl)benzyl]-1H-pyrazole-4-carboxamide)、(II-B046) N-環丙基-3-(二氟甲基)-5-氟-N-(2-氟-6-異丙基苯甲基)-1-甲基-1H-吡唑-4-羧醯胺 (N-cyclopropyl-3-(difluoromethyl)-5-fluoro-N-(2-fluoro-6-isopropylbenzyl)-1-methyl-1H-pyrazole-4-carboxamide)、(II-B047) N-環丙基-3-(二氟甲基)-5-氟-N-(2-異丙基-5-甲基苯甲基)-1-甲基-1H-吡唑-4-羧醯胺 (N-cyclopropyl-3-(difluoromethyl)-5-fluoro-N-(2-isopropyl-5-methylbenzyl)-1-methyl-1H­pyrazole-4-carboxamide)、(II-B048) N-環丙基-3-(二氟甲基)-5-氟-N-(2-異丙基苯甲基)-1-甲基-1H-吡唑-4-甲硫醯胺 (N-cyclopropyl-3-(difluoromethyl)-5-fluoro-N-(2-isopropylbenzyl)-1-methyl-1H-pyrazole-4-carbothioamide)、(II-B049) N-環丙基-3-(二氟甲基)-5-氟-N-(2-異丙基苯甲基)-1-甲基-1H-吡唑-4-羧醯胺 (N-cyclopropyl-3-(difluoromethyl)-5-fluoro-N-(2-isopropylbenzyl)-1-methyl-1H-pyrazole-4-carboxamide)、(II-B050) N-環丙基-3-(二氟甲基)-5-氟-N-(5-氟-2-異丙基苯甲基)-1-甲基-1H-吡唑-4-羧醯胺 (N-cyclopropyl-3-(difluoromethyl)-5-fluoro-N-(5-fluoro-2-isopropylbenzyl)-1-methyl-1H-pyrazole-4-carboxamide)、(II-B051) )N-環丙基-3-(二氟甲基)-N-(2-乙基-4,5-二甲基苯甲基)-5-氟-1-甲基-1H-吡唑-4-羧醯胺 (N-cyclopropyl-3-(difluoromethyl)-N-(2-ethyl-4,5-dimethylbenzyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide)、(II-B052) N-環丙基-3-(二氟甲基)-N-(2-乙基-5-氟苯甲基)-5-氟-1-甲基-1H-吡唑-4-羧醯胺 (N-cyclopropyl-3-(difluoromethyl)-N-(2-ethyl-5-fluorobenzyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide)、(II-B053) N-環丙基-3-(二氟甲基)-N-(2-乙基-5-甲基苯甲基)-5-氟-1-甲基-1H-吡唑-4-羧醯胺 (N-cyclopropyl-3-(difluoromethyl)-N-(2-ethyl-5-methylbenzyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide)、(II-B054) N-環丙基-N-(2-環丙基-5-氟苯甲基)-3-(二氟甲基)-5-氟-1-甲基-1H-吡唑-4-羧醯胺 (N-cyclopropyl-N-(2-cyclopropyl-5-fluorobenzyl)-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide)、(II-B055) N-環丙基-N-(2-環丙基-5-甲基苯甲基)-3-(二氟甲基)-5-氟-1-甲基-1H-吡唑-4-羧醯胺 (N-cyclopropyl-N-(2-cyclopropyl-5-methylbenzyl)-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide)、(II-B056) N-環丙基-N-(2-環丙基苯甲基)-3-(二氟甲基)-5-氟-1-甲基-1H-吡唑-4-羧醯胺 (N-cyclopropyl-N-(2-cyclopropylbenzyl)-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide)、(II-B057) 2-(二氟甲基)-N-(1,1-二甲基-3-丙基-2,3-二氫-1H-茚-4-基)煙鹼醯胺 (2-(difluoromethyl)-N-(l,1-dimethyl-3-propyl-2,3-dihydro-1H-inden-4-yl)nicotinamide)、(II-B058) 吡唑甲醯胺類殺菌劑 (pyrapropoyne)、(II-B059) 因吡氟沙 (inpyrfluxam)、(II-B060) 滅普寧 (mepronil)、(II-B061) 異氟丙啶 (isoflucypram)、(II-B062) 嘉保信 (oxycarboxin)、(II-B063) α-(甲氧基亞胺基)-N-甲基-2-[[[1-[3-(三氟甲基)苯基]乙氧基]亞胺基]甲基]苯乙醯胺 (α-(methoxyimino)-N-methyl-2-[[[1-[3-(trifluoromethyl)phenyl]ethoxy]imino]methyl]benzeneacetamide)、(II-B064) 二氟林 (diflumetorim)、(II-B065) 賽氟滅 (thifluzamide)、(II-B066) 甲呋醯胺 (fenfuram)、(II-B067) 麥鏽靈 (benodanil);(II-B) Inhibitors of complex I (complex I) or complex II (complex II) of the respiratory chain, such as (II-B001) benzovindiflupyr, (II-B002) bexafin (bixafen), (II-B003) boscalid, (II-B004) carboxin, (II-B005) fluopyram, (II-B006) flutolanil ), (II-B007) fluoxapyroxad (fluxapyroxad), (II-B008) furametpyr, (II-B009) isofetamid, (II-B010) isopyrazam ( Anti-epimeric enantiomer (anti-epimeric enantiomer 1R,4S,9S), (II-B011) 4R,9R)), (II-B012) isopyrazam (anti-epimeric racemate 1RS,4SR,9SR) (isopyrazam (anti-epimeric racemate 1RS,4SR,9SR)), (II-B013) Accounting (isopyrazam (mixture of syn-epimeric racemate 1RS, 4SR, 9RS and anti-epimeric racemate 1RS, 4SR, 9RS and anti-epimeric racemate 1RS,4SR,9SR)), (II-B014) (isopyrazam (syn-epimeric enantiomer 1R,4S,9R)), (II-B015 ) (isopyrazam (syn-epimeric enantiomer 1S,4R,9S)), (II-B016) 1RS, 4SR, 9RS) (isopyrazam (syn-epimeric racemate 1RS, 4SR, 9RS)), (II-B017) Benfufen (penflufen), (II-B018) Benthiopyrad, (II-B019 ) Pydiflumetofen, (II-B020) Pyraziflumid, (II-B021) Sedaxane, (II-B022) 1,3-Dimethyl-N-(1,1 ,3-Trimethyl-2,3-dihydro-1H-inden-4-yl)-1H-pyrazole-4-carboxamide (1,3-dimethyl-N-(1,1,3-trimethyl -2,3-dihydro-1H-inden-4-yl)-1H-pyrazole-4-carboxamide), (II-B023) 1,3-Dimethyl-N-[(3R)-1,1,3 -Trimethyl-2,3-dihydro-1H-inden-4-yl]-1H-pyrazole-4-carboxamide (1,3-dimethyl-N-[(3R)-1,l,3 -trimethyl-2,3-dihydro-1H-inden-4-yl]-1H-pyrazole-4-carboxamide), (II-B024) 1,3-Dimethyl-N-[(3S)-1,1 ,3-Trimethyl-2,3-dihydro-1H-inden-4-yl]-1H-pyrazole-4-carboxamide (1,3-dimethyl-N-[(3S)-1,1 ,3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1H-pyrazole-4-carboxamide), (II-B025) 1-methyl-3-(trifluoromethyl)-N- [2'-(trifluoromethyl)biphenyl-2-yl]-1H-pyrazole-4-carboxamide (1-methyl-3-(trifluoromethyl)-N-[2'-(trifluoromethyl)biphenyl- 2-yl]-1H-pyrazole-4-carboxamide), (II-B026) 2-fluoro-6-(trifluoromethyl)-N-(1,1,3-trimethyl-2,3-di Hydrogen-1H-inden-4-yl)benzamide (2-fluoro-6-(trifluoromethyl)-N-(1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl)benzamide ), (II-B027) 3-(difluoromethyl)-1-methyl-N-(1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl)- 1H-pyrazole-4-carboxamide (3-(difluoromethyl)-1-methyl-N-(1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl)-1Hpyrazole-4 -carboxamid e), (II-B028) 3-(difluoromethyl)-1-methyl-N-[(3R)-1,1,3-trimethyl-2,3-dihydro-1H-indene- 4-yl]-1H-pyrazole-4-carboxamide (3-(difluoromethyl)-1-methyl-N-[(3R)-1,1,3-trimethyl-2,3-dihydro-1Hinden-4 -yl]-1H-pyrazole-4-carboxamide) (inpyrfluxam, inpyrfluxam), (II-B029) 3-(difluoromethyl)-1-methyl-N-[(3S)-1,1 ,3-Trimethyl-2,3-dihydro-1H-inden-4-yl]-1H-pyrazole-4-carboxamide (3-(difluoromethyl)-1-methyl-N-[(3S) -1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1H-pyrazole-4-carboxamide), (II-B030) 3-(difluoromethyl)-N-( 7-fluoro-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl)-1-methyl-1H-pyrazole-4-carboxamide (3-(difluoromethyl )-N-(7-fluoro-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl)-1-methyl-1H-pyrazole-4-carboxamide) (fluindazole , Fluindapyr), (II-B031) 3-(difluoromethyl)-N-[(3R)-7-fluoro-1,1,3-trimethyl-2,3-dihydro-1H-indene- 4-yl]-1-methyl-1H-pyrazole-4-carboxamide (3-(difluoromethyl)-N-[(3R)-7-fluoro-l,1,3-trimethyl-2,3- dihydro-1H-inden-4-yl]-1-methyl-1H-pyrazole-4-carboxamide), (II-B032) 3-(difluoromethyl)-N-[(3S)-7-fluoro-1 ,1,3-Trimethyl-2,3-dihydro-1H-inden-4-yl]-1-methyl-1H-pyrazole-4-carboxamide (3-(difluoromethyl)-N-[ (3S)-7-fluoro-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1-methyl-1H-pyrazole-4-carboxamide), (II-B033) 5 ,8-Difluoro-N-[2-(2-fluoro-4-{[4-(trifluoromethyl)pyridine -2-yl]oxy}phenyl)ethyl]quinazolin-4-amine (5,8-difluoro-N-[2-(2-fluoro-4-{[4-(trifluoromethyl)pyridin-2- yl]oxy}phenyl)ethyl]quinazolin-4-amine), (II-B034) N-(2-cyclopentyl-5-fluorobenzyl)-N-cyclopropyl-3-(difluoromethyl )-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide (N-(2-cyclopentyl-5-fluorobenzyl)-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1- methyl-1-H-pyrazole-4-carboxamide), (II-B035) N-(2-tert-butyl-5-methylbenzyl)-N-cyclopropyl-3-(difluoromethyl )-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide (N-(2-tert-butyl-5-methylbenzyl)-N-cyclopropyl-3-(difluoromethyl)-5-fluoro- 1-methyl-1Hpyrazole-4-carboxamide), (II-B036) N-(2-tert-butylbenzyl)-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1 -Methyl-1H-pyrazole-4-carboxamide (N-(2-tert-butylbenzyl)-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide ), (II-B037) N-(5-chloro-2-ethylbenzyl)-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyridine Azole-4-carboxamide (N-(5-chloro-2-ethylbenzyl)-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide), (II- B038) N-(5-chloro-2-isopropylbenzyl)-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4- Carboxamide (N-(5-chloro-2-isopropylbenzyl)-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide) (isoflucypram) , (II -B039) N-[(1R,4S)-9-(Dichloromethylene)-1,2,3,4-tetrahydro-1,4-methylenenaphthalen-5-yl]-3-( Difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide (N-[(1R,4S)-9-(dichloromethylene)-1,2,3,4-tetrahydro-1,4 -methanonaphthalen-5-yl]-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide), (II-B040) N-[(1S,4R)-9-(dichloromethylene) -1,2,3,4-tetrahydro-1,4-methylenenaphthalen-5-yl]-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide (N-[(1S,4R)-9-(dichloromethylene)-1,2,3,4-tetrahydro-1,4-methanonaphthalen-5-yl]-3-(difluoromethyl)-1-methyl-1H-pyrazole -4-carboxamide), (II-B041) N-[1-(2,4-dichlorophenyl)-1-methoxyprop-2-yl]-3-(difluoromethyl)-1- Methyl-1H-pyrazole-4-carboxamide (N-[1-(2,4-dichlorophenyl)-l-methoxypropan-2-yl]-3-(difluoromethyl)-1-methyl1H-pyrazole-4- carboxamide), (II-B042) N-[2-chloro-6-(trifluoromethyl)benzyl]-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl Base-1H-pyrazole-4-carboxamide (N-[2-chloro-6-(trifluoromethyl)benzyl]-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole- 4-carboxamide), (II-B043) N-[3-chloro-2-fluoro-6-(trifluoromethyl)benzyl]-N-cyclopropyl-3-(difluoromethyl)-5 -Fluoro-1-methyl-1H-pyrazole-4-carboxamide (N-[3-chloro-2-fluoro-6-(trifluoromethyl)benzyl]-N-cyclopropyl-3-(difluoromethyl)-5- fluoro-1-methyl-1H-pyrazole-4-carboxamide), (II-B044) N-[5-chloro -2-(trifluoromethyl)benzyl]-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide (N -[5-chloro-2-(trifluoromethyl)benzyl]-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide), (II-B045) N-cyclopropyl Base-3-(difluoromethyl)-5-fluoro-1-methyl-N-[5-methyl-2-(trifluoromethyl)benzyl]-1H-pyrazole-4-carboxylate Amine (N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-N-[5-methyl-2-(trifluoromethyl)benzyl]-1H-pyrazole-4-carboxamide), (II-B046) N -Cyclopropyl-3-(difluoromethyl)-5-fluoro-N-(2-fluoro-6-isopropylbenzyl)-1-methyl-1H-pyrazole-4-carboxamide (N-cyclopropyl-3-(difluoromethyl)-5-fluoro-N-(2-fluoro-6-isopropylbenzyl)-1-methyl-1H-pyrazole-4-carboxamide), (II-B047) N-cyclopropyl -3-(Difluoromethyl)-5-fluoro-N-(2-isopropyl-5-methylbenzyl)-1-methyl-1H-pyrazole-4-carboxamide (N- cyclopropyl-3-(difluoromethyl)-5-fluoro-N-(2-isopropyl-5-methylbenzyl)-1-methyl-1Hpyrazole-4-carboxamide), (II-B048) N-cyclopropyl-3-(two Fluoromethyl)-5-fluoro-N-(2-isopropylbenzyl)-1-methyl-1H-pyrazole-4-methionamide (N-cyclopropyl-3-(difluoromethyl)-5 -fluoro-N-(2-isopropylbenzyl)-1-methyl-1H-pyrazole-4-carbothioamide), (II-B049) N-cyclopropyl-3-(difluoromethyl)-5-fluoro-N- (2-isopropylbenzyl)-1-methyl-1H-pyrazole-4-carboxamide (N-cyclopropyl-3-(difluoromethyl)-5-fluoro-N-(2-isopropylbenzyl)-1 -methyl-1H- pyrazole-4-carboxamide), (II-B050) N-cyclopropyl-3-(difluoromethyl)-5-fluoro-N-(5-fluoro-2-isopropylbenzyl)-1- Methyl-1H-pyrazole-4-carboxamide (N-cyclopropyl-3-(difluoromethyl)-5-fluoro-N-(5-fluoro-2-isopropylbenzyl)-1-methyl-1H-pyrazole-4- carboxamide), (II-B051) ) N-cyclopropyl-3-(difluoromethyl)-N-(2-ethyl-4,5-dimethylbenzyl)-5-fluoro-1- Methyl-1H-pyrazole-4-carboxamide (N-cyclopropyl-3-(difluoromethyl)-N-(2-ethyl-4,5-dimethylbenzyl)-5-fluoro-1-methyl-1H-pyrazole- 4-carboxamide), (II-B052) N-cyclopropyl-3-(difluoromethyl)-N-(2-ethyl-5-fluorobenzyl)-5-fluoro-1-methyl- 1H-pyrazole-4-carboxamide (N-cyclopropyl-3-(difluoromethyl)-N-(2-ethyl-5-fluorobenzyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide), (II-B053) N-cyclopropyl-3-(difluoromethyl)-N-(2-ethyl-5-methylbenzyl)-5-fluoro-1-methyl-1H-pyrazole -4-Carboxamide (N-cyclopropyl-3-(difluoromethyl)-N-(2-ethyl-5-methylbenzyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide), (II-B054 ) N-cyclopropyl-N-(2-cyclopropyl-5-fluorobenzyl)-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxy Amide (N-cyclopropyl-N-(2-cyclopropyl-5-fluorobenzyl)-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide), (II-B055) N-cyclo Propyl-N-(2-cyclopropyl-5-methylbenzyl)-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide ( N-cyclopropyl-N-(2-cyclopropyl-5-methylbenzyl)-3- (difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide), (II-B056) N-cyclopropyl-N-(2-cyclopropylbenzyl)-3-(difluoro Methyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide (N-cyclopropyl-N-(2-cyclopropylbenzyl)-3-(difluoromethyl)-5-fluoro-1-methyl- 1H-pyrazole-4-carboxamide), (II-B057) 2-(difluoromethyl)-N-(1,1-dimethyl-3-propyl-2,3-dihydro-1H-indene- 4-yl)nicotinamide (2-(difluoromethyl)-N-(l,1-dimethyl-3-propyl-2,3-dihydro-1H-inden-4-yl)nicotinamide), (II-B058) Pyrapropoyne, (II-B059) inpyrfluxam, (II-B060) mepronil, (II-B061) isoflucypram, ( II-B062) oxycarboxin, (II-B063) α-(methoxyimino)-N-methyl-2-[[[1-[3-(trifluoromethyl)phenyl] Ethoxy]imino]methyl]phenylacetamide (α-(methoxyimino)-N-methyl-2-[[[1-[3-(trifluoromethyl)phenyl]ethoxy]imino]methyl]benzeneacetamide), (II-B064) diflumetorim, (II-B065) thifluzamide, (II-B066) fenfuram, (II-B067) benodanil;

(II-C) 呼吸鏈複合物III (complex III)的抑制劑,可例舉如(II-C001) 滅脫定 (ametoctradin)、(II-C002) 安美速 (amisulbrom)、(II-C003) 亞托敏 (azoxystrobin)、(II-C004) 甲香菌酯 (coumethoxystrobin)、(II-C005) 丁香菌酯 (coumoxystrobin)、(II-C006) 賽發滅 (cyazofamid)、(II-C007) 醚菌胺 (dimoxystrobin)、(II-C008) 烯肟菌酯 (enoxastrobin)、(II-C009) 凡殺同 (famoxadone)、(II-C010) 芬滅酮 (fenamidone)、(II-C011) 吩嘧菌酯 (flufenoxystrobin)、(II-C012) 氟嘧菌酯 (fluoxastrobin)、(II-C013) 克收欣 (kresoxim-methyl)、(II-C014) 氧菌胺 (metominostrobin)、(II-C015) 肟醚菌胺 (orysastrobin)、(II-C016) 啶氧菌酯 (picoxystrobin)、(II-C017) 唑菌胺酯 (pyraclostrobin)、(II-C018) 唑胺菌酯 (pyrametostrobin)、(II-C019) 唑菌酯 (pyraoxystrobin)、(II-C020) 三氟敏 (trifloxystrobin)、(II-C021) (2E)-2-{2-[({[(1E)-1-(3-{[(E)-1-氟-2-苯基乙烯基]氧}苯基)亞乙基]胺基}氧)甲基]苯基}-2-(甲氧基亞胺基)-N-甲基乙醯胺 ((2E)-2-{2-[({[(1E)-1-(3-{[(E)-1-fluoro-2-phenylvinyl]oxy}phenyl)ethylidene]amino}oxy)methyl]phenyl}-2-(methoxyimino)-N-methylacetamide)、(II-C022) (2E,3Z)-5-{[1-(4-氯苯基)-1H-吡唑-3-基]氧}-2-(甲氧基亞胺基)-N,3-二甲基戊-3-烯醯胺 ((2E,3Z)-5-{[1-(4-chlorophenyl)-1H-pyrazol-3-yl]oxy}-2-(methoxyimino)-N,3-dimethylpent-3-enamide)、(II-C023) (2R)-2-{2-[(2,5-二甲基苯氧基)甲基]苯基}-2-甲氧基-N-甲基乙醯胺 ((2R)-2-{2-[(2,5-dimethylphenoxy)methyl]phenyl}-2-methoxy-N-methylacetamide)、(II-C024) (2S)-2-{2-[(2,5-二甲基苯氧基)甲基]苯基}-2-甲氧基-N-甲基乙醯胺 ((2S)-2-{2-[(2,5-dimethylphenoxy)methyl]phenyl}-2-methoxy-N-methylacetamide)、(II-C025) (3S,6S,7R,8R)-8-苄基-3-[({3-[(異丁醯氧基)甲氧基]-4-甲氧基吡啶-2-基}羰基)胺基]-6-甲基-4,9-二氧代-1,5-二氧代-7-基-2-甲基丙酸酯 ((3S,6S,7R,8R)-8-benzyl-3-[({3-[(isobutyryloxy)methoxy]-4-methoxypyridin-2-yl}carbonyl)amino]-6-methyl-4,9-dioxo-1,5-dioxonan-7-yl-2- methylpropanoate)(芬吡沙密,Fenpicoxamid)、(II-C026) 2-{2-[(2,5-二甲基苯氧基)甲基]苯基}-2-甲氧基-N-甲基乙醯胺 (2-{2-[(2,5-dimethylphenoxy)methyl]phenyl}-2-methoxy-N-methylacetamide)(滿得賓,Mandestrobin)、(II-C027) N-(3-乙基-3,5,5-三甲基環己基)-3-甲醯胺基-2-羥基苯醯胺 (N-(3-ethyl- 3,5,5-trimethylcyclohexyl)-3-formamido-2-hydroxybenzamide)、(II-C028) (2E,3Z)-5-{[1-(4-氯-2-氟苯基)-1H-吡唑-3-基]氧基}-2-(甲氧基亞胺基)-N,3-二甲基戊-3-烯醯胺 ((2E,3Z)-5-{[1-(4-chloro-2-fluorophenyl)-1H-pyrazol-3-yl]oxy}-2-(methoxyimino)-N,3-dimethylpent-3-enamide)、(II-C029) 甲基{5-[3-(2,4-二甲基苯基)-1H-吡唑-1-基]-2-甲基芐基}胺基甲酸酯 (methyl {5-[3-(2,4-dimethylphenyl)-1H-pyrazol-1-yl]-2-methylbenzyl}carbamate)、(II-C030) 1-(2-{[1-(4-氯苯基)吡唑-3-基]氧基甲基}-3-甲基苯基)-1,4-二氫-4-甲基-5H-四唑-5-酮 (1-(2-{[1-(4-chlorophenyl)pyrazol-3-yl]oxymethyl}-3-methylphenyl)-1,4-dihydro-4-methyl-5H-tetrazol-5-one)(甲基四吡咯,Metyltetraprole)、(II-C031) 氟吡沙胺 (florylpicoxamid)、(II-C032) 吡苯卡 (pyribencarb)、(II-C033) α-(甲氧基亞胺基)-N-甲基-2-[[[1-[3-(三氟甲基)苯基]乙氧基]亞胺基]甲基]苯乙醯胺 (α-(methoxyimino)-N-methyl-2-[[[1-[3-(trifluoromethyl)phenyl]ethoxy]imino]methyl]benzeneacetamide)、(II-C034) metarylpicoxamid;(II-C) Inhibitors of respiratory chain complex III (complex III), such as (II-C001) ametoctradin, (II-C002) amisulbrom, (II-C003) Azoxystrobin, (II-C004) coumethoxystrobin, (II-C005) coumoxystrobin, (II-C006) cyazofamid, (II-C007) ether Dimoxystrobin, (II-C008) enoxastrobin, (II-C009) famoxadone, (II-C010) fenamidone, (II-C011) phenazine Flufenoxystrobin, (II-C012) Fluoxastrobin, (II-C013) Kresoxim-methyl, (II-C014) Metominostrobin, (II-C015) Orysastrobin, (II-C016) picoxystrobin, (II-C017) pyraclostrobin, (II-C018) pyrastrobin, (II- C019) Pyraoxystrobin, (II-C020) Trifloxystrobin, (II-C021) (2E)-2-{2-[({[(1E)-1-(3-{[ (E)-1-fluoro-2-phenylvinyl]oxy}phenyl)ethylene]amino}oxy)methyl]phenyl}-2-(methoxyimino)-N-methyl ((2E)-2-{2-[({[(1E)-1-(3-{[(E)-1-fluoro-2-phenylvinyl]oxy}phenyl)ethylene]amino}oxy )methyl]phenyl}-2-(methoxyimino)-N-methylacetamide), (II-C022) (2E,3Z)-5-{[1-(4-chlorophenyl)-1H-pyrazol-3-yl ]oxy}-2-(methoxyimino)-N,3-dimethylpent-3-enamide ((2E,3Z)-5-{[1-(4-chlorophenyl)-1H- pyrazol-3-yl]ox y}-2-(methoxyimino)-N,3-dimethylpent-3-enamide), (II-C023) (2R)-2-{2-[(2,5-dimethylphenoxy)methyl] Phenyl}-2-methoxy-N-methylacetamide ((2R)-2-{2-[(2,5-dimethylphenoxy)methyl]phenyl}-2-methoxy-N-methylacetamide), ( II-C024) (2S)-2-{2-[(2,5-Dimethylphenoxy)methyl]phenyl}-2-methoxy-N-methylacetamide ((2S) -2-{2-[(2,5-dimethylphenoxy)methyl]phenyl}-2-methoxy-N-methylacetamide), (II-C025) (3S,6S,7R,8R)-8-benzyl-3- [({3-[(isobutyryloxy)methoxy]-4-methoxypyridin-2-yl}carbonyl)amino]-6-methyl-4,9-dioxo-1, 5-dioxo-7-yl-2-methylpropionate ((3S,6S,7R,8R)-8-benzyl-3-[({3-[(isobutyryloxy)methoxy]-4-methoxypyridin- 2-yl}carbonyl)amino]-6-methyl-4,9-dioxo-1,5-dioxonan-7-yl-2-methylpropanoate) (Fenpicoxamid), (II-C026) 2-{ 2-[(2,5-Dimethylphenoxy)methyl]phenyl}-2-methoxy-N-methylacetamide (2-{2-[(2,5-dimethylphenoxy)methyl ]phenyl}-2-methoxy-N-methylacetamide) (Mandestrobin, Mandestrobin), (II-C027) N-(3-ethyl-3,5,5-trimethylcyclohexyl)-3-formyl Amino-2-hydroxybenzamide (N-(3-ethyl-3,5,5-trimethylcyclohexyl)-3-formamido-2-hydroxybenzamide), (II-C028) (2E,3Z)-5-{[ 1-(4-Chloro-2-fluorophenyl)-1H-pyrazol-3-yl]oxy}-2-(methoxyimino)-N,3-dimethylpent-3-ene Amide ((2E,3Z)-5-{[1-(4-chloro-2-fluorophenyl)-1H-pyrazol-3-yl]oxy}-2-(methoxyimino)-N,3-d imethylpent-3-enamide), (II-C029) methyl{5-[3-(2,4-dimethylphenyl)-1H-pyrazol-1-yl]-2-methylbenzyl}amine Carbamate (methyl {5-[3-(2,4-dimethylphenyl)-1H-pyrazol-1-yl]-2-methylbenzyl}carbamate), (II-C030) 1-(2-{[1- (4-chlorophenyl)pyrazol-3-yl]oxymethyl}-3-methylphenyl)-1,4-dihydro-4-methyl-5H-tetrazol-5-one (1 -(2-{[1-(4-chlorophenyl)pyrazol-3-yl]oxymethyl}-3-methylphenyl)-1,4-dihydro-4-methyl-5H-tetrazol-5-one) (methyl tetrapyrrole , Metyltetraprole), (II-C031) florylpicoxamid, (II-C032) pyribencarb, (II-C033) α-(methoxyimino)-N-methyl- 2-[[[1-[3-(Trifluoromethyl)phenyl]ethoxy]imino]methyl]phenylacetamide (α-(methoxyimino)-N-methyl-2-[[[ 1-[3-(trifluoromethyl)phenyl]ethoxy]imino]methyl]benzeneacetamide), (II-C034) metalylpicoxamid;

(II-D) 有絲分裂和細胞分裂的抑制劑,可例舉如(II-D001) 貝芬替 (carbendazim)、(II-D002) 乙黴威 (diethofencarb)、(II-D003) 噻唑菌胺 (ethaboxam)、(II-D004) 氟比來 (fluopicolide)、(II-D005) 賓克隆 (pencycuron)、(II-D006) 腐絕 (thiabendazole)、(II-D007) 甲基硫菌靈 (thiophanate-methyl)、(II-D008) 座賽胺 (zoxamide)、(II-D009) 3-氯-4-(2,6-二氟苯基)-6-甲基-5-苯基噠嗪 (3-chloro-4-(2,6-difluorophenyl)-6-methyl-5- phenylpyridazine)、(II-D010) 3-氯-5-(4-氯苯基)-4-(2,6-二氟苯基)-6-甲基噠嗪 (3-chloro-5-(4-chlorophenyl)-4-(2,6-difluorophenyl)-6-methylpylidazine)、(II-D011) 3-氯-5-(6-氯吡啶-3-基)-6-甲基-4-(2,4,6-三氟苯基)噠嗪 (3-chloro-5-(6-chloropyridin-3-yl)-6-methyl-4-(2,4,6-trifluorophenyl) pyridazine)、(II-D012) 4-(2-溴-4-氟苯基)-N-(2,6-二氟苯基)-1,3-二甲基-1H-吡唑-5-胺 (4-(2-bromo-4-fluorophenyl)-N-(2,6-difluorophenyl)-l,3-dimethyl-1H-pyrazol-5-amine)、(II-D013) 4-(2-溴-4-氟苯基)-N-(2-溴-6-氟苯基)-1,3-二甲基-1H-吡唑-5-胺 (4-(2-bromo-4-fluorophenyl)-N-(2-bromo-6-fluorophenyl)-l,3-dimethyl-1H-pyrazol-5-amine)、(II-D014) 4-(2-溴-4-氟苯基)-N-(2-溴苯基)-1,3-二甲基-1H-吡唑-5-胺 (4-(2-bromo-4-fluorophenyl)-N-(2-bromophenyl)-1,3-dimethyl-1H-pyrazol-5-amine)、(II-D015) 4-(2-溴-4-氟苯基)-N-(2-氯-6-氟苯基)-1,3-二甲基-1H-吡唑-5-胺 (4-(2-bromo-4-fluorophenyl)-N-(2-chloro-6-fluorophenyl)-l,3-dimethyl-1H-pyrazol-5-amine)、(II-D016) 4-(2-溴-4-氟苯基)-N-(2-氯苯基)-1,3-二甲基-1H-吡唑-5-胺 (4-(2-bromo-4-fluorophenyl)-N-(2-chlorophenyl)-l,3-dimethyl-1H-pyrazol-5-amine)、(II-D017) 4-(2-溴-4-氟苯基)-N-(2-氟苯基)-1,3-二甲基-1H-吡唑-5-胺 (4-(2-bromo-4-fluorophenyl)-N-(2-fluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine)、(II-D018) 4-(2-氯-4-氟苯基)-N-(2,6-二氟苯基))-1,3-二甲基-1H-吡唑-5-胺 (4-(2-chloro-4-fluorophenyl)-N-(2,6-difluorophenyl)-l,3-dimethyl-1H-pyrazol-5-amine)、(II-D019) 4-(2-氯-4-氟苯基)-N-(2-氯-6-氟苯基)-1,3-二甲基-1H-吡唑-5-胺 (4-(2-chloro-4-fluorophenyl)-N-(2-chloro-6-fluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine)、(II-D020) 4-(2-氯-4-氟苯基)-N-(2-氯苯基)-1,3-二甲基-1H-吡唑-5-胺 (4-(2-chloro-4-fluorophenyl)-N-(2-chlorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine)、(II-D021) 4-(2-氯-4-氟苯基)-N-(2-氟苯基)-1,3-二甲基-1H-吡唑-5-胺 (4-(2-chloro-4-fluorophenyl)-N-(2-fluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine)、(II-D022) 4-(4-氯苯基)-5-(2,6-二氟苯基)-3,6-二甲基噠嗪 (4-(4-chlorophenyl)-5-(2,6-difluorophenyl)-3,6- dimethylpyridazine)、(II-D023) N-(2-溴-6-氟苯基)-4-(2-氯-4-氟苯基)-l,3-二甲基-1H-吡唑-5-胺 (N-(2-bromo-6-fluorophenyl)-4-(2-chloro-4-fluorophenyl)-l,3-dimethyl-1H-pyrazol-5-amine)、(II-D024) N-(2-溴苯基)-4-(2-氯-4-氟苯基)-1,3-二甲基-1H-吡唑-5-胺 (N-(2-bromophenyl)-4-(2-chloro-4-fluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine)、(II-D025) N-(4-氯-2,6-二氟苯基)-4-(2-氯-4-氟苯基)-1,3-二甲基-1H-吡唑-5-胺 (N-(4-chloro-2,6-difluorophenyl)-4-(2-chloro-4-fluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine)、(II-D026) 免賴得 (benomyl);(II-D) Inhibitors of mitosis and cell division, such as (II-D001) carbendazim, (II-D002) diethofencarb, (II-D003) ethaboxam ( ethaboxam), (II-D004) fluopicolide, (II-D005) pencycuron, (II-D006) thiabendazole, (II-D007) thiophanate-methyl (thiophanate- methyl), (II-D008) zoxamide, (II-D009) 3-chloro-4-(2,6-difluorophenyl)-6-methyl-5-phenylpyridazine (3 -chloro-4-(2,6-difluorophenyl)-6-methyl-5-phenylpyridazine), (II-D010) 3-chloro-5-(4-chlorophenyl)-4-(2,6-difluoro Phenyl)-6-methylpyridazine (3-chloro-5-(4-chlorophenyl)-4-(2,6-difluorophenyl)-6-methylpyridazine), (II-D011) 3-chloro-5-( 6-chloropyridin-3-yl)-6-methyl-4-(2,4,6-trifluorophenyl)pyridazine (3-chloro-5-(6-chloropyridin-3-yl)-6- methyl-4-(2,4,6-trifluorophenyl) pyridazine), (II-D012) 4-(2-bromo-4-fluorophenyl)-N-(2,6-difluorophenyl)-1, 3-Dimethyl-1H-pyrazol-5-amine (4-(2-bromo-4-fluorophenyl)-N-(2,6-difluorophenyl)-l,3-dimethyl-1H-pyrazol-5-amine ), (II-D013) 4-(2-bromo-4-fluorophenyl)-N-(2-bromo-6-fluorophenyl)-1,3-dimethyl-1H-pyrazole-5- Amine (4-(2-bromo-4-fluorophenyl)-N-(2-bromo-6-fluorophenyl)-l,3-dimethyl-1H-pyrazol-5-amine), (II-D014) 4-(2 -Bromo-4-fluorophenyl)-N-(2-bromophenyl)-1,3-dimethyl-1H-pyrazol-5-amine (4-(2-bromo-4-fluorophenyl)-N -(2-bromophenyl)-1,3-dimethyl -1H-pyrazol-5-amine), (II-D015) 4-(2-bromo-4-fluorophenyl)-N-(2-chloro-6-fluorophenyl)-1,3-dimethyl -1H-pyrazol-5-amine (4-(2-bromo-4-fluorophenyl)-N-(2-chloro-6-fluorophenyl)-l,3-dimethyl-1H-pyrazol-5-amine), ( II-D016) 4-(2-bromo-4-fluorophenyl)-N-(2-chlorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine (4-(2- bromo-4-fluorophenyl)-N-(2-chlorophenyl)-l,3-dimethyl-1H-pyrazol-5-amine), (II-D017) 4-(2-bromo-4-fluorophenyl)-N -(2-fluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine(4-(2-bromo-4-fluorophenyl)-N-(2-fluorophenyl)-1,3- dimethyl-1H-pyrazol-5-amine), (II-D018) 4-(2-chloro-4-fluorophenyl)-N-(2,6-difluorophenyl))-1,3-dimethyl Base-1H-pyrazol-5-amine (4-(2-chloro-4-fluorophenyl)-N-(2,6-difluorophenyl)-l,3-dimethyl-1H-pyrazol-5-amine), (II -D019) 4-(2-chloro-4-fluorophenyl)-N-(2-chloro-6-fluorophenyl)-1,3-dimethyl-1H-pyrazole-5-amine (4- (2-chloro-4-fluorophenyl)-N-(2-chloro-6-fluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine), (II-D020) 4-(2-chloro-4 -Fluorophenyl)-N-(2-chlorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine (4-(2-chloro-4-fluorophenyl)-N-(2- chlorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine), (II-D021) 4-(2-chloro-4-fluorophenyl)-N-(2-fluorophenyl)-1,3 -Dimethyl-1H-pyrazol-5-amine (4-(2-chloro-4-fluorophenyl)-N-(2-fluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine), ( II-D022) 4-(4-Chlorobenzene Base)-5-(2,6-difluorophenyl)-3,6-dimethylpyridazine (4-(4-chlorophenyl)-5-(2,6-difluorophenyl)-3,6-dimethylpyridazine) 、(II-D023) N-(2-bromo-6-fluorophenyl)-4-(2-chloro-4-fluorophenyl)-l,3-dimethyl-1H-pyrazol-5-amine (N-(2-bromo-6-fluorophenyl)-4-(2-chloro-4-fluorophenyl)-l,3-dimethyl-1H-pyrazol-5-amine), (II-D024) N-(2- Bromophenyl)-4-(2-chloro-4-fluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine (N-(2-bromophenyl)-4-(2-chloro -4-fluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine), (II-D025) N-(4-chloro-2,6-difluorophenyl)-4-(2-chloro- 4-fluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine (N-(4-chloro-2,6-difluorophenyl)-4-(2-chloro-4-fluorophenyl)- 1,3-dimethyl-1H-pyrazol-5-amine), (II-D026) benomyl;

(II-E) 可具有多位點作用的化合物,可例舉如 (II-E001) 波爾多液 (bordeaux mixture)、(II-E002) 四氯丹 (captafol)、(II-E003) 蓋普丹 (captan)、(II-E004) 四氯異苯腈 (chlorothalonil)、(II-E005) 氫氧化銅、(II-E006) 環烷酸銅 (copper naphthenate)、(II-E007) 氧化銅、(II-E008) 氧氯化銅 (copper oxychloride)、(II-E009) 硫酸銅 (copper sulfate)、(II-E010) 腈硫醌 (dithianon)、(II-E011) 多果定 (dodine)、(II-E012) 福爾培 (folpet)、(II-E013) 鋅錳乃浦 (mancozeb)、(II-E014) 代森猛 (maneb)、(II-E015) 免得爛 (metiram)、(II-E016) 免得爛鋅 (metiram zinc)、(II-E017) 喹啉銅 (oxine-copper)、(II-E018) 甲基鋅乃浦 (propineb)、(II-E019) 硫和硫製備物 (sulfur preparations),例如多硫化鈣 (calcium polysulfide)、(II-E020) 福美雙 (thiram)、(II-E021) 代森鋅 (zineb)、(II-E022) 福美鋅 (ziram)、(II-E023) 6-乙基-5,7-二氧-6,7-二氫-5H-吡咯並[3’,4’:5,6][1,4]二硫並[2,3-c][1,2]噻唑-3-腈 (6-ethyl-5,7-dioxo-6,7-dihydro-5H­pynolo[3’,4’:5,6][1,4]dithiino[2,3-c] [1,2]thiazole-3-carbonitrile、(II-E024) 富爾邦 (ferbam)、(II-E025) 益發靈 (dichlofluanid)、(II-E026) 甲基益發靈 (tolylfluanid)、(II-E027) 雙胍鹽 (guazatine)、(II-E028) 克熱淨 (iminoctadine)、(II-E029) 敵菌靈 (anilazine)、(II-E030) 滅蟎猛 (quinomethionate);(II-E) Compounds that may act at multiple sites, such as (II-E001) bordeaux mixture, (II-E002) captafol, (II-E003) captafane (captan), (II-E004) tetrachloroisobenzonitrile (chlorothalonil), (II-E005) copper hydroxide, (II-E006) copper naphthenate, (II-E007) copper oxide, ( II-E008) Copper oxychloride, (II-E009) Copper sulfate, (II-E010) Dithianon, (II-E011) Dodine, ( II-E012) Folpet, (II-E013) Mancozeb, (II-E014) Maneb, (II-E015) Metiram, (II-E015) E016) Metiram zinc, (II-E017) oxine-copper, (II-E018) propineb, (II-E019) sulfur and sulfur preparations (sulfur preparations), such as calcium polysulfide, (II-E020) thiram, (II-E021) zineb, (II-E022) ziram, (II-E023 ) 6-ethyl-5,7-dioxo-6,7-dihydro-5H-pyrrolo[3',4':5,6][1,4]dithio[2,3-c] [1,2]thiazole-3-carbonitrile (6-ethyl-5,7-dioxo-6,7-dihydro-5Hpynolo[3',4':5,6][1,4]dithiino[2,3- c] [1,2] thiazole-3-carbonitrile, (II-E024) Fuerbang (ferbam), (II-E025) Yifaling (dichlofluanid), (II-E026) methylyifaling (tolylfluanid), ( II-E027) Guazatine, (II-E028) iminoctadine, (II-E029) anilazine, (II-E030) quinometh ionate);

(II-F) 可誘發宿主防禦之化合物,可例舉如(II-F001) 阿拉酸式苯-S-甲基 (acibenzolar-S-methyl)、(II-F002) 亞汰尼 (isotianil)、(II-F003) 撲殺熱 (probenazole)、(II-F004) 噻醯菌胺 (tiadinil);(II-F) Compounds that can induce host defense, such as (II-F001) acibenzolar-S-methyl, (II-F002) isotianil, (II-F003) probenazole, (II-F004) tiadinil;

(II-G) 胺基酸及/或蛋白質生物合成之抑制劑,可例舉如(II-G001) 賽普洛 (cyprodinil)、(II-G002) 嘉賜黴素 (kasugamycin)、(II-G003) 嘉賜黴素鹽酸鹽水合物 (kasugamycin hydrochloride hydrate)、(II-G004) 土黴素 (oxytetracycline)、(II-G005) 派美尼 (pyrimethanil)、(II-G006) 3-(5-氟-3,3,4,4-四甲基-3,4-二氫異喹啉-1-基)喹啉 (3-(5-fluoro-3,3,4,4-tetramethyl-3,4-dihydroisoquinolin-1-yl)quinoline)、(II-G007) 麥穗寧 (fuberidazole)、(II-G008) 硫菌靈 (thiophanate)、(II-G009) 滅瘟素-S (blasticidin-S)、(II-G010) 鏈黴素 (streptomycin)、(II-G011) 滅派林 (mepanipyrim);(II-G) Inhibitors of amino acid and/or protein biosynthesis, such as (II-G001) cyprodinil, (II-G002) kasugamycin, (II-G002) G003) kasugamycin hydrochloride hydrate, (II-G004) oxytetracycline, (II-G005) pyrimethanil, (II-G006) 3-(5- Fluoro-3,3,4,4-tetramethyl-3,4-dihydroisoquinolin-1-yl)quinoline (3-(5-fluoro-3,3,4,4-tetramethyl-3, 4-dihydroisoquinolin-1-yl)quinoline), (II-G007) fuberidazole, (II-G008) thiophanate, (II-G009) blasticidin-S (blasticidin-S) , (II-G010) streptomycin, (II-G011) mepanipyrim;

(II-H) ATP產生之抑制劑,可例舉如(II-H001) 矽噻菌胺 (silthiofam)、(II-H002) 三苯基乙酸錫 (fentin acetate)、(II-H003) 三苯錫氯 (fentin chloride)、(II-H004) 毒菌錫 (fentin hydroxide);(II-H) Inhibitors of ATP production, such as (II-H001) silthiofam, (II-H002) fentin acetate, (II-H003) triphenyl Fentin chloride, (II-H004) fentin hydroxide;

(II-I) 細胞壁合成抑制劑,可例舉如(II-I001) 苯噻菌胺 (benthiavalicarb)、(II-I002) 達滅芬 (dimethomorph)、(II-I003) 氟嗎啉 (flumorph)、(II-I004) 丙森鋅 (iprovalicarb)、(II-I005) 曼普胺 (mandipropamid)、(II-I006) 丁吡嗎啉 (pyrimorph)、(II-I007) 纈菌胺 (valifenalate)、(II-I008) (2E)-3-(4-叔丁基苯基)-3-(2-氯吡啶-4-基)-1-(嗎啉-4-基)丙-2-烯-1-酮 ((2E)-3-(4-tert-butylphenyl)-3-(2-chloropyridin-4-yl)-l-(morpholin-4-yl)prop-2-en-1-one)、(II-I009) (2Z)-3-(4-叔丁基苯基)-3-(2-氯吡啶-4-基)-1-(嗎啉-4-基)丙-2-烯-1-酮 ((2Z)-3-(4-tert-butylphenyl)-3-(2-chloropyridin-4-yl)-1-(morpholin-4-yl)prop-2-en-1-one)、(II-I010) 苯噻菌胺-異丙基 (benthiavalicarb-isopropyl)、(II-I011) 保粒黴素 (polyoxins)、(II-I012) N-[2-[4-[[3-(4-氯苯基)-2-丙炔-1-基]氧基]-3- (N-[2-[4-[[3-(4-chlorophenyl)-2-propyn-1-yl]oxy]-3-)、(II-I013) 甲氧基苯基]乙基]-3-甲基-2-[(甲基磺醯基)-胺基]丁醯胺 (methoxyphenyl]ethyl]-3-methyl-2-[(methylsulfonyl)-amino]butanamide)、(II-I014) N-[2-[4-[[3-(4-氯苯基)-2-丙炔-1-基]氧基]-3-甲氧基苯基]-乙基]-3-甲基-2-[(乙基磺醯基)胺基]丁醯胺 (N-[2-[4-[[3-(4-chlorophenyl)-2-propyn-1-yl]oxy]-3-methoxyphenyl]-ethyl]-3-methyl-2-[(ethylsulfonyl)amino]butanamide);(II-I) Cell wall synthesis inhibitors, such as (II-I001) benthiavalicarb, (II-I002) dimethomorph, (II-I003) flumorph , (II-I004) iprovalicarb, (II-I005) mandipropamid, (II-I006) pyrimorph, (II-I007) valifenalate, (II-I008) (2E)-3-(4-tert-butylphenyl)-3-(2-chloropyridin-4-yl)-1-(morpholin-4-yl)prop-2-ene- 1-keto ((2E)-3-(4-tert-butylphenyl)-3-(2-chloropyridin-4-yl)-l-(morpholin-4-yl)prop-2-en-1-one), (II-I009) (2Z)-3-(4-tert-butylphenyl)-3-(2-chloropyridin-4-yl)-1-(morpholin-4-yl)prop-2-ene- 1-keto ((2Z)-3-(4-tert-butylphenyl)-3-(2-chloropyridin-4-yl)-1-(morpholin-4-yl)prop-2-en-1-one), (II-I010) Benthiavalicarb-isopropyl, (II-I011) Polyoxins, (II-I012) N-[2-[4-[[3-( 4-Chlorophenyl)-2-propyn-1-yl]oxyl]-3-(N-[2-[4-[[3-(4-chlorophenyl)-2-propyn-1-yl]oxy ]-3-), (II-I013) Methoxyphenyl]ethyl]-3-methyl-2-[(methylsulfonyl)-amino]butyramide (methoxyphenyl]ethyl]-3 -methyl-2-[(methylsulfonyl)-amino]butanamide), (II-I014) N-[2-[4-[[3-(4-chlorophenyl)-2-propyn-1-yl]oxy base]-3-methoxyphenyl]-ethyl]-3-methyl-2-[(ethylsulfonyl)amino]butyramide (N-[2-[4-[[3- (4-chlorophenyl)-2-propyn-1-yl]oxy]-3-methoxyphenyl]-ethyl]-3-methyl-2-[(ethylsulfonyl)amino]butanamid e);

(II-J) 脂質和膜合成之抑制劑,可例舉如(II-J001) 普拔克 (propamocarb)、(II-J002) 普拔克鹽酸鹽 (propamocarb hydrochloride)、(II-J003) 脫克松 (tolclofos-methyl)、(II-J004) 雙硫磷 (difenphos)、(II- J005) 愛得寶 (iodocarb)、(II-J006) 硫菌威 (prothiocarb)、(II-J007) 護粒松 (edifenphos)、(II-J008) 丙基喜樂松 (iprobenfos)、(II-J009) 白粉松 (pyrazophos)、(II-J010) 亞賜圃 (isoprothiolane)、(II-J011) 依得利 (etridiazole)、(II-J012) 聯苯 (biphenyl)、(II-J013) 地茂丹 (chloroneb)、(II-J014) 大克爛 (dicloran)、(II-J015) 喹啉 (quintozene)、(II-J016) 四氯硝基苯 (tecnazene);(II-J) Inhibitors of lipid and membrane synthesis, such as (II-J001) propamocarb, (II-J002) propamocarb hydrochloride, (II-J003) Tolclofos-methyl, (II-J004) Difenphos, (II-J005) Iodocarb, (II-J006) Prothiocarb, (II-J007) Edifenphos, (II-J008) Iprobenfos, (II-J009) Pyrazophos, (II-J010) Isoprothiolane, (II-J011) Eide Etridiazole, (II-J012) biphenyl, (II-J013) chloroneb, (II-J014) dicloran, (II-J015) quintozene , (II-J016) tetrachloronitrobenzene (tecnazene);

(II-K) 黑色素生物合成抑制劑,可例舉如(II-K001) 三環唑 (tricyclazole)、(II-K002) 2,2,2-三氟乙基{3-甲基-1-[(4-甲基苯甲醯基)胺基]丁烷-2-基}胺基甲酸酯 (2,2,2-trifluoroethyl {3-methyl-1-[(4-methylbenzoyl)amino]butan-2-yl}carbamate)、(II-K003) 加普胺 (carpropamid)、(II-K004) 雙氯氰菊酯 (diclocymet)、(II-K005) 芬諾尼 (fenoxanil)、(II-K006) 熱必斯 (fthalide)、(II-K007) 百快隆 (pyroquilon);(II-K) Melanin biosynthesis inhibitors, such as (II-K001) tricyclazole (tricyclazole), (II-K002) 2,2,2-trifluoroethyl {3-methyl-1- [(4-Methylbenzoyl)amino]butan-2-yl}carbamate (2,2,2-trifluoroethyl {3-methyl-1-[(4-methylbenzoyl)amino]butan -2-yl}carbamate), (II-K003) carpropamid, (II-K004) diclocymet, (II-K005) fenoxanil, (II-K006) heat (fthalide), (II-K007) Pyroquilon (pyroquilon);

(II-L) 核酸合成抑制劑,可例舉如(II-L001) 本達樂 (benalaxyl)、(II-L002) 右本達樂 (benalaxyl-M (kiralaxyl))、(II-L003) 滅達樂 (metalaxyl)、(II-L004) 右滅達樂 (metalaxyl-M)(甲芬沙姆,mefenoxam)、(II-L005) 依瑞莫 (ethirimol)、(II-L006) 呋霜靈 (furalaxyl)、(II-L007) 呋醯胺 (ofurace)、(II-L008) 歐索林酸 (oxolinic acid)、(II-L009) 殺紋寧 (hymexazole)、(II-L010) 辛噻酮 (octhilinone)、(II-L011) 布瑞莫 (bupirimate)、(II-L012) 二甲嘧酚 (dimethirimol);(II-L) Nucleic acid synthesis inhibitors, such as (II-L001) Benalaxyl (benalaxyl), (II-L002) Right Benalaxyl (benalaxyl-M (kiralaxyl)), (II-L003) Inhibitor Dale (metalaxyl), (II-L004) dextromethorphan (metalaxyl-M) (Mefenoxam, mefenoxam), (II-L005) Yi Rui Mo (ethirimol), (II-L006) furaxyl ( furalaxyl), (II-L007) ofurace, (II-L008) oxolinic acid, (II-L009) hymexazole, (II-L010) octhilone ( octhilinone), (II-L011) bupirimate, (II-L012) dimethirimol;

(II-M) 訊息傳遞之抑制劑,可例舉如(II-M001) 護汰寧 (fludioxonil)、(II-M002) 依普同 (iprodione)、(II-M003) 撲滅寧 (procymidone)、(II-M004) 普快淨 (proquinazid)、(II-M005) 快諾芬 (quinoxyfen)、(II-M006) 免克寧(vinclozolin)、(II-M007) 克氯得 (chlozolinate)、(II-M008) 拌種咯 (fenpiclonil)、(II-M009) 普快淨 (proquinazid)、(II-M010) 2-丁氧基-6-碘-3-丙基-4H-1-苯並吡喃-4-酮 (2-butoxy-6-iodo-3-propyl-4H-1-benzopyran-one);(II-M) Inhibitors of signal transmission, such as (II-M001) fludioxonil, (II-M002) iprodione, (II-M003) procymidone, (II-M004) proquinazid, (II-M005) quinoxyfen, (II-M006) vinclozolin, (II-M007) chlozolinate, (II- M008) fenpiclonil, (II-M009) proquinazid, (II-M010) 2-butoxy-6-iodo-3-propyl-4H-1-benzopyran- 4-keto (2-butoxy-6-iodo-3-propyl-4H-1-benzopyran-one);

(II-N) 可作為去偶合劑之化合物,可例舉如(II-N001) 扶吉胺 (fluazinam)、(II-N002) 甲基敵蟎普 (meptyldinocap)、(II-N003) 百蟎克 (binapacryl)、(II-N004) 敵蟎普 (dinocap);(II-N) A compound that can be used as a decoupling agent, such as (II-N001) fluazinam, (II-N002) meptyldinocap, (II-N003) mite Gram (binapacryl), (II-N004) dinocap (dinocap);

(II-O) 其他殺真菌劑,可例舉如(II-O001) 離層酸 (abscisic acid)、(II-O002) 本噻唑 (benthiazole)、(II-O003) 貝梭沙今 (bethoxazin)、(II-O004) 卡普黴素 (capsimycin)、(II-O005) 卡吩 (carvone)、(II-O006) 蟎離丹 (chinomethionat)、(II-O007) 庫發尼 (cufraneb)、(II-O008) 賽芬胺 (cyflufenamid)、(II-O009) 克絕 (cymoxanil)、(II-O010) 環丙磺草胺 (cyprosulfamide)、(II-O011) 噻菌淨 (flutianil)、(II-O012) 福賽得鋁 (fosetyl­aluminium)、(II-O013) 福賽得鈣 (fosetyl-calcium)、(II-O014) 福賽得鈉 (fosetyl-sodium)、(II-O015) 異硫氰酸甲酯 (methyl isothiocyanate)、(II-O016) 滅芬農 (metrafenone)、(II-O017) 米德黴 (mildiomycin)、(II-O018) 納坦黴素 (natamycin)、(II-O019) 二甲基二硫代胺甲酸鎳 (nickel dimethyldithiocarbamate)、(II-O020) 硝基太-異丙基 (nitrothal-isopropyl)、(II-O021) 歐賽保 (oxamocarb)、(II-O022) 氧硫普靈 (oxathiapiprolin)、(II-O023) 歐芬汀 (oxyfenthiin)、(II-O024) 五氯酚及其鹽類 (pentachlorophenol and salts)、(II-O025) 膦酸及其鹽類 (phosphorous acid and its salts)、(II-O026) 霜黴威乙膦酸鹽 (propamocarb-fosetylate)、(II-O027) 必伏農 (pyriofenone)(克吩農,chlazafenone)、(II-O028) 特伏克 (tebufloquin)、(II-O029) 特伏爛 (tecloftalam)、(II-O030) 特利吩 (tolnifanide)、(I-O031) 1-(4-{4-[(5R)-5-(2,6-二氟苯基)-4,5-二氫-1,2-唑-3-基]-1,3-噻唑-2-基}哌啶-1-基)-2-[5-甲基-3-(三氟甲基)-1H-吡唑-1-基]乙酮 (1-(4-{4-[(5R)-5-(2,6-difluorophenyl)-4,5-dihydro-1,2-oxazol-3-yl]-1,3-thiazol-2-yl}piperidin-1-yl)-2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]ethanone)、(II-O032) 1-(4-{4-[(5S)-5-(2,6-二氟苯基)-4,5-二氫-1,2-唑-3-基]-1,3-噻唑-2-基}哌啶-1-基)-2-[5-甲基-3-(三氟甲基)-1H-吡唑-1-基]乙酮 (1-(4-{4-[(5S)-5-(2,6-difluorophenyl)-4,5-dihydro-1,2-oxazol-3-yl]-l,3-thiazol-2-yl}piperidin-1-yl)-2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]ethanone)、(II-O033) 2-(6-苯甲基吡啶-2-基)喹唑啉 (2-(6-benzylpyridin-2-yl)quinazoline)、(II-O034) 2,6-二甲基-1H,5H-[1,4]二硫雜環己烯並[2,3-c:5,6-c’]二吡咯-1,3,5,7(2H,6H)-四酮 (2,6-dimethyl-1H,5H-[1,4]dithiino[2,3-c:5,6-c’]dipyrrole-1,3,5,7(2H,6H)-tetrone)、(II-O035) 2-[3,5-雙(二氟甲基)-1H-吡唑-1-基]-1-[4-(4-{5-[2-(丙-2-炔-1-基氧)苯基]-4,5-二氫-1,2-唑-3-基}-1,3-噻唑-2-基)哌啶-1-基]乙酮 (2-[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]-1-[4-(4-{5-[2-(prop-2-yn-1-yloxy)phenyl]-4,5-dihydro-l,2-oxazol-3-yl}-l,3-thiazol-2-yl)piperidin-1-yl]ethanone)、(II-O036) 2-[3,5-雙(二氟甲基)-1H-吡唑-1-基]-1-[4-(4-{5-[2-氯-6-(丙-2-炔-1-基氧)苯基]-4,5-二氫-1,2-唑-3-基}-1,3-噻唑-2-基)哌啶-1-基]乙酮 (2-[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]-1-[4-(4-{5-[2-chloro-6-(prop-2-yn-1-yloxy)phenyl]-4,5-dihydro-1,2-oxazol-3-yl}-1,3-thiazol-2-yl)piperidin-1-yl]ethanone)、(II-O037) 2-[3,5-雙(二氟甲基)-1H-吡唑-1-基]-1-[4-(4-{5-[2-氟-6-(丙-2-炔-1-基氧)苯基]-4,5-二氫-1,2-唑-3-基}-1,3-噻唑-2-基)哌啶-1-基]乙酮 (2-[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]-1-[4-(4-{5-[2-fluoro-6-(prop-2-yn-1-yloxy)phenyl]-4,5-dihydro-l,2-oxazol-3-yl}-l,3-thiazol-2- yl)piperidin-1-yl]ethanone)、(II-O038) 2-[6-(3-氟-4-甲氧基苯基)-5-甲基吡啶-2-基]喹唑啉 (2-[6-(3-fluoro-4-methoxyphenyl)-5-methylpyridin-2-yl]quinazoline)、(II-O039) 2-{(5R)-3-[2-(1-{[3,5-雙(二氟甲基)-1H-吡唑-1-基]乙醯基}哌啶-4-基)-1,3-噻唑-4-基]-4,5-二氫-1,2-唑-5-基}-3-氯苯基甲磺酸酯 (2-{(5R)-3-[2-(1-{[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1,3-thiazol-4-yl]-4,5-dihydro-l,2-oxazol-5-yl}-3-chlorophenyl methanesulfonate)、(II-O040) 2-{(5S)-3-[2-(1-{[3,5-雙(二氟甲基)-1H-吡唑-1-基]乙醯基}哌啶-4-基)-1,3-噻唑-4-基]-4,5-二氫-1,2-唑-5-基}-3-氯苯基甲磺酸酯 (2-{(5S)-3-[2-(1-{[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1,3-thiazol-4-yl]-4,5-dihydro-1,2-oxazol-5-yl}-3-chlorophenyl methanesulfonate)、(II-O041) 2-{2-[(7,8-二氟-2-甲基喹啉-3-基)氧]-6-氟苯基}丙-2-醇 (2-{2-[(7,8-difluoro-2-methylquinolin-3-yl)oxy]-6-fluorophenyl}propan-2-ol)、(II-O042) 2-{2-氟-6-[(8-氟-2-甲基喹啉-3-基)氧]苯基}丙-2-醇 (2-{2-fluoro-6-[(8-fluoro-2-methylquinolin-3-yl)oxy]phenyl}propan-2-ol)、(II-O043) 2-{3-[2-(1-{[3,5-雙(二氟甲基)-1H-吡唑-1-基]乙醯基}哌啶-4-基)-1,3-噻唑-4- 基]-4,5-二氫-1,2-唑-5-基}-3-氯苯基甲磺酸酯 (2-{3-[2-(1-{[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1,3-thiazol-4-yl]-4,5-dihydro-1,2-oxazol-5-yl}-3-chlorophenyl methanesulfonate)(氟醚菌醯胺,fluoxapiprolin)、(II-O044) 2-{3-[2-(1-{[3,5-雙(二氟甲基)-1H-吡唑-1-基]乙醯基}哌啶-4-基)-1,3-噻唑-4-基]-4,5-二氫-1,2-唑-5-基}苯基甲磺酸酯 (2-{3-[2-(1-{[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1,3-thiazol-4-yl]-4,5-dihydro-1,2-oxazol-5-yl}phenyl methanesulfonate)、(II-O045) 2-苯基酚及其鹽類 (2-phenylphenol and salts)、(II-O046) 3-(4,4,5-三氟-3,3-二甲基-3,4-二氫異喹啉-1-基)喹啉 (3-(4,4,5-trifluoro-3,3-dimethyl-3,4-dihydroisoquinolin-1-yl)quinoline)、(II-O047) 3-(4,4-二氟-3,3-二甲基-3,4-二氫異喹啉-1-基)喹啉 (3-(4,4-difluoro-3,3-dimethyl-3,4-dihydroisoquinolin-1-yl)quinoline)(喹富美林,Quinofumelin)、(II-O048) 4-胺基-5-氟嘧啶-2-醇(互變異構形:4-胺基-5-氟嘧啶-2(1H)-酮) (4-amino-5-fluoropyrimidin-2-ol (tautomeric form: 4-amino-5- fluoropyrimidin-2(1H)-one))、(II-O049) 4-側氧基-4-[(2-苯基乙基)胺基]丁酸 (4-oxo-4-[(2-phenylethyl)amino]butanoic acid)、(II-O050) 5-胺基-1,3,4-噻二唑-2-硫醇 (5-amino-1,3,4-thiadiazole-2-thiol)、(II-O051) 5-氯-N’-苯基-N’-(丙-2-炔-1-基)噻吩-2-磺醯基醯肼 (5-chloro-N’-phenyl-N’-(prop-2-yn-1-yl)thiophene-2-sulfonohydrazide)、(II-O052) 5-氟-2-[(4-氟苯甲基)氧]嘧啶-4-胺 (5-fluoro-2-[(4-fluorobenzyl)oxy]pyrimidin-4-amine)、(II-O053) 5-氟-2-[(4-甲基苯甲基)氧]嘧啶-4-胺 (5-fluoro-2-[(4-methylbenzyl)oxy]pyrimidin-4-amine)、(II-O054) 9-氟-2,2-二甲基-5-(喹啉-3-基)-2,3-二氫-1,4-並苯並氮平 (9-fluoro-2,2-dimethyl-5-(quinolin-3-yl)-2,3-dihydro-1,4-benzoxazepine)、(II-O055) {6-[({[(Z)-(1-甲基-1H-四唑-5-基)(苯基)亞甲基]胺基}氧)甲基]吡啶-2-基}胺甲酸丁-3-炔-1-基酯 (but-3-yn-1-yl{6-[({[(Z)-(l-methyl-1H-tetrazol-5-yl)(phenyl)methylene]amino}oxy)methyl]pyridin-2-yl}carbamate)、(II-O056) (2Z)-3-胺基-2-腈基-3-苯基丙烯酸乙酯 (ethyl (2Z)-3-amino-2-cyano-3-phenylacrylate)、(II-O057) 吩-1-羧酸 (phenazine-1-carboxylic acid)、(II-O058) 3,4,5-三羥基苯甲酸丙酯 (propyl 3,4,5-trihydroxybenzoate)、(II-O059) 喹啉-8-醇 (quinolin-8-ol)、(II-O060) 喹啉-8-醇硫酸鹽 (2:1) (quinolin-8-ol sulfate (2:1))、(II-O061) {6-[({[(1-甲基-1H-四唑-5-基)(苯基)亞甲基]胺基}氧)甲基]吡啶-2-基}胺甲酸第三丁酯 (tert-butyl {6-[({[(1-methyl-1H-tetrazol-5-yl)(phenyl)methylene]amino}oxy)methyl]pyridin-2-yl}carbamate)、(II-O062) 5‑氟‑4‑亞胺基‑3‑甲基‑1‑[(4‑甲基苯基)磺醯基]‑3,4‑二氫嘧啶‑2(1H)‑酮 (5-fluoro-4-imino-3-methyl-1-[(4-methylphenyl)sulfonyl]-3,4-dihydropyrimidin-2(1H)-one)、(II-O063) 吡啶氯甲基 (pyridachlometyl)、(II-O064) 伊匹芬喹 (ipflufenoquin)、(II-O065) 氯胺吡啶芬 (aminopyrifen)、(II-O066) N-[[(環丙基-甲氧基)胺基][6-(二氟甲氧基)-2,3-二氟苯基]-亞甲基]苯乙醯胺 (N-[[(cyclopropyl-methoxy)amino][6-(difluoromethoxy)-2,3-difluorophenyl]-methylene]benzeneacetamide)、(II-O067) 滅速克 (methasulfocarb)、(II-O068) 代森鈉 (nabam)、(II-O069) 萬得寧 (oxine copper)、(II-O070) 滅菌磷 (ditalimfos)、(II-O071) 敵菌酮 (drazoxolon)、(II-O072) 甲苯氟磺胺 (tolyfluanide)、(II-O073) 苄氯三唑醇 (diclobutrazol)、(II-O074) 酯菌胺 (cyprofuram)、(II-O075) 磷酸及其鹽類 (phophorous acid and salts)、(II-O076) 富米綜 (ferimzone)、(II-O077) pyrrolnitrin、(II-O078) 咪唑嗪 (triazoxide)、(II-O079) 氟硫滅 (flusulfamide)、(II-O080) 達滅淨 (diclomezine)、(II-O081) 礦物油 (mineral oils)、(II-O082) 有機油 (organic oils)、(II-O083) 無機油 (inorganic oils)、(II-O084) 碳酸氫鉀 (potassium bicarbonate)、(II-O085) 甲磺酸鐵 (ferric methanearsonate)、(II-O086) 4-氟苯基-N-[1-[[[[1-(4-腈基苯基)乙基]磺醯基]甲基]丙基]胺基甲酸酯 (4-fluorophenyl-N-[1-[[[1-(4-cyanophenyl)ethyl]sulfonyl]msethyl]propyl]carbamate)、(II-O087) 5-氯-6-(2,4,6-三氟苯基)-7-(4-甲基哌啶-1-基)[1,2,4]三唑並[1,5-a]嘧啶 (5-chloro-6-(2,4,6-trifluorophenyl)-7-(4-methylpiperidin-1-yl)[1,2,4]triazolo[1,5-a]pyrimidine)、(II-O088) N-[4-[4-氯-3-(三氟甲基)苯氧基]-2,5-二甲基苯基]-N-乙基-N-甲基甲亞胺 (N-[4-[4-chloro-3-(trifluoromethyl)phenoxy]-2,5-dimethylphenyl]-N- ethyl-N-methylmethanimidamide);(II-O) Other fungicides, for example (II-O001) abscisic acid, (II-O002) bethiazole (benthiazole), (II-O003) bethoxazin , (II-O004) capsimycin, (II-O005) carvone, (II-O006) chinomethionat, (II-O007) cufraneb, ( II-O008) Cyflufenamide, (II-O009) Cymoxanil, (II-O010) Cyprosulfamide, (II-O011) Flutianil, (II -O012) fosetylaluminium, (II-O013) fosetyl-calcium, (II-O014) fosetyl-sodium, (II-O015) isothiocyanate Methyl isothiocyanate, (II-O016) metrafenone, (II-O017) mildiomycin, (II-O018) natamycin, (II-O019) II Nickel dimethyldithiocarbamate, (II-O020) nitrothal-isopropyl, (II-O021) oxamocarb, (II-O022) oxysulfur Oxathiapiprolin, (II-O023) oxyfenthiin, (II-O024) pentachlorophenol and salts, (II-O025) phosphonic acid and its salts and its salts), (II-O026) propamocarb-fosetylate, (II-O027) pyriofenone (chlazafenone), (II-O028) tervoc (tebufloquin), (II-O029) tecloftalam (tecloftalam), (II-O030) tolnifanide, (I-O031) 1-(4-{4-[(5R)-5-(2,6-difluorophenyl)-4,5-dihydro-1,2-oxazol-3-yl]-1 ,3-Thiazol-2-yl}piperidin-1-yl)-2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]ethanone (1-(4 -{4-[(5R)-5-(2,6-difluorophenyl)-4,5-dihydro-1,2-oxazol-3-yl]-1,3-thiazol-2-yl}piperidin-1- yl)-2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]ethanone), (II-O032) 1-(4-{4-[(5S)-5-(2, 6-difluorophenyl)-4,5-dihydro-1,2-oxazol-3-yl]-1,3-thiazol-2-yl}piperidin-1-yl)-2-[5-methyl Base-3-(trifluoromethyl)-1H-pyrazol-1-yl]ethanone (1-(4-{4-[(5S)-5-(2,6-difluorophenyl)-4,5- dihydro-1,2-oxazol-3-yl]-l,3-thiazol-2-yl}piperidin-1-yl)-2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl ]ethanone), (II-O033) 2-(6-benzylpyridin-2-yl)quinazoline (2-(6-benzylpyridin-2-yl)quinazoline), (II-O034) 2,6- Dimethyl-1H,5H-[1,4]dithieno[2,3-c:5,6-c']dipyrrole-1,3,5,7(2H,6H)- Tetraketone (2,6-dimethyl-1H,5H-[1,4]dithiino[2,3-c:5,6-c']dipyrrole-1,3,5,7(2H,6H)-tetrone) , (II-O035) 2-[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]-1-[4-(4-{5-[2-(propane-2- Alkyn-1-yloxy)phenyl]-4,5-dihydro-1,2-oxazol-3-yl}-1,3-thiazol-2-yl)piperidin-1-yl]ethanone (2 -[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]-1-[4-(4-{5-[2-(prop-2-yn-1-yloxy)phenyl]-4, 5-dihydro-l,2-oxazol-3-yl}-l,3-thiazol-2-yl)piperidin-1-yl]ethan one), (II-O036) 2-[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]-1-[4-(4-{5-[2-chloro-6 -(prop-2-yn-1-yloxy)phenyl]-4,5-dihydro-1,2-oxazol-3-yl}-1,3-thiazol-2-yl)piperidine-1- Base] ethyl ketone (2-[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]-1-[4-(4-{5-[2-chloro-6-(prop-2-yn -1-yloxy)phenyl]-4,5-dihydro-1,2-oxazol-3-yl}-1,3-thiazol-2-yl)piperidin-1-yl]ethanone), (II-O037) 2 -[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]-1-[4-(4-{5-[2-fluoro-6-(prop-2-yne-1 -yloxy)phenyl]-4,5-dihydro-1,2-oxazol-3-yl}-1,3-thiazol-2-yl)piperidin-1-yl]ethanone (2-[3 ,5-bis(difluoromethyl)-1H-pyrazol-1-yl]-1-[4-(4-{5-[2-fluoro-6-(prop-2-yn-1-yloxy)phenyl]-4 ,5-dihydro-l,2-oxazol-3-yl}-l,3-thiazol-2-yl)piperidin-1-yl]ethanone), (II-O038) 2-[6-(3-fluoro- 4-methoxyphenyl)-5-methylpyridin-2-yl]quinazoline (2-[6-(3-fluoro-4-methoxyphenyl)-5-methylpyridin-2-yl]quinazoline), ( II-O039) 2-{(5R)-3-[2-(1-{[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidine-4 -yl)-1,3-thiazol-4-yl]-4,5-dihydro-1,2-oxazol-5-yl}-3-chlorophenyl methanesulfonate (2-{(5R)- 3-[2-(1-{[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1,3-thiazol-4-yl]-4,5 -dihydro-l,2-oxazol-5-yl}-3-chlorophenyl methanesulfonate), (II-O040) 2-{(5S)-3-[2-(1-{[3,5-bis(difluoro Methyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1,3-thiazole- 4-yl]-4,5-dihydro-1,2-oxazol-5-yl}-3-chlorophenyl mesylate (2-{(5S)-3-[2-(1-{[ 3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1,3-thiazol-4-yl]-4,5-dihydro-1,2-oxazol-5 -yl}-3-chlorophenyl methanesulfonate), (II-O041) 2-{2-[(7,8-difluoro-2-methylquinolin-3-yl)oxy]-6-fluorophenyl}propane -2-alcohol (2-{2-[(7,8-difluoro-2-methylquinolin-3-yl)oxy]-6-fluorophenyl}propan-2-ol), (II-O042) 2-{2- Fluoro-6-[(8-fluoro-2-methylquinolin-3-yl)oxy]phenyl}propan-2-alcohol (2-{2-fluoro-6-[(8-fluoro-2-methylquinolin -3-yl)oxy]phenyl}propan-2-ol), (II-O043) 2-{3-[2-(1-{[3,5-bis(difluoromethyl)-1H-pyrazole -1-yl]acetyl}piperidin-4-yl)-1,3-thiazol-4-yl]-4,5-dihydro-1,2-oxazol-5-yl}-3-chlorobenzene Methanesulfonate (2-{3-[2-(1-{[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1,3-thiazol -4-yl]-4,5-dihydro-1,2-oxazol-5-yl}-3-chlorophenyl methanesulfonate) (fluoxazolamide, fluoxapiprolin), (II-O044) 2-{3-[2 -(1-{[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1,3-thiazol-4-yl]- 4,5-Dihydro-1,2-oxazol-5-yl}phenyl mesylate (2-{3-[2-(1-{[3,5-bis(difluoromethyl)-1H-pyrazol- 1-yl]acetyl}piperidin-4-yl)-1,3-thiazol-4-yl]-4,5-dihydro-1,2-oxazol-5-yl}phenyl methanesulfonate), (II-O045) 2 -Phenylphenol and its salts (2-phenylphenol and sa lts), (II-O046) 3-(4,4,5-trifluoro-3,3-dimethyl-3,4-dihydroisoquinolin-1-yl)quinoline (3-(4, 4,5-trifluoro-3,3-dimethyl-3,4-dihydroisoquinolin-1-yl)quinoline), (II-O047) 3-(4,4-difluoro-3,3-dimethyl-3, 4-Dihydroisoquinolin-1-yl)quinoline (3-(4,4-difluoro-3,3-dimethyl-3,4-dihydroisoquinolin-1-yl)quinoline) (Quinofumelin, Quinofumelin), (II-O048) 4-Amino-5-fluoropyrimidin-2-ol (tautomeric form: 4-amino-5-fluoropyrimidin-2(1H)-one) (4-amino-5-fluoropyrimidin- 2-ol (tautomeric form: 4-amino-5-fluoropyrimidin-2(1H)-one)), (II-O049) 4-oxo-4-[(2-phenylethyl)amino]butyl Acid (4-oxo-4-[(2-phenylethyl)amino]butanoic acid), (II-O050) 5-amino-1,3,4-thiadiazole-2-thiol (5-amino-1 ,3,4-thiadiazole-2-thiol), (II-O051) 5-chloro-N'-phenyl-N'-(prop-2-yn-1-yl)thiophene-2-sulfonylhydrazine (5-chloro-N'-phenyl-N'-(prop-2-yn-1-yl)thiophene-2-sulfonohydrazide), (II-O052) 5-fluoro-2-[(4-fluorobenzyl ) Oxygen] pyrimidin-4-amine (5-fluoro-2-[(4-fluorobenzyl)oxy]pyrimidin-4-amine), (II-O053) 5-fluoro-2-[(4-methylbenzyl ) Oxygen] pyrimidin-4-amine (5-fluoro-2-[(4-methylbenzyl)oxy]pyrimidin-4-amine), (II-O054) 9-fluoro-2,2-dimethyl-5-( Quinolin-3-yl)-2,3-dihydro-1,4-benzozepine (9-fluoro-2,2-dimethyl-5-(quinolin-3-yl)-2,3-dihydro -1,4-benzoxazepine), (II-O055) {6-[({[(Z)-(1-methyl-1H-tetrazol-5-yl)(phenyl)methylene]amino} oxygen )methyl]pyridin-2-yl}carbamic acid but-3-yn-1-yl ester (but-3-yn-1-yl{6-[({[(Z)-(l-methyl-1H- tetrazol-5-yl)(phenyl)methylene]amino}oxy)methyl]pyridin-2-yl}carbamate), (II-O056) (2Z)-3-amino-2-cyano-3-phenylacrylic acid Ethyl (2Z)-3-amino-2-cyano-3-phenylacrylate, (II-O057) phenazine-1-carboxylic acid, (II-O058) 3,4, Propyl 3,4,5-trihydroxybenzoate, (II-O059) quinolin-8-ol, (II-O060) quinolin-8-ol sulfate Salt (2:1) (quinolin-8-ol sulfate (2:1)), (II-O061) {6-[({[(1-methyl-1H-tetrazol-5-yl)(phenyl ) methylene] amino} oxygen) methyl] pyridin-2-yl} tert-butyl carbamate (tert-butyl {6-[({[(1-methyl-1H-tetrazol-5-yl)( phenyl)methylene]amino}oxy)methyl]pyridin-2-yl}carbamate), (II-O062) 5‑fluoro‑4‑imino‑3‑methyl‑1‑[(4‑methylphenyl) Sulfonyl]‑3,4‑dihydropyrimidin‑2(1H)‑one (5-fluoro-4-imino-3-methyl-1-[(4-methylphenyl)sulfonyl]-3,4-dihydropyrimidin-2 (1H)-one), (II-O063) pyridachlometyl, (II-O064) ipflufenoquin, (II-O065) aminopyrifen, (II-O066 ) N-[[(cyclopropyl-methoxy)amino][6-(difluoromethoxy)-2,3-difluorophenyl]-methylene]phenylacetamide (N-[ [(cyclopropyl-methoxy)amino][6-(difluoromethoxy)-2,3-difluorophenyl]-methylene]benzeneacetamide), (II-O067) sulfocarb), (II-O068) nabam, (II-O069) oxine copper, (II-O070) ditalimfos, (II-O071) drazoxolon , (II-O072) tolyfluanide, (II-O073) diclobutrazol, (II-O074) cyprofuram, (II-O075) phosphoric acid and its salts ( Phophorous acid and salts), (II-O076) ferimzone, (II-O077) pyrrolnitrin, (II-O078) triazoxide, (II-O079) flusulfamide, (II -O080) Diclomezine, (II-O081) Mineral oils, (II-O082) Organic oils, (II-O083) Inorganic oils, (II-O084 ) potassium bicarbonate (potassium bicarbonate), (II-O085) ferric methanesulfonate (ferric methanesonate), (II-O086) 4-fluorophenyl-N-[1-[[[[1-(4-cyano Phenyl)ethyl]sulfonyl]methyl]propyl]carbamate (4-fluorophenyl-N-[1-[[[1-(4-cyanophenyl)ethyl]sulfonyl]msethyl]propyl]carbamate ), (II-O087) 5-chloro-6-(2,4,6-trifluorophenyl)-7-(4-methylpiperidin-1-yl)[1,2,4]triazolo [1,5-a]pyrimidine (5-chloro-6-(2,4,6-trifluorophenyl)-7-(4-methylpiperidin-1-yl)[1,2,4]triazolo[1,5-a ]pyrimidine), (II-O088) N-[4-[4-chloro-3-(trifluoromethyl)phenoxy]-2,5-dimethylphenyl]-N-ethyl-N- Methylmethanimidamide (N-[4-[4-chloro-3-(trifluoromethyl)phenoxy]-2,5-dimethylphenyl]-N-ethyl-N-methylmethanimidamide );

(II-P) HDAC抑制劑,可例舉如(II-P001) N-(1-乙基環丙基)-4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯醯胺 (N-(1-ethylcyclopropyl)-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide)、(II-P002) N-(2-異丙基環丙基)-4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯醯胺 (N-(2-isopropylcyclopropyl)-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide)、(II-P003) N-(2-甲基環丙基)-4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯醯胺 (N-(2-methylcyclopropyl)-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide)、(II-P004) N-(1-甲基環丙基)-4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯醯胺 (N-(1-methylcyclopropyl)-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide)、(II-P005) N-(2-乙基環丙基)-4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯醯胺 (N-(2-ethylcyclopropyl)-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide)、(II-P006) N-(2,4-二氟苯基)-4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯醯胺 (N-(2,4-difluorophenyl)-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide)、(II-P007) 5-(三氟甲基)-3-[4-[[3-(三氟甲基)-1,2,4-三唑-1-基]甲基]苯基]-1,2,4-噁二唑 (5-(trifluoromethyl)-3-[4-[[3-(trifluoromethyl)-1,2,4triazol-1-yl]methyl]phenyl]-1,2,4-oxadiazole)、(II-P008) 2-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]-1,2,4-三唑-3-腈 (2-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4- triazole-3-carbonitrile)、(II-P009) 1-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]吡唑-4-羧酸乙酯 (ethyl 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylate)、(II-P010) N-環丙基-1-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]吡唑-4-甲醯胺 (N-cyclopropyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxamide)、(II-P011) N,N-二甲基-1-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]吡唑-4-甲醯胺 (N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxamide)、(II-P012) N-甲基-1-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]吡唑-4-甲醯胺 (N-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxamide)、(II-P013) N,N,-二甲基-H[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]-1,2,4-三唑-3-胺 (N,N,-dimethyl-H[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-triazol-3-amine)、(II-P014) 3-[4-[(5-乙基磺醯基-1,2,4-三唑-1-基)甲基]苯基]-5-(三氟甲基)-1,2,4-噁二唑 (3-[4-[(5-ethylsulfanyl-1,2,4-triazol-1-yl)methyl]phenyl]-5- (trifluoromethyl)-1,2,4-oxadiazole)、(II-P015) 3-[4-(三唑[4,5-b]吡啶-1-基甲基)苯基]-5-(三氟甲基)-1,2,4-噁二唑 (3-[4-(triazolo[4,5-b]pyridin-1-ylmethyl)phenyl]-5-(trifluoromethyl)-1,2,4-oxadiazole)、(II-P016) 3-[4-(三唑[4,5-b]吡啶-2-基甲基)苯基]-5-(三氟甲基)-1,2,4-噁二唑 (3-[4-(triazolo[4,5-b]pyridin-2-ylmethyl)phenyl]-5-(trifluoromethyl)-1,2,4-oxadiazole)、(II-P017) 3-[4-(三唑[4,5-b]吡啶-3-基甲基)苯基]-5-(三氟甲基)-1,2,4-噁二唑 (3-[4-(triazolo[4,5-b]pyridin-3-ylmethyl)phenyl]-5-(trifluoromethyl)-1,2,4-oxadiazole)、(II-P018) 1-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]吡唑-4-羧酸甲酯 (methyl 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylate)、(II-P019) 乙基 1-[[3-氟-4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]吡唑-4-羧酸乙酯 (ethyl 1-[[3-fluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylate)、(II-P020) N,N- 二乙基-1-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]吡唑-4-甲醯胺 (N,N-diethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxamide)、(II-P021) N-甲氧基-N-甲基-1-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]吡唑-4-甲醯胺 (N-methoxy-N-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxamide)、(II-P022) 1-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]吡唑-4-羧酸丙基酯 (propyl 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylate)、(II-P023) N-甲氧基-1-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]吡唑-4-羧醯胺 (N-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl] methyl]pyrazole-4-carboxamide)、(II-P024) N-乙基-1-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]吡唑-4-羧醯胺 (N-ethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxamide)、(II-P025) 1-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]吡唑-4-羧醯胺 (1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxamide)、(II-P026) N -甲氧基-1-[1-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]吡唑-4-基]亞胺 (N-methoxy-1-[1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl] methyl]pyrazol-4-yl]methanimine)、(II-P027) 1-[1-[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]乙基]吡唑-4-羧酸乙基酯 (ethyl 1-[1-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]ethyl]pyrazole-4-carboxylate)、(II-P028) 1-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]吡咯烷-2-酮 (1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl] pyrrolidin-2-one)、(II-P029) 1-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]哌啶-2-酮 (1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]piperidin-2-one)、(II-P030) 4-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]嗎啉-3-酮 (4-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]morpholin-3-one)、(II-P031) 4,4-二甲基-2-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]異噁唑啉-3-酮 (4,4-dimethyl-2-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl] methyl]isoxazolidin-3-one)、(II-P032) 2-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]異噁唑啉-3-酮 (2-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl] isoxazolidin-3-one)、(II-P033) 5,5-二甲基-2-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]異噁唑啉-3-酮 (5,5-dimethyl-2-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]isoxazolidin-3-one)、(II-P034) 3,3-二甲基-1[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]哌啶-2-酮 (3,3-dimethyl-1[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]piperidin-2-one)、(II-P035) 1-[[2-氟-4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]吡咯烷-2-酮 (1-[[2-fluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrrolidin-2-one)、(II-P036) 1-[[2-氟-4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]哌啶-2-酮 (1-[[2-fluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]piperidin-2-one)、(II-P037) 2-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]噁嗪-3-酮 (2-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]oxazinan-3-one)、(II-P038) 1-[[3-氟-4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]哌啶-2-酮 (1-[[3-fluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]piperidin-2-one)、(II-P039) 3-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]唑烷-2-酮 (3-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]oxazolidin-2-one)、(II-P040) 1-甲基-3-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]咪唑啉啶-2-酮 (1-methyl-3-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]imidazolidin-2-one)、(II-P041) 1-[[3-氟-4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]-3,3-二甲基-哌啶-2-酮 (1-[[3-fluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-3,3-dimethyl-piperidin-2-one)、(II-P042) 1-[[3-氟-4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]吡咯烷-2-酮 (1-[[3-fluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrrolidin-2-one)、(II-P043) 2-[[3-氟-4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]-4,4-二甲基-異噁唑啉-3-酮 (2-[[3-fluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-4,4-dimethyl-isoxazolidin-3-one)、(II-P044) 2-[[2,3-二氟-4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]異噁唑啉-3-酮 (2-[[2,3-difluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]isoxazolidin-3-one)、(II-P045) 2-[[3-氟-4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]異噁唑啉-3-酮 (2-[[3-fluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]isoxazolidin-3-one)、(II-P046) 1-[[3-氟-4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]氮雜烷-2-酮 (1-[[3-fluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]azepan-2-one)、(II-P047) N-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]丙醯胺 (N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide)、(II-P048) 2,2-二甲基-N-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]丁基-3-炔醯胺 (2,2-dimethyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]but-3-ynamide)、(II-P049) N-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]丁醯胺 (N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]butanamide)、(II-P050) 3-甲基-N-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]丁醯胺 (3-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]butanamide)、(II-P051) 2-甲基-N-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]丙基-2-烯胺 (2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]prop-2-enamide)、(II-P052) 2-甲基-N-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]丁醯胺 (2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]butanamide)、(II-P053) 2-甲氧基-N-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基] (2-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl])、(II-P054) 3,3,3-三氟-N-[[3-氟-4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]丙醯胺 (3,3,3-trifluoro-N-[[3-fluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide)、(II-P055) 3,3,3-三氟-N-[[2-氟-4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]丙醯胺 (3,3,3-trifluoro-N-[[2-fluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide)、(II-P056) N-[[2,3-二氟-4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]丁醯胺 (N-[[2,3-difluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl] methyl]butanamide)、(II-P057) N-[[2,3-二氟-4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]-3,3,3-三氟-丙醯胺 (N-[[2,3-difluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-3,3,3-trifluoro-propanamide)、(II-P058) 2-(二氟甲氧基)-N-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]乙醯胺 (2-(difluoromethoxy)-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]acetamide)、(II-P059) 2-甲氧基-2-甲基-N-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]丙醯胺 (2-methoxy-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide)、(II-P060) 1-甲基-3-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]脲 (1-methyl-3-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea)、(II-P061) 1-乙基-1-甲基-3-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]脲 (1-ethyl-1-methyl-3-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea)、(II-P062) 1-乙氧基-3-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]脲 (1-ethoxy-3-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea)、(II-P063) 1-甲氧基-1-甲基-3-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基] (1-methoxy-1-methyl-3-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl])、(II-P064) 1,1-二乙基-3-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]脲 (1,1-diethyl-3-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea)、(II-P065) N-甲氧基-N-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]環丙烷羧醯胺 (N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl] methyl]cyclopropanecarboxamide)、(II-P066) N-甲氧基-N-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]戊基-4-炔醯胺 (N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pent-4-ynamide)、(II-P067) N-甲氧基-2-甲基-N-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]丙基-2-烯胺 (N-methoxy-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]prop-2-enamide)、(II-P068) N,2-二甲氧基-N-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]丙醯胺 (N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide)、(II-P069) N-環丙基-3,3,3-三氟-N-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]丙醯胺 (N-cyclopropyl-3,3,3-trifluoro-N-[[4-[5-(trifluoromethyl)-1,2,4- oxadiazol-3-yl]phenyl]methyl]propanamide)、(II-P070) 2,2-二氟-N-(2-甲氧基乙基)-N-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]環丙烷羧醯胺 (2,2-difluoro-N-(2-methoxyethyl)-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclo propanecarboxamide)、(II-P071) N-乙基-2-甲基-N-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]丙醯胺 (N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide)、(II-P072) N-[[3-氟-4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]-N-甲氧基-丙醯胺 (N-[[3-fluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-N-methoxy-propanamide)、(II-P073) 2-甲氧基-N-(2,2,2-三氟乙基)-N-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]乙醯胺 (2-methoxy-N-(2,2,2-trifluoroethyl)-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl] acetamide)、(II-P074) N-[[2,3-二氟-4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]-N-甲氧基-環丙烷羧醯胺 (N-[[2,3-difluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-N-methoxy-cyclopropane carboxamide)、(II-P075) 2-(二氟甲氧基)-N-甲基-N-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]乙醯胺 (2-(difluoromethoxy)-N-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]acetamide)、(II-P076) N-乙氧基-2-甲氧基-N-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]丙醯胺 (N-ethoxy-2-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide)、(II-P077) N-異丙基-N-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]四氫呋喃-2-羧醯胺 (N-isopropyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]tetrahydrofuran-2-carboxamide)、(II-P078) 1-甲氧基-3-甲基-1-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]脲 (1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea)、(II-P079) 3-環丙基-1-甲氧基-1-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]脲 (3-cyclopropyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea)、(II-P080) 3-乙氧基-1-甲氧基-1-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]脲 (3-ethoxy-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea)、(II-P081) 3-烯丙基-1-甲氧基-1-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]脲 (3-allyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea)、(II-P082) 1-環丙基-3-甲氧基-3-甲基-1-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]脲 (1-cyclopropyl-3-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea)、(II-P083) 3-異丙基-1-甲氧基-1-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]脲 (3-isopropyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea)、(II-P084) 1-甲氧基-3-丙基-2-炔基-1-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]脲 (1-methoxy-3-prop-2-ynyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea)、(II-P085) 1-[[3-氟-4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]-1-甲氧基-3-甲基-脲 (1-[[3-fluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1-methoxy-3-methyl-urea)、(II-P086) 3-(環丙基甲基)-1-甲基-1-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]脲 (3-(cyclopropylmethyl)-1-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea)、(II-P087) 1-乙基-3-(2,2,2-三氟乙基)-1-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3- 基]苯基]甲基]脲 (1-ethyl-3-(2,2,2-trifluoroethyl)-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea)、(II-P088) 1,3-二甲氧基-1-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]脲 (1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea)、(II-P089) 3-乙基-1-甲氧基-1-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]脲 (3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea)、(II-P090) N-甲基-4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯醯胺 (N-methyl-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide)、(II-P091) N-[(E)-甲氧基亞胺基甲基]-4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯醯胺 (N-[(E)-methoxyiminomethyl]-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide)、(II-P092) N-[(Z)-甲氧基亞胺基甲基]-4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯醯胺 (N-[(Z)-methoxyiminomethyl]-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide)、(II-P093) N-[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]環丙烷甲醯胺 (N-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]cyclopropanecarboxamide)、(II-P094) N-(2-氟苯基)-4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯醯胺 (N-(2-fluorophenyl)-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide)、(II-P095) 2,2-二氟-N-甲基-2-[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]乙醯胺 (2,2-difluoro-N-methyl-2-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]acetamide)、(II-P096) N-烯丙基-N-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]乙醯胺 (N-allyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]acetamide)、(II-P097) N-[(E)-N-甲氧基-C-甲基-碳亞胺基]-4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯醯胺 (N-[(E)-N-methoxy-C-methyl-carbonimidoyl]-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide)、(II-P098) N-[(Z)-N-甲氧基-C-甲基-亞胺亞甲基]-4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯醯胺 (N-[(Z)-N-methoxy-C-methyl-carbonimidoyl]-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide)、(II-P100) N-烯丙基-N-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]丙醯胺 (N-allyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide)、(II-P101) 4,4-二甲基-1-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]吡咯烷-2-酮 (4,4-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl] methyl]pyrrolidin-2-one)、(II-P102) N-甲基-4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯甲硫醯胺 (N-methyl-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzenecarbothioamide)、(II-P103) 5-甲基-1-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]吡咯烷-2-酮 (5-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrrolidin-2-one)、(II-P104) N-甲基-4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯甲甲醯胺 (N-methyl-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzenecarboxamide)、(II-P105) N1-甲基-N2-(4-(5-(三氟甲基)-1,2,4-噁二唑-3-基)苄基)草醯胺 (N1-methyl-N2-(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl) oxalamide); (II-P) HDAC inhibitors, for example (II-P001) N-(1-ethylcyclopropyl)-4-[5-(trifluoromethyl)-1,2,4-oxadi Azol-3-yl]benzamide (N-(1-ethylcyclopropyl)-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide), (II-P002) N-( 2-isopropylcyclopropyl)-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide (N-(2-isopropylcyclopropyl)-4- [5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide), (II-P003) N-(2-methylcyclopropyl)-4-[5-(trifluoromethyl) -1,2,4-Oxadiazol-3-yl]benzamide (N-(2-methylcyclopropyl)-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide) , (II-P004) N-(1-methylcyclopropyl)-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide (N- (1-methylcyclopropyl)-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide), (II-P005) N-(2-ethylcyclopropyl)-4-[ 5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide (N-(2-ethylcyclopropyl)-4-[5-(trifluoromethyl)-1,2,4- oxadiazol-3-yl]benzamide), (II-P006) N-(2,4-difluorophenyl)-4-[5-(trifluoromethyl)-1,2,4-oxadiazole-3 -yl]benzamide (N-(2,4-difluorophenyl)-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide), (II-P007) 5-(three Fluoromethyl)-3-[4-[[3-(trifluoromethyl)-1,2,4-triazol-1-yl]methyl]phenyl]-1,2,4-oxadiazole (5-(trifluoromethyl)-3-[4-[[3-(trifluoromethyl)-1,2,4triazol-1-yl]methyl]phenyl]-1,2,4-oxadiazole), (II-P008) 2 -[[4-[5-(trifluoromethyl base)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-triazole-3-carbonitrile (2-[[4-[5-(trifluoromethyl)- 1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-triazole-3-carbonitrile), (II-P009) 1-[[4-[5-(trifluoromethyl) -1,2,4-Oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester (ethyl 1-[[4-[5-(trifluoromethyl)-1,2,4 -oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylate), (II-P010) N-cyclopropyl-1-[[4-[5-(trifluoromethyl)-1,2,4 -Oxadiazol-3-yl]phenyl]methyl]pyrazole-4-formamide (N-cyclopropyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3 -yl]phenyl]methyl]pyrazole-4-carboxamide), (II-P011) N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxa Oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxamide (N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3 -yl]phenyl]methyl]pyrazole-4-carboxamide), (II-P012) N-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazole- 3-yl]phenyl]methyl]pyrazole-4-formamide (N-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl] methyl]pyrazole-4-carboxamide), (II-P013) N,N,-Dimethyl-H[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl ]phenyl]methyl]-1,2,4-triazole-3-amine (N,N,-dimethyl-H[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl ]phenyl]methyl]-1,2,4-triazol-3-amine), (II-P014) 3-[4-[(5-ethylsulfonyl-1,2,4-triazole-1- base)methyl]phenyl]-5-(trifluoromethyl)-1,2,4-oxadiazole (3-[4-[ (5-ethylsulfanyl-1,2,4-triazol-1-yl)methyl]phenyl]-5-(trifluoromethyl)-1,2,4-oxadiazole), (II-P015) 3-[4-(triazole [4,5-b]pyridin-1-ylmethyl)phenyl]-5-(trifluoromethyl)-1,2,4-oxadiazole (3-[4-(triazolo[4,5- b]pyridin-1-ylmethyl)phenyl]-5-(trifluoromethyl)-1,2,4-oxadiazole), (II-P016) 3-[4-(triazole[4,5-b]pyridine-2- ylmethyl)phenyl]-5-(trifluoromethyl)-1,2,4-oxadiazole (3-[4-(triazolo[4,5-b]pyridin-2-ylmethyl)phenyl]- 5-(trifluoromethyl)-1,2,4-oxadiazole), (II-P017) 3-[4-(triazol[4,5-b]pyridin-3-ylmethyl)phenyl]-5-( Trifluoromethyl)-1,2,4-oxadiazole (3-[4-(triazolo[4,5-b]pyridin-3-ylmethyl)phenyl]-5-(trifluoromethyl)-1,2,4 -oxadiazole), (II-P018) 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4- Methyl carboxylate (methyl 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylate), (II-P019) ethyl 1 -[[3-fluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester (ethyl 1-[[3-fluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylate), (II-P020) N,N- Ethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxamide (N, N-diethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxamide), (II-P021) N-methoxy-N-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methanol Base]pyrazole-4-carboxamide (N-methoxy-N-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole- 4-carboxamide), (II-P022) 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4 -Propyl carboxylate (propyl 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylate), (II-P023) N -Methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxamide ( N-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxamide), (II-P024) N-ethyl- 1-[[4-[5-(Trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxamide (N-ethyl-1 -[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxamide), (II-P025) 1-[[4-[5-( Trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxamide (1-[[4-[5-(trifluoromethyl)-1, 2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxamide), (II-P026) N-methoxy-1-[1-[[4-[5-(trifluoromethyl) -1,2,4-Oxadiazol-3-yl]phenyl]methyl]pyrazol-4-yl]imine (N-methoxy-1-[1-[[4-[5-(trifluoromethyl) -1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazol-4-yl]methanimine), (II-P027) 1-[1-[4-[5-(trifluoromethyl)-1 ,2,4-Oxadiazol-3-yl]phenyl]ethyl]pyrazole-4 -Ethyl carboxylate (ethyl 1-[1-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]ethyl]pyrazole-4-carboxylate), (II-P028 ) 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrrolidin-2-one (1-[[4- [5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrrolidin-2-one), (II-P029) 1-[[4-[5-(trifluoromethyl) -1,2,4-oxadiazol-3-yl]phenyl]methyl]piperidin-2-one (1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3 -yl]phenyl]methyl]piperidin-2-one), (II-P030) 4-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzene Base] methyl] morpholin-3-one (4-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]morpholin-3-one), (II -P031) 4,4-Dimethyl-2-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]isoxazole Lin-3-one (4,4-dimethyl-2-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]isoxazolidin-3-one), (II -P032) 2-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]isoxazolin-3-one (2- [[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl] isoxazolidin-3-one), (II-P033) 5,5-dimethyl-2-[ [4-[5-(Trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]isoxazolin-3-one (5,5-dimethyl-2- [[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]isoxazolidin-3-one), (II-P034) 3,3-dimethyl-1[4 -[5-(trifluoromethyl)-1,2,4-oxa Oxadiazol-3-yl]phenyl]methyl]piperidin-2-one (3,3-dimethyl-1[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl ]methyl]piperidin-2-one), (II-P035) 1-[[2-fluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzene Base] methyl] pyrrolidin-2-one (1-[[2-fluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrrolidin-2-one ), (II-P036) 1-[[2-fluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]piperidine- 2-Keto (1-[[2-fluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]piperidin-2-one), (II-P037) 2 -[[4-[5-(Trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]oxazin-3-one (2-[[4-[5 -(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]oxazinan-3-one), (II-P038) 1-[[3-fluoro-4-[5-(trifluoromethyl base)-1,2,4-oxadiazol-3-yl]phenyl]methyl]piperidin-2-one (1-[[3-fluoro-4-[5-(trifluoromethyl)-1,2 ,4-oxadiazol-3-yl]phenyl]methyl]piperidin-2-one), (II-P039) 3-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazole -3-yl]phenyl]methyl]oxazolidin-2-one (3-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]oxazolidin-2 -one), (II-P040) 1-methyl-3-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl] Imidazolidin-2-one (1-methyl-3-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]imidazolidin-2-one), (II -P041) 1-[[3-fluoro-4-[5-(trifluoromethyl)-1 ,2,4-oxadiazol-3-yl]phenyl]methyl]-3,3-dimethyl-piperidin-2-one (1-[[3-fluoro-4-[5-(trifluoromethyl )-1,2,4-oxadiazol-3-yl]phenyl]methyl]-3,3-dimethyl-piperidin-2-one), (II-P042) 1-[[3-fluoro-4-[5- (Trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrrolidin-2-one (1-[[3-fluoro-4-[5-(trifluoromethyl) -1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrrolidin-2-one), (II-P043) 2-[[3-fluoro-4-[5-(trifluoromethyl)-1 ,2,4-oxadiazol-3-yl]phenyl]methyl]-4,4-dimethyl-isoxazolin-3-one (2-[[3-fluoro-4-[5- (trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-4,4-dimethyl-isoxazolidin-3-one), (II-P044) 2-[[2,3-difluoro- 4-[5-(Trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]isoxazolin-3-one (2-[[2,3-difluoro -4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]isoxazolidin-3-one), (II-P045) 2-[[3-fluoro-4-[5 -(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]isoxazolin-3-one (2-[[3-fluoro-4-[5- (trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]isoxazolidin-3-one), (II-P046) 1-[[3-fluoro-4-[5-(trifluoromethyl )-1,2,4-oxadiazol-3-yl]phenyl]methyl]azalan-2-one (1-[[3-fluoro-4-[5-(trifluoromethyl)-1,2 ,4-oxadiazol-3-yl]phenyl]methyl]azepan-2-one), (II-P047) N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazole -3-yl]phenyl]methyl]acrylamide (N-[[4-[5-(trifluoromethyl)-1,2,4-oxa diazol-3-yl]phenyl]methyl]propanamide), (II-P048) 2,2-dimethyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadi Azol-3-yl]phenyl]methyl]butyl-3-ynamide (2,2-dimethyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl]phenyl]methyl]but-3-ynamide), (II-P049) N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl ]methyl]butanamide (N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]butanamide), (II-P050) 3-methyl- N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]butyramide (3-methyl-N-[[4- [5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]butanamide), (II-P051) 2-methyl-N-[[4-[5-(trifluoromethyl )-1,2,4-oxadiazol-3-yl]phenyl]methyl]propyl-2-enamine (2-methyl-N-[[4-[5-(trifluoromethyl)-1,2 ,4-oxadiazol-3-yl]phenyl]methyl]prop-2-enamide), (II-P052) 2-methyl-N-[[4-[5-(trifluoromethyl)-1,2, 4-oxadiazol-3-yl]phenyl]methyl]butyramide (2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl ]methyl]butanamide), (II-P053) 2-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl] Methyl] (2-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]), (II-P054) 3,3,3- Trifluoro-N-[[3-fluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide (3,3 ,3-trifluoro-N-[[3-fluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiaz ol-3-yl]phenyl]methyl]propanamide), (II-P055) 3,3,3-trifluoro-N-[[2-fluoro-4-[5-(trifluoromethyl)-1,2 ,4-Oxadiazol-3-yl]phenyl]methyl]propionamide (3,3,3-trifluoro-N-[[2-fluoro-4-[5-(trifluoromethyl)-1,2, 4-oxadiazol-3-yl]phenyl]methyl]propanamide), (II-P056) N-[[2,3-difluoro-4-[5-(trifluoromethyl)-1,2,4-oxa Oxadiazol-3-yl]phenyl]methyl]butyramide (N-[[2,3-difluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl] methyl]butanamide), (II-P057) N-[[2,3-difluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl] Methyl]-3,3,3-trifluoro-propionamide (N-[[2,3-difluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl] methyl]-3,3,3-trifluoro-propanamide), (II-P058) 2-(difluoromethoxy)-N-[[4-[5-(trifluoromethyl)-1,2,4 -oxadiazol-3-yl]phenyl]methyl]acetamide (2-(difluoromethoxy)-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl] phenyl]methyl]acetamide), (II-P059) 2-methoxy-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazole-3 -yl]phenyl]methyl]propionamide (2-methoxy-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl] propanamide), (II-P060) 1-methyl-3-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea (1-methyl-3-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea), (II-P061) 1-ethyl-1-methyl Base-3-[[4-[5-(trifluoromethyl)-1,2,4 -Oxadiazol-3-yl]phenyl]methyl]urea (1-ethyl-1-methyl-3-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl] phenyl]methyl]urea), (II-P062) 1-ethoxy-3-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl ]methyl]urea (1-ethoxy-3-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea), (II-P063) 1-methoxy Oxygen-1-methyl-3-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl] (1-methoxy-1 -methyl-3-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]), (II-P064) 1,1-diethyl-3-[ [4-[5-(Trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea (1,1-diethyl-3-[[4-[5- (trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea), (II-P065) N-methoxy-N-[[4-[5-(trifluoromethyl)- 1,2,4-Oxadiazol-3-yl]phenyl]methyl]cyclopropanecarboxamide (N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol -3-yl]phenyl]methyl]cyclopropanecarboxamide), (II-P066) N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazole-3 -yl]phenyl]methyl]pentyl-4-ynamide (N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl ]pent-4-ynamide), (II-P067) N-methoxy-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazole- 3-yl]phenyl]methyl]propyl-2-enamine (N-methoxy-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl ]phenyl]methyl]prop-2-enamide), (II-P068) N,2-two Methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide (N,2-dimethoxy- N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide), (II-P069) N-cyclopropyl-3,3,3-tri Fluoro-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide (N-cyclopropyl-3,3, 3-trifluoro-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide), (II-P070) 2,2-difluoro-N- (2-Methoxyethyl)-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropanecarboxylate Amine (2,2-difluoro-N-(2-methoxyethyl)-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclo propanecarboxamide), ( II-P071) N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl] Propanamide (N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide), (II-P072) N -[[3-fluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-N-methoxy-propionamide ( N-[[3-fluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-N-methoxy-propanamide), (II-P073) 2-methoxy Base-N-(2,2,2-trifluoroethyl)-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl] Methyl]acetamide (2-methoxy-N-(2,2,2-trifluoroethyl)-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl] methyl] acetamide), (II-P074) N-[[2,3-Difluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-N-methoxy- Cyclopropanecarboxamide (N-[[2,3-difluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-N-methoxy-cyclopropane carboxamide), (II-P075) 2-(Difluoromethoxy)-N-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl] Phenyl]methyl]acetamide (2-(difluoromethoxy)-N-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]acetamide ), (II-P076) N-ethoxy-2-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzene Base] methyl] propanamide (N-ethoxy-2-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide), ( II-P077) N-isopropyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]tetrahydrofuran-2- Carboxamide (N-isopropyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]tetrahydrofuran-2-carboxamide), (II-P078) 1 -Methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea (1- methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea), (II-P079) 3-cyclopropyl-1 -Methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea (3-cyclopropyl-1-methoxy -1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea), (II-P080) 3-ethoxy-1-methoxy- 1-[[4-[5-(trifluoromethyl )-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea (3-ethoxy-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4 -oxadiazol-3-yl]phenyl]methyl]urea), (II-P081) 3-allyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2 ,4-Oxadiazol-3-yl]phenyl]methyl]urea (3-allyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl]phenyl]methyl]urea), (II-P082) 1-cyclopropyl-3-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2 ,4-Oxadiazol-3-yl]phenyl]methyl]urea (1-cyclopropyl-3-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4- oxadiazol-3-yl]phenyl]methyl]urea), (II-P083) 3-isopropyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2, 4-oxadiazol-3-yl]phenyl]methyl]urea (3-isopropyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl ]phenyl]methyl]urea), (II-P084) 1-methoxy-3-propyl-2-ynyl-1-[[4-[5-(trifluoromethyl)-1,2,4 -Oxadiazol-3-yl]phenyl]methyl]urea (1-methoxy-3-prop-2-ynyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol- 3-yl]phenyl]methyl]urea), (II-P085) 1-[[3-fluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl] Phenyl]methyl]-1-methoxy-3-methyl-urea (1-[[3-fluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl ]methyl]-1-methoxy-3-methyl-urea), (II-P086) 3-(cyclopropylmethyl)-1-methyl-1-[[4-[5-(trifluoromethyl) -1,2,4-Oxadiazol-3-yl]phenyl]methyl]urea (3-(cyclopropylmethyl)-1-methyl-1-[[4-[5- (trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea), (II-P087) 1-ethyl-3-(2,2,2-trifluoroethyl)-1- [[4-[5-(Trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea (1-ethyl-3-(2,2,2-trifluoroethyl )-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea), (II-P088) 1,3-dimethoxy-1- [[4-[5-(Trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea (1,3-dimethoxy-1-[[4-[5 -(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea), (II-P089) 3-ethyl-1-methoxy-1-[[4-[5-( Trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea (3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1 ,2,4-oxadiazol-3-yl]phenyl]methyl]urea), (II-P090) N-methyl-4-[5-(trifluoromethyl)-1,2,4-oxadiazole- 3-yl]benzamide (N-methyl-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide), (II-P091) N-[(E)-methoxy N-[(E)-methoxyiminomethyl]-4- [5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide), (II-P092) N-[(Z)-methoxyiminomethyl]-4-[5-( Trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide (N-[(Z)-methoxyiminomethyl]-4-[5-(trifluoromethyl)-1,2,4-oxadiazol -3-yl]benzamide), (II-P093) N-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]cyclopropaneformamide (N-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl]phenyl]cyclopropanecarboxamide), (II-P094) N-(2-fluorophenyl)-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzoyl Amine (N-(2-fluorophenyl)-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide), (II-P095) 2,2-difluoro-N-methyl -2-[4-[5-(Trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]acetamide (2,2-difluoro-N-methyl-2-[ 4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]acetamide), (II-P096) N-allyl-N-[[4-[5-(trifluoromethyl base)-1,2,4-oxadiazol-3-yl]phenyl]methyl]acetamide (N-allyl-N-[[4-[5-(trifluoromethyl)-1,2,4- oxadiazol-3-yl]phenyl]methyl]acetamide), (II-P097) N-[(E)-N-methoxy-C-methyl-carbimido]-4-[5-(trifluoro Methyl)-1,2,4-oxadiazol-3-yl]benzamide (N-[(E)-N-methoxy-C-methyl-carbonimidoyl]-4-[5-(trifluoromethyl)-1 ,2,4-oxadiazol-3-yl]benzamide), (II-P098) N-[(Z)-N-methoxy-C-methyl-iminomethylene]-4-[5-( Trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide (N-[(Z)-N-methoxy-C-methyl-carbonimidoyl]-4-[5-(trifluoromethyl) -1,2,4-oxadiazol-3-yl]benzamide), (II-P100) N-allyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxa Oxadiazol-3-yl]phenyl]methyl]propionamide (N-allyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl] propanamide), (II-P101) 4,4-Dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl Base] pyrrolidin-2-one (4,4-dimethyl-1-[[4-[5-(trifluo romethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrrolidin-2-one), (II-P102) N-methyl-4-[5-(trifluoromethyl)-1, 2,4-oxadiazol-3-yl]benzonecarbothioamide (N-methyl-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzenecarbothioamide), (II-P103 ) 5-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrrolidin-2-one (5 -methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrrolidin-2-one), (II-P104) N-methyl-4 -[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide (N-methyl-4-[5-(trifluoromethyl)-1,2,4- oxadiazol-3-yl]benzenecarboxamide), (II-P105) N1-methyl-N2-(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl ) oxalamide (N1-methyl-N2-(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl) oxalamide);

(II-Q) 可作為保護劑的化合物,例如(II-Q001) 1-(2,4-二氯苯基)-5-(乙氧基羰基)-5-甲基-2-吡唑啉-3-羧酸 (1-(2,4-dichlorophenyl)-5-(ethoxycarbonyl)-5-methyl-2-pyrazoline-3-carboxylic acid)、(II-Q002) 1-(2,4-二氯苯基)-5-(乙氧基羰基)-5-甲基-2-吡唑啉-3-羧酸乙酯 (ethyl 1-(2,4-dichlorophenyl)-5-(ethoxycarbonyl)-5-methyl-2-pyrazoline-3-carboxylate) (mefenpyr (-diethyl))、(II-Q003) 苯諾沙克 (benoxacor)、(II-Q004) 解毒喹 (cloquintocet-mexyl)、(II-Q005) 枯草隆 (cumyluron)、(II-Q006) 解草胺腈 (cymetrinil)、(II-Q007) 殺草隆 (daimuron)、(II-Q008) 二氯丙烯胺 (dichlormid)、(II-Q009) 大賽克農 (dicyclonon)、(II-Q010) 增效磷 (dietholate)、(II-Q011) 哌草丹 (dimepiperate)、(II-Q012) 解草唑 (fenchlorazole-ethyl)、(II-Q013) 解草啶 (fenclorim)、(II-Q014) 解草胺 (flurazole)、(II-Q015) 氟草肟 (fluxofenim)、II-Q016) 解草噁唑 (furilazole)、(II-Q017) 雙苯噁唑酸 (isoxadifen-ethyl)、(II-Q018) 唑解草酯 (mefenpyr-diethyl)、(II-Q019) 梅芬內 (mephenate)、(II-Q020) 苯草酮 (methoxyphenone)、(II-Q021) 萘二甲酸酐 (naphthalic anhydride)、(II-Q022) 解草腈 (oxabetrinil)、(II-Q023) AD-67、(II-Q024) 環丙磺醯胺 (cyprosulfamide)、(II-Q025) 呋喃解草唑及其相應的R異構物 (furilazole and the corresponding R isomer)、(II-Q026) 雙苯噁唑酸乙酯 (isoxadifenethyl)、(II-Q027) N-(胺基羰基)-2-甲苯磺醯胺 (N-(aminocarbonyl)-2-methylbenzenesulfonamide)、(II-Q028) N-(胺基-羰基)-2-氟苯磺醯胺 (N-(aminocarbonyl)-2-fluorobenzenesulfonamide)、(II-Q029) 1-溴-4-[(氯甲基)磺醯基]苯 (1-bromo-4-[(chloromethyl)sulfonyl]benzene)、(II-Q030) 2-(二氯甲基)-2-甲基-1,3-二氧五環烷 (2-(dichloromethyl)-2-methyl-1,3-dioxolane) (MG 191)、(II-Q031) 4-(二氯乙醯基)-1-氧雜-4-偶氮螺[4.5]癸烷 (4-(dichloroacetyl)-1-oxa-4-azospiro-[4.5]decane) (MON 4660)、(II-Q032) 2,2-二氯-1-(2,2,5-三甲基-3-噁唑烷基)-乙酮 (2,2-dichloro-1-(2,2,5-trimethyl-3-oxazolidinyl)-ethanone)、(II-Q033) 2-甲氧基-N-[[4-[[(甲胺基)羰基]胺基]苯基]磺醯基]-苯醯胺 (2-methoxy-N-[[4-[[(methylamino)carbonyl]amino]phenyl]sulfonyl]-benzamide)、(II-Q034) 2-甲氧基-N-[[4-[[(甲胺基)羰基]胺基]苯基]磺醯基]-苯醯胺 (2-methoxy-N-[[4-[[(methylamino)carbonyl]amino]-phenyl]sulfonyl]-benzamide);以及(II-Q) Compounds that can be used as protective agents, such as (II-Q001) 1-(2,4-dichlorophenyl)-5-(ethoxycarbonyl)-5-methyl-2-pyrazoline -3-carboxylic acid (1-(2,4-dichlorophenyl)-5-(ethoxycarbonyl)-5-methyl-2-pyrazoline-3-carboxylic acid), (II-Q002) 1-(2,4-dichloro Phenyl)-5-(ethoxycarbonyl)-5-methyl-2-pyrazoline-3-carboxylic acid ethyl ester (ethyl 1-(2,4-dichlorophenyl)-5-(ethoxycarbonyl)-5- methyl-2-pyrazoline-3-carboxylate) (mefenpyr (-diethyl)), (II-Q003) benoxacor, (II-Q004) cloquintocet-mexyl, (II-Q005) subtilis Cumyluron, (II-Q006) cymetrinil, (II-Q007) daimuron, (II-Q008) dichlormid, (II-Q009) Daike Dicyclonon, (II-Q010) Dietholate, (II-Q011) Dimepiperate, (II-Q012) Fenchlorazole-ethyl, (II-Q013) Fenclorim, (II-Q014) flurazole, (II-Q015) fluxofenim, II-Q016) furilazole, (II-Q017) bisbenzoxazole Acid (isoxadifen-ethyl), (II-Q018) Mefenpyr-diethyl, (II-Q019) Mephenate, (II-Q020) Methoxyphenone, (II-Q021 ) naphthalic anhydride, (II-Q022) oxabetrinil, (II-Q023) AD-67, (II-Q024) cyprosulfamide, (II-Q025) Furilazole and its corresponding R isomers (furilazole and the corre sponding R isomer), (II-Q026) isoxadifenethyl, (II-Q027) N-(aminocarbonyl)-2-toluenesulfonamide (N-(aminocarbonyl)-2-methylbenzenesulfonamide ), (II-Q028) N-(amino-carbonyl)-2-fluorobenzenesulfonamide (N-(aminocarbonyl)-2-fluorobenzenesulfonamide), (II-Q029) 1-bromo-4-[(chloroform Base) sulfonyl] benzene (1-bromo-4-[(chloromethyl)sulfonyl]benzene), (II-Q030) 2-(dichloromethyl)-2-methyl-1,3-dioxane Alkane (2-(dichloromethyl)-2-methyl-1,3-dioxolane) (MG 191), (II-Q031) 4-(dichloroacetyl)-1-oxa-4-azospiro[4.5 ]decane (4-(dichloroacetyl)-1-oxa-4-azospiro-[4.5]decane) (MON 4660), (II-Q032) 2,2-dichloro-1-(2,2,5-tri Methyl-3-oxazolidinyl)-ethanone (2,2-dichloro-1-(2,2,5-trimethyl-3-oxazolidinyl)-ethanone), (II-Q033) 2-methoxy- N-[[4-[[(methylamino)carbonyl]amino]phenyl]sulfonyl]-benzamide (2-methoxy-N-[[4-[[(methylamino)carbonyl]amino]phenyl ]sulfonyl]-benzamide), (II-Q034) 2-methoxy-N-[[4-[[(methylamino)carbonyl]amino]phenyl]sulfonyl]-benzamide (2- methoxy-N-[[4-[[(methylamino)carbonyl]amino]-phenyl]sulfonyl]-benzamide); and

(II-R) 生物殺真菌劑,可例舉如(II-R001) 枯草芽孢桿菌合成 ( Bacillus subtilis syn.)、(II-R002) 枯草芽孢桿菌QST713株 ( Bacillus subtilisstrain QST713)、(II-R003) 枯草芽孢桿菌BU1814株 ( Bacillus subtilisstrain BU1814)、(II-R004) 枯草桿菌變種解澱粉芽孢桿菌 ( Bacillus subtilis var. amyloliquefaciens) 菌株FZB24 (strain FZB24)、(II-R005) 解澱粉芽孢桿菌 ( Bacillus amyloliquefaciens) 菌株MBI 600 (strain MBI600)、(II-R006) 解澱粉芽孢桿菌菌株D747 ( Bacillus amyloliquefaciensstrain D747)、(II-R007) 解澱粉芽孢桿菌 ( Bacillus amyloliquefaciens) 菌株D727 (strain D727)、(II-R008) 解澱粉芽孢桿菌 ( Bacillus amyloliquefaciens)菌株ENV503 (strain ENV503)、(II-R009) 深綠木黴菌 ( Tricoderma atroviride) 菌株SC1 (strain SC1)、(II-R010) 蕈狀芽孢桿菌分離物 (Bacillus mycoidesisolate)、(II-R011) 綠針假單胞菌菌株 AFS009 ( Pseudomonas chlororaphisstrain AFS009)、(II-R012) 利迪鏈黴菌 WYEC 108 ( Streptomyces lydicusstrain WYEC108)、(II-R013) 出芽短梗黴菌菌株DSM14940及DSM14941之混合物 ( Aureobasidium pullulansstrain DSM 14940 + Pullulansstrain DSM 14941)、(II-R014) 茶樹 ( Melameuca alternifolia) 萃取物、(II-R015) 菲律賓木桔萃取物 ( Swinglea glutinosaextract)、(II-R016) 磷酸鈣鹽/亞磷酸鈣 (calcium salt of phosphorus acid/calcium phosphite)、(II-R017) 吸水鏈黴菌 ( Streptomyces hygroscopicus)(維利黴素,validamycin)、(II-R018) 高地芽孢桿菌 ( Bacillus altudinis)、(II-R019) 解澱粉芽孢桿菌 ( Bacillus amyloliquefaciens)、(II-R020) 解澱粉芽孢桿菌植物亞種 MBI 600 ( Bacillus amyloliquefaciens ssp. PlantarumMBI 600) (II-27)、(II-R021) 解澱粉芽孢桿菌植物亞種 D747 ( Bacillus amyloliquefaciens ssp. plantarumD747)、(II-R022) 巨大芽孢桿菌 ( Bacillus megaterium)、(II-R023) 莫哈韋芽孢桿菌 ( Bacillus mojavensis) (II-28)、(II-R024) 蕈狀芽孢桿菌 ( Bacillus mycoides)、(II-R025) 短小芽孢桿菌 ( Bacillus pumilus) INR-7 (II-29)、(II-R026) 短小芽抱桿菌 ( Bacillus pumilus) GHA 180、(II-R027) 簡單芽孢桿菌 ( Bacillus simplex) (II-30)、(II-R028) 索立思芽孢桿菌 ( Bacillus solisalsi) (II-31)、(II-R029) 伯克霍爾德氏菌屬 ( Burkholderia sp.)、(II-R030) 密執安棍狀桿菌 ( Clavibacter michiganensis)(噬菌體,bacteriophages) (II-32)、(II-R031) 粉紅膠黴菌 ( Gliocladium roseum) (II-33)、(II-R032) 赫色小球殼孢菌 ( Microsphaeropsis ochracea)、(II-R033) 白色產氣黴 ( Muscodor albus)、(II-R034) 蜂房類芽孢桿菌 ( Paenibacillus alvei)、(II-R035) 多黏類芽孢桿菌 ( Paenibacillus polymyxa) (II-34)、(II-R036) 成團泛菌 (Pantoea agglomerans)(II-35)、(II-R037) 泛菌 ( Pantoea vagans)、(II-R038) 拜萊青黴菌 ( Penicillium bilaiae)、(II-R039) 假單胞菌屬 ( Pseudomonas sp.) (II-R040) 綠針假單胞菌 ( Pseudomonas chloraphis)、(II-R041) 螢光假單胞菌 ( Pseudomonas fluorescens)、(II-R042) 菌寄生球殼菌 ( Sphaerodes mycoparasitica) (II-36)、(II-R043) 紫黑鏈黴菌 ( Streptomyces violaceusniger) (II-38)、(II-R044) 頂孢木黴JM41R ( Trichoderma fertileJM41R) (II-39)、(II-R045) 同擔子菌 ( Typhula phacorrhiza) (II-40)、(II-R046) 大麗輪枝菌 ( Verticillium dahlia) (II-42)、(II-R047) 矮南瓜黃化嵌紋病毒 (zucchini yellow mosaic virus)(無毒菌株,avirulent strain)。 (II-R) Biological fungicides, for example (II-R001) Bacillus subtilis syn ., (II-R002) Bacillus subtilis strain QST713 ( Bacillus subtilis strain QST713), (II- R003) Bacillus subtilis strain BU1814 ( Bacillus subtilis strain BU1814), (II-R004) Bacillus subtilis var. amyloliquefaciens strain FZB24 (strain FZB24), (II-R005) Bacillus amyloliquefaciens ( Bacillus amyloliquefaciens ) strain MBI 600 (strain MBI600), (II-R006) Bacillus amyloliquefaciens strain D747 ( Bacillus amyloliquefaciens strain D747), (II-R007) Bacillus amyloliquefaciens ( Bacillus amyloliquefaciens ) strain D727 (strain D727), ( II-R008) Bacillus amyloliquefaciens strain ENV503 (strain ENV503), (II-R009) Tricoderma atroviride strain SC1 (strain SC1), (II-R010) Bacillus mycoides isolate (Bacillus mycoides isolate), (II-R011) Pseudomonas chlororaphis strain AFS009 ( Pseudomonas chlororaphis strain AFS009), (II-R012) Streptomyces lydicus strain WYEC 108 ( Streptomyces lydicus strain WYEC108), (II-R013) budding Mixture of Aureobasidium pullulans strain DSM14940 and DSM14941 ( Aureobasidium pullulans strain DSM 14940 + Pullulans strain DSM 14941), (II-R014) tea tree ( Melameuca alternifolia ) extract, (II-R015) Philippine orange extract ( Swinglea glutinosa extract) 、(II-R016) Calcium salt of phosphorus acid/calcium phosphite, (II-R017) Streptomyces hygroscopicus (Vilimycin, validamycin), (II-R018) Bacillus altudinis ), (II-R019) Bacillus amyloliquefaciens ( Bacillus amyloliquefaciens ), (II-R020) Bacillus amyloliquefaciens ssp. Plantarum MBI 600 ( Bacillus amyloliquefaciens ssp. Plantarum MBI 600) (II-27 ), (II-R021 ) Bacillus amyloliquefaciens ssp. plantarum D747, (II-R022) Bacillus megaterium , (II-R023) Bacillus mojavensis (II-28), (II-R024) Bacillus mycoides , (II-R025) Bacillus pumilus INR-7 (II-29), (II-R026) Bacillus pumilus GHA 180 , (II-R027) Bacillus simplex (II-30), (II-R028) Bacillus solisalsi (II-31), (II-R029) Burkholderia Burkholderia sp. , (II-R030) Clavibacter michiganensis (bacteriophages) (II-32), (II-R031) Gliocladium roseum (II-33 ), (II-R032) Microsphaeropsis ochracea , (II-R033) Muscodor albus , (II-R034) Paenibacillus alvei , (II- R035) Paenibacillus polymyxa ( Paeni bacillus polymyxa ) (II-34), (II-R036) Pantoea agglomerans (II-35), (II-R037) Pantoea vagans ), (II-R038) Penicillium bayley ( Penicillium bilaiae ), (II-R039) Pseudomonas sp. , (II-R040) Pseudomonas chloraphis , (II-R041) Pseudomonas fluorescens ), (II-R042) Sphaerodes mycoparasitica (II-36), (II-R043) Streptomyces violaceusniger (II-38), (II-R044) Trichoderma acremonium JM41R ( Trichoderma fertile JM41R) (II-39), (II-R045) Typhula phacorrhiza (II-40), (II-R046) Verticillium dahlia (II-42), (II-R047) Zucchini yellow mosaic virus (avirulent strain).

在一較佳實施例中,本案的農業化學組成物包含至少一種選自以下各組的殺真菌活性化合物 (II)作為一組分 (2):In a preferred embodiment, the agricultural chemical composition of the present case comprises at least one fungicidally active compound (II) selected from the following groups as a component (2):

(II-A) 甾醇生物合成的抑制劑,舉例而言,可為(II-A001) 環克座 (cyproconazole)、(II-A002) 待克利 (difenoconazole)、(II-A003) 依普座 (epoxiconazole)、(II-A004) 環醯菌胺 (fenhexamid)、(II-A005) 苯鏽啶 (fenpropidin)、(II-A006) 芬普福 (fenpropimorph)、(II-A007) 胺苯吡菌酮 (fenpyrazamine)、(II-A008) 氟喹唑 (fluquinconazole)、(II-A009) 護汰芬 (flutriafol)、(II-A010) 依滅列 (imazalil)、(II-A011) 依滅列硫酸鹽 (imazalil sulfate)、(II-A012) 種菌唑 (ipconazole)、(II-A013) 滅特座 (metconazole)、(II-A014) 邁克尼 (myclobutanil)、(II-A015) 巴克素 (paclobutrazol)、(II-A016) 撲克拉 (prochloraz)、(II-A017) 普克利 (propiconazole)、(II-A018) 丙硫菌唑 (prothioconazole)、(II-A019) 啶菌㗁唑 (pyrisoxazole)、(II-A020) 葚孢菌素 (spiroxamine)、(II-A021) 得克利 (tebuconazole)、(II-A022) 四克利 (tetraconazole)、(II-A023) 三泰隆 (triadimenol)、(II-A024) 三得芬 (tridemorph)、(II-A025) 滅菌唑 (triticonazole)、(II-A026) (1R,2S,5S)-5-(4-氯苄基)-2-(氯甲基)-2-甲基-1-(1H-1,2,4-三唑-1-基甲基)環戊醇 ((1R,2S,5S)-5-(4-chlorobenzyl)-2-(chloromethyl)-2-methyl-l-(1H-1,2,4-triazol-1­ylmethyl)cyclopentanol、(II-A027) (1S,2R,5R)-5-(4-氯苄基)-2-(氯甲基)-2-甲基-1-(1H-1,2,4-三唑-1-基甲基)環戊醇 ((1S,2R,5R)-5-(4-chlorobenzyl)-2-(chloromethyl)-2-methyl-1-(1H-1,2,4-triazol-l-ylmethyl)cyclopentanol)、(II-A028) (2R)-2-(1-氯環丙基)-4-[(1R)-2,2-二氯環丙基]-1-(1H-1,2,4-三唑-1-基)丁-2-醇 ((2R)-2-(1-chlorocyclopropyl)-4-[(1R)-2,2-dichlorocyclopropyl]-1-(1H-1,2,4-triazol-1-yl)butan-2-ol)、(II-A029) (2R)-2-(1-氯環丙基)-4-[(1S)-2,2-二氯環丙基]-1-(1H-1,2,4-三唑-1-基)丁-2-醇 ((2R)-2-(1-chlorocyclopropyl)-4-[(1S)-2,2-dichlorocyclopropyl]-1-(1H-1,2,4-triazol-1-yl)butan-2-ol)、(II-A030) (2R)-2-[4-(4-氯苯氧基)-2-(三氟甲基)苯基]-1-(1H-1,2,4-三唑-1-基)丙-2-醇 ((2R)-2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1H-1,2,4-triazol-1-yl)propan-2-ol)、(II-A031) (2S)-2-(1-氯環丙基)-4-[(1R)-2,2-二氯環丙基]-1-(1H-1,2,4-三唑-1-基)丁-2-醇 ((2S)-2-(1-chlorocyclopropyl)-4-[(1R)-2,2-dichlorocyclopropyl]-1-(1H-l,2,4-triazol-1-yl)butan-2-ol)、(II-A032)     (2S)-2-(1-氯環丙基)-4-[(1S)-2,2-二氯環丙基]-1-(1H-1,2,4-三唑-1-基)丁-2-醇 ((2S)-2-(1-chlorocyclopropyl)-4-[(1S)-2,2-dichlorocyclopropyl]-1-(1H-1,2,4-triazol-1-yl)butan-2-ol)、(II-A033) (2S)-2-[4-(4-氯苯氧基)-2-(三氟甲基)苯基]-1-(1H-1,2,4-三唑-1-基)丙-2-醇 ((2S)-2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1H-1,2,4-triazol-1-yl)propan-2-ol)、(II-A034) (R)-[3-(4-氯-2-氟苯基)-5-(2,4-二氟苯基)-1,2-噁唑-4-基](吡啶-3-基)甲醇 ((R)-[3-(4-chloro-2-fluorophenyl)-5-(2,4-difluorophenyl)-1,2-oxazol-4-yl](pyridin-3-yl)methanol)、(II-A035) (S)[3-(4-氯-2-氟苯基)-5-(2,4-二氟苯基)-1,2-噁唑-4-基](吡啶-3-基)甲醇 ((S)­[3-(4-chloro-2-fluorophenyl)-5-(2,4-difluorophenyl)-1,2-oxazol-4-yl](pyridin-3-yl)methanol)、(II-A036) [3-(4-氯-2-氟苯基)-5-(2,4-二氟苯基)-1,2-噁唑-4-基](吡啶-3-基)甲醇 ([3-(4-chloro-2-fluorophenyl)-5-(2,4-difluorophenyl)-1,2-oxazol-4-yl](pyridin-3-yl)methanol)、(II-A037) 1-({(2R,4S)-2-[2-氯-4-(4-氯苯氧基)苯基]-4-甲基-1,3-二氧戊環-2-基}甲基)-1H-1,2,4-三唑 (1-({(2R,4S)-2-[2-chloro-4-(4-chlorophenoxy)phenyl]-4-methyl-1,3-dioxolan-2-yl}methyl)-1H-1,2,4-triazole)、(II-A038) 1-({(2S,4S)-2-[2-氯-4-(4-氯苯氧基)苯基]-4-甲基-1,3-二氧戊環-2-基}甲基)-1H-1,2,4-三唑 (1-({(2S,4S)-2-[2-chloro-4-(4-chlorophenoxy)phenyl]-4-methyl-l,3-dioxolan-2-yl}methyl)-1H-1,2,4-triazole)、(II-A039) 1-{[3-(2-氯苯基)-2-(2,4-二氟苯基)環氧乙烷-2-基]甲基}-1H-1,2,4-三唑-5-基硫氰酸酯 (1-{[3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-1H-1,2,4-triazol-5-yl thiocyanate)、(II-A040) 1-{[rel(2R,3R)-3-(2-氯苯基)-2-(2,4-二氟苯基)環氧乙烷-2-基]甲基}-1H-1,2,4-三唑-5-基硫氰酸酯 (1-{[rel(2R,3R)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-1H-1,2,4-triazol-5-yl thiocyanate)、(II-A041) 1-{[rel(2R,3S)-3-(2-氯苯基)-2-(2,4-二氟苯基)環氧乙烷-2-基]甲基}-1H-1,2,4-三唑-5-基硫氰酸酯 (1-{[rel(2R,3S)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-1H-1,2,4-triazol-5-yl thiocyanate)、(II-A042) 2-[(2R,4R,5R)-1-(2,4-二氯苯基)-5-羥基-2,6,6-三甲基庚烷-4-基]-2,4-二氫-3H-1,2,4-三唑-3-硫酮 (2-[(2R,4R,5R)-1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione)、(II-A043) 2-[(2R,4R,5S)-1-(2,4-二氯苯基)-5-羥基-2,6,6-三甲基庚烷-4-基]-2,4-二氫-3H-1,2,4-三唑-3-硫酮 (2-[(2R,4R,5S)-1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione)、(II-A044) 2-[(2R,4S,5R)-1- (2,4-二氯苯基)-5-羥基-2,6,6-三甲基庚烷-4-基]-2,4-二氫-3H-1,2,4-三唑-3-硫酮 (2-[(2R,4S,5R)- l-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione)、(II-A045) 2-[(2R,4S,5S)-1-(2,4-二氯苯基)-5-羥基-2,6,6-三甲基庚烷-4-基]-2,4-二氫-3H-1,2,4-三唑-3-硫酮 (2-[(2R,4S,5S)-l-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione)、(II-A046) 2-[(2S,4R,5R)-1-(2,4-二氯苯基)-5-羥基-2,6,6-三甲基庚烷-4-基]-2,4-二氫-3H-1,2,4-三唑-3-硫酮 (2-[(2S,4R,5R)-1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione)、(II-A047) 2-[(2S,4R,5S)-1-(2,4-二氯苯基)-5-羥基-2,6,6-三甲基庚烷-4-基]-2,4-二氫-3H-1,2,4-三唑-3-硫酮 (2-[(2S,4R,5S)-1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione)、(II-A048) 2-[(2S,4S,5R)-1-(2,4-二氯苯基)-5-羥基-2,6,6-三甲基庚烷-4-基]-2,4-二氫-3H-1,2,4-三唑-3-硫酮 (2-[(2S,4S,5R)-1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione)、(II-A049) 2-[(2S,4S,5S)-1-(2,4-二氯苯基)-5-羥基-2,6,6-三甲基庚烷-4-基]-2,4-二氫-3H-1,2,4-三唑-3-硫酮 (2-[(2S,4S,5S)-l-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione)、(II-A050) 2-[1-(2,4-二氯苯基)-5-羥基-2,6,6-三甲基庚烷-4-基]-2,4-二氫-3H-1,2,4-三唑-3-硫酮 (2-[1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione)、(II-A051) 2-[2-氯-4-(2,4-二氯苯氧基)苯基]-l-(1H-1,2,4-三唑-1-基)丙-2-醇 (2-[2-chloro-4-(2,4-dichlorophenoxy)phenyl]-l-(1H-1,2,4-triazol-1-yl) propan-2-ol)、(II-A052) 2-[2-氯-4-(4-氯苯氧基)苯基]-1-(1H-1,2,4-三唑-1-基)丁-2-醇 (2-[2-chloro-4-(4-chlorophenoxy)phenyl]-1-(1H-1,2,4-triazol-1-yl)butan-2-ol)、(II-A053) 2-[4-(4-氯苯氧基)-2-(三氟甲基)苯基]-1-(1H-1,2,4-三唑-1-基)丁-2-醇 (2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1H-1,2,4-triazol-1-yl)butan-2-ol)、(II-A054) 2-[4-(4-氯苯氧基)-2-(三氟甲基)苯基]-1-(1H-1,2,4-三唑-1-基)戊-2-醇 (2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1H-1,2,4-triazol-l -yl)pentan-2-ol)、(II-A055) 2-[4-(4-氯苯氧基)-2-(三氟甲基)苯基]-1-(1H-1,2,4-三唑-1-基)丙-2-醇 (2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1H-1,2,4-triazol-1-yl)propan-2-ol)、(II-A056) 2-{[3-(2-氯苯基)-2-(2,4-二氟苯基)環氧乙烷-2-基]甲基}-2,4-二氫-3H-1,2,4-三唑-3-硫酮 (2-{[3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-2,4-dihydro-3H-l,2,4-triazole-3-thione)、(II-A057) 2-{[rel(2R,3R)-3-(2-氯苯基)-2-(2,4-二氟苯基)環氧乙烷-2-基]甲基}-2,4-二氫-3H-1,2,4-三唑-3-硫酮 (2-{[rel(2R,3R)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-2,4-dihydro-3H-1,2,4-triazole-3-thione)、(II-A058) 2-{[rel(2R,3S)-3-(2-氯苯基)-2-(2,4-二氟苯基)環氧乙烷-2-基]甲基}-2,4-二氫-3H-l,2,4-三唑-3-硫酮 (2-{[rel(2R,3S)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-2,4-dihydro-3H-l,2,4-triazole-3-thione)、(II-A059) 5-(4-氯芐基)-2-(氯甲基)-2-甲基-1-(1H-1,2,4-三唑-1-基甲基)環戊醇 (5-(4-chlorobenzyl)-2-(chloromethyl)-2-methyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol)、(II-A060) 5-(烯丙基硫基)-1-{[3-(2-氯苯基)-2-(2,4-二氟苯基)環氧乙烷-2-基]甲基}-1H-1,2,4-三唑 (5-(allylsulfanyl)-1-{[3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-1H-1,2,4-triazole)、(II-A061) 5-(烯丙基硫烷基)-1-{[rel(2R,3R)-3-2-氯苯基)-2-(2,4-二氟苯基)環氧乙烷-2-基]甲基}-1H-1,2,4-三唑 (5-(allylsulfanyl)-1-{[rel(2R,3R)-3-2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-1H-1,2,4-triazole)、(II-A062) 5-(烯丙基硫烷基)-1-{[rel(2R,3S)-3-(2-氯苯基)-2-(2,4-二氟苯基)環氧乙烷-2-基]甲基}-1H-1,2,4-三唑 (5-(allylsulfanyl)-1-{[rel(2R,3S)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-1H-1,2,4-triazole)、(II-A063) N’-(2,5-二甲基-4-{[3-(1,1,2,2-四氟乙氧基)苯基]硫基}苯基)-N-乙基-N-甲基亞胺基甲醯胺 (N’-(2,5-dimethyl-4-{[3-(1,1,2,2-tetrafluoroethoxy)phenyl]sulfanyl}phenyl)-N-ethyl-N­methylimidoformamide)、(II-A064) N’-(2,5-二甲基-4-{[3-(2,2,2-三氟乙氧基)苯基]硫基}苯基)N-乙基-N-甲基亞胺基甲醯胺 (N’-(2,5-dimethyl-4-{[3-(2,2,2-trifluoroethoxy)phenyl]sulfanyl}phenyl)­N-ethyl-N-methylimidoformamide)、(II-A065) N’-(2,5-二甲基-4-{[3-(2,2,3,3-四氟丙氧基)苯基]硫基}苯基)-N-乙基-N-甲基亞胺基甲醯胺 (N’-(2,5-dimethyl-4-{[3-(2,2,3,3-tetrafluoropropoxy)phenyl]sulfanyl}phenyl)-N-ethyl-N-methylimidoformamide)、(II-A066) 5-二甲基-4-{[3-(五氟乙氧基)苯基]硫基}苯基)-N-乙基-N-甲基亞胺基甲醯胺 (N’-(2,5-dimethyl-4-{[3-(pentafluoroethoxy)phenyl]sulfanyl}phenyl)-N-ethyl-N-methylimidoformamide)、(II-A067) N’-(2,N’-(2,5-二甲基) -4-{3-[(1,1,2,2-四氟乙基)硫烷基]苯氧基}苯基)-N-乙基-N-甲基亞胺基甲醯胺 (N’-(2,5-dimethyl-4-{3-[(1,l,2,2-tetrafluoroethyl)sulfanyl]phenoxy}phenyl)-N-ethyl-N­methylimidoformamide)、(II-A068) N’-(2,5-二甲基-4-{3-[(2,2,2-三氟乙基)硫烷基]苯氧基}苯基)N-乙基-N-甲基亞胺基甲醯胺 (N’-(2,5-dimethyl-4-{3-[(2,2,2-trifluoroethyl)sulfanyl]phenoxy}phenyl)­N-ethyl-N-methylimidoformamide)、(II-A069) N’-(2,5-二甲基-4-{3-[(2,2,3,3-四氟丙基)硫烷基]苯氧基}苯基)-N-乙基-N-甲基亞胺基甲醯胺 (N’-(2,5-dimethyl-4-{3-[(2,2,3,3-tetrafluoropropyl)sulfanyl]phenoxy}phenyl)-N-ethyl-N-methylimidoformamide、(II-A070) N’-(2,5-二甲基-4-{3-[(五氟乙基)硫烷基]苯氧基}苯基)-N-乙基-N-甲基亞胺基甲醯胺 (N’-(2,5- dimethyl-4-{3-[(pentafluoroethyl)sulfanyl]phenoxy}phenyl)-N-ethyl-N-methylimidoformamide)、(II-A071) N’-(2,5-二甲基-4-苯氧基苯基)-N-乙基-N-甲基亞胺基甲醯胺 (N’-(2,5-dimethyl-4-phenoxyphenyl)-N-ethyl-N-methylimidoformamide)、(II-A072) N’-(4-{[3-(二氟甲氧基)苯基]硫烷基}-2,5-二甲基苯基)-N-乙基-N-甲基亞胺基甲醯胺 (N’-(4-{[3-(difluoromethoxy)phenyl]sulfanyl}-2,5-dimethylphenyl)-N-ethyl-N-methylimidoformamide)、(II-A073) N’(4-{3-[(二氟甲基)硫烷基]苯氧基}-2 ,5-二甲基苯基)-N-乙基-N-甲基亞胺基甲醯胺 (N’­(4-{3-[(difluoromethyl)sulfanyl]phenoxy}-2,5-dimethylphenyl)-N-ethyl-N-methylimidoformamide)、(II-A074) N’-[5-溴-6-(2,3-二氫-1H-茚-2-氧基)-2-甲基吡啶-3-基]-N-乙基-N-甲基亞胺基甲醯胺 (N’-[5-bromo-6-(2,3-dihydro-1H-inden-2-yloxy)-2-methylpyridin-3-yl]-N-ethyl-N­methylimidoformamide)、(II-A075) N’-{4-[(4,5-二氯-1,3-噻唑-2-基)氧]-2,5-二甲基苯基}-N-乙基-N-甲基亞胺基甲醯胺 (N’-{4-[(4,5-dichloro-1,3-thiazol-2-yl)oxy]-2,5-dimethylphenyl}-N­ethyl-N-methylimidoformamide)、(II-A076) N’-{5-溴-6-[(1R)-1-(3,5-二氟苯基)乙氧基]-2-甲基吡啶-3-基}-N-乙基-N-甲基亞胺基甲醯胺 (N’-{5-bromo-6-[(1R)-1-(3,5-difluorophenyl)ethoxy]-2-methylpyridin-3-yl}-N-ethyl-N-methylimidofonnamide)、(II-A077) N’-{5-溴-6-[(1S)-1-(3,5-二氟苯基)乙氧基]-2-甲基吡啶-3-基}-N-乙基-N-甲基亞胺基甲醯胺 (N’-{5-bromo-6-[(1S)-1-(3,5-difluorophenyl)ethoxy]-2-methylpyridin-3-yl}-N-ethyl-N-methylimidoformamide)、(II-A078) N’-{5-溴-6-[(順式-4-異丙基環己基)氧]-2-甲基吡啶-3-基}-N-乙基-N-甲基亞胺基甲醯胺 (N’-{5-bromo-6-[(cis-4-isopropylcyclohexyl)oxy]-2-methylpyridin-3-yl}-N-ethyl-N-methylimidofornamide)、(II-A079) N’-{5-溴-6-[(反式-4-異丙基環己基)氧]-2-甲基吡啶-3-基}-N-乙基-N-甲基亞胺基甲醯胺 N’-{5-bromo-6-[(trans-4-isopropylcyclohexyl)oxy]-2-methylpyridin-3-yl}-N-ethyl-N­methylimidoformamide)、(II-A080) N’-{5-溴-6-[1-(3,5-二氟苯基)乙氧基]-2-甲基吡啶-3-基}-N-乙基-N-甲基亞胺基甲醯胺 (N’-{5-bromo-6-[1-(3,5-difluorophenyl)ethoxy]-2-methylpyridin-3-yl}­N-ethyl-N-methylimidoformamide)、(II-A081) 滅芬座 (mefentrifluconazole)、(II-A082) 異芬三氟康唑 (ipfentrifluconazole)、(II-A083) 1-(2,4-二氟苯基)-2-(1H-1,2,4-三唑-1-基)-1-[1-(2,6-二氟-4-氯苯氧基)環丙基]乙醇 (1-(2,4-difluorophenyl)-2-(1H-1,2,4-triazol-1-yl)-1-[1-(2,6-difluoro-4-chlorophenoxy)cyclopropyl]ethanol)、(II-A084) 1-[2-(1-氯環丙基)-3-(2-氟苯基)-2-羥丙基]-1H-咪唑-5-腈 (1-[2-(l-chlorocyclopropyl)-3-(2-fluorophenyl)-2-hydroxypropyl]-1H-imidazole-5-carbonitrile)、(II-A085) 特比萘芬 (terbinafine)、(II-A086) 丁硫菌酸鹽 (buthiobate)、(II-A087) 比芬諾 (pyrifenox)、(II-A088) 芬瑞莫 (fenarimol)、(II-A089) 尼瑞莫 (nuarimol)、(II-A090) 嘧菌醇 (triarimol)、(II-A091) 賽福寧 (triforine)、(II-A092) 克黴唑 (clotrimazole)、(II-A093) 益康唑 (econazole)、(II-A094) 異康唑 (isoconazole)、(II-A095) 咪康唑 (miconazole)、(II-A096) 氧唑菌 (oxpoconazole)、(II-A097) 披扶座 (pefurazoate)、(II-A098) 氟蟲唑 (triflumizole)、(II-A099) 氮唑康唑 (azaconazole)、(II-A100) 雙苯三唑醇 (bitertanol)、(II-A101) 溴康唑 (bromuconazole)、(II-A102) 達克利 (diniconazole)、(II-A103) 達克利-M (diniconazole-M)、(II-A104) 乙環唑 (etaconazole)、(II-A105) 芬克座 (fenbuconazole)、(II-A106) 菲克利 (hexaconazole)、(II-A107) 易胺座 (imibenconazole)、(II-A108) 平克座 (penconazole)、(II-A109) 西咪康唑 (simeconazole)、(II-A110) 三泰芬 (triadimefon)、(II-A111) 單克素 (uniconazole)、(II-A112) 稗草畏 (pyributicarb)、(II-A113) 十二嗎啉 (dodemorph)、(II-A114) 歐地莫 (aldimorph)、(II-A115) 三芬醯胺 (trimorphamide)、(II-A116) 粉病靈 (piperalin)、(II-A117) 萘替芬 (naftifine);(II-A) Inhibitors of sterol biosynthesis, for example, may be (II-A001) cyproconazole, (II-A002) difenoconazole, (II-A003) iptr ( epoxiconazole), (II-A004) fenhexamid, (II-A005) fenpropidin, (II-A006) fenpropimorph, (II-A007) fenpropidin (fenpyrazamine), (II-A008) fluquinconazole, (II-A009) flutriafol, (II-A010) imazalil, (II-A011) imazalil sulfate (imazalil sulfate), (II-A012) ipconazole, (II-A013) metconazole, (II-A014) myclobutanil, (II-A015) paclobutrazol, (II-A016) Prochloraz, (II-A017) Propiconazole, (II-A018) Prothioconazole, (II-A019) Pyrisoxazole, (II -A020) spiroxamine, (II-A021) tebuconazole, (II-A022) tetraconazole, (II-A023) triadimenol, (II-A024) three Tridemorph, (II-A025) triticonazole, (II-A026) (1R,2S,5S)-5-(4-chlorobenzyl)-2-(chloromethyl)-2- Methyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol ((1R,2S,5S)-5-(4-chlorobenzyl)-2-(chloromethyl)-2 -methyl-l-(1H-1,2,4-triazol-1ylmethyl)cyclopentanol, (II-A027) (1S,2R,5R)-5-(4-chlorobenzyl)-2-(chloromethyl )-2-methyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol ((1S,2R,5R)-5-(4-chlorobenzyl)-2-(chloromethyl)-2-methyl-1-(1H-1,2,4-triazol-l-ylmethyl)cyclopentanol), (II- A028) (2R)-2-(1-chlorocyclopropyl)-4-[(1R)-2,2-dichlorocyclopropyl]-1-(1H-1,2,4-triazole-1 -yl)butan-2-ol ((2R)-2-(1-chlorocyclopropyl)-4-[(1R)-2,2-dichlorocyclopropyl]-1-(1H-1,2,4-triazol-1- yl)butan-2-ol), (II-A029) (2R)-2-(1-chlorocyclopropyl)-4-[(1S)-2,2-dichlorocyclopropyl]-1-( 1H-1,2,4-triazol-1-yl)butan-2-ol ((2R)-2-(1-chlorocyclopropyl)-4-[(1S)-2,2-dichlorocyclopropyl]-1-( 1H-1,2,4-triazol-1-yl)butan-2-ol), (II-A030) (2R)-2-[4-(4-chlorophenoxy)-2-(trifluoromethane Base)phenyl]-1-(1H-1,2,4-triazol-1-yl)propan-2-alcohol ((2R)-2-[4-(4-chlorophenoxy)-2-(trifluoromethyl) phenyl]-1-(1H-1,2,4-triazol-1-yl)propan-2-ol), (II-A031) (2S)-2-(1-chlorocyclopropyl)-4-[ (1R)-2,2-dichlorocyclopropyl]-1-(1H-1,2,4-triazol-1-yl)butan-2-ol ((2S)-2-(1-chlorocyclopropyl) -4-[(1R)-2,2-dichlorocyclopropyl]-1-(1H-l,2,4-triazol-1-yl)butan-2-ol), (II-A032) (2S)-2- (1-Chlorocyclopropyl)-4-[(1S)-2,2-dichlorocyclopropyl]-1-(1H-1,2,4-triazol-1-yl)butan-2-ol ((2S)-2-(1-chlorocyclopropyl)-4-[(1S)-2,2-dichlorocyclopropyl]-1-(1H-1,2,4-triazol-1-yl)butan-2-ol) , (II-A033) (2S)-2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1H-1,2,4 -Triazol-1-yl)propan-2-ol ((2S)-2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1H-1,2,4-triazol- 1-yl)propan-2-ol), (II-A034) (R)-[3-(4-chloro-2-fluorophenyl)-5-(2,4-difluorophenyl)-1, 2-oxazol-4-yl](pyridin-3-yl)methanol ((R)-[3-(4-chloro-2-fluorophenyl)-5-(2,4-difluorophenyl)-1,2-oxazol -4-yl](pyridin-3-yl)methanol), (II-A035) (S)[3-(4-chloro-2-fluorophenyl)-5-(2,4-difluorophenyl) -1,2-oxazol-4-yl](pyridin-3-yl)methanol ((S)[3-(4-chloro-2-fluorophenyl)-5-(2,4-difluorophenyl)-1,2 -oxazol-4-yl](pyridin-3-yl)methanol), (II-A036) [3-(4-chloro-2-fluorophenyl)-5-(2,4-difluorophenyl)- 1,2-oxazol-4-yl](pyridin-3-yl)methanol ([3-(4-chloro-2-fluorophenyl)-5-(2,4-difluorophenyl)-1,2-oxazol-4 -yl](pyridin-3-yl)methanol), (II-A037) 1-({(2R,4S)-2-[2-chloro-4-(4-chlorophenoxy)phenyl]-4 -Methyl-1,3-dioxolan-2-yl}methyl)-1H-1,2,4-triazole (1-({(2R,4S)-2-[2-chloro-4 -(4-chlorophenoxy)phenyl]-4-methyl-1,3-dioxolan-2-yl}methyl)-1H-1,2,4-triazole), (II-A038) 1-({(2S,4S )-2-[2-chloro-4-(4-chlorophenoxy)phenyl]-4-methyl-1,3-dioxolan-2-yl}methyl)-1H-1,2 ,4-Triazole (1-({(2S,4S)-2-[2-chloro-4-(4-chlorophenoxy)phenyl]-4-methyl-l,3-dioxolan-2-yl}methyl)- 1H-1,2,4-triazole), (II-A039) 1-{[3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxirane-2-yl ]Methyl}-1H- 1,2,4-triazol-5-ylthiocyanate (1-{[3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-1H-1 ,2,4-triazol-5-yl thiocyanate), (II-A040) 1-{[rel(2R,3R)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl )Oxiran-2-yl]methyl}-1H-1,2,4-triazol-5-ylthiocyanate (1-{[rel(2R,3R)-3-(2-chlorophenyl )-2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-1H-1,2,4-triazol-5-yl thiocyanate), (II-A041) 1-{[rel(2R,3S )-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-1H-1,2,4-triazole-5- thiocyanate (1-{[rel(2R,3S)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-1H-1,2,4 -triazol-5-yl thiocyanate), (II-A042) 2-[(2R,4R,5R)-1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethyl Heptane-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione (2-[(2R,4R,5R)-1-(2,4- dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione), (II-A043) 2-[( 2R,4R,5S)-1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H- 1,2,4-triazole-3-thione (2-[(2R,4R,5S)-1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl ]-2,4-dihydro-3H-1,2,4-triazole-3-thione), (II-A044) 2-[(2R,4S,5R)-1-(2,4-dichlorophenyl )-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione (2-[( 2R,4S,5R)- l-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione), (II -A045) 2-[(2R,4S,5S)-1-(2,4-dichlorophenyl)-5-hydroxyl-2,6,6-trimethylheptane-4-yl]-2, 4-Dihydro-3H-1,2,4-triazole-3-thione (2-[(2R,4S,5S)-l-(2,4-dichlorophenyl)-5-hydroxy-2,6, 6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione), (II-A046) 2-[(2S,4R,5R)-1-(2 ,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3- Thione (2-[(2S,4R,5R)-1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1 ,2,4-triazole-3-thione), (II-A047) 2-[(2S,4R,5S)-1-(2,4-dichlorophenyl)-5-hydroxyl-2,6,6 -Trimethylheptane-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione (2-[(2S,4R,5S)-1-(2 ,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione), (II-A048) 2 -[(2S,4S,5R)-1-(2,4-Dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro -3H-1,2,4-triazole-3-thione (2-[(2S,4S,5R)-1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan- 4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione), (II-A049) 2-[(2S,4S,5S)-1-(2,4-two Chlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione (2 -[(2S,4S,5S)-l-(2, 4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione), (II-A050) 2- [1-(2,4-Dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4- Triazole-3-thione (2-[1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2, 4-triazole-3-thione), (II-A051) 2-[2-chloro-4-(2,4-dichlorophenoxy)phenyl]-l-(1H-1,2,4-tri Azol-1-yl) propan-2-ol (2-[2-chloro-4-(2,4-dichlorophenoxy)phenyl]-l-(1H-1,2,4-triazol-1-yl) propan- 2-ol), (II-A052) 2-[2-Chloro-4-(4-chlorophenoxy)phenyl]-1-(1H-1,2,4-triazol-1-yl)butyl -2-alcohol (2-[2-chloro-4-(4-chlorophenoxy)phenyl]-1-(1H-1,2,4-triazol-1-yl)butan-2-ol), (II-A053 ) 2-[4-(4-Chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1H-1,2,4-triazol-1-yl)butan-2-ol (2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1H-1,2,4-triazol-1-yl)butan-2-ol), (II-A054) 2 -[4-(4-Chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1H-1,2,4-triazol-1-yl)pentan-2-ol (2 -[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1H-1,2,4-triazol-l-yl)pentan-2-ol), (II-A055) 2-[ 4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1H-1,2,4-triazol-1-yl)propan-2-ol (2-[ 4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1H-1,2,4-triazol-1-yl)propan-2-ol), (I I-A056) 2-{[3-(2-Chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-2,4-dihydro- 3H-1,2,4-triazole-3-thione (2-{[3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-2,4- dihydro-3H-l,2,4-triazole-3-thione), (II-A057) 2-{[rel(2R,3R)-3-(2-chlorophenyl)-2-(2,4- Difluorophenyl)oxirane-2-yl]methyl}-2,4-dihydro-3H-1,2,4-triazole-3-thione (2-{[rel(2R,3R )-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-2,4-dihydro-3H-1,2,4-triazole-3-thione), ( II-A058) 2-{[rel(2R,3S)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl}- 2,4-Dihydro-3H-l,2,4-triazole-3-thione (2-{[rel(2R,3S)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl )oxiran-2-yl]methyl}-2,4-dihydro-3H-l,2,4-triazole-3-thione), (II-A059) 5-(4-chlorobenzyl)-2-(chloro Methyl)-2-methyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol (5-(4-chlorobenzyl)-2-(chloromethyl)-2-methyl -1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol), (II-A060) 5-(allylthio)-1-{[3-(2-chlorophenyl)- 2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-1H-1,2,4-triazole(5-(allylsulfanyl)-1-{[3-(2 -chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-1H-1,2,4-triazole), (II-A061) 5-(allylsulfanyl)-1 -{[rel(2R,3R)-3-2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-1H-1,2, 4-triazole (5-(allylsulfan yl)-1-{[rel(2R,3R)-3-2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-1H-1,2,4-triazole), (II-A062) 5-(allylsulfanyl)-1-{[rel(2R,3S)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)cyclo Oxyethane-2-yl]methyl}-1H-1,2,4-triazole(5-(allylsulfanyl)-1-{[rel(2R,3S)-3-(2-chlorophenyl)-2- (2,4-difluorophenyl)oxiran-2-yl]methyl}-1H-1,2,4-triazole), (II-A063) N'-(2,5-dimethyl-4-{[3- (1,1,2,2-tetrafluoroethoxy)phenyl]thio}phenyl)-N-ethyl-N-methyliminoformamide (N'-(2,5-dimethyl -4-{[3-(1,1,2,2-tetrafluoroethoxy)phenyl]sulfanyl}phenyl)-N-ethyl-Nmethylimidoformamide), (II-A064) N'-(2,5-dimethyl-4 -{[3-(2,2,2-Trifluoroethoxy)phenyl]thio}phenyl)N-ethyl-N-methyliminoformamide (N'-(2,5 -dimethyl-4-{[3-(2,2,2-trifluoroethoxy)phenyl]sulfanyl}phenyl)N-ethyl-N-methylimidoformamide), (II-A065) N'-(2,5-dimethyl- 4-{[3-(2,2,3,3-tetrafluoropropoxy)phenyl]thio}phenyl)-N-ethyl-N-methyliminoformamide (N'- (2,5-dimethyl-4-{[3-(2,2,3,3-tetrafluoropropoxy)phenyl]sulfanyl}phenyl)-N-ethyl-N-methylimidoformamide), (II-A066) 5-dimethyl -4-{[3-(Pentafluoroethoxy)phenyl]thio}phenyl)-N-ethyl-N-methyliminoformamide (N'-(2,5-dimethyl- 4-{[3-(pentafluoroethoxy)phenyl]sulfanyl}phenyl)-N-ethyl-N-methylimidoformamide), (II-A067) N'-(2,N'-(2,5-dimethyl) -4-{3-[(1,1,2,2-tetrafluoroethyl)sulfanyl]phenoxy}phenyl)-N-ethyl-N-methyliminoformamide (N '-(2,5-dimethyl-4-{3-[(1,l,2,2-tetrafluoroethyl)sulfanyl]phenoxy}phenyl)-N-ethyl-Nmethylimidoformamide), (II-A068) N'-(2 ,5-Dimethyl-4-{3-[(2,2,2-trifluoroethyl)sulfanyl]phenoxy}phenyl)N-ethyl-N-methyliminoformyl Amine (N'-(2,5-dimethyl-4-{3-[(2,2,2-trifluoroethyl)sulfanyl]phenoxy}phenyl)N-ethyl-N-methylimidoformamide), (II-A069) N'- (2,5-Dimethyl-4-{3-[(2,2,3,3-tetrafluoropropyl)sulfanyl]phenoxy}phenyl)-N-ethyl-N-methyl Iminoformamide (N'-(2,5-dimethyl-4-{3-[(2,2,3,3-tetrafluoropropyl)sulfanyl]phenoxy}phenyl)-N-ethyl-N-methylimidoformamide, ( II-A070) N'-(2,5-Dimethyl-4-{3-[(pentafluoroethyl)sulfanyl]phenoxy}phenyl)-N-ethyl-N-methylidene Aminoformamide (N'-(2,5-dimethyl-4-{3-[(pentafluoroethyl)sulfanyl]phenoxy}phenyl)-N-ethyl-N-methylimidoformamide), (II-A071) N'-( 2,5-Dimethyl-4-phenoxyphenyl)-N-ethyl-N-methyliminoformamide (N'-(2,5-dimethyl-4-phenoxyphenyl)-N- ethyl-N-methylimidoformamide), (II-A072) N'-(4-{[3-(difluoromethoxy)phenyl]sulfanyl}-2,5-dimethylphenyl)-N- Ethyl-N-methyliminoformamide (N'-(4-{[3-(difluoromethoxy)phenyl]sulfanyl}-2,5-dimethylphenyl)-N-ethyl-N-methylimidoformamide), (II -A073) N'(4-{3-[(difluoromethyl)sulfanyl]phenoxy}-2,5-dimethylphenyl)-N-ethyl-N-methylimino Formamide (N'(4-{3-[(difluoromethyl)sulfanyl]phenoxy}-2,5-dimethylphenyl)-N-ethyl-N-methylimidoformamide), (II-A074) N'-[5-bromo-6-( 2,3-Dihydro-1H-indene-2-oxyl)-2-methylpyridin-3-yl]-N-ethyl-N-methyliminoformamide (N'-[5- bromo-6-(2,3-dihydro-1H-inden-2-yloxy)-2-methylpyridin-3-yl]-N-ethyl-Nmethylimidoformamide), (II-A075) N'-{4-[(4 ,5-dichloro-1,3-thiazol-2-yl)oxy]-2,5-dimethylphenyl}-N-ethyl-N-methyliminoformamide (N'-{ 4-[(4,5-dichloro-1,3-thiazol-2-yl)oxy]-2,5-dimethylphenyl}-Nethyl-N-methylimidoformamide), (II-A076) N'-{5-bromo- 6-[(1R)-1-(3,5-difluorophenyl)ethoxy]-2-methylpyridin-3-yl}-N-ethyl-N-methyliminoformamide (N'-{5-bromo-6-[(1R)-1-(3,5-difluorophenyl)ethoxy]-2-methylpyridin-3-yl}-N-ethyl-N-methylimidofonnamide), (II-A077 ) N'-{5-bromo-6-[(1S)-1-(3,5-difluorophenyl)ethoxy]-2-methylpyridin-3-yl}-N-ethyl-N -Methyliminoformamide (N'-{5-bromo-6-[(1S)-1-(3,5-difluorophenyl)ethoxy]-2-methylpyridin-3-yl}-N-ethyl- N-methylimidoformamide), (II-A078) N'-{5-bromo-6-[(cis-4-isopropylcyclohexyl)oxy]-2-methylpyridin-3-yl}-N-ethyl Base-N-methyliminoformamide (N'-{5-bromo-6-[(cis-4-isopropylcyclohexyl)oxy]-2-methylpyridin-3-yl}-N-ethyl-N-methylimidofornamide ), (II-A079) N'-{5-bromo-6-[(trans-4-isopropylcyclohexyl)oxy]-2-methylpyridin-3-yl}-N-ethyl-N -Methylpyridin-3-yl}-N-ethyl-Nmethylimidoformamide), (II-A080 ) N'-{5-bromo-6-[1-(3,5-difluorophenyl)ethoxy]-2-methylpyridin-3-yl}-N-ethyl-N-methylidene Aminoformamide (N'-{5-bromo-6-[1-(3,5-difluorophenyl)ethoxy]-2-methylpyridin-3-yl}N-ethyl-N-methylimidoformamide), (II-A081 ) Mefentrifluconazole, (II-A082) Isofen trifluconazole (ipfentrifluconazole), (II-A083) 1-(2,4-difluorophenyl)-2-(1H-1,2, 4-triazol-1-yl)-1-[1-(2,6-difluoro-4-chlorophenoxy)cyclopropyl]ethanol (1-(2,4-difluorophenyl)-2-(1H -1,2,4-triazol-1-yl)-1-[1-(2,6-difluoro-4-chlorophenoxy)cyclopropyl]ethanol), (II-A084) 1-[2-(1-chlorocyclic Propyl)-3-(2-fluorophenyl)-2-hydroxypropyl]-1H-imidazole-5-carbonitrile (1-[2-(l-chlorocyclopropyl)-3-(2-fluorophenyl)-2- hydroxypropyl]-1H-imidazole-5-carbonitrile), (II-A085) terbinafine, (II-A086) buthiobate, (II-A087) bifenox , (II-A088) Fenarimol, (II-A089) Nuarimol, (II-A090) Triarimol, (II-A091) Triforine, ( II-A092) clotrimazole, (II-A093) econazole, (II-A094) isoconazole, (II-A095) miconazole, (II- A096) Oxpoconazole, (II-A097) pefurazoate, (II-A098) triflumizole, (II-A099) azaconazole, (II-A100) bitertanol , (II-A101) bromuconazole, (II-A102) diniconazole, (II-A103) diniconazole-M, (II-A104) etaconazole , (II-A105) Fenke (fenbuconazole), (II-A106) Fickley (hexaconazole), (II-A107) Yimin (imibenconazole), (II-A108) Pink (penconazole), (II -A109) simeconazole, (II-A110) triadimefon, (II-A111) uniconazole, (II-A112) pyributicarb, (II- A113) dodemorph, (II-A114) aldimorph, (II-A115) trimorphamide, (II-A116) piperalin, (II- A117) Naftifine (naftifine);

(II-B) 關於呼吸鏈複合物I (complex I)或複合物II (complex II)的抑制劑,可例如(II-B001) 苯索伏比 (benzovindiflupyr)、(II-B002) 拜沙芬 (bixafen)、(II-B003) 白克列 (boscalid)、(II-B004) 萎鏽靈 (carboxin)、(II- B005) 氟派瑞 (fluopyram)、(II-B006) 福多寧 (flutolanil)、(II-B007) 氟克殺 (fluxapyroxad)、(II-B008) 福拉比 (furametpyr)、(II-B009) 抑吩滅 (isofetamid)、(II-B010) 亞派占 (isopyrazam)(反差向鏡像異構物 (anti-epimeric enantiomer) 1R,4S,9S)、(II-B011) 亞派占(反差向對映異構物1S,4R,9R)(isopyrazam (anti-epimeric enantiomer 1S,4R,9R))、(II-B012) 亞派占(反差向異構消旋物1RS,4SR,9SR)(isopyrazam (anti-epimeric racemate 1RS,4SR,9SR))、(II-B013) 亞派占(同差向異構消旋物1RS,4SR,9RS與反差向異構消旋物1RS,4SR,9SR之混合物)(isopyrazam (mixture of syn-epimeric racemate 1RS,4SR,9RS and anti-epimeric racemate 1RS,4SR,9SR))、(II-B014) 亞派占(同差向異構消旋物1R,4S,9R) (isopyrazam (syn-epimeric enantiomer 1R,4S,9R))、(II-B015) 亞派占(同差向異構消旋物1S,4R,9S) (isopyrazam (syn-epimeric enantiomer 1S,4R,9S))、(II-B016) 亞派占(同差向異構消旋物1RS,4SR,9RS)(isopyrazam (syn-epimeric racemate 1RS,4SR,9RS))、(II-B017) 本福吩 (penflufen)、(II-B018) 本賽能 (penthiopyrad)、(II-B019) 派滅芬 (pydiflumetofen)、(II-B020) 必福滅 (pyraziflumid)、(II-B021) 速達散 (sedaxane)、(II-B022) 1,3-二甲基-N-(1,1,3-三甲基-2,3-二氫-1H-茚-4-基)-1H-吡唑-4-羧醯胺 (1,3-dimethyl-N-(1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl)-l H-pyrazole-4-carboxamide)、(II-B023) 1,3-二甲基-N-[(3R)-1,1,3-三甲基-2,3-二氫 -1H-茚-4-基]-1H-吡唑-4-羧醯胺 (1,3-dimethyl-N-[(3R)-1,l,3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1H-pyrazole-4-carboxamide)、(II-B024) 1,3-二甲基-N-[(3S)-1,1,3-三甲基-2,3-二氫-1H-茚-4-基]-1H-吡唑-4-羧醯胺 (1,3-dimethyl-N-[(3S)-1,1,3-trimethyl-2,3-dihydro- 1H-inden-4-yl]-1H-pyrazole-4- carboxamide)、(II-B025) 1-甲基-3-(三氟甲基)-N-[2’-(三氟甲基)聯苯-2-基]-1H-吡唑-4-羧醯胺 (1-methyl-3-(trifluoromethyl)-N-[2’-(trifluoromethyl)biphenyl-2-yl]-1H-pyrazole-4-carboxamide)、(II-B026) 2-氟-6-(三氟甲基)-N-(1,1,3-三甲基-2,3-二氫-1H-茚-4-基)苯醯胺 (2-fluoro-6-(trifluoromethyl)-N-(1,1,3-trimethyl-2,3-dihydro-1H-inden-4- yl)benzamide)、(II-B027) 3-(二氟甲基)-1-甲基-N-(1,1,3-三甲基-2,3-二氫-1H-茚-4-基)-1H-吡唑-4-羧醯胺 (3-(difluoromethyl)-1-methyl-N-(1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl)-1H­pyrazole-4-carboxamide)、(II-B028) 3-(二氟甲基)-1-甲基-N-[(3R)-1,1,3-三甲基-2,3-二氫-1H-茚-4-基]-1H-吡唑-4-羧醯胺 (3-(difluoromethyl)-1-methyl-N-[(3R)-1,1,3-trimethyl-2,3-dihydro-1H­inden-4-yl]-1H-pyrazole-4-carboxamide)(因吡氟沙,inpyrfluxam)、(II-B029) 3-(二氟甲基)-1-甲基-N-[(3S)-1,1,3-三甲基-2,3-二氫-1H-茚-4-基]-1H-吡唑-4-羧醯胺 (3-(difluoromethyl)-1-methyl-N-[(3S)-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1H-pyrazole-4-carboxamide)、(II-B030) 3-(二氟甲基)-N-(7-氟-1,1,3-三甲基-2,3-二氫-1H-茚-4-基)-1-甲基-1H-吡唑-4-羧醯胺 (3-(difluoromethyl)-N-(7-fluoro-1,1,3- trimethyl-2,3-dihydro-1H-inden-4-yl)-1-methyl-1H-pyrazole-4-carboxamide)(氟茚唑菌胺,Fluindapyr)、(II-B031) 3-(二氟甲基)-N-[(3R)-7-氟-1,1,3-三甲基-2,3-二氫-1H-茚-4-基]-1-甲基-1H-吡唑-4-羧醯胺 (3- (difluoromethyl)-N-[(3R)-7-fluoro-l,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1-methyl-1H-pyrazole-4-carboxamide)、(II-B032) 3-(二氟甲基)-N-[(3S)-7-氟-1,1,3-三甲基-2,3-二氫-1H-茚-4-基]-1-甲基-1H-吡唑-4-羧醯胺 (3-(difluoromethyl)-N-[(3S)-7-fluoro-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1-methyl- l H-pyrazole-4-carboxamide)、(II-B033) 5,8-二氟-N-[2-(2-氟-4-{[4-(三氟甲基)吡啶-2-基]氧}苯基)乙基]喹唑啉-4-胺 (5,8-difluoro-N-[2-(2-fluoro-4-{[4-(trifluoromethyl)pyridin-2-yl]oxy}phenyl)ethyl]quinazolin-4-amine)、(II-B034) N-(2-環戊基-5-氟苯甲基)-N-環丙基-3-(二氟甲基)-5-氟-1-甲基-1H-吡唑-4-羧醯胺 (N-(2-cyclopentyl-5-fluorobenzyl)-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1-H-pyrazole-4-carboxamide)、(II-B035) N-(2-第三丁基-5-甲基苯甲基)-N-環丙基-3-(二氟甲基)-5-氟-1-甲基-1H-吡唑-4-羧醯胺 (N-(2-tert-butyl-5-methylbenzyl)-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H­pyrazole-4-carboxamide)、(II-B036) N-(2-第三丁基苯甲基)-N-環丙基-3-(二氟甲基)-5-氟-1-甲基-1H-吡唑-4-羧醯胺 (N-(2-tert-butylbenzyl)-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide)、(II-B037) N-(5-氯-2-乙基苯甲基)-N-環丙基-3-(二氟甲基)-5-氟-1-甲基-1H-吡唑-4-羧醯胺 (N-(5-chloro-2-ethylbenzyl)-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide)、(II-B038) N-(5-氯-2-異丙基苯甲基)-N-環丙基-3-(二氟甲基)-5-氟-1-甲基-1H-吡唑-4-羧醯胺 (N-(5-chloro-2-isopropylbenzyl)-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide)(異氟丙啶,isoflucpyram)、(II-B039) N-[(1R,4S)-9-(二氯亞甲基)-1,2,3,4-四氫-1,4-甲撐基萘-5-基]-3-(二氟甲基)-1-甲基-1H-吡唑-4-羧醯胺 (N-[(1R,4S)-9-(dichloromethylene)-1,2,3,4-tetrahydro-1,4-methanonaphthalen-5-yl]-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide)、(II-B040) N-[(1S,4R)-9-(二氯亞甲基)-1,2,3,4-四氫-1,4-甲撐基萘-5-基]-3-(二氟甲基)-1-甲基-1H-吡唑-4-羧醯胺 (N-[(1S,4R)-9-(dichloromethylene)-1,2,3,4-tetrahydro-1,4-methanonaphthalen-5-yl]-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide)、(II-B041) N-[1-(2,4-二氯苯基)-1-甲氧基丙-2-基]-3-(二氟甲基)-1-甲基-1H-吡唑-4-羧醯胺 (N-[1-(2,4-dichlorophenyl)-l-methoxypropan-2-yl]-3-(difluoromethyl)-1-methyl­1H-pyrazole-4-carboxamide)、(II-B042) N-[2-氯-6-(三氟甲基)苯甲基]-N-環丙基-3-(二氟甲基)-5-氟-1-甲基-1H-吡唑-4-羧醯胺 (N-[2-chloro-6-(trifluoromethyl)benzyl]-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide)、(II-B043) N-[3-氯-2-氟-6-(三氟甲基)苯甲基]-N-環丙基-3-(二氟甲基)-5-氟-1-甲基-1H-吡唑-4-羧醯胺 (N-[3-chloro-2-fluoro-6-(trifluoromethyl)benzyl]-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4- carboxamide)、(II-B044)      N-[5-氯 -2-(三氟甲基)苯甲基]-N-環丙基-3-(二氟甲基)-5-氟-1-甲基-1H-吡唑-4-羧醯胺 (N-[5-chloro-2-(trifluoromethyl)benzyl]-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide)、(II-B045) N-環丙基-3-(二氟甲基)-5-氟-1-甲基-N-[5-甲基-2-(三氟甲基)苯甲基]-1H-吡唑-4-羧醯胺 (N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-N-[5-methyl-2-(trifluoromethyl)benzyl]-1H-pyrazole-4-carboxamide)、(II-B046) N-環丙基-3-(二氟甲基)-5-氟-N-(2-氟-6-異丙基苯甲基)-1-甲基-1H-吡唑-4-羧醯胺 (N-cyclopropyl-3-(difluoromethyl)-5-fluoro-N-(2-fluoro-6-isopropylbenzyl)-1-methyl-1H-pyrazole-4-carboxamide)、(II-B047) N-環丙基-3-(二氟甲基)-5-氟-N-(2-異丙基-5-甲基苯甲基)-1-甲基-1H-吡唑-4-羧醯胺 (N-cyclopropyl-3-(difluoromethyl)-5-fluoro-N-(2-isopropyl-5-methylbenzyl)-1-methyl-1H­pyrazole-4-carboxamide)、(II-B048) N-環丙基-3-(二氟甲基)-5-氟-N-(2-異丙基苯甲基)-1-甲基-1H-吡唑-4-甲硫醯胺 (N-cyclopropyl-3-(difluoromethyl)-5-fluoro-N-(2-isopropylbenzyl)-1-methyl-1H-pyrazole-4-carbothioamide)、(II-B049) N-環丙基-3-(二氟甲基)-5-氟-N-(2-異丙基苯甲基)-1-甲基-1H-吡唑-4-羧醯胺 (N-cyclopropyl-3-(difluoromethyl)-5-fluoro-N-(2-isopropylbenzyl)-1-methyl-1H-pyrazole-4-carboxamide)、(II-B050) N-環丙基-3-(二氟甲基)-5-氟-N-(5-氟-2-異丙基苯甲基)-1-甲基-1H-吡唑-4-羧醯胺 (N-cyclopropyl-3-(difluoromethyl)-5-fluoro-N-(5-fluoro-2-isopropylbenzyl)-1-methyl-1H-pyrazole-4-carboxamide)、(II-B051) )N-環丙基-3-(二氟甲基)-N-(2-乙基-4,5-二甲基苯甲基)-5-氟-1-甲基-1H-吡唑-4-羧醯胺 (N-cyclopropyl-3-(difluoromethyl)-N-(2-ethyl-4,5-dimethylbenzyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide)、(II-B052) N-環丙基-3-(二氟甲基)-N-(2-乙基-5-氟苯甲基)-5-氟-1-甲基-1H-吡唑-4-羧醯胺 (N-cyclopropyl-3-(difluoromethyl)-N-(2-ethyl-5-fluorobenzyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide)、(II-B053) N-環丙基-3-(二氟甲基)-N-(2-乙基-5-甲基苯甲基)-5-氟-1-甲基-1H-吡唑-4-羧醯胺 (N-cyclopropyl-3-(difluoromethyl)-N-(2-ethyl-5-methylbenzyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide)、(II-B054) N-環丙基-N-(2-環丙基-5-氟苯甲基)-3-(二氟甲基)-5-氟-1-甲基-1H-吡唑-4-羧醯胺 (N-cyclopropyl-N-(2-cyclopropyl-5-fluorobenzyl)-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide)、(II-B055) N-環丙基-N-(2-環丙基-5-甲基苯甲基)-3-(二氟甲基)-5-氟-1-甲基-1H-吡唑-4-羧醯胺 (N-cyclopropyl-N-(2-cyclopropyl-5-methylbenzyl)-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide)、(II-B056) N-環丙基-N-(2-環丙基苯甲基)-3-(二氟甲基)-5-氟-1-甲基-1H-吡唑-4-羧醯胺 (N-cyclopropyl-N-(2-cyclopropylbenzyl)-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide)、(II-B057) 2-(二氟甲基)-N-(1,1-二甲基-3-丙基-2,3-二氫-1H-茚-4-基)菸鹼醯胺 (2-(difluoromethyl)-N-(l,1-dimethyl-3-propyl-2,3-dihydro-1H-inden-4-yl)nicotinamide)、(II-B058) 吡唑甲醯胺類殺菌劑 (pyrapropoyne)、(II-B059) 因吡氟沙 (inpyrfluxam)、(II-B060) 滅普寧 (mepronil)、(II-B061) 異氟丙啶 (isoflucypram)、(II-B062) 嘉保信 (oxycarboxin)、(II-B063) α-(甲氧基亞胺基)-N-甲基-2-[[[1-[3-(三氟甲基)苯基]乙氧基]亞胺基]甲基]苯乙醯胺 (α-(methoxyimino)-N-methyl-2-[[[1-[3-(trifluoromethyl)phenyl]ethoxy]imino]methyl]benzeneacetamide)、(II-B064) 二氟林 (diflumetorim)、(II-B065) 賽氟滅 (thifluzamide)、(II-B066) 甲呋醯胺 (fenfuram)、(II-B067) 麥鏽靈 (benodanil);(II-B) Inhibitors of complex I (complex I) or complex II (complex II) of the respiratory chain, such as (II-B001) benzovindiflupyr, (II-B002) bexafin (bixafen), (II-B003) boscalid, (II-B004) carboxin, (II-B005) fluopyram, (II-B006) flutolanil ), (II-B007) fluoxapyroxad (fluxapyroxad), (II-B008) furametpyr, (II-B009) isofetamid, (II-B010) isopyrazam ( Anti-epimeric enantiomer (anti-epimeric enantiomer 1R,4S,9S), (II-B011) 4R,9R)), (II-B012) isopyrazam (anti-epimeric racemate 1RS,4SR,9SR) (isopyrazam (anti-epimeric racemate 1RS,4SR,9SR)), (II-B013) Accounting (isopyrazam (mixture of syn-epimeric racemate 1RS, 4SR, 9RS and anti-epimeric racemate 1RS, 4SR, 9RS and anti-epimeric racemate 1RS,4SR,9SR)), (II-B014) (isopyrazam (syn-epimeric enantiomer 1R,4S,9R)), (II-B015 ) (isopyrazam (syn-epimeric enantiomer 1S,4R,9S)), (II-B016) 1RS, 4SR, 9RS) (isopyrazam (syn-epimeric racemate 1RS, 4SR, 9RS)), (II-B017) Benfufen (penflufen), (II-B018) Benthiopyrad, (II-B019 ) Pydiflumetofen, (II-B020) Pyraziflumid, (II-B021) Sedaxane, (II-B022) 1,3-Dimethyl-N-(1,1 ,3-Trimethyl-2,3-dihydro-1H-inden-4-yl)-1H-pyrazole-4-carboxamide (1,3-dimethyl-N-(1,1,3-trimethyl -2,3-dihydro-1H-inden-4-yl)-l H-pyrazole-4-carboxamide), (II-B023) 1,3-Dimethyl-N-[(3R)-1,1, 3-Trimethyl-2,3-dihydro-1H-inden-4-yl]-1H-pyrazole-4-carboxamide (1,3-dimethyl-N-[(3R)-1,l, 3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1H-pyrazole-4-carboxamide), (II-B024) 1,3-Dimethyl-N-[(3S)-1, 1,3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1H-pyrazole-4-carboxamide (1,3-dimethyl-N-[(3S)-1, 1,3-trimethyl-2,3-dihydro- 1H-inden-4-yl]-1H-pyrazole-4-carboxamide), (II-B025) 1-methyl-3-(trifluoromethyl)-N -[2'-(trifluoromethyl)biphenyl-2-yl]-1H-pyrazole-4-carboxamide (1-methyl-3-(trifluoromethyl)-N-[2'-(trifluoromethyl)biphenyl -2-yl]-1H-pyrazole-4-carboxamide), (II-B026) 2-fluoro-6-(trifluoromethyl)-N-(1,1,3-trimethyl-2,3- Dihydro-1H-inden-4-yl)benzamide (2-fluoro-6-(trifluoromethyl)-N-(1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl) benzamide), (II-B027) 3-(difluoromethyl)-1-methyl-N-(1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl) -1H-pyrazole-4-carboxamide (3-(difluoromethyl)-1-methyl-N-(1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl)-1Hpyrazole- 4-carboxami de), (II-B028) 3-(difluoromethyl)-1-methyl-N-[(3R)-1,1,3-trimethyl-2,3-dihydro-1H-indene- 4-yl]-1H-pyrazole-4-carboxamide (3-(difluoromethyl)-1-methyl-N-[(3R)-1,1,3-trimethyl-2,3-dihydro-1Hinden-4 -yl]-1H-pyrazole-4-carboxamide) (inpyrfluxam, inpyrfluxam), (II-B029) 3-(difluoromethyl)-1-methyl-N-[(3S)-1,1 ,3-Trimethyl-2,3-dihydro-1H-inden-4-yl]-1H-pyrazole-4-carboxamide (3-(difluoromethyl)-1-methyl-N-[(3S) -1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1H-pyrazole-4-carboxamide), (II-B030) 3-(difluoromethyl)-N-( 7-fluoro-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl)-1-methyl-1H-pyrazole-4-carboxamide (3-(difluoromethyl )-N-(7-fluoro-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl)-1-methyl-1H-pyrazole-4-carboxamide) (fluindazole , Fluindapyr), (II-B031) 3-(difluoromethyl)-N-[(3R)-7-fluoro-1,1,3-trimethyl-2,3-dihydro-1H-indene- 4-yl]-1-methyl-1H-pyrazole-4-carboxamide (3-(difluoromethyl)-N-[(3R)-7-fluoro-l,1,3-trimethyl-2,3- dihydro-1H-inden-4-yl]-1-methyl-1H-pyrazole-4-carboxamide), (II-B032) 3-(difluoromethyl)-N-[(3S)-7-fluoro-1 ,1,3-Trimethyl-2,3-dihydro-1H-inden-4-yl]-1-methyl-1H-pyrazole-4-carboxamide (3-(difluoromethyl)-N-[ (3S)-7-fluoro-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1-methyl- l H-pyrazole-4-carboxamide), (II-B033) 5,8-Difluoro-N-[2-(2-fluoro-4-{[4-(trifluoromethyl Base)pyridin-2-yl]oxy}phenyl)ethyl]quinazolin-4-amine (5,8-difluoro-N-[2-(2-fluoro-4-{[4-(trifluoromethyl)pyridin -2-yl]oxy}phenyl)ethyl]quinazolin-4-amine), (II-B034) N-(2-cyclopentyl-5-fluorobenzyl)-N-cyclopropyl-3-(di Fluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide (N-(2-cyclopentyl-5-fluorobenzyl)-N-cyclopropyl-3-(difluoromethyl)-5-fluoro -1-methyl-1-H-pyrazole-4-carboxamide), (II-B035) N-(2-tert-butyl-5-methylbenzyl)-N-cyclopropyl-3-(two Fluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide (N-(2-tert-butyl-5-methylbenzyl)-N-cyclopropyl-3-(difluoromethyl)-5 -fluoro-1-methyl-1Hpyrazole-4-carboxamide), (II-B036) N-(2-tert-butylbenzyl)-N-cyclopropyl-3-(difluoromethyl)-5- Fluoro-1-methyl-1H-pyrazole-4-carboxamide (N-(2-tert-butylbenzyl)-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole- 4-carboxamide), (II-B037) N-(5-chloro-2-ethylbenzyl)-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl- 1H-pyrazole-4-carboxamide (N-(5-chloro-2-ethylbenzyl)-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide), (II-B038) N-(5-Chloro-2-isopropylbenzyl)-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole -4-Carboxamide (N-(5-chloro-2-isopropylbenzyl)-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide) (isofluoropropidine , isoflucpyram) 、(II-B039) N-[(1R,4S)-9-(Dichloromethylene)-1,2,3,4-tetrahydro-1,4-methylenenaphthalen-5-yl]- 3-(Difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide (N-[(1R,4S)-9-(dichloromethylene)-1,2,3,4-tetrahydro- 1,4-methanonaphthalen-5-yl]-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide), (II-B040) N-[(1S,4R)-9-(difluoromethyl Methyl)-1,2,3,4-tetrahydro-1,4-methylenenaphthalen-5-yl]-3-(difluoromethyl)-1-methyl-1H-pyrazole-4- Carboxamide (N-[(1S,4R)-9-(dichloromethylene)-1,2,3,4-tetrahydro-1,4-methanonaphthalen-5-yl]-3-(difluoromethyl)-1-methyl- 1H-pyrazole-4-carboxamide), (II-B041) N-[1-(2,4-dichlorophenyl)-1-methoxypropan-2-yl]-3-(difluoromethyl) -1-Methyl-1H-pyrazole-4-carboxamide (N-[1-(2,4-dichlorophenyl)-l-methoxypropan-2-yl]-3-(difluoromethyl)-1-methyl1H-pyrazole -4-carboxamide), (II-B042) N-[2-chloro-6-(trifluoromethyl)benzyl]-N-cyclopropyl-3-(difluoromethyl)-5-fluoro- 1-Methyl-1H-pyrazole-4-carboxamide (N-[2-chloro-6-(trifluoromethyl)benzyl]-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H -pyrazole-4-carboxamide), (II-B043) N-[3-chloro-2-fluoro-6-(trifluoromethyl)benzyl]-N-cyclopropyl-3-(difluoromethyl )-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide (N-[3-chloro-2-fluoro-6-(trifluoromethyl)benzyl]-N-cyclopropyl-3-(difluoromethyl) -5-fluoro-1-methyl-1H-pyrazole-4-carboxamide), (II-B044) N-[5-Chloro-2-(trifluoromethyl)benzyl]-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4 -Carboxamide (N-[5-chloro-2-(trifluoromethyl)benzyl]-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide), (II- B045) N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-N-[5-methyl-2-(trifluoromethyl)benzyl]-1H-pyridine Pyrazole-4-carboxamide (N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-N-[5-methyl-2-(trifluoromethyl)benzyl]-1H-pyrazole-4-carboxamide), (II-B046) N-cyclopropyl-3-(difluoromethyl)-5-fluoro-N-(2-fluoro-6-isopropylbenzyl)-1-methyl-1H-pyrazole -4-Carboxamide (N-cyclopropyl-3-(difluoromethyl)-5-fluoro-N-(2-fluoro-6-isopropylbenzyl)-1-methyl-1H-pyrazole-4-carboxamide), (II-B047 ) N-cyclopropyl-3-(difluoromethyl)-5-fluoro-N-(2-isopropyl-5-methylbenzyl)-1-methyl-1H-pyrazole-4- Carboxamide (N-cyclopropyl-3-(difluoromethyl)-5-fluoro-N-(2-isopropyl-5-methylbenzyl)-1-methyl-1Hpyrazole-4-carboxamide), (II-B048) N-cyclopropyl Base-3-(difluoromethyl)-5-fluoro-N-(2-isopropylbenzyl)-1-methyl-1H-pyrazole-4-methionamide (N-cyclopropyl-3 -(difluoromethyl)-5-fluoro-N-(2-isopropylbenzyl)-1-methyl-1H-pyrazole-4-carbothioamide), (II-B049) N-cyclopropyl-3-(difluoromethyl)- 5-fluoro-N-(2-isopropylbenzyl)-1-methyl-1H-pyrazole-4-carboxamide (N-cyclopropyl-3-(difluoromethyl)-5-fluoro-N-( 2-isopropylbenzyl)-1-m ethyl-1H-pyrazole-4-carboxamide), (II-B050) N-cyclopropyl-3-(difluoromethyl)-5-fluoro-N-(5-fluoro-2-isopropylbenzyl )-1-methyl-1H-pyrazole-4-carboxamide (N-cyclopropyl-3-(difluoromethyl)-5-fluoro-N-(5-fluoro-2-isopropylbenzyl)-1-methyl-1H- pyrazole-4-carboxamide), (II-B051) ) N-cyclopropyl-3-(difluoromethyl)-N-(2-ethyl-4,5-dimethylbenzyl)-5- Fluoro-1-methyl-1H-pyrazole-4-carboxamide (N-cyclopropyl-3-(difluoromethyl)-N-(2-ethyl-4,5-dimethylbenzyl)-5-fluoro-1-methyl- 1H-pyrazole-4-carboxamide), (II-B052) N-cyclopropyl-3-(difluoromethyl)-N-(2-ethyl-5-fluorobenzyl)-5-fluoro-1 -Methyl-1H-pyrazole-4-carboxamide (N-cyclopropyl-3-(difluoromethyl)-N-(2-ethyl-5-fluorobenzyl)-5-fluoro-1-methyl-1H-pyrazole-4 -carboxamide), (II-B053) N-cyclopropyl-3-(difluoromethyl)-N-(2-ethyl-5-methylbenzyl)-5-fluoro-1-methyl- 1H-pyrazole-4-carboxamide (N-cyclopropyl-3-(difluoromethyl)-N-(2-ethyl-5-methylbenzyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide), (II-B054) N-cyclopropyl-N-(2-cyclopropyl-5-fluorobenzyl)-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole -4-Carboxamide (N-cyclopropyl-N-(2-cyclopropyl-5-fluorobenzyl)-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide), (II-B055 ) N-cyclopropyl-N-(2-cyclopropyl-5-methylbenzyl)-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4- Carboxamide (N-cyclopropyl-N-(2-cyclopropyl-5-methylb enzyl)-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide), (II-B056) N-cyclopropyl-N-(2-cyclopropylbenzyl)- 3-(Difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide (N-cyclopropyl-N-(2-cyclopropylbenzyl)-3-(difluoromethyl)-5-fluoro -1-methyl-1H-pyrazole-4-carboxamide), (II-B057) 2-(difluoromethyl)-N-(1,1-dimethyl-3-propyl-2,3-dihydro -1H-inden-4-yl)nicotinamide (2-(difluoromethyl)-N-(l,1-dimethyl-3-propyl-2,3-dihydro-1H-inden-4-yl)nicotinamide), (II-B058) pyrapropoyne, (II-B059) inpyrfluxam, (II-B060) mepronil, (II-B061) isoflurane (isoflucypram), (II-B062) oxycarboxin, (II-B063) α-(methoxyimino)-N-methyl-2-[[[1-[3-(trifluoromethyl Base) phenyl] ethoxy] imino] methyl] phenylacetamide (α-(methoxyimino)-N-methyl-2-[[[1-[3-(trifluoromethyl)phenyl]ethoxy]imino] methyl]benzoneacetamide), (II-B064) diflumetorim, (II-B065) thifluzamide, (II-B066) fenfuram, (II-B067) matropin (benodanil);

(II-C) 呼吸鏈複合物 III (complex III) 的抑制劑,可例舉如 (II-C001) 滅脫定 (ametoctradin)、(II-C002) 安美速 (amisulbrom)、(II-C003) 亞托敏 (azoxystrobin)、(II-C004) 甲香菌酯 (coumethoxystrobin)、(II-C005) 丁香菌酯 (coumoxystrobin)、(II-C006) 賽發滅 (cyazofamid)、(II-C007) 醚菌胺 (dimoxystrobin)、(II-C008) 烯肟菌酯 (enoxastrobin)、(II-C009) 凡殺同 (famoxadone)、(II-C010) 芬滅酮 (fenamidone)、(II-C011) 吩嘧菌酯 (flufenoxystrobin)、(II-C012) 氟嘧菌酯 (fluoxastrobin)、(II-C013) 克收欣 (kresoxim-methyl)、(II-C014) 氧菌胺 (metominostrobin)、(II-C015) 肟醚菌胺 (orysastrobin)、(II-C016) 啶氧菌酯 (picoxystrobin)、(II-C017) 唑菌胺酯 (pyraclostrobin)、(II-C018) 唑胺菌酯 (pyrametostrobin)、(II-C019) 唑菌酯 (pyraoxystrobin)、(II-C020) 三氟敏 (trifloxystrobin)、(II-C021) (2E)-2-{2-[({[(1E)-1-(3-{[(E)-1-氟-2-苯基乙烯基]氧}苯基)亞乙基]胺基}氧)甲基]苯基}-2-(甲氧基亞胺基)-N-甲基乙醯胺 ((2E)-2-{2-[({[(1E)-1-(3-{[(E)-1-fluoro-2-phenylvinyl]oxy}phenyl)ethylidene]amino}oxy)methyl]phenyl}-2-(methoxyimino)-N-methylacetamide)、(II-C022) (2E,3Z)-5-{[1-(4-氯苯基)-1H-吡唑-3-基]氧}-2-(甲氧基亞胺基)-N,3-二甲基戊-3-烯醯胺 ((2E,3Z)-5-{[1-(4-chlorophenyl)-1H-pyrazol-3-yl]oxy}-2-(methoxyimino)-N,3-dimethylpent-3-enamide)、(II-C023) (2R)-2-{2-[(2,5-二甲基苯氧基)甲基]苯基}-2-甲氧基-N-甲基乙醯胺 ((2R)-2-{2-[(2,5-dimethylphenoxy)methyl]phenyl}-2-methoxy-N-methylacetamide)、(II-C024) (2S)-2-{2-[(2,5-二甲基苯氧基)甲基]苯基}-2-甲氧基-N-甲基乙醯胺 ((2S)-2-{2-[(2,5-dimethylphenoxy)methyl]phenyl}-2-methoxy-N-methylacetamide)、(II-C025) (3S,6S,7R,8R)-8-苄基-3-[({3-[(異丁醯氧基)甲氧基]-4-甲氧基吡啶-2-基}羰基)胺基]-6-甲基-4,9-二氧代-1,5-二氧代-7-基-2-甲基丙酸酯) ((3S,6S,7R,8R)-8-benzyl-3-[({3-[(isobutyryloxy)methoxy]-4-methoxypyridin-2-yl}carbonyl)amino]-6-methyl-4,9-dioxo-1,5-dioxonan-7-yl-2-methylpropanoate)(芬吡沙密,Fenpicoxamid)、(II-C026) 2-{2-[(2,5-二甲基苯氧基)甲基]苯基}-2-甲氧基-N-甲基乙醯胺 (2-{2-[(2,5- dimethylphenoxy)methyl]phenyl}-2-methoxy-N-methylacetamide)(滿得賓,Mandestrobin)、(II-C027) N-(3-乙基-3,5,5-三甲基環己基)-3-甲醯胺基-2-羥基苯醯胺 (N-(3-ethyl-3,5,5-trimethylcyclohexyl)-3-formamido-2-hydroxybenzamide)、(II-C028) (2E,3Z)-5-{[1-(4-氯-2-氟苯基) -1H-吡唑-3-基]氧基}-2-(甲氧基亞胺基)-N,3-二甲基戊-3-烯醯胺 ((2E,3Z)-5-{[1-(4-chloro-2-fluorophenyl)-1H-pyrazol-3-yl]oxy}-2-(methoxyimino)-N,3-dimethylpent-3-enamide)、(II-C029) 甲基{5-[3-(2,4-二甲基苯基)-1H-吡唑-1-基]-2-甲基芐基}胺基甲酸酯 (methyl {5-[3-(2,4-dimethylphenyl)-1H-pyrazol-1-yl]-2-methylbenzyl}carbamate)、(II-C030) 1-(2-{[1-(4-氯苯基)吡唑-3-基]氧基甲基}-3-甲基苯基)-1,4-二氫-4-甲基-5H-四唑-5-酮 (1-(2-{[1-(4-chlorophenyl)pyrazol-3-yl]oxymethyl}-3-methylphenyl)-1,4-dihydro-4-methyl-5H-tetrazol-5-one)(甲基四吡咯,Metyltetraprole)、(II-C031) 氟吡沙胺 (florylpicoxamid)、(II-C032) 吡苯卡 (pyribencarb)、(II-C033) α-(甲氧基亞胺基)-N-甲基-2-[[[1-[3-(三氟甲基)苯基]乙氧基]亞胺基]甲基]苯乙醯胺 (α-(methoxyimino)-N-methyl-2-[[[1-[3-(trifluoromethyl)phenyl]ethoxy]imino]methyl]benzeneacetamide)、(II-C034) metarylpicoxamid ((2S,3S)-3-(2-Methylphenyl)-2-butanyl N-{[4-methoxy-3-(propionyloxy)-2-pyridinyl]carbonyl}-L-alaninate);(II-C) Inhibitors of respiratory chain complex III (complex III), such as (II-C001) ametoctradin, (II-C002) amisulbrom, (II-C003) Azoxystrobin, (II-C004) coumethoxystrobin, (II-C005) coumoxystrobin, (II-C006) cyazofamid, (II-C007) ether Dimoxystrobin, (II-C008) enoxastrobin, (II-C009) famoxadone, (II-C010) fenamidone, (II-C011) phenazine Flufenoxystrobin, (II-C012) Fluoxastrobin, (II-C013) Kresoxim-methyl, (II-C014) Metominostrobin, (II-C015) Orysastrobin, (II-C016) picoxystrobin, (II-C017) pyraclostrobin, (II-C018) pyrastrobin, (II- C019) Pyraoxystrobin, (II-C020) Trifloxystrobin, (II-C021) (2E)-2-{2-[({[(1E)-1-(3-{[ (E)-1-fluoro-2-phenylvinyl]oxy}phenyl)ethylene]amino}oxy)methyl]phenyl}-2-(methoxyimino)-N-methyl ((2E)-2-{2-[({[(1E)-1-(3-{[(E)-1-fluoro-2-phenylvinyl]oxy}phenyl)ethylene]amino}oxy )methyl]phenyl}-2-(methoxyimino)-N-methylacetamide), (II-C022) (2E,3Z)-5-{[1-(4-chlorophenyl)-1H-pyrazol-3-yl ]oxy}-2-(methoxyimino)-N,3-dimethylpent-3-enamide ((2E,3Z)-5-{[1-(4-chlorophenyl)-1H- pyrazol-3-yl ]oxy}-2-(methoxyimino)-N,3-dimethylpent-3-enamide), (II-C023) (2R)-2-{2-[(2,5-dimethylphenoxy)methyl ]phenyl}-2-methoxy-N-methylacetamide ((2R)-2-{2-[(2,5-dimethylphenoxy)methyl]phenyl}-2-methoxy-N-methylacetamide), (II-C024) (2S)-2-{2-[(2,5-Dimethylphenoxy)methyl]phenyl}-2-methoxy-N-methylacetamide ((2S )-2-{2-[(2,5-dimethylphenoxy)methyl]phenyl}-2-methoxy-N-methylacetamide), (II-C025) (3S,6S,7R,8R)-8-benzyl-3 -[({3-[(isobutyryloxy)methoxy]-4-methoxypyridin-2-yl}carbonyl)amino]-6-methyl-4,9-dioxo-1 ,5-dioxo-7-yl-2-methylpropionate) ((3S,6S,7R,8R)-8-benzyl-3-[({3-[(isobutyryloxy)methoxy]-4- methoxypyridin-2-yl}carbonyl)amino]-6-methyl-4,9-dioxo-1,5-dioxonan-7-yl-2-methylpropanoate) (Fenpicoxamid), (II-C026) 2 -{2-[(2,5-Dimethylphenoxy)methyl]phenyl}-2-methoxy-N-methylacetamide (2-{2-[(2,5-dimethylphenoxy )methyl]phenyl}-2-methoxy-N-methylacetamide) (Mandestrobin, Mandestrobin), (II-C027) N-(3-ethyl-3,5,5-trimethylcyclohexyl)-3- Formamido-2-hydroxybenzamide (N-(3-ethyl-3,5,5-trimethylcyclohexyl)-3-formamido-2-hydroxybenzamide), (II-C028) (2E,3Z)-5- {[1-(4-Chloro-2-fluorophenyl)-1H-pyrazol-3-yl]oxy}-2-(methoxyimino)-N,3-dimethylpenta-3 -Enamide ((2E,3Z)-5-{[1-(4-chloro-2-fluorophenyl)-1H-pyrazol-3-yl]oxy}-2-(methoxyimino)-N ,3-dimethylpent-3-enamide), (II-C029) methyl{5-[3-(2,4-dimethylphenyl)-1H-pyrazol-1-yl]-2-methylbenzyl Base} carbamate (methyl {5-[3-(2,4-dimethylphenyl)-1H-pyrazol-1-yl]-2-methylbenzyl}carbamate), (II-C030) 1-(2-{ [1-(4-Chlorophenyl)pyrazol-3-yl]oxymethyl}-3-methylphenyl)-1,4-dihydro-4-methyl-5H-tetrazole-5- Ketone (1-(2-{[1-(4-chlorophenyl)pyrazol-3-yl]oxymethyl}-3-methylphenyl)-1,4-dihydro-4-methyl-5H-tetrazol-5-one) (formazol Metyltetraprole), (II-C031) florylpicoxamid, (II-C032) pyribencarb, (II-C033) α-(methoxyimino)-N- Methyl-2-[[[1-[3-(trifluoromethyl)phenyl]ethoxy]imino]methyl]phenylacetamide (α-(methoxyimino)-N-methyl-2- [[[1-[3-(trifluoromethyl)phenyl]ethoxy]imino]methyl]benzeneacetamide), (II-C034) metalylpicoxamid ((2S,3S)-3-(2-Methylphenyl)-2-butanyl N-{[ 4-methoxy-3-(propionyloxy)-2-pyridinyl]carbonyl}-L-alaninate);

(II-D) 有絲分裂和細胞分裂的抑制劑、可例舉如(II-D001) 貝芬替 (carbendazim)、(II-D002) 乙黴威 (diethofencarb)、(II-D003) 噻唑菌胺 (ethaboxam)、(II-D004) 氟比來 (fluopicolide)、(II-D005) 賓克隆 (pencycuron)、(II-D006) 腐絕 (thiabendazole)、(II-D007) 甲基硫菌靈 (thiophanate-methyl)、(II-D008) 座賽胺 (zoxamide)、(II-D009) 3-氯-4-(2,6-二氟苯基)-6-甲基-5-苯基噠嗪 (3-chloro-4-(2,6-difluorophenyl)-6-methyl-5- phenylpyridazine)、(II-D010) 3-氯-5-(4-氯苯基)-4-(2,6-二氟苯基)-6-甲基噠嗪 (3-chloro-5-(4-chlorophenyl)-4-(2,6-difluorophenyl)-6-methylpylidazine)、(II-D011) 3-氯-5-(6-氯吡啶-3-基)-6-甲基-4-(2,4,6-三氟苯基)噠嗪 (3-chloro-5-(6-chloropyridin-3-yl)-6-methyl-4-(2,4,6-trifluorophenyl)pyridazine)、(II-D012) 4-(2-溴-4-氟苯基)-N-(2,6-二氟苯基)-1,3-二甲基-1H-吡唑-5-胺 (4-(2-bromo-4-fluorophenyl)-N-(2,6-difluorophenyl)-l,3-dimethyl-1H-pyrazol-5-amine)、(II-D013) 4-(2-溴-4-氟苯基)-N-(2-溴-6-氟苯基)-1,3-二甲基-1H-吡唑-5-胺 (4-(2-bromo-4-fluorophenyl)-N-(2-bromo-6-fluorophenyl)-l,3-dimethyl-1H-pyrazol-5-amine)、(II-D014) 4-(2-溴-4-氟苯基)-N-(2-溴苯基)-1,3-二甲基-1H-吡唑-5-胺 (4-(2-bromo-4-fluorophenyl)-N-(2-bromophenyl)-1,3-dimethyl-1H-pyrazol-5-amine)、(II-D015) 4-(2-溴-4-氟苯基)-N-(2-氯-6-氟苯基)-1,3-二甲基-1H-吡唑-5-胺 (4-(2-bromo-4-fluorophenyl)-N-(2-chloro-6-fluorophenyl)-l,3-dimethyl-1H-pyrazol-5-amine)、(II-D016) 4-(2-溴-4-氟苯基)-N-(2-氯苯基)-1,3-二甲基-1H-吡唑-5-胺 (4-(2-bromo-4-fluorophenyl)-N-(2-chlorophenyl)-l,3-dimethyl-1H-pyrazol-5-amine)、(II-D017) 4-(2-溴-4-氟苯基)-N-(2-氟苯基)-1,3-二甲基-1H-吡唑-5-胺 (4-(2-bromo-4-fluorophenyl)-N-(2-fluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine)、(II-D018) 4-(2-氯-4-氟苯基)-N-(2,6-二氟苯基))-1,3-二甲基-1H-吡唑-5-胺 (4-(2-chloro-4-fluorophenyl)-N-(2,6-difluorophenyl)-l,3-dimethyl-1H-pyrazol-5-amine)、(II-D019) 4-(2-氯-4-氟苯基)-N-(2-氯-6-氟苯基)-1,3-二甲基-1H-吡唑-5-胺 (4-(2-chloro-4-fluorophenyl)-N-(2-chloro-6-fluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine)、(II-D020) 4-(2-氯-4-氟苯基)-N-(2-氯苯基)-1,3-二甲基-1H-吡唑-5-胺 (4-(2-chloro-4-fluorophenyl)-N-(2-chlorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine)、(II-D021) 4-(2-氯-4-氟苯基)-N-(2-氟苯基)-1,3-二甲基-1H-吡唑-5-胺 (4-(2-chloro-4-fluorophenyl)-N-(2-fluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine)、(II-D022) 4-(4-氯苯基)-5-(2,6-二氟苯基)-3,6-二甲基噠嗪 (4-(4-chlorophenyl)-5-(2,6-difluorophenyl)-3,6-dimethylpyridazine)、(II-D023) N-(2-溴-6-氟苯基)-4-(2-氯-4-氟苯基)-l,3-二甲基-1H-吡唑-5-胺 (N-(2-bromo-6-fluorophenyl)-4-(2-chloro-4-fluorophenyl)-l,3-dimethyl-1H-pyrazol-5-amine)、(II-D024) N-(2-溴苯基)-4-(2-氯-4-氟苯基)-1,3-二甲基-1H-吡唑-5-胺 (N-(2-bromophenyl)-4-(2-chloro-4-fluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine)、(II-D025) N-(4-氯-2,6-二氟苯基)-4-(2-氯-4-氟苯基)-1,3-二甲基-1H-吡唑-5-胺 (N-(4-chloro-2,6-difluorophenyl)-4-(2-chloro-4-fluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine)、(II-D026) 免賴得 (benomyl);(II-D) Inhibitors of mitosis and cell division, such as (II-D001) carbendazim, (II-D002) diethofencarb, (II-D003) ethaboxam ( ethaboxam), (II-D004) fluopicolide, (II-D005) pencycuron, (II-D006) thiabendazole, (II-D007) thiophanate-methyl (thiophanate- methyl), (II-D008) zoxamide, (II-D009) 3-chloro-4-(2,6-difluorophenyl)-6-methyl-5-phenylpyridazine (3 -chloro-4-(2,6-difluorophenyl)-6-methyl-5-phenylpyridazine), (II-D010) 3-chloro-5-(4-chlorophenyl)-4-(2,6-difluoro Phenyl)-6-methylpyridazine (3-chloro-5-(4-chlorophenyl)-4-(2,6-difluorophenyl)-6-methylpyridazine), (II-D011) 3-chloro-5-( 6-chloropyridin-3-yl)-6-methyl-4-(2,4,6-trifluorophenyl)pyridazine (3-chloro-5-(6-chloropyridin-3-yl)-6- methyl-4-(2,4,6-trifluorophenyl)pyridazine), (II-D012) 4-(2-bromo-4-fluorophenyl)-N-(2,6-difluorophenyl)-1, 3-Dimethyl-1H-pyrazol-5-amine (4-(2-bromo-4-fluorophenyl)-N-(2,6-difluorophenyl)-l,3-dimethyl-1H-pyrazol-5-amine ), (II-D013) 4-(2-bromo-4-fluorophenyl)-N-(2-bromo-6-fluorophenyl)-1,3-dimethyl-1H-pyrazole-5- Amine (4-(2-bromo-4-fluorophenyl)-N-(2-bromo-6-fluorophenyl)-l,3-dimethyl-1H-pyrazol-5-amine), (II-D014) 4-(2 -Bromo-4-fluorophenyl)-N-(2-bromophenyl)-1,3-dimethyl-1H-pyrazol-5-amine (4-(2-bromo-4-fluorophenyl)-N -(2-bromophenyl)-1,3-dimethyl- 1H-pyrazol-5-amine), (II-D015) 4-(2-bromo-4-fluorophenyl)-N-(2-chloro-6-fluorophenyl)-1,3-dimethyl- 1H-pyrazol-5-amine (4-(2-bromo-4-fluorophenyl)-N-(2-chloro-6-fluorophenyl)-l,3-dimethyl-1H-pyrazol-5-amine), (II -D016) 4-(2-bromo-4-fluorophenyl)-N-(2-chlorophenyl)-1,3-dimethyl-1H-pyrazoles-5-amine (4-(2-bromo -4-fluorophenyl)-N-(2-chlorophenyl)-l,3-dimethyl-1H-pyrazol-5-amine), (II-D017) 4-(2-bromo-4-fluorophenyl)-N- (2-fluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine (4-(2-bromo-4-fluorophenyl)-N-(2-fluorophenyl)-1,3-dimethyl -1H-pyrazol-5-amine), (II-D018) 4-(2-chloro-4-fluorophenyl)-N-(2,6-difluorophenyl))-1,3-dimethyl -1H-pyrazol-5-amine (4-(2-chloro-4-fluorophenyl)-N-(2,6-difluorophenyl)-l,3-dimethyl-1H-pyrazol-5-amine), (II- D019) 4-(2-chloro-4-fluorophenyl)-N-(2-chloro-6-fluorophenyl)-1,3-dimethyl-1H-pyrazole-5-amine (4-( 2-chloro-4-fluorophenyl)-N-(2-chloro-6-fluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine), (II-D020) 4-(2-chloro-4- Fluorophenyl)-N-(2-chlorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine (4-(2-chloro-4-fluorophenyl)-N-(2-chlorophenyl )-1,3-dimethyl-1H-pyrazol-5-amine), (II-D021) 4-(2-chloro-4-fluorophenyl)-N-(2-fluorophenyl)-1,3- Dimethyl-1H-pyrazol-5-amine (4-(2-chloro-4-fluorophenyl)-N-(2-fluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine), (II -D022) 4-(4-Chlorophenyl )-5-(2,6-difluorophenyl)-3,6-dimethylpyridazine (4-(4-chlorophenyl)-5-(2,6-difluorophenyl)-3,6-dimethylpyridazine), (II-D023) N-(2-bromo-6-fluorophenyl)-4-(2-chloro-4-fluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine ( N-(2-bromo-6-fluorophenyl)-4-(2-chloro-4-fluorophenyl)-l,3-dimethyl-1H-pyrazol-5-amine), (II-D024) N-(2-bromo Phenyl)-4-(2-chloro-4-fluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine (N-(2-bromophenyl)-4-(2-chloro- 4-fluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine), (II-D025) N-(4-chloro-2,6-difluorophenyl)-4-(2-chloro-4 -Fluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine (N-(4-chloro-2,6-difluorophenyl)-4-(2-chloro-4-fluorophenyl)-1 ,3-dimethyl-1H-pyrazol-5-amine), (II-D026) benomyl;

(II-E) 可具有多位點作用的化合物,可例舉如 (II-E001) 波爾多液 (bordeaux mixture)、(II-E002) 四氯丹 (captafol)、(II-E003) 蓋普丹 (captan)、(II-E004) 四氯異苯腈 (chlorothalonil)、(II-E005) 氫氧化銅、(II-E006) 環烷酸銅 (copper naphthenate)、(II-E007) 氧化銅、(II-E008) 氧氯化銅 (copper oxychloride)、(II-E009) 硫酸銅 (copper sulfate)、(II-E010) 腈硫醌 (dithianon)、(II-E011) 多果定 (dodine)、(II-E012) 福爾培 (folpet)、(II-E013) 鋅錳乃浦 (mancozeb)、(II-E014) 代森猛 (maneb)、(II-E015) 免得爛 (metiram)、(II-E016) 免得爛鋅 (metiram zinc)、(II-E017) 喹啉銅 (oxine-copper)、(II-E018) 甲基鋅乃浦 (propineb)、(II-E019) 硫和硫製備物,例如多硫化鈣 (sulfur and sulfur preparations including calcium polysulfide)、(II-E020) 福美雙 (thiram)、(II-E021) 代森鋅 (zineb)、(II-E022) 福美鋅 (ziram)、(II-E023) 6-乙基-5,7-二氧-6,7-二氫-吡咯並[3’,4’:5,6][1,4]二硫並[2,3-c][1,2]噻唑-3-腈 (6-ethyl-5,7-dioxo-6,7-dihydro-5H­pynolo[3’,4’:5,6][1,4]dithiino[2,3-c] [1,2]thiazole-3-carbonitrile、(II-E024) 富爾邦 (ferbam)、(II-E025) 益發靈 (dichlofluanid)、(II-E026) 甲基益發靈 (tolylfluanid)、(II-E027) 雙胍鹽 (guazatine)、(II-E028) 克熱淨 (iminoctadine)、(II-E029) 敵菌靈 (anilazine)、(II-E030) 滅蟎猛 (quinomethionate);(II-E) Compounds that may act at multiple sites, such as (II-E001) bordeaux mixture, (II-E002) captafol, (II-E003) captafane (captan), (II-E004) tetrachloroisobenzonitrile (chlorothalonil), (II-E005) copper hydroxide, (II-E006) copper naphthenate, (II-E007) copper oxide, ( II-E008) Copper oxychloride, (II-E009) Copper sulfate, (II-E010) Dithianon, (II-E011) Dodine, ( II-E012) Folpet, (II-E013) Mancozeb, (II-E014) Maneb, (II-E015) Metiram, (II-E015) E016) metiram zinc, (II-E017) oxine-copper, (II-E018) methyl zinc propineb, (II-E019) sulfur and sulfur preparations such as Calcium polysulfide (sulfur and sulfur preparations including calcium polysulfide), (II-E020) thiram (thiram), (II-E021) zineb, (II-E022) thiram (ziram), (II- E023) 6-Ethyl-5,7-dioxo-6,7-dihydro-pyrrolo[3',4':5,6][1,4]dithio[2,3-c][ 1,2]thiazole-3-carbonitrile (6-ethyl-5,7-dioxo-6,7-dihydro-5Hpynolo[3',4':5,6][1,4]dithiino[2,3-c ] [1,2]thiazole-3-carbonitrile, (II-E024) Fuerbang (ferbam), (II-E025) Yifaling (dichlofluanid), (II-E026) methylyifaling (tolylfluanid), (II -E027) Guazatine, (II-E028) Iminoctadine, (II-E029) Anilazine, (II-E030 ) quinomethionate;

(II-I) 細胞壁合成抑制劑,可例舉如(II-I001) 苯噻菌胺 (benthiavalicarb)、(II-I002) 達滅芬 (dimethomorph)、(II-I003) 氟嗎啉 (flumorph)、(II-I004) 丙森鋅 (iprovalicarb)、(II-I005) 曼普胺 (mandipropamid)、(II-I006) 丁吡嗎啉 (pyrimorph)、(II-I007) 纈菌胺 (valifenalate)、(II-I008) (2E)-3-(4-叔丁基苯基)-3-(2-氯吡啶-4-基)-1-(嗎啉-4-基)丙-2-烯-1-酮 ((2E)-3-(4-tert-butylphenyl)-3-(2-chloropyridin-4-yl)-l-(morpholin-4-yl)prop-2-en-1-one)、(II-I009) (2Z)-3-(4-叔丁基苯基)-3-(2-氯吡啶-4-基)-1-(嗎啉-4-基)丙-2-烯-1-酮 ((2Z)-3-(4-tert-butylphenyl)-3-(2-chloropyridin-4-yl)-1-(morpholin-4-yl)prop-2-en-1-one)、(II-I010) 苯噻菌胺-異丙基 (benthiavalicarb-isopropyl)、(II-I011) 保粒黴素 (polyoxins)、(II-I012) N-[2-[4-[[3-(4-氯苯基)-2-丙炔-1-基]氧基]-3-(N-[2-[4-[[3-(4-chlorophenyl)-2-propyn-1-yl]oxy]-3-)、(II-I013) 甲氧基苯基]乙基]-3-甲基-2-[(甲基磺醯基)-胺基]丁醯胺 (methoxyphenyl]ethyl]-3-methyl-2-[(methylsulfonyl)-amino]butanamide)、(II-I014) N-[2-[4-[[3-(4-氯苯基)-2-丙炔-1-基]氧基]-3-甲氧基苯基]-乙基]-3-甲基-2-[(乙基磺醯基)胺基]丁醯胺 (N-[2-[4-[[3-(4-chlorophenyl)-2-propyn-1-yl]oxy]-3-methoxyphenyl]-ethyl]-3-methyl-2-[(ethylsulfonyl)amino]butanamide);(II-I) Cell wall synthesis inhibitors, such as (II-I001) benthiavalicarb, (II-I002) dimethomorph, (II-I003) flumorph , (II-I004) iprovalicarb, (II-I005) mandipropamid, (II-I006) pyrimorph, (II-I007) valifenalate, (II-I008) (2E)-3-(4-tert-butylphenyl)-3-(2-chloropyridin-4-yl)-1-(morpholin-4-yl)prop-2-ene- 1-keto ((2E)-3-(4-tert-butylphenyl)-3-(2-chloropyridin-4-yl)-l-(morpholin-4-yl)prop-2-en-1-one), (II-I009) (2Z)-3-(4-tert-butylphenyl)-3-(2-chloropyridin-4-yl)-1-(morpholin-4-yl)prop-2-ene- 1-keto ((2Z)-3-(4-tert-butylphenyl)-3-(2-chloropyridin-4-yl)-1-(morpholin-4-yl)prop-2-en-1-one), (II-I010) Benthiavalicarb-isopropyl, (II-I011) Polyoxins, (II-I012) N-[2-[4-[[3-( 4-Chlorophenyl)-2-propyn-1-yl]oxy]-3-(N-[2-[4-[[3-(4-chlorophenyl)-2-propyn-1-yl]oxy ]-3-), (II-I013) Methoxyphenyl]ethyl]-3-methyl-2-[(methylsulfonyl)-amino]butyramide (methoxyphenyl]ethyl]-3 -methyl-2-[(methylsulfonyl)-amino]butanamide), (II-I014) N-[2-[4-[[3-(4-chlorophenyl)-2-propyn-1-yl]oxy base]-3-methoxyphenyl]-ethyl]-3-methyl-2-[(ethylsulfonyl)amino]butyramide (N-[2-[4-[[3- (4-chlorophenyl)-2-propyn-1-yl]oxy]-3-methoxyphenyl]-ethyl]-3-methyl-2-[(ethylsulfonyl)amino]butanamide );

(II-J) 脂質和膜合成之抑制劑,可例舉如(II-J001) 普拔克 (propamocarb)、(II-J002) 普拔克鹽酸鹽 (propamocarb hydrochloride)、(II-J003) 脫克松 (tolclofos-methyl)、(II-J004) 雙硫磷 (difenphos)、(II-J005) 愛得寶 (iodocarb)、(II-J006) 硫菌威 (prothiocarb)、(II-J007) 護粒松 (edifenphos)、(II-J008) 丙基喜樂松 (iprobenfos)、(II-J009) 白粉松 (pyrazophos)、(II-J010) 亞賜圃 (isoprothiolane)、(II-J011) 依得利 (etridiazole)、(II-J012) 聯苯 (biphenyl)、(II-J013) 地茂丹 (chloroneb)、(II-J014) 大克爛 (dicloran)、(II-J015) 喹啉 (quintozene)、(II-J016) 四氯硝基苯 (tecnazene);(II-J) Inhibitors of lipid and membrane synthesis, such as (II-J001) propamocarb, (II-J002) propamocarb hydrochloride, (II-J003) Tolclofos-methyl, (II-J004) Difenphos, (II-J005) Iodocarb, (II-J006) Prothiocarb, (II-J007) Edifenphos, (II-J008) Iprobenfos, (II-J009) Pyrazophos, (II-J010) Isoprothiolane, (II-J011) Eide Etridiazole, (II-J012) biphenyl, (II-J013) chloroneb, (II-J014) dicloran, (II-J015) quintozene , (II-J016) tetrachloronitrobenzene (tecnazene);

(II-L) 核酸合成抑制劑,可例舉如(II-L001) 本達樂 (benalaxyl)、(II-L002) 右本達樂 (benalaxyl-M (kiralaxyl))、(II-L003) 滅達樂 (metalaxyl)、(II-L004) 右滅達樂 (metalaxyl-M)(甲芬沙姆,mefenoxam)、(II-L005) 依瑞莫 (ethirimol)、(II-L006) 呋霜靈 (furalaxyl)、(II-L007) 呋醯胺 (ofurace)、(II-L008) 歐索林酸 (oxolinic acid)、(II-L009) 殺紋寧 (hymexazole)、(II-L010) 辛噻酮 (octhilinone)、(II-L011) 布瑞莫 (bupirimate)、(II-L012) 二甲嘧酚 (dimethirimol);(II-L) Nucleic acid synthesis inhibitors, such as (II-L001) Benalaxyl (benalaxyl), (II-L002) Right Benalaxyl (benalaxyl-M (kiralaxyl)), (II-L003) Inhibitor Dale (metalaxyl), (II-L004) dextromethorphan (metalaxyl-M) (Mefenoxam, mefenoxam), (II-L005) Yi Rui Mo (ethirimol), (II-L006) furaxyl ( furalaxyl), (II-L007) ofurace, (II-L008) oxolinic acid, (II-L009) hymexazole, (II-L010) octhilone ( octhilinone), (II-L011) bupirimate, (II-L012) dimethirimol;

(II-N) 可作為去偶合劑之化合物,可例舉如(II-N001) 扶吉胺 (fluazinam)、(II-N002) 甲基敵蟎普 (meptyldinocap)、(II-N003) 百蟎克 (binapacryl)、(II-N004) 敵蟎普 (dinocap);(II-N) A compound that can be used as a decoupling agent, such as (II-N001) fluazinam, (II-N002) meptyldinocap, (II-N003) mite Gram (binapacryl), (II-N004) dinocap (dinocap);

(II-O) 其他殺真菌劑,可例舉如(II-O001) 離層酸 (abscisic acid)、(II-O002) 本噻唑 (benthiazole)、(II-O003) 貝梭沙今 (bethoxazin)、(II-O004) 卡普黴素 (capsimycin)、(II-O005) 卡吩 (carvone)、(II-O006) 蟎離丹 (chinomethionat)、(II-O007) 庫發尼 (cufraneb)、(II-O008) 賽芬胺 (cyflufenamid)、(II-O009) 克絕 (cymoxanil)、(II-O010) 環丙磺草胺 (cyprosulfamide)、(II-O011) 噻菌淨 (flutianil)、(II-O012) 福賽得鋁 (fosetyl­aluminium)、(II-O013) 福賽得鈣 (fosetyl-calcium)、(II-O014) 福賽得鈉 (fosetyl-sodium)、(II-O015) 異硫氰酸甲酯 (methyl isothiocyanate)、(II-O016) 滅芬農 (metrafenone)、(II-O017) 米德黴 (mildiomycin)、(II-O018) 納坦黴素 (natamycin)、(II-O019) 二甲基二硫代胺甲酸鎳 (nickel dimethyldithiocarbamate)、(II-O020) 硝基太-異丙基 (nitrothal-isopropyl)、(II-O021) 歐賽保 (oxamocarb)、(II-O022) 氧硫普靈 (oxathiapiprolin)、(II-O023) 歐芬汀 (oxyfenthiin)、(II-O024) 五氯酚及其鹽類 (pentachlorophenol and salts)、(II-O025) 膦酸及其鹽類 (phosphorous acid and its salts)、(II-O026) 霜黴威乙膦酸鹽 (propamocarb-fosetylate)、(II-O027) 必伏農 (pyriofenone)(克吩農,chlazafenone)、(II-O028) 特伏克 (tebufloquin)、(II-O029) 特伏爛 (tecloftalam)、(II-O030) 特利吩 (tolnifanide)、(I-O031) 1-(4-{4-[(5R)-5-(2,6-二氟苯基)-4,5-二氫-1,2-唑-3-基]-1,3-噻唑-2-基}哌啶-1-基)-2-[5-甲基-3-(三氟甲基)-1H-吡唑-1-基]乙酮 (1-(4-{4-[(5R)-5-(2,6-difluorophenyl)-4,5-dihydro-1,2-oxazol-3-yl]-1,3-thiazol-2-yl}piperidin-1-yl)-2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]ethanone)、(II-O032) 1-(4-{4-[(5S)-5-(2,6-二氟苯基)-4,5-二氫-1,2-唑-3-基]-1,3-噻唑-2-基}哌啶-1-基)-2-[5-甲基-3-(三氟甲基)-1H-吡唑-1-基]乙酮 (1-(4-{4-[(5S)-5-(2,6-difluorophenyl)-4,5-dihydro-1,2-oxazol-3-yl]-l,3-thiazol-2-yl}piperidin-1-yl)-2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]ethanone)、(II-O033) 2-(6-苯甲基吡啶-2-基)喹唑啉 (2-(6-benzylpyridin-2-yl)quinazoline)、(II-O034) 2,6-二甲基-1H,5H-[1,4]二硫雜環己烯並[2,3-c:5,6-c’]二吡咯-1,3,5,7(2H,6H)-四酮 (2,6-dimethyl-1H,5H-[1,4]dithiino[2,3-c:5,6-c’]dipyrrole-1,3,5,7(2H,6H)-tetrone)、(II-O035) 2-[3,5-雙(二氟甲基)-1H-吡唑-1-基]-1-[4-(4-{5-[2-(丙-2-炔-1-基氧)苯基]-4,5-二氫-1,2-唑-3-基}-1,3-噻唑-2-基)哌啶-1-基]乙酮 (2-[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]-1-[4-(4-{5-[2-(prop-2-yn-1-yloxy)phenyl]-4,5-dihydro-l,2-oxazol-3-yl}-l,3-thiazol-2-yl)piperidin-1-yl]ethanone)、(II-O036) 2-[3,5-雙(二氟甲基)-1H-吡唑-1-基]-1-[4-(4-{5-[2-氯-6-(丙-2-炔-1-基氧)苯基]-4,5-二氫-1,2-唑-3-基}-1,3-噻唑-2-基)哌啶-1-基]乙酮 (2-[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]-1-[4-(4-{5-[2-chloro-6-(prop-2-yn-1-yloxy)phenyl]-4,5-dihydro-1,2-oxazol-3-yl}-1,3-thiazol-2-yl)piperidin-1-yl]ethanone)、(II-O037) 2-[3,5-雙(二氟甲基)-1H-吡唑-1-基]-1-[4-(4-{5-[2-氟-6-(丙-2-炔-1-基氧)苯基]-4,5-二氫-1,2-唑-3-基}-1,3-噻唑-2-基)哌啶-1-基]乙酮 (2-[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]-1-[4-(4-{5-[2-fluoro-6-(prop-2-yn-1-yloxy)phenyl]-4,5-dihydro-l,2-oxazol-3-yl}-l,3-thiazol-2-yl)piperidin-1-yl]ethanone)、(II-O038) 2-[6-(3-氟-4-甲氧基苯基)-5-甲基吡啶-2-基]喹唑啉 (2-[6-(3-fluoro-4-methoxyphenyl)-5-methylpyridin-2-yl]quinazoline)、(II-O039) 2-{(5R)-3-[2-(1-{[3,5-雙(二氟甲基)-1H-吡唑-1-基]乙醯基}哌啶-4-基)-1,3-噻唑-4-基]-4,5-二氫-1,2-唑-5-基}-3-氯苯基甲磺酸酯 (2-{(5R)-3-[2-(1-{[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1,3-thiazol-4-yl]-4,5-dihydro-l,2-oxazol-5-yl}-3-chlorophenyl methanesulfonate)、(II-O040) 2-{(5S)-3-[2-(1-{[3,5-雙(二氟甲基)-1H-吡唑-1-基]乙醯基}哌啶-4-基)-1,3-噻唑-4-基]-4,5-二氫-1,2-唑-5-基}-3-氯苯基甲磺酸酯 (2-{(5S)-3-[2-(1-{[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1,3-thiazol-4-yl]-4,5-dihydro-1,2-oxazol-5-yl}-3-chlorophenyl methanesulfonate)、(II-O041) 2-{2-[(7,8-二氟-2-甲基喹啉-3-基)氧]-6-氟苯基}丙-2-醇 (2-{2-[(7,8-difluoro-2-methylquinolin-3-yl)oxy]-6-fluorophenyl}propan-2-ol)、(II-O042) 2-{2-氟-6-[(8-氟-2-甲基喹啉-3-基)氧]苯基}丙-2-醇 (2-{2-fluoro-6-[(8-fluoro-2-methylquinolin-3-yl)oxy]phenyl}propan-2-ol)、(II-O043) 2-{3-[2-(1-{[3,5-雙(二氟甲基)-1H-吡唑-1-基]乙醯基}哌啶-4-基)-1,3-噻唑-4- 基]-4,5-二氫-1,2-唑-5-基}-3-氯苯基甲磺酸酯 (2-{3-[2-(1-{[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1,3-thiazol-4-yl]-4,5-dihydro-1,2-oxazol-5-yl}-3-chlorophenyl methanesulfonate)(氟醚菌醯胺,fluoxapiprolin)、(II-O044)       2-{3-[2-(1-{[3,5-雙(二氟甲基)-1H-吡唑-1-基]乙醯基}哌啶-4-基)-1,3-噻唑-4-基]-4,5-二氫-1,2-唑-5-基}苯基甲磺酸酯 (2-{3-[2-(1-{[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1,3-thiazol-4-yl]-4,5-dihydro-1,2-oxazol-5-yl}phenyl methanesulfonate)、(II-O045) 2-苯基酚及其鹽類 (2-phenylphenol and salts)、(II-O046) 3-(4,4,5-三氟-3,3-二甲基-3,4-二氫異喹啉-1-基)喹啉 (3-(4,4,5-trifluoro-3,3-dimethyl-3,4-dihydroisoquinolin-1-yl)quinoline)、(II-O047) 3-(4,4-二氟-3,3-二甲基-3,4-二氫異喹啉-1-基)喹啉 (3-(4,4-difluoro-3,3-dimethyl-3,4-dihydroisoquinolin-1-yl)quinoline)(喹富美林,Quinofumelin)、(II-O048) 4-胺基-5-氟嘧啶-2-醇(互變異構形:4-胺基-5-氟嘧啶-2(1H)-酮) (4-amino-5-fluoropyrimidin-2-ol (tautomeric form: 4-amino-5- fluoropyrimidin-2(1H)-one))、(II-O049) 4-側氧基-4-[(2-苯基乙基)胺基]丁酸 (4-oxo-4-[(2-phenylethyl)amino]butanoic acid)、(II-O050) 5-胺基-1,3,4-噻二唑-2-硫醇 (5-amino-1,3,4-thiadiazole-2-thiol)、(II-O051) 5-氯-N’-苯基-N’-(丙-2-炔-1-基)噻吩-2-磺醯基醯肼 (5-chloro-N’-phenyl-N’-(prop-2-yn-1-yl)thiophene-2-sulfonohydrazide)、(II-O052) 5-氟-2-[(4-氟苯甲基)氧]嘧啶-4-胺 (5-fluoro-2-[(4-fluorobenzyl)oxy]pyrimidin-4-amine)、(II-O053) 5-氟-2-[(4-甲基苯甲基)氧]嘧啶-4-胺 (5-fluoro-2-[(4-methylbenzyl)oxy]pyrimidin-4-amine)、(II-O054) 9-氟-2,2-二甲基-5-(喹啉-3-基)-2,3-二氫-1,4-並苯並氮平 (9-fluoro-2,2-dimethyl-5-(quinolin-3-yl)-2,3-dihydro-1,4-benzoxazepine)、(II-O055) {6-[({[(Z)-(1-甲基-1H-四唑-5-基)(苯基)亞甲基]胺基}氧)甲基]吡啶-2-基}胺甲酸丁-3-炔-1-基酯 (but-3-yn-1-yl{6-[({[(Z)-(l-methyl-1H-tetrazol-5-yl)(phenyl)methylene]amino} oxy)methyl]pyridin-2-yl}carbamate)、(II-O056) (2Z)-3-胺基-2-腈基-3-苯基丙烯酸乙酯 (ethyl (2Z)-3-amino-2- cyano-3-phenylacrylate)、(II-O057) 吩嗪-1-羧酸 (phenazine-1-carboxylic acid)、(II-O058) 3,4,5-三羥基苯甲酸丙酯 (propyl 3,4,5-trihydroxybenzoate)、(II-O059) 喹啉-8-醇 (quinolin-8-ol)、(II-O060) 喹啉-8-醇硫酸鹽 (2:1) (quinolin-8-ol sulfate (2:1))、(II-O061) {6-[({[(1-甲基-1H-四唑-5-基)(苯基)亞甲基]胺基}氧)甲基]吡啶-2-基}胺甲酸第三丁酯 (tert-butyl {6-[({[(1-methyl-1H-tetrazol-5-yl)(phenyl)methylene]amino}oxy)methyl]pyridin-2-yl}carbamate)、(II-O062) 5‑氟‑4‑亞胺基‑3‑甲基‑1‑[(4‑甲基苯基)磺醯基]‑3,4‑二氫嘧啶‑2(1H)‑酮 (5-fluoro-4-imino-3-methyl-1-[(4-methylphenyl)sulfonyl]-3,4-dihydropyrimidin-2(1H)-one)、(II-O063) 吡啶氯甲基 (pyridachlometyl)、(II-O064) 伊匹芬喹 (ipflufenoquin)、(II-O065) 氯胺吡啶芬 (aminopyrifen)、(II-O066) N-[[(環丙基-甲氧基)胺基][6-(二氟甲氧基)-2,3-二氟苯基]-亞甲基]苯乙醯胺 (N-[[(cyclopropyl-methoxy)amino][6-(difluoromethoxy)-2,3-difluorophenyl]-methylene]benzeneacetamide)、(II-O067) 滅速克 (methasulfocarb)、(II-O068) 代森鈉 (nabam)、(II-O069) 萬得寧 (oxine copper)、(II-O070) 滅菌磷 (ditalimfos)、(II-O071) 敵菌酮 (drazoxolon)、(II-O072) 甲苯氟磺胺 (tolyfluanide)、(II-O073) 苄氯三唑醇 (diclobutrazol)、(II-O074) 酯菌胺 (cyprofuram)、(II-O075) 磷酸及其鹽類 (phophorous acid and salts)、(II-O076) 富米綜 (ferimzone)、(II-O077) pyrrolnitrin、(II-O078) 咪唑嗪 (triazoxide)、(II-O079) 氟硫滅 (flusulfamide)、(II-O080) 達滅淨 (diclomezine)、(II-O081) 礦物油 (mineral oils)、(II-O082) 有機油 (organic oils)、(II-O083) 無機油 (inorganic oils)、(II-O084) 碳酸氫鉀 (potassium bicarbonate)、(II-O085) 甲磺酸鐵 (ferric methanearsonate)、(II-O086) 4-氟苯基-N-[1-[[[[1-(4-腈基苯基)乙基]磺醯基]甲基]丙基]胺基甲酸酯 (4-fluorophenyl-N-[1-[[[1-(4-cyanophenyl)ethyl]sulfonyl]msethyl]propyl]carbamate)、(II-O087) 5-氯-6-(2,4,6-三氟苯基)-7-(4-甲基哌啶-1-基)[1,2,4]三唑並[1,5-a]嘧啶 (5-chloro-6-(2,4,6-trifluorophenyl)-7-(4-methylpiperidin-1-yl)[1,2,4]triazolo[1,5-a]pyrimidine)、(II-O088) N-[4-[4-氯-3-(三氟甲基)苯氧基]-2,5-二甲基苯基]-N-乙基-N-甲基甲亞胺 (N-[4-[4-chloro-3-(trifluoromethyl)phenoxy]-2,5-dimethylphenyl]-N-ethyl-N-methylmethanimidamide);(II-O) Other fungicides, for example (II-O001) abscisic acid, (II-O002) bethiazole (benthiazole), (II-O003) bethoxazin , (II-O004) capsimycin, (II-O005) carvone, (II-O006) chinomethionat, (II-O007) cufraneb, ( II-O008) Cyflufenamide, (II-O009) Cymoxanil, (II-O010) Cyprosulfamide, (II-O011) Flutianil, (II -O012) fosetylaluminium, (II-O013) fosetyl-calcium, (II-O014) fosetyl-sodium, (II-O015) isothiocyanate Methyl isothiocyanate, (II-O016) metrafenone, (II-O017) mildiomycin, (II-O018) natamycin, (II-O019) II Nickel dimethyldithiocarbamate, (II-O020) nitrothal-isopropyl, (II-O021) oxamocarb, (II-O022) oxysulfur Oxathiapiprolin, (II-O023) oxyfenthiin, (II-O024) pentachlorophenol and salts, (II-O025) phosphonic acid and its salts and its salts), (II-O026) propamocarb-fosetylate, (II-O027) pyriofenone (chlazafenone), (II-O028) tervoc (tebufloquin), (II-O029) tecloftalam (tecloftalam), (II-O030) tolnifanide, (I-O031) 1-(4-{4-[(5R)-5-(2,6-difluorophenyl)-4,5-dihydro-1,2-oxazol-3-yl]-1 ,3-Thiazol-2-yl}piperidin-1-yl)-2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]ethanone (1-(4 -{4-[(5R)-5-(2,6-difluorophenyl)-4,5-dihydro-1,2-oxazol-3-yl]-1,3-thiazol-2-yl}piperidin-1- yl)-2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]ethanone), (II-O032) 1-(4-{4-[(5S)-5-(2, 6-difluorophenyl)-4,5-dihydro-1,2-oxazol-3-yl]-1,3-thiazol-2-yl}piperidin-1-yl)-2-[5-methyl Base-3-(trifluoromethyl)-1H-pyrazol-1-yl]ethanone (1-(4-{4-[(5S)-5-(2,6-difluorophenyl)-4,5- dihydro-1,2-oxazol-3-yl]-l,3-thiazol-2-yl}piperidin-1-yl)-2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl ]ethanone), (II-O033) 2-(6-benzylpyridin-2-yl)quinazoline (2-(6-benzylpyridin-2-yl)quinazoline), (II-O034) 2,6- Dimethyl-1H,5H-[1,4]dithieno[2,3-c:5,6-c']dipyrrole-1,3,5,7(2H,6H)- Tetraketone (2,6-dimethyl-1H,5H-[1,4]dithiino[2,3-c:5,6-c']dipyrrole-1,3,5,7(2H,6H)-tetrone) , (II-O035) 2-[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]-1-[4-(4-{5-[2-(propane-2- Alkyn-1-yloxy)phenyl]-4,5-dihydro-1,2-oxazol-3-yl}-1,3-thiazol-2-yl)piperidin-1-yl]ethanone (2 -[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]-1-[4-(4-{5-[2-(prop-2-yn-1-yloxy)phenyl]-4, 5-dihydro-l,2-oxazol-3-yl}-l,3-thiazol-2-yl)piperidin-1-yl]ethan one), (II-O036) 2-[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]-1-[4-(4-{5-[2-chloro-6 -(prop-2-yn-1-yloxy)phenyl]-4,5-dihydro-1,2-oxazol-3-yl}-1,3-thiazol-2-yl)piperidine-1- Base] ethyl ketone (2-[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]-1-[4-(4-{5-[2-chloro-6-(prop-2-yn -1-yloxy)phenyl]-4,5-dihydro-1,2-oxazol-3-yl}-1,3-thiazol-2-yl)piperidin-1-yl]ethanone), (II-O037) 2 -[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]-1-[4-(4-{5-[2-fluoro-6-(prop-2-yne-1 -yloxy)phenyl]-4,5-dihydro-1,2-oxazol-3-yl}-1,3-thiazol-2-yl)piperidin-1-yl]ethanone (2-[3 ,5-bis(difluoromethyl)-1H-pyrazol-1-yl]-1-[4-(4-{5-[2-fluoro-6-(prop-2-yn-1-yloxy)phenyl]-4 ,5-dihydro-l,2-oxazol-3-yl}-l,3-thiazol-2-yl)piperidin-1-yl]ethanone), (II-O038) 2-[6-(3-fluoro- 4-methoxyphenyl)-5-methylpyridin-2-yl]quinazoline (2-[6-(3-fluoro-4-methoxyphenyl)-5-methylpyridin-2-yl]quinazoline), ( II-O039) 2-{(5R)-3-[2-(1-{[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidine-4 -yl)-1,3-thiazol-4-yl]-4,5-dihydro-1,2-oxazol-5-yl}-3-chlorophenyl methanesulfonate (2-{(5R)- 3-[2-(1-{[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1,3-thiazol-4-yl]-4,5 -dihydro-l,2-oxazol-5-yl}-3-chlorophenyl methanesulfonate), (II-O040) 2-{(5S)-3-[2-(1-{[3,5-bis(difluoro Methyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1,3-thiazole-4 -yl]-4,5-dihydro-1,2-oxazol-5-yl}-3-chlorophenyl mesylate (2-{(5S)-3-[2-(1-{[3 ,5-bis(difluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1,3-thiazol-4-yl]-4,5-dihydro-1,2-oxazol-5- yl}-3-chlorophenylmethanesulfonate), (II-O041) 2-{2-[(7,8-difluoro-2-methylquinolin-3-yl)oxy]-6-fluorophenyl}propane- 2-alcohol (2-{2-[(7,8-difluoro-2-methylquinolin-3-yl)oxy]-6-fluorophenyl}propan-2-ol), (II-O042) 2-{2-fluoro -6-[(8-fluoro-2-methylquinolin-3-yl)oxy]phenyl}propan-2-ol (2-{2-fluoro-6-[(8-fluoro-2-methylquinolin- 3-yl)oxy]phenyl}propan-2-ol), (II-O043) 2-{3-[2-(1-{[3,5-bis(difluoromethyl)-1H-pyrazole- 1-yl]acetyl}piperidin-4-yl)-1,3-thiazol-4-yl]-4,5-dihydro-1,2-oxazol-5-yl}-3-chlorophenyl Mesylate (2-{3-[2-(1-{[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1,3-thiazol- 4-yl]-4,5-dihydro-1,2-oxazol-5-yl}-3-chlorophenyl methanesulfonate) (fluoxazolamide, fluoxapiprolin), (II-O044) 2-{3-[2- (1-{[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1,3-thiazol-4-yl]-4 ,5-Dihydro-1,2-oxazol-5-yl}phenyl methanesulfonate (2-{3-[2-(1-{[3,5-bis(difluoromethyl)-1H-pyrazol-1 -yl]acetyl}piperidin-4-yl)-1,3-thiazol-4-yl]-4,5-dihydro-1,2-oxazol-5-yl}phenyl methanesulfonate), (II-O045) 2- Phenylphenol and its salts (2-phenylphenol a nd salts), (II-O046) 3-(4,4,5-trifluoro-3,3-dimethyl-3,4-dihydroisoquinolin-1-yl)quinoline (3-(4 ,4,5-trifluoro-3,3-dimethyl-3,4-dihydroisoquinolin-1-yl)quinoline), (II-O047) 3-(4,4-difluoro-3,3-dimethyl-3 ,4-Dihydroisoquinolin-1-yl)quinoline (3-(4,4-difluoro-3,3-dimethyl-3,4-dihydroisoquinolin-1-yl)quinoline) (Quinofumelin) , (II-O048) 4-amino-5-fluoropyrimidin-2-ol (tautomeric form: 4-amino-5-fluoropyrimidin-2(1H)-one) (4-amino-5-fluoropyrimidin -2-ol (tautomeric form: 4-amino-5-fluoropyrimidin-2(1H)-one)), (II-O049) 4-oxo-4-[(2-phenylethyl)amino] Butanoic acid (4-oxo-4-[(2-phenylethyl)amino]butanoic acid), (II-O050) 5-amino-1,3,4-thiadiazole-2-thiol (5-amino- 1,3,4-thiadiazole-2-thiol), (II-O051) 5-chloro-N'-phenyl-N'-(prop-2-yn-1-yl)thiophene-2-sulfonyl Hydrazine (5-chloro-N'-phenyl-N'-(prop-2-yn-1-yl)thiophene-2-sulfonohydrazide), (II-O052) 5-fluoro-2-[(4-fluorobenzyl Base) oxygen] pyrimidin-4-amine (5-fluoro-2-[(4-fluorobenzyl)oxy]pyrimidin-4-amine), (II-O053) 5-fluoro-2-[(4-methylbenzyl Base) oxygen] pyrimidin-4-amine (5-fluoro-2-[(4-methylbenzyl)oxy]pyrimidin-4-amine), (II-O054) 9-fluoro-2,2-dimethyl-5- (Quinolin-3-yl)-2,3-dihydro-1,4-benzozepine (9-fluoro-2,2-dimethyl-5-(quinolin-3-yl)-2,3- dihydro-1,4-benzoxazepine), (II-O055) {6-[({[(Z)-(1-methyl-1H-tetrazol-5-yl)(phenyl)methylene ]amino}oxy)methyl]pyridin-2-yl}carbamic acid but-3-yn-1-yl ester (but-3-yn-1-yl{6-[({[(Z)-(l -methyl-1H-tetrazol-5-yl)(phenyl)methylene]amino}oxy)methyl]pyridin-2-yl}carbamate), (II-O056) (2Z)-3-amino-2-nitrile- 3-phenyl acrylate ethyl ester (ethyl (2Z)-3-amino-2-cyano-3-phenylacrylate), (II-O057) phenazine-1-carboxylic acid (phenazine-1-carboxylic acid), (II- O058) 3,4,5-trihydroxybenzoic acid propyl ester (propyl 3,4,5-trihydroxybenzoate), (II-O059) quinolin-8-ol (quinolin-8-ol), (II-O060) quinol Quinolin-8-ol sulfate (2:1) (quinolin-8-ol sulfate (2:1)), (II-O061) {6-[({[(1-methyl-1H-tetrazole-5 -yl)(phenyl)methylene]amino}oxy)methyl]pyridin-2-yl}carbamic acid tert-butyl ester (tert-butyl {6-[({[(1-methyl-1H-tetrazol -5-yl)(phenyl)methylene]amino}oxy)methyl]pyridin-2-yl}carbamate), (II-O062) 5‑fluoro‑4‑imino‑3‑methyl‑1‑[(4 ‑Methylphenyl)sulfonyl]‑3,4‑dihydropyrimidin‑2(1H)‑one (5-fluoro-4-imino-3-methyl-1-[(4-methylphenyl)sulfonyl]-3 ,4-dihydropyrimidin-2(1H)-one), (II-O063) pyridachlometyl, (II-O064) ipflufenoquin, (II-O065) chlorampyrifen (aminopyrifen ), (II-O066) N-[[(cyclopropyl-methoxy)amino][6-(difluoromethoxy)-2,3-difluorophenyl]-methylene]phenylethyl Amide (N-[[(cyclopropyl-methoxy)amino][6-(difluoromethoxy)-2,3-difluorophenyl]-methylene]benzeneacetamide), (II-O067) gram (methasulfocarb), (II-O068) nabam, (II-O069) oxine copper, (II-O070) ditalimfos, (II-O071) difendone ( drazoxolon), (II-O072) tolyfluanide, (II-O073) diclobutrazol, (II-O074) cyprofuram, (II-O075) phosphoric acid and its salts (phophorous acid and salts), (II-O076) ferimzone, (II-O077) pyrrolnitrin, (II-O078) triazoxide, (II-O079) flusulfamide, (II-O080) Diclomezine, (II-O081) Mineral oils, (II-O082) Organic oils, (II-O083) Inorganic oils, (II -O084) Potassium bicarbonate, (II-O085) Ferric methanesulfonate, (II-O086) 4-fluorophenyl-N-[1-[[[[1-(4- cyanophenyl)ethyl]sulfonyl]methyl]propyl]carbamate (4-fluorophenyl-N-[1-[[[1-(4-cyanophenyl)ethyl]sulfonyl]msethyl]propyl ]carbamate), (II-O087) 5-chloro-6-(2,4,6-trifluorophenyl)-7-(4-methylpiperidin-1-yl)[1,2,4]tri Azolo[1,5-a]pyrimidine (5-chloro-6-(2,4,6-trifluorophenyl)-7-(4-methylpiperidin-1-yl)[1,2,4]triazolo[1,5 -a]pyrimidine), (II-O088) N-[4-[4-chloro-3-(trifluoromethyl)phenoxy]-2,5-dimethylphenyl]-N-ethyl- N-Methylmethanimine (N-[4-[4-chloro-3-(trifluoromethyl)phenoxy]-2,5-dimethylphenyl]-N-ethyl-N-methylmethanim idamide);

(II-P) HDAC抑制劑,可例舉如(II-P001) N-(1-乙基環丙基)-4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯醯胺 (N-(1-ethylcyclopropyl)-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide)、(II-P002) N-(2-異丙基環丙基)-4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯醯胺 (N-(2-isopropylcyclopropyl)-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide)、(II-P003) N-(2-甲基環丙基)-4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯醯胺 (N-(2-methylcyclopropyl)-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl] benzamide)、(II-P004) N-(1-甲基環丙基)-4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯醯胺 (N-(1-methylcyclopropyl)-4-[5-(trifluoromethyl)-1,2,4- oxadiazol-3-yl]benzamide)、(II-P005) N-(2-乙基環丙基)-4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯醯胺 (N-(2-ethylcyclopropyl)-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl] benzamide)、(II-P006) N-(2,4-二氟苯基)-4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯醯胺 (N-(2,4-difluorophenyl)-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl] benzamide)、(II-P007) 5-(三氟甲基)-3-[4-[[3-(三氟甲基)-1,2,4triazol-1-基]甲基]苯基]-1,2,4-噁二唑 (5-(trifluoromethyl)-3-[4-[[3-(trifluoromethyl)-1,2,4triazol-1-yl]methyl]phenyl]-1,2,4-oxadiazole)、(II-P008) 2-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]-1,2,4-三唑-3-腈 (2-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-triazole-3-carbonitrile)、(II-P009) 1-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]吡唑-4-羧酸乙基酯 (ethyl 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylate)、(II-P010) N-環丙基-1-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]吡唑-4-甲醯胺 (N-cyclopropyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxamide)、(II-P011) N,N-二甲基-1-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]吡唑-4-羧醯胺 (N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxamide)、(II-P012) N-甲基-1-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]吡唑-4-羧醯胺 (N-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxamide)、(II-P013) N,N,-二甲基-H[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]-1,2,4-三唑-3-胺 (N,N,-dimethyl-H[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-triazol-3-amine)、(II-P014) 3-[4-[(5-乙基磺醯基-1,2,4-三唑-1-基)甲基]苯基]-5-(三氟甲基)-1,2,4-噁二唑 (3-[4-[(5-ethylsulfanyl-1,2,4-triazol-1-yl)methyl]phenyl]-5-(trifluoromethyl)-1,2,4-oxadiazole)、(II-P015) 3-[4-(三唑[4,5-b]吡啶-1-基甲基)苯基]-5-(三氟甲基)-1,2,4-噁二唑 (3-[4-(triazolo[4,5-b]pyridin-1-ylmethyl)phenyl]-5-(trifluoromethyl)-1,2,4-oxadiazole)、(II-P016) 3-[4-(三唑[4,5-b]吡啶-2-基甲基)苯基]-5-(三氟甲基)-1,2,4-噁二唑 (3-[4-(triazolo[4,5-b]pyridin-2-ylmethyl)phenyl]-5-(trifluoromethyl)-1,2,4-oxadiazole)、(II-P017) 3-[4-(三唑[4,5-b]吡啶-3-基甲基)苯基]-5-(三氟甲基)-1,2,4-噁二唑 (3-[4-(triazolo[4,5-b]pyridin-3-ylmethyl)phenyl]-5-(trifluoromethyl)-1,2,4-oxadiazole)、(II-P018) 1-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]吡唑-4-羧酸甲酯 (methyl 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylate)、(II-P019) 乙基 1-[[3-氟-4-[5-(三氟甲基)-1 ,2,4-噁二唑-3-基]苯基]甲基]吡唑-4-羧酸乙酯 (ethyl 1-[[3-fluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylate)、(II-P020) N,N-二乙基-1-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]吡唑-4-羧醯胺 (N,N-diethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxamide)、(II-P021) N-甲氧基-N -甲基-1-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]吡唑-4-羧醯胺 (N-methoxy-N-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxamide)、(II-P022) 1-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]吡唑-4-羧酸丙酯 (propyl 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylate)、(II-P023) N -甲氧基-1-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]吡唑-4-羧醯胺 (N-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxamide)、(II-P024) N-乙基-1-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]吡唑-4-羧醯胺 (N-ethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxamide)、(II-P025) 1-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]吡唑-4-羧醯胺 (1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxamide)、(II-P026) N-甲氧基-1-[1-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]吡唑-4-基]亞胺 (N-methoxy-1-[1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazol-4-yl]methanimine)、(II-P027) 1-[1-[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]乙基]吡唑-4-羧酸乙酯 (ethyl 1-[1-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]ethyl]pyrazole-4-carboxylate)、(II-P028) 1-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]吡咯烷-2-酮 (1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrrolidin-2-one)、(II-P029) 1-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]哌啶-2-酮 (1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]piperidin-2-one)、(II-P030) 4-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]嗎啉-3-酮 (4-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl] morpholin-3-one)、(II-P031) 4,4-二甲基-2-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]異噁唑啉-3-酮 (4,4-dimethyl-2-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]isoxazolidin-3-one)、(II-P032) 2-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]異噁唑啉-3-酮 (2-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]isoxazolidin-3-one)、(II-P033) 5,5-二甲基-2-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]異噁唑啉-3-酮 (5,5-dimethyl-2-[[4-[5-(trifluoromethyl)-1 ,2,4-oxadiazol-3-yl]phenyl]methyl]isoxazolidin-3-one)、(II-P034) 3,3-二甲基-1[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]哌啶-2-酮 (3,3-dimethyl-1 [4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]piperidin-2-one)、(II-P035) 1-[[2-氟-4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]吡咯烷-2-酮 (1-[[2-fluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrrolidin-2-one)、(II-P036) 1-[[2-氟-4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]哌啶-2-酮 (1-[[2-fluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]piperidin-2-one)、(II-P037) 2-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]噁嗪-3-酮 (2-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]oxazinan-3-one)、(II-P038) 1-[[3-氟-4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]哌啶-2-酮 (1-[[3-fluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]piperidin-2-one)、(II-P039) 3-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]唑烷-2-酮 (3-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]oxazolidin-2-one)、(II-P040) 1-甲基-3-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]咪唑啉啶-2-酮 (1-methyl-3-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]imidazolidin-2-one)、(II-P041) 1-[[3-氟-4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]-3,3-二甲基-哌啶-2-酮 (1-[[3-fluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-3,3-dimethyl-piperidin-2-one)、(II-P042) 1-[[3-氟-4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]吡咯烷-2-酮 (1-[[3-fluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrrolidin-2-one)、(II-P043) 2-[[3-氟-4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]-4,4-二甲基-異噁唑啉-3-酮 (2-[[3-fluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-4,4-dimethyl-isoxazolidin-3-one)、(II-P044) 2-[[2,3-二氟-4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]異噁唑啉-3-酮 (2-[[2,3-difluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]isoxazolidin-3-one)、(II-P045) 2-[[3-氟-4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]異噁唑啉-3-酮 (2-[[3-fluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]isoxazolidin-3-one)、(II-P046) 1-[[3-氟-4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]氮雜烷-2-酮 (1-[[3-fluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]azepan-2-one)、(II-P047) N-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]丙醯胺 (N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide)、(II-P048) 2,2-二甲基-N-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]丁基-3-炔醯胺 (2,2-dimethyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]but-3-ynamide)、(II-P049) N-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]丁醯胺 (N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]butanamide)、(II-P050) 3-甲基-N-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]丁醯胺 (3-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]butanamide)、(II-P051) 2-甲基-N-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]丙基-2-烯醯胺 (2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]prop-2-enamide)、(II-P052) 2-甲基-N-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]丁醯胺 (2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]butanamide)、(II-P053) 2-甲氧基-N-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基] (2-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl])、(II-P054) 3,3,3-三氟-N-[[3-氟-4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]丙醯胺 (3,3,3-trifluoro-N-[[3-fluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide)、(II-P055) 3,3,3-三氟-N-[[2-氟-4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]丙醯胺 (3,3,3-trifluoro-N-[[2-fluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide)、(II-P056) N-[[2,3-二氟-4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]丁醯胺 (N-[[2,3-difluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]butanamide)、(II-P057) N-[[2,3-二氟-4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]-3,3,3-三氟-丙醯胺 (N-[[2,3-difluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-3,3,3-trifluoro-propanamide)、(II-P058) 2-(二氟甲氧基)-N-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]乙醯胺 (2-(difluoromethoxy)-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]acetamide)、(II-P059) 2-甲氧基-2-甲基-N-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]丙醯胺 (2-methoxy-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide)、(II-P060) 1-甲基-3-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]脲 (1-methyl-3-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea)、(II-P061) 1-乙基-1-甲基-3-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]脲 (1-ethyl-1-methyl-3-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea)、(II-P062) 1-乙氧基-3-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]脲 (1-ethoxy-3-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea)、(II-P063) 1-甲氧基-1-甲基-3-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基] (1-methoxy-1-methyl-3-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl])、(II-P064) 1,1-二乙基-3-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]脲 (1,1-diethyl-3-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea)、(II-P065) N-甲氧基-N-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]環丙烷羧醯胺 (N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropanecarboxamide)、(II-P066) N-甲氧基-N-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]戊基-4-炔醯胺 (N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pent-4-ynamide)、(II-P067) N-甲氧基-2-甲基-N-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]丙基-2-烯醯胺 (N-methoxy-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]prop-2-enamide)、(II-P068) N,2-二甲氧基-N-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]丙醯胺 (N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide)、(II-P069) N-環丙基-3,3,3-三氟-N-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]丙醯胺 (N-cyclopropyl-3,3,3-trifluoro-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide)、(II-P070) 2,2-二氟-N-(2-甲氧基乙基)-N-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]環丙烷羧醯胺 (2,2-difluoro-N-(2-methoxyethyl)-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclo propanecarboxamide)、(II-P071) N-乙基-2-甲基-N-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]丙醯胺 (N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide)、(II-P072) N-[[3-氟-4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]-N-甲氧基-丙醯胺 (N-[[3-fluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-N-methoxy-propanamide)、(II-P073) 2-甲氧基-N-(2,2,2-三氟乙基)-N-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]乙醯胺 (2-methoxy-N-(2,2,2-trifluoroethyl)-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl] acetamide)、(II-P074) N-[[2,3-二氟-4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]-N-甲氧基-環丙烷羧醯胺 (N-[[2,3-difluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-N-methoxy-cyclopropane carboxamide)、(II-P075) 2-(二氟甲氧基)-N-甲基-N-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]乙醯胺 (2-(difluoromethoxy)-N-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]acetamide)、(II-P076) N-乙氧基-2-甲氧基-N-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]丙醯胺 (N-ethoxy-2-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide)、(II-P077) N-異丙基-N-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]四氫呋喃-2-羧醯胺 (N-isopropyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]tetrahydrofuran-2-carboxamide)、(II-P078) 1-甲氧基-3-甲基-1-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]脲 (1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea)、(II-P079) 3-環丙基-1-甲氧基-1-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]脲 (3-cyclopropyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea)、(II-P080) 3-乙氧基-1-甲氧基-1-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]脲 (3-ethoxy-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea)、(II-P081) 3-烯丙基-1-甲氧基-1-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]脲 (3-allyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea)、(II-P082) 1-環丙基-3-甲氧基-3-甲基-1-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]脲 (1-cyclopropyl-3-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea)、(II-P083) 3-異丙基-1-甲氧基-1-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]脲 (3-isopropyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea)、(II-P084) 1-甲氧基-3-丙基-2-炔基-1-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]脲 (1-methoxy-3-prop-2-ynyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea)、(II-P085) 1-[[3-氟-4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]-1-甲氧基-3-甲基-脲 (1-[[3-fluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1-methoxy-3-methyl-urea)、(II-P086) 3-(環丙基甲基)-1-甲基-1-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]脲 (3-(cyclopropylmethyl)-1-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea)、(II-P087) 1-乙基-3-(2,2,2-三氟乙基)-1-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]脲 (1-ethyl-3-(2,2,2-trifluoroethyl)-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea)、(II-P088) 1,3-二甲氧基-1-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]脲 (1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea)、(II-P089) 3-乙基-1-甲氧基-1-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]脲 (3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea)、(II-P090) N-甲基-4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯醯胺 (N-methyl-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide)、(II-P091) N-[(E)-甲氧基亞胺基甲基]-4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯醯胺 (N-[(E)-methoxyiminomethyl]-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide)、(II-P092) N-[(Z)-甲氧基亞胺基甲基]-4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯醯胺 (N-[(Z)-methoxyiminomethyl]-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide)、(II-P093) N-[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]環丙烷羧醯胺 (N-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]cyclopropanecarboxamide)、(II-P094) N-(2-氟苯基)-4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯醯胺 (N-(2-fluorophenyl)-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide)、(II-P095) 2,2-二氟-N-甲基-2-[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]乙醯胺 (2,2-difluoro-N-methyl-2-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]acetamide)、(II-P096) N-烯丙基-N-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]乙醯胺 (N-allyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]acetamide)、(II-P097) N-[(E)-N-甲氧基-C-甲基-亞胺亞甲基]-4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯醯胺 (N-[(E)-N-methoxy-C-methyl-carbonimidoyl]-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide)、(II-P098) N-[(Z)-N-甲氧基-C-甲基-亞胺亞甲基]-4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯醯胺 (N-[(Z)-N-methoxy-C-methyl-carbonimidoyl]-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide)、(II-P100) N-烯丙基-N-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]丙醯胺 (N-allyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide)、(II-P101) 4,4-二甲基-1-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]吡咯烷-2-酮 (4,4-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrrolidin-2-one)、(II-P102) N-甲基-4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯甲硫醯胺 (N-methyl-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzenecarbothioamide)、(II-P103) 5-甲基-1-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]吡咯烷-2-酮 (5-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrrolidin-2-one)、(II-P104) N-甲基-4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯甲羧醯胺 (N-methyl-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzenecarboxamide)、(II-P105) N1-甲基-N2-(4-(5-(三氟甲基)-1,2,4-噁二唑-3-基)苄基)草醯胺 (N1-methyl-N2-(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)oxalamide);以及 (II-P) HDAC inhibitors, for example (II-P001) N-(1-ethylcyclopropyl)-4-[5-(trifluoromethyl)-1,2,4-oxadi Azol-3-yl]benzamide (N-(1-ethylcyclopropyl)-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide), (II-P002) N-( 2-isopropylcyclopropyl)-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide (N-(2-isopropylcyclopropyl)-4- [5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide), (II-P003) N-(2-methylcyclopropyl)-4-[5-(trifluoromethyl) -1,2,4-oxadiazol-3-yl]benzamide (N-(2-methylcyclopropyl)-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide , (II-P004) N-(1-methylcyclopropyl)-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide (N- (1-methylcyclopropyl)-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide), (II-P005) N-(2-ethylcyclopropyl)-4-[ 5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide (N-(2-ethylcyclopropyl)-4-[5-(trifluoromethyl)-1,2,4- oxadiazol-3-yl] benzamide), (II-P006) N-(2,4-difluorophenyl)-4-[5-(trifluoromethyl)-1,2,4-oxadiazole-3 -yl] benzamide (N-(2,4-difluorophenyl)-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl] benzamide), (II-P007) 5-(three Fluoromethyl)-3-[4-[[3-(trifluoromethyl)-1,2,4triazol-1-yl]methyl]phenyl]-1,2,4-oxadiazole (5- (trifluoromethyl)-3-[4-[[3-(trifluoromethyl)-1,2,4triazol-1-yl]methyl]phenyl]-1,2,4-oxadiazole), (II-P008) 2-[[ 4 -[5-(Trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-triazole-3-carbonitrile (2-[[4 -[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-triazole-3-carbonitrile), (II-P009) 1-[[4-[ 5-(Trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester (ethyl 1-[[4-[5- (trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylate), (II-P010) N-cyclopropyl-1-[[4-[5-(trifluoro Methyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxamide (N-cyclopropyl-1-[[4-[5-(trifluoromethyl)- 1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxamide), (II-P011) N,N-dimethyl-1-[[4-[5-(trifluoromethyl )-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxamide (N,N-dimethyl-1-[[4-[5-(trifluoromethyl)- 1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxamide), (II-P012) N-methyl-1-[[4-[5-(trifluoromethyl)-1 ,2,4-Oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxamide (N-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4 -oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxamide), (II-P013) N,N,-dimethyl-H[4-[5-(trifluoromethyl)-1,2, 4-Oxadiazol-3-yl]phenyl]methyl]-1,2,4-triazol-3-amine (N,N,-dimethyl-H[4-[5-(trifluoromethyl)-1, 2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-triazol-3-amine), (II-P014) 3-[4-[(5-ethylsulfonyl-1, 2,4-triazol-1-yl)methyl]phenyl]-5-(trifluoromethyl)-1,2,4-oxadiazole (3-[4-[(5-ethylsulfanyl-1,2,4-triazol-1-yl)methyl]phenyl]-5-(trifluoromethyl)-1,2,4-oxadiazole), (II-P015) 3 -[4-(triazol[4,5-b]pyridin-1-ylmethyl)phenyl]-5-(trifluoromethyl)-1,2,4-oxadiazole (3-[4- (triazolo[4,5-b]pyridin-1-ylmethyl)phenyl]-5-(trifluoromethyl)-1,2,4-oxadiazole), (II-P016) 3-[4-(triazole[4,5 -b]pyridin-2-ylmethyl)phenyl]-5-(trifluoromethyl)-1,2,4-oxadiazole (3-[4-(triazolo[4,5-b]pyridin- 2-ylmethyl)phenyl]-5-(trifluoromethyl)-1,2,4-oxadiazole), (II-P017) 3-[4-(triazol[4,5-b]pyridin-3-ylmethyl) Phenyl]-5-(trifluoromethyl)-1,2,4-oxadiazole (3-[4-(triazolo[4,5-b]pyridin-3-ylmethyl)phenyl]-5-(trifluoromethyl )-1,2,4-oxadiazole), (II-P018) 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methanol Base] pyrazole-4-carboxylic acid methyl ester (methyl 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylate), ( II-P019) Ethyl 1-[[3-fluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4 -Carboxylic acid ethyl ester (ethyl 1-[[3-fluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylate), (II- P020) N,N-Diethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4 -Carboxamide (N,N-diethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carbox amide), (II-P021) N-methoxy-N-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzene Base] methyl] pyrazole-4-carboxamide (N-methoxy-N-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl ]pyrazole-4-carboxamide), (II-P022) 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole Propyl 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylate), (II-P023 ) N-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxyl Amine (N-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxamide), (II-P024) N-ethyl Base-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxamide (N-ethyl -1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxamide), (II-P025) 1-[[4-[5 -(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxamide (1-[[4-[5-(trifluoromethyl)- 1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxamide), (II-P026) N-methoxy-1-[1-[[4-[5-(trifluoromethyl Base)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazol-4-yl]imine (N-methoxy-1-[1-[[4-[5-( trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazol-4-yl]methanimine), (II-P027) 1-[1-[4-[5-(trifluoromethyl) -1,2,4-Oxadiazol-3-yl]phenyl]ethyl ]pyrazole-4-carboxylic acid ethyl ester (ethyl 1-[1-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]ethyl]pyrazole-4-carboxylate), (II-P028) 1-[[4-[5-(Trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrrolidin-2-one (1- [[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrrolidin-2-one), (II-P029) 1-[[4-[5-(three Fluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]piperidin-2-one (1-[[4-[5-(trifluoromethyl)-1,2,4 -oxadiazol-3-yl]phenyl]methyl]piperidin-2-one), (II-P030) 4-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazole-3 -yl]phenyl]methyl]morpholin-3-one (4-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]morpholin-3-one ), (II-P031) 4,4-Dimethyl-2-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl ]isoxazolin-3-one (4,4-dimethyl-2-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]isoxazolidin-3-one ), (II-P032) 2-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]isoxazoline-3- Ketone (2-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]isoxazolidin-3-one), (II-P033) 5,5-dimethyl -2-[[4-[5-(Trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]isoxazolin-3-one (5,5- dimethyl-2-[[4-[5-(trifluoromethyl)-1 ,2,4-oxadiazol-3-yl]phenyl]methyl]isoxazolidin-3-one), (II-P034) 3,3-dimethyl -1[4-[5-(trifluoromethyl)-1,2, 4-oxadiazol-3-yl]phenyl]methyl]piperidin-2-one (3,3-dimethyl-1 [4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl]phenyl]methyl]piperidin-2-one), (II-P035) 1-[[2-fluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazole-3- Base] phenyl] methyl] pyrrolidin-2-one (1-[[2-fluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrrolidin- 2-one), (II-P036) 1-[[2-fluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl] Piperidin-2-one (1-[[2-fluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]piperidin-2-one), (II- P037) 2-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]oxazin-3-one (2-[[4 -[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]oxazinan-3-one), (II-P038) 1-[[3-fluoro-4-[5-( Trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]piperidin-2-one (1-[[3-fluoro-4-[5-(trifluoromethyl)- 1,2,4-oxadiazol-3-yl]phenyl]methyl]piperidin-2-one), (II-P039) 3-[[4-[5-(trifluoromethyl)-1,2,4- Oxadiazol-3-yl]phenyl]methyl]oxazolidine-2-one (3-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl] oxazolidin-2-one), (II-P040) 1-methyl-3-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl] Methyl]imidazolidin-2-one (1-methyl-3-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]imidazolidin-2-one) , (II-P041) 1-[[3-fluoro-4-[5-(trifluoromethyl base)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-3,3-dimethyl-piperidin-2-one (1-[[3-fluoro-4-[ 5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-3,3-dimethyl-piperidin-2-one), (II-P042) 1-[[3-fluoro-4 -[5-(Trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrrolidin-2-one (1-[[3-fluoro-4-[5 -(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrrolidin-2-one), (II-P043) 2-[[3-fluoro-4-[5-(trifluoromethyl base)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-4,4-dimethyl-isoxazolin-3-one (2-[[3-fluoro-4 -[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-4,4-dimethyl-isoxazolidin-3-one), (II-P044) 2-[[2,3 -Difluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]isoxazolin-3-one (2-[[2 ,3-difluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]isoxazolidin-3-one), (II-P045) 2-[[3-fluoro- 4-[5-(Trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]isoxazolin-3-one (2-[[3-fluoro-4 -[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]isoxazolidin-3-one), (II-P046) 1-[[3-fluoro-4-[5-( Trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]azepine-2-one (1-[[3-fluoro-4-[5-(trifluoromethyl) -1,2,4-oxadiazol-3-yl]phenyl]methyl]azepan-2-one), (II-P047) N-[[4-[5-(trifluoromethyl)-1,2,4 -Oxadiazol-3-yl]phenyl]methyl]propionamide (N-[[4-[5-(trifluoromethyl)-1,2,4 -oxadiazol-3-yl]phenyl]methyl]propanamide), (II-P048) 2,2-dimethyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxa Oxadiazol-3-yl]phenyl]methyl]butyl-3-ynamide (2,2-dimethyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3 -yl]phenyl]methyl]but-3-ynamide), (II-P049) N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzene Base]methyl]butanamide (N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]butanamide), (II-P050) 3-methyl -N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]butyramide (3-methyl-N-[[4 -[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]butanamide), (II-P051) 2-methyl-N-[[4-[5-(trifluoromethyl Base)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propyl-2-enamide (2-methyl-N-[[4-[5-(trifluoromethyl)-1 ,2,4-oxadiazol-3-yl]phenyl]methyl]prop-2-enamide), (II-P052) 2-methyl-N-[[4-[5-(trifluoromethyl)-1, 2,4-Oxadiazol-3-yl]phenyl]methyl]butyramide (2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl ]phenyl]methyl]butanamide), (II-P053) 2-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzene base] methyl] (2-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]), (II-P054) 3,3, 3-trifluoro-N-[[3-fluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]acrylamide (3 ,3,3-trifluoro-N-[[3-fluoro-4-[5-(trifluoromethyl)-1,2,4-ox adiazol-3-yl]phenyl]methyl]propanamide), (II-P055) 3,3,3-trifluoro-N-[[2-fluoro-4-[5-(trifluoromethyl)-1,2 ,4-Oxadiazol-3-yl]phenyl]methyl]propionamide (3,3,3-trifluoro-N-[[2-fluoro-4-[5-(trifluoromethyl)-1,2, 4-oxadiazol-3-yl]phenyl]methyl]propanamide), (II-P056) N-[[2,3-difluoro-4-[5-(trifluoromethyl)-1,2,4-oxa Oxadiazol-3-yl]phenyl]methyl]butyramide (N-[[2,3-difluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl] methyl]butanamide), (II-P057) N-[[2,3-difluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl] Methyl]-3,3,3-trifluoro-propionamide (N-[[2,3-difluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl] methyl]-3,3,3-trifluoro-propanamide), (II-P058) 2-(difluoromethoxy)-N-[[4-[5-(trifluoromethyl)-1,2,4 -oxadiazol-3-yl]phenyl]methyl]acetamide (2-(difluoromethoxy)-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl] phenyl]methyl]acetamide), (II-P059) 2-methoxy-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazole-3 -yl]phenyl]methyl]propionamide (2-methoxy-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl] propanamide), (II-P060) 1-methyl-3-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea (1-methyl-3-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea), (II-P061) 1-ethyl-1-methyl Base-3-[[4-[5-(trifluoromethyl)-1 ,2,4-Oxadiazol-3-yl]phenyl]methyl]urea (1-ethyl-1-methyl-3-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol- 3-yl]phenyl]methyl]urea), (II-P062) 1-ethoxy-3-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazole-3- Base]phenyl]methyl]urea (1-ethoxy-3-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea), (II-P063 ) 1-methoxy-1-methyl-3-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl] (1 -methoxy-1-methyl-3-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]), (II-P064) 1,1-diethyl -3-[[4-[5-(Trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea (1,1-diethyl-3-[[4 -[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea), (II-P065) N-methoxy-N-[[4-[5-(trifluoro Methyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropanecarboxamide (N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2 ,4-oxadiazol-3-yl]phenyl]methyl]cyclopropanecarboxamide), (II-P066) N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxa Oxadiazol-3-yl]phenyl]methyl]pentyl-4-ynamide (N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl ]phenyl]methyl]pent-4-ynamide), (II-P067) N-methoxy-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4- Oxadiazol-3-yl]phenyl]methyl]propyl-2-enamide (N-methoxy-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4- oxadiazol-3-yl]phenyl]methyl]prop-2-enamide), (II-P068) N ,2-Dimethoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide (N, 2-dimethoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide), (II-P069) N-cyclopropyl-3,3 ,3-Trifluoro-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide (N-cyclopropyl- 3,3,3-trifluoro-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide), (II-P070) 2,2-di Fluoro-N-(2-methoxyethyl)-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl] Cyclopropanecarboxamide (2,2-difluoro-N-(2-methoxyethyl)-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclo propanecarboxamide), (II-P071) N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl ]methyl]propanamide (N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide), (II -P072) N-[[3-fluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-N-methoxy- Propanamide (N-[[3-fluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-N-methoxy-propanamide), (II-P073) 2-Methoxy-N-(2,2,2-trifluoroethyl)-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl ]phenyl]methyl]acetamide (2-methoxy-N-(2,2,2-trifluoroethyl)-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl]phenyl]methyl]acetamide), (II-P07 4) N-[[2,3-difluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-N-methoxy N-[[2,3-difluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-N-methoxy-cyclopropane carboxamide ), (II-P075) 2-(difluoromethoxy)-N-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazole-3- Base]phenyl]methyl]acetamide (2-(difluoromethoxy)-N-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl ]acetamide), (II-P076) N-ethoxy-2-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl N-ethoxy-2-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide 、(II-P077) N-isopropyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]tetrahydrofuran- 2-Carboxamide (N-isopropyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]tetrahydrofuran-2-carboxamide), (II-P078 ) 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea ( 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea), (II-P079) 3-cyclopropyl -1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea (3-cyclopropyl-1 -methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea), (II-P080) 3-ethoxy-1-methoxy Base-1-[[4-[5-(three Fluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea (3-ethoxy-1-methoxy-1-[[4-[5-(trifluoromethyl)-1, 2,4-oxadiazol-3-yl]phenyl]methyl]urea), (II-P081) 3-allyl-1-methoxy-1-[[4-[5-(trifluoromethyl)- 1,2,4-Oxadiazol-3-yl]phenyl]methyl]urea (3-allyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol -3-yl]phenyl]methyl]urea), (II-P082) 1-cyclopropyl-3-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)- 1,2,4-Oxadiazol-3-yl]phenyl]methyl]urea (1-cyclopropyl-3-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2 ,4-oxadiazol-3-yl]phenyl]methyl]urea), (II-P083) 3-isopropyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1 ,2,4-Oxadiazol-3-yl]phenyl]methyl]urea (3-isopropyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol- 3-yl]phenyl]methyl]urea), (II-P084) 1-methoxy-3-propyl-2-ynyl-1-[[4-[5-(trifluoromethyl)-1, 2,4-Oxadiazol-3-yl]phenyl]methyl]urea (1-methoxy-3-prop-2-ynyl-1-[[4-[5-(trifluoromethyl)-1,2,4 -oxadiazol-3-yl]phenyl]methyl]urea), (II-P085) 1-[[3-fluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazole-3 -yl]phenyl]methyl]-1-methoxy-3-methyl-urea (1-[[3-fluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl]phenyl]methyl]-1-methoxy-3-methyl-urea), (II-P086) 3-(cyclopropylmethyl)-1-methyl-1-[[4-[5-(trifluoro Methyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea (3-(cyclopropylmethyl)-1-methyl-1-[[4- [5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea), (II-P087) 1-ethyl-3-(2,2,2-trifluoroethyl) -1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea (1-ethyl-3-(2,2, 2-trifluoroethyl)-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea), (II-P088) 1,3-dimethoxy -1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea (1,3-dimethoxy-1-[[4 -[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea), (II-P089) 3-ethyl-1-methoxy-1-[[4-[ 5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea (3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl )-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea), (II-P090) N-methyl-4-[5-(trifluoromethyl)-1,2,4-oxa Oxadiazol-3-yl]benzamide (N-methyl-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide), (II-P091) N-[(E) -Methoxyiminomethyl]-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide (N-[(E)-methoxyiminomethyl] -4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide), (II-P092) N-[(Z)-methoxyiminomethyl]-4-[ 5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide (N-[(Z)-methoxyiminomethyl]-4-[5-(trifluoromethyl)-1,2, 4-oxadiazol-3-yl]benzamide), (II-P093) N-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]cyclopropane Carboxamide (N-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol- 3-yl]phenyl]cyclopropanecarboxamide), (II-P094) N-(2-fluorophenyl)-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl] Benzamide (N-(2-fluorophenyl)-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide), (II-P095) 2,2-difluoro-N- Methyl-2-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]acetamide (2,2-difluoro-N-methyl-2 -[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]acetamide), (II-P096) N-allyl-N-[[4-[5-(trifluoromethyl) Fluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]acetamide (N-allyl-N-[[4-[5-(trifluoromethyl)-1,2, 4-oxadiazol-3-yl]phenyl]methyl]acetamide), (II-P097) N-[(E)-N-methoxy-C-methyl-iminomethylene]-4-[5- (Trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide (N-[(E)-N-methoxy-C-methyl-carbonimidoyl]-4-[5-(trifluoromethyl )-1,2,4-oxadiazol-3-yl]benzamide), (II-P098) N-[(Z)-N-methoxy-C-methyl-iminomethylene]-4-[ 5-(Trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide (N-[(Z)-N-methoxy-C-methyl-carbonimidoyl]-4-[5- (trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide), (II-P100) N-allyl-N-[[4-[5-(trifluoromethyl)-1,2, 4-Oxadiazol-3-yl]phenyl]methyl]propionamide (N-allyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl ]methyl]propanamide), (II-P101) 4,4-Dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzene Base] methyl] pyrrolidin-2-one (4,4-dimethyl-1-[[4-[5-(trif luoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrrolidin-2-one), (II-P102) N-methyl-4-[5-(trifluoromethyl)-1, 2,4-oxadiazol-3-yl]benzonecarbothioamide (N-methyl-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzenecarbothioamide), (II-P103 ) 5-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrrolidin-2-one (5 -methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrrolidin-2-one), (II-P104) N-methyl-4 -[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzylcarboxamide (N-methyl-4-[5-(trifluoromethyl)-1,2,4- oxadiazol-3-yl]benzenecarboxamide), (II-P105) N1-methyl-N2-(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl ) oxalamide (N1-methyl-N2-(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)oxalamide); and

(II-R) 生物殺真菌劑,可例舉如(II-R001) 枯草芽孢桿菌合成 ( Bacillus subtilis syn.)、(II-R002) 枯草芽孢桿菌QST713株 ( Bacillus subtilisstrain QST713)、(II-R003) 枯草芽孢桿菌BU1814株 ( Bacillus subtilisstrain BU1814)、(II-R004) 枯草桿菌變種解澱粉芽孢桿菌 ( Bacillus subtilis var. amyloliquefaciens) 菌株FZB24 (strain FZB24)、(II-R005) 解澱粉芽孢桿菌 ( Bacillus amyloliquefaciens) 菌株MBI 600 (strain MBI600)、(II-R006) 解澱粉芽孢桿菌菌株D747 ( Bacillus amyloliquefaciensstrain D747)、(II-R007) 解澱粉芽孢桿菌 ( Bacillus amyloliquefaciens)菌株D727 (strain D727)、(II-R008) 解澱粉芽孢桿菌 ( Bacillus amyloliquefaciens)菌株ENV503 (strain ENV503)、(II-R009) 深綠木黴菌 ( Tricoderma atroviride)菌株SC1 (strain SC1)、(II-R010) 蕈狀芽孢桿菌分離物 (Bacillus mycoidesisolate)、(II-R011) 綠針假單胞菌菌株AFS009 ( Pseudomonas chlororaphisstrain AFS009)、(II-R012) 利迪鏈黴菌WYEC 108 ( Streptomyces lydicusstrain WYEC108)、(II-R013) 出芽短梗黴菌菌株DSM14940及DSM14941之混合物 ( Aureobasidium pullulansstrain DSM 14940 + Pullulansstrain DSM 14941)、(II-R014) 茶樹 ( Melameuca alternifolia)萃取物、(II-R015) 菲律賓木桔萃取物 ( Swinglea glutinosaextract)、(II-R016) 磷酸鈣鹽/亞磷酸鈣 (calcium salt of phosphorus acid/calcium phosphite)、(II-R017) 吸水鏈黴菌 ( Streptomyces hygroscopicus)(維利黴素,validamycin)、(II-R018) 高地芽孢桿菌 ( Bacillus altudinis)、(II-R019) 解澱粉芽孢桿菌 ( Bacillus amyloliquefaciens)、(II-R020) 解澱粉芽孢桿菌植物亞種MBI 600 ( Bacillus amyloliquefaciens ssp. PlantarumMBI 600) (II-27)、(II-R021) 解澱粉芽孢桿菌植物亞種D747 ( Bacillus amyloliquefaciens ssp. PlantarumD747)、(II-R022) 巨大芽孢桿菌 ( Bacillus megaterium)、(II-R023) 莫哈韋芽孢桿菌 ( Bacillus mojavensis) (II-28)、(II-R024) 蕈狀芽孢桿菌 ( Bacillus mycoides)、(II-R025) 短小芽孢桿菌 ( Bacillus pumilus) INR-7 (II-29)、(II-R026) 短小芽抱桿菌 ( Bacillus pumilus)GHA 180、(II-R027) 簡單芽孢桿菌 ( Bacillus simplex) (II-30)、(II-R028) 索立思芽孢桿菌 ( Bacillus solisalsi) (II-31)、(II-R029) 伯克霍爾德氏菌屬 ( Burkholderia sp.)、(II-R030) 密執安棍狀桿菌 ( Clavibacter michiganensis)(噬菌體,bacteriophages) (II-32)、(II-R031) 粉紅膠黴菌 ( Gliocladium roseum) (II-33)、(II-R032) 赫色小球殼孢菌 ( Microsphaeropsis ochracea)、(II-R033) 白色產氣黴 ( Muscodor albus)、(II-R034) 蜂房類芽孢桿菌 ( Paenibacillus alvei)、(II-R035) 多黏類芽孢桿菌 ( Paenibacillus polymyxa) (II-34)、(II-R036) 成團泛菌 (Pantoea agglomerans)(II-35)、(II-R037) 泛菌 ( Pantoea vagans)、(II-R038) 拜萊青黴菌 ( Penicillium bilaiae)、(II-R039) 假單胞菌屬 ( Pseudomonas sp.)、(II-R040) 綠針假單胞菌 ( Pseudomonas chloraphis)、(II-R041) 螢光假單胞菌 ( Pseudomonas fluorescens)、(II-R042) 菌寄生球殼菌 ( Sphaerodes mycoparasitica) (II-36)、(II-R043) 紫黑鏈黴菌 ( Streptomyces violaceusniger) (II-38)、(II-R044) 頂孢木黴JM41R ( Trichoderma fertileJM41R) (II-39)、(II-R045) 同擔子菌 ( Typhula phacorrhiza) (II-40)、(II-R046) 大麗輪枝菌 ( Verticillium dahlia) (II-42)、(II-R047) 矮南瓜黃化嵌紋病毒 (zucchini yellow mosaic virus)(無毒菌株,avirulent strain)。 (II-R) Biological fungicides, for example (II-R001) Bacillus subtilis syn ., (II-R002) Bacillus subtilis strain QST713 ( Bacillus subtilis strain QST713), (II- R003) Bacillus subtilis strain BU1814 ( Bacillus subtilis strain BU1814), (II-R004) Bacillus subtilis var. amyloliquefaciens strain FZB24 (strain FZB24), (II-R005) Bacillus amyloliquefaciens ( Bacillus amyloliquefaciens ) strain MBI 600 (strain MBI600), (II-R006) Bacillus amyloliquefaciens strain D747 ( Bacillus amyloliquefaciens strain D747), (II-R007) Bacillus amyloliquefaciens ( Bacillus amyloliquefaciens ) strain D727 (strain D727), ( II-R008) Bacillus amyloliquefaciens strain ENV503 (strain ENV503), (II-R009) Tricoderma atroviride strain SC1 (strain SC1), (II-R010) Bacillus mycoides isolate (Bacillus mycoides isolate), (II-R011) Pseudomonas chlororaphis strain AFS009 ( Pseudomonas chlororaphis strain AFS009), (II-R012) Streptomyces lydicus strain WYEC 108 ( Streptomyces lydicus strain WYEC108), (II-R013) budding Mixture of Aureobasidium pullulans strain DSM14940 and DSM14941 ( Aureobasidium pullulans strain DSM 14940 + Pullulans strain DSM 14941), (II-R014) tea tree ( Melameuca alternifolia ) extract, (II-R015) Philippine citrus extract ( Swinglea glutinosa extract) , (II-R016) calcium phosphate Salt/calcium phosphite (calcium salt of phosphorus acid/calcium phosphite), (II-R017) Streptomyces hygroscopicus (Vilimycin, validamycin), (II-R018) Bacillus altudinis , (II-R019) Bacillus amyloliquefaciens ( Bacillus amyloliquefaciens ), (II-R020) Bacillus amyloliquefaciens ssp. Plantarum MBI 600 ( Bacillus amyloliquefaciens ssp. Plantarum MBI 600 ) (II-27 ), (II-R021 ) Amyloliquefaciens Bacillus amyloliquefaciens ssp. Plantarum D747, (II-R022) Bacillus megaterium , (II-R023) Bacillus mojavensis (II-28), (II -R024) Bacillus mycoides , (II-R025) Bacillus pumilus INR-7 (II-29), (II-R026) Bacillus pumilus GHA 180, ( II-R027) Bacillus simplex (II-30), (II-R028) Bacillus solisalsi (II-31), (II-R029) Burkholderia ( Burkholderia sp. ), (II-R030) Clavibacter michiganensis (bacteriophages) (II-32), (II-R031) Gliocladium roseum (II-33), (II-R032) Microsphaeropsis ochracea , (II-R033) Muscodor albus , (II-R034) Paenibacillus alvei , (II-R035) Paenibacillus polymyxa llus polymyxa ) (II-34), (II-R036) Pantoea agglomerans (II-35), (II-R037) Pantoea vagans ), (II-R038) Penicillium bayley ( Penicillium bilaiae ), (II-R039) Pseudomonas sp. ), (II-R040) Pseudomonas chloraphis , (II-R041) Pseudomonas fluorescens ), (II-R042) Sphaerodes mycoparasitica (II-36), (II-R043) Streptomyces violaceusniger (II-38), (II-R044) Trichoderma acremonium JM41R ( Trichoderma fertile JM41R) (II-39), (II-R045) Typhula phacorrhiza (II-40), (II-R046) Verticillium dahlia (II-42), (II-R047) Zucchini yellow mosaic virus (avirulent strain).

在一更佳的實施例中,本案的農業化學組成物包含至少一種選自以下組的殺真菌活性化合物 (II)作為一組分 (2):In a more preferred embodiment, the agricultural chemical composition of the present case comprises at least one fungicidally active compound (II) selected from the following group as a component (2):

(II-A) 甾醇生物合成的抑制劑,例如,(II-A002) 待克利 (difenoconazole)、(II-A021) 得克利 (tebuconazole)、(II-A081) 滅芬座 (mefentrifluconazole);(II-A) Inhibitors of sterol biosynthesis, for example, (II-A002) difenoconazole, (II-A021) tebuconazole, (II-A081) mefentrifluconazole;

(II-B) 呼吸鏈複合物I (complex I)或複合物II (complex II)的抑制劑,例如,(II-B001) 苯索伏比 (benzovindiflupyr)、(II-B003) 白克列 (boscalid)、(II- B005) 氟派瑞 (fluopyram)、(II-B007) 氟克殺 (fluxapyroxad);(II-B) Inhibitors of respiratory chain complex I (complex I) or complex II (complex II), for example, (II-B001) benzovindiflupyr, (II-B003) buclide ( boscalid), (II-B005) fluopyram, (II-B007) fluoxapyroxad;

(II-C) 呼吸鏈複合物III (complex III)的抑制劑,例如,(II-C001) 滅脫定 (ametoctradin)、(II-C002) 安美速 (amisulbrom)、(II-C003) 亞托敏 (azoxystrobin)、(II-C006) 賽發滅 (cyazofamid)、(II-C009) 凡殺同 (famoxadone)、(II-C010) 芬滅酮 (fenamidone)、(II-C016) 啶氧菌酯 (picoxystrobin)、(II-C017) 唑菌胺酯 (pyraclostrobin)、(II-C020) 三氟敏 (trifloxystrobin)、(II-C030) 甲基四吡咯 (Metyltetraprole);(II-C) Inhibitors of respiratory chain complex III, for example, (II-C001) ametoctradin, (II-C002) amisulbrom, (II-C003) yator Azoxystrobin, (II-C006) cyazofamid, (II-C009) famoxadone, (II-C010) fenamidone, (II-C016) picoxystrobin (picoxystrobin), (II-C017) pyraclostrobin (pyraclostrobin), (II-C020) trifluorinated (trifloxystrobin), (II-C030) methyl tetrapyrrole (Metyltetraprole);

(II-D) 有絲分裂和細胞分裂的抑制劑,例如,(II-D003) 噻唑菌胺 (ethaboxam)、(II-D004) 氟比來 (fluopicolide)、(II-D008) 座賽胺 (zoxamide);(II-D) Inhibitors of mitosis and cell division, for example, (II-D003) ethaboxam, (II-D004) fluopicolide, (II-D008) zoxamide ;

(II-E) 可具有多位點作用的化合物,例如,(II-E004) 四氯異苯腈 (chlorothalonil)、(II-E005) 氫氧化銅、(II-E008) 氧氯化銅 (copper oxychloride)、(II-E009) 硫酸銅 (copper sulfate)、(II-E010) 腈硫醌 (dithianon)、(II-E012) 福爾培 (folpet)、(II-E013) 鋅錳乃浦 (mancozeb)、(II-E015) 免得爛 (metiram)、(II-E018) 甲基鋅乃浦 (propineb);(II-E) Compounds that may have multisite effects, for example, (II-E004) chlorothalonil, (II-E005) copper hydroxide, (II-E008) copper oxychloride (copper oxychloride), (II-E009) copper sulfate (copper sulfate), (II-E010) dithianon (dithianon), (II-E012) folpet (II-E013) zinc manganese Naipu (mancozeb) ), (II-E015) lest rot (metiram), (II-E018) methyl zinc Naipu (propineb);

(II-I) 細胞壁合成之抑制劑,例如,(II-I001) 苯噻菌胺 (benthiavalicarb)、(II-I002) 達滅芬 (dimethomorph)、(II-I004) 丙森鋅 (iprovalicarb)、(II-I005) 曼普胺 (mandipropamid)、(II-I007) 纈菌胺 (valifenalate);(II-I) Inhibitors of cell wall synthesis, for example, (II-I001) benthiavalicarb, (II-I002) dimethomorph, (II-I004) iprovalicarb, (II-I005) mandipropamid, (II-I007) valifenalate;

(II-J) 脂質和膜合成之抑制劑,例如,(II-J001) 普拔克 (propamocarb);(II-J) Inhibitors of lipid and membrane synthesis, for example, (II-J001) propamocarb;

(II-L) 核酸合成之抑制劑,例如,(II-L004) 甲芬沙姆 (mefenoxam);(II-L) Inhibitors of nucleic acid synthesis, for example, (II-L004) mefenoxam;

(II-N) 可作為去耦合劑之化合物,例如,(II-N001) 扶吉胺 (fluazinam);以及(II-N) Compounds that can act as decouplers, for example, (II-N001) fluazinam; and

(II-O) 其他殺真菌劑,例如,(II-O009) 克絕 (cymoxanil)、(II-O012) 福賽得鋁 (fosetyl­aluminium);(II-O) Other fungicides, for example, (II-O009) cymoxanil, (II-O012) fosetylaluminium;

在一實施例中,本案的農業化學組成物包含至少一種選自以下各組的殺蟲或殺線蟲活性化合物 (III)作為一組分 (2):In one embodiment, the agricultural chemical composition of the present invention comprises at least one insecticidal or nematicidal active compound (III) selected from the following groups as a component (2):

(III-A) 乙醯膽鹼酯酶 (AChE)抑制劑,選自以下各類:(III-A) Inhibitors of acetylcholinesterase (AChE) selected from the following classes:

(III-A1) 胺基甲酸酯 (carbamates),例如,(III-A1001) 棉靈威 (alanycarb)、(III-A1002) 得滅克 (aldicarb)、(III-A1003) 免敵克 (bendiocarb)、(III-A1004) 免扶克 (benfuracarb)、(III-A1005) 佈嘉信 (butocarboxim)、(III-A1006) 丁酮碸威 (butoxycarboxim)、(III-A1007) 加保利 (carbaryl)、(III-A1008) 加保扶 (carbofuran)、(III-A1009) 丁基加保扶 (carbosulfan)、(III-A1010) 殺蟲丹 (ethiofencarb)、(III-A1011) 丁基滅必蝨 (fenobucarb)、(III-A1012) 複滅蟎 (formetanate)、(III-A1013) 呋線威 (furathiocarb)、(III-A1014) 滅必蝨 (isoprocarb)、(III-A1015) 滅賜克 (methiocarb)、(III-A1016) 納乃得 (methomyl)、(III-A1017) 治滅蝨 (metolcarb)、(III-A1018) 歐殺滅 (oxamyl)、(III-A1019) 比加普 (pirimicarb)、(III-A1020) 安丹 (propoxur)、(III-A1021) 硫敵克 (thiodicarb)、(III-A1022) 硫伐隆 (thiofanox)、(III-A1023) 唑蚜威 (triazamate)、(III-A1024) 混滅威 (trimethacarb)、(III-A1025) 滅克蝨 (XMC, 3,5-Xylyl methylcarbamate)、(III-A1026) 滅殺威 (xylylcarb);(III-A1) Carbamates, for example, (III-A1001) alanycarb, (III-A1002) aldicarb, (III-A1003) bendiocarb ), (III-A1004) benfuracarb, (III-A1005) butocarboxim, (III-A1006) butoxycarboxim, (III-A1007) carbaryl, ( III-A1008) carbofuran, (III-A1009) butyl carbosulfan, (III-A1010) ethiofencarb, (III-A1011) butyl fenobucarb , (III-A1012) formetanate, (III-A1013) furathiocarb, (III-A1014) isoprocarb, (III-A1015) methiocarb, ( III-A1016) Nanoide (methomyl), (III-A1017) Metolcarb, (III-A1018) Oxamyl, (III-A1019) Pirimicarb, (III-A1019) A1020) propoxur, (III-A1021) thiodicarb, (III-A1022) thiofanox, (III-A1023) triazamate, (III-A1024) mixed Trimethacarb, (III-A1025) XMC, 3,5-Xylyl methylcarbamate, (III-A1026) xylylcarb;

(III-A2) 有機磷酸酯 (organophosphates),例如,(III-A2001) 歐殺松 (acephate)、(III-A2002) 亞滅松 (azamethiphos)、(III-A2003) 穀速松-乙酯 (azinphos-ethyl)、(III-A2004) 穀速松-甲酯 (azinphos-methyl)、(III-A2005) 硫線磷 (cadusafos)、(III-A2006) 氯氧磷 (chlorethoxyfos)、(III-A2007) 氯芬松 (chlorfenvinphos)、(III-A2008) 氯甲磷 (chlormephos)、(III-A2009) 陶斯松 (chlorpyrifos)、(III-A2010) 陶斯松-甲酯 (chlorpyrifos-methyl)、(III-A2011) 蠅毒磷 (coumaphos)、(III-A2012) 氰乃松 (cyanophos)、(III-A2013) 甲基硫代內吸磷 (demeton-S-methyl)、(III-A2014) 大利松 (diazinon)、(III-A2015) 二氯松 (dichlorvos, DDVP)、(III-A2016) 雙特松 (dicrotophos)、(III-A2017) 大滅松 (dimethoate)、(III-A2018) 甲基毒蟲畏 (dimethylvinphos)、(III-A2019) 二硫松 (disulfoton)、(III-A2020) 一品松 (O-Ehtyl-O-pnitrophenyl thionobenzenephosphonate, EPN)、(III-A2021) 愛殺松 (ethion)、(III-A2022) 普伏松 (ethoprophos)、(III-A2023) 胺磺磷 (famphur)、(III-A2024) 芬滅松 (fenamiphos)、(III-A2025) 撲滅松 (fenitrothion)、(III-A2026) 芬殺松 (fenthion)、(III-A2027) 福賽絕 (fosthiazate)、(III-A2028) 飛達松 (heptenophos)、(III-A2029) 新煙磷 (imicyafos)、(III-A2030) 亞芬松 (isofenphos)、(III-A2031) O-(甲氧基胺基硫基-磷醯基)水楊酸異丙酯 (isopropyl o-(methoxyaminothio-phosphoryl) salicylate)、(III-A2032) 加福松 (isoxathion)、(III-A2033) 馬拉硫磷 (malathion)、(III-A2034) 滅加松 (mecarbam)、(III-A2035) 達馬松 (methamidophos)、(III-A2036) 滅大松 (methidathion)、(III-A2037) 美文松 (mevinphos)、(III-A2038) 亞素靈 (monocrotophos)、(III-A2039) 乃力松 (naled)、(III-A2040) 毆滅松 (omethoate)、(III-A2041) 甲基滅多松 (oxydemeton-methyl)、(III-A2042) 巴拉松 (parathion)、(III-A2043) 甲基巴拉松 (parathion-methyl)、(III-A2044) 賽達松 (phenthoate)、(III-A2045) 福瑞松 (phorate)、(III-A2046) 裕必松 (phosalone)、(III-A2047) 益滅松 (phosmet)、(III-A2048) 福賜米松 (phosphamidon)、(III-A2049) 巴賽松 (phoxim)、(III-A2050) 亞特松-甲酯 (pirimiphos-methyl)、(III-A2051) 布飛松 (profenofos)、(III-A2052) 撲達松 (propetamphos)、(III-A2053) 普硫松 (prothiofos)、(III-A2054) 白克松 (pyraclofos)、(III-A2055) 必芬松 (pyridaphenthion)、(III-A2056) 拜裕松 (quinalphos)、(III-A2057) 治螟磷 (sulfotep)、(III-A2058) 丁基嘧啶磷 (tebupirimfos)、(III-A2059) 亞培松 (temephos)、(III-A2060) 託福松 (terbufos)、(III-A2061) 樂本松 (tetrachlorvinphos)、(III-A2062) 硫滅松 (thiometon)、(III-A2063) 三落松 (triazophos)、(III-A2064) 三氯松 (triclorfon)、(III-A2065) 繁米松 (vamidothion);(III-A2) Organophosphates (organophosphates), for example, (III-A2001) acephate, (III-A2002) azamethiphos, (III-A2003) azamethiphos, (III-A2003) azamethiphos-ethyl ester ( azinphos-ethyl), (III-A2004) azinphos-methyl, (III-A2005) cadusafos, (III-A2006) chlorethoxyfos, (III-A2007 ) Chlorfenvinphos, (III-A2008) Chlormephos, (III-A2009) Chlorpyrifos, (III-A2010) Chlorpyrifos-methyl, (III-A2011) Coumaphos, (III-A2012) cyanophos, (III-A2013) demeton-S-methyl, (III-A2014) diazinon, (III-A2015) Dichlorvos (DDVP), (III-A2016) Dicrotophos, (III-A2017) Dimethoate, (III-A2018) Dimethylvinphos ), (III-A2019) disulfoton (disulfoton), (III-A2020) pine pine (O-Ehtyl-O-pnitrophenyl thionobenzenephosphonate, EPN), (III-A2021) ethion, (III-A2022 ) Ethoprophos, (III-A2023) Famphur, (III-A2024) Fenamiphos, (III-A2025) Fenitrothion, (III-A2026) Fenza Pine (fenthion), (III-A2027) fosthiazate, (III-A2028) heptenophos, (III-A2029) imicyafos, (III-A2030) pine ( isofenphos ), (III-A2031) O-(methoxyaminothio-phosphoryl) isopropyl o-(methoxyaminothio-phosphoryl) salicylate, (III-A2032) isoxathion , (III-A2033) Malathion (malathion), (III-A2034) Mecarbam, (III-A2035) Methamidophos, (III-A2036) Methidathion, ( III-A2037) Mevinphos, (III-A2038) Monocrotophos, (III-A2039) Naled, (III-A2040) Omethoate, (III-A2041 ) oxydemeton-methyl, (III-A2042) parathion, (III-A2043) parathion-methyl, (III-A2044) phenthoate , (III-A2045) phorate, (III-A2046) phosalone, (III-A2047) phosmet, (III-A2048) phosphamidon, (III -A2049) phoxim, (III-A2050) pirimiphos-methyl, (III-A2051) profenofos, (III-A2052) propetamphos, (III-A2053) prothiofos, (III-A2054) pyraclofos, (III-A2055) pyridaphenthion, (III-A2056) quinalphos, (III-A2057 ) sulfotep, (III-A2058) tebupirimfos, (III-A2059) temephos, (III-A2060) terbufos, (III-A2061) le The pine (tetrachlorvinphos), (III-A2062 ) thiometon, (III-A2063) triazophos, (III-A2064) triclorfon, (III-A2065) vamidothion;

(III-B) γ-胺基丁酸 (GABA)閘控氯離子通道阻斷劑,選自以下各類:(III-B) Gamma-aminobutyric acid (GABA)-gated chloride channel blockers selected from the group consisting of:

(III-B1) 環戊二烯-有機氯 (cyclodiene organochlorines),例如(III-B1001) 可氯丹 (chlordane)、(III-B1002) 安殺番 (endosulfan);(III-B1) Cyclodiene organochlorines, such as (III-B1001) chlordane, (III-B1002) endosulfan;

(III-B2) 苯基吡唑(非潑羅,fiproles),例如,(III-B2001) 乙蟲清 (ethiprole)、(III-B2002) 費普尼 (fipronil)、(III-B2003) 丁烯氟蟲腈 (flufiprole)、(III-B2004) 啶吡唑蟲胺 (pyrafluprole)、(III-B2005) 吡唑蟲啶 (pyriprole);(III-B2) Phenylpyrazoles (fiproles), for example, (III-B2001) ethiprole, (III-B2002) fipronil, (III-B2003) butene Fipronil (flufiprole), (III-B2004) pyrafluprole, (III-B2005) pyriprole;

(III-C) 鈉通道調節劑,選自以下各類:(III-C) Sodium channel modulators selected from the following classes:

(III-C1) 除蟲菊精和類除蟲菊精類 (pyrethroids/pyrethrins),例如,(III-C1001) 阿納寧 (acrinathrin)、(III-C1002) 亞烈寧 (allethrin)、(III-C1003) d-順式反式亞烈寧 (d-cis-trans allethrin)、(III-C1004) d-反式亞烈寧 (d-trans-allethrin)、(III-C1005) 畢芬寧 (bifenthrin)、(III-C1006) 拜烈寧 (bioallethrin)、(III-C1007) S-環戊烯基拜烈寧異構物 (bioallethrin s-cyclopentenyl isomer)、(III-C1008) 苄呋菊脂 (bioresmethrin)、(III-C1009) 賽保寧 (cycloprothrin)、(III-C1010) 賽扶寧 (cyfluthrin)、(III-C1011) β-賽扶寧、(III-C1012) 賽洛寧 (cyhalothrin)、(III-C1013) λ-賽洛寧、(III-C1014) γ-賽洛寧、(III-C1015) 賽滅寧 (cypermethrin)、(III-C1016) α-賽滅寧、(III-C1017) β-賽滅寧、(III-C1018) θ-賽滅寧、(III-C1019) ξ-賽滅寧、(III-C1020) 賽酚寧 (cyphenothrin)、(III-C1021) [(1R)-反式異構物] ((1R)-trans-isomers)、(III-C1022) 第滅寧 (deltamethrin)、(III-C1023) 烯炔菊酯[(EZ)-(1R)-異構物]、(III-C1024) 益化利 (esfenvalerate)、(III-C1025) 依芬寧 (etofenprox)、(III-C1026) 芬普寧 (fenpropathrin)、(III-C1027) 芬化利 (fenvalerate)、(III-C1028) 護賽寧 (flucythrinate)、(III-C1029) 福滅寧 (flumethrin)、(III-C1030) τ-福化利 (tau-fluvalinate)、(III-C1031) 合芬寧 (halfenprox)、(III-C1032) 依普寧 (imiprothrin)、(III-C1033) 氯氟醚菊酯 (meperfluthrin)、(III-C1034) 美特寧 (metofluthrin)、(III-C1035) 滅伏靈 (momfluorothrin)、(III-C1036) 剋特寧 (kadethrin)、(III-C1037) 百滅寧 (permethrin)、(III-C1038) 苯醚菊酯[(1R)-反式異構物] (phenothrin [(1R)-trans-isomer])、(III-C1039) 普亞列寧 (prallethrin)、(III-C1040) 丙氟菊酯 (profluthrin)、(III-C1041) 除蟲菊素 (pyrethrins) (除蟲菊,pyrethrum)、(III-C1042) 苄呋菊脂 (resmethrin)、(III-C1043) 矽護芬 (silafluofen)、(III-C1044) 汰福寧 (tefluthrin)、(III-C1045) 四氟醚菊酯 (tetramethylfluthrin)、(III-C1046) 治滅寧 (tetramethrin)、(III-C1047) 治滅寧[(1R)-異構物] (tetramethrin [(1R)-isomers])、(III-C1048) 泰滅寧 (tralomethrin)、(III-C1049) 拜富寧 (transfluthrin);(III-C1) Pyrethrins and pyrethroids/pyrethrins, for example, (III-C1001) acrinathrin, (III-C1002) allethrin, (III- C1003) d-cis-trans allethrin, (III-C1004) d-trans allethrin, (III-C1005) bifenthrin, (III-C1006) bioallethrin, (III-C1007) S-cyclopentenyl isomer (bioallethrin s-cyclopentenyl isomer), (III-C1008) bioresmethrin, (III-C1009) cycloprothrin, (III-C1010) cyfluthrin, (III-C1011) β-cycloprothrin, (III-C1012) cyhalothrin, (III- C1013) λ-xeronine, (III-C1014) γ-xeronine, (III-C1015) cypermethrin, (III-C1016) α-cypermethrin, (III-C1017) β-cypermethrin Cyphenothrin, (III-C1018) θ-cyphenothrin, (III-C1019) ξ-cyphenothrin, (III-C1020) cyphenothrin, (III-C1021) [(1R)-trans iso Constructs] ((1R)-trans-isomers), (III-C1022) deltamethrin, (III-C1023) ethynthrin [(EZ)-(1R)-isomers], (III -C1024) esfenvalerate, (III-C1025) etofenprox, (III-C1026) fenpropathrin, (III-C1027) fenvalerate, (III-C1028) Flucythrinate, (III-C1029) flumethrin, (III-C1030) tau-fluvalinate, (III-C1031) halfenprox, (III- C1032) YP imiprothrin, (III-C1033) meperfluthrin, (III-C1034) metofluthrin, (III-C1035) momfluorothrin, (III-C1036) Ket Ning (kadethrin), (III-C1037) permethrin (III-C1038) phenothrin [(1R)-trans isomer] (phenothrin [(1R)-trans-isomer]), (III-C1039) prallethrin, (III-C1040) profluthrin, (III-C1041) pyrethrins (pyrethrum), (III-C1042) Resmethrin, (III-C1043) silafluofen, (III-C1044) tefluthrin, (III-C1045) tetramethylfluthrin, (III-C1046 ) Tetramethrin, (III-C1047) Tetramethrin [(1R)-isomers] (tetramethrin [(1R)-isomers]), (III-C1048) Tetramethrin, (III -C1049) Bai Funing (transfluthrin);

(III-C2) 有機氯類 (organochlorine),例如,(III-C2001) 滴滴涕 (DDT)、(III-C2002) 甲氧基氯 (methoxychlor);(III-C2) Organochlorines, such as (III-C2001) DDT, (III-C2002) methoxychlor;

(III-D) 菸鹼乙醯膽鹼受體 (nAChR)競爭性調節劑,選自以下各類:(III-D) Nicotinic acetylcholine receptor (nAChR) competitive modulators selected from the following classes:

(III-D1) 新菸鹼類似物 (neonicotinoids),例如,(III-D1001) 亞滅培 (acetamiprid)、(III-D1002) 可尼丁(clothianidin)、(III-D1003) 達特南 (dinotefuran)、(III-D1004) 益達胺 (imidacloprid)、(III-D1005) 烯啶蟲胺 (nitenpyram)、(III-D1006) 噻蟲啉 (thiacloprid)、(III-D1007) 噻蟲嗪 (thiamethoxam)、(III-D1008) 1-[(6-氯-3-吡啶基)甲基]-2,3,5,6,7,8-六氫-9-硝基-(5S,8R)-5,8-環氧-H-咪唑並[1,2-a]氮呯 (1-[(6-chloro-3-pyridinyl)methyl]-2,3,5,6,7,8-hexahydro-9-nitro-(5S,8R)-5,8-epoxy-H-imidazo[1,2-a]azepine)、(III-D1009) (1-[(6-氯-3-吡啶基)甲基]-2-硝基-1-[(E)-亞戊基胺基]胍 (1-[(6-chloro-3-pyridyl)methyl]-2-nitro-1-[(E)-pentylideneamino]guanidine、(III-D1010) 1-[(6-氯-3-吡啶基)甲基]-7-甲基-8-硝基-5-丙氧基-3,5,6,7-四氫-2H-咪唑並[1,2-a]吡啶 (1-[(6-chloro-3-pyridyl)methyl]-7-methyl-8-nitro-5-propoxy-3,5,6,7-tetrahydro-2H-imidazo[1,2-a]pyridine);(III-D1) Neonicotinoids, eg, (III-D1001) acetamiprid, (III-D1002) clothianidin, (III-D1003) dinotefuran ), (III-D1004) imidacloprid, (III-D1005) nitenpyram, (III-D1006) thiacloprid, (III-D1007) thiamethoxam 、(III-D1008) 1-[(6-chloro-3-pyridyl)methyl]-2,3,5,6,7,8-hexahydro-9-nitro-(5S,8R)-5 ,8-Epoxy-H-imidazo[1,2-a]nitrogen (1-[(6-chloro-3-pyridinyl)methyl]-2,3,5,6,7,8-hexahydro-9 -nitro-(5S,8R)-5,8-epoxy-H-imidazo[1,2-a]azepine), (III-D1009) (1-[(6-chloro-3-pyridyl)methyl] -2-nitro-1-[(E)-pentylideneamino]guanidine (1-[(6-chloro-3-pyridyl)methyl]-2-nitro-1-[(E)-pentylideneamino]guanidine 、(III-D1010) 1-[(6-chloro-3-pyridyl)methyl]-7-methyl-8-nitro-5-propoxy-3,5,6,7-tetrahydro- 2H-imidazo[1,2-a]pyridine (1-[(6-chloro-3-pyridyl)methyl]-7-methyl-8-nitro-5-propoxy-3,5,6,7-tetrahydro- 2H-imidazo[1,2-a]pyridine);

(III-D2001) 菸鹼;(III-D2001) Nicotine;

(III-D3) 甲硫胺酸磺醯亞胺 (sulfoximines),例如,(III-D3001) 速殺氟 (sulfoxaflor);(III-D3) Methionine sulfoximines, for example, (III-D3001) sulfoxaflor;

(III-D4) 丁烯羥酸內酯 (butenolides),例如,(III-D4001) 氟吡呋喃酮 (flupyradifurone);(III-D4) butenolides, for example, (III-D4001) flupyradifurone;

(III-D5) 中離子化合物 (mesoionics),例如,(III-D5001) 氟美派 (triflumezopyrim)、(III-D5002) 二氯滅座替 (dichloromezotiaze);(III-D5) mesoionics, for example, (III-D5001) triflumezopyrim, (III-D5002) dichloromezotiaze;

(III-D6) 伸二氫吡啶基化合物 (pyridylidenes),例如,(III-D6001) 氟必靈 (flupyrimin);(III-D6) pyridylidenes, for example, (III-D6001) flupyrimin;

(III-E) 菸鹼乙醯膽鹼 (nAChR) 受體異位調節劑-位點I,選自以下各類:(III-E) Nicotinic acetylcholine (nAChR) receptor ectopic modulator-site I, selected from the class of:

(III-E1) 賜諾殺類 (spinosyns),例如,(III-E1001) 賜諾特 (spinetoram)、(III-E1002) 賜諾殺 (spinosad);(III-E1) Spinosyns, for example, (III-E1001) spinetoram, (III-E1002) spinosad;

(III-F) 麩胺酸閘控氯通道 (GluCl)異位調節劑,選自以下各類:(III-F) Glutamine-gated chloride channel (GluCl) ectopic modulators selected from the group consisting of:

(III-F1) 阿維菌素類 (avermectin)/米爾倍黴素類 (milbemycin),例如,(III-F1001) 阿巴汀 (abamectin)、(III-F1002) 因滅汀苯甲酸酯 (emamectin benzoate)、(III-F1003) 雷匹美汀 (lepimectin)、(III-F1004) 密滅汀 (milbemectin);(III-F1) avermectins/milbemycins, e.g. (III-F1001) abamectin, (III-F1002) inphenetin benzoate ( emamectin benzoate), (III-F1003) rapimectin, (III-F1004) milbemectin;

(III-G) 青春激素模擬物,選自以下各類:(III-G) Mimetics of youth hormones, selected from the following classes:

(III-G1) 青少年激素類似物,例如,(III-G1001) 烯蟲乙酯 (hydroprene)、(III-G1002) 烯蟲炔酯 (kinoprene)、(III-G1003) 美賜平 (methoprene);(III-G1) Juvenile hormone analogues, e.g., (III-G1001) methoprene (hydroprene), (III-G1002) methoprene (kinoprene), (III-G1003) methoprene;

(III-G2001) 芬諾克 (fenoxycarb);(III-G2001) Fenoxycarb;

(III-G3001) 百利普芬 (pyriproxyfen);(III-G3001) pyriproxyfen;

(III-H) 多重非特異性(多位點)抑制劑,選自以下各類:(III-H) Multiple non-specific (multi-site) inhibitors selected from the following classes:

(III-H1) 烷基鹵化物,例如,(III-H1001) 溴化甲烷、(III-H1002) 其他烷基鹵化物;(III-H1) Alkyl halides, for example, (III-H1001) Methyl bromide, (III-H1002) Other alkyl halides;

(III-H2001) 氯化苦 (chloropicrin);(III-H2001) Chloropicrin;

(III-H3) 氟化物,例如,(III-H3001) 冰晶石 (cryolite)(氟鋁化鈉,sodium aluminium fluoride)、(III-H3002) 磺醯氟 (sulfuryl fluoride);(III-H3) Fluorides such as (III-H3001) cryolite (sodium aluminum fluoride), (III-H3002) sulfuryl fluoride;

(III-H4) 硼酸鹽 (borates),例如,(III-H4001) 硼砂 (borax)、(III-H4002) 硼酸 (boric acid)、(III-H4003) 八硼酸二鈉 (disodium octaborate)、(III-H4004) 硼酸鈉 (sodium borate)、(III-H4005) 偏硼酸鈉 (sodium metaborate);(III-H4) Borates, for example, (III-H4001) borax, (III-H4002) boric acid, (III-H4003) disodium octaborate, (III-H4003) -H4004) sodium borate (sodium borate), (III-H4005) sodium metaborate (sodium metaborate);

(III-H5001) 酒石酸銻鉀 (tartar emetic);(III-H5001) Antimony Potassium Tartrate (tartar emetic);

(III-H6) 異氰酸甲酯產生劑,例如,(III-H6001) 必速滅 (diazomet)、(III-H6002) 威百畝 (metam);(III-H6) Methyl isocyanate generators, for example, (III-H6001) diazomet, (III-H6002) metam;

(III-I) 弦音器官TRPV通道調節劑,選自以下各類:(III-I) string organ TRPV channel modulator, selected from the following categories:

(III-I1) 吡啶偶氮甲鹼衍生物 (pyridine azomethine derivatives),例如,(III-I1001) 派滅淨 (pymetrozine)、(III-I1002) 氟蟲吡喹 (pyrifluquinazon);(III-I1) pyridine azomethine derivatives, for example, (III-I1001) pymetrozine, (III-I1002) pyrifluquinazon;

(III-I2001) 啶喃環丙蟲酯 (afidopyropen);(III-I2001) Afidopyropen;

(III-J) 影響CHS1的蟎生長抑制劑,選自以下各類:(III-J) Mite growth inhibitors affecting CHS1 selected from the following classes:

(III-J1) 克芬蟎 (clofentezine)、氟蟎嗪 (diflovidazin)、合賽多 (hexythiazox)等,例如,(III-J1001) 克芬蟎、(III-J1002) 合賽多、(III-J1003) 氟蟎嗪;(III-J1) clofentezine, diflovidazin, hexythiazox, etc., for example, (III-J1001) clofentezine, (III-J1002) hexythiazox, (III- J1003) Flufenazin;

(III-J2003) 依殺蟎 (etoxazole);(III-J2003) etoxazole;

(III-K) 昆蟲中腸膜的微生物干擾劑,選自以下各類:(III-K) Microbial disruptors of insect midgut membranes selected from the group consisting of:

(III-K1) 蘇力菌及其產生的殺蟲蛋白,例如,(III-K1001) 蘇力菌 ( Bacillus thuringiensis)、(III-K1002) 蘇力菌以色列變種 ( Bacillus thuringiensisvar. israelensis)、(III-K1003) 蘇力菌亞莎華變種 ( Bacillus thuringiensisvar. aizawai)、(III-K1004) 蘇力菌庫斯塔克變種 ( Bacillus thuringiensisvar. kurstaki)、(III-K1005) 蘇力菌坦尼布列翁斯變種 ( Bacillus thuringiensisvar. tenebrionis)、(III-K1006) Cry1Ab,、(III-K1007) Cry1Ac、(III-K1008) Cry1Fa、(III-K1009) Cry1A.105、(III-K1010) Cry2Ab、(III-K1011) Vip3A、(III-K1012) mCry3A、(III-K1013) Cry3Ab、(III-K1014) Cry3Bb、(III-K1015) Cry34/35Ab1; (III-K1) Bacillus thuringiensis and its insecticidal protein, for example, (III-K1001) Bacillus thuringiensis , (III-K1002) Bacillus thuringiensis var. israelensis , ( III-K1003) Bacillus thuringiensis var. aizawai , (III-K1004) Bacillus thuringiensis var. kurstaki , (III-K1005) Bacillus thuringiensis var. kurstaki Bacillus thuringiensis var. tenebrionis , (III-K1006) Cry1Ab, (III-K1007) Cry1Ac, (III-K1008) Cry1Fa, (III-K1009) Cry1A.105, (III-K1010) Cry2Ab , (III-K1011) Vip3A, (III-K1012) mCry3A, (III-K1013) Cry3Ab, (III-K1014) Cry3Bb, (III-K1015) Cry34/35Ab1;

(III-K2001) 圓形芽孢桿菌 ( Bacillus sphaericus); (III-K2001) Bacillus sphaericus ;

(III-L) 粒線體ATP合成酶之抑制劑,選自以下各類:(III-L) Inhibitors of mitochondrial ATP synthase selected from the following categories:

(III-L1001) 汰芬諾克 (diafenthiuron);(III-L1001) Diafenthiuron (diafenthiuron);

(III-L2) 有機錫殺蟎劑,例如,(III-L2001) 三唑錫 (azocyclotin)、(III-L2002) 錫蟎丹 (cyhexatin)、(III-L2003) 芬布錫 (fenbutatin oxide);(III-L2) Organotin acaricides, for example, (III-L2001) azocyclotin, (III-L2002) cyhexatin, (III-L2003) fenbutatin oxide;

(III-L3001) 毆蟎多 (propargite);(III-L3001) Propargite (propargite);

(III-L4001) 得脫蟎 (tetradifon);(III-L4001) Tetradifon;

(III-M) 藉由干擾質子梯度而作用之氧化磷酸化去耦合劑,選自以下各類:(III-M) Oxidative phosphorylation decouplers acting by interfering with the proton gradient, selected from the following classes:

(III-M1) 吡咯 (pyrroles),例如,(III-M1001) 克凡派 (chlorfenapyr);(III-M1) pyrroles, e.g. (III-M1001) chlorfenapyr;

(III-M2) 二硝基苯酚 (dinitrophenols),例如,(III-M2001) 二硝基甲酚 (dinitro-ortho-cresol, DNOC);(III-M2) dinitrophenols, for example, (III-M2001) dinitro-ortho-cresol (DNOC);

(III-M3001) 氟蟲胺 (sulfluramid);(III-M3001) Sulfluramid (sulfluramid);

(III-N) 菸鹼乙醯膽鹼受體 (nAChR)通道阻斷劑,選自以下各類:(III-N) Nicotinic acetylcholine receptor (nAChR) channel blockers selected from the following classes:

(III-N1) 沙蠶毒素類似物 (nereistoxin analogues),例如,(III-N1001) 免速達 (bensultap)、(III-N1002) 培丹鹽酸鹽 (cartap hydrochloride)、(III-N1003) 硫賜安 (thiocylam)、(III-N1004) 殺蟲雙鈉 (thiosultap-sodium);(III-N1) Nereistoxin analogues, for example, (III-N1001) bensultap, (III-N1002) cartap hydrochloride, (III-N1003) sulfur An (thiocylam), (III-N1004) thiosultap-sodium;

(III-O) 影響CHS1的幾丁質生物合成抑制劑,選自以下各類:(III-O) Chitin biosynthesis inhibitors affecting CHS1 selected from the following classes:

(III-O1) 苯甲醯脲 (benzoylureas),例如,(III-O1001) 雙三氟蟲脲 (bistrifluron)、(III-O1002) 克福隆 (chlorfluazuron)、(III-O1003) 二福隆 (diflubenzuron)、(III-O1004) 氟環脲 (flucycloxuron)、(III-O1005) 氟芬隆 (flufenoxuron)、(III-O1006) 六伏隆 (hexaflumuron)、(III-O1007) 祿芬隆 (lufenuron)、(III-O1008) 諾伐隆 (novaluron)、(III-O1009) 多氟脲 (noviflumuron)、(III-O1010) 得福隆 (teflubenzuron)、(III-O1011) 三福隆 (triflumuron);(III-O1) Benzoylureas, for example, (III-O1001) bistrifluron, (III-O1002) chlorfluazuron, (III-O1003) difluazuron ( diflubenzuron), (III-O1004) flucycloxuron, (III-O1005) flufenoxuron, (III-O1006) hexaflumuron, (III-O1007) lufenuron , (III-O1008) novaluron, (III-O1009) noviflumuron, (III-O1010) teflubenzuron, (III-O1011) triflumuron;

(III-P) 第1型之幾丁質生物合成抑制劑,例如,(III-P1001) 布芬淨 (buprofezin);(III-P) Type 1 chitin biosynthesis inhibitors, for example, (III-P1001) buprofezin;

(III-Q) 蛻皮干擾劑,選自以下各類:(III-Q) Moulting disruptors selected from the following classes:

(III-Q1) 用於雙翅目 (Dipteran)(亦即雙翅目昆蟲)之干擾劑,例如,(III-Q1001) 賽滅淨 (cyromazine);(III-Q1) Interfering agents of the order Dipteran (i.e. insects of the order Diptera), for example, (III-Q1001) cyromazine;

(III-R) 蛻皮素受體促效劑,選自以下各類:(III-R) Ecdysone receptor agonists selected from the group consisting of:

(III-R1) 二醯基聯胺類 (diacylhydrazines),例如,(III-R1001) 滅芬諾 (methoxyfenozide)、(III-R1002) 得芬諾 (tebufenozide)、(III-R1003) 合芬隆 (halofenozide)、(III-R1004) 呋喃蟲醯肼 (fufenozide)、(III-R1005) 可芬諾 (chromafenozide);(III-R1) Diacylhydrazines, for example, (III-R1001) methoxyfenozide, (III-R1002) tebufenozide, (III-R1003) fenoxetine ( halofenozide), (III-R1004) fufenozide, (III-R1005) chromafenozide;

(III-S) 奧克巴胺受體促效劑,例如,(III-S1001) 三亞蟎 (amitraz);(III-S) Octopamine receptor agonists, for example, (III-S1001) amitraz;

(III-T) 粒線體複合物III電子傳遞抑制劑,例如,(III-T1001) 愛美松 (hydramethylnone)、(III-T2001) 亞醌蟎 (acequinocyl)、(III-T3001) 嘧蟎酯 (fluacrypyrim)、(III-T4001) 畢芬載 (Bifenazate);(III-T) Mitochondrial complex III electron transport inhibitors, for example, (III-T1001) hydramethylnone, (III-T2001) acequinocyl, (III-T3001) pyrimifen ( fluacrypyrim), (III-T4001) Bifenazate;

(III-U) 粒線體複合物I電子傳遞抑制劑,選自以下各類:(III-U) Mitochondrial complex I electron transport inhibitors selected from the following classes:

(III-U1) 電子傳遞抑制劑 (Mitochondrial complex I electron transport inhibitors, METI)殺蟎劑和殺蟲劑,例如,(III-U1001) 芬殺蟎 (fenazaquin)、(III-U1002) 芬普蟎 (fenpyroximate)、(III-U1003) 嘧蟎醚 (pyrimidifen)、(III-U1004) 畢達本 (pyridaben)、(III-U1005) 得芬瑞 (tebufenpyrad)、(III-U1006) 脫芬瑞 (tolfenpyrad);(III-U1) Mitochondrial complex I electron transport inhibitors (METI) acaricides and insecticides, for example, (III-U1001) fenazaquin, (III-U1002) Fenpro mite ( fenpyroximate), (III-U1003) pyrimidifen, (III-U1004) pyridaben, (III-U1005) tebufenpyrad, (III-U1006) tolfenpyrad ;

(III-U2001) 魚藤精 (rotenone);(III-U2001) Rotenone (rotenone);

(III-V) 電壓依賴性之鈉通道阻斷劑,選自以下各類:(III-V) Voltage-dependent sodium channel blockers selected from the following classes:

(III-V1) 噁二嗪 (oxadiazines),例如,(III-V1001) 因得克 (indoxacarb);(III-V1) oxadiazines, e.g. (III-V1001) indoxacarb;

(III-V2) 縮胺脲 (semicarbazones),例如,(III-V2001) 美氟綜 (metaflumizone);(III-V2) semicarbazones, for example, (III-V2001) metaflumizone;

(III-V3001) 1-[(E)-[2-(4-腈基苯基)-1-[3-(三氟甲基)苯基]亞乙基]胺基]-3-[4-(二氟甲氧基)苯基]脲 (1-[(E)-[2-(4-cyanophenyl)-1-[3-(trifluoromethyl)phenyl]ethylidene]amino]-3-[4-(difluoromethoxy)phenyl]urea);(III-V3001) 1-[(E)-[2-(4-cyanophenyl)-1-[3-(trifluoromethyl)phenyl]ethylene]amino]-3-[4 -(Difluoromethoxy)phenyl]urea (1-[(E)-[2-(4-cyanophenyl)-1-[3-(trifluoromethyl)phenyl]ethylene]amino]-3-[4-( difluoromethoxy)phenyl]urea);

(III-V4001) 2-[3-(乙磺醯基)吡啶-2-基]-5-[三氟(甲磺醯基)]-1,3-苯並噁唑 (2-[3-(ethanesulfonyl)pyridin-2-yl]-5-[trifluoro(methanesulfonyl)]-1,3-benzoxazole (oxazosulfyl))(歐賽菲,oxazosulfyl);(III-V4001) 2-[3-(Ethylsulfonyl)pyridin-2-yl]-5-[trifluoro(methylsulfonyl)]-1,3-benzoxazole (2-[3- (ethanesulfonyl)pyridin-2-yl]-5-[trifluoro(methanesulfonyl)]-1,3-benzoxazole (oxazosulfyl)) (Ocean, oxazosulfyl);

(III-W) 乙醯輔酶A羧化酶抑制劑,選自以下各類:(III-W) Acetyl-CoA carboxylase inhibitors selected from the following classes:

(III-W1) 特窗酸 (tetronic acid)以及特特拉姆酸 (tetramic acid)之衍生物,例如,(III-W1001) 賜派芬 (spirodiclofen)、(III-W1002) 賜滅芬 (spiromesifen)、(III-W1003) 賜派酮 (spiropidion)、(III-W1004) 賜派滅 (spirotetramat);(III-W1) Derivatives of tetronic acid and tetramic acid, for example, (III-W1001) spirodiclofen, (III-W1002) spiromesifen ), (III-W1003) spiropidion, (III-W1004) spirotetramat;

(III-X) 粒線體複合物IV電子傳遞抑制劑,選自以下各類:(III-X) Mitochondrial complex IV electron transport inhibitors selected from the following classes:

(III-X1001) 磷化物 (phosphides),例如,(III-X1001) 磷化鋁、(III-X1002) 磷化鈣、(III-X1003) 膦 (phosphine)、(III-X1004) 磷化鋅;(III-X1001) phosphides, for example, (III-X1001) aluminum phosphide, (III-X1002) calcium phosphide, (III-X1003) phosphine, (III-X1004) zinc phosphide;

(III-X2) 氰化物,例如,(III-X2001) 氰化鈣、(III-X2002) 氰化鉀、(III-X2003) 氰化鈉;(III-X2) Cyanides, for example, (III-X2001) calcium cyanide, (III-X2002) potassium cyanide, (III-X2003) sodium cyanide;

(III-Y) 粒線體複合物II電子傳遞抑制劑,選自以下各類:(III-Y) Mitochondrial complex II electron transport inhibitors selected from the following classes:

(III-Y1001) β-酮腈 (beta-ketonitrile)衍生物,例如,(III-Y1001) 賽派芬 (cyenopyrafen)、(III-Y1002) 賽芬蟎 (cyflumetofen);(III-Y1001) beta-ketonitrile derivatives, for example, (III-Y1001) cyenopyrafen, (III-Y1002) cyflumetofen;

(III-Y2) 苯胺基甲醯 (carboxanilides),例如,(III-Y2001) 派氟丁胺 (pyflubumide);(III-Y2) Carboxanilides, for example, (III-Y2001) pyflubumide;

(III-Z) 雷若丁受體調節劑,選自以下各類:(III-Z) Ranerodine receptor modulators selected from the group consisting of:

(III-Z1) 二醯胺類 (diamides),例如,(III-Z1001) 氟大滅 (flubendiamide)、(III-Z1002) 剋安勃 (chlorantraniliprole) (Rynaxypyr®)、(III-Z1003) 賽安勃 (cyantraniliprole) (Rynaxypyr®)、(III-Z1004) 環溴蟲醯胺 (cyclaniliprole)、(III-Z1005) 特安勃 (tetraniliprole)、(III-Z1006) 四氯蟲醯胺 (tetra-chlorantraniliprole)、(III-Z1007) (R)-3-氯-N1-{2-甲基-4-[1,2,2,2-四氟-1-(三氟甲基)乙基]苯基}-N2-(1-甲基-2-甲基磺醯基乙基)鄰苯二甲醯胺 ((R)-3-Chlor-N1-{2-methyl-4-[1,2,2,2-tetrafluor-1-(trifluormethyl)ethyl]phenyl}-N2-(1-methyl-2-methylsulfonylethyl)phthalamid)、(III-Z1008) (S)-3-氯-N1-{2-甲基-4-[1,2,2,2-四氟-1-(三氟甲基)乙基]苯基}-N2-(1-甲基-2-甲基磺醯基乙基)鄰苯二甲醯胺 ((S)-3-Chlor-N1-{2-methyl-4-[1,2,2,2-tetrafluor-1-(trifluormethyl)ethyl]phenyl}-N2-(1-methyl-2-methylsulfonylethyl)phthalamid)、(III-Z1009) 甲基-2-[3,5-二溴-2-({[3-溴-1-(3-氯吡啶-2-基)-1H-吡唑-5-基]羰基}胺基)苯甲醯基]-1,2 -二甲基肼羧酸 (methyl-2-[3,5-dibromo-2-({[3-bromo-1-(3-chlorpyridin-2-yl)-1H-pyrazol-5-yl]carbonyl}amino)benzoyl]-1,2-dimethylhydrazinecarboxylate)、(III-Z1010) N-[2-(5-胺基-1,3,4-噻二唑-2-基)-4-氯-6-甲基-苯基]-5-溴-2-(3-氯-2-吡啶基)吡唑-3-羧醯胺 (N-[2-(5-amino-1,3,4-thiadiazol-2-yl)-4-chloro-6-methyl-phenyl]-5-bromo-2-(3-chloro-2-pyridyl)pyrazole-3-carboxamide)、(III-Z1011) 5-氯-2-(3-氯-2-吡啶基)-N-[2,4-二氯-6-[(1-腈基-1-甲基-乙基)胺基甲醯基]苯基]吡唑-3-羧醯胺 (5-chloro-2-(3-chloro-2-pyridyl)-N-[2,4-dichloro-6-[(1-cyano-1-methyl-ethyl)carbamoyl]phenyl]pyrazole-3-carboxamide)、(III-Z1012) 5-溴-N-[2,4-二氯-6-(甲基胺基甲醯基)苯基]-2-(3,5-二氯-2-吡啶基)吡唑-3-羧醯胺 5-bromo-N-[2,4-dichloro-6-(methylcarbamoyl)phenyl]-2-(3,5-dichloro-2-pyridyl)pyrazole-3-carboxamide、(III-Z1013) N-[2-(叔丁基胺基甲醯基)-4-氯-6-甲基-苯基]-2-(3-氯-2-吡啶基)-5-(氟甲氧基)吡唑-3-羧醯胺(N-[2-(tert-butylcarbamoyl)-4-chloro-6-methyl-phenyl]-2-(3-chloro-2-pyridyl)-5-(fluoromethoxy)pyrazole-3-carboxamide)、(III-Z1014) N2-(1-腈基-1-甲基-乙基)-N1-(2,4-二甲基苯基)-3-碘-鄰苯二甲醯胺 (N2-(1-cyano-1-methyl-ethyl)-N1-(2,4-dimethylphenyl)-3-iodo-phthalamide)、3-氯-N2-(1-腈基-1-甲基-乙基)-N1-(2,4-二甲基苯基)鄰苯二甲醯胺 (3-chloro-N2-(1-cyano-1-methyl-ethyl)-N1-(2,4-dimethylphenyl)phthalamide);(III-Z1) Diamides, eg, (III-Z1001) flubendiamide, (III-Z1002) chlorantraniliprole (Rynaxypyr®), (III-Z1003) Cyan Cyantraniliprole (Rynaxypyr®), (III-Z1004) Cyclaniliprole, (III-Z1005) Tetraniliprole, (III-Z1006) Tetra-chlorantraniliprole 、(III-Z1007) (R)-3-chloro-N1-{2-methyl-4-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]phenyl} -N2-(1-methyl-2-methylsulfonylethyl)phthalamide ((R)-3-Chlor-N1-{2-methyl-4-[1,2,2, 2-tetrafluor-1-(trifluormethyl)ethyl]phenyl}-N2-(1-methyl-2-methylsulfonylethyl)phthalamid), (III-Z1008) (S)-3-chloro-N1-{2-methyl-4 -[1,2,2,2-Tetrafluoro-1-(trifluoromethyl)ethyl]phenyl}-N2-(1-methyl-2-methylsulfonylethyl)phthalamide Amide ((S)-3-Chlor-N1-{2-methyl-4-[1,2,2,2-tetrafluor-1-(trifluormethyl)ethyl]phenyl}-N2-(1-methyl-2- methylsulfonylethyl)phthalamid), (III-Z1009) methyl-2-[3,5-dibromo-2-({[3-bromo-1-(3-chloropyridin-2-yl)-1H-pyrazole- 5-yl]carbonyl}amino)benzoyl]-1,2-dimethylhydrazinecarboxylic acid (methyl-2-[3,5-dibromo-2-({[3-bromo-1-(3 -chlorpyridin-2-yl)-1H-pyrazol-5-yl]carbonyl}amino)benzoyl]-1,2-dimethylhydrazinecarboxylate), (III-Z1010) N-[2-(5-amino-1,3, 4-thiadiazol-2-yl)-4-chloro-6-methyl-phenyl]-5-bromo-2-(3-chloro-2-pyridyl)pyrazole-3-carboxamide (N -[2-(5-ami no-1,3,4-thiadiazol-2-yl)-4-chloro-6-methyl-phenyl]-5-bromo-2-(3-chloro-2-pyridyl)pyrazole-3-carboxamide), (III -Z1011) 5-chloro-2-(3-chloro-2-pyridyl)-N-[2,4-dichloro-6-[(1-cyano-1-methyl-ethyl)aminomethyl Acyl]phenyl]pyrazole-3-carboxamide (5-chloro-2-(3-chloro-2-pyridyl)-N-[2,4-dichloro-6-[(1-cyano-1- methyl-ethyl)carbamoyl]phenyl]pyrazole-3-carboxamide), (III-Z1012) 5-bromo-N-[2,4-dichloro-6-(methylaminoformyl)phenyl]-2 -(3,5-Dichloro-2-pyridyl)pyrazole-3-carboxamide 5-bromo-N-[2,4-dichloro-6-(methylcarbamoyl)phenyl]-2-(3,5- dichloro-2-pyridyl)pyrazole-3-carboxamide, (III-Z1013) N-[2-(tert-butylaminoformyl)-4-chloro-6-methyl-phenyl]-2-(3 -Chloro-2-pyridyl)-5-(fluoromethoxy)pyrazole-3-carboxamide (N-[2-(tert-butylcarbamoyl)-4-chloro-6-methyl-phenyl]-2- (3-chloro-2-pyridyl)-5-(fluoromethoxy)pyrazole-3-carboxamide), (III-Z1014) N2-(1-cyano-1-methyl-ethyl)-N1-(2,4 -Dimethylphenyl)-3-iodo-phthalamide (N2-(1-cyano-1-methyl-ethyl)-N1-(2,4-dimethylphenyl)-3-iodo-phthalamide), 3-Chloro-N2-(1-cyano-1-methyl-ethyl)-N1-(2,4-dimethylphenyl)phthalamide (3-chloro-N2-(1- cyano-1-methyl-ethyl)-N1-(2,4-dimethylphenyl)phthalamide);

(III-AA) 弦音器官調節劑-未定義的目標位點,例如,(III-AA1001) 氟尼胺 (flonicamid);(III-AA) Chord Organ Modulators - undefined target site, e.g., (III-AA1001) flonicamid;

(III-BB) γ-胺基丁酸 (GABA)閘控氯離子通道阻斷劑,選自以下各類:(III-BB) Blockers of gamma-aminobutyric acid (GABA)-gated chloride channels selected from the group consisting of:

(III-BB1) 間二醯胺 (meta-diamides),例如,(III-BB1001) 溴蟲氟苯雙醯胺 (broflanilide);(III-BB1) meta-diamides, e.g. (III-BB1001) broflanilide;

(III-BB2) 異噁唑啉,例如,(III-BB2001) 氣釀醯胺 (fluxametamide)、(III-BB2002) 抑克斯能 (isocycloseram);(III-BB2) isoxazolines, for example, (III-BB2001) fluxametamide, (III-BB2002) isocycloseram;

(III-CC) 桿狀病毒,選自以下各類:(III-CC) Baculovirus, selected from the following classes:

(III-CC1) 顆粒體病毒 (Granuloviruses, GVs),例如,(III-CC1001) 蘋果蠹蛾 ( Cydia pomonella) GV、(III-CC1002) 偽蘋果蠹蛾 ( Thaumatotibia leucotreta) GV; (III-CC1) Granuloviruses (GVs), for example, (III-CC1001) Cydia pomonella GV, (III-CC1002) Pseudo codling moth ( Thaumatobia leucotreta ) GV;

(III-CC2) 核多角體病毒 (nucleopolyhedroviruses, NPVs),例如,(III-CC2001) 黎豆夜蛾 ( Anticarsia gemmatalis)之繁殼核多角體病毒 (Multi-nucleocapsid nucleopolyhedroviruses, MNPV)、(III-CC2002) 棉鈴實夜蛾 ( Helicoverpa armigera)之核多角體病毒; (III-CC2) Nucleopolyhedroviruses (NPVs), for example, (III-CC2001) Multi-nucleocapsid nucleopolyhedroviruses ( MNPV ) of Anticarsia gemmatalis, (III-CC2002 ) nuclear polyhedrosis virus of cotton boll moth ( Helicoverpa armigera );

(III-DD) 菸鹼乙醯膽鹼受體異位調節劑-位點II,例如,(III-DD1001) GS-ω/κ HXTX-Hv1a胜肽 (GS omega/kappa HXTX-Hv1a peptide);(III-DD) Nicotinic acetylcholine receptor ectopic modulator-site II, for example, (III-DD1001) GS-ω/κ HXTX-Hv1a peptide (GS omega/kappa HXTX-Hv1a peptide);

(III-EE) 作用方式未知或不確定之殺蟲活性化合物,例如,(III-EE1001) 艾特本 (afidopyropen)、(III-EE1002) 印楝素 (azadirachtin)、(III-EE1003) 磺胺蟎酯 (amidoflumet)、(III-EE1004) 苯賽滅 (benzoximate)、(III-EE1005) 苯吡莫賽 (benzpyrimoxan)、(III-EE1006) 必芬賽 (bifenazate)、(III-EE1007) 新殺蟎 (bromopropylate)、(III-EE1008) 滅蟎猛 (chinomethionat)、(III-EE1009) 克利得 (cryolite)、(III-EE1010) 大克蟎 (dicofol)、(III-EE1011) 伏吩靈 (flufenerim)、(III-EE1012) 氟喹啉 (flometoquin)、(III-EE1013) 氟赫吩 (fluhexafon)、(III-EE1014) 氟速吩 (fluensulfone)、(III-EE1015) 伏達隆 (flupyradifurone)、(III-EE1016) 石灰硫黃合劑 (lime sulphur)、(III-EE1017) 鋅錳乃浦 (mancozeb)、(III-EE1018) 協力精 (piperonyl butoxide)、(III-EE1019) 吡啶蟲丙醚 (pyridalyl)、(III-EE1020) 必伏松 (pyrifluquinazon)、(III-EE1021) 碸蟲啶 (sulfoxaflor)、(III-EE1022) 硫、(III-EE1023) 4-[5-(3,5-二氯-苯基)-5-三氟甲基-4,5-二氫-異噁唑-3-基]-2-甲基-N-[(2,2,2-三氟-乙基胺基甲醯基)-甲基]-苯醯胺 (4-[5-(3,5-Dichloro-phenyl)-5-trifluoromethyl-4,5-dihydro-isoxazol-3-yl]-2-methyl-N-[(2,2,2-trifluoro-ethylcarbamoyl)-methyl]-benzamide)、(III-EE1024) 環丙基乙酸 (cyclopropaneacetic acid)、(III-EE1025) 1,1’-[(3S,4R,4aR,6S,6aS,12R,12aS,12bS)-4-[[(2-環丙基乙醯基)氧基]甲基]-1,3,4,4a,5,6,6a,12,12a,12b-十氫-12-羥基-4,6a,12b-三甲基-11-氧代-9-(3-吡啶基)-2H,11H-萘並[2,1-b]吡喃[3,4-e]吡喃-3,6-二基]酯 (1,1’-[(3S,4R,4aR,6S,6aS,12R,12aS,12bS)-4-[[(2-cyclopropylacetyl)oxy]methyl]-1,3,4,4a,5,6,6a,12,12a,12b-decahydro-12-hydroxy-4,6a,12b-trimethyl-11-oxo-9-(3-pyridinyl)-2H,11H-naphtho[2,1-b]pyrano[3,4-e]pyran-3,6-diyl]ester、(III-EE1026) 11-(4-氯-2,6-二甲基苯基)-12-羥基-1,4-二氧-9-氮雜二螺[4.2.4.2]-十四碳-11-烯-10-酮 (11-(4-chloro-2,6-dimethylphenyl)-12-hydroxy-1,4-dioxa-9-azadispiro[4.2.4.2]-tetradec-11-en-10-one)、(III-EE1027) 4,3-(4’-氟-2,4-二甲基聯苯-3-基)-4-羥基-8-氧杂-1-氮雜螺[4.5]-十烷-3-烯-2-酮 (4,3-(4’-fluoro-2,4-dimethylbiphenyl-3-yl)-4-hydroxy-8-oxa-1-azaspiro[4.5]dec-3-en-2-one、(III-EE1028) 1-[2-氟-4-甲基-5-[(2,2,2-三氟乙基)亞磺醯基]苯基]-3-(三氟甲基)-1H-1,2,4-三唑-5-胺 (1-[2-fluoro-4-methyl-5-[(2,2,2-trifluoroethyl)sulfinyl]phenyl]-3-(trifluoromethyl)-1H-1,2,4-triazole-5-amine)、(III-EE1029) 基於強固芽胞桿菌之活性劑 (actives on basis of bacillus firmus (Votivo), II-1582)、(III-EE1030) (E/Z)-N-[1-[(6-氯-3-吡啶基)甲基]-2-吡啶基]-2,2,2-三氟-乙醯胺 ((E/Z)-N-[1-[(6-chloro-3-pyridyl)methyl]-2-pyridylidene]-2,2,2-trifluoro-acetamide)、(III-EE1031) (E/Z)-N-[1-[(6-氯-5-氟-3-吡啶基)甲基]-2-吡啶亞基]-2,2,2-三氟-乙醯胺 ((E/Z)-N-[1-[(6-chloro-5-fluoro-3-pyridyl)methyl]-2-pyridylidene]-2,2,2-trifluoro-acetamide)、(III-EE1032) (E/Z)-2,2,2-三氟-N-[1-[(6-氟-3-吡啶基)甲基]-2-吡啶基]乙醯胺 ((E/Z)-2,2,2-trifluoro-N-[1-[(6-fluoro-3-pyridyl)methyl]-2-pyridylidene]acetamide)、(III-EE1033) (E/Z)-N-[1-[(6-溴-3-吡啶基)甲基]-2-吡啶基]-2,2,2-三氟-乙醯胺 ((E/Z)-N-[1-[(6-bromo-3-pyridyl)methyl]-2-pyridylidene]-2,2,2-trifluoro-acetamide)、(III-EE1034) (E/Z)-N-[1-[1-[(6-氯-3-吡啶基)乙基]-2-吡啶基]-2,2,2-三氟-乙醯胺 ((E/Z)-N-[1-[1-(6-chloro-3-pyridyl)ethyl]-2-pyridylidene]-2,2,2-trifluoro-acetamide)、(III-EE1035) (E/Z)-N-[1-[(6-氯-3-吡啶基)甲基]-2-吡啶基]-2,2-二氟-乙醯胺 ((E/Z)-N-[1-[(6-chloro-3-pyridyl)methyl]-2-pyridylidene]-2,2-difluoro-acetamide)、(III-EE1036) (E/Z)-2-氯-N-[1-[(6-氯-3-吡啶基)甲基]-2-吡啶基]-2,2-二氟-乙醯胺 ((E/Z)-2-chloro-N-[1-[(6-chloro-3-pyridyl)methyl]-2-pyridylidene]-2,2-difluoro-acetamide)、(III-EE1037) (E/Z)-N-[1-[(2-氯嘧啶-5-基)甲基]-2-亞吡啶]-2,2,2-三氟乙醯胺 ((E/Z)-N-[1-[(2-chloropyrimidin-5-yl)methyl]-2-pyridylidene]-2,2,2-trifluoro-acetamide)、(III-EE1038) (E/Z)-N-[1-[(6-氯-3-吡啶基)甲基]-2-吡啶基]-2,2,3,3,3-五氟丙醯胺 ((E/Z)-N-[1-[(6-chloro-3-pyridyl)methyl]-2-pyridylidene]-2,2,3,3,3-pentafluoro-propanamide)、(III-EE1039) 氟美派 (triflumezopyrim)、(III-EE1040) 4-[5-[3-氯-5-(三氟甲基)苯基]-5-(三氟甲基)-4H-異噁唑-3-基]-N-[2-氧代-2-(2,2,2-三氟乙胺基 )乙基]萘-1-羧醯胺 (4-[5-[3-chloro-5-(trifluoromethyl)phenyl]-5-(trifluoromethyl)-4H-isoxazol-3-yl]-N-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]naphthalene-1-carboxamide)、(III-EE1041) 3-[3-氯-5-(三氟甲基)苯基]-4-氧代-1-(嘧啶-5-基甲基)吡啶並[1,2-a]嘧啶鎓-2-油酸鹽 (3-[3-chloro-5-(trifluoromethyl)phenyl]-4-oxo-1-(pyrimidin-5-ylmethyl)pyrido[1,2-a]pyrimidin-1-ium-2-olate)、(III-EE1042) 8-氯-N-[2-氯-5-甲氧基苯基)磺醯基]-6-三氟甲基)-咪唑並[1,2-a]吡啶-2-羧醯胺 (8-chloro-N-[2-chloro-5-methoxyphenyl)sulfonyl]-6-trifluoromethyl)-imidazo[1,2-a]pyridine-2-carboxamide)、(III-EE1043) 4-[5-(3,5-二氯苯基)-5-(三氟甲基)-4H-異噁唑-3-基]-2-甲基-N-(1-側氧基硫雜環丁烷-3-基)苯醯胺 (4-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4H-isoxazol-3-yl]-2-methyl-N-(1-oxothietan-3-yl)benzamide)、(III-EE1044) 5-[3-[2,6-二氯-4-(3,3-二氯烯丙氧基)苯氧基]丙氧基]-1H-吡唑 (5-[3-[2,6-dichloro-4-(3,3-dichloroallyloxyl)phenoxy]propoxy]-1H-pyrazole)、(III-EE1045) 益達胺 (dimpropyridaz)、(III-EE1046) 吡啶菌醯胺 (tyclopyrazoflor)、(III-EE1047) 尼可氟酮 (nicofluprole)、(III-EE1048) 阿西諾吡 (acynonapyr);(III-EE) Insecticidally active compounds with unknown or uncertain mode of action, e.g. (III-EE1001) afidopyropen, (III-EE1002) azadirachtin, (III-EE1003) sulfamites Amidoflumet, (III-EE1004) benzoximate, (III-EE1005) benzpyrimoxan, (III-EE1006) bifenazate, (III-EE1007) new acaricide (bromopropylate), (III-EE1008) chinomethionat, (III-EE1009) cryolite, (III-EE1010) dicofol, (III-EE1011) flufenerim , (III-EE1012) Flumetoquin, (III-EE1013) Fluhexafon, (III-EE1014) Fluensulfone, (III-EE1015) Flupyradifurone, ( III-EE1016) lime sulfur (lime sulfur), (III-EE1017) zinc manganese Naipu (mancozeb), (III-EE1018) piperonyl butoxide, (III-EE1019) pyridalyl , (III-EE1020) pyrifluquinazon, (III-EE1021) sulfoxaflor, (III-EE1022) sulfur, (III-EE1023) 4-[5-(3,5-dichloro- Phenyl)-5-trifluoromethyl-4,5-dihydro-isoxazol-3-yl]-2-methyl-N-[(2,2,2-trifluoro-ethylaminomethyl Acyl)-methyl]-benzamide (4-[5-(3,5-Dichloro-phenyl)-5-trifluoromethyl-4,5-dihydro-isoxazol-3-yl]-2-methyl-N- [(2,2,2-trifluoro-ethylcarbamoyl)-methyl]-benzamide), (III-EE1024) cyclopropaneacetic acid, (III-EE1025) 1,1'-[(3S,4R,4aR,6S,6aS,12R,12aS,12bS)-4-[[(2-cyclopropylacetyl)oxy]methyl]-1,3,4 ,4a,5,6,6a,12,12a,12b-decahydro-12-hydroxyl-4,6a,12b-trimethyl-11-oxo-9-(3-pyridyl)-2H,11H- Naphtho[2,1-b]pyrano[3,4-e]pyran-3,6-diyl]ester (1,1'-[(3S,4R,4aR,6S,6aS,12R,12aS ,12bS)-4-[[(2-cyclopropylacetyl)oxy]methyl]-1,3,4,4a,5,6,6a,12,12a,12b-decahydro-12-hydroxy-4,6a,12b- trimethyl-11-oxo-9-(3-pyridinyl)-2H,11H-naphtho[2,1-b]pyrano[3,4-e]pyran-3,6-diyl]ester, (III-EE1026) 11 -(4-Chloro-2,6-dimethylphenyl)-12-hydroxy-1,4-dioxo-9-azadispiro[4.2.4.2]-tetradec-11-ene-10- Ketone (11-(4-chloro-2,6-dimethylphenyl)-12-hydroxy-1,4-dioxa-9-azadispiro[4.2.4.2]-tetradec-11-en-10-one), (III-EE1027 ) 4,3-(4'-fluoro-2,4-dimethylbiphenyl-3-yl)-4-hydroxy-8-oxa-1-azaspiro[4.5]-decane-3-ene -2-keto(4,3-(4'-fluoro-2,4-dimethylbiphenyl-3-yl)-4-hydroxy-8-oxa-1-azaspiro[4.5]dec-3-en-2-one, (III-EE1028) 1-[2-Fluoro-4-methyl-5-[(2,2,2-trifluoroethyl)sulfinyl]phenyl]-3-(trifluoromethyl)- 1H-1,2,4-triazol-5-amine (1-[2-fluoro-4-methyl-5-[(2,2,2-trifluoroethyl)sulfinyl]phenyl]-3-(trifluoromethyl)-1H -1,2,4-triazole-5-amine), (III-EE1029) actives on basis of bacillus firmus (Votivo), II-1582), (III-EE1030) (E /Z)-N-[1-[(6-chloro-3-pyridyl)methyl]-2-pyridyl]-2,2,2-trifluoro-acetamide ((E/Z)-N -[1-[(6-chloro-3-pyridyl)methyl]-2-pyridylidene]-2,2,2-trifluoro-acetamide), (III-EE1031) (E/Z)-N-[1-[ (6-Chloro-5-fluoro-3-pyridyl)methyl]-2-pyridylidene]-2,2,2-trifluoro-acetamide ((E/Z)-N-[1-[ (6-chloro-5-fluoro-3-pyridyl)methyl]-2-pyridylidene]-2,2,2-trifluoro-acetamide), (III-EE1032) (E/Z)-2,2,2-tri Fluoro-N-[1-[(6-fluoro-3-pyridyl)methyl]-2-pyridyl]acetamide ((E/Z)-2,2,2-trifluoro-N-[1- [(6-fluoro-3-pyridyl)methyl]-2-pyridylidene]acetamide), (III-EE1033) (E/Z)-N-[1-[(6-bromo-3-pyridyl)methyl] -2-pyridyl]-2,2,2-trifluoro-acetamide ((E/Z)-N-[1-[(6-bromo-3-pyridyl)methyl]-2-pyridylidene]-2 ,2,2-trifluoro-acetamide), (III-EE1034) (E/Z)-N-[1-[1-[(6-chloro-3-pyridyl)ethyl]-2-pyridyl]- 2,2,2-Trifluoro-acetamide ((E/Z)-N-[1-[1-(6-chloro-3-pyridyl)ethyl]-2-pyridylidene]-2,2,2- trifluoro-acetamide), (III-EE1035) (E/Z)-N-[1-[(6-chloro-3-pyridyl)methyl]-2-pyridyl]-2,2-difluoro-ethyl Amide ((E/Z)-N-[1-[(6-chloro-3-pyridyl)methyl]-2-pyridylidene]-2,2-difluoro-acetamide), (III-EE1036) (E/Z )-2-chloro-N-[1-[(6-chloro-3-pyridyl)methyl]-2-pyridyl]-2,2-difluoro-acetamide ((E/Z)-2 -chloro-N-[1-[(6-chloro-3-pyridyl)methyl]-2-pyridylidene]-2,2-difluoro- acetamide), (III-EE1037) (E/Z)-N-[1-[(2-chloropyrimidin-5-yl)methyl]-2-pyridine]-2,2,2-trifluoroacetyl Amine ((E/Z)-N-[1-[(2-chloropyrimidin-5-yl)methyl]-2-pyridylidene]-2,2,2-trifluoro-acetamide), (III-EE1038) (E/ Z)-N-[1-[(6-chloro-3-pyridyl)methyl]-2-pyridyl]-2,2,3,3,3-pentafluoropropionamide ((E/Z) -N-[1-[(6-chloro-3-pyridyl)methyl]-2-pyridylidene]-2,2,3,3,3-pentafluoro-propanamide), (III-EE1039) triflumezopyrim , (III-EE1040) 4-[5-[3-Chloro-5-(trifluoromethyl)phenyl]-5-(trifluoromethyl)-4H-isoxazol-3-yl]-N- [2-Oxo-2-(2,2,2-trifluoroethylamino)ethyl]naphthalene-1-carboxamide (4-[5-[3-chloro-5-(trifluoromethyl)phenyl]- 5-(trifluoromethyl)-4H-isoxazol-3-yl]-N-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]naphthalene-1-carboxamide), (III-EE1041) 3-[ 3-Chloro-5-(trifluoromethyl)phenyl]-4-oxo-1-(pyrimidin-5-ylmethyl)pyrido[1,2-a]pyrimidinium-2-oleate ( 3-[3-chloro-5-(trifluoromethyl)phenyl]-4-oxo-1-(pyrimidin-5-ylmethyl)pyrido[1,2-a]pyrimidin-1-ium-2-olate), (III- EE1042) 8-Chloro-N-[2-chloro-5-methoxyphenyl)sulfonyl]-6-trifluoromethyl)-imidazo[1,2-a]pyridine-2-carboxamide (8-chloro-N-[2-chloro-5-methoxyphenyl)sulfonyl]-6-trifluoromethyl)-imidazo[1,2-a]pyridine-2-carboxamide), (III-EE1043) 4-[5-( 3,5-Dichlorophenyl)-5-(trifluoromethyl)-4H-isoxazol-3-yl]-2-methyl-N-(1-oxo Thietan-3-yl)benzamide (4-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4H-isoxazol-3-yl]-2-methyl-N-(1 -oxothietan-3-yl)benzamide), (III-EE1044) 5-[3-[2,6-dichloro-4-(3,3-dichloroallyloxy)phenoxy]propoxy] -1H-pyrazole (5-[3-[2,6-dichloro-4-(3,3-dichloroallyloxyl)phenoxy]propoxy]-1H-pyrazole), (III-EE1045) Dimpropyridaz, ( III-EE1046) tyclopyrazoflor, (III-EE1047) nicofluprole, (III-EE1048) acynonapyr;

(III-FF) 生物性殺蟲劑 (biopesticides),選自以下各類:(III-FF) Biological insecticides (biopesticides) selected from the following classes:

(III-FF1) 微生物殺蟲劑 (Microbial pesticides),例如,(III-FF1001) 強固芽胞桿菌 ( Bacillus firmus)、(III-FF1002) 蘇力菌醋螟亞種 ( Bacillus thuringiensissubsp. galleriae)、(III-FF1003) 蘇力菌庫斯塔克亞種 ( Bacillus thuringiensissubsp. kurstaki)、(III-FF1004) 白殭菌 ( Beauveria bassiana)、(III-FF1005) 伯克霍爾德菌屬 ( Burkholderiasp.)、(III-FF1006) 鐵杉紫色桿菌 ( Chromobacterium subtsugae)、(III-FF1007) 鐵杉紫色桿菌新種 ( Chromobacterium subtsugaesp. nov.)、(III-FF1008) 玫煙色擬青黴 ( Isaria fumosorosea)、(III-FF1009) 長孢輪枝菌 ( Lecanicillium longisporum)、(III-FF1010) 蠟蚧輪枝菌 ( Lecanicillium muscarium)(原為 Verticillium lecanii)、(III-FF1011) 黑殭菌 ( Metarhizium anisopliae)、(III-FF1012) 黃綠綠僵菌 ( Metarhizium anisopliaevar. acridum)、(III-FF1013) 玫煙色擬青黴阿波普卡菌株97 ( Paecilomyces fumosoroseusApopka strain 97)、(III-FF1014) 淡紫紫孢菌 ( Purpureocillium lilacinus)、(III-FF1015) 金龜子類芽孢桿菌 ( Paenibacillus popilliae)、(III-FF1016) 巴斯德菌屬 ( Pasteuriaspp.)、(III-FF1017) 擬斯紮瓦巴氏桿菌 ( Pasteuria nishizawae)、(III-FF1018) 腎形巴氏桿菌 ( Pasteuria reneformis)、(III-FF1019) usgae巴氏桿菌 ( Pasteuria usagae)、(III-FF1020) 螢光假單胞菌 ( Pseudomonas fluorescens)、(III-FF1021) 夜蛾斯氏線蟲 ( Steinernema feltiae)、(III-FF1022) Streptomces galbus、(III-FF1023) 沃巴赫氏菌 ( Wolbachia pipientis(Zap));以及 (III-FF1) Microbial pesticides, for example, (III-FF1001) Bacillus firmus , (III-FF1002) Bacillus thuringiensis subsp. galleriae , ( III-FF1003) Bacillus thuringiensis subsp. kurstaki , (III-FF1004) Beauveria bassiana , (III-FF1005) Burkholderia sp. ), (III-FF1006) Chromobacterium subtsugae , (III-FF1007) Chromobacterium subtsugae sp. nov., (III-FF1008) Isaria fumosorosea , (III-FF1009) Lecanicillium longisporum , (III-FF1010) Lecanicillium muscarium (formerly Verticillium lecanii ), (III-FF1011) Metarhizium anisopliae , ( III-FF1012) Metarhizium anisopliae var. acridum , (III-FF1013) Paecilomyces fumosoroseus Apopka strain 97 ( Paecilomyces fumosoroseus Apopka strain 97), (III-FF1014) P. Purpureocillium lilacinus ), (III-FF1015) Paenibacillus popilliae , (III-FF1016) Pasteuria spp., (III-FF1017) Pasteuria nishizawae , (III-FF1018) Pasteuria reneformis ( Pasteuria reneformis ), (III-FF1019) Pasteuria usgae ( Pasteuria usagae ), ( III-FF1020) Pseudomonas fluorescens , (III-FF1021) Steinernema feltiae , (III-FF1022) Streptomces galbus , (III-FF1023) Wolbachia pipientis (Zap)); and

(III-GG) 具有殺蟲、殺蟎、殺軟體動物、費洛蒙及/或殺線蟲活性的生化殺害蟲劑,例如,(III-GG1001) L-香芹酮 (L-carvone)、(III-GG1002) 檸檬醛 (citral)、(III-GG1003) (E,Z)-7,9-十二碳二烯-1-基乙酸酯 ((E,Z)-7,9-dodecadien-1-yl acetate)、(III-GG1004) 甲酸乙酯 (ethyl formate)、(III-GG1005) (E,Z)-癸二烯酸(E,Z)-2,4-乙酯(梨酯) ((E,Z)-2,4-ethyl decadienoate (pear ester))、(III-GG1006) (Z,Z,E)-7,11,13-十六碳三烯醛 ((Z,Z,E)-7,11,13-hexadecatrienal)、(III-GG1007) 丁酸庚酯 (heptyl butyrate)、(III-GG1008) 肉豆蔻酸異丙酯 (isopropyl myristate)、(III-GG1009) 異戊烯酸熏衣草酯 (lavanulyl senecioate)、(III-GG1010) 2-甲基1-丁醇、(III-GG1011) 甲基丁香酚 (methyl eugenol)、(III-GG1012) 茉莉酸甲酯 (methyl jasmonate)、(III-GG1013) (E,Z)-2,13-十八碳二烯-1-醇 ((E,Z)-2,13-octadecadien-1-ol)、(III-GG1014) (E,Z)-2,13-十八碳二烯-1-醇乙酸酯 ((E,Z)-2,13-octadecadien-1-ol acetate)、(III-GG1015) (E,Z)-3,13-十八碳二烯-1-醇 ((E,Z)-3,13-octadecadien-1-ol)、(III-GG1016) R-1-辛烯-3-醇 (R-1-octen-3-ol)、(III-GG1017) 噴他特馬農 (pentatermanone)、(III-GG1018) 矽酸鉀 (potassium silicate)、(III-GG1019) 山梨糖醇辛酸酯 (sorbitol actanoate)、(III-GG1020) 乙酸(E,Z,Z)-3,8,11-十四碳三烯酯 ((E,Z,Z)-3,8,11-tetradecatrienyl acetate)、(III-GG1021) 乙酸(Z,E)-9,12-十四烷二烯-1-基酯 ((Z,E)-9,12-tetradecadien-1-yl acetate)、(III-GG1022) Z-7-十四碳烯-2-酮 (Z-7-tetradecen-2-one)、Z-9-十四碳烯-1-基乙酸酯 (Z-9-tetradecen-1-yl acetate)、(III-GG1023) Z-11-十四烯醛 (Z-11-tetradecenal)、(III-GG1024) Z-11-十四碳烯-1-醇 (Z-11-tetradecen-1-ol)、(III-GG1025) 黑綠荊樹 ( Acacia negra) 萃取物、(III-GG1026) 葡萄柚籽及果肉萃取物、(III-GG1027) 土荊芥 ( Chenopodium ambrosiodae) 萃取物、(III-GG1028) 脂肪酸與甘油或丙二醇的單酯 (fatty acid monoester with glycerol or propanediol)、(III-GG1029) 貓薄荷油 (catnip oil)、(III-GG1030) 苦楝油 (neem oil)、(III-GG1031) 皂萃取物 (quillay extract)、(III-GG1032) 萬壽菊油 (tagetes oil)。 (III-GG) Biochemical insecticides having insecticidal, acaricidal, molluscicidal, pheromone and/or nematicidal activity, for example, (III-GG1001) L-carvone (L-carvone), ( III-GG1002) citral, (III-GG1003) (E,Z)-7,9-dodecadien-1-yl acetate ((E,Z)-7,9-dodecadien- 1-yl acetate), (III-GG1004) ethyl formate (ethyl formate), (III-GG1005) (E,Z)-decadienoic acid (E,Z)-2,4-ethyl ester (pearyl ester) ((E,Z)-2,4-ethyl decadienoate (pear ester)), (III-GG1006) (Z,Z,E)-7,11,13-hexadecatrienal ((Z,Z, E)-7,11,13-hexadecatrienal), (III-GG1007) heptyl butyrate, (III-GG1008) isopropyl myristate, (III-GG1009) isoamyl Lavanulyl senecioate, (III-GG1010) 2-methyl-1-butanol, (III-GG1011) methyl eugenol, (III-GG1012) methyl jasmonate ), (III-GG1013) (E,Z)-2,13-octadecadien-1-ol ((E,Z)-2,13-octadecadien-1-ol), (III-GG1014) ( E,Z)-2,13-octadecadien-1-ol acetate ((E,Z)-2,13-octadecadien-1-ol acetate), (III-GG1015) (E,Z) -3,13-octadecadien-1-ol ((E,Z)-3,13-octadecadien-1-ol), (III-GG1016) R-1-octene-3-ol (R- 1-octen-3-ol), (III-GG1017) pentatermanone, (III-GG1018) potassium silicate (III-GG1019) sorbitol actanoate ), (III-GG1020) (E,Z,Z)-3,8,11-tetradecatrienyl acetate ((E,Z,Z)-3,8,11-tetradecatrienyl ace tate), (III-GG1021) (Z,E)-9,12-tetradecadien-1-yl acetate ((Z,E)-9,12-tetradecadien-1-yl acetate), (III -GG1022) Z-7-tetradecen-2-one (Z-7-tetradecen-2-one), Z-9-tetradecen-1-yl acetate (Z-9-tetradecen-1 -yl acetate), (III-GG1023) Z-11-tetradecenal (Z-11-tetradecenal), (III-GG1024) Z-11-tetradecen-1-ol (Z-11-tetradecen- 1-ol), (III-GG1025) Black Nepeta ( Acacia negra ) Extract, (III-GG1026) Grapefruit Seed and Pulp Extract, (III-GG1027) Nepeta ( Chenopodium ambrosiodae ) Extract, (III -GG1028) fatty acid monoester with glycerol or propanediol, (III-GG1029) catnip oil, (III-GG1030) neem oil, (III-GG1031 ) quillay extract, (III-GG1032) tagetes oil.

在一較佳實施例中,本案的農業化學組成物包含至少一種選自以下組的殺蟲或殺線蟲活性化合物 (III)作為一組分 (2):In a preferred embodiment, the agricultural chemical composition of the present case comprises at least one insecticidal or nematicidal active compound (III) selected from the following group as a component (2):

(III-B) γ-胺基丁酸 (GABA)閘控氯離子通道阻斷劑,選自以下各類:(III-B) Gamma-aminobutyric acid (GABA)-gated chloride channel blockers selected from the group consisting of:

(III-B1) 環戊二烯-有機氯 (cyclodiene organochlorines),例如(III-B1001) 可氯丹 (chlordane)、(III-B1002) 安殺番 (endosulfan);(III-B1) Cyclodiene organochlorines, such as (III-B1001) chlordane, (III-B1002) endosulfan;

(III-B2) 苯基吡唑(非潑羅,fiproles),例如,(III-B2001) 益斯普 (ethiprole)、(III-B2002) 費普尼 (fipronil)、(III-B2003) 丁烯氟蟲腈 (flufiprole)、(III-B2004) 啶吡唑蟲胺 (pyrafluprole)、(III-B2005) 吡唑蟲啶 (pyriprole);(III-B2) Phenylpyrazoles (fiproles), for example, (III-B2001) ethiprole, (III-B2002) fipronil, (III-B2003) butene Fipronil (flufiprole), (III-B2004) pyrafluprole, (III-B2005) pyriprole;

(III-C) 鈉通道調節劑,選自以下各類:(III-C) Sodium channel modulators selected from the following classes:

(III-C1) 除蟲菊精和類除蟲菊精類 (pyrethroids/pyrethrins),例如,(III-C1001) 阿納寧 (acrinathrin)、(III-C1002) 亞烈寧 (allethrin)、(III-C1003) d-順式反式亞烈寧 (d-cis-trans allethrin)、(III-C1004) d-反式亞烈寧 (d-trans-allethrin)、(III-C1005) 畢芬寧 (bifenthrin)、(III-C1006) 拜烈寧 (bioallethrin)、(III-C1007) S-環戊烯基拜烈寧異構物 (bioallethrin s-cyclopentenyl isomer)、(III-C1008) 苄呋菊脂 (bioresmethrin)、(III-C1009) 賽保寧 (cycloprothrin)、(III-C1010) 賽扶寧 (cyfluthrin)、(III-C1011) β-賽扶寧、(III-C1012) 賽洛寧 (cyhalothrin)、(III-C1013) λ-賽洛寧、(III-C1014) γ-賽洛寧、(III-C1015) 賽滅寧 (cypermethrin)、(III-C1016) α-賽滅寧、(III-C1017) β-賽滅寧、(III-C1018) θ-賽滅寧、(III-C1019) ξ-賽滅寧、(III-C1020) 賽酚寧、(III-C1021) [(1R)-反式異構物]、(III-C1022) 第滅寧 (deltamethrin)、(III-C1023) 烯炔菊酯[(EZ)-(1R)-異構物]、(III-C1024) 益化利 (esfenvalerate)、(III-C1025) 依芬寧 (etofenprox)、(III-C1026) 芬普寧 (fenpropathrin)、(III-C1027) 芬化利 (fenvalerate)、(III-C1028) 護賽寧 (flucythrinate)、(III-C1029) 福滅寧 (flumethrin)、(III-C1030) τ-福化利 (tau-fluvalinate)、(III-C1031) 合芬寧 (halfenprox)、(III-C1032) 依普寧 (imiprothrin)、(III-C1033) 氯氟醚菊酯 (meperfluthrin)、(III-C1034) 美特寧 (metofluthrin)、(III-C1035) 滅伏靈 (momfluorothrin)、(III-C1036) 剋特寧 (kadethrin)、(III-C1037) 百滅寧 (permethrin)、(III-C1038) 苯醚菊酯[(1R)-反式異構物] (phenothrin [(1R)-trans-isomer])、(III-C1039) 普亞列寧 (prallethrin)、(III-C1040) 丙氟菊酯 (profluthrin)、(III-C1041) 除蟲菊素 (pyrethrins) (除蟲菊,pyrethrum)、(III-C1042) 苄呋菊脂 (resmethrin)、(III-C1043) 矽護芬 (silafluofen)、(III-C1044) 汰福寧 (tefluthrin)、(III-C1045) 四氟醚菊酯 (tetramethylfluthrin)、(III-C1046) 治滅寧 (tetramethrin)、(III-C1047) 治滅寧[(1R)-異構物] (tetramethrin [(1R)-isomers])、(III-C1048) 泰滅寧 (tralomethrin)、(III-C1049) 拜富寧 (transfluthrin);(III-C1) Pyrethrins and pyrethroids/pyrethrins, for example, (III-C1001) acrinathrin, (III-C1002) allethrin, (III- C1003) d-cis-trans allethrin, (III-C1004) d-trans allethrin, (III-C1005) bifenthrin, (III-C1006) bioallethrin, (III-C1007) S-cyclopentenyl isomer (bioallethrin s-cyclopentenyl isomer), (III-C1008) bioresmethrin, (III-C1009) cycloprothrin, (III-C1010) cyfluthrin, (III-C1011) β-cycloprothrin, (III-C1012) cyhalothrin, (III- C1013) λ-xeronine, (III-C1014) γ-xeronine, (III-C1015) cypermethrin, (III-C1016) α-cypermethrin, (III-C1017) β-cypermethrin Cyphenin, (III-C1018) θ-Saphenin, (III-C1019) ξ-Saphenin, (III-C1020) Cyphenin, (III-C1021) [(1R)-trans isomer] , (III-C1022) deltamethrin, (III-C1023) ethynthrin [(EZ)-(1R)-isomer], (III-C1024) esfenvalerate, (III -C1025) Etofenprox, (III-C1026) Fenpropathrin, (III-C1027) Fenvalerate, (III-C1028) Flucythrinate, (III-C1029) Flumethrin, (III-C1030) tau-fluvalinate, (III-C1031) halffenprox, (III-C1032) imiprothrin, (III-C1033 ) Chlorfluethrin (m eperfluthrin), (III-C1034) metofluthrin, (III-C1035) momfluorothrin, (III-C1036) kadethrin, (III-C1037) permethrin , (III-C1038) phenothrin [(1R)-trans isomer] (phenothrin [(1R)-trans-isomer]), (III-C1039) prallethrin, (III-C1040 ) profluthrin, (III-C1041) pyrethrins (pyrethrum), (III-C1042) resmethrin, (III-C1043) pyrethrin (silafluofen), (III-C1044) tefithrin, (III-C1045) tetramethylfluthrin, (III-C1046) tetramethrin, (III-C1047) tetramethrin [(1R)-isomers] (tetramethrin [(1R)-isomers]), (III-C1048) tralomethrin, (III-C1049) transfluthrin;

(III-C2) 有機氯類,例如,(III-C2001) 滴滴涕 (DDT)、(III-C2002) 甲氧基氯 (methoxychlor);(III-C2) Organochlorines such as (III-C2001) DDT, (III-C2002) methoxychlor;

(III-D) 菸鹼乙醯膽鹼受體 (nAChR)競爭性調節劑,選自以下各類:(III-D) Nicotinic acetylcholine receptor (nAChR) competitive modulators selected from the following classes:

(III-D1) 新菸鹼類似物,例如,(III-D1001) 亞滅培 (acetamiprid)、(III-D1002) 可尼丁(clothianidin)、(III-D1003) 達特南 (dinotefuran)、(III-D1004) 益達胺 (imidacloprid)、(III-D1005) 烯啶蟲胺 (nitenpyram)、(III-D1006) 噻蟲啉 (thiacloprid)、(III-D1007) 噻蟲嗪 (thiamethoxam)、(III-D1008) 1-[(6-氯-3-吡啶基)甲基]-2,3,5,6,7,8-六氫-9-硝基-(5S,8R)-5,8-環氧-H-咪唑並[1,2-a]氮呯 (1-[(6-chloro-3-pyridinyl)methyl]-2,3,5,6,7,8-hexahydro-9-nitro-(5S,8R)-5,8-epoxy-H-imidazo[1,2-a]azepine)、(III-D1009) (1-[(6-氯-3-吡啶基)甲基]-2-硝基-1-[(E)-亞戊基胺基]胍 (1-[(6-chloro-3-pyridyl)methyl]-2-nitro-1-[(E)-pentylideneamino]guanidine、(III-D1010) 1-[(6-氯-3-吡啶基)甲基]-7-甲基-8-硝基-5-丙氧基-3,5,6,7-四氫-2H-咪唑並[1,2-a]吡啶 (1-[(6-chloro-3-pyridyl)methyl]-7-methyl-8-nitro-5-propoxy-3,5,6,7-tetrahydro-2H-imidazo[1,2-a]pyridine);(III-D1) Neonicotinoid analogs, for example, (III-D1001) acetamiprid, (III-D1002) clothianidin, (III-D1003) dinotefuran, ( III-D1004) imidacloprid, (III-D1005) nitenpyram, (III-D1006) thiacloprid, (III-D1007) thiamethoxam, (III -D1008) 1-[(6-chloro-3-pyridyl)methyl]-2,3,5,6,7,8-hexahydro-9-nitro-(5S,8R)-5,8- Epoxy-H-imidazo[1,2-a]nitro-(1-[(6-chloro-3-pyridinyl)methyl]-2,3,5,6,7,8-hexahydro-9-nitro- (5S,8R)-5,8-epoxy-H-imidazo[1,2-a]azepine), (III-D1009) (1-[(6-chloro-3-pyridyl)methyl]-2- Nitro-1-[(E)-pentylideneamino]guanidine (1-[(6-chloro-3-pyridyl)methyl]-2-nitro-1-[(E)-pentylideneamino]guanidine, (III -D1010) 1-[(6-Chloro-3-pyridyl)methyl]-7-methyl-8-nitro-5-propoxy-3,5,6,7-tetrahydro-2H-imidazole And[1,2-a]pyridine (1-[(6-chloro-3-pyridyl)methyl]-7-methyl-8-nitro-5-propoxy-3,5,6,7-tetrahydro-2H-imidazo [1,2-a]pyridine);

(III-D2001) 菸鹼;(III-D2001) Nicotine;

(III-D3) 甲硫胺酸磺醯亞胺,例如,(III-D3001) 速殺氟 (sulfoxaflor);(III-D3) Methionine sulfonyl imide, for example, (III-D3001) sulfoxaflor;

(III-D4) 丁烯羥酸內酯,例如,(III-D4001) 氟吡呋喃酮 (flupyradifurone);(III-D4) Butenolides, for example, (III-D4001) flupyradifurone;

(III-D5) 中離子化合物,例如,(III-D5001) 氟美派 (triflumezopyrim)、(III-D5002) 二氯滅座替 (dichloromezotiaze);(III-D5) Neutral ionic compounds, for example, (III-D5001) triflumezopyrim, (III-D5002) dichloromezotiaze;

(III-D6) 伸二氫吡啶基化合物,例如,(III-D6001) 氟必靈 (flupyrimin);(III-D6) Dihydropyridyl compounds, for example, (III-D6001) flupyrimin;

(III-E) 菸鹼乙醯膽鹼 (nAChR)受體異位調節劑-位點I,選自以下各類:(III-E) Nicotinic acetylcholine (nAChR) receptor ectopic modulator-site I, selected from the following classes:

(III-E1) 賜諾殺類 (spinosyns),例如,(III-E1001) 賜諾特 (spinetoram)、(III-E1002) 賜諾殺 (spinosad);(III-E1) Spinosyns, for example, (III-E1001) spinetoram, (III-E1002) spinosad;

(III-F) 麩胺酸閘控氯通道 (GluCl)異位調節劑,選自以下各類:(III-F) Glutamine-gated chloride channel (GluCl) ectopic modulators selected from the group consisting of:

(III-F1) 阿維菌素類 (avermectin)/米爾倍黴素類 (milbemycin),例如,(III-F1001) 阿巴汀 (abamectin)、(III-F1002) 因滅汀苯甲酸酯 (emamectin benzoate)、(III-F1003) 雷匹美汀 (lepimectin)、(III-F1004) 密滅汀 (milbemectin);(III-F1) avermectins/milbemycins, e.g. (III-F1001) abamectin, (III-F1002) inphenetin benzoate ( emamectin benzoate), (III-F1003) rapimectin, (III-F1004) milbemectin;

(III-G) 青春激素模擬物,選自以下各類:(III-G) Mimetics of youth hormones, selected from the following classes:

(III-G1) 青少年激素類似物,例如,(III-G1001) 烯蟲乙酯 (hydroprene)、(III-G1002) 烯蟲炔酯 (kinoprene)、(III-G1003) 美賜平 (methoprene);(III-G1) Juvenile hormone analogues, e.g., (III-G1001) methoprene (hydroprene), (III-G1002) methoprene (kinoprene), (III-G1003) methoprene;

(III-G2001) 芬諾克 (fenoxycarb);(III-G2001) Fenoxycarb;

(III-G3001) 百利普芬 (pyriproxyfen);(III-G3001) pyriproxyfen;

(III-I) 弦音器官TRPV通道調節劑,選自以下各類:(III-I) string organ TRPV channel modulator, selected from the following categories:

(III-I1) 吡啶偶氮甲鹼衍生物 (pyridine azomethine derivatives),例如,(III-I1001) 派滅淨 (pymetrozine)、(III-I1002) 氟蟲吡喹 (pyrifluquinazon);(III-I1) pyridine azomethine derivatives, for example, (III-I1001) pymetrozine, (III-I1002) pyrifluquinazon;

(III-I2001) 啶喃環丙蟲酯 (afidopyropen);(III-I2001) Afidopyropen;

(III-K) 昆蟲中腸膜的微生物干擾劑,選自以下各類:(III-K) Microbial disruptors of insect midgut membranes selected from the group consisting of:

(III-K1) 蘇力菌及其產生的殺蟲蛋白,例如,(III-K1001) 蘇力菌 ( Bacillus thuringiensis)、(III-K1002) 蘇力菌以色列變種 ( Bacillus thuringiensisvar. israelensis)、(III-K1003) 蘇力菌亞莎華變種 ( Bacillus thuringiensisvar. aizawai)、(III-K1004) 蘇力菌庫斯塔克變種 ( Bacillus thuringiensisvar. kurstaki)、(III-K1005) 蘇力菌坦尼布列翁斯變種 ( Bacillus thuringiensisvar. tenebrionis)、(III-K1006) Cry1Ab,、(III-K1007) Cry1Ac、(III-K1008) Cry1Fa、(III-K1009) Cry1A.105、(III-K1010) Cry2Ab、(III-K1011) Vip3A、(III-K1012) mCry3A、(III-K1013) Cry3Ab、(III-K1014) Cry3Bb、(III-K1015) Cry34/35Ab1; (III-K1) Bacillus thuringiensis and its insecticidal protein, for example, (III-K1001) Bacillus thuringiensis , (III-K1002) Bacillus thuringiensis var. israelensis , ( III-K1003) Bacillus thuringiensis var. aizawai , (III-K1004) Bacillus thuringiensis var. kurstaki , (III-K1005) Bacillus thuringiensis var. kurstaki Bacillus thuringiensis var. tenebrionis , (III-K1006) Cry1Ab, (III-K1007) Cry1Ac, (III-K1008) Cry1Fa, (III-K1009) Cry1A.105, (III-K1010) Cry2Ab , (III-K1011) Vip3A, (III-K1012) mCry3A, (III-K1013) Cry3Ab, (III-K1014) Cry3Bb, (III-K1015) Cry34/35Ab1;

(III-K2001) 圓形芽孢桿菌;(III-K2001) Bacillus circulus;

(III-M) 藉由干擾質子梯度而作用之氧化磷酸化去耦合劑,選自以下各類:(III-M) Oxidative phosphorylation decouplers acting by interfering with the proton gradient, selected from the following classes:

(III-M1) 吡咯,例如,(III-M1001) 克凡派 (chlorfenapyr);(III-M1) pyrrole, for example, (III-M1001) chlorfenapyr;

(III-M2) 二硝基苯酚,例如,(III-M2001) 二硝基甲酚 (dinitro-ortho-cresol, DNOC);(III-M2) Dinitrophenols, for example, (III-M2001) dinitro-ortho-cresol (DNOC);

(III-M3001) 氟蟲胺 (sulfluramid);(III-M3001) Sulfluramid (sulfluramid);

(III-V) 電壓依賴性之鈉通道阻斷劑,選自以下各類:(III-V) Voltage-dependent sodium channel blockers selected from the following classes:

(III-V1) 噁二嗪,例如,(III-V1001) 因得克 (indoxacarb);(III-V1) oxadiazines, for example, (III-V1001) indoxacarb;

(III-V2) 縮胺脲,例如,(III-V2001) 美氟綜 (metaflumizone);(III-V2) semicarbazones, for example, (III-V2001) metaflumizone;

(III-V3001) 1-[(E)-[2-(4-腈基苯基)-1-[3-(三氟甲基)苯基]亞乙基]胺基]-3-[4-(二氟甲氧基)苯基]脲 (1-[(E)-[2-(4-cyanophenyl)-1-[3-(trifluoromethyl)phenyl]ethylidene]amino]-3-[4-(difluoromethoxy)phenyl]urea);(III-V3001) 1-[(E)-[2-(4-cyanophenyl)-1-[3-(trifluoromethyl)phenyl]ethylene]amino]-3-[4 -(Difluoromethoxy)phenyl]urea (1-[(E)-[2-(4-cyanophenyl)-1-[3-(trifluoromethyl)phenyl]ethylene]amino]-3-[4-( difluoromethoxy)phenyl]urea);

(III-V4001) 2-[3-(乙磺醯基)吡啶-2-基]-5-[三氟(甲磺醯基)]-1,3-苯並噁唑 (2-[3-(ethanesulfonyl)pyridin-2-yl]-5-[trifluoro(methanesulfonyl)]-1,3-benzoxazole (oxazosulfyl))(歐賽菲,oxazosulfyl);(III-V4001) 2-[3-(Ethylsulfonyl)pyridin-2-yl]-5-[trifluoro(methylsulfonyl)]-1,3-benzoxazole (2-[3- (ethanesulfonyl)pyridin-2-yl]-5-[trifluoro(methanesulfonyl)]-1,3-benzoxazole (oxazosulfyl)) (Ocean, oxazosulfyl);

(III-Z) 雷若丁受體調節劑,選自以下各類:(III-Z) Ranerodine receptor modulators selected from the group consisting of:

(III-Z1) 二醯胺類,例如,(III-Z1001) 氟大滅 (flubendiamide)、(III-Z1002) 剋安勃 (chlorantraniliprole) (Rynaxypyr®)、(III-Z1003) 賽安勃 (cyantraniliprole) (Rynaxypyr®)、(III-Z1004) 環溴蟲醯胺 (cyclaniliprole)、(III-Z1005) 特安勃 (tetraniliprole)、(III-Z1006) 四氯蟲醯胺 (tetra-chlorantraniliprole)、(III-Z1007) (R)-3-氯-N1-{2-甲基-4-[1,2,2,2-四氟-1-(三氟甲基)乙基]苯基}-N2-(1-甲基-2-甲基磺醯基乙基)鄰苯二甲醯胺 ((R)-3-Chlor-N1-{2-methyl-4-[1,2,2,2-tetrafluor-1-(trifluormethyl)ethyl]phenyl}-N2-(1-methyl-2-methylsulfonylethyl)phthalamid)、(III-Z1008) (S)-3-氯-N1-{2-甲基-4-[1,2,2,2-四氟-1-(三氟甲基)乙基]苯基}-N2-(1-甲基-2-甲基磺醯基乙基)鄰苯二甲醯胺 ((S)-3-Chlor-N1-{2-methyl-4-[1,2,2,2-tetrafluor-1-(trifluormethyl)ethyl]phenyl}-N2-(1-methyl-2-methylsulfonylethyl)phthalamid)、(III-Z1009) 甲基-2-[3,5-二溴-2-({[3-溴-1-(3-氯吡啶-2-基)-1H-吡唑-5-基]羰基}胺基)苯甲醯基]-1,2-二甲基肼羧酸 (methyl-2-[3,5-dibromo-2-({[3-bromo-1-(3-chlorpyridin-2-yl)-1H-pyrazol-5-yl]carbonyl}amino)benzoyl]-1,2-dimethylhydrazinecarboxylate)、(III-Z1010) N-[2-(5-胺基-1,3,4-噻二唑-2-基)-4-氯-6-甲基-苯基]-5-溴-2-(3-氯-2-吡啶基)吡唑-3-羧醯胺 (N-[2-(5-amino-1,3,4-thiadiazol-2-yl)-4-chloro-6-methyl-phenyl]-5-bromo-2-(3-chloro-2-pyridyl)pyrazole-3-carboxamide)、(III-Z1011) 5-氯-2-(3-氯-2-吡啶基)-N-[2,4-二氯-6-[(1-腈基-1-甲基-乙基)胺基甲醯基]苯基]吡唑-3-羧醯胺 (5-chloro-2-(3-chloro-2-pyridyl)-N-[2,4-dichloro-6-[(1-cyano-1-methyl-ethyl)carbamoyl]phenyl]pyrazole-3-carboxamide)、(III-Z1012) 5-溴-N-[2,4-二氯-6-(甲基胺基甲醯基)苯基]-2-(3,5-二氯-2-吡啶基)吡唑-3-羧醯胺 5-bromo-N-[2,4-dichloro-6-(methylcarbamoyl)phenyl]-2-(3,5-dichloro-2-pyridyl)pyrazole-3-carboxamide、(III-Z1013) N-[2-(叔丁基胺基甲醯基)-4-氯-6-甲基-苯基]-2-(3-氯-2-吡啶基)-5-(氟甲氧基)吡唑-3-羧醯胺 (N-[2-(tert-butylcarbamoyl)-4-chloro-6-methyl-phenyl]-2-(3-chloro-2-pyridyl)-5-(fluoromethoxy)pyrazole-3-carboxamide)、(III-Z1014) N2-(1-腈基-1-甲基-乙基)-N1-(2,4-二甲基苯基)-3-碘-鄰苯二甲醯胺 (N2-(1-cyano-1-methyl-ethyl)-N1-(2,4-dimethylphenyl)-3-iodo-phthalamide)、3-氯-N2-(1-腈基-1-甲基-乙基)-N1-(2,4-二甲基苯基)鄰苯二甲醯胺 (3-chloro-N2-(1-cyano-1-methyl-ethyl)-N1-(2,4-dimethylphenyl)phthalamide);(III-Z1) Diamides, for example, (III-Z1001) flubendiamide, (III-Z1002) chlorantraniliprole (Rynaxypyr®), (III-Z1003) cyantraniliprole ) (Rynaxypyr®), (III-Z1004) cyclaniliprole, (III-Z1005) tetraniliprole, (III-Z1006) tetra-chlorantraniliprole, (III -Z1007) (R)-3-chloro-N1-{2-methyl-4-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]phenyl}-N2- (1-Methyl-2-methylsulfonylethyl)phthalamide ((R)-3-Chlor-N1-{2-methyl-4-[1,2,2,2-tetrafluor -1-(trifluormethyl)ethyl]phenyl}-N2-(1-methyl-2-methylsulfonylethyl)phthalamid), (III-Z1008) (S)-3-chloro-N1-{2-methyl-4-[1 ,2,2,2-Tetrafluoro-1-(trifluoromethyl)ethyl]phenyl}-N2-(1-methyl-2-methylsulfonylethyl)phthalamide ( (S)-3-Chlor-N1-{2-methyl-4-[1,2,2,2-tetrafluor-1-(trifluormethyl)ethyl]phenyl}-N2-(1-methyl-2-methylsulfonylethyl)phthalamid ), (III-Z1009) methyl-2-[3,5-dibromo-2-({[3-bromo-1-(3-chloropyridin-2-yl)-1H-pyrazol-5-yl ]carbonyl}amino)benzoyl]-1,2-dimethylhydrazinecarboxylic acid (methyl-2-[3,5-dibromo-2-({[3-bromo-1-(3-chlorpyridin- 2-yl)-1H-pyrazol-5-yl]carbonyl}amino)benzoyl]-1,2-dimethylhydrazinecarboxylate), (III-Z1010) N-[2-(5-amino-1,3,4-thiol Oxadiazol-2-yl)-4-chloro-6-methyl-phenyl]-5-bromo-2-(3-chloro-2-pyridyl)pyrazole-3-carboxamide (N-[2 -(5-amino-1,3,4-thi adiazol-2-yl)-4-chloro-6-methyl-phenyl]-5-bromo-2-(3-chloro-2-pyridyl)pyrazole-3-carboxamide), (III-Z1011) 5-chloro-2 -(3-Chloro-2-pyridyl)-N-[2,4-dichloro-6-[(1-cyano-1-methyl-ethyl)aminoformyl]phenyl]pyrazole -3-Carboxamide (5-chloro-2-(3-chloro-2-pyridyl)-N-[2,4-dichloro-6-[(1-cyano-1-methyl-ethyl)carbamoyl]phenyl] pyrazole-3-carboxamide), (III-Z1012) 5-bromo-N-[2,4-dichloro-6-(methylaminoformyl)phenyl]-2-(3,5-dichloro -2-pyridyl)pyrazole-3-carboxamide 5-bromo-N-[2,4-dichloro-6-(methylcarbamoyl)phenyl]-2-(3,5-dichloro-2-pyridyl)pyrazole- 3-carboxamide, (III-Z1013) N-[2-(tert-butylaminoformyl)-4-chloro-6-methyl-phenyl]-2-(3-chloro-2-pyridyl) -5-(fluoromethoxy)pyrazole-3-carboxamide (N-[2-(tert-butylcarbamoyl)-4-chloro-6-methyl-phenyl]-2-(3-chloro-2-pyridyl )-5-(fluoromethoxy)pyrazole-3-carboxamide), (III-Z1014) N2-(1-cyano-1-methyl-ethyl)-N1-(2,4-dimethylphenyl)- 3-iodo-phthalamide (N2-(1-cyano-1-methyl-ethyl)-N1-(2,4-dimethylphenyl)-3-iodo-phthalamide), 3-chloro-N2-(1 -Nitryl-1-methyl-ethyl)-N1-(2,4-dimethylphenyl)phthalamide (3-chloro-N2-(1-cyano-1-methyl-ethyl) -N1-(2,4-dimethylphenyl)phthalamide);

(III-BB) γ-胺基丁酸 (GABA)閘控氯離子通道阻斷劑,選自以下各類:(III-BB) Blockers of gamma-aminobutyric acid (GABA)-gated chloride channels selected from the group consisting of:

(III-BB1) 間二醯胺 (meta-diamides),例如,溴蟲氟苯雙醯胺 (broflanilide);(III-BB1) Meta-diamides such as broflanilide;

(III-BB2) 異噁唑啉,例如,(III-BB2001) 氣釀醯胺 (fluxametamide)、(III-BB2002) 抑克斯能 (isocycloseram);以及(III-BB2) isoxazolines such as (III-BB2001) fluxametamide, (III-BB2002) isocycloseram; and

(III-EE) 作用方式未知或不確定之殺蟲活性化合物,例如,(III-EE1001) 艾特本 (afidopyropen)、(III-EE1002) 印楝素 (azadirachtin)、(III-EE1003) 磺胺蟎酯 (amidoflumet)、(III-EE1004) 苯賽滅 (benzoximate)、(III-EE1005) 苯吡莫賽 (benzpyrimoxan)、(III-EE1006) 必芬賽 (bifenazate)、(III-EE1007) 新殺蟎 (bromopropylate)、(III-EE1008) 滅蟎猛 (chinomethionat)、(III-EE1009) 克利得 (cryolite)、(III-EE1010) 大克蟎 (dicofol)、(III-EE1011) 伏吩靈 (flufenerim)、(III-EE1012) 氟喹啉 (flometoquin)、(III-EE1013) 氟赫吩 (fluhexafon)、(III-EE1014) 氟速吩 (fluensulfone)、(III-EE1015) 伏達隆 (flupyradifurone)、(III-EE1016) 石灰硫黃合劑 (lime sulphur)、(III-EE1017) 鋅錳乃浦 (mancozeb)、(III-EE1018) 協力精 (piperonyl butoxide)、(III-EE1019) 吡啶蟲丙醚 (pyridalyl)、(III-EE1020) 必伏松 (pyrifluquinazon)、(III-EE1021) 碸蟲啶 (sulfoxaflor)、(III-EE1022) 硫、(III-EE1023) 4-[5-(3,5-二氯-苯基)-5-三氟甲基-4,5-二氫-異噁唑-3-基]-2-甲基-N-[(2,2,2-三氟-乙基胺基甲醯基) -甲基]-苯醯胺 (4-[5-(3,5-Dichloro-phenyl)-5-trifluoromethyl-4,5-dihydro-isoxazol-3-yl]-2-methyl-N-[(2,2,2-trifluoro-ethylcarbamoyl)-methyl]-benzamide)、(III-EE1024) 環丙基乙酸 (cyclopropaneacetic acid)、(III-EE1025) 1,1’-[(3S,4R,4aR,6S,6aS,12R,12aS,12bS)-4-[[(2-環丙基乙醯基)氧基]甲基]-1,3,4,4a,5,6,6a,12,12a,12b-十氫-12-羥基-4,6a,12b-三甲基-11-氧代-9-(3-吡啶基)-2H,11H-萘並[2,1-b]吡喃[3,4-e]吡喃-3,6-二基]酯 (1,1’-[(3S,4R,4aR,6S,6aS,12R,12aS,12bS)-4-[[(2-cyclopropylacetyl)oxy]methyl]-1,3,4,4a,5,6,6a,12,12a,12b-decahydro-12-hydroxy-4,6a,12b-trimethyl-11-oxo-9-(3-pyridinyl)-2H,11H-naphtho[2,1-b]pyrano[3,4-e]pyran-3,6-diyl]ester、(III-EE1026) 11-(4-氯-2,6-二甲基苯基)-12-羥基-1,4-二氧-9-氮雜二螺[4.2.4.2]-十四碳-11-烯-10-酮 (11-(4-chloro-2,6-dimethylphenyl)-12-hydroxy-1,4-dioxa-9-azadispiro[4.2.4.2]-tetradec-11-en-10-one)、(III-EE1027) 4,3-(4’-氟-2,4-二甲基聯苯-3-基)-4-羥基-8-氧杂-1-氮雜螺[4.5]-十烷-3-烯-2-酮 (4,3-(4’-fluoro-2,4-dimethylbiphenyl-3-yl)-4-hydroxy-8-oxa-1-azaspiro[4.5]dec-3-en-2-one、(III-EE1028) 1-[2-氟-4-甲基-5-[(2,2,2-三氟乙基)亞磺醯基]苯基]-3-(三氟甲基)-1H-1,2,4-三唑-5-胺 (1-[2-fluoro-4-methyl-5-[(2,2,2-trifluoroethyl)sulfinyl]phenyl]-3-(trifluoromethyl)-1H-1,2,4-triazole-5-amine)、(III-EE1029) 基於強固芽胞桿菌之活性劑 (actives on basis of bacillus firmus(Votivo, II-1582))、(III-EE1030) (E/Z)-N-[1-[(6-氯-3-吡啶基)甲基]-2-吡啶基]-2,2,2-三氟-乙醯胺 ((E/Z)-N-[1-[(6-chloro-3-pyridyl)methyl]-2-pyridylidene]-2,2,2-trifluoro-acetamide)、(III-EE1031) (E/Z)-N-[1-[(6-氯-5-氟-3-吡啶基)甲基]-2-吡啶亞基]-2,2,2-三氟-乙醯胺 ((E/Z)-N-[1-[(6-chloro-5-fluoro-3-pyridyl)methyl]-2-pyridylidene]-2,2,2-trifluoro-acetamide)、(III-EE1032) (E/Z)-2,2,2-三氟-N-[1-[(6-氟-3-吡啶基)甲基]-2-吡啶基]乙醯胺 ((E/Z)-2,2,2-trifluoro-N-[1-[(6-fluoro-3-pyridyl)methyl]-2-pyridylidene]acetamide)、(III-EE1033) (E/Z)-N-[1-[(6-氟-3-吡啶基)甲基]-2-吡啶基]-2,2,2-三氟-乙醯胺 ((E/Z)-N-[1-[(6-bromo-3-pyridyl)methyl]-2-pyridylidene]-2,2,2-trifluoro-acetamide)、(III-EE1034) (E/Z)-N-[1-[1-[(6-氯-3-吡啶基)乙基]-2-吡啶基]-2,2,2-三氟-乙醯胺 ((E/Z)-N-[1-[1-(6-chloro-3-pyridyl)ethyl]-2-pyridylidene]-2,2,2-trifluoro-acetamide)、(III-EE1035) (E/Z)-N-[1-[(6-氯-3-吡啶基)甲基]-2-吡啶基]-2,2-二氟-乙醯胺 ((E/Z)-N-[1-[(6-chloro-3-pyridyl)methyl]-2-pyridylidene]-2,2-difluoro-acetamide)、(III-EE1036) (E/Z)-2-氯-N-[1-[(6-氯-3-吡啶基)甲基]-2-吡啶基]-2,2-二氟-乙醯胺 ((E/Z)-2-chloro-N-[1-[(6-chloro-3-pyridyl)methyl]-2-pyridylidene]-2,2-difluoro-acetamide)、(III-EE1037) (E/Z)-N-[1-[(2-氯嘧啶-5-基)甲基]-2-亞吡啶]-2,2,2-三氟乙醯胺 ((E/Z)-N-[1-[(2-chloropyrimidin-5-yl)methyl]-2-pyridylidene]-2,2,2-trifluoro-acetamide)、(III-EE1038) (E/Z)-N-[1-[(6-氯-3-吡啶基)甲基]-2-吡啶基]-2,2,3,3,3-五氟丙醯胺 ((E/Z)-N-[1-[(6-chloro-3-pyridyl)methyl]-2-pyridylidene]-2,2,3,3,3-pentafluoro-propanamide)、(III-EE1039) 氟美派 (triflumezopyrim)、(III-EE1040) 4-[5-[3-氯-5-(三氟甲基)苯基]-5-(三氟甲基)-4H-異噁唑-3-基]-N-[2-氧代-2-(2,2,2-三氟乙胺基 )乙基]萘-1-羧醯胺 (4-[5-[3-chloro-5-(trifluoromethyl)phenyl]-5-(trifluoromethyl)-4H-isoxazol-3-yl]-N-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]naphthalene-1-carboxamide)、(III-EE1041) 3-[3-氯-5-(三氟甲基)苯基]-4-氧代-1-(嘧啶-5-基甲基)吡啶並[1,2-a]嘧啶鎓-2-油酸鹽 (3-[3-chloro-5-(trifluoromethyl)phenyl]-4-oxo-1-(pyrimidin-5-ylmethyl)pyrido[1,2-a]pyrimidin-1-ium-2-olate)、(III-EE1042) 8-氯-N-[2-氯-5-甲氧基苯基)磺醯基]-6-三氟甲基)-咪唑並[1,2-a]吡啶-2-羧醯胺 (8-chloro-N-[2-chloro-5-methoxyphenyl)sulfonyl]-6-trifluoromethyl)-imidazo[1,2-a]pyridine-2-carboxamide)、(III-EE1043) 4-[5-(3,5-二氯苯基)-5-(三氟甲基)-4H-異噁唑-3-基]-2-甲基-N-(1-側氧基硫雜環丁烷-3-基)苯醯胺 (4-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4H-isoxazol-3-yl]-2-methyl-N-(1-oxothietan-3-yl)benzamide)、(III-EE1044) 5-[3-[2,6-二氯-4-(3,3-二氯烯丙氧基)苯氧基]丙氧基]-1H-吡唑 (5-[3-[2,6-dichloro-4-(3,3-dichloroallyloxyl)phenoxy]propoxy]-1H-pyrazole)、(III-EE1045) 益達胺 (dimpropyridaz)、(III-EE1046) 吡啶菌醯胺 (tyclopyrazoflor)、(III-EE1047) 尼可氟酮 (nicofluprole)、(III-EE1048) 阿西諾吡 (acynonapyr); (III-EE) Insecticidally active compounds with unknown or uncertain mode of action, e.g. (III-EE1001) afidopyropen, (III-EE1002) azadirachtin, (III-EE1003) sulfamites Amidoflumet, (III-EE1004) benzoximate, (III-EE1005) benzpyrimoxan, (III-EE1006) bifenazate, (III-EE1007) new acaricide (bromopropylate), (III-EE1008) chinomethionat, (III-EE1009) cryolite, (III-EE1010) dicofol, (III-EE1011) flufenerim , (III-EE1012) Flumetoquin, (III-EE1013) Fluhexafon, (III-EE1014) Fluensulfone, (III-EE1015) Flupyradifurone, ( III-EE1016) lime sulfur (lime sulfur), (III-EE1017) zinc manganese Naipu (mancozeb), (III-EE1018) piperonyl butoxide, (III-EE1019) pyridalyl , (III-EE1020) pyrifluquinazon, (III-EE1021) sulfoxaflor, (III-EE1022) sulfur, (III-EE1023) 4-[5-(3,5-dichloro- Phenyl)-5-trifluoromethyl-4,5-dihydro-isoxazol-3-yl]-2-methyl-N-[(2,2,2-trifluoro-ethylaminomethyl Acyl)-methyl]-benzamide (4-[5-(3,5-Dichloro-phenyl)-5-trifluoromethyl-4,5-dihydro-isoxazol-3-yl]-2-methyl-N- [(2,2,2-trifluoro-ethylcarbamoyl)-methyl]-benzamide), (III-EE1024) cyclopropaneacetic acid, (III-EE1025) 1,1'-[(3S,4R,4aR ,6S,6a S,12R,12aS,12bS)-4-[[(2-Cyclopropylacetyl)oxy]methyl]-1,3,4,4a,5,6,6a,12,12a,12b- Decahydro-12-hydroxy-4,6a,12b-trimethyl-11-oxo-9-(3-pyridyl)-2H,11H-naphtho[2,1-b]pyran[3,4 -e]pyran-3,6-diyl]ester (1,1'-[(3S,4R,4aR,6S,6aS,12R,12aS,12bS)-4-[[(2-cyclopropylacetyl)oxy] methyl]-1,3,4,4a,5,6,6a,12,12a,12b-decahydro-12-hydroxy-4,6a,12b-trimethyl-11-oxo-9-(3-pyridinyl)-2H ,11H-naphtho[2,1-b]pyrano[3,4-e]pyran-3,6-diyl]ester, (III-EE1026) 11-(4-chloro-2,6-dimethylphenyl )-12-Hydroxy-1,4-dioxo-9-azadispiro[4.2.4.2]-tetradec-11-en-10-one (11-(4-chloro-2,6-dimethylphenyl) -12-hydroxy-1,4-dioxa-9-azadispiro[4.2.4.2]-tetradec-11-en-10-one), (III-EE1027) 4,3-(4'-fluoro-2,4- Dimethylbiphenyl-3-yl)-4-hydroxy-8-oxa-1-azaspiro[4.5]-decane-3-en-2-one (4,3-(4'-fluoro- 2,4-dimethylbiphenyl-3-yl)-4-hydroxy-8-oxa-1-azaspiro[4.5]dec-3-en-2-one, (III-EE1028) 1-[2-fluoro-4-methyl Base-5-[(2,2,2-trifluoroethyl)sulfinyl]phenyl]-3-(trifluoromethyl)-1H-1,2,4-triazole-5-amine ( 1-[2-fluoro-4-methyl-5-[(2,2,2-trifluoroethyl)sulfinyl]phenyl]-3-(trifluoromethyl)-1H-1,2,4-triazole-5-amine), ( III-EE1029) Actives on basis of bacillus firmus (Votivo, II-1582), (III-EE1030) (E/Z)-N-[1-[(6-chloro-3 -pyridyl)methyl]-2- Pyridyl]-2,2,2-trifluoro-acetamide ((E/Z)-N-[1-[(6-chloro-3-pyridyl)methyl]-2-pyridylidene]-2,2, 2-trifluoro-acetamide), (III-EE1031) (E/Z)-N-[1-[(6-chloro-5-fluoro-3-pyridyl)methyl]-2-pyridylidene]-2 ,2,2-Trifluoro-acetamide ((E/Z)-N-[1-[(6-chloro-5-fluoro-3-pyridyl)methyl]-2-pyridylidene]-2,2,2 -trifluoro-acetamide), (III-EE1032) (E/Z)-2,2,2-trifluoro-N-[1-[(6-fluoro-3-pyridyl)methyl]-2-pyridyl ]acetamide ((E/Z)-2,2,2-trifluoro-N-[1-[(6-fluoro-3-pyridyl)methyl]-2-pyridylidene]acetamide), (III-EE1033) ( E/Z)-N-[1-[(6-fluoro-3-pyridyl)methyl]-2-pyridyl]-2,2,2-trifluoro-acetamide ((E/Z)- N-[1-[(6-bromo-3-pyridyl)methyl]-2-pyridylidene]-2,2,2-trifluoro-acetamide), (III-EE1034) (E/Z)-N-[1- [1-[(6-Chloro-3-pyridyl)ethyl]-2-pyridyl]-2,2,2-trifluoro-acetamide ((E/Z)-N-[1-[1 -(6-chloro-3-pyridyl)ethyl]-2-pyridylidene]-2,2,2-trifluoro-acetamide), (III-EE1035) (E/Z)-N-[1-[(6-chloro -3-pyridyl)methyl]-2-pyridyl]-2,2-difluoro-acetamide ((E/Z)-N-[1-[(6-chloro-3-pyridyl)methyl] -2-pyridylidene]-2,2-difluoro-acetamide), (III-EE1036) (E/Z)-2-chloro-N-[1-[(6-chloro-3-pyridyl)methyl]- 2-pyridyl]-2,2-difluoro-acetamide ((E/Z)-2-chloro-N-[1-[(6-chloro-3-pyridyl)methyl]-2-pyridylidene]- 2,2-difluoro-acetamide), (III-EE1037) (E/Z)-N-[1 -[(2-Chloropyrimidin-5-yl)methyl]-2-pyridine]-2,2,2-trifluoroacetamide ((E/Z)-N-[1-[(2-chloropyrimidin -5-yl)methyl]-2-pyridylidene]-2,2,2-trifluoro-acetamide), (III-EE1038) (E/Z)-N-[1-[(6-chloro-3-pyridyl )methyl]-2-pyridyl]-2,2,3,3,3-pentafluoropropionamide ((E/Z)-N-[1-[(6-chloro-3-pyridyl)methyl] -2-pyridylidene]-2,2,3,3,3-pentafluoro-propanamide), (III-EE1039) triflumezopyrim, (III-EE1040) 4-[5-[3-chloro-5- (Trifluoromethyl)phenyl]-5-(trifluoromethyl)-4H-isoxazol-3-yl]-N-[2-oxo-2-(2,2,2-trifluoroethyl Amino)ethyl]naphthalene-1-carboxamide (4-[5-[3-chloro-5-(trifluoromethyl)phenyl]-5-(trifluoromethyl)-4H-isoxazol-3-yl]-N-[ 2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]naphthalene-1-carboxamide), (III-EE1041) 3-[3-chloro-5-(trifluoromethyl)phenyl]-4- Oxo-1-(pyrimidin-5-ylmethyl)pyrido[1,2-a]pyrimidinium-2-oleate (3-[3-chloro-5-(trifluoromethyl)phenyl]-4-oxo -1-(pyrimidin-5-ylmethyl)pyrido[1,2-a]pyrimidin-1-ium-2-olate), (III-EE1042) 8-chloro-N-[2-chloro-5-methoxy Phenyl)sulfonyl]-6-trifluoromethyl)-imidazo[1,2-a]pyridine-2-carboxamide (8-chloro-N-[2-chloro-5-methoxyphenyl)sulfonyl] -6-trifluoromethyl)-imidazo[1,2-a]pyridine-2-carboxamide), (III-EE1043) 4-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl) -4H-isoxazol-3-yl]-2-methyl-N-(1-oxothietane-3-yl)benzamide (4-[5-(3,5-dichlorophenyl )-5 -(trifluoromethyl)-4H-isoxazol-3-yl]-2-methyl-N-(1-oxothietan-3-yl)benzamide), (III-EE1044) 5-[3-[2,6-dichloro- 4-(3,3-dichloroallyloxy)phenoxy]propoxy]-1H-pyrazole(5-[3-[2,6-dichloro-4-(3,3-dichloroallyloxyl)phenoxy ]propoxy]-1H-pyrazole), (III-EE1045) dimpropyridaz, (III-EE1046) tyclopyrazoflor, (III-EE1047) nicofluprole, (III- EE1048) Acenopi (acynonapyr);

在一較佳實施例中,本案的農業化學組成物包含至少一種選自以下組的殺蟲或殺線蟲活性化合物 (III)作為一組分 (2):In a preferred embodiment, the agricultural chemical composition of the present case comprises at least one insecticidal or nematicidal active compound (III) selected from the following group as a component (2):

(III-B) γ-胺基丁酸 (GABA)閘控氯離子通道阻斷劑,選自以下各類:(III-B) Gamma-aminobutyric acid (GABA)-gated chloride channel blockers selected from the group consisting of:

(III-B2) 苯基吡唑(非潑羅,fiproles),例如,(III-B2002) 費普尼 (fipronil);(III-B2) Phenylpyrazoles (fiproles), e.g. (III-B2002) fipronil;

(III-D) 菸鹼乙醯膽鹼受體 (nAChR)競爭性調節劑,選自以下各類:(III-D) Nicotinic acetylcholine receptor (nAChR) competitive modulators selected from the following classes:

(III-D1) 新菸鹼類似物,例如,(III-D1002) 可尼丁(clothianidin)、(III-D1004) 益達胺 (imidacloprid)、(III-D1007) 噻蟲嗪 (thiamethoxam);(III-D1) Neonicotinoid analogs, for example, (III-D1002) clothianidin, (III-D1004) imidacloprid, (III-D1007) thiamethoxam;

(III-Z) 雷若丁受體調節劑,選自以下各類:(III-Z) Ranerodine receptor modulators selected from the group consisting of:

(III-Z1) 二醯胺類,例如,(III-Z1002) 剋安勃 (chlorantraniliprole)、(III-Z1003) 賽安勃 (cyantraniliprole)、(III-Z1005) 特安勃 (tetraniliprole);(III-Z1) Diamides, for example, (III-Z1002) chlorantraniliprole, (III-Z1003) cyantraniliprole, (III-Z1005) tetraniliprole;

在一較佳實施例中,本案的農業化學組成物包含至少一種選自以下組的殺真菌活性化合物 (II)及/或至少一種殺蟲或殺線蟲活性化合物 (III)作為一組分 (2):In a preferred embodiment, the agricultural chemical composition of the present case comprises at least one fungicidal active compound (II) and/or at least one insecticidal or nematicidal active compound (III) selected from the following group as a component (2 ):

(II-A) 甾醇生物合成的抑制劑,例如,(II-A002) 待克利 (difenoconazole)、(II-A021) 得克利 (tebuconazole)、(II-A081) 滅芬座 (mefentrifluconazole);(II-A) Inhibitors of sterol biosynthesis, for example, (II-A002) difenoconazole, (II-A021) tebuconazole, (II-A081) mefentrifluconazole;

(II-B) 呼吸鏈複合物I (complex I)或複合物II (complex II)的抑制劑,例如,(II-B001) 苯索伏比 (benzovindiflupyr)、(II-B003) 白克列 (boscalid)、(II- B005) 氟派瑞 (fluopyram)、(II-B007) 氟克殺 (fluxapyroxad);(II-B) Inhibitors of respiratory chain complex I (complex I) or complex II (complex II), for example, (II-B001) benzovindiflupyr, (II-B003) buclide ( boscalid), (II-B005) fluopyram, (II-B007) fluoxapyroxad;

(II-C) 呼吸鏈複合物III (complex III)的抑制劑,例如,(II-C001) 滅脫定 (ametoctradin)、(II-C002) 安美速 (amisulbrom)、(II-C003) 亞托敏 (azoxystrobin)、(II-C006) 賽發滅 (cyazofamid)、(II-C009) 凡殺同 (famoxadone)、(II-C010) 芬滅酮 (fenamidone)、(II-C016) 啶氧菌酯 (picoxystrobin)、(II-C017) 唑菌胺酯 (pyraclostrobin)、(II-C020) 三氟敏 (trifloxystrobin)、(II-C030) 甲基四吡咯 (Metyltetraprole);(II-C) Inhibitors of respiratory chain complex III, for example, (II-C001) ametoctradin, (II-C002) amisulbrom, (II-C003) yator Azoxystrobin, (II-C006) cyazofamid, (II-C009) famoxadone, (II-C010) fenamidone, (II-C016) picoxystrobin (picoxystrobin), (II-C017) pyraclostrobin (pyraclostrobin), (II-C020) trifluorinated (trifloxystrobin), (II-C030) methyl tetrapyrrole (Metyltetraprole);

(II-D) 有絲分裂和細胞分裂的抑制劑,例如,(II-D003) 噻唑菌胺 (ethaboxam)、(II-D004) 氟比來 (fluopicolide)、(II-D008) 座賽胺 (zoxamide);(II-D) Inhibitors of mitosis and cell division, for example, (II-D003) ethaboxam, (II-D004) fluopicolide, (II-D008) zoxamide ;

(II-E) 可具有多位點作用的化合物,例如,(II-E004) 四氯異苯腈 (chlorothalonil)、(II-E005) 氫氧化銅、(II-E008) 氧氯化銅 (copper oxychloride)、(II-E009) 硫酸銅 (copper sulfate)、(II-E010) 腈硫醌 (dithianon)、(II-E012) 福爾培 (folpet)、(II-E013) 鋅錳乃浦 (mancozeb)、(II-E015) 免得爛 (metiram)、(II-E018) 甲基鋅乃浦 (propineb);(II-E) Compounds that may have multisite effects, for example, (II-E004) chlorothalonil, (II-E005) copper hydroxide, (II-E008) copper oxychloride (copper oxychloride), (II-E009) copper sulfate (copper sulfate), (II-E010) dithianon (dithianon), (II-E012) folpet (II-E013) zinc manganese Naipu (mancozeb) ), (II-E015) lest rot (metiram), (II-E018) methyl zinc Naipu (propineb);

(II-I) 細胞壁合成之抑制劑,例如,(II-I001) 苯噻菌胺 (benthiavalicarb)、(II-I002) 達滅芬 (dimethomorph)、(II-I004) 丙森鋅 (iprovalicarb)、(II-I005) 曼普胺 (mandipropamid)、(II-I007) 纈菌胺 (valifenalate);(II-I) Inhibitors of cell wall synthesis, for example, (II-I001) benthiavalicarb, (II-I002) dimethomorph, (II-I004) iprovalicarb, (II-I005) mandipropamid, (II-I007) valifenalate;

(II-J) 脂質和膜合成之抑制劑,例如,(II-J001) 普拔克 (propamocarb);(II-J) Inhibitors of lipid and membrane synthesis, for example, (II-J001) propamocarb;

(II-L) 核酸合成之抑制劑,例如,(II-L004) 甲芬沙姆 (mefenoxam);(II-L) Inhibitors of nucleic acid synthesis, for example, (II-L004) mefenoxam;

(II-N) 可作為去耦合劑之化合物,例如,(II-N001) 扶吉胺 (fluazinam);(II-N) Compounds that can be used as decoupling agents, for example, (II-N001) fluazinam;

(II-O) 其他殺真菌劑,例如,(II-O009) 克絕 (cymoxanil)、(II-O012) 福賽得鋁 (fosetyl­aluminium);(III-B) γ-胺基丁酸 (GABA) 閘控氯離子通道阻斷劑,選自以下各類:(II-O) Other fungicides, for example, (II-O009) Cymoxanil, (II-O012) Fosetylaluminium; (III-B) Gamma-aminobutyric acid (GABA) Gated chloride channel blockers selected from the group consisting of:

(III-B2) 苯基吡唑(非潑羅,fiproles),例如,(III-B2002) 費普尼 (fipronil);(III-B2) Phenylpyrazoles (fiproles), e.g. (III-B2002) fipronil;

(III-D) 菸鹼乙醯膽鹼受體 (nAChR)競爭性調節劑,選自以下各類:(III-D) Nicotinic acetylcholine receptor (nAChR) competitive modulators selected from the following classes:

(III-D1) 新菸鹼類似物,例如,(III-D1002) 可尼丁(clothianidin)、(III-D1004) 益達胺 (imidacloprid)、(III-D1007) 噻蟲嗪 (thiamethoxam);(III-D1) Neonicotinoid analogs, for example, (III-D1002) clothianidin, (III-D1004) imidacloprid, (III-D1007) thiamethoxam;

(III-Z) 雷若丁受體調節劑,選自以下各類:(III-Z) Ranerodine receptor modulators selected from the group consisting of:

(III-Z1) 二醯胺類,例如,(III-Z1002) 剋安勃 (chlorantraniliprole)、(III-Z1003) 賽安勃 (cyantraniliprole)、(III-Z1005) 特安勃 (tetraniliprole)。(III-Z1) Diamides, for example, (III-Z1002) chlorantraniliprole, (III-Z1003) cyantraniliprole, (III-Z1005) tetraniliprole.

所有提及之各類的(II-A)至(II-R)及/或(III-A)至(III-GG)的混合用成分,如果它們其中的官能基團性質允許,可選擇性地與合適的鹼或酸形成鹽類。Mixing ingredients of (II-A) to (II-R) and/or (III-A) to (III-GG) of all mentioned classes, optionally if the nature of the functional groups in them allows form salts with suitable bases or acids.

在組分 (1)或組分 (2)能以互變異構形式存在的情況下,應理解到此些化合物在上文和下文中在允許的情況下還包括相應的互變異構形式,即使此些互變異構物並未在每一情況下被具體提及。Where component (1) or component (2) can exist in tautomeric forms, it should be understood that these compounds above and below also include the corresponding tautomeric forms where permitted, even if These tautomers are not specifically mentioned in each case.

此處以其通用名稱記載的活性成分為已知且已公開於其他文件或資料,例如,於「The pesticide manual (16th Ed. British Crop Protection Council)」中或可在網路資源檢索到(例如於www.alanwood.net/pesticides)。The active ingredients described herein by their common names are known and have been published in other documents or sources, for example, in "The pesticide manual (16th Ed. British Crop Protection Council)" or can be retrieved from Internet resources (for example, at www.alanwood.net/pesticides).

在一較佳實施例中,本案的農業化學組成物包含至少一種選自以下之殺真菌活性化合物 (II)作為一組分 (2):鋅錳乃浦 (mancozeb)、福爾培 (folpet)、福賽得鋁 (fosetyl­aluminium)、免得爛 (metiram)、腈硫醌 (dithianon)、甲芬沙姆 (mefenoxam)、賽發滅 (cyazofamid)、安美速 (amisulbrom)、克絕 (cymoxanil)、扶吉胺 (fluazinam)、普拔克 (propamocarb)、座賽胺 (zoxamide)、噻唑菌胺 (ethaboxam)、氟比來 (fluopicolide)、滅脫定 (ametoctradin)、凡殺同 (famoxadone)、達滅芬 (dimethomorph)、纈菌胺 (valifenalate)、待克利 (difenoconazole)、滅芬座 (mefentrifluconazole)、亞托敏 (azoxystrobin)、唑菌胺酯 (pyraclostrobin)、三氟敏 (trifloxystrobin)、芬滅酮 (fenamidone)、氟派瑞 (fluopyram)、白克列 (boscalid)、四氯異苯腈 (chlorothalonil)、甲基鋅乃浦 (propineb)、硫酸銅、氫氧化銅、氫氧化銅、氧硫普靈 (oxathiapiprolin)、氟醚菌醯胺 (fluoxapiprolin)、苯噻菌胺 (benthiavalicarb)、丙森鋅 (iprovalicarb)、曼普胺 (mandipropamid)、得克利 (tebuconazole)、甲基四吡咯 (Metyltetraprole)、啶氧菌酯 (picoxystrobin)、氟克殺 (fluxapyroxad) 以及苯索伏比 (benzovindiflupyr)。In a preferred embodiment, the agricultural chemical composition of the present case comprises at least one fungicidally active compound (II) selected from the following as a component (2): zinc manganese Naipu (mancozeb), Folpe (folpet) , Fosetylaluminium, Metiram, Dithianon, Mefenoxam, Cyazofamid, Amisulbrom, Cymoxanil, Fu Fluazinam, propamocarb, zoxamide, ethaboxam, fluopicolide, ametoctradin, famoxadone, damet Dimethomorph, valifenalate, difenoconazole, mefentrifluconazole, azoxystrobin, pyraclostrobin, trifloxystrobin, phenidone (fenamidone), fluopyram, boscalid, chlorothalonil, propineb, copper sulfate, copper hydroxide, copper hydroxide, oxathacap oxathiapiprolin, fluoxapiprolin, benthiavalicarb, iprovalicarb, mandipropamid, tebuconazole, Metyltetraprole, picoxystrobin, fluxapyroxad, and benzovindiflupyr.

在一較佳實施例中,本案的農業化學組成物包含至少一種選自以下的殺蟲或殺線蟲活性化合物 (III)作為一組分 (2):益達胺 (imidacloprid)、可尼丁(clothianidin)、噻蟲嗪 (thiamethoxam)、費普尼 (fipronil)、剋安勃 (chlorantraniliprole)、賽安勃 (cyantraniliprole)以及特安勃 (tetraniliprole)。In a preferred embodiment, the agricultural chemical composition of the present case comprises at least one insecticidal or nematicidal active compound (III) selected from the following as a component (2): imidacloprid (imidacloprid), canidine ( clothianidin), thiamethoxam, fipronil, chlorantraniliprole, cyantraniliprole, and tetraniliprole.

以下的組合係本案農業化學組成物之具體實施例的例舉。The following combinations are examples of specific embodiments of the agricultural chemical composition of the present case.

在一實施例中,如下方表1和表2中所列出的組合,其中組分 (1)係如式 (I)所示之化合物,組分 (2)係選自如本文中所定義的(III-A1001)至(III-FF1023)各組:In one embodiment, the combination listed in Table 1 and Table 2 below, wherein component (1) is a compound represented by formula (I), and component (2) is selected from the group consisting of (III-A1001) to (III-FF1023) each group:

在一實施例中,如下方表1所列之組合,其中組分 (1)係一如式 (I)所示之化合物,組分 (2)係選自如本文中所定義的(II-A001)至(II-R047)各組。據此,舉例而言,若組分 (2)為(II-A001) 環克座 (cyproconazole),則該組合將表示成「(I)+(II-A001)」。In one embodiment, the combination listed in Table 1 below, wherein component (1) is a compound as shown in formula (I), and component (2) is selected from (II-A001 ) to (II-R047) groups. Accordingly, for example, if component (2) is (II-A001) cyproconazole, the combination will be expressed as "(I)+(II-A001)".

表1:(I)+(II-A001)、(I)+(II-A002)、(I)+(II-A003)、(I)+(II-A004)、(I)+(II-A005)、(I)+(II-A006)、(I)+(II-A007)、(I)+(II-A008)、(I)+(II-A009)、(I)+(II-A010)、(I)+(II-A011)、(I)+(II-A012)、(I)+(II-A013)、(I)+(II-A014)、(I)+(II-A015)、(I)+(II-A016)、(I)+(II-A017)、(I)+(II-A018)、(I)+(II-A019)、(I)+(II-A020)、(I)+(II-A021)、(I)+(II-A022)、(I)+(II-A023)、(I)+(II-A024)、(I)+(II-A025)、(I)+(II-A026)、(I)+(II-A027)、(I)+(II-A028)、(I)+(II-A029)、(I)+(II-A030)、(I)+(II-A031)、(I)+(II-A032)、(I)+(II-A033)、(I)+(II-A034)、(I)+(II-A035)、(I)+(II-A036)、(I)+(II-A037)、(I)+(II-A038)、(I)+(II-A039)、(I)+(II-A040)、(I)+(II-A041)、(I)+(II-A042)、(I)+(II-A043)、(I)+(II-A044)、(I)+(II-A045)、(I)+(II-A046)、(I)+(II-A047)、(I)+(II-A048)、(I)+(II-A049)、(I)+(II-A050)、(I)+(II-A051)、(I)+(II-A052)、(I)+(II-A053)、(I)+(II-A054)、(I)+(II-A055)、(I)+(II-A056)、(I)+(II-A057)、(I)+(II-A058)、(I)+(II-A059)、(I)+(II-A060)、(I)+(II-A061)、(I)+(II-A062)、(I)+(II-A063)、(I)+(II-A064)、(I)+(II-A065)、(I)+(II-A066)、(I)+(II-A067)、(I)+(II-A068)、(I)+(II-A069)、(I)+(II-A070)、(I)+(II-A071)、(I)+(II-A072)、(I)+(II-A073)、(I)+(II-A074)、(I)+(II-A075)、(I)+(II-A076)、(I)+(II-A077)、(I)+(II-A078)、(I)+(II-A079)、(I)+(II-A080)、(I)+(II-A081)、(I)+(II-A082)、(I)+(II-A083)、(I)+(II-A084)、(I)+(II-A085)、(I)+(II-A086)、(I)+(II-A087)、(I)+(II-A088)、(I)+(II-A089)、(I)+(II-A090)、(I)+(II-A091)、(I)+(II-A092)、(I)+(II-A093)、(I)+(II-A094)、(I)+(II-A095)、(I)+(II-A096)、(I)+(II-A097)、(I)+(II-A098)、(I)+(II-A099)、(I)+(II-A100)、(I)+(II-A101)、(I)+(II-A102)、(I)+(II-A103)、(I)+(II-A104)、(I)+(II-A105)、(I)+(II-A106)、(I)+(II-A107)、(I)+(II-A108)、(I)+(II-A109)、(I)+(II-A110)、(I)+(II-A111)、(I)+(II-A112)、(I)+(II-A113)、(I)+(II-A114)、(I)+(II-A115)、(I)+(II-A116)、(I)+(II-A117)、(I)+(II-B001)、(I)+(II-B002)、(I)+(II-B003)、(I)+(II-B004)、(I)+(II-B005)、(I)+(II-B006)、(I)+(II-B007)、(I)+(II-B008)、(I)+(II-B009)、(I)+(II-B010)、(I)+(II-B011)、(I)+(II-B012)、(I)+(II-B013)、(I)+(II-B014)、(I)+(II-B015)、(I)+(II-B016)、(I)+(II-B017)、(I)+(II-B018)、(I)+(II-B019)、(I)+(II-B020)、(I)+(II-B021)、(I)+(II-B022)、(I)+(II-B023)、(I)+(II-B024)、(I)+(II-B025)、(I)+(II-B026)、(I)+(II-B027)、(I)+(II-B028)、(I)+(II-B029)、(I)+(II-B030)、(I)+(II-B031)、(I)+(II-B032)、(I)+(II-B033)、(I)+(II-B034)、(I)+(II-B035)、(I)+(II-B036)、(I)+(II-B037)、(I)+(II-B038)、(I)+(II-B039)、(I)+(II-B040)、(I)+(II-B041)、(I)+(II-B042)、(I)+(II-B043)、(I)+(II-B044)、(I)+(II-B045)、(I)+(II-B046)、(I)+(II-B047)、(I)+(II-B048)、(I)+(II-B049)、(I)+(II-B050)、(I)+(II-B051)、(I)+(II-B052)、(I)+(II-B053)、(I)+(II-B054)、(I)+(II-B055)、(I)+(II-B056)、(I)+(II-B057)、(I)+(II-B058)、(I)+(II-B059)、(I)+(II-B060)、(I)+(II-B061)、(I)+(II-B062)、(I)+(II-B063)、(I)+(II-B064)、(I)+(II-B065)、(I)+(II-B066)、(I)+(II-B068)、(I)+(II-B069)、(I)+(II-C001)、(I)+(II-C002)、(I)+(II-C003)、(I)+(II-C004)、(I)+(II-C005)、(I)+(II-C006)、(I)+(II-C007)、(I)+(II-C008)、(I)+(II-C009)、(I)+(II-C010)、(I)+(II-C011)、(I)+(II-C012)、(I)+(II-C013)、(I)+(II-C014)、(I)+(II-C015)、(I)+(II-C016)、(I)+(II-C017)、(I)+(II-C018)、(I)+(II-C019)、(I)+(II-C020)、(I)+(II-C021)、(I)+(II-C022)、(I)+(II-C023)、(I)+(II-C024)、(I)+(II-C025)、(I)+(II-C026)、(I)+(II-C027)、(I)+(II-C028)、(I)+(II-C029)、(I)+(II-C030)、(I)+(II-C031)、(I)+(II-C032)、(I)+(II-C033)、(I)+(II-C034)、(I)+(II-D001)、(I)+(II-D002)、(I)+(II-D003)、(I)+(II-D004)、(I)+(II-D005)、(I)+(II-D006)、(I)+(II-D007)、(I)+(II-D008)、(I)+(II-D009)、(I)+(II-D010)、(I)+(II-D011)、(I)+(II-D012)、(I)+(II-D013)、(I)+(II-D014)、(I)+(II-D015)、(I)+(II-D016)、(I)+(II-D017)、(I)+(II-D018)、(I)+(II-D019)、(I)+(II-D020)、(I)+(II-D021)、(I)+(II-D022)、(I)+(II-D023)、(I)+(II-D024)、(I)+(II-D025)、(I)+(II-D026)、(I)+(II-E001)、(I)+(II-E002)、(I)+(II-E003)、(I)+(II-E004)、(I)+(II-E005)、(I)+(II-E006)、(I)+(II-E007)、(I)+(II-E008)、(I)+(II-E009)、(I)+(II-E010)、(I)+(II-E011)、(I)+(II-E012)、(I)+(II-E013)、(I)+(II-E014)、(I)+(II-E015)、(I)+(II-E016)、(I)+(II-E017)、(I)+(II-E018)、(I)+(II-E019)、(I)+(II-E020)、(I)+(II-E021)、(I)+(II-E022)、(I)+(II-E023)、(I)+(II-E024)、(I)+(II-E025)、(I)+(II-E026)、(I)+(II-E027)、(I)+(II-E028)、(I)+(II-E029)、(I)+(II-E030)、(I)+(II-F001)、(I)+(II-F002)、(I)+(II-F003)、(I)+(II-F004)、(I)+(II-G001)、(I)+(II-G002)、(I)+(II-G003)、(I)+(II-G004)、(I)+(II-G005)、(I)+(II-G006)、(I)+(II-G007)、(I)+(II-G008)、(I)+(II-G009)、(I)+(II-G0010)、(I)+(II-G0011)、(I)+(II-H001)、(I)+(II-H002)、(I)+(II-H003)、(I)+(II-H004)、(I)+(II-I001)、(I)+(II-I002)、(I)+(II-I003)、(I)+(II-I004)、(I)+(II-I005)、(I)+(II-I006)、(I)+(II-I007)、(I)+(II-I008)、(I)+(II-I009)、(I)+(II-I010)、(I)+(II-I011)、(I)+(II-I012)、(I)+(II-I013)、(I)+(II-I014)、(I)+(II-J001)、(I)+(II-J002)、(I)+(II-J003)、(I)+(II-J004)、(I)+(II-J005)、(I)+(II-J006)、(I)+(II-J007)、(I)+(II-J008)、(I)+(II-J009)、(I)+(II-J0010)、(I)+(II-J011)、(I)+(II-J012)、(I)+(II-J013)、(I)+(II-J014)、(I)+(II-J015)、(I)+(II-J015)、(I)+(II-J016)、(I)+(II-K001)、(I)+(II-K002)、(I)+(II-K003)、(I)+(II-K004)、(I)+(II-K005)、(I)+(II-K006)、(I)+(II-K007)、(I)+(II-L001)、(I)+(II-L002)、(I)+(II-L003)、(I)+(II-L004)、(I)+(II-L005)、(I)+(II-L006)、(I)+(II-L007)、(I)+(II-L008)、(I)+(II-L009)、(I)+(II-L010)、(I)+(II-L011)、(I)+(II-L012)、(I)+(II-M001)、(I)+(II-M002)、(I)+(II-M003)、(I)+(II-M004)、(I)+(II-M005)、(I)+(II-M006)、(I)+(II-M007)、(I)+(II-M008)、(I)+(II-M009)、(I)+(II-M010)、(I)+(II-N001)、(I)+(II-N002)、(I)+(II-N003)、(I)+(II-N004)、(I)+(II-O001)、(I)+(II-O002)、(I)+(II-O003)、(I)+(II-O004)、(I)+(II-O005)、(I)+(II-O006)、(I)+(II-O007)、(I)+(II-O008)、(I)+(II-O009)、(I)+(II-O010)、(I)+(II-O011)、(I)+(II-O012)、(I)+(II-O013)、(I)+(II-O014)、(I)+(II-O015)、(I)+(II-O016)、(I)+(II-O017)、(I)+(II-O018)、(I)+(II-O019)、(I)+(II-O020)、(I)+(II-O021)、(I)+(II-O022)、(I)+(II-O023)、(I)+(II-O024)、(I)+(II-O025)、(I)+(II-O026)、(I)+(II-O027)、(I)+(II-O028)、(I)+(II-O029)、(I)+(II-O030)、(I)+(II-O031)、(I)+(II-O032)、(I)+(II-O033)、(I)+(II-O034)、(I)+(II-O035)、(I)+(II-O036)、(I)+(II-O037)、(I)+(II-O038)、(I)+(II-O039)、(I)+(II-O040)、(I)+(II-O041)、(I)+(II-O042)、(I)+(II-O043)、(I)+(II-O044)、(I)+(II-O045)、(I)+(II-O046)、(I)+(II-O047)、(I)+(II-O048)、(I)+(II-O049)、(I)+(II-O050)、(I)+(II-O051)、(I)+(II-O052)、(I)+(II-O053)、(I)+(II-O054)、(I)+(II-O055)、(I)+(II-O056)、(I)+(II-O057)、(I)+(II-O058)、(I)+(II-O059)、(I)+(II-O060)、(I)+(II-O061)、(I)+(II-O062)、(I)+(II-O063)、(I)+(II-O064)、(I)+(II-O065)、(I)+(II-O066)、(I)+(II-O067)、(I)+(II-O068)、(I)+(II-O069)、(I)+(II-O070)、(I)+(II-O071)、(I)+(II-O072)、(I)+(II-O073)、(I)+(II-O074)、(I)+(II-O075)、(I)+(II-O076)、(I)+(II-O077)、(I)+(II-O078)、(I)+(II-O079)、(I)+(II-O080)、(I)+(II-O081)、(I)+(II-O082)、(I)+(II-O083)、(I)+(II-O084)、(I)+(II-O085)、(I)+(II-O086)、(I)+(II-O087)、(I)+(II-O088)、(I)+(II-P001)、(I)+(II-P002)、(I)+(II-P003)、(I)+(II-P004)、(I)+(II-P005)、(I)+(II-P006)、(I)+(II-P007)、(I)+(II-P008)、(I)+(II-P009)、(I)+(II-P010)、(I)+(II-P011)、(I)+(II-P012)、(I)+(II-P013)、(I)+(II-P014)、(I)+(II-P015)、(I)+(II-P016)、(I)+(II-P017)、(I)+(II-P018)、(I)+(II-P019)、(I)+(II-P020)、(I)+(II-P021)、(I)+(II-P022)、(I)+(II-P023)、(I)+(II-P024)、(I)+(II-P025)、(I)+(II-P026)、(I)+(II-P027)、(I)+(II-P028)、(I)+(II-P029)、(I)+(II-P030)、(I)+(II-P031)、(I)+(II-P032)、(I)+(II-P033)、(I)+(II-P034)、(I)+(II-P035)、(I)+(II-P036)、(I)+(II-P037)、(I)+(II-P038)、(I)+(II-P039)、(I)+(II-P040)、(I)+(II-P041)、(I)+(II-P042)、(I)+(II-P043)、(I)+(II-P044)、(I)+(II-P045)、(I)+(II-P046)、(I)+(II-P047)、(I)+(II-P048)、(I)+(II-P049)、(I)+(II-P050)、(I)+(II-P051)、(I)+(II-P052)、(I)+(II-P053)、(I)+(II-P054)、(I)+(II-P055)、(I)+(II-P056)、(I)+(II-P057)、(I)+(II-P058)、(I)+(II-P059)、(I)+(II-P060)、(I)+(II-P061)、(I)+(II-P062)、(I)+(II-P063)、(I)+(II-P064)、(I)+(II-P065)、(I)+(II-P066)、(I)+(II-P067)、(I)+(II-P068)、(I)+(II-P069)、(I)+(II-P070)、(I)+(II-P071)、(I)+(II-P072)、(I)+(II-P073)、(I)+(II-P074)、(I)+(II-P075)、(I)+(II-P076)、(I)+(II-P077)、(I)+(II-P078)、(I)+(II-P079)、(I)+(II-P080)、(I)+(II-P081)、(I)+(II-P082)、(I)+(II-P083)、(I)+(II-P084)、(I)+(II-P085)、(I)+(II-P086)、(I)+(II-P087)、(I)+(II-P088)、(I)+(II-P089)、(I)+(II-P090)、(I)+(II-P091)、(I)+(II-P092)、(I)+(II-P093)、(I)+(II-P094)、(I)+(II-P095)、(I)+(II-P096)、(I)+(II-P097)、(I)+(II-P098)、(I)+(II-P099)、(I)+(II-P100)、(I)+(II-P101)、(I)+(II-P102)、(I)+(II-P103)、(I)+(II-P104)、(I)+(II-Q001)、(I)+(II-Q002)、(I)+(II-Q003)、(I)+(II-Q004)、(I)+(II-Q005)、(I)+(II-Q006)、(I)+(II-Q007)、(I)+(II-Q008)、(I)+(II-Q009)、(I)+(II-Q010)、(I)+(II-Q011)、(I)+(II-Q012)、(I)+(II-Q013)、(I)+(II-Q014)、(I)+(II-Q015)、(I)+(II-Q016)、(I)+(II-Q017)、(I)+(II-Q018)、(I)+(II-Q019)、(I)+(II-Q020)、(I)+(II-Q021)、(I)+(II-Q022)、(I)+(II-Q023)、(I)+(II-Q024)、(I)+(II-Q025)、(I)+(II-Q026)、(I)+(II-Q027)、(I)+(II-Q028)、(I)+(II-Q029)、(I)+(II-Q030)、(I)+(II-Q031)、(I)+(II-Q032)、(I)+(II-Q033)、(I)+(II-Q034)、(I)+(II-R001)、(I)+(II-R002)、(I)+(II-R003)、(I)+(II-R004)、(I)+(II-R005)、(I)+(II-R006)、(I)+(II-R007)、(I)+(II-R008)、(I)+(II-R009)、(I)+(II-R010)、(I)+(II-R011)、(I)+(II-R012)、(I)+(II-R013)、(I)+(II-R014)、(I)+(II-R015)、(I)+(II-R016)、(I)+(II-R017)、(I)+(II-R018)、(I)+(II-R019)、(I)+(II-R020)、(I)+(II-R021)、(I)+(II-R022)、(I)+(II-R023)、(I)+(II-R024)、(I)+(II-R025)、(I)+(II-R026)、(I)+(II-R027)、(I)+(II-R028)、(I)+(II-R029)、(I)+(II-R030)、(I)+(II-R031)、(I)+(II-R032)、(I)+(II-R033)、(I)+(II-R034)、(I)+(II-R035)、(I)+(II-R036)、(I)+(II-R037)、(I)+(II-R038)、(I)+(II-R039)、(I)+(II-R040)、(I)+(II-R041)、(I)+(II-R042)、(I)+(II-R043)、(I)+(II-R044)、(I)+(II-R045)、(I)+(II-R046)、(I)+(II-R047)。Table 1: (I)+(II-A001), (I)+(II-A002), (I)+(II-A003), (I)+(II-A004), (I)+(II- A005), (I)+(II-A006), (I)+(II-A007), (I)+(II-A008), (I)+(II-A009), (I)+(II- A010), (I)+(II-A011), (I)+(II-A012), (I)+(II-A013), (I)+(II-A014), (I)+(II- A015), (I)+(II-A016), (I)+(II-A017), (I)+(II-A018), (I)+(II-A019), (I)+(II- A020), (I)+(II-A021), (I)+(II-A022), (I)+(II-A023), (I)+(II-A024), (I)+(II- A025), (I)+(II-A026), (I)+(II-A027), (I)+(II-A028), (I)+(II-A029), (I)+(II- A030), (I)+(II-A031), (I)+(II-A032), (I)+(II-A033), (I)+(II-A034), (I)+(II- A035), (I)+(II-A036), (I)+(II-A037), (I)+(II-A038), (I)+(II-A039), (I)+(II- A040), (I)+(II-A041), (I)+(II-A042), (I)+(II-A043), (I)+(II-A044), (I)+(II- A045), (I)+(II-A046), (I)+(II-A047), (I)+(II-A048), (I)+(II-A049), (I)+(II- A050), (I)+(II-A051), (I)+(II-A052), (I)+(II-A053), (I)+(II-A054), (I)+(II- A055), (I)+(II-A056), (I)+(II-A057), (I)+(II-A058), (I)+(II-A059), (I)+(II- A060), (I)+(II-A061), (I)+(II-A062), (I)+(II-A063), (I)+(II-A064), (I)+(II- A065), (I)+(II-A066), (I)+(II-A067), (I)+(II-A068), (I)+(II-A069), (I)+(II- A070), (I)+(II-A071), (I) +(II-A072), (I)+(II-A073), (I)+(II-A074), (I)+(II-A075), (I)+(II-A076), (I) +(II-A077), (I)+(II-A078), (I)+(II-A079), (I)+(II-A080), (I)+(II-A081), (I) +(II-A082), (I)+(II-A083), (I)+(II-A084), (I)+(II-A085), (I)+(II-A086), (I) +(II-A087), (I)+(II-A088), (I)+(II-A089), (I)+(II-A090), (I)+(II-A091), (I) +(II-A092), (I)+(II-A093), (I)+(II-A094), (I)+(II-A095), (I)+(II-A096), (I) +(II-A097), (I)+(II-A098), (I)+(II-A099), (I)+(II-A100), (I)+(II-A101), (I) +(II-A102), (I)+(II-A103), (I)+(II-A104), (I)+(II-A105), (I)+(II-A106), (I) +(II-A107), (I)+(II-A108), (I)+(II-A109), (I)+(II-A110), (I)+(II-A111), (I) +(II-A112), (I)+(II-A113), (I)+(II-A114), (I)+(II-A115), (I)+(II-A116), (I) +(II-A117), (I)+(II-B001), (I)+(II-B002), (I)+(II-B003), (I)+(II-B004), (I) +(II-B005), (I)+(II-B006), (I)+(II-B007), (I)+(II-B008), (I)+(II-B009), (I) +(II-B010), (I)+(II-B011), (I)+(II-B012), (I)+(II-B013), (I)+(II-B014), (I) +(II-B015), (I)+(II-B016), (I)+(II-B017), (I)+(II-B018), (I)+(II-B019), (I) +(II-B020), (I)+(II-B021), (I)+(II-B022), (I)+(II-B023), (I)+(II-B024), (I) +(II-B025), (I)+(II-B 026), (I)+(II-B027), (I)+(II-B028), (I)+(II-B029), (I)+(II-B030), (I)+(II- B031), (I)+(II-B032), (I)+(II-B033), (I)+(II-B034), (I)+(II-B035), (I)+(II- B036), (I)+(II-B037), (I)+(II-B038), (I)+(II-B039), (I)+(II-B040), (I)+(II- B041), (I)+(II-B042), (I)+(II-B043), (I)+(II-B044), (I)+(II-B045), (I)+(II- B046), (I)+(II-B047), (I)+(II-B048), (I)+(II-B049), (I)+(II-B050), (I)+(II- B051), (I)+(II-B052), (I)+(II-B053), (I)+(II-B054), (I)+(II-B055), (I)+(II- B056), (I)+(II-B057), (I)+(II-B058), (I)+(II-B059), (I)+(II-B060), (I)+(II- B061), (I)+(II-B062), (I)+(II-B063), (I)+(II-B064), (I)+(II-B065), (I)+(II- B066), (I)+(II-B068), (I)+(II-B069), (I)+(II-C001), (I)+(II-C002), (I)+(II- C003), (I)+(II-C004), (I)+(II-C005), (I)+(II-C006), (I)+(II-C007), (I)+(II- C008), (I)+(II-C009), (I)+(II-C010), (I)+(II-C011), (I)+(II-C012), (I)+(II- C013), (I)+(II-C014), (I)+(II-C015), (I)+(II-C016), (I)+(II-C017), (I)+(II- C018), (I)+(II-C019), (I)+(II-C020), (I)+(II-C021), (I)+(II-C022), (I)+(II- C023), (I)+(II-C024), (I)+(II-C025), (I)+(II-C026), (I)+(II-C027), (I)+(II- C028), (I)+(II-C029), ( I)+(II-C030), (I)+(II-C031), (I)+(II-C032), (I)+(II-C033), (I)+(II-C034), ( I)+(II-D001), (I)+(II-D002), (I)+(II-D003), (I)+(II-D004), (I)+(II-D005), ( I)+(II-D006), (I)+(II-D007), (I)+(II-D008), (I)+(II-D009), (I)+(II-D010), ( I)+(II-D011), (I)+(II-D012), (I)+(II-D013), (I)+(II-D014), (I)+(II-D015), ( I)+(II-D016), (I)+(II-D017), (I)+(II-D018), (I)+(II-D019), (I)+(II-D020), ( I)+(II-D021), (I)+(II-D022), (I)+(II-D023), (I)+(II-D024), (I)+(II-D025), ( I)+(II-D026), (I)+(II-E001), (I)+(II-E002), (I)+(II-E003), (I)+(II-E004), ( I)+(II-E005), (I)+(II-E006), (I)+(II-E007), (I)+(II-E008), (I)+(II-E009), ( I)+(II-E010), (I)+(II-E011), (I)+(II-E012), (I)+(II-E013), (I)+(II-E014), ( I)+(II-E015), (I)+(II-E016), (I)+(II-E017), (I)+(II-E018), (I)+(II-E019), ( I)+(II-E020), (I)+(II-E021), (I)+(II-E022), (I)+(II-E023), (I)+(II-E024), ( I)+(II-E025), (I)+(II-E026), (I)+(II-E027), (I)+(II-E028), (I)+(II-E029), ( I)+(II-E030), (I)+(II-F001), (I)+(II-F002), (I)+(II-F003), (I)+(II-F004), ( I)+(II-G001), (I)+(II-G002), (I)+(II-G003), (I)+(II-G004), (I)+(II-G005), ( I)+(II-G006), (I)+(II -G007), (I)+(II-G008), (I)+(II-G009), (I)+(II-G0010), (I)+(II-G0011), (I)+(II -H001), (I)+(II-H002), (I)+(II-H003), (I)+(II-H004), (I)+(II-I001), (I)+(II -I002), (I)+(II-I003), (I)+(II-I004), (I)+(II-I005), (I)+(II-I006), (I)+(II -I007), (I)+(II-I008), (I)+(II-I009), (I)+(II-I010), (I)+(II-I011), (I)+(II -I012), (I)+(II-I013), (I)+(II-I014), (I)+(II-J001), (I)+(II-J002), (I)+(II -J003), (I)+(II-J004), (I)+(II-J005), (I)+(II-J006), (I)+(II-J007), (I)+(II -J008), (I)+(II-J009), (I)+(II-J0010), (I)+(II-J011), (I)+(II-J012), (I)+(II -J013), (I)+(II-J014), (I)+(II-J015), (I)+(II-J015), (I)+(II-J016), (I)+(II -K001), (I)+(II-K002), (I)+(II-K003), (I)+(II-K004), (I)+(II-K005), (I)+(II -K006), (I)+(II-K007), (I)+(II-L001), (I)+(II-L002), (I)+(II-L003), (I)+(II -L004), (I)+(II-L005), (I)+(II-L006), (I)+(II-L007), (I)+(II-L008), (I)+(II -L009), (I)+(II-L010), (I)+(II-L011), (I)+(II-L012), (I)+(II-M001), (I)+(II -M002), (I)+(II-M003), (I)+(II-M004), (I)+(II-M005), (I)+(II-M006), (I)+(II -M007), (I)+(II-M008), (I)+(II-M009), (I)+(II-M010), (I)+(II-N001), (I)+(II -N002), (I)+(II-N0 03), (I)+(II-N004), (I)+(II-O001), (I)+(II-O002), (I)+(II-O003), (I)+(II- O004), (I)+(II-O005), (I)+(II-O006), (I)+(II-O007), (I)+(II-O008), (I)+(II- O009), (I)+(II-O010), (I)+(II-O011), (I)+(II-O012), (I)+(II-O013), (I)+(II- O014), (I)+(II-O015), (I)+(II-O016), (I)+(II-O017), (I)+(II-O018), (I)+(II- O019), (I)+(II-O020), (I)+(II-O021), (I)+(II-O022), (I)+(II-O023), (I)+(II- O024), (I)+(II-O025), (I)+(II-O026), (I)+(II-O027), (I)+(II-O028), (I)+(II- O029), (I)+(II-O030), (I)+(II-O031), (I)+(II-O032), (I)+(II-O033), (I)+(II- O034), (I)+(II-O035), (I)+(II-O036), (I)+(II-O037), (I)+(II-O038), (I)+(II- O039), (I)+(II-O040), (I)+(II-O041), (I)+(II-O042), (I)+(II-O043), (I)+(II- O044), (I)+(II-O045), (I)+(II-O046), (I)+(II-O047), (I)+(II-O048), (I)+(II- O049), (I)+(II-O050), (I)+(II-O051), (I)+(II-O052), (I)+(II-O053), (I)+(II- O054), (I)+(II-O055), (I)+(II-O056), (I)+(II-O057), (I)+(II-O058), (I)+(II- O059), (I)+(II-O060), (I)+(II-O061), (I)+(II-O062), (I)+(II-O063), (I)+(II- O064), (I)+(II-O065), (I)+(II-O066), (I)+(II-O067), (I)+(II-O068), (I)+(II- O069), (I)+(II-O070), (I )+(II-O071), (I)+(II-O072), (I)+(II-O073), (I)+(II-O074), (I)+(II-O075), (I )+(II-O076), (I)+(II-O077), (I)+(II-O078), (I)+(II-O079), (I)+(II-O080), (I )+(II-O081), (I)+(II-O082), (I)+(II-O083), (I)+(II-O084), (I)+(II-O085), (I )+(II-O086), (I)+(II-O087), (I)+(II-O088), (I)+(II-P001), (I)+(II-P002), (I )+(II-P003), (I)+(II-P004), (I)+(II-P005), (I)+(II-P006), (I)+(II-P007), (I )+(II-P008), (I)+(II-P009), (I)+(II-P010), (I)+(II-P011), (I)+(II-P012), (I )+(II-P013), (I)+(II-P014), (I)+(II-P015), (I)+(II-P016), (I)+(II-P017), (I )+(II-P018), (I)+(II-P019), (I)+(II-P020), (I)+(II-P021), (I)+(II-P022), (I )+(II-P023), (I)+(II-P024), (I)+(II-P025), (I)+(II-P026), (I)+(II-P027), (I )+(II-P028), (I)+(II-P029), (I)+(II-P030), (I)+(II-P031), (I)+(II-P032), (I )+(II-P033), (I)+(II-P034), (I)+(II-P035), (I)+(II-P036), (I)+(II-P037), (I )+(II-P038), (I)+(II-P039), (I)+(II-P040), (I)+(II-P041), (I)+(II-P042), (I )+(II-P043), (I)+(II-P044), (I)+(II-P045), (I)+(II-P046), (I)+(II-P047), (I )+(II-P048), (I)+(II-P049), (I)+(II-P050), (I)+(II-P051), (I)+(II-P052), (I )+(II-P053), (I)+(II- P054), (I)+(II-P055), (I)+(II-P056), (I)+(II-P057), (I)+(II-P058), (I)+(II- P059), (I)+(II-P060), (I)+(II-P061), (I)+(II-P062), (I)+(II-P063), (I)+(II- P064), (I)+(II-P065), (I)+(II-P066), (I)+(II-P067), (I)+(II-P068), (I)+(II- P069), (I)+(II-P070), (I)+(II-P071), (I)+(II-P072), (I)+(II-P073), (I)+(II- P074), (I)+(II-P075), (I)+(II-P076), (I)+(II-P077), (I)+(II-P078), (I)+(II- P079), (I)+(II-P080), (I)+(II-P081), (I)+(II-P082), (I)+(II-P083), (I)+(II- P084), (I)+(II-P085), (I)+(II-P086), (I)+(II-P087), (I)+(II-P088), (I)+(II- P089), (I)+(II-P090), (I)+(II-P091), (I)+(II-P092), (I)+(II-P093), (I)+(II- P094), (I)+(II-P095), (I)+(II-P096), (I)+(II-P097), (I)+(II-P098), (I)+(II- P099), (I)+(II-P100), (I)+(II-P101), (I)+(II-P102), (I)+(II-P103), (I)+(II- P104), (I)+(II-Q001), (I)+(II-Q002), (I)+(II-Q003), (I)+(II-Q004), (I)+(II- Q005), (I)+(II-Q006), (I)+(II-Q007), (I)+(II-Q008), (I)+(II-Q009), (I)+(II- Q010), (I)+(II-Q011), (I)+(II-Q012), (I)+(II-Q013), (I)+(II-Q014), (I)+(II- Q015), (I)+(II-Q016), (I)+(II-Q017), (I)+(II-Q018), (I)+(II-Q019), (I)+(II- Q020), (I)+(II-Q021), (I)+(II-Q022), (I)+(II-Q023), (I)+(II-Q024), (I)+(II-Q025), (I)+(II-Q026), (I)+(II-Q027), (I)+(II-Q028), (I)+(II-Q029), (I)+(II-Q030), (I)+(II-Q031), (I)+(II-Q032), (I)+(II-Q033), (I)+(II-Q034), (I)+(II-R001), (I)+(II-R002), (I)+(II-R003), (I)+(II-R004), (I)+(II-R005), (I)+(II-R006), (I)+(II-R007), (I)+(II-R008), (I)+(II-R009), (I)+(II-R010), (I)+(II-R011), (I)+(II-R012), (I)+(II-R013), (I)+(II-R014), (I)+(II-R015), (I)+(II-R016), (I)+(II-R017), (I)+(II-R018), (I)+(II-R019), (I)+(II-R020), (I)+(II-R021), (I)+(II-R022), (I)+(II-R023), (I)+(II-R024), (I)+(II-R025), (I)+(II-R026), (I)+(II-R027), (I)+(II-R028), (I)+(II-R029), (I)+(II-R030), (I)+(II-R031), (I)+(II-R032), (I)+(II-R033), (I)+(II-R034), (I)+(II-R035), (I)+(II-R036), (I)+(II-R037), (I)+(II-R038), (I)+(II-R039), (I)+(II-R040), (I)+(II-R041), (I)+(II-R042), (I)+(II-R043), (I)+(II-R044), (I)+(II-R045), (I)+(II-R046), (I)+(II-R047).

在一實施例中,如下方表2所列之組合,其中組分 (1)係一如式 (I)所示之化合物,組分 (2)係選自如本文中所定義的 (III-A1001)至 (III-FF1023)各組。據此,舉例而言,若組分 (2)為 (III-A1001) 棉靈威 (alanycarb),則該組合將表示成「(I)+(III-A1001)」。In one embodiment, the combination listed in Table 2 below, wherein component (1) is a compound as shown in formula (I), and component (2) is selected from (III-A1001) as defined herein ) to (III-FF1023) groups. Accordingly, for example, if component (2) is (III-A1001) alanycarb, the combination would be expressed as "(I)+(III-A1001)".

表2:(I)+(III-A1001)、(I)+(III-A1002)、(I)+(III-A1003)、(I)+(III-A1004)、(I)+(III-A1005)、(I)+(III-A1006)、(I)+(III-A1007)、(I)+(III-A1008)、(I)+(III-A1009)、(I)+(III-A1010)、(I)+(III-A1011)、(I)+(III-A1012)、(I)+(III-A1013)、(I)+(III-A1014)、(I)+(III-A1015)、(I)+(III-A1016)、(I)+(III-A1017)、(I)+(III-A1018)、(I)+(III-A1019)、(I)+(III-A1020)、(I)+(III-A1021)、(I)+(III-A1022)、(I)+(III-A1023)、(I)+(III-A1024)、(I)+(III-A1025)、(I)+(III-A1026)、(I)+(III-A2001)、(I)+(III-A2002)、(I)+(III-A2003)、(I)+(III-A2004)、(I)+(III-A2005)、(I)+(III-A2006)、(I)+(III-A2007)、(I)+(III-A2008)、(I)+(III-A2009)、(I)+(III-A2010)、(I)+(III-A2011)、(I)+(III-A2012)、(I)+(III-A2013)、(I)+(III-A2014)、(I)+(III-A2015)、(I)+(III-A2016)、(I)+(III-A2017)、(I)+(III-A2018)、(I)+(III-A2019)、(I)+(III-A2020)、(I)+(III-A2021)、(I)+(III-A2022)、(I)+(III-A2023)、(I)+(III-A2024)、(I)+(III-A2025)、(I)+(III-A2026)、(I)+(III-A2027)、(I)+(III-A2028)、(I)+(III-A2029)、(I)+(III-A2030)、(I)+(III-A2031)、(I)+(III-A2032)、(I)+(III-A2033)、(I)+(III-A2034)、(I)+(III-A2035)、(I)+(III-A2036)、(I)+(III-A2037)、(I)+(III-A2038)、(I)+(III-A2039)、(I)+(III-A2040)、(I)+(III-A2041)、(I)+(III-A2042)、(I)+(III-A2043)、(I)+(III-A2044)、(I)+(III-A2045)、(I)+(III-A2046)、(I)+(III-A2047)、(I)+(III-A2048)、(I)+(III-A2049)、(I)+(III-A2050)、(I)+(III-A2051)、(I)+(III-A2052)、(I)+(III-A2053)、(I)+(III-A2054)、(I)+(III-A2055)、(I)+(III-A2056)、(I)+(III-A2057)、(I)+(III-A2058)、(I)+(III-A2059)、(I)+(III-A2060)、(I)+(III-A2061)、(I)+(III-A2062)、(I)+(III-A2063)、(I)+(III-A2064)、(I)+(III-A2065)、(I)+(III-B1001)、(I)+(III-B1002)、(I)+(III-B2001)、(I)+(III-B2002)、(I)+(III-B2003)、(I)+(III-B2004)、(I)+(III-B2005)、(I)+(III-C1001)、(I)+(III-C1002)、(I)+(III-C1003)、(I)+(III-C1004)、(I)+(III-C1005)、(I)+(III-C1006)、(I)+(III-C1007)、(I)+(III-C1008)、(I)+(III-C1009)、(I)+(III-C1010)、(I)+(III-C1011)、(I)+(III-C1012)、(I)+(III-C1013)、(I)+(III-C1014)、(I)+(III-C1015)、(I)+(III-C1016)、(I)+(III-C1017)、(I)+(III-C1018)、(I)+(III-C1019)、(I)+(III-C1020)、(I)+(III-C1021)、(I)+(III-C1022)、(I)+(III-C1023)、(I)+(III-C1024)、(I)+(III-C1025)、(I)+(III-C1026)、(I)+(III-C1027)、(I)+(III-C1028)、(I)+(III-C1029)、(I)+(III-C1030)、(I)+(III-C1031)、(I)+(III-C1032)、(I)+(III-C1033)、(I)+(III-C1034)、(I)+(III-C1035)、(I)+(III-C1036)、(I)+(III-C1037)、(I)+(III-C1038)、(I)+(III-C1039)、(I)+(III-C1040)、(I)+(III-C1041)、(I)+(III-C1042)、(I)+(III-C1043)、(I)+(III-C1044)、(I)+(III-C1045)、(I)+(III-C1046)、(I)+(III-C1047)、(I)+(III-C1048)、(I)+(III-C1049)、(I)+(III-C2001)、(I)+(III-C2002)、(I)+(III-D1001)、(I)+(III-D1002)、(I)+(III-D1003)、(I)+(III-D1004)、(I)+(III-D1005)、(I)+(III-D1006)、(I)+(III-D1007)、(I)+(III-D1008)、(I)+(III-D1009)、(I)+(III-D1010)、(I)+(III-D2001)、(I)+(III-D3001)、(I)+(III-D4001)、(I)+(III-D5001)、(I)+(III-D5002)、(I)+(III-D6001)、(I)+(III-E1001)、(I)+(III-E1002)、(I)+(III-F1001)、(I)+(III-F1002)、(I)+(III-F1003)、(I)+(III-F1004)、(I)+(III-G1001)、(I)+(III-G1002)、(I)+(III-G1003)、(I)+(III-G2001)、(I)+(III-G3001)、(I)+(III-H4001)、(I)+(III-H4002)、(I)+(III-H4003)、(I)+(III-H4004)、(I)+(III-H4005)、(I)+(III-H5001)、(I)+(III-H6001)、(I)+(III-H6002)、(I)+(III-I1001)、(I)+(III-I1002)、(I)+(III-I2001)、(I)+(III-J1001)、(I)+(III-J1002)、(I)+(III-J1003)、(I)+(III-J2003)、(I)+(III-K1001)、(I)+(III-K1002)、(I)+(III-K1003)、(I)+(III-K1004)、(I)+(III-K1005)、(I)+(III-K1006)、(I)+(III-K1007)、(I)+(III-K1008)、(I)+(III-K1009)、(I)+(III-K1010)、(I)+(III-K1011)、(I)+(III-K1012)、(I)+(III-K1013)、(I)+(III-K1014)、(I)+(III-K1015)、(I)+(III-K2001)、(I)+(III-L1001)、(I)+(III-L2001)、(I)+(III-L2002)、(I)+(III-L2003)、(I)+(III-L3001)、(I)+(III-L4001)、(I)+(III-M1001)、(I)+(III-M2001)、(I)+(III-M3001)、(I)+(III-N1001)、(I)+(III-N1002)、(I)+(III-N1003)、(I)+(III-N1004)、(I)+(III-O1001)、(I)+(III-O1002)、(I)+(III-O1003)、(I)+(III-O1004)、(I)+(III-O1005)、(I)+(III-O1006)、(I)+(III-O1007)、(I)+(III-O1008)、(I)+(III-O1009)、(I)+(III-O1010)、(I)+(III-O1011)、(I)+(III-P1001)、(I)+(III-Q1001)、(I)+(III-R1001)、(I)+(III-R1002)、(I)+(III-R1003)、(I)+(III-R1004)、(I)+(III-R1005)、(I)+(III-S1001)、(I)+(III-T1001)、(I)+(III-T2001)、(I)+(III-T3001)、(I)+(III-T4001)、(I)+(III-U1001)、(I)+(III-U1002)、(I)+(III-U1003)、(I)+(III-U1004)、(I)+(III-U1005)、(I)+(III-U1006)、(I)+(III-U2001)、(I)+(III-V1001)、(I)+(III-V2001)、(I)+(III-V3001)、(I)+(III-V4001)、(I)+(III-W1001)、(I)+(III-W1002)、(I)+(III-W1003)、(I)+(III-W1004)、(I)+(III-X1001)、(I)+(III-X1002)、(I)+(III-X1003)、(I)+(III-X1004)、(I)+(III-X2001)、(I)+(III-X2002)、(I)+(III-X2003)、(I)+(III-Y1001)、(I)+(III-Y1002)、(I)+(III-Y2001)、(I)+(III-Z1001)、(I)+(III-Z1002)、(I)+(III-Z1003)、(I)+(III-Z1004)、(I)+(III-Z1005)、(I)+(III-Z1006)、(I)+(III-Z1007)、(I)+(III-Z1008)、(I)+(III-Z1009)、(I)+(III-Z1010)、(I)+(III-Z1011)、(I)+(III-Z1012)、(I)+(III-Z1013)、(I)+(III-Z1014)、(I)+(III-AA1001)、(I)+(III-BB1001)、(I)+(III-BB2001)、(I)+(III-BB2002)、(I)+(III-CC1001)、(I)+(III-CC1002)、(I)+(III-CC2001)、(I)+(III-CC2002)、(I)+(III-DD1001)、(I)+(III-EE1001)、(I)+(III-EE1002)、(I)+(III-EE1003)、(I)+(III-EE1004)、(I)+(III-EE1005)、(I)+(III-EE1006)、(I)+(III-EE1007)、(I)+(III-EE1008)、(I)+(III-EE1009)、(I)+(III-EE1010)、(I)+(III-EE1011)、(I)+(III-EE1012)、(I)+(III-EE1013)、(I)+(III-EE1014)、(I)+(III-EE1015)、(I)+(III-EE1016)、(I)+(III-EE1017)、(I)+(III-EE1018)、(I)+(III-EE1019)、(I)+(III-EE1020)、(I)+(III-EE1021)、(I)+(III-EE1022)、(I)+(III-EE1023)、(I)+(III-EE1024)、(I)+(III-EE1025)、(I)+(III-EE1026)、(I)+(III-EE1027)、(I)+(III-EE1028)、(I)+(III-EE1029)、(I)+(III-EE1030)、(I)+(III-EE1031)、(I)+(III-EE1032)、(I)+(III-EE1033)、(I)+(III-EE1034)、(I)+(III-EE1035)、(I)+(III-EE1036)、(I)+(III-EE1037)、(I)+(III-EE1038)、(I)+(III-EE1039)、(I)+(III-EE1040)、(I)+(III-EE1041)、(I)+(III-EE1042)、(I)+(III-EE1043)、(I)+(III-EE1044)、(I)+(III-EE1045)、(I)+(III-EE1046)、(I)+(III-EE1047)、(I)+(III-EE1048)、(I)+(III-FF1001)、(I)+(III-FF1002)、(I)+(III-FF1003)、(I)+(III-FF1004)、(I)+(III-FF1005)、(I)+(III-FF1006)、(I)+(III-FF1007)、(I)+(III-FF1008)、(I)+(III-FF1009)、(I)+(III-FF1010)、(I)+(III-FF1011)、(I)+(III-FF1012)、(I)+(III-FF1013)、(I)+(III-FF1014)、(I)+(III-FF1015)、(I)+(III-FF1016)、(I)+(III-FF1017)、(I)+(III-FF1018)、(I)+(III-FF1019)、(I)+(III-FF1020)、(I)+(III-FF1021)、(I)+(III-FF1022)、(I)+(III-FF1023)。Table 2: (I)+(III-A1001), (I)+(III-A1002), (I)+(III-A1003), (I)+(III-A1004), (I)+(III- A1005), (I)+(III-A1006), (I)+(III-A1007), (I)+(III-A1008), (I)+(III-A1009), (I)+(III- A1010), (I)+(III-A1011), (I)+(III-A1012), (I)+(III-A1013), (I)+(III-A1014), (I)+(III- A1015), (I)+(III-A1016), (I)+(III-A1017), (I)+(III-A1018), (I)+(III-A1019), (I)+(III- A1020), (I)+(III-A1021), (I)+(III-A1022), (I)+(III-A1023), (I)+(III-A1024), (I)+(III- A1025), (I)+(III-A1026), (I)+(III-A2001), (I)+(III-A2002), (I)+(III-A2003), (I)+(III- A2004), (I)+(III-A2005), (I)+(III-A2006), (I)+(III-A2007), (I)+(III-A2008), (I)+(III- A2009), (I)+(III-A2010), (I)+(III-A2011), (I)+(III-A2012), (I)+(III-A2013), (I)+(III- A2014), (I)+(III-A2015), (I)+(III-A2016), (I)+(III-A2017), (I)+(III-A2018), (I)+(III- A2019), (I)+(III-A2020), (I)+(III-A2021), (I)+(III-A2022), (I)+(III-A2023), (I)+(III- A2024), (I)+(III-A2025), (I)+(III-A2026), (I)+(III-A2027), (I)+(III-A2028), (I)+(III- A2029), (I)+(III-A2030), (I)+(III-A2031), (I)+(III-A2032), (I)+(III-A2033), (I)+(III- A2034), (I)+(III-A2035), (I)+(III-A2036), (I)+( III-A2037), (I)+(III-A2038), (I)+(III-A2039), (I)+(III-A2040), (I)+(III-A2041), (I)+( III-A2042), (I)+(III-A2043), (I)+(III-A2044), (I)+(III-A2045), (I)+(III-A2046), (I)+( III-A2047), (I)+(III-A2048), (I)+(III-A2049), (I)+(III-A2050), (I)+(III-A2051), (I)+( III-A2052), (I)+(III-A2053), (I)+(III-A2054), (I)+(III-A2055), (I)+(III-A2056), (I)+( III-A2057), (I)+(III-A2058), (I)+(III-A2059), (I)+(III-A2060), (I)+(III-A2061), (I)+( III-A2062), (I)+(III-A2063), (I)+(III-A2064), (I)+(III-A2065), (I)+(III-B1001), (I)+( III-B1002), (I)+(III-B2001), (I)+(III-B2002), (I)+(III-B2003), (I)+(III-B2004), (I)+( III-B2005), (I)+(III-C1001), (I)+(III-C1002), (I)+(III-C1003), (I)+(III-C1004), (I)+( III-C1005), (I)+(III-C1006), (I)+(III-C1007), (I)+(III-C1008), (I)+(III-C1009), (I)+( III-C1010), (I)+(III-C1011), (I)+(III-C1012), (I)+(III-C1013), (I)+(III-C1014), (I)+( III-C1015), (I)+(III-C1016), (I)+(III-C1017), (I)+(III-C1018), (I)+(III-C1019), (I)+( III-C1020), (I)+(III-C1021), (I)+(III-C1022), (I)+(III-C1023), (I)+(III-C1024), (I)+( III-C1025), (I)+(III-C1026), (I)+(III-C102 7), (I)+(III-C1028), (I)+(III-C1029), (I)+(III-C1030), (I)+(III-C1031), (I)+(III- C1032), (I)+(III-C1033), (I)+(III-C1034), (I)+(III-C1035), (I)+(III-C1036), (I)+(III- C1037), (I)+(III-C1038), (I)+(III-C1039), (I)+(III-C1040), (I)+(III-C1041), (I)+(III- C1042), (I)+(III-C1043), (I)+(III-C1044), (I)+(III-C1045), (I)+(III-C1046), (I)+(III- C1047), (I)+(III-C1048), (I)+(III-C1049), (I)+(III-C2001), (I)+(III-C2002), (I)+(III- D1001), (I)+(III-D1002), (I)+(III-D1003), (I)+(III-D1004), (I)+(III-D1005), (I)+(III- D1006), (I)+(III-D1007), (I)+(III-D1008), (I)+(III-D1009), (I)+(III-D1010), (I)+(III- D2001), (I)+(III-D3001), (I)+(III-D4001), (I)+(III-D5001), (I)+(III-D5002), (I)+(III- D6001), (I)+(III-E1001), (I)+(III-E1002), (I)+(III-F1001), (I)+(III-F1002), (I)+(III- F1003), (I)+(III-F1004), (I)+(III-G1001), (I)+(III-G1002), (I)+(III-G1003), (I)+(III- G2001), (I)+(III-G3001), (I)+(III-H4001), (I)+(III-H4002), (I)+(III-H4003), (I)+(III- H4004), (I)+(III-H4005), (I)+(III-H5001), (I)+(III-H6001), (I)+(III-H6002), (I)+(III- I1001), (I)+(III-I1002), (I)+(III-I2001), (I)+( III-J1001), (I)+(III-J1002), (I)+(III-J1003), (I)+(III-J2003), (I)+(III-K1001), (I)+( III-K1002), (I)+(III-K1003), (I)+(III-K1004), (I)+(III-K1005), (I)+(III-K1006), (I)+( III-K1007), (I)+(III-K1008), (I)+(III-K1009), (I)+(III-K1010), (I)+(III-K1011), (I)+( III-K1012), (I)+(III-K1013), (I)+(III-K1014), (I)+(III-K1015), (I)+(III-K2001), (I)+( III-L1001), (I)+(III-L2001), (I)+(III-L2002), (I)+(III-L2003), (I)+(III-L3001), (I)+( III-L4001), (I)+(III-M1001), (I)+(III-M2001), (I)+(III-M3001), (I)+(III-N1001), (I)+( III-N1002), (I)+(III-N1003), (I)+(III-N1004), (I)+(III-O1001), (I)+(III-O1002), (I)+( III-O1003), (I)+(III-O1004), (I)+(III-O1005), (I)+(III-O1006), (I)+(III-O1007), (I)+( III-O1008), (I)+(III-O1009), (I)+(III-O1010), (I)+(III-O1011), (I)+(III-P1001), (I)+( III-Q1001), (I)+(III-R1001), (I)+(III-R1002), (I)+(III-R1003), (I)+(III-R1004), (I)+( III-R1005), (I)+(III-S1001), (I)+(III-T1001), (I)+(III-T2001), (I)+(III-T3001), (I)+( III-T4001), (I)+(III-U1001), (I)+(III-U1002), (I)+(III-U1003), (I)+(III-U1004), (I)+( III-U1005), (I)+(III-U1006), (I)+(III-U200 1), (I)+(III-V1001), (I)+(III-V2001), (I)+(III-V3001), (I)+(III-V4001), (I)+(III- W1001), (I)+(III-W1002), (I)+(III-W1003), (I)+(III-W1004), (I)+(III-X1001), (I)+(III- X1002), (I)+(III-X1003), (I)+(III-X1004), (I)+(III-X2001), (I)+(III-X2002), (I)+(III- X2003), (I)+(III-Y1001), (I)+(III-Y1002), (I)+(III-Y2001), (I)+(III-Z1001), (I)+(III- Z1002), (I)+(III-Z1003), (I)+(III-Z1004), (I)+(III-Z1005), (I)+(III-Z1006), (I)+(III- Z1007), (I)+(III-Z1008), (I)+(III-Z1009), (I)+(III-Z1010), (I)+(III-Z1011), (I)+(III- Z1012), (I)+(III-Z1013), (I)+(III-Z1014), (I)+(III-AA1001), (I)+(III-BB1001), (I)+(III- BB2001), (I)+(III-BB2002), (I)+(III-CC1001), (I)+(III-CC1002), (I)+(III-CC2001), (I)+(III- CC2002), (I)+(III-DD1001), (I)+(III-EE1001), (I)+(III-EE1002), (I)+(III-EE1003), (I)+(III- EE1004), (I)+(III-EE1005), (I)+(III-EE1006), (I)+(III-EE1007), (I)+(III-EE1008), (I)+(III- EE1009), (I)+(III-EE1010), (I)+(III-EE1011), (I)+(III-EE1012), (I)+(III-EE1013), (I)+(III- EE1014), (I)+(III-EE1015), (I)+(III-EE1016), (I)+(III-EE1017), (I)+(III-EE1018), (I)+(III- EE1019), (I)+(III- EE1020), (I)+(III-EE1021), (I)+(III-EE1022), (I)+(III-EE1023), (I)+(III-EE1024), (I)+(III- EE1025), (I)+(III-EE1026), (I)+(III-EE1027), (I)+(III-EE1028), (I)+(III-EE1029), (I)+(III- EE1030), (I)+(III-EE1031), (I)+(III-EE1032), (I)+(III-EE1033), (I)+(III-EE1034), (I)+(III- EE1035), (I)+(III-EE1036), (I)+(III-EE1037), (I)+(III-EE1038), (I)+(III-EE1039), (I)+(III- EE1040), (I)+(III-EE1041), (I)+(III-EE1042), (I)+(III-EE1043), (I)+(III-EE1044), (I)+(III- EE1045), (I)+(III-EE1046), (I)+(III-EE1047), (I)+(III-EE1048), (I)+(III-FF1001), (I)+(III- FF1002), (I)+(III-FF1003), (I)+(III-FF1004), (I)+(III-FF1005), (I)+(III-FF1006), (I)+(III- FF1007), (I)+(III-FF1008), (I)+(III-FF1009), (I)+(III-FF1010), (I)+(III-FF1011), (I)+(III- FF1012), (I)+(III-FF1013), (I)+(III-FF1014), (I)+(III-FF1015), (I)+(III-FF1016), (I)+(III- FF1017), (I)+(III-FF1018), (I)+(III-FF1019), (I)+(III-FF1020), (I)+(III-FF1021), (I)+(III- FF1022), (I)+(III-FF1023).

在一實施例中,組分 (1)與組分 (2)間的重量比在表1的組合[(I)+(II-A001)至(I)+(II-R047)]中或是在表2的組合[(I)+(III-A1001)至(I)+(III-FF1023)]中係介於5,000:1至1:5,000之間。In one embodiment, the weight ratio between component (1) and component (2) is in the combination [(I)+(II-A001) to (I)+(II-R047)] of Table 1 or In the combination [(I)+(III-A1001) to (I)+(III-FF1023)] in Table 2, it is between 5,000:1 and 1:5,000.

在一實施例中,組分 (1)與組分 (2)間的重量比在表1的組合[(I)+(II-A001)至(I)+(II-R047)]中或是在表2的組合[(I)+(III-A1001)至(I)+(III-FF1023)]中係介於1,000:1至1:1,000之間。In one embodiment, the weight ratio between component (1) and component (2) is in the combination [(I)+(II-A001) to (I)+(II-R047)] of Table 1 or In the combination [(I)+(III-A1001) to (I)+(III-FF1023)] in Table 2, it is between 1,000:1 and 1:1,000.

在一實施例中,組分 (1)與組分 (2)間的重量比在表1的組合[(I)+(II-A001)至(I)+(II-R047)]中或是在表2的組合[(I)+(III-A1001)至(I)+(III-FF1023)]中係介於500:1至1:500之間。In one embodiment, the weight ratio between component (1) and component (2) is in the combination [(I)+(II-A001) to (I)+(II-R047)] of Table 1 or In the combination [(I)+(III-A1001) to (I)+(III-FF1023)] in Table 2, it is between 500:1 and 1:500.

在一實施例中,組分 (1)與組分 (2)間的重量比在表1的組合[(I)+(II-A001)至(I)+(II-R047)]中或是在表2的組合[(I)+(III-A1001)至(I)+(III-FF1023)]中係介於100:1至1:100之間。In one embodiment, the weight ratio between component (1) and component (2) is in the combination [(I)+(II-A001) to (I)+(II-R047)] of Table 1 or In the combination [(I)+(III-A1001) to (I)+(III-FF1023)] in Table 2, it is between 100:1 and 1:100.

在一實施例中,組分 (1)與組分 (2)間的重量比在表1的組合[(I)+(II-A001)至(I)+(II-R047)]中或是在表2的組合[(I)+(III-A1001)至(I)+(III-FF1023)]中係介於50:1至1:50之間。In one embodiment, the weight ratio between component (1) and component (2) is in the combination [(I)+(II-A001) to (I)+(II-R047)] of Table 1 or In the combination [(I)+(III-A1001) to (I)+(III-FF1023)] in Table 2, it is between 50:1 and 1:50.

在一實施例中,組分 (1)與組分 (2)間的重量比在表1的組合[(I)+(II-A001)至(I)+(II-R047)]中或是在表2的組合[(I)+(III-A1001)至(I)+(III-FF1023)]中係介於20:1至1:20之間。In one embodiment, the weight ratio between component (1) and component (2) is in the combination [(I)+(II-A001) to (I)+(II-R047)] of Table 1 or In the combination [(I)+(III-A1001) to (I)+(III-FF1023)] in Table 2, it is between 20:1 and 1:20.

在一實施例中,組分 (1)與組分 (2)間的重量比在表1的組合[(I)+(II-A001)至(I)+(II-R047)]中或是在表2的組合[(I)+(III-A1001)至(I)+(III-FF1023)]中係介於5:1至1:5之間。In one embodiment, the weight ratio between component (1) and component (2) is in the combination [(I)+(II-A001) to (I)+(II-R047)] of Table 1 or In the combination [(I)+(III-A1001) to (I)+(III-FF1023)] in Table 2, it is between 5:1 and 1:5.

在一實施例中,組分 (1)與組分 (2)間的重量比在表1的組合[(I)+(II-A001)至(I)+(II-R047)]中或是在表2的組合[(I)+(III-A1001)至(I)+(III-FF1023)]中係介於3:1至1:3之間。In one embodiment, the weight ratio between component (1) and component (2) is in the combination [(I)+(II-A001) to (I)+(II-R047)] of Table 1 or In the combination [(I)+(III-A1001) to (I)+(III-FF1023)] in Table 2, it is between 3:1 and 1:3.

在一實施例中,組分 (1)與組分 (2)間的重量比在表1的組合[(I)+(II-A001)至(I)+(II-R047)]中或是在表2的組合[(I)+(III-A1001)至(I)+(III-FF1023)]中係介於2:1至1:2之間。In one embodiment, the weight ratio between component (1) and component (2) is in the combination [(I)+(II-A001) to (I)+(II-R047)] of Table 1 or In the combination [(I)+(III-A1001) to (I)+(III-FF1023)] in Table 2, it is between 2:1 and 1:2.

在一實施例中,組分 (1)與組分 (2)間的重量比在表1的組合[(I)+(II-A001)至(I)+(II-R047)]中或是在表2的組合[(I)+(III-A1001)至(I)+(III-FF1023)]中係1:1。In one embodiment, the weight ratio between component (1) and component (2) is in the combination [(I)+(II-A001) to (I)+(II-R047)] of Table 1 or In the combination [(I)+(III-A1001) to (I)+(III-FF1023)] of Table 2 is 1:1.

在一實施例中,如下方表3和表4中所列出的組合,其中組分 (1)係化合物 (I-1)且組分 (2)係選自如本文中所定義的(III-A1001)至(III-FF1023)各組:In one embodiment, the combinations listed in Table 3 and Table 4 below, wherein component (1) is compound (I-1) and component (2) is selected from (III-1) as defined herein A1001) to (III-FF1023) each group:

在一實施例中,如下方表3所列之組合,其中組分 (1)係化合物 (I-1)且組分 (2)係選自如本文中所定義的(II-A001)至(II-R047)各組。據此,舉例而言,若組分 (2)為(II-A001) 環克座 (cyproconazole),則該組合將表示成 「(I-1)+(II-A001)」。In one embodiment, the combination as listed in Table 3 below, wherein component (1) is compound (I-1) and component (2) is selected from (II-A001) to (II) as defined herein -R047) each group. Accordingly, for example, if component (2) is (II-A001) cyproconazole, the combination would be expressed as "(I-1)+(II-A001)".

表3:(I-1)+(II-A001)、(I-1)+(II-A002)、(I-1)+(II-A003)、(I-1)+(II-A004)、(I-1)+(II-A005)、(I-1)+(II-A006)、(I-1)+(II-A007)、(I-1)+(II-A008)、(I-1)+(II-A009)、(I-1)+(II-A010)、(I-1)+(II-A011)、(I-1)+(II-A012)、(I-1)+(II-A013)、(I-1)+(II-A014)、(I-1)+(II-A015)、(I-1)+(II-A016)、(I-1)+(II-A017)、(I-1)+(II-A018)、(I-1)+(II-A019)、(I-1)+(II-A020)、(I-1)+(II-A021)、(I-1)+(II-A022)、(I-1)+(II-A023)、(I-1)+(II-A024)、(I-1)+(II-A025)、(I-1)+(II-A026)、(I-1)+(II-A027)、(I-1)+(II-A028)、(I-1)+(II-A029)、(I-1)+(II-A030)、(I-1)+(II-A031)、(I-1)+(II-A032)、(I-1)+(II-A033)、(I-1)+(II-A034)、(I-1)+(II-A035)、(I-1)+(II-A036)、(I-1)+(II-A037)、(I-1)+(II-A038)、(I-1)+(II-A039)、(I-1)+(II-A040)、(I-1)+(II-A041)、(I-1)+(II-A042)、(I-1)+(II-A043)、(I-1)+(II-A044)、(I-1)+(II-A045)、(I-1)+(II-A046)、(I-1)+(II-A047)、(I-1)+(II-A048)、(I-1)+(II-A049)、(I-1)+(II-A050)、(I-1)+(II-A051)、(I-1)+(II-A052)、(I-1)+(II-A053)、(I-1)+(II-A054)、(I-1)+(II-A055)、(I-1)+(II-A056)、(I-1)+(II-A057)、(I-1)+(II-A058)、(I-1)+(II-A059)、(I-1)+(II-A060)、(I-1)+(II-A061)、(I-1)+(II-A062)、(I-1)+(II-A063)、(I-1)+(II-A064)、(I-1)+(II-A065)、(I-1)+(II-A066)、(I-1)+(II-A067)、(I-1)+(II-A068)、(I-1)+(II-A069)、(I-1)+(II-A070)、(I-1)+(II-A071)、(I-1)+(II-A072)、(I-1)+(II-A073)、(I-1)+(II-A074)、(I-1)+(II-A075)、(I-1)+(II-A076)、(I-1)+(II-A077)、(I-1)+(II-A078)、(I-1)+(II-A079)、(I-1)+(II-A080)、(I-1)+(II-A081)、(I-1)+(II-A082)、(I-1)+(II-A083)、(I-1)+(II-A084)、(I-1)+(II-A085)、(I-1)+(II-A086)、(I-1)+(II-A087)、(I-1)+(II-A088)、(I-1)+(II-A089)、(I-1)+(II-A090)、(I-1)+(II-A091)、(I-1)+(II-A092)、(I-1)+(II-A093)、(I-1)+(II-A094)、(I-1)+(II-A095)、(I-1)+(II-A096)、(I-1)+(II-A097)、(I-1)+(II-A098)、(I-1)+(II-A099)、(I-1)+(II-A100)、(I-1)+(II-A101)、(I-1)+(II-A102)、(I-1)+(II-A103)、(I-1)+(II-A104)、(I-1)+(II-A105)、(I-1)+(II-A106)、(I-1)+(II-A107)、(I-1)+(II-A108)、(I-1)+(II-A109)、(I-1)+(II-A110)、(I-1)+(II-A111)、(I-1)+(II-A112)、(I-1)+(II-A113)、(I-1)+(II-A114)、(I-1)+(II-A115)、(I-1)+(II-A116)、(I-1)+(II-A117)、(I-1)+(II-B001)、(I-1)+(II-B002)、(I-1)+(II-B003)、(I-1)+(II-B004)、(I-1)+(II-B005)、(I-1)+(II-B006)、(I-1)+(II-B007)、(I-1)+(II-B008)、(I-1)+(II-B009)、(I-1)+(II-B010)、(I-1)+(II-B011)、(I-1)+(II-B012)、(I-1)+(II-B013)、(I-1)+(II-B014)、(I-1)+(II-B015)、(I-1)+(II-B016)、(I-1)+(II-B017)、(I-1)+(II-B018)、(I-1)+(II-B019)、(I-1)+(II-B020)、(I-1)+(II-B021)、(I-1)+(II-B022)、(I-1)+(II-B023)、(I-1)+(II-B024)、(I-1)+(II-B025)、(I-1)+(II-B026)、(I-1)+(II-B027)、(I-1)+(II-B028)、(I-1)+(II-B029)、(I-1)+(II-B030)、(I-1)+(II-B031)、(I-1)+(II-B032)、(I-1)+(II-B033)、(I-1)+(II-B034)、(I-1)+(II-B035)、(I-1)+(II-B036)、(I-1)+(II-B037)、(I-1)+(II-B038)、(I-1)+(II-B039)、(I-1)+(II-B040)、(I-1)+(II-B041)、(I-1)+(II-B042)、(I-1)+(II-B043)、(I-1)+(II-B044)、(I-1)+(II-B045)、(I-1)+(II-B046)、(I-1)+(II-B047)、(I-1)+(II-B048)、(I-1)+(II-B049)、(I-1)+(II-B050)、(I-1)+(II-B051)、(I-1)+(II-B052)、(I-1)+(II-B053)、(I-1)+(II-B054)、(I-1)+(II-B055)、(I-1)+(II-B056)、(I-1)+(II-B057)、(I-1)+(II-B058)、(I-1)+(II-B059)、(I-1)+(II-B060)、(I-1)+(II-B061)、(I-1)+(II-B062)、(I-1)+(II-B063)、(I-1)+(II-B064)、(I-1)+(II-B065)、(I-1)+(II-B066)、(I-1)+(II-B068)、(I-1)+(II-B069)、(I-1)+(II-C001)、(I-1)+(II-C002)、(I-1)+(II-C003)、(I-1)+(II-C004)、(I-1)+(II-C005)、(I-1)+(II-C006)、(I-1)+(II-C007)、(I-1)+(II-C008)、(I-1)+(II-C009)、(I-1)+(II-C010)、(I-1)+(II-C011)、(I-1)+(II-C012)、(I-1)+(II-C013)、(I-1)+(II-C014)、(I-1)+(II-C015)、(I-1)+(II-C016)、(I-1)+(II-C017)、(I-1)+(II-C018)、(I-1)+(II-C019)、(I-1)+(II-C020)、(I-1)+(II-C021)、(I-1)+(II-C022)、(I-1)+(II-C023)、(I-1)+(II-C024)、(I-1)+(II-C025)、(I-1)+(II-C026)、(I-1)+(II-C027)、(I-1)+(II-C028)、(I-1)+(II-C029)、(I-1)+(II-C030)、(I-1)+(II-C031)、(I-1)+(II-C032)、(I)+ (II-C033)、(I)+ (II-C034)、(I-1)+(II-D001)、(I-1)+(II-D002)、(I-1)+(II-D003)、(I-1)+(II-D004)、(I-1)+(II-D005)、(I-1)+(II-D006)、(I-1)+(II-D007)、(I-1)+(II-D008)、(I-1)+(II-D009)、(I-1)+(II-D010)、(I-1)+(II-D011)、(I-1)+(II-D012)、(I-1)+(II-D013)、(I-1)+(II-D014)、(I-1)+(II-D015)、(I-1)+(II-D016)、(I-1)+(II-D017)、(I-1)+(II-D018)、(I-1)+(II-D019)、(I-1)+(II-D020)、(I-1)+(II-D021)、(I-1)+(II-D022)、(I-1)+(II-D023)、(I-1)+(II-D024)、(I-1)+(II-D025)、(I-1)+(II-D026)、(I-1)+(II-E001)、(I-1)+(II-E002)、(I-1)+(II-E003)、(I-1)+(II-E004)、(I-1)+(II-E005)、(I-1)+(II-E006)、(I-1)+(II-E007)、(I-1)+(II-E008)、(I-1)+(II-E009)、(I-1)+(II-E010)、(I-1)+(II-E011)、(I-1)+(II-E012)、(I-1)+(II-E013)、(I-1)+(II-E014)、(I-1)+(II-E015)、(I-1)+(II-E016)、(I-1)+(II-E017)、(I-1)+(II-E018)、(I-1)+(II-E019)、(I-1)+(II-E020)、(I-1)+(II-E021)、(I-1)+(II-E022)、(I-1)+(II-E023)、(I-1)+(II-E024)、(I-1)+(II-E025)、(I-1)+(II-E026)、(I-1)+(II-E027)、(I-1)+(II-E028)、(I-1)+(II-E029)、(I-1)+(II-E030)、(I-1)+(II-F001)、(I-1)+(II-F002)、(I-1)+(II-F003)、(I-1)+(II-F004)、(I-1)+(II-G001)、(I-1)+(II-G002)、(I-1)+(II-G003)、(I-1)+(II-G004)、(I-1)+(II-G005)、(I-1)+(II-G006)、(I-1)+(II-G007)、(I-1)+(II-G008)、(I-1)+(II-G009)、(I-1)+(II-G0010)、(I-1)+(II-G0011)、(I-1)+(II-H001)、(I-1)+(II-H002)、(I-1)+(II-H003)、(I-1)+(II-H004)、(I-1)+(II-I001)、(I-1)+(II-I002)、(I-1)+(II-I003)、(I-1)+(II-I004)、(I-1)+(II-I005)、(I-1)+(II-I006)、(I-1)+(II-I007)、(I-1)+(II-I008)、(I-1)+(II-I009)、(I-1)+(II-I010)、(I-1)+(II-I011)、(I-1)+(II-I012)、(I-1)+(II-I013)、(I-1)+(II-I014)、(I-1)+(II-J001)、(I-1)+(II-J002)、(I-1)+(II-J003)、(I-1)+(II-J004)、(I-1)+(II-J005)、(I-1)+(II-J006)、(I-1)+(II-J007)、(I-1)+(II-J008)、(I-1)+(II-J009)、(I-1)+(II-J0010)、(I-1)+(II-J011)、(I-1)+(II-J012)、(I-1)+(II-J013)、(I-1)+(II-J014)、(I-1)+(II-J015)、(I-1)+(II-J015)、(I-1)+(II-J016)、(I-1)+(II-K001)、(I-1)+(II-K002)、(I-1)+(II-K003)、(I-1)+(II-K004)、(I-1)+(II-K005)、(I-1)+(II-K006)、(I-1)+(II-K007)、(I-1)+(II-L001)、(I-1)+(II-L002)、(I-1)+(II-L003)、(I-1)+(II-L004)、(I-1)+(II-L005)、(I-1)+(II-L006)、(I-1)+(II-L007)、(I-1)+(II-L008)、(I-1)+(II-L009)、(I-1)+(II-L010)、(I-1)+(II-L011)、(I-1)+(II-L012)、(I-1)+(II-M001)、(I-1)+(II-M002)、(I-1)+(II-M003)、(I-1)+(II-M004)、(I-1)+(II-M005)、(I-1)+(II-M006)、(I-1)+(II-M007)、(I-1)+(II-M008)、(I-1)+(II-M009)、(I-1)+(II-M010)、(I-1)+(II-N001)、(I-1)+(II-N002)、(I-1)+(II-N003)、(I-1)+(II-N004)、(I-1)+(II-O001)、(I-1)+(II-O002)、(I-1)+(II-O003)、(I-1)+(II-O004)、(I-1)+(II-O005)、(I-1)+(II-O006)、(I-1)+(II-O007)、(I-1)+(II-O008)、(I-1)+(II-O009)、(I-1)+(II-O010)、(I-1)+(II-O011)、(I-1)+(II-O012)、(I-1)+(II-O013)、(I-1)+(II-O014)、(I-1)+(II-O015)、(I-1)+(II-O016)、(I-1)+(II-O017)、(I-1)+(II-O018)、(I-1)+(II-O019)、(I-1)+(II-O020)、(I-1)+(II-O021)、(I-1)+(II-O022)、(I-1)+(II-O023)、(I-1)+(II-O024)、(I-1)+(II-O025)、(I-1)+(II-O026)、(I-1)+(II-O027)、(I-1)+(II-O028)、(I-1)+(II-O029)、(I-1)+(II-O030)、(I-1)+(II-O031)、(I-1)+(II-O032)、(I-1)+(II-O033)、(I-1)+(II-O034)、(I-1)+(II-O035)、(I-1)+(II-O036)、(I-1)+(II-O037)、(I-1)+(II-O038)、(I-1)+(II-O039)、(I-1)+(II-O040)、(I-1)+(II-O041)、(I-1)+(II-O042)、(I-1)+(II-O043)、(I-1)+(II-O044)、(I-1)+(II-O045)、(I-1)+(II-O046)、(I-1)+(II-O047)、(I-1)+(II-O048)、(I-1)+(II-O049)、(I-1)+(II-O050)、(I-1)+(II-O051)、(I-1)+(II-O052)、(I-1)+(II-O053)、(I-1)+(II-O054)、(I-1)+(II-O055)、(I-1)+(II-O056)、(I-1)+(II-O057)、(I-1)+(II-O058)、(I-1)+(II-O059)、(I-1)+(II-O060)、(I-1)+(II-O061)、(I-1)+(II-O062)、(I-1)+(II-O063)、(I-1)+(II-O064)、(I-1)+(II-O065)、(I-1)+(II-O066)、(I-1)+(II-O067)、(I-1)+(II-O068)、(I-1)+(II-O069)、(I-1)+(II-O070)、(I-1)+(II-O071)、(I-1)+(II-O072)、(I-1)+(II-O073)、(I-1)+(II-O074)、(I-1)+(II-O075)、(I-1)+(II-O076)、(I-1)+(II-O077)、(I-1)+(II-O078)、(I-1)+(II-O079)、(I-1)+(II-O080)、(I-1)+(II-O081)、(I-1)+(II-O082)、(I-1)+(II-O083)、(I-1)+(II-O084)、(I-1)+(II-O085)、(I-1)+(II-O086)、(I-1)+(II-O087)、(I-1)+(II-O088)、(I-1)+(II-P001)、(I-1)+(II-P002)、(I-1)+(II-P003)、(I-1)+(II-P004)、(I-1)+(II-P005)、(I-1)+(II-P006)、(I-1)+(II-P007)、(I-1)+(II-P008)、(I-1)+(II-P009)、(I-1)+(II-P010)、(I-1)+(II-P011)、(I-1)+(II-P012)、(I-1)+(II-P013)、(I-1)+(II-P014)、(I-1)+(II-P015)、(I-1)+(II-P016)、(I-1)+(II-P017)、(I-1)+(II-P018)、(I-1)+(II-P019)、(I-1)+(II-P020)、(I-1)+(II-P021)、(I-1)+(II-P022)、(I-1)+(II-P023)、(I-1)+(II-P024)、(I-1)+(II-P025)、(I-1)+(II-P026)、(I-1)+(II-P027)、(I-1)+(II-P028)、(I-1)+(II-P029)、(I-1)+(II-P030)、(I-1)+(II-P031)、(I-1)+(II-P032)、(I-1)+(II-P033)、(I-1)+(II-P034)、(I-1)+(II-P035)、(I-1)+(II-P036)、(I-1)+(II-P037)、(I-1)+(II-P038)、(I-1)+(II-P039)、(I-1)+(II-P040)、(I-1)+(II-P041)、(I-1)+(II-P042)、(I-1)+(II-P043)、(I-1)+(II-P044)、(I-1)+(II-P045)、(I-1)+(II-P046)、(I-1)+(II-P047)、(I-1)+(II-P048)、(I-1)+(II-P049)、(I-1)+(II-P050)、(I-1)+(II-P051)、(I-1)+(II-P052)、(I-1)+(II-P053)、(I-1)+(II-P054)、(I-1)+(II-P055)、(I-1)+(II-P056)、(I-1)+(II-P057)、(I-1)+(II-P058)、(I-1)+(II-P059)、(I-1)+(II-P060)、(I-1)+(II-P061)、(I-1)+(II-P062)、(I-1)+(II-P063)、(I-1)+(II-P064)、(I-1)+(II-P065)、(I-1)+(II-P066)、(I-1)+(II-P067)、(I-1)+(II-P068)、(I-1)+(II-P069)、(I-1)+(II-P070)、(I-1)+(II-P071)、(I-1)+(II-P072)、(I-1)+(II-P073)、(I-1)+(II-P074)、(I-1)+(II-P075)、(I-1)+(II-P076)、(I-1)+(II-P077)、(I-1)+(II-P078)、(I-1)+(II-P079)、(I-1)+(II-P080)、(I-1)+(II-P081)、(I-1)+(II-P082)、(I-1)+(II-P083)、(I-1)+(II-P084)、(I-1)+(II-P085)、(I-1)+(II-P086)、(I-1)+(II-P087)、(I-1)+(II-P088)、(I-1)+(II-P089)、(I-1)+(II-P090)、(I-1)+(II-P091)、(I-1)+(II-P092)、(I-1)+(II-P093)、(I-1)+(II-P094)、(I-1)+(II-P095)、(I-1)+(II-P096)、(I-1)+(II-P097)、(I-1)+(II-P098)、(I-1)+(II-P099)、(I-1)+(II-P100)、(I-1)+(II-P101)、(I-1)+(II-P102)、(I-1)+(II-P103)、(I-1)+(II-P104)、(I-1)+(II-Q001)、(I-1)+(II-Q002)、(I-1)+(II-Q003)、(I-1)+(II-Q004)、(I-1)+(II-Q005)、(I-1)+(II-Q006)、(I-1)+(II-Q007)、(I-1)+(II-Q008)、(I-1)+(II-Q009)、(I-1)+(II-Q010)、(I-1)+(II-Q011)、(I-1)+(II-Q012)、(I-1)+(II-Q013)、(I-1)+(II-Q014)、(I-1)+(II-Q015)、(I-1)+(II-Q016)、(I-1)+(II-Q017)、(I-1)+(II-Q018)、(I-1)+(II-Q019)、(I-1)+(II-Q020)、(I-1)+(II-Q021)、(I-1)+(II-Q022)、(I-1)+(II-Q023)、(I-1)+(II-Q024)、(I-1)+(II-Q025)、(I-1)+(II-Q026)、(I-1)+(II-Q027)、(I-1)+(II-Q028)、(I-1)+(II-Q029)、(I-1)+(II-Q030)、(I-1)+(II-Q031)、(I-1)+(II-Q032)、(I-1)+(II-Q033)、(I-1)+(II-Q034)、(I-1)+(II-R001)、(I-1)+(II-R002)、(I-1)+(II-R003)、(I-1)+(II-R004)、(I-1)+(II-R005)、(I-1)+(II-R006)、(I-1)+(II-R007)、(I-1)+(II-R008)、(I-1)+(II-R009)、(I-1)+(II-R010)、(I-1)+(II-R011)、(I-1)+(II-R012)、(I-1)+(II-R013)、(I-1)+(II-R014)、(I-1)+(II-R015)、(I-1)+(II-R016)、(I-1)+(II-R017)、(I-1)+(II-R018)、(I-1)+(II-R019)、(I-1)+(II-R020)、(I-1)+(II-R021)、(I-1)+(II-R022)、(I-1)+(II-R023)、(I-1)+(II-R024)、(I-1)+(II-R025)、(I-1)+(II-R026)、(I-1)+(II-R027)、(I-1)+(II-R028)、(I-1)+(II-R029)、(I-1)+(II-R030)、(I-1)+(II-R031)、(I-1)+(II-R032)、(I-1)+(II-R033)、(I-1)+(II-R034)、(I-1)+(II-R035)、(I-1)+(II-R036)、(I-1)+(II-R037)、(I-1)+(II-R038)、(I-1)+(II-R039)、(I-1)+(II-R040)、(I-1)+(II-R041)、(I-1)+(II-R042)、(I-1)+(II-R043)、(I-1)+(II-R044)、(I-1)+(II-R045)、(I-1)+(II-R046)、(I-1)+(II-R047)。Table 3: (I-1)+(II-A001), (I-1)+(II-A002), (I-1)+(II-A003), (I-1)+(II-A004) , (I-1)+(II-A005), (I-1)+(II-A006), (I-1)+(II-A007), (I-1)+(II-A008), ( I-1)+(II-A009), (I-1)+(II-A010), (I-1)+(II-A011), (I-1)+(II-A012), (I- 1)+(II-A013), (I-1)+(II-A014), (I-1)+(II-A015), (I-1)+(II-A016), (I-1) +(II-A017), (I-1)+(II-A018), (I-1)+(II-A019), (I-1)+(II-A020), (I-1)+( II-A021), (I-1)+(II-A022), (I-1)+(II-A023), (I-1)+(II-A024), (I-1)+(II- A025), (I-1)+(II-A026), (I-1)+(II-A027), (I-1)+(II-A028), (I-1)+(II-A029) , (I-1)+(II-A030), (I-1)+(II-A031), (I-1)+(II-A032), (I-1)+(II-A033), ( I-1)+(II-A034), (I-1)+(II-A035), (I-1)+(II-A036), (I-1)+(II-A037), (I- 1)+(II-A038), (I-1)+(II-A039), (I-1)+(II-A040), (I-1)+(II-A041), (I-1) +(II-A042), (I-1)+(II-A043), (I-1)+(II-A044), (I-1)+(II-A045), (I-1)+( II-A046), (I-1)+(II-A047), (I-1)+(II-A048), (I-1)+(II-A049), (I-1)+(II- A050), (I-1)+(II-A051), (I-1)+(II-A052), (I-1)+(II-A053), (I-1)+(II-A054) , (I-1)+(II-A055), (I-1)+(II-A056), (I-1)+(II-A057), (I-1)+(II-A058), ( I-1)+(II-A059), (I-1)+(II-A060), (I-1)+(II-A061), (I-1)+(II-A062), (I- 1) +(II-A063), (I-1)+(II-A064), (I-1)+(II-A065), (I-1)+(II-A066), (I-1)+( II-A067), (I-1)+(II-A068), (I-1)+(II-A069), (I-1)+(II-A070), (I-1)+(II- A071), (I-1)+(II-A072), (I-1)+(II-A073), (I-1)+(II-A074), (I-1)+(II-A075) , (I-1)+(II-A076), (I-1)+(II-A077), (I-1)+(II-A078), (I-1)+(II-A079), ( I-1)+(II-A080), (I-1)+(II-A081), (I-1)+(II-A082), (I-1)+(II-A083), (I- 1)+(II-A084), (I-1)+(II-A085), (I-1)+(II-A086), (I-1)+(II-A087), (I-1) +(II-A088), (I-1)+(II-A089), (I-1)+(II-A090), (I-1)+(II-A091), (I-1)+( II-A092), (I-1)+(II-A093), (I-1)+(II-A094), (I-1)+(II-A095), (I-1)+(II- A096), (I-1)+(II-A097), (I-1)+(II-A098), (I-1)+(II-A099), (I-1)+(II-A100) , (I-1)+(II-A101), (I-1)+(II-A102), (I-1)+(II-A103), (I-1)+(II-A104), ( I-1)+(II-A105), (I-1)+(II-A106), (I-1)+(II-A107), (I-1)+(II-A108), (I- 1)+(II-A109), (I-1)+(II-A110), (I-1)+(II-A111), (I-1)+(II-A112), (I-1) +(II-A113), (I-1)+(II-A114), (I-1)+(II-A115), (I-1)+(II-A116), (I-1)+( II-A117), (I-1)+(II-B001), (I-1)+(II-B002), (I-1)+(II-B003), (I-1)+(II- B004), (I-1)+(II-B005), (I-1)+(II-B006), (I-1)+(II-B007), (I-1)+(II-B00 8), (I-1)+(II-B009), (I-1)+(II-B010), (I-1)+(II-B011), (I-1)+(II-B012) , (I-1)+(II-B013), (I-1)+(II-B014), (I-1)+(II-B015), (I-1)+(II-B016), ( I-1)+(II-B017), (I-1)+(II-B018), (I-1)+(II-B019), (I-1)+(II-B020), (I- 1)+(II-B021), (I-1)+(II-B022), (I-1)+(II-B023), (I-1)+(II-B024), (I-1) +(II-B025), (I-1)+(II-B026), (I-1)+(II-B027), (I-1)+(II-B028), (I-1)+( II-B029), (I-1)+(II-B030), (I-1)+(II-B031), (I-1)+(II-B032), (I-1)+(II- B033), (I-1)+(II-B034), (I-1)+(II-B035), (I-1)+(II-B036), (I-1)+(II-B037) , (I-1)+(II-B038), (I-1)+(II-B039), (I-1)+(II-B040), (I-1)+(II-B041), ( I-1)+(II-B042), (I-1)+(II-B043), (I-1)+(II-B044), (I-1)+(II-B045), (I- 1)+(II-B046), (I-1)+(II-B047), (I-1)+(II-B048), (I-1)+(II-B049), (I-1) +(II-B050), (I-1)+(II-B051), (I-1)+(II-B052), (I-1)+(II-B053), (I-1)+( II-B054), (I-1)+(II-B055), (I-1)+(II-B056), (I-1)+(II-B057), (I-1)+(II- B058), (I-1)+(II-B059), (I-1)+(II-B060), (I-1)+(II-B061), (I-1)+(II-B062) , (I-1)+(II-B063), (I-1)+(II-B064), (I-1)+(II-B065), (I-1)+(II-B066), ( I-1)+(II-B068), (I-1)+(II-B069), (I-1)+(II-C001), (I-1)+(II-C002), (I- 1) +(II-C003), (I-1)+(II-C004), (I-1)+(II-C005), (I-1)+(II-C006), (I-1)+( II-C007), (I-1)+(II-C008), (I-1)+(II-C009), (I-1)+(II-C010), (I-1)+(II- C011), (I-1)+(II-C012), (I-1)+(II-C013), (I-1)+(II-C014), (I-1)+(II-C015) , (I-1)+(II-C016), (I-1)+(II-C017), (I-1)+(II-C018), (I-1)+(II-C019), ( I-1)+(II-C020), (I-1)+(II-C021), (I-1)+(II-C022), (I-1)+(II-C023), (I- 1)+(II-C024), (I-1)+(II-C025), (I-1)+(II-C026), (I-1)+(II-C027), (I-1) +(II-C028), (I-1)+(II-C029), (I-1)+(II-C030), (I-1)+(II-C031), (I-1)+( II-C032), (I)+ (II-C033), (I)+ (II-C034), (I-1)+(II-D001), (I-1)+(II-D002), ( I-1)+(II-D003), (I-1)+(II-D004), (I-1)+(II-D005), (I-1)+(II-D006), (I- 1)+(II-D007), (I-1)+(II-D008), (I-1)+(II-D009), (I-1)+(II-D010), (I-1) +(II-D011), (I-1)+(II-D012), (I-1)+(II-D013), (I-1)+(II-D014), (I-1)+( II-D015), (I-1)+(II-D016), (I-1)+(II-D017), (I-1)+(II-D018), (I-1)+(II- D019), (I-1)+(II-D020), (I-1)+(II-D021), (I-1)+(II-D022), (I-1)+(II-D023) , (I-1)+(II-D024), (I-1)+(II-D025), (I-1)+(II-D026), (I-1)+(II-E001), ( I-1)+(II-E002), (I-1)+(II-E003), (I-1)+(II-E004), (I-1)+(II-E005) , (I-1)+(II-E006), (I-1)+(II-E007), (I-1)+(II-E008), (I-1)+(II-E009), ( I-1)+(II-E010), (I-1)+(II-E011), (I-1)+(II-E012), (I-1)+(II-E013), (I- 1)+(II-E014), (I-1)+(II-E015), (I-1)+(II-E016), (I-1)+(II-E017), (I-1) +(II-E018), (I-1)+(II-E019), (I-1)+(II-E020), (I-1)+(II-E021), (I-1)+( II-E022), (I-1)+(II-E023), (I-1)+(II-E024), (I-1)+(II-E025), (I-1)+(II- E026), (I-1)+(II-E027), (I-1)+(II-E028), (I-1)+(II-E029), (I-1)+(II-E030) , (I-1)+(II-F001), (I-1)+(II-F002), (I-1)+(II-F003), (I-1)+(II-F004), ( I-1)+(II-G001), (I-1)+(II-G002), (I-1)+(II-G003), (I-1)+(II-G004), (I- 1)+(II-G005), (I-1)+(II-G006), (I-1)+(II-G007), (I-1)+(II-G008), (I-1) +(II-G009), (I-1)+(II-G0010), (I-1)+(II-G0011), (I-1)+(II-H001), (I-1)+( II-H002), (I-1)+(II-H003), (I-1)+(II-H004), (I-1)+(II-I001), (I-1)+(II- I002), (I-1)+(II-I003), (I-1)+(II-I004), (I-1)+(II-I005), (I-1)+(II-I006) , (I-1)+(II-I007), (I-1)+(II-I008), (I-1)+(II-I009), (I-1)+(II-I010), ( I-1)+(II-I011), (I-1)+(II-I012), (I-1)+(II-I013), (I-1)+(II-I014), (I- 1)+(II-J001), (I-1)+(II-J002), (I-1)+(II-J003), (I-1)+(II-J004), (I-1) +(II-J005), (I-1)+(II-J006), (I-1)+(II-J007), (I-1)+(II-J008), (I-1)+( II-J009), (I-1)+(II-J0010), (I-1)+(II-J011), (I-1)+(II-J012), (I-1)+(II- J013), (I-1)+(II-J014), (I-1)+(II-J015), (I-1)+(II-J015), (I-1)+(II-J016) , (I-1)+(II-K001), (I-1)+(II-K002), (I-1)+(II-K003), (I-1)+(II-K004), ( I-1)+(II-K005), (I-1)+(II-K006), (I-1)+(II-K007), (I-1)+(II-L001), (I- 1)+(II-L002), (I-1)+(II-L003), (I-1)+(II-L004), (I-1)+(II-L005), (I-1) +(II-L006), (I-1)+(II-L007), (I-1)+(II-L008), (I-1)+(II-L009), (I-1)+( II-L010), (I-1)+(II-L011), (I-1)+(II-L012), (I-1)+(II-M001), (I-1)+(II- M002), (I-1)+(II-M003), (I-1)+(II-M004), (I-1)+(II-M005), (I-1)+(II-M006) , (I-1)+(II-M007), (I-1)+(II-M008), (I-1)+(II-M009), (I-1)+(II-M010), ( I-1)+(II-N001), (I-1)+(II-N002), (I-1)+(II-N003), (I-1)+(II-N004), (I- 1)+(II-O001), (I-1)+(II-O002), (I-1)+(II-O003), (I-1)+(II-O004), (I-1) +(II-O005), (I-1)+(II-O006), (I-1)+(II-O007), (I-1)+(II-O008), (I-1)+( II-O009), (I-1)+(II-O010), (I-1)+(II-O011), (I-1)+(II-O012), (I-1)+(II- O013), (I-1)+(II-O014), (I-1)+(II-O015), (I-1)+(II-O016), (I-1)+(II-O0 17), (I-1)+(II-O018), (I-1)+(II-O019), (I-1)+(II-O020), (I-1)+(II-O021) , (I-1)+(II-O022), (I-1)+(II-O023), (I-1)+(II-O024), (I-1)+(II-O025), ( I-1)+(II-O026), (I-1)+(II-O027), (I-1)+(II-O028), (I-1)+(II-O029), (I- 1)+(II-O030), (I-1)+(II-O031), (I-1)+(II-O032), (I-1)+(II-O033), (I-1) +(II-O034), (I-1)+(II-O035), (I-1)+(II-O036), (I-1)+(II-O037), (I-1)+( II-O038), (I-1)+(II-O039), (I-1)+(II-O040), (I-1)+(II-O041), (I-1)+(II- O042), (I-1)+(II-O043), (I-1)+(II-O044), (I-1)+(II-O045), (I-1)+(II-O046) , (I-1)+(II-O047), (I-1)+(II-O048), (I-1)+(II-O049), (I-1)+(II-O050), ( I-1)+(II-O051), (I-1)+(II-O052), (I-1)+(II-O053), (I-1)+(II-O054), (I- 1)+(II-O055), (I-1)+(II-O056), (I-1)+(II-O057), (I-1)+(II-O058), (I-1) +(II-O059), (I-1)+(II-O060), (I-1)+(II-O061), (I-1)+(II-O062), (I-1)+( II-O063), (I-1)+(II-O064), (I-1)+(II-O065), (I-1)+(II-O066), (I-1)+(II- O067), (I-1)+(II-O068), (I-1)+(II-O069), (I-1)+(II-O070), (I-1)+(II-O071) , (I-1)+(II-O072), (I-1)+(II-O073), (I-1)+(II-O074), (I-1)+(II-O075), ( I-1)+(II-O076), (I-1)+(II-O077), (I-1)+(II-O078), (I-1)+(II-O079), (I- 1 )+(II-O080), (I-1)+(II-O081), (I-1)+(II-O082), (I-1)+(II-O083), (I-1)+ (II-O084), (I-1)+(II-O085), (I-1)+(II-O086), (I-1)+(II-O087), (I-1)+(II -O088), (I-1)+(II-P001), (I-1)+(II-P002), (I-1)+(II-P003), (I-1)+(II-P004 ), (I-1)+(II-P005), (I-1)+(II-P006), (I-1)+(II-P007), (I-1)+(II-P008), (I-1)+(II-P009), (I-1)+(II-P010), (I-1)+(II-P011), (I-1)+(II-P012), (I -1)+(II-P013), (I-1)+(II-P014), (I-1)+(II-P015), (I-1)+(II-P016), (I-1 )+(II-P017), (I-1)+(II-P018), (I-1)+(II-P019), (I-1)+(II-P020), (I-1)+ (II-P021), (I-1)+(II-P022), (I-1)+(II-P023), (I-1)+(II-P024), (I-1)+(II -P025), (I-1)+(II-P026), (I-1)+(II-P027), (I-1)+(II-P028), (I-1)+(II-P029 ), (I-1)+(II-P030), (I-1)+(II-P031), (I-1)+(II-P032), (I-1)+(II-P033), (I-1)+(II-P034), (I-1)+(II-P035), (I-1)+(II-P036), (I-1)+(II-P037), (I -1)+(II-P038), (I-1)+(II-P039), (I-1)+(II-P040), (I-1)+(II-P041), (I-1 )+(II-P042), (I-1)+(II-P043), (I-1)+(II-P044), (I-1)+(II-P045), (I-1)+ (II-P046), (I-1)+(II-P047), (I-1)+(II-P048), (I-1)+(II-P049), (I-1)+(II -P050), (I-1)+(II-P051), (I-1)+(II-P052), (I-1)+(II-P053), (I-1)+(II-P0 54), (I-1)+(II-P055), (I-1)+(II-P056), (I-1)+(II-P057), (I-1)+(II-P058) , (I-1)+(II-P059), (I-1)+(II-P060), (I-1)+(II-P061), (I-1)+(II-P062), ( I-1)+(II-P063), (I-1)+(II-P064), (I-1)+(II-P065), (I-1)+(II-P066), (I- 1)+(II-P067), (I-1)+(II-P068), (I-1)+(II-P069), (I-1)+(II-P070), (I-1) +(II-P071), (I-1)+(II-P072), (I-1)+(II-P073), (I-1)+(II-P074), (I-1)+( II-P075), (I-1)+(II-P076), (I-1)+(II-P077), (I-1)+(II-P078), (I-1)+(II- P079), (I-1)+(II-P080), (I-1)+(II-P081), (I-1)+(II-P082), (I-1)+(II-P083) , (I-1)+(II-P084), (I-1)+(II-P085), (I-1)+(II-P086), (I-1)+(II-P087), ( I-1)+(II-P088), (I-1)+(II-P089), (I-1)+(II-P090), (I-1)+(II-P091), (I- 1)+(II-P092), (I-1)+(II-P093), (I-1)+(II-P094), (I-1)+(II-P095), (I-1) +(II-P096), (I-1)+(II-P097), (I-1)+(II-P098), (I-1)+(II-P099), (I-1)+( II-P100), (I-1)+(II-P101), (I-1)+(II-P102), (I-1)+(II-P103), (I-1)+(II- P104), (I-1)+(II-Q001), (I-1)+(II-Q002), (I-1)+(II-Q003), (I-1)+(II-Q004) , (I-1)+(II-Q005), (I-1)+(II-Q006), (I-1)+(II-Q007), (I-1)+(II-Q008), ( I-1)+(II-Q009), (I-1)+(II-Q010), (I-1)+(II-Q011), (I-1)+(II-Q012), (I- 1 )+(II-Q013), (I-1)+(II-Q014), (I-1)+(II-Q015), (I-1)+(II-Q016), (I-1)+ (II-Q017), (I-1)+(II-Q018), (I-1)+(II-Q019), (I-1)+(II-Q020), (I-1)+(II -Q021), (I-1)+(II-Q022), (I-1)+(II-Q023), (I-1)+(II-Q024), (I-1)+(II-Q025 ), (I-1)+(II-Q026), (I-1)+(II-Q027), (I-1)+(II-Q028), (I-1)+(II-Q029), (I-1)+(II-Q030), (I-1)+(II-Q031), (I-1)+(II-Q032), (I-1)+(II-Q033), (I -1)+(II-Q034), (I-1)+(II-R001), (I-1)+(II-R002), (I-1)+(II-R003), (I-1 )+(II-R004), (I-1)+(II-R005), (I-1)+(II-R006), (I-1)+(II-R007), (I-1)+ (II-R008), (I-1)+(II-R009), (I-1)+(II-R010), (I-1)+(II-R011), (I-1)+(II -R012), (I-1)+(II-R013), (I-1)+(II-R014), (I-1)+(II-R015), (I-1)+(II-R016 ), (I-1)+(II-R017), (I-1)+(II-R018), (I-1)+(II-R019), (I-1)+(II-R020), (I-1)+(II-R021), (I-1)+(II-R022), (I-1)+(II-R023), (I-1)+(II-R024), (I -1)+(II-R025), (I-1)+(II-R026), (I-1)+(II-R027), (I-1)+(II-R028), (I-1 )+(II-R029), (I-1)+(II-R030), (I-1)+(II-R031), (I-1)+(II-R032), (I-1)+ (II-R033), (I-1)+(II-R034), (I-1)+(II-R035), (I-1)+(II-R036), (I-1)+(II -R037), (I-1)+(II-R038), (I-1)+(II-R039), (I-1)+(II-R040), (I-1)+(II-R0 41), (I-1)+(II-R042), (I-1)+(II-R043), (I-1)+(II-R044), (I-1)+(II-R045) , (I-1)+(II-R046), (I-1)+(II-R047).

在一實施例中,如下方表4所列之組合,其中組分 (1)係化合物 (I-1)且組分 (2)係選自如本文中所定義的(III-A1001)至(III-FF1023)各組。據此,舉例而言,若組分 (2)為(III-A1001) 棉靈威 (alanycarb),則該組合將表示成 「(I-1)+(III-A1001)」。In one embodiment, the combination as listed in Table 4 below, wherein component (1) is compound (I-1) and component (2) is selected from (III-A1001) to (III) as defined herein -FF1023) each group. Accordingly, for example, if component (2) is (III-A1001) alanycarb, the combination would be expressed as "(I-1)+(III-A1001)".

表4:(I-1)+(III-A1001)、(I-1)+(III-A1002)、(I-1)+(III-A1003)、(I-1)+(III-A1004)、(I-1)+(III-A1005)、(I-1)+(III-A1006)、(I-1)+(III-A1007)、(I-1)+(III-A1008)、(I-1)+(III-A1009)、(I-1)+(III-A1010)、(I-1)+(III-A1011)、(I-1)+(III-A1012)、(I-1)+(III-A1013)、(I-1)+(III-A1014)、(I-1)+(III-A1015)、(I-1)+(III-A1016)、(I-1)+(III-A1017)、(I-1)+(III-A1018)、(I-1)+(III-A1019)、(I-1)+(III-A1020)、(I-1)+(III-A1021)、(I-1)+(III-A1022)、(I-1)+(III-A1023)、(I-1)+(III-A1024)、(I-1)+(III-A1025)、(I-1)+(III-A1026)、(I-1)+(III-A2001)、(I-1)+(III-A2002)、(I-1)+(III-A2003)、(I-1)+(III-A2004)、(I-1)+(III-A2005)、(I-1)+(III-A2006)、(I-1)+(III-A2007)、(I-1)+(III-A2008)、(I-1)+(III-A2009)、(I-1)+(III-A2010)、(I-1)+(III-A2011)、(I-1)+(III-A2012)、(I-1)+(III-A2013)、(I-1)+(III-A2014)、(I-1)+(III-A2015)、(I-1)+(III-A2016)、(I-1)+(III-A2017)、(I-1)+(III-A2018)、(I-1)+(III-A2019)、(I-1)+(III-A2020)、(I-1)+(III-A2021)、(I-1)+(III-A2022)、(I-1)+(III-A2023)、(I-1)+(III-A2024)、(I-1)+(III-A2025)、(I-1)+(III-A2026)、(I-1)+(III-A2027)、(I-1)+(III-A2028)、(I-1)+(III-A2029)、(I-1)+(III-A2030)、(I-1)+(III-A2031)、(I-1)+(III-A2032)、(I-1)+(III-A2033)、(I-1)+(III-A2034)、(I-1)+(III-A2035)、(I-1)+(III-A2036)、(I-1)+(III-A2037)、(I-1)+(III-A2038)、(I-1)+(III-A2039)、(I-1)+(III-A2040)、(I-1)+(III-A2041)、(I-1)+(III-A2042)、(I-1)+(III-A2043)、(I-1)+(III-A2044)、(I-1)+(III-A2045)、(I-1)+(III-A2046)、(I-1)+(III-A2047)、(I-1)+(III-A2048)、(I-1)+(III-A2049)、(I-1)+(III-A2050)、(I-1)+(III-A2051)、(I-1)+(III-A2052)、(I-1)+(III-A2053)、(I-1)+(III-A2054)、(I-1)+(III-A2055)、(I-1)+(III-A2056)、(I-1)+(III-A2057)、(I-1)+(III-A2058)、(I-1)+(III-A2059)、(I-1)+(III-A2060)、(I-1)+(III-A2061)、(I-1)+(III-A2062)、(I-1)+(III-A2063)、(I-1)+(III-A2064)、(I-1)+(III-A2065)、(I-1)+(III-B1001)、(I-1)+(III-B1002)、(I-1)+(III-B2001)、(I-1)+(III-B2002)、(I-1)+(III-B2003)、(I-1)+(III-B2004)、(I-1)+(III-B2005)、(I-1)+(III-C1001)、(I-1)+(III-C1002)、(I-1)+(III-C1003)、(I-1)+(III-C1004)、(I-1)+(III-C1005)、(I-1)+(III-C1006)、(I-1)+(III-C1007)、(I-1)+(III-C1008)、(I-1)+(III-C1009)、(I-1)+(III-C1010)、(I-1)+(III-C1011)、(I-1)+(III-C1012)、(I-1)+(III-C1013)、(I-1)+(III-C1014)、(I-1)+(III-C1015)、(I-1)+(III-C1016)、(I-1)+(III-C1017)、(I-1)+(III-C1018)、(I-1)+(III-C1019)、(I-1)+(III-C1020)、(I-1)+(III-C1021)、(I-1)+(III-C1022)、(I-1)+(III-C1023)、(I-1)+(III-C1024)、(I-1)+(III-C1025)、(I-1)+(III-C1026)、(I-1)+(III-C1027)、(I-1)+(III-C1028)、(I-1)+(III-C1029)、(I-1)+(III-C1030)、(I-1)+(III-C1031)、(I-1)+(III-C1032)、(I-1)+(III-C1033)、(I-1)+(III-C1034)、(I-1)+(III-C1035)、(I-1)+(III-C1036)、(I-1)+(III-C1037)、(I-1)+(III-C1038)、(I-1)+(III-C1039)、(I-1)+(III-C1040)、(I-1)+(III-C1041)、(I-1)+(III-C1042)、(I-1)+(III-C1043)、(I-1)+(III-C1044)、(I-1)+(III-C1045)、(I-1)+(III-C1046)、(I-1)+(III-C1047)、(I-1)+(III-C1048)、(I-1)+(III-C1049)、(I-1)+(III-C2001)、(I-1)+(III-C2002)、(I-1)+(III-D1001)、(I-1)+(III-D1002)、(I-1)+(III-D1003)、(I-1)+(III-D1004)、(I-1)+(III-D1005)、(I-1)+(III-D1006)、(I-1)+(III-D1007)、(I-1)+(III-D1008)、(I-1)+(III-D1009)、(I-1)+(III-D1010)、(I-1)+(III-D2001)、(I-1)+(III-D3001)、(I-1)+(III-D4001)、(I-1)+(III-D5001)、(I-1)+(III-D5002)、(I-1)+(III-D6001)、(I-1)+(III-E1001)、(I-1)+(III-E1002)、(I-1)+(III-F1001)、(I-1)+(III-F1002)、(I-1)+(III-F1003)、(I-1)+(III-F1004)、(I-1)+(III-G1001)、(I-1)+(III-G1002)、(I-1)+(III-G1003)、(I-1)+(III-G2001)、(I-1)+(III-G3001)、(I-1)+(III-H4001)、(I-1)+(III-H4002)、(I-1)+(III-H4003)、(I-1)+(III-H4004)、(I-1)+(III-H4005)、(I-1)+(III-H5001)、(I-1)+(III-H6001)、(I-1)+(III-H6002)、(I-1)+(III-I1001)、(I-1)+(III-I1002)、(I-1)+(III-I2001)、(I-1)+(III-J1001)、(I-1)+(III-J1002)、(I-1)+(III-J1003)、(I-1)+(III-J2003)、(I-1)+(III-K1001)、(I-1)+(III-K1002)、(I-1)+(III-K1003)、(I-1)+(III-K1004)、(I-1)+(III-K1005)、(I-1)+(III-K1006)、(I-1)+(III-K1007)、(I-1)+(III-K1008)、(I-1)+(III-K1009)、(I-1)+(III-K1010)、(I-1)+(III-K1011)、(I-1)+(III-K1012)、(I-1)+(III-K1013)、(I-1)+(III-K1014)、(I-1)+(III-K1015)、(I-1)+(III-K2001)、(I-1)+(III-L1001)、(I-1)+(III-L2001)、(I-1)+(III-L2002)、(I-1)+(III-L2003)、(I-1)+(III-L3001)、(I-1)+(III-L4001)、(I-1)+(III-M1001)、(I-1)+(III-M2001)、(I-1)+(III-M3001)、(I-1)+(III-N1001)、(I-1)+(III-N1002)、(I-1)+(III-N1003)、(I-1)+(III-N1004)、(I-1)+(III-O1001)、(I-1)+(III-O1002)、(I-1)+(III-O1003)、(I-1)+(III-O1004)、(I-1)+(III-O1005)、(I-1)+(III-O1006)、(I-1)+(III-O1007)、(I-1)+(III-O1008)、(I-1)+(III-O1009)、(I-1)+(III-O1010)、(I-1)+(III-O1011)、(I-1)+(III-P1001)、(I-1)+(III-Q1001)、(I-1)+(III-R1001)、(I-1)+(III-R1002)、(I-1)+(III-R1003)、(I-1)+(III-R1004)、(I-1)+(III-R1005)、(I-1)+(III-S1001)、(I-1)+(III-T1001)、(I-1)+(III-T2001)、(I-1)+(III-T3001)、(I-1)+(III-T4001)、(I-1)+(III-U1001)、(I-1)+(III-U1002)、(I-1)+(III-U1003)、(I-1)+(III-U1004)、(I-1)+(III-U1005)、(I-1)+(III-U1006)、(I-1)+(III-U2001)、(I-1)+(III-V1001)、(I-1)+(III-V2001)、(I-1)+(III-V3001)、(I-1)+(III-V4001)、(I-1)+(III-W1001)、(I-1)+(III-W1002)、(I-1)+(III-W1003)、(I-1)+(III-W1004)、(I-1)+(III-X1001)、(I-1)+(III-X1002)、(I-1)+(III-X1003)、(I-1)+(III-X1004)、(I-1)+(III-X2001)、(I-1)+(III-X2002)、(I-1)+(III-X2003)、(I-1)+(III-Y1001)、(I-1)+(III-Y1002)、(I-1)+(III-Y2001)、(I-1)+(III-Z1001)、(I-1)+(III-Z1002)、(I-1)+(III-Z1003)、(I-1)+(III-Z1004)、(I-1)+(III-Z1005)、(I-1)+(III-Z1006)、(I-1)+(III-Z1007)、(I-1)+(III-Z1008)、(I-1)+(III-Z1009)、(I-1)+(III-Z1010)、(I-1)+(III-Z1011)、(I-1)+(III-Z1012)、(I-1)+(III-Z1013)、(I-1)+(III-Z1014)、(I-1)+(III-AA1001)、(I-1)+(III-BB1001)、(I-1)+(III-BB2001)、(I-1)+(III-BB2002)、(I-1)+(III-CC1001)、(I-1)+(III-CC1002)、(I-1)+(III-CC2001)、(I-1)+(III-CC2002)、(I-1)+(III-DD1001)、(I-1)+(III-EE1001)、(I-1)+(III-EE1002)、(I-1)+(III-EE1003)、(I-1)+(III-EE1004)、(I-1)+(III-EE1005)、(I-1)+(III-EE1006)、(I-1)+(III-EE1007)、(I-1)+(III-EE1008)、(I-1)+(III-EE1009)、(I-1)+(III-EE1010)、(I-1)+(III-EE1011)、(I-1)+(III-EE1012)、(I-1)+(III-EE1013)、(I-1)+(III-EE1014)、(I-1)+(III-EE1015)、(I-1)+(III-EE1016)、(I-1)+(III-EE1017)、(I-1)+(III-EE1018)、(I-1)+(III-EE1019)、(I-1)+(III-EE1020)、(I-1)+(III-EE1021)、(I-1)+(III-EE1022)、(I-1)+(III-EE1023)、(I-1)+(III-EE1024)、(I-1)+(III-EE1025)、(I-1)+(III-EE1026)、(I-1)+(III-EE1027)、(I-1)+(III-EE1028)、(I-1)+(III-EE1029)、(I-1)+(III-EE1030)、(I-1)+(III-EE1031)、(I-1)+(III-EE1032)、(I-1)+(III-EE1033)、(I-1)+(III-EE1034)、(I-1)+(III-EE1035)、(I-1)+(III-EE1036)、(I-1)+(III-EE1037)、(I-1)+(III-EE1038)、(I-1)+(III-EE1039)、(I-1)+(III-EE1040)、(I-1)+(III-EE1041)、(I-1)+(III-EE1042)、(I-1)+(III-EE1043)、(I-1)+(III-EE1044)、(I-1)+(III-EE1045)、(I-1)+(III-EE1046)、(I-1)+(III-EE1047)、(I-1)+(III-EE1048)、(I-1)+(III-FF1001)、(I-1)+(III-FF1002)、(I-1)+(III-FF1003)、(I-1)+(III-FF1004)、(I-1)+(III-FF1005)、(I-1)+(III-FF1006)、(I-1)+(III-FF1007)、(I-1)+(III-FF1008)、(I-1)+(III-FF1009)、(I-1)+(III-FF1010)、(I-1)+(III-FF1011)、(I-1)+(III-FF1012)、(I-1)+(III-FF1013)、(I-1)+(III-FF1014)、(I-1)+(III-FF1015)、(I-1)+(III-FF1016)、(I-1)+(III-FF1017)、(I-1)+(III-FF1018)、(I-1)+(III-FF1019)、(I-1)+(III-FF1020)、(I-1)+(III-FF1021)、(I-1)+(III-FF1022)、(I-1)+(III-FF1023)。Table 4: (I-1)+(III-A1001), (I-1)+(III-A1002), (I-1)+(III-A1003), (I-1)+(III-A1004) , (I-1)+(III-A1005), (I-1)+(III-A1006), (I-1)+(III-A1007), (I-1)+(III-A1008), ( I-1)+(III-A1009), (I-1)+(III-A1010), (I-1)+(III-A1011), (I-1)+(III-A1012), (I- 1)+(III-A1013), (I-1)+(III-A1014), (I-1)+(III-A1015), (I-1)+(III-A1016), (I-1) +(III-A1017), (I-1)+(III-A1018), (I-1)+(III-A1019), (I-1)+(III-A1020), (I-1)+( III-A1021), (I-1)+(III-A1022), (I-1)+(III-A1023), (I-1)+(III-A1024), (I-1)+(III- A1025), (I-1)+(III-A1026), (I-1)+(III-A2001), (I-1)+(III-A2002), (I-1)+(III-A2003) , (I-1)+(III-A2004), (I-1)+(III-A2005), (I-1)+(III-A2006), (I-1)+(III-A2007), ( I-1)+(III-A2008), (I-1)+(III-A2009), (I-1)+(III-A2010), (I-1)+(III-A2011), (I- 1)+(III-A2012), (I-1)+(III-A2013), (I-1)+(III-A2014), (I-1)+(III-A2015), (I-1) +(III-A2016), (I-1)+(III-A2017), (I-1)+(III-A2018), (I-1)+(III-A2019), (I-1)+( III-A2020), (I-1)+(III-A2021), (I-1)+(III-A2022), (I-1)+(III-A2023), (I-1)+(III- A2024), (I-1)+(III-A2025), (I-1)+(III-A2026), (I-1)+(III-A2027), (I-1)+(III-A2028) , (I-1)+(III-A2029), (I-1)+( III-A2030), (I-1)+(III-A2031), (I-1)+(III-A2032), (I-1)+(III-A2033), (I-1)+(III- A2034), (I-1)+(III-A2035), (I-1)+(III-A2036), (I-1)+(III-A2037), (I-1)+(III-A2038) , (I-1)+(III-A2039), (I-1)+(III-A2040), (I-1)+(III-A2041), (I-1)+(III-A2042), ( I-1)+(III-A2043), (I-1)+(III-A2044), (I-1)+(III-A2045), (I-1)+(III-A2046), (I- 1)+(III-A2047), (I-1)+(III-A2048), (I-1)+(III-A2049), (I-1)+(III-A2050), (I-1) +(III-A2051), (I-1)+(III-A2052), (I-1)+(III-A2053), (I-1)+(III-A2054), (I-1)+( III-A2055), (I-1)+(III-A2056), (I-1)+(III-A2057), (I-1)+(III-A2058), (I-1)+(III- A2059), (I-1)+(III-A2060), (I-1)+(III-A2061), (I-1)+(III-A2062), (I-1)+(III-A2063) , (I-1)+(III-A2064), (I-1)+(III-A2065), (I-1)+(III-B1001), (I-1)+(III-B1002), ( I-1)+(III-B2001), (I-1)+(III-B2002), (I-1)+(III-B2003), (I-1)+(III-B2004), (I- 1)+(III-B2005), (I-1)+(III-C1001), (I-1)+(III-C1002), (I-1)+(III-C1003), (I-1) +(III-C1004), (I-1)+(III-C1005), (I-1)+(III-C1006), (I-1)+(III-C1007), (I-1)+( III-C1008), (I-1)+(III-C1009), (I-1)+(III-C1010), (I-1)+(III-C1011), (I-1)+(III- C1012), (I-1)+(III-C1013) , (I-1)+(III-C1014), (I-1)+(III-C1015), (I-1)+(III-C1016), (I-1)+(III-C1017), ( I-1)+(III-C1018), (I-1)+(III-C1019), (I-1)+(III-C1020), (I-1)+(III-C1021), (I- 1)+(III-C1022), (I-1)+(III-C1023), (I-1)+(III-C1024), (I-1)+(III-C1025), (I-1) +(III-C1026), (I-1)+(III-C1027), (I-1)+(III-C1028), (I-1)+(III-C1029), (I-1)+( III-C1030), (I-1)+(III-C1031), (I-1)+(III-C1032), (I-1)+(III-C1033), (I-1)+(III- C1034), (I-1)+(III-C1035), (I-1)+(III-C1036), (I-1)+(III-C1037), (I-1)+(III-C1038) , (I-1)+(III-C1039), (I-1)+(III-C1040), (I-1)+(III-C1041), (I-1)+(III-C1042), ( I-1)+(III-C1043), (I-1)+(III-C1044), (I-1)+(III-C1045), (I-1)+(III-C1046), (I- 1)+(III-C1047), (I-1)+(III-C1048), (I-1)+(III-C1049), (I-1)+(III-C2001), (I-1) +(III-C2002), (I-1)+(III-D1001), (I-1)+(III-D1002), (I-1)+(III-D1003), (I-1)+( III-D1004), (I-1)+(III-D1005), (I-1)+(III-D1006), (I-1)+(III-D1007), (I-1)+(III- D1008), (I-1)+(III-D1009), (I-1)+(III-D1010), (I-1)+(III-D2001), (I-1)+(III-D3001) , (I-1)+(III-D4001), (I-1)+(III-D5001), (I-1)+(III-D5002), (I-1)+(III-D6001), ( I-1)+(III-E1001), (I-1)+(II I-E1002), (I-1)+(III-F1001), (I-1)+(III-F1002), (I-1)+(III-F1003), (I-1)+(III- F1004), (I-1)+(III-G1001), (I-1)+(III-G1002), (I-1)+(III-G1003), (I-1)+(III-G2001) , (I-1)+(III-G3001), (I-1)+(III-H4001), (I-1)+(III-H4002), (I-1)+(III-H4003), ( I-1)+(III-H4004), (I-1)+(III-H4005), (I-1)+(III-H5001), (I-1)+(III-H6001), (I- 1)+(III-H6002), (I-1)+(III-I1001), (I-1)+(III-I1002), (I-1)+(III-I2001), (I-1) +(III-J1001), (I-1)+(III-J1002), (I-1)+(III-J1003), (I-1)+(III-J2003), (I-1)+( III-K1001), (I-1)+(III-K1002), (I-1)+(III-K1003), (I-1)+(III-K1004), (I-1)+(III- K1005), (I-1)+(III-K1006), (I-1)+(III-K1007), (I-1)+(III-K1008), (I-1)+(III-K1009) , (I-1)+(III-K1010), (I-1)+(III-K1011), (I-1)+(III-K1012), (I-1)+(III-K1013), ( I-1)+(III-K1014), (I-1)+(III-K1015), (I-1)+(III-K2001), (I-1)+(III-L1001), (I- 1)+(III-L2001), (I-1)+(III-L2002), (I-1)+(III-L2003), (I-1)+(III-L3001), (I-1) +(III-L4001), (I-1)+(III-M1001), (I-1)+(III-M2001), (I-1)+(III-M3001), (I-1)+( III-N1001), (I-1)+(III-N1002), (I-1)+(III-N1003), (I-1)+(III-N1004), (I-1)+(III- O1001), (I-1)+(III-O1002), ( I-1)+(III-O1003), (I-1)+(III-O1004), (I-1)+(III-O1005), (I-1)+(III-O1006), (I- 1)+(III-O1007), (I-1)+(III-O1008), (I-1)+(III-O1009), (I-1)+(III-O1010), (I-1) +(III-O1011), (I-1)+(III-P1001), (I-1)+(III-Q1001), (I-1)+(III-R1001), (I-1)+( III-R1002), (I-1)+(III-R1003), (I-1)+(III-R1004), (I-1)+(III-R1005), (I-1)+(III- S1001), (I-1)+(III-T1001), (I-1)+(III-T2001), (I-1)+(III-T3001), (I-1)+(III-T4001) , (I-1)+(III-U1001), (I-1)+(III-U1002), (I-1)+(III-U1003), (I-1)+(III-U1004), ( I-1)+(III-U1005), (I-1)+(III-U1006), (I-1)+(III-U2001), (I-1)+(III-V1001), (I- 1)+(III-V2001), (I-1)+(III-V3001), (I-1)+(III-V4001), (I-1)+(III-W1001), (I-1) +(III-W1002), (I-1)+(III-W1003), (I-1)+(III-W1004), (I-1)+(III-X1001), (I-1)+( III-X1002), (I-1)+(III-X1003), (I-1)+(III-X1004), (I-1)+(III-X2001), (I-1)+(III- X2002), (I-1)+(III-X2003), (I-1)+(III-Y1001), (I-1)+(III-Y1002), (I-1)+(III-Y2001) , (I-1)+(III-Z1001), (I-1)+(III-Z1002), (I-1)+(III-Z1003), (I-1)+(III-Z1004), ( I-1)+(III-Z1005), (I-1)+(III-Z1006), (I-1)+(III-Z1007), (I-1)+(III-Z1008), (I- 1)+(III-Z1009), (I-1)+(III- Z1010), (I-1)+(III-Z1011), (I-1)+(III-Z1012), (I-1)+(III-Z1013), (I-1)+(III-Z1014) , (I-1)+(III-AA1001), (I-1)+(III-BB1001), (I-1)+(III-BB2001), (I-1)+(III-BB2002), ( I-1)+(III-CC1001), (I-1)+(III-CC1002), (I-1)+(III-CC2001), (I-1)+(III-CC2002), (I- 1)+(III-DD1001), (I-1)+(III-EE1001), (I-1)+(III-EE1002), (I-1)+(III-EE1003), (I-1) +(III-EE1004), (I-1)+(III-EE1005), (I-1)+(III-EE1006), (I-1)+(III-EE1007), (I-1)+( III-EE1008), (I-1)+(III-EE1009), (I-1)+(III-EE1010), (I-1)+(III-EE1011), (I-1)+(III- EE1012), (I-1)+(III-EE1013), (I-1)+(III-EE1014), (I-1)+(III-EE1015), (I-1)+(III-EE1016) , (I-1)+(III-EE1017), (I-1)+(III-EE1018), (I-1)+(III-EE1019), (I-1)+(III-EE1020), ( I-1)+(III-EE1021), (I-1)+(III-EE1022), (I-1)+(III-EE1023), (I-1)+(III-EE1024), (I- 1)+(III-EE1025), (I-1)+(III-EE1026), (I-1)+(III-EE1027), (I-1)+(III-EE1028), (I-1) +(III-EE1029), (I-1)+(III-EE1030), (I-1)+(III-EE1031), (I-1)+(III-EE1032), (I-1)+( III-EE1033), (I-1)+(III-EE1034), (I-1)+(III-EE1035), (I-1)+(III-EE1036), (I-1)+(III- EE1037), (I-1)+(III-EE1038), (I-1)+(III-EE1039), (I-1)+(II I-EE1040), (I-1)+(III-EE1041), (I-1)+(III-EE1042), (I-1)+(III-EE1043), (I-1)+(III- EE1044), (I-1)+(III-EE1045), (I-1)+(III-EE1046), (I-1)+(III-EE1047), (I-1)+(III-EE1048) , (I-1)+(III-FF1001), (I-1)+(III-FF1002), (I-1)+(III-FF1003), (I-1)+(III-FF1004), ( I-1)+(III-FF1005), (I-1)+(III-FF1006), (I-1)+(III-FF1007), (I-1)+(III-FF1008), (I- 1)+(III-FF1009), (I-1)+(III-FF1010), (I-1)+(III-FF1011), (I-1)+(III-FF1012), (I-1) +(III-FF1013), (I-1)+(III-FF1014), (I-1)+(III-FF1015), (I-1)+(III-FF1016), (I-1)+( III-FF1017), (I-1)+(III-FF1018), (I-1)+(III-FF1019), (I-1)+(III-FF1020), (I-1)+(III- FF1021), (I-1)+(III-FF1022), (I-1)+(III-FF1023).

在一實施例中,組分 (1)與組分 (2)間的重量比在表3的組合[(I-1)+(II-A001)至(I-1)+(II-R047)]中或是在表4的組合[(I-1)+(III-A1001)至(I-1)+(III-FF1023)]中係介於1,000:1至1:1,000之間。In one embodiment, the weight ratio between component (1) and component (2) is in the combination [(I-1)+(II-A001) to (I-1)+(II-R047) of Table 3 ] or in the combination [(I-1)+(III-A1001) to (I-1)+(III-FF1023)] in Table 4 is between 1,000:1 and 1:1,000.

在一實施例中,組分 (1)與組分 (2)間的重量比在表3的組合[(I-1)+(II-A001)至(I-1)+(II-R047)]中或是在表4的組合[(I-1)+(III-A1001)至(I-1)+(III-FF1023)]中係介於500:1至1:500之間。In one embodiment, the weight ratio between component (1) and component (2) is in the combination [(I-1)+(II-A001) to (I-1)+(II-R047) of Table 3 ] or in the combination [(I-1)+(III-A1001) to (I-1)+(III-FF1023)] in Table 4 is between 500:1 and 1:500.

在一實施例中,組分 (1)與組分 (2)間的重量比在表3的組合[(I-1)+(II-A001)至(I-1)+(II-R047)]中或是在表4的組合[(I-1)+(III-A1001)至(I-1)+(III-FF1023)]中係介於100:1至1:100之間。In one embodiment, the weight ratio between component (1) and component (2) is in the combination [(I-1)+(II-A001) to (I-1)+(II-R047) of Table 3 ] or in the combination [(I-1)+(III-A1001) to (I-1)+(III-FF1023)] in Table 4 is between 100:1 and 1:100.

在一實施例中,組分 (1)與組分 (2)間的重量比在表3的組合[(I-1)+(II-A001)至(I-1)+(II-R047)]中或是在表4的組合[(I-1)+(III-A1001)至(I-1)+(III-FF1023)]中係介於50:1至1:50之間。In one embodiment, the weight ratio between component (1) and component (2) is in the combination [(I-1)+(II-A001) to (I-1)+(II-R047) of Table 3 ] or in the combination [(I-1)+(III-A1001) to (I-1)+(III-FF1023)] in Table 4 is between 50:1 and 1:50.

在一實施例中,組分 (1)與組分 (2)間的重量比在表3的組合[(I-1)+(II-A001)至(I-1)+(II-R047)]中或是在表4的組合[(I-1)+(III-A1001)至(I-1)+(III-FF1023)]中係介於20:1至1:20之間。In one embodiment, the weight ratio between component (1) and component (2) is in the combination [(I-1)+(II-A001) to (I-1)+(II-R047) of Table 3 ] or in the combination [(I-1)+(III-A1001) to (I-1)+(III-FF1023)] in Table 4 is between 20:1 and 1:20.

在一實施例中,組分 (1)與組分 (2)間的重量比在表3的組合[(I-1)+(II-A001)至(I-1)+(II-R047)]中或是在表4的組合[(I-1)+(III-A1001)至(I-1)+(III-FF1023)]中係介於5:1至1:5之間。In one embodiment, the weight ratio between component (1) and component (2) is in the combination [(I-1)+(II-A001) to (I-1)+(II-R047) of Table 3 ] or in the combination [(I-1)+(III-A1001) to (I-1)+(III-FF1023)] in Table 4 is between 5:1 and 1:5.

在一實施例中,組分 (1)與組分 (2)間的重量比在表3的組合[(I-1)+(II-A001)至(I-1)+(II-R047)]中或是在表4的組合[(I-1)+(III-A1001)至(I-1)+(III-FF1023)]中係介於3:1至1:3之間。In one embodiment, the weight ratio between component (1) and component (2) is in the combination [(I-1)+(II-A001) to (I-1)+(II-R047) of Table 3 ] or in the combination [(I-1)+(III-A1001) to (I-1)+(III-FF1023)] in Table 4 is between 3:1 and 1:3.

在一實施例中,組分 (1)與組分 (2)間的重量比在表3的組合[(I-1)+(II-A001)至(I-1)+(II-R047)]中或是在表4的組合[(I-1)+(III-A1001)至(I-1)+(III-FF1023)]中係介於2:1至1:2之間。In one embodiment, the weight ratio between component (1) and component (2) is in the combination [(I-1)+(II-A001) to (I-1)+(II-R047) of Table 3 ] or in the combination [(I-1)+(III-A1001) to (I-1)+(III-FF1023)] in Table 4 is between 2:1 and 1:2.

在一實施例中,組分 (1)與組分 (2)間的重量比在表3的組合[(I-1)+(II-A001)至(I-1)+(II-R047)]中或是在表4的組合[(I-1)+(III-A1001)至(I-1)+(III-FF1023)]中係1:1。In one embodiment, the weight ratio between component (1) and component (2) is in the combination [(I-1)+(II-A001) to (I-1)+(II-R047) of Table 3 ] or 1:1 in the combination [(I-1)+(III-A1001) to (I-1)+(III-FF1023)] in Table 4.

較佳地,如下方表5所列之組合,其中組分 (1)係一如式 (I)所示之化合物,組分 (2)係選自如本文中所定義的(II-A001)至(II-R047)中與表5所述對應的化合物。Preferably, the combination listed in Table 5 below, wherein component (1) is a compound as shown in formula (I), and component (2) is selected from (II-A001) to Compounds corresponding to those described in Table 5 in (II-R047).

表5:(I)+(II-A002)、(I)+(II-A021)、(I)+(II-A081)、(I)+(II-B001)、(I)+(II-B003)、(I)+(II-B005)、(I)+(II-B007)、(I)+(II-C001)、(I)+(II-C002)、(I)+(II-C003)、(I)+(II-C006)、(I)+(II-C009)、(I)+(II-C010)、(I)+(II-C016)、(I)+(II-C017)、(I)+(II-C020)、(I)+(II-C030)、(I)+(II-D003)、(I)+(II-D004)、(I)+(II-D008)、(I)+(II-E004)、(I)+(II-E005)、(I)+(II-E008)、(I)+(II-E009)、(I)+(II-E010)、(I)+(II-E012)、(I)+(II-E013)、(I)+(II-E015)、(I)+(II-E018)、(I)+(II-I001)、(I)+(II-I002)、(I)+(II-I004)、(I)+(II-I005)、(I)+(II-I007)、(I)+(II-J001)、(I)+(II-L004)、(I)+(II-N001)、(I)+(II-O009)、(I)+(II-O012)、(I)+(II-O022)、(I)+(II-O043)。Table 5: (I)+(II-A002), (I)+(II-A021), (I)+(II-A081), (I)+(II-B001), (I)+(II- B003), (I)+(II-B005), (I)+(II-B007), (I)+(II-C001), (I)+(II-C002), (I)+(II- C003), (I)+(II-C006), (I)+(II-C009), (I)+(II-C010), (I)+(II-C016), (I)+(II- C017), (I)+(II-C020), (I)+(II-C030), (I)+(II-D003), (I)+(II-D004), (I)+(II- D008), (I)+(II-E004), (I)+(II-E005), (I)+(II-E008), (I)+(II-E009), (I)+(II- E010), (I)+(II-E012), (I)+(II-E013), (I)+(II-E015), (I)+(II-E018), (I)+(II- I001), (I)+(II-I002), (I)+(II-I004), (I)+(II-I005), (I)+(II-I007), (I)+(II- J001), (I)+(II-L004), (I)+(II-N001), (I)+(II-O009), (I)+(II-O012), (I)+(II- O022), (I)+(II-O043).

更佳地,如下方表6所列之組合,其中組分 (1)係化合物 (I-1)且組分 (2)係選自如本文中所定義的(II-A001)至(II-R047)中與表6所述對應的化合物。More preferably, the combination listed in Table 6 below, wherein component (1) is compound (I-1) and component (2) is selected from (II-A001) to (II-R047) as defined herein ) corresponding to the compounds described in Table 6.

表6:(I-1)+(II-A002)、(I-1)+(II-A021)、(I-1)+(II-A081)、(I-1)+(II-B001)、(I-1)+(II-B003)、(I-1)+(II-B005)、(I-1)+(II-B007)、(I-1)+(II-C001)、(I-1)+(II-C002)、(I-1)+(II-C003)、(I-1)+(II-C006)、(I-1)+(II-C009)、(I-1)+(II-C010)、(I-1)+(II-C016)、(I-1)+(II-C017)、(I-1)+(II-C020)、(I-1)+(II-C030)、(I-1)+(II-D003)、(I-1)+(II-D004)、(I-1)+(II-D008)、(I-1)+(II-E004)、(I-1)+(II-E005)、(I-1)+(II-E008)、(I-1)+(II-E009)、(I-1)+(II-E010)、(I-1)+(II-E012)、(I-1)+(II-E013)、(I-1)+(II-E015)、(I-1)+(II-E018)、(I-1)+(II-I001)、(I-1)+(II-I002)、(I-1)+(II-I004)、(I-1)+(II-I005)、(I-1)+(II-I007)、(I-1)+(II-J001)、(I-1)+(II-L004)、(I-1)+(II-N001)、(I-1)+(II-O009)、(I-1)+(II-O012)、(I-1)+(II-O022)、(I-1)+(II-O043)。Table 6: (I-1)+(II-A002), (I-1)+(II-A021), (I-1)+(II-A081), (I-1)+(II-B001) , (I-1)+(II-B003), (I-1)+(II-B005), (I-1)+(II-B007), (I-1)+(II-C001), ( I-1)+(II-C002), (I-1)+(II-C003), (I-1)+(II-C006), (I-1)+(II-C009), (I- 1)+(II-C010), (I-1)+(II-C016), (I-1)+(II-C017), (I-1)+(II-C020), (I-1) +(II-C030), (I-1)+(II-D003), (I-1)+(II-D004), (I-1)+(II-D008), (I-1)+( II-E004), (I-1)+(II-E005), (I-1)+(II-E008), (I-1)+(II-E009), (I-1)+(II- E010), (I-1)+(II-E012), (I-1)+(II-E013), (I-1)+(II-E015), (I-1)+(II-E018) , (I-1)+(II-I001), (I-1)+(II-I002), (I-1)+(II-I004), (I-1)+(II-I005), ( I-1)+(II-I007), (I-1)+(II-J001), (I-1)+(II-L004), (I-1)+(II-N001), (I- 1)+(II-O009), (I-1)+(II-O012), (I-1)+(II-O022), (I-1)+(II-O043).

較佳地,如下方表7所列之組合,其中組分 (1)係如式 (I)所示之化合物,組分 (2)係選自如本文中所定義的(I-1)+(III-A1001)至(I-1)+(III-FF1023)中與表7所述對應的化合物。Preferably, the combination listed in Table 7 below, wherein component (1) is a compound shown in formula (I), and component (2) is selected from (I-1)+( III-A1001) to (I-1)+(III-FF1023) corresponding to the compounds described in Table 7.

表7:(I)+(III-B2002)、(I)+(III-D1002)、(I)+(III-D1004)、(I)+(III-D1007)、(I)+(III-Z1002)、(I)+(III-Z1003)、(I)+(III-Z1005)。Table 7: (I)+(III-B2002), (I)+(III-D1002), (I)+(III-D1004), (I)+(III-D1007), (I)+(III- Z1002), (I)+(III-Z1003), (I)+(III-Z1005).

更佳地,如下方表8所列之組合,其中組分 (1)係化合物 (I-1)且組分 (2)係選自如本文中所定義的(III-A1001)至(III-FF1023)中與表8所述對應的化合物。More preferably, the combination as listed in Table 8 below, wherein component (1) is compound (I-1) and component (2) is selected from (III-A1001) to (III-FF1023) as defined herein ) corresponding to the compounds described in Table 8.

表8:(I-1)+(III-B2002)、(I-1)+(III-D1002)、(I-1)+(III-D1004)、(I-1)+(III-D1007)、(I-1)+(III-Z1002)、(I-1)+(III-Z1003)、(I-1)+(III-Z1007)。Table 8: (I-1)+(III-B2002), (I-1)+(III-D1002), (I-1)+(III-D1004), (I-1)+(III-D1007) , (I-1)+(III-Z1002), (I-1)+(III-Z1003), (I-1)+(III-Z1007).

在另一實施例中,本案的農業化學組成物係一如式 (I)所示之活性化合物作為組分 (1)以及至少一活性組分 (2)之混合物。In another embodiment, the agrochemical composition of the present application is a mixture of an active compound represented by formula (I) as component (1) and at least one active component (2).

在另一實施例中,本案的農業化學組成物係一如式 (I)所示之活性化合物作為組分 (1)與二種殺真菌活性化合物 (II)作為組分 (2)之混合物、或是與二種殺蟲或殺線蟲活性化合物 (III)作為組分 (2)之混合物、或是與一種殺真菌活性化合物 (II)以及一種殺蟲或殺線蟲活性化合物 (III)共同作為組分 (2)之混合物。In another embodiment, the agrochemical composition of the present case is a mixture of an active compound as shown in formula (I) as component (1) and two fungicidally active compounds (II) as component (2), Either as a mixture of two insecticidally or nematicidally active compounds (III) as component (2), or together as a group with one fungicidally active compound (II) and one insecticidally or nematically active compound (III) The mixture of (2).

在另一實施例中,本案的農業化學組成物係一如式 (I)所示之活性化合物作為組分 (1),配上一種殺真菌活性化合物 (II)作為一組分 (2)以及一種另外的活性組分 (3);或者配上一種殺蟲或殺線蟲活性化合物 (III)作為一組分 (2)以及一種另外的活性組分 (3)之混合物;所述另外的活性組分 (3)例如:In another embodiment, the agrochemical composition of the present case is an active compound as shown in formula (I) as component (1), coupled with a fungicidal active compound (II) as a component (2) and An additional active ingredient (3); or a mixture of an insecticidal or nematicidal active compound (III) as an ingredient (2) and an additional active ingredient (3); said additional active ingredient points (3) for example:

a) 一種或多種具有殺蟎、殺藻 (algicidal)、殺卵 (avicidal)、殺菌、殺真菌、除草、殺蟲、殺軟體動物 (molluscicidal)、殺線蟲、殺囓齒動物(rodenticidal) 或殺病毒特性的化合物;或a) One or more of the acaricidal, algicidal, ovicidal, bactericidal, fungicidal, herbicidal, insecticidal, molluscicidal, nematicidal, rodenticidal or virucidal characteristic compounds; or

(b) 作為拒食劑 (antifeedants)、驅鳥劑 (bird repellents)、化學滅菌劑 (chemosterilants)、除草劑保護劑 (herbicide safeners)、昆蟲引誘劑 (insect attractants)、驅蟲劑 (insect repellents)、哺乳動物驅避劑 (mammal repellents)、交配干擾劑 (mating disrupters)、植物活化劑 (plant activators)、植物生長調節劑 (plant growth regulators)或增效劑 (synergists) 的一種或多種化合物;(b) as antifeedants, bird repellents, chemosterilants, herbicide safeners, insect attractants, insect repellents, One or more compounds that are mammal repellents, mating disrupters, plant activators, plant growth regulators or synergists;

作為組分 (2)的化合物 (II)及/或化合物 (III)獨立地選自本文中所述的化合物,前提係組分 (2)與組分 (3)不同。Compound (II) and/or compound (III) as component (2) are independently selected from the compounds described herein, provided that component (2) is different from component (3).

在另一實施例中,本案的農業化學組成物係一如式 (I)所示之活性化合物作為組分 (1),配上三種殺真菌活性化合物 (II)作為組分 (2);或者配上三種殺蟲或殺線蟲活性化合物 (III)作為組分 (2)之混合物。在另一實施例中,本案的農業化學組成物係一如式 (I)所示之活性化合物作為組分 (1),配上二種殺真菌活性化合物 (II)作為一組分 (2)以及一種另外的活性組分 (3);或者配上二種殺蟲或殺線蟲活性化合物 (III)作為一組分 (2)以及一種另外的活性組分 (3)之混合物。舉例而言,可為如式 (I)所示之化合物 + 選自二種殺真菌活性化合物 (II)/二種殺蟲或殺線蟲活性化合物 (III)的兩種活性組分 (2)+一種本文所述之另外的活性組分 (3)(共有4種組合方式)。In another embodiment, the agrochemical composition of the present case is an active compound as shown in formula (I) as component (1), coupled with three fungicidal active compounds (II) as component (2); or A mixture of three insecticidally or nematicidally active compounds (III) is added as component (2). In another embodiment, the agrochemical composition of the present case is an active compound as shown in formula (I) as component (1), coupled with two kinds of fungicidal active compounds (II) as a component (2) and an additional active ingredient (3); or a mixture of two insecticidal or nematicidal active compounds (III) as an ingredient (2) and an additional active ingredient (3). For example, it can be a compound represented by formula (I) + two active components (2) selected from two fungicidal active compounds (II)/two insecticidal or nematicidal active compounds (III) + An additional active ingredient (3) as described herein (4 combinations in total).

本案的農業化學組成物特別適用於控制節肢動物害蟲 (arthropodal pests),例如蛛形綱動物 (arachnids)、多足綱動物 (myriapedes)、昆蟲和線蟲。The agricultural chemical compositions of the present invention are particularly useful for controlling arthropodal pests such as arachnids, myriapedes, insects and nematodes.

本案的新穎農業化學組成物具有有效的殺微生物活性及/或殺昆蟲或殺線蟲活性。此些組合物可用於控制非所欲之微生物,例如非所欲之真菌和細菌及/或害蟲和蟎蟲。此些組合物在作物保護(控制引起植物病害的微生物和/或用於控制害蟲和蟎蟲)或保護材料(例如工業材料、木材、儲存之貨物)等領域中特別有用。更具體地,本案的農業化學組成物可用於保護例如種子、發芽之植物、出苗的幼苗、植物、植物的部分、果實以及植物生長的土壤免於有害微生物的侵害。The novel agricultural chemical composition of the present case has effective microbicidal activity and/or insecticidal or nematicidal activity. Such compositions are useful for controlling undesired microorganisms, such as undesired fungi and bacteria and/or pests and mites. Such compositions are particularly useful in the fields of crop protection (control of plant disease-causing microorganisms and/or for controlling pests and mites) or protection of materials (eg industrial materials, wood, stored goods). More specifically, the agricultural chemical composition of the present invention can be used to protect, for example, seeds, germinated plants, emerging seedlings, plants, plant parts, fruits, and soil in which plants grow from harmful microorganisms.

本案的農業化學組成物可用於植物病原性真菌的治療性或保護性/預防性控制。因此,本發明亦涉及藉由使用本案之新穎農業化學組成物以控制植物性病原真菌的治療和保護方法,所述組合物係施用於植物、植物的部分、種子、果實或植物生長的土壤。The agrochemical compositions of the present case can be used for therapeutic or protective/preventive control of phytopathogenic fungi. Therefore, the present invention also relates to methods of treatment and protection for the control of phytopathogenic fungi by using the novel agrochemical compositions of the present application, which are applied to plants, plant parts, seeds, fruits or the soil on which the plants grow.

由於植物對於本案的新穎農業化學組成物在防治植物病害所需的濃度下仍有良好的耐受性,故本案之組合物可用於處理植物的地上部分、植物的繁殖物和種子以及土壤。Since plants still have good tolerance to the novel agricultural chemical composition of this case at the concentration required for controlling plant diseases, the composition of this case can be used to treat aerial parts of plants, plant propagation products and seeds, and soil.

本案之新穎農業化學組成物可用以處理所有植物和植物之部分。「植物」係指所有植物和植物種群,例如所欲及非所欲的野生植物、栽培品種 (cultivars)和植物品種(無論是否受植物品種或植物育種者權利的保護)。栽培品種和植物品種可以是藉由常規繁殖和育種方法獲得的植物,這些方法可以輔以一種或多種生物技術方法,例如使用雙單倍體 (double haploids)、原生質體融合 (protoplast fusion)、隨機和定點突變 (random and directed mutagenesis)、分子或遺傳標記或藉由生物工程和基因工程方法。「植物之部分」係指植物的所有地上和地下的部分和植物器官,例如芽、葉、花及根,其中於此列舉出如葉、針、莖、桿、花、果實體、果實及種子以及根、塊莖及塊根。植物部分亦包括作物及栽植及繁殖材料,例如種苗、塊莖、塊根、插枝及種子。The novel agricultural chemical composition of the present invention can be used to treat all plants and plant parts. "Plant" means all plants and plant populations such as wild plants, cultivars and plant varieties (whether or not protected by plant variety or plant breeder's rights), both desired and undesired. Cultivars and plant varieties may be plants obtained by conventional methods of propagation and breeding which may be supplemented by one or more biotechnological methods such as the use of double haploids, protoplast fusion, random And site-directed mutagenesis (random and directed mutagenesis), molecular or genetic markers or by bioengineering and genetic engineering methods. "Parts of a plant" means all above- and below-ground parts and plant organs of a plant, such as buds, leaves, flowers and roots, of which there are examples such as leaves, needles, stems, stalks, flowers, fruit bodies, fruits and seeds and roots, tubers and tubers. Plant parts also include crops and planting and propagation material, for example seedlings, tubers, roots, cuttings and seeds.

植物對於本案的新穎農業化學組成物具有良好的耐受性、且本案的農業化學組成物具有良好的恆溫毒性和良好的環境耐受性,適用於保護植物和植物器官,提高收穫產量及改善收穫物的品質。其等適合作為作物保護組合物。其等對於一般敏感性及抗性物種具有活性且可用於所有或部分發展階段。Plants have good tolerance to the novel agricultural chemical composition of this case, and the agricultural chemical composition of this case has good constant temperature toxicity and good environmental tolerance, and is suitable for protecting plants and plant organs, increasing harvest yield and improving harvest quality of things. These are suitable as crop protection compositions. They are active against generally sensitive and resistant species and can be used at all or part of the developmental stages.

用語「其所在地 (locus thereof)」包括土壤、植物或植物部分的周圍環境以及在播種/種植植物或植物部分之前、期間或之後使用的設備或工具。The term "locus thereof" includes soil, surroundings of plants or plant parts and equipment or implements used before, during or after sowing/planting plants or plant parts.

將本案的化合物或是在本案的化合物任選包含其他相容化合物的組成物中施用於植物或植物材料或其所在地,包括藉由本案所屬技術領域中具有通常知識者已知的技術施用,包括但不限於噴灑、塗抹 (coating)、浸置 (dipping)、燻蒸 (fumigating)、浸漬 (impregnating)、注射以及噴粉 (dusting)。Applying the compounds of the present invention or in the composition of the compounds of the present invention optionally containing other compatible compounds to the plant or plant material or its locus, including by techniques known to those skilled in the art to which the present invention belongs, including But not limited to spraying, coating, dipping, fumigating, impregnating, injecting and dusting.

如本文中所用,用語「控制」包括針對非所欲的微生物的治療與保護性處理及/或控制害蟲與蟎蟲。非所欲的微生物可以是病原細菌或病原真菌,更具體地是植物病原細菌或植物病原性真菌。As used herein, the term "control" includes curative and protective treatments against unwanted microorganisms and/or control of pests and mites. Unwanted microorganisms may be pathogenic bacteria or fungi, more particularly phytopathogenic bacteria or fungi.

植物病原微生物:Phytopathogenic microorganisms:

如本文後方所詳細描述,此等植物病原微生物係廣泛範圍之植物病害的致病原因 (causal agents)。As described in detail later herein, these phytopathogenic microorganisms are the causal agents of a wide range of plant diseases.

具體地,本案之農業化學組成物可作為殺真菌劑使用。更具體而言,所述組合物可用於作物保護,例如用以控制非所欲之真菌,例如根腫菌綱( Plasmodiophoromycetes)、卵菌綱( Oomycetes)、壺菌綱( Chytridiomycetes)、接合菌綱( Zygomycetes)、子囊菌綱( Ascomycetes)、擔子菌綱( Basidiomycetes) 及半知菌綱( Deuteromycetes)。 Specifically, the agricultural chemical composition of this case can be used as a fungicide. More specifically, the composition can be used in crop protection, e.g. for the control of undesirable fungi, e.g. Plasmodiophoromycetes , Oomycetes , Chytridiomycetes , Zygomycetes ( Zygomycetes ), Ascomycetes ( Ascomycetes ), Basidiomycetes ( Basidiomycetes ) and Deuteromycetes .

本案之農業化學組成物亦可作為殺細菌劑使用。更具體而言,所述組合物可用於作物保護,例如用以控制非所欲之細菌,例如假單胞菌科 ( Pseudomonadaceae)、根瘤菌科 ( Rhizobiaceae)、黃單胞菌科 ( Xanthomonadaceae)、腸內菌科 ( Enterobacteriaceae)、棒狀桿菌科 ( Corynebacteriaceae)及鏈絲菌科 ( Streptomycetaceae)。 The agricultural chemical composition of this case can also be used as a bactericide. More specifically, the composition can be used in crop protection, e.g. to control undesired bacteria, such as Pseudomonadaceae , Rhizobiaceae , Xanthomonadaceae , Enterobacteriaceae , Corynebacteriaceae and Streptomycetaceae .

本案亦關於一種控制非所欲之微生物的方法,例如非所欲之真菌,其包括將至少一種本案之新穎農業化學組成物施用於微生物及/或其棲息地(施用於植物、植物的部分、種子、果實或植物生長的土壤)的步驟。The present case also relates to a method of controlling unwanted microorganisms, such as unwanted fungi, comprising applying at least one novel agrochemical composition of the present invention to the microorganisms and/or their habitat (applied to plants, plant parts, seeds, fruit or the soil in which the plant grows).

一般而言,當欲使用本案之農業化學組成物於治療或保護方法以控制植物病原性真菌時,係將有效且無植物毒性劑量之所述組合物施用於植物、植物的部分、種子、果實或植物生長的土壤。Generally speaking, when the agricultural chemical composition of the present invention is intended to be used in a therapeutic or protective method to control phytopathogenic fungi, an effective and non-phytotoxic dose of said composition is applied to plants, plant parts, seeds, fruits or the soil in which plants grow.

「有效且無植物毒性的劑量」係指足以控制或消滅存在於或易於出現在農田上的真菌並且不會對所述作物產生任何植物毒性症狀的劑量。此種劑量可在寬廣的範圍內變化,其取決於要防治的真菌、作物的類型、氣候條件以及使用本案的何種組合物。所述劑量可以藉由本案發明所屬技術領域中具有通常知識者之能力範圍內的系統性田野試驗 (systematic field trials)來確定。"Effective and non-phytotoxic dose" means a dose sufficient to control or destroy fungi present or liable to occur on a field of crops without causing any phytotoxic symptoms to the crop. Such dosages can vary within wide limits, depending on the fungi to be controlled, the type of crop, the climatic conditions and which compositions of the invention are used. The dosage can be determined by systematic field trials that are within the ability of those skilled in the art of the present invention.

本案的新穎農業化學組成物可以施用於任何植物或植物部分。The novel agrochemical compositions of the present invention may be applied to any plant or plant part.

本文中之植物係指所有的植物及植物群,例如,想要的及不想要的野生植物或作物植物(包括自然成長的作物植物)。作物植物可為可藉由習用培植及最優化方法或藉由生物科技及基因工程方法或此等方法之組合所得到的植物,包括基因改造植物(GMO或稱基因轉殖植物)及包括栽培品種植物,其為植物培育者之權利所保護或未保護者。Plants herein refer to all plants and groups of flora, for example, desired and undesired wild plants or crop plants (including naturally growing crop plants). Crop plants are plants obtainable by conventional breeding and optimization methods or by biotechnology and genetic engineering methods or a combination of these methods, including genetically modified plants (GMO or genetically modified plants) and including cultivars Plants, which are protected or not protected by plant breeders' rights.

「基因改造植物(GMO或基因轉殖植物)」是異源基因(或稱外源基因)已穩定整合到基因體中的植物。所述「異源基因(或稱外源基因)」基本上係指在引入核、葉綠體或粒線體基因體中時,從植物外部提供或於植物外部組裝的基因。此基因藉由表現相關蛋白質或多肽或藉由下調或抑制植物中存在之其他基因(使用例如反義技術 (antisense technology)、共抑制技術、RNA干擾-RNAi技術或微RNA-miRNA技術)賦予轉化植物新的或改良的農藝特性或其他特性。位於基因組中之異源基因亦稱為轉殖基因或轉基因 (transgene)。由在植物基因體中之特定位置定義之轉殖基因稱為轉化 (transformation)或轉殖基因事件 (transgenic event)。A "genetically modified plant (GMO or transgenic plant)" is a plant in which a heterologous gene (or exogenous gene) has been stably integrated into the genome. The "heterologous gene (or exogenous gene)" basically refers to a gene provided from outside the plant or assembled outside the plant when introduced into the nucleus, chloroplast or mitochondrial genome. This gene confers transformation by expressing the relevant protein or polypeptide or by down-regulating or inhibiting other genes present in the plant (using e.g. antisense technology, co-suppression technology, RNA interference-RNAi technology or microRNA-miRNA technology) New or improved agronomic or other characteristics of plants. A heterologous gene located in the genome is also called a transgene or a transgene. A transgene defined by a specific position in the plant genome is called a transformation or transgenic event.

用語「植物栽培品種」應理解為表示具有新穎特性(「性狀」)且已藉由習知育種、誘發突變或重組DNA技術獲得的植物。其可為栽培品種、變種、生物型或基因型。The term "plant cultivars" is understood to mean plants having novel properties ("traits") which have been obtained by conventional breeding, mutagenesis or recombinant DNA techniques. It may be a cultivar, variety, biotype or genotype.

用語「植物部分」應理解為表示地上和地下植物的所有部分和器官,例如幼芽、葉片、針葉、莖梗 (stalk)、莖稈 (stem)、花朵、子實體、果實、種子、根部、塊莖及根莖。植物部分亦包括收穫的物質及無性與有性繁殖物質,例如插條、塊莖、根莖、幼枝及種子。The term "plant parts" is understood to mean all parts and organs of plants above and below ground, such as shoots, leaves, needles, stalks, stems, flowers, fruiting bodies, fruits, seeds, roots , tubers and rhizomes. Plant parts also include harvested material and vegetative and generative propagation material, for example cuttings, tubers, rhizomes, shoots and seeds.

可根據本文所描述之方法處理之植物包括以下:棉花、亞麻、葡萄藤、水果、蔬菜,例如薔薇科 ( Rosaceae sp.)(舉例而言,諸如蘋果及梨的仁果 (pome fruits),以及例如杏、櫻桃、杏仁、桃的核果 (stone fruits),以及諸如草莓的無核小水果 (soft fruits))、茶藨子科 ( Ribesioidae sp.)、胡桃科 ( Juglandaceae sp.)、樺科 ( Betulaceaesp.)、漆樹科( Anacardiaceaesp.)、山毛櫸科 ( Fagaceaesp.)、桑科 ( Moraceaesp.)、木樨科 ( Oleaceaesp.)、獼猴桃科 ( Actinidaceaesp.)、樟科 ( Lauraceaesp.)、芭蕉科 ( Musaceaesp.)(例如,香蕉樹及人造林)、茜草科 ( Rubiaceaesp.)(例如咖啡)、茶科 ( Theaceaesp.)、梧桐科 ( Sterculiceaesp.)、芸香科 (Rutaceae sp.)(例如,檸檬、柑橘及葡萄柚);茄科 ( Solanaceaesp.)(例如蕃茄)、百合科 ( Liliaceaesp.)、菊科 ( Asteraceaesp.)(例如萵苣)、傘形科(Umbelliferae sp.)、十字花科( Cruciferaesp.)、藜科( Chenopodiaceaesp.)、葫蘆科( Cucurbitaceaesp.)(例如胡瓜)、蔥科( Alliaceaesp.)(例如韭菜、洋蔥)、蝶形花科 ( Papilionaceaesp.)(例如豆類);長軸作物植物,諸如禾本科 ( Gramineaesp.)(例如,玉米、草皮、穀類,諸如小麥、粗麥、稻穀、大麥、燕麥、栗及黑小麥)、菊科 ( Asteraceaesp.)(例如葵花)、十字花科 ( Brassicaceaesp.)(例如白球甘藍、紅球甘藍、椰菜、花椰菜、孢子甘藍、白菜、球莖甘藍、蘿蔔及油菜、芥菜、辣根及水芹)、豆科 ( Fabacaesp.)(例如,豆子、花生)、蝶形花科 ( Papilionaceaesp.)(例如大豆)、茄科 ( Solanaceaesp.)(例如馬鈴薯)、藜科 ( Chenopodiaceaesp.)(例如糖用甜菜、飼用甜菜、紅頭菜、甜菜根);供園林及林地用之有用植物及觀賞性植物;及此等植物中之每一者的經基因修飾之變體。 Plants that may be treated according to the methods described herein include the following: cotton, flax, vines, fruits, vegetables, such as Rosaceae sp. (for example, pome fruits such as apples and pears, and For example stone fruits of apricots, cherries, almonds, peaches, and soft fruits such as strawberries), Ribesioidae sp. , Juglandaceae sp., Betaceae ( Betulaceae sp.), Anacardiaceae sp., Fagaceae sp., Moraceae sp., Oleaceae sp., Actinidaceae sp., Lauraceae sp. .), Musaceae sp. (e.g. banana trees and plantations), Rubiaceae sp. (e.g. coffee), Theaceae sp., Sterculiceae sp., Rutaceae (Rutaceae sp.) (for example, lemons, mandarins, and grapefruit); Solanaceae sp. (for example, tomato), Liliaceae (for example), Liliaceae sp., Asteraceae sp. (for example, lettuce), umbrellas Umbelliferae sp., Cruciferae sp., Chenopodiaceae sp., Cucurbitaceae sp. (eg cucumbers), Alliaceae sp. (eg leeks, onions), Papilionaceae sp. (e.g. beans); long axis crop plants such as Gramineae sp. (e.g. maize, turf, cereals such as wheat, couscous, rice, barley, oats, chestnut and Triticale), Asteraceae sp. (such as sunflower), Brassicaceae sp. (such as white cabbage, red cabbage, broccoli, cauliflower, Brussels sprouts, bok choy, kohlrabi, radish and rapeseed, mustard greens, horseradish, and cress), Fabacae sp. (e.g., beans, peanuts), Papilionaceae sp. (e.g., soybeans), Solanaceae sp. (e.g., potatoes), Chenopodiaceae sp. (for example sugar beets, fodder beets, red cabbage, beetroot); useful plants for gardens and woodlands and ornamental plants; and genetically modified variants of each of these plants.

可根據本發明治療的真菌病原體疾病之非限制性實例包括:Non-limiting examples of fungal pathogenic diseases that may be treated in accordance with the present invention include:

由白粉病病原體引起的疾病,例如白粉病菌屬 ( Blumeriaspecies),例如禾本科布氏白粉菌 ( Blumeria graminis);叉絲單囊殼屬 ( Podosphaeraspecies),例如白叉絲單囊殼 ( Podosphaera leucotricha);單絲殼屬 ( Sphaerothecaspecies),例如單絲殼白粉菌 ( Sphaerotheca fuliginea);鉤絲殼屬 ( Uncinulaspecies),例如葡萄白粉病菌 ( Uncinula necator);白粉菌屬 ( Erysiphe species),例如胡瓜白粉病 ( Erysiphe cichoracearu); Diseases caused by powdery mildew pathogens such as Blumeria species such as Blumeria graminis ; Podosphaera species such as Podosphaera leucotricha ); Sphaerotheca species, such as Sphaerotheca fuliginea ; Uncinula species, such as Uncinula necator ; Erysiphe species , such as cucumber Powdery mildew ( Erysiphe cichoracearu );

由鏽病病原體 (rust disease pathogens)引起之病害,該等鏽病病原體例如:膠鏽菌屬 ( Gymnosporangiumspecies),例如褐色膠鏽菌 ( Gymnosporangium sabinae);駝孢鏽菌屬 ( Hemileiaspecies),例如咖啡駝孢鏽菌( Hemileia vastatrix);層鏽菌屬 ( Phakopsora species),例如大豆鏽菌 ( Phakopsora pachyrhizi) 或層鏽層假尾孢菌 ( Phakopsora meibomiae);柄鏽菌屬 ( Pucciniaspecies),例如麥類葉鏽病菌 ( Puccinia recondita)、禾柄鏽菌奧德條形柄鏽菌 (Puccinia graminis) 或 條形銹病菌 (Puccinia striiformis);單孢鏽菌屬 ( Uromycesspecies),例如菜豆鏽病菌 ( Uromyces appendiculatus); Diseases caused by rust disease pathogens such as: Gymnosporangium species, such as Gymnosporangium sabinae ; Hemileia species, such as coffee camel Hemileia vastatrix ; Phakopsora species such as soybean rust ( Phakopsora pachyrhizi ) or Phakopsora meibomiae ; Puccinia species such as wheat Leaf rust ( Puccinia recondita ), Puccinia graminis or Puccinia striiformis; Uromyces species such as Uromyces appendiculatus );

由來自卵菌綱(Oomycetes)之群的病原體引起之病害,該等病原體例如:白鏽病屬 ( Albugospecies),例如白鏽菌 ( Albugo candida);萵苣露菌病菌屬 ( Bremiaspecies),例如萵苣露菌病 ( Bremia lactucae);霜黴菌屬 ( Peronosporaspecies),例如豌豆霜黴菌 ( Peronospora pisi) 或芸苔根腫菌 ( P . Brassicae);疫黴菌屬);疫黴菌屬 ( Phytophthoraspecies),例如致病疫黴 ( Phytophthora infestans);單軸黴屬 ( Plasmoparaspecies),例如葡萄生單軸黴 ( Plasmopara viticola);假霜黴屬 ( Pseudoperonosporaspecies),例如葎草假霜黴 ( Pseudoperonospora humuli) 或古巴假霜黴菌 ( Pseudoperonospora cubensis);腐黴菌屬 ( Pythiumspecies),例如終極腐黴菌 ( Pythium ultimum);以及其他如螺殼狀絲囊霉 ( Aphanomyces cochlioides)、( Labyrinthvia zosterae)、高梁霜指黴 ( Peronosclerospora sorghi) 及 Seierospara graminicolaDiseases caused by pathogens from the group of Oomycetes, such as: Albugo species, such as Albugo candida ; Bremia species, such as lettuce Bremia lactucae ; Peronospora species such as Peronospora pisi or P. Brassicae ; Phytophthora); Phytophthora species such as Phytophthora infestans ; Plasmopara species such as Plasmopara viticola ; Pseudoperonospora species such as Pseudoperonospora humuli or Cuban Pseudoperonospora cubensis ; Pythium species such as Pythium ultimum ; and others such as Aphanomyces cochlioides , Labyrinthvia zosterae , Peronosclerospora sorhi ) and Seierospara graminicola .

由例如以下所引起之葉斑病及葉萎病:鏈隔孢菌屬 ( Alternariaspecies),例如茄鏈隔孢菌 ( Alternaria solani);尾孢菌屬 ( Cercosporaspecies),例如甜菜尾孢菌 ( Cercospora beticola);黑星病菌屬 ( Cladiosporiumspecies),例如黃瓜黑星病菌 ( Cladiosporium cucumerinum);旋孢腔菌屬 ( Cochliobolusspecies),例如禾旋孢腔菌 ( Cochliobolus sativus) (分生孢子形式 (conidial form):內臍蠕孢屬 (Drechslera),同義詞:長蠕孢菌 (Helminthosporium)) 或宮部旋孢腔菌 ( Cochliobolus miyabeanus);刺盤孢屬 ( Colletotrichumspecies),例如菜豆炭疽病菌 ( Colletotrichum lindemuthanium);棒孢黴屬 ( Corynesporaspecies),例如多主棒孢黴 ( Corynespora cassiicola);孔雀斑菌屬 ( Cycloconiumspecies),例如油橄欖孔雀斑菌 ( Cycloconium oleaginum);黑點病菌屬 ( Diaporthespecies),例如柑橘黑點病菌 ( Diaporthe citri);痂囊腔菌屬 ( Elsinoespecies),例如柑桔痂囊腔菌 ( Elsinoe fawcettii);炭疽病菌屬 ( Gloeosporiumspecies),例如桃炭疽病菌 ( Gloeosporium laeticolor);小叢殼屬 ( Glomerellaspecies),例如圍小叢殼菌 ( Glomerella cingulata);球座菌屬 ( Guignardiaspecies),例如葡萄球座菌 ( Guignardia bidwelli);小球腔菌屬 ( Leptosphaeriaspecies),例如十字花科小球腔菌 ( Leptosphaeria maculans);稻瘟菌屬 ( Magnaporthespecies),例如稻瘟菌 ( Magnaporthe grisea);微結節菌屬 ( Microdochiumspecies),例如雪黴枯葉病菌 ( Microdochium nivale);球腔菌屬 ( Mycosphaerellaspecies),例如禾生球腔菌 ( Mycosphaerella graminicola)、落花生球腔菌 ( Mycosphaerella arachidicola) 或斐濟球腔菌 ( Mycosphaerella fijiensis);暗球腔菌屬 ( Phaeosphaeriaspecies),例如小麥葉枯病菌 ( Phaeosphaeria nodorum);核腔菌屬 ( Pyrenophoraspecies),例如大麥網斑病菌 ( Pyrenophora teres) 或偃麥草核腔菌 ( Pyrenophora tritici repentis);柱隔孢屬 ( Ramulariaspecies),例如柱隔孢 ( Ramularia collo-cygni) 或白斑柱隔孢 ( Ramularia areola);雲紋病菌屬 ( Rhynchosporiumspecies),例如大麥雲紋病菌 ( Rhynchosporiumsecalis);殼針孢屬 ( Septoriaspecies),例如芹菜小殼針孢 ( Septoria apii) 或番茄殼針孢 ( Septoria lycopersici);殼多孢屬 ( Stagonosporaspecies),例如小麥殼多孢菌 ( Stagonospora nodorum);核瑚菌屬 ( Typhulaspecies),例如肉孢核瑚菌 ( Typhula incarnata);黑星菌屬 ( Venturiaspecies),例如蘋果黑星病菌 ( Venturia inaequalis); Leaf spot and leaf wilt caused by, for example, Alternaria species, such as Alternaria solani ; Cercospora species, such as Cercospora beta ( Cercospora beticola ); Cladiosporium species such as Cladiosporium cucumerinum ; Cochliobolus species such as Cochliobolus sativus (conidial form): Drechslera, synonym: Helminthosporium) or Cochliobolus miyabeanus ; Colletotrichum species, eg Colletotrichum lindemuthanium Corynespora species, e.g. Corynespora cassiicola ; Cycloconium species, e.g. Cycloconium oleaginum ; Diaporthe species, e.g. Diaporthe citri ; Elsinoe species such as Elsinoe fawcettii ; Gloeosporium species such as Gloeosporium laeticolor ; Glomerella species, such as Glomerella cingulata ; Guignardia species, such as Guignardia bidwelli ; Leptosphaeria species, such as Crucifera Leptosphaeria maculans ; Magnaporthe species, such as Magnaporthe grisea ; Microdochium species, such as snow Microdochium nivale ; Mycosphaerella species, such as Mycosphaerella graminicola , Mycosphaerella arachidicola or Mycosphaerella fijiensis ; Mycosphaerella fijiensis ( Phaeosphaeria species), such as wheat leaf blight ( Phaeosphaeria nodorum ); Pyrenophora species, such as Pyrenophora teres or Pyrenophora tritici repentis ; Ramularia species), such as Ramularia collo-cygni or Ramularia areola ; Rhynchosporium species, such as Rhynchosporium secalis; Septoria species ), such as Septoria apii or Septoria lycopersici ; Stagonospora species, such as Stagonospora nodorum ; Typhula species , such as Typhula incarnata ; Venturia species, such as Venturia inaequalis ;

由例如以下所引起之根部及莖稈病害:伏革菌屬 ( Corticiumspecies),例如禾穀鐮孢伏革菌 ( Corticium graminearum);鐮菌屬 ( Fusariumspecies),例如尖孢鐮刀菌 ( Fusarium oxysporum);頂囊殼屬 ( Gaeumannomycesspecies),例如禾草頂囊殼菌 ( Gaeumannomyces graminis);根腫菌屬 ( Plasmodiophoraspecies),例如甘藍根腫菌 ( Plasmodiophora brassicae);絲核菌屬 ( Rhizoctoniaspecies),例如立枯絲核菌 ( Rhizoctonia solani);帚枝黴屬 ( Sarocladiumspecies),例如稻葉鞘腐敗病菌 ( Sarocladium oryzae);小核菌屬 ( Sclerotiumspecies),例如稻小核菌 ( Sclerotium oryzae);塔普斯菌屬 ( Tapesiaspecies),例如塔普斯梭狀芽胞桿菌 ( Tapesia acuformis);根串珠黴屬 ( Thielaviopsisspecies),例如菫菜根腐病菌 ( Thielaviopsis basicola); Root and stem diseases caused by, for example, Corticium species, such as Corticium graminearum ; Fusarium species, such as Fusarium oxysporum ); Gaeumannomyces species such as Gaeumannomyces graminis ; Plasmodiophora species such as Plasmodiophora brassicae ; Rhizoctonia species , such as Rhizoctonia solani ( Rhizoctonia solani ); Sarocladium species, such as Sarocladium oryzae ; Sclerotium species, such as Sclerotium oryzae ; Tapesia species, such as Tapesia acuformis ; Thielaviopsis species, such as Thielaviopsis basicola ;

由例如以下所引起之穗及圓錐花序 (panicle)病害(包括玉米穗軸):鏈隔孢菌屬 ( Alternariaspecies),例如交鏈孢菌 ( Alternaria spp.);麴菌屬 ( Aspergillusspecies),例如黃麴菌 ( Aspergillus flavus);分枝孢子菌屬 ( Cladosporiumspecies),例如芽枝狀枝孢黴 ( Cladosporium cladosporioides);麥角菌屬 ( Clavicepsspecies),例如紫黑麥角菌 ( Claviceps purpurea);鐮菌屬 ( Fusariumspecies),例如黃色鐮孢菌 ( Fusarium culmorum);赤黴菌屬 ( Gibberellaspecies),例如玉米赤黴 ( Gibberella zeae);小畫線殼屬 ( Monographellaspecies),例如雪黴小畫線殼 ( Monographella nivalis);殼多孢菌屬 ( Stagnosporaspecies),例如小麥殼多孢菌 ( Stagonospora nodorum); Ear and panicle diseases (including corn cobs) caused by, for example, Alternaria species, such as Alternaria spp .; Aspergillus species, For example, Aspergillus flavus ; Cladosporium species, such as Cladosporium cladosporioides ; Claviceps species, such as Claviceps purpurea ; Fusarium species, e.g. Fusarium culmorum ; Gibberella species, e.g. Gibberella zeae ; Monographella species, e.g. Wire shells ( Monographella nivalis ); Stagnospora species such as Stagonospora nodorum ;

由黑穗病真菌 (smut fungi)引起之病害,該等黑穗病真菌例如:蜀黍小黑穗病菌屬 ( Sphacelothecaspecies),例如高粱絲黑粉菌 ( Sphacelotheca reiliana);腥黑粉菌屬 ( Tilletiaspecies),例如小麥矮腥黑粉菌 ( Tilletia cariesTilletia controversa);條黑粉菌屬 ( Urocystisspecies),例如隱條黑粉菌 ( Urocystis occulta);黑粉菌屬 ( Ustilagospecies),例如麥散黑粉菌 ( Ustilago nuda); Diseases caused by smut fungi such as: Sphacelotheca species, such as Sphacelotheca reiliana ; Tilletia species), such as Tilletia caries or Tilletia controversa ; Urocystis species, such as Urocystis occulta ; Ustilago species, such as wheat Smut fungus ( Ustilago nuda );

由例如以下引起之果腐病:麴菌屬 ( Aspergillusspecies),例如黃麴菌 ( Aspergillus flavus);葡萄孢屬 ( Botrytisspecies),例如灰葡萄孢菌 ( Botrytis cinerea);青黴菌屬 ( Penicilliumspecies),例如擴展青黴 ( Penicillium expansum) 或產紫青黴 ( Penicillium purpurogenum);根黴菌屬 ( Rhizopusspecies),例如匍枝根黴 ( Rhizopus stolonifer);核盤菌屬 ( Sclerotiniaspecies),例如向日葵核盤菌 ( Sclerotinia sclerotiorum);輪枝孢屬 ( Verticiliumspecies),例如黃萎輪枝黴 ( Verticilium alboatrum); Fruit rot caused by, for example, Aspergillus species, such as Aspergillus flavus ; Botrytis species, such as Botrytis cinerea ; Penicillium species ), such as Penicillium expansum or Penicillium purpurogenum ; Rhizopus species, such as Rhizopus stolonifer ; Sclerotinia species, such as Sclerotinia helianthus ( Sclerotinia sclerotiorum ); Verticilium species, such as Verticilium alboatrum ;

由例如以下所引起之種子及土壤媒介腐病、萎病以及苗木病害:鏈隔孢菌屬,例如嗜甘藍鏈隔孢菌 ( Alternaria brassicicola);絲囊黴屬 ( Aphanomycesspecies),例如兵豆絲囊黴 ( Aphanomyces euteiches);囊二孢菌 ( Ascochytaspecies),例如晶狀囊二孢菌 ( Ascochyta lentis);麴菌屬,例如黃麴菌;分枝孢子菌屬,例如分枝孢子菌 ( Cladosporium herbarum);旋孢腔菌屬,例如禾旋孢腔菌(分生孢子形式:內臍蠕孢屬、雙孔孢菌屬 (Bipolaris),同義詞:長蠕孢菌 ( Helminthosporium));刺盤孢屬,例如仙人掌炭疽刺盤孢菌 ( Colletotrichum coccodes);鐮菌屬,例如黃色鐮孢菌;赤黴菌屬,例如玉米赤黴 ( Gibberella zeae) ;殼球孢屬 ( Macrophominaspecies),例如萊豆殼球孢菌 ( Macrophomina phaseolina);微結節菌屬 ( Microdochiumspecies),例如雪黴枯葉病菌 ( Microdochium nivale) ;小畫線殼屬 ( Monographellaspecies),例如雪黴小畫線殼病菌 ( Monographella nivalis);青黴菌屬,例如擴展青黴;莖點黴屬 ( Phomaspecies),例如黑脛莖點黴 ( Phoma lingam);擬莖點黴屬 ( Phomopsisspecies),例如大豆擬莖點黴;疫黴菌屬 ( Phytophthoraspecies),例如惡疫黴 ( Phytophthora cactorum);核腔菌屬 ( Pyrenophoraspecies),例如大麥核腔菌 ( Pyrenophora graminea);梨孢黴屬 ( Pyriculariaspecies),例如稻梨孢黴 ( Pyricularia oryzae);腐黴菌屬 ( Pythiumspecies),例如終極腐黴菌 ( Pythium ultimum);絲核菌屬 ( Rhizoctoniaspecies),例如立枯絲核菌 ( Rhizoctonia solani);根黴菌屬 ( Rhizopusspecies),例如米根黴 ( Rhizopus oryzae);小核菌屬 ( Sclerotiumspecies),例如白絹病小核菌 ( Sclerotium rolfsii);殼針孢屬 (Septoria species),例如穎枯殼針孢菌 ( Septoria nodorum);核瑚菌屬 ( Typhulaspecies),例如內孢核瑚菌 ( Typhula incarnata);輪枝菌屬 ( Verticilliumspecies),例如大麗花輪枝孢菌 ( Verticillium dahliae); Seed and soil borne rot, wilt and seedling diseases caused by, for example, Alternaria brassicicola ; Aphanomyces species, such as lentil silk Aphanomyces euteiches ; Ascochyta species, such as Ascochyta lentis ; Aspergillus, such as Aspergillus flavus; Cladosporium, such as Cladosporium herbarum ); Helminthosporium, e.g. Helminthosporium (conidial form: Helminthosporium, Bipolaris, synonym: Helminthosporium ( Helminthosporium )); Genus, such as Colletotrichum coccodes ; Fusarium, such as Fusarium chrysogenum; Gibberella, such as Gibberella zeae ; Macrophomina species, such as Laybean shell Microphomina phaseolina ; Microdochium species, such as Microdochium nivale ; Monographella species, such as Monographella nivalis ; Penicillium, such as Penicillium expanse; Phoma species, such as Phoma lingam ; Phomopsis species, such as Phomopsis soybean; Phytophthora ( Phytophthora species), such as Phytophthora cactorum ; Pyrenophora species, such as Pyrenophora graminea ; Pyricularia species, such as Pyricularia oryzae ; Pythium species, such as Pythium ultimum ; Rhizoctonia species, such as Rhizoctonia solani ; Rhizopus species, such as Rhizopus oryzae ( Rhizopu s oryzae ); Sclerotium species, such as Sclerotium rolfsii ; Septoria species, such as Septoria nodorum ; Sclerotium species ( Typhula species), such as Typhula incarnata ; Verticillium species, such as Verticillium dahliae ;

由例如以下所引起之癌症、蟲癭 (galls)及叢枝病 (witches’ broom):叢赤殼菌屬 ( Nectriaspecies),例如,仁果乾癌叢赤殼菌 ( Nectria galligena); Cancer, galls and witches' broom caused by, for example, Nectria species, eg, Nectria galligena ;

由例如以下所引起之萎病:輪枝菌屬,例如鏈核盤菌屬 ( Moniliniaspecies),例如拉克撒鏈核盤菌 ( Monilinia laxa); wilts caused by, for example, Verticillium species, such as Monilinia species, such as Monilinia laxa ;

由例如以下所引起之葉片、花及果實之畸形:外擔菌屬 ( Exobasidiumspecies),例如,壞損外擔菌 ( Exobasidium vexans);外囊菌屬 ( Taphrinaspecies),例如,畸形外囊菌 ( Taphrina deformans); Malformations of leaves, flowers and fruits caused by, for example, Exobasidium species, e.g., Exobasidium vexans ; Taphrina species, e.g., Exobacterium teratosa ( Taphrina deformans );

由例如以下引起之木本植物之退行性病害:埃斯卡屬 ( Escaspecies),例如,根黴格孢菌 ( Phaeomoniella chlamydospora)、褐枝頂孢黴 ( Phaeoacremonium aleophilum)或地中海嗜藍孢孔菌 ( Fomitiporia mediterranea);靈芝屬 ( Ganodermaspecies),例如,島靈芝 ( Ganoderma boninense); Degenerative diseases of woody plants caused by, for example, Esca species, for example, Phaeomoniella chlamydospora , Phaeoacremonium aleophilum or Mediterranean cyanophilus ( Fomitiporia mediterranea ); Ganoderma species, eg Ganoderma boninense ;

由例如以下引起之花及種子病害:葡萄孢屬 ( Botrytisspecies),例如灰葡萄孢菌 ( Botrytis cinerea); Flower and seed diseases caused by, for example, Botrytis species, such as Botrytis cinerea ;

由以下引起之植物塊莖之病害:絲核菌屬 ( Rhizoctoniaspecies),例如,立枯絲核菌 ( Rhizoctonia solani);長蠕孢菌屬,例如,立枯長蠕孢菌 ( Helminthosporium solani); Diseases of plant tubers caused by: Rhizoctonia species, for example, Rhizoctonia solani ; Helminthosporium, for example, Helminthosporium solani ;

由細菌性病原體所引起之病害,該等細菌性病原體例如黃單胞菌屬 ( Xanthomonasspecies),例如水稻白葉枯病黃單胞菌 ( Xanthomonas campestris pv. oryzae);假單胞菌屬,例如胡瓜細菌性葉斑病菌 ( Pseudomonas syringae pv. lachrymans);軟腐菌屬 ( Erwiniaspecies),例如梨火傷病菌 ( Erwinia amylovora);羅爾斯頓菌屬 ( Ralstoniaspecies),例如茄科羅爾斯頓菌 ( Ralstonia solanacearum); Diseases caused by bacterial pathogens such as Xanthomonas species, such as Xanthomonas campestris pv. oryzae ; Pseudomonas species, such as cucumber Bacterial leaf spot ( Pseudomonas syringae pv. lachrymans ); Erwinia species, such as Erwinia amylovora ; Ralstonia species, such as Ralstonia solanaceae ( Ralstonia solanacearum );

由例如以下所引起之根及莖基部真菌性病害:黑根腐病(野百合尾孢菌 ( Calonectria crotalariae))、炭腐病(菜豆立枯病菌 ( Macrophomina phaseolina))、鐮菌枯萎病 (fusarium blight) 或萎蔫病 (wilt)、根腐病以及豆莢及根頸腐病(尖孢鐮刀菌 ( Fusarium oxysporum)、直喙鐮孢 ( Fusarium orthoceras)、半裸鐮孢 ( Fusarium semitectum)、木賊鐮孢 ( Fusarium equiseti))、細圓盤黴根腐病(褐紅壞死病病菌 ( Mycoleptodiscus terrestris))、赤殼菌 (neocosmospora)(侵菅新赤殼菌 ( Neocosmospora vasinfecta))、豆莢及莖稈枯萎病(大豆黑點病菌 ( Diaporthe phaseolorum))、莖潰瘍(大豆黑點病菌變種 ( Diaporthe phaseolorum var.caulivora))、疫黴菌腐病 (phytophthora rot)(大雄疫黴菌 ( Phytophthora megasperma))、褐莖腐病(大豆莖褐腐病菌 ( Phialophora gregata))、腐黴菌腐病(瓜果腐黴 ( Pythium aphanidermatum)、畸雌腐黴 ( Pythium irregulare)、德巴利腐黴 ( Pythium debaryanum)、群結腐黴 ( Pythium myriotylum)、終極腐黴 ( Pythium ultimum))、絲核菌根腐病 (rhizoctonia root rot)、莖腐病及猝倒病(立枯絲核菌 ( Rhizoctonia solani))、核盤菌莖腐病(向日葵核盤菌 ( Sclerotinia sclerotiorum))、核盤菌白絹病(白絹病核盤菌 ( Sclerotinia rolfsii))、根串珠黴根腐病(菫菜根腐病菌 ( Thielaviopsis basicola))。 Fungal diseases of roots and stem bases caused by, for example, black root rot ( Calonectria crotalariae ), charcoal rot (Macrophomina phaseolina ), fusarium wilt blight) or wilt (wilt), root rot and bean pod and root neck rot ( Fusarium oxysporum , Fusarium orthoceras , Fusarium semimitectum , Fusarium equisetum ( Fusarium equiseti )), disc mold root rot ( Mycoleptodiscus terrestris ), neocosmospora ( Neocosmospora vasinfecta ), pod and stem blight ( Soybean black spot fungus ( Diaporthe phaseolorum )), stem canker ( Diaporthe phaseolorum var. caulivora ), phytophthora rot ( Phytophthora megasperma ), brown stem rot ( Soybean stem brown rot ( Phialophora gregata )), Pythium rot (Pythium aphanidermatum, Pythium irregulare , Pythium debaryanum , Pythium myriotylum ), Pythium ultimum ), rhizoctonia root rot, stem rot and damping-off ( Rhizoctonia solani ), sclerotinia stem rot ( Sclerotinia sclerotiorum ), Sclerotinia sclerotiorum ( Sclerotinia rolfsii ), Rhizoctonia root rot ( Thielaviopsis basicola ).

本案之新穎農業化學組成物包含對控制特定真菌病害特別有用的組分 (1)和組分 (2)。這些組合物被認為特別適用於控制由某些病原體所引起的卵菌綱疾病,所述病原體例如:致病疫黴 ( Phytophthora infestans)、大雄疫黴菌 ( Phytophthora megasperma)、煙草黑脛病菌 ( Phytophthora parasitica)、樟疫黴 ( Phytophthora cinnamomi)、番椒疫病菌 ( Phytophthora capsici)、煙草疫黴菌 ( Phytophthora nicotianae)、棕櫚疫病菌 ( Phytophthora palmivora)、瓜果腐黴 ( Pythium aphanidermatum)、葡萄生單軸黴 ( Plasmopara viticola)、霜黴病菌 ( Peronospora tabacina)、寄生霜黴菌 ( Peronospora parasitica)、大蔥霜黴菌 ( Peronospora destructor)、樹狀霜黴 ( Peronospora arborescens)、古巴假霜黴菌 ( Pseudoperonospora cubensis)、葎草假霜黴 ( Pseudoperonospora humuli)、以及萵苣露菌病 ( Bremia lactucae)。 The novel agricultural chemical composition of the present case comprises component (1) and component (2) which are particularly useful for controlling specific fungal diseases. These compositions are considered to be particularly useful in the control of oomycete diseases caused by pathogens such as: Phytophthora infestans , Phytophthora megasperma , tobacco blackleg fungus ( Phytophthora parasitica ), Phytophthora cinnamomi , Phytophthora capsici , Phytophthora nicotianae , Phytophthora palmivora , Pythium aphanidermatum , Plasma viticola ( Plasmopara viticola ), Peronospora tabacina , Peronospora parasitica , Peronospora destructor , Peronospora arborescens , Pseudoperonospora cubensis , Humulus pseudofrost mildew ( Pseudoperonospora humuli ), and lettuce dewmycosis ( Bremia lactucae ).

昆蟲、蛛形綱動物、蟎及線蟲:Insects, arachnids, mites and nematodes:

本案的殺蟲組合物特別適用於有效防治以下害蟲:The insecticidal composition of this case is particularly suitable for effectively controlling the following pests:

屬於鱗翅目 (Lepidoptera)之昆蟲者,例如,梁劍紋夜蛾 ( Acronicta major)、茶姬捲葉蛾 ( Adoxophyes orana)、白斑煩夜蛾 ( Aedia leucomelas)、地老虎屬 ( Agrotisspp.)、例如普通夜蛾 ( Agrotis fucosa)、黃地老虎 ( Agrotis segetum)、小地老虎 ( Agrotis ypsilon);棉葉波紋夜蛾 ( Alabama argillacea)、黎豆夜蛾 ( Anticarsia gemmatalis)、夜蛾屬 ( Anticarsiaspp.)、蘋果銀蛾 ( Argyresthia conjugella)、丫紋夜蛾 ( Autographa gamma)、甘藍夜蛾 ( Barathra brassicae)、棉葉穿孔潜蛾 ( Bucculatrix thurberiella)、松尺蠖 ( Bupalus piniarius)、樅卷葉蛾 ( Cacoecia murinana)、黃尾卷葉蛾 ( Cacoecia podana)、煙捲葉蛾 ( Capua reticulana)、蘋果蠹蛾 ( Carpocapsa pomonella)、冬尺蛾 ( Cheimatobia brumata);螟屬 ( Chilospp.),如二化螟 ( Chilo suppressalis);雲杉卷葉蛾 ( Choristoneura fumiferana)、雲杉芽卷蛾 (Choristoneura occidentalis)、一星粘蟲 ( Cirphis unipuncta)、葡萄果蠹蛾 ( Clysia ambiguella)、捲螟屬 ( Cnaphalocerusspp.)、蘋果小卷蛾 ( Cydia pomonella)、松毛蟲 ( Dendrolimus pini)、黃瓜絹野螟 ( Diaphania nitidalis)、西南玉米杆草螟 ( Diatraea grandiosella)、埃及鑽夜蛾 ( Earias insulana)、南美玉米苗斑螟 ( Elasmopalpus lignosellus)、乾果粉斑螟 ( Ephestia cautella)、地中海粉斑螟 ( Ephestia kuehniella)、葡萄與蘋果捲葉蛾 ( Eupoecilia ambiguella)、黃毒蛾 ( Euproctis chrysorrhoea)、切根蟲屬 ( Euxoaspp.)、歐洲松梢小卷蛾 ( Evetria bouliana);褐夜蛾屬 ( Feltiaspp.),如粒膚地虎 ( Feltia subterranean);蠟螟 ( Galleria mellonella)、李小食心蟲 ( Grapholitha funebrana)、梨小食心蟲 ( Grapholitha molesta);鈴夜蛾屬 ( Helicoverpaspp.),如番茄夜蛾 ( Helicoverpa armigera)、玉米穗蟲 ( Helicoverpa zea);棉鈴蟲屬 ( Heliothisspp.),如棉鈴蟲 ( Heliothis armigera)、菸芽夜蛾 ( Heliothis virescens)、美洲棉鈴蟲 (Heliothis zea);菜心野螟 ( Hellula undalis)、灰裙希伯利亞蛾 ( Hibernia defoliaria)、褐織蛾 ( Hofmannophila pseudospretella)、茶長卷蛾 ( Homona magnanima)、美國白蛾 (Hyphantria cunea)、櫻桃巢蛾 ( Hyponomeuta padella)、蘋果巢蛾 ( Hyponomeuta malinellus)、番茄蟲蛾 ( Keiferia lycopersicella)、鐵杉尺蠖蛾 ( Lambdina fiscellaria);貪夜蛾屬 ( Laphygmaspp.),如甜菜夜蛾 ( Laphygma exigua);咖啡點潜葉蛾 ( Leucoptera coffeella)、旋紋潜蛾 ( Leucoptera scitella)、蘋果斑幕潜葉蛾 ( Lithocolletis blancardella)、綠果冬夜蛾 ( Lithophane antennata)、葡萄漿果小卷蛾 ( Lobesia botrana)、豆白隆切根蟲 ( Loxagrotis albicosta)、甜菜網螟 ( Loxostege sticticalis);毒蛾屬 ( Lymantriaspp.),如舞毒蛾 ( Lymantria dispar)、模毒蛾 ( Lymantria monacha);窄翅潛葉蛾 ( Lyonetia clerkella)、黃褐天幕毛蟲 ( Malacosoma neustria);夜蛾屬 ( Mamestraspp.),如甘藍夜蛾 ( Mamestra brassicae);稻毛脛夜蛾 ( Mocis repanda)、粘蟲 ( Mythimna separata)、黃杉合毒蛾 ( Orgyia pseudotsugata); 夜蛾屬 ( Oriaspp.);稈野螟屬 ( Ostriniaspp.),如歐洲玉米螟 ( Ostrinia nubilalis); 稻葉甲 ( Oulema oryzae)、冬夜蛾 ( Panolis flammea);紅鈴蟲屬 ( Pectinophoraspp.),如棉花紅鈴蟲 ( Pectinophora gossypiella);疆夜蛾 ( Peridroma saucia)、圓掌舟蛾 ( Phalera bucephala);煙尺蛾屬 ( Phthorimaeaspp.),如馬鈴薯塊莖蛾 (Phthorimaea operculella);橘細潛蛾 ( Phyllocnistis citrella);菜粉蝶屬 ( Pierisspp.),如歐洲粉蝶 ( Pieris brassicae)、菜粉蝶 ( Pieris rapae);苜蓿綠夜蛾 ( Plathypena scabra)、菜蛾 ( Plutella maculipennis)、小菜蛾 ( Plutella xylostella)、斜紋夜蛾屬 ( Prodeniaspp.)、粘蟲屬 ( Pseudaletiaspp.)、大豆夜蛾 ( Pseudoplusia includens)、玉米螟 ( Pyrausta nubilalis)、美松梢小卷蛾 ( Rhyacionia frustrana)、馬鈐薯潛葉蟲 ( Scrobipalpula absoluta)、麥蛾 ( Sitotroga cerealella)、葡萄卷葉蛾 ( Sparganothis pilleriana);灰翅夜蛾屬 ( Spodopteraspp.),如草地夜蛾 ( Spodoptera frugiperda)、海灰翅夜蛾 ( Spodoptera littoralis)、斜紋夜蛾 ( Spodoptera litura);松異周蛾 ( Thaumatopoea pityocampa)、金美夜蛾 ( Thermesia gemmatalis)、袋穀蛾 ( Tinea pellionella)、幕穀蛾 ( Tineola bisselliella)、櫟綠卷蛾 ( Tortrix viridana);粉夜蛾屬 ( Trichoplusiaspp.),如粉紋夜蛾 ( Trichoplusia ni);番茄斑潛蠅 ( Tuta absoluta) 和雲杉小卷葉蛾 ( Zeiraphera canadensis);屬於甲蟲(鞘翅目,Coleoptera)者,例如菜豆象 ( Acanthoscehdes obtectus)、喙麗金龜屬 ( Adoretusspp.)、楊樹螢葉甲 ( Agelastica alni)、梨窄吉丁 ( Agrilus sinuatus);叩頭蟲屬 ( Agriotesspp.),如細胸叩頭蟲 ( Agriotes fuscicollis)、條叩頭蟲 ( Agriotes lineatus)、暗色叩頭蟲 ( Agriotes obscurus);馬鈴薯鰓金龜 ( Amphimallus solstitialis)、異形方胸材小蠹 ( Anisandrus dispar)、家具竊蠹 ( Anobium punctatum)、紅銅麗金龜 ( Anomala rufocuprea);星天牛屬 ( Anoplophoraspp.),如光肩星天牛 ( Anoplophora glabripennis);花象屬 ( Anthonomusspp.),如棉鈴象甲 ( Anthonomus grandis)、蘋花象 ( Anthonomus pomorum);圓皮蠹屬 ( Anthrenusspp.)、優繭蜂側刺葉蚤 ( Aphthona euphoridae);甘蔗金龜屬 ( Apogoniaspp.);紅尾叩頭蟲 ( Athous haemorrhoidalis);隱翅甲屬 ( Atomariaspp.),如甜菜隱食甲 ( Atomaria linearis);毛皮蠹屬 ( Attagenusspp.);黃守瓜 ( Aulacophora femoralis)、縱坑切梢小蠹 ( Blastophagus piniperda)、粗紋小蜂 ( Blitophaga undata)、菜豆象 ( Bruchidius obtectus);豆象屬 ( Bruchusspp.),如歐洲兵豆象 ( Bruchus lentis)、豌豆象 ( Bruchus pisorum)、蠶豆象 ( Bruchus rufimanus);蘋卷象 ( Byctiscus betulae)、綠豆象 ( Callosobruchus chinensis)、甜菜大龜甲 ( Cassida nebulosa)、豆葉甲 ( Cerotoma trifurcata)、金花金龜 ( Cetonia aurata);龜象屬 ( Ceuthorhynchusspp.),如白菜籽龜 象 ( Ceuthorrhynchus assimilis)、芫菁龜象 ( Ceuthorrhynchus napi);甜菜脛跳甲 ( Chaetocnema tibialis)、牛蒡象甲 ( Cleonus mendicus);寬胸叩頭蟲屬 ( Conoderusspp.),如煙草金針蟲 ( Conoderus vespertinus);根頸象屬 ( Cosmopolitesspp.)、新西蘭草地蠐螬 ( Costelytra zealandica)、石刁柏負 泥蟲 ( Crioceris asparagi)、楊幹隱喙象 ( Cryptorhynchus lapathi);叩甲屬 ( Cteniceraspp.),如草原谷金針蟲 ( Ctenicera destructor);象蟲屬 ( Curculiospp.)、蛀莖蟲 ( Dectes texanus)、皮蠹屬 ( Dermestesspp.);葉甲屬 ( Diabroticaspp.),如黃瓜十二星葉甲 ( Diabrotica12 -punctata)、南美葉甲 ( Diabrotica speciosa)、長角葉甲 ( Diabrotica longicornis)、黃瓜半星葉甲 ( Diabrotica semipunctata)、玉米根螢葉甲 ( Diabrotica virgifera);食植瓢蟲屬 ( Epilachnaspp.),如墨西哥豆瓢蟲 ( Epilachna varivestis)、馬鈴薯瓢蟲 (Epilachna vigintioctomaculata);毛跳甲屬 ( Epitrixspp.),如煙草跳甲 ( Epitrix hirtipennis);棉灰蒙象變種 ( Eutinobothrus brasiliensis)、煙草鑽孔蟲 ( Faustinus cubae)、麥蛛甲 ( Gibbium psylloides)、非洲獨角仙 ( Heteronychus arator)、優佳金龜 ( Hylamorpha elegans)、歐洲松樹皮象 ( Hylobius abietis)、家天牛 ( Hylotrupes bajulus)、埃及苜蓿葉 象 ( Hypera brunneipennis)、紫苜蓿葉象 ( Hypera postica)、果小蠹屬 ( Hypothenemusspp.)、雲杉八齒小蠹 ( Ips typographus)、鰓角金龜 ( Lachnosterna consanguinea)、煙草負泥蟲 ( Lema bilineata)、黑角負泥蟲 ( Lema melanopus);馬鈴薯葉甲屬 (Leptinotarsa spp.),如馬鈴薯葉甲 ( Leptinotarsa decemlineata);甜菜叩甲 ( Limonius californicus)、稻水象甲 ( Lissorhoptrus oryzophilus)、稻水象甲 ( Lissorhoptrus oryzophilus)、筒喙象屬 ( Lixusspp.);粉蠹屬 ( Lyctusspp.),如褐粉蠹 ( Lyctus bruneus);玉米叩甲蟲 (Melanotus communis);菜花露尾甲屬 ( Meligethesspp.),如油菜露尾甲 ( Meligethes aeneus);大栗鰓金龜 ( Melolontha hippocastani)、五月鰓金龜 ( Melolontha melolontha)、( Migdolusspp.);墨天牛屬 ( Monochamusspp.),如松墨天牛 ( Monochamus alternatus);南美果樹象甲 ( Naupactus xanthographus)、黃蛛甲 ( Niptus hololeucus)、椰蛀犀金龜 ( Oryctes rhinoceros)、鋸穀盜 ( Oryzaephilus surinamensis)、黑葡萄耳象 ( Otiorrhynchus sulcatus)、草莓根象甲 ( Otiorrhynchus ovatus)、黑葡萄耳象 ( Otiorrhynchus sulcatus)、水稻負泥蟲 ( Oulema oryzae)、小青花金龜 ( Oxycetonia jucunda)、辣根猿葉甲 ( Phaedon cochleariae)、梨樹葉象 ( Phyllobius pyri)、庭園發麗金龜 ( Phyllopertha horticola);食葉鰓金龜屬 ( Phyllophagaspp.);條跳甲屬 ( Phyllotretaspp.),如油菜藍跳甲 ( Phyllotreta chrysocephala)、大豆淡足跳甲 ( Phyllotreta nemorum)、黃曲條菜跳甲 ( Phyllotreta striolata);食葉鰓金龜屬 ( Phyllophagaspp.)、庭園發麗金龜 ( Phyllopertha horticola)、日本大蠊 ( Popillia japonica)、小象甲屬 ( Premnotrypesspp.)、油菜藍跳甲 ( Psylliodes chrysocephala)、蛛甲屬 ( Ptinusspp.)、暗色瓢蟲 ( Rhizobius ventralis)、穀蠹 (Rhizopertha dominica)、豌豆葉象 ( Sitona lineatus);穀象屬 ( Sitophilusspp.),穀象 ( Sitophilus granaria)、玉米象 ( Sitophilus zeamais);尖隱喙象屬 ( Sphenophorusspp.),如里維斯尖隱喙象 ( Sphenophorus levis);莖 幹象屬 ( Sternechusspp.),如大豆莖象 ( Sternechus subsignatus);寬幅天牛屬 ( Symphyletesspp.)、黃粉蟲 ( Tenebrio molitor);擬穀盜屬 ( Triboliumspp.),如赤擬穀盜 ( Tribolium castaneum);斑皮蠹屬 ( Trogodermaspp.)、籽象屬 ( Tychiusspp.)、脊虎天牛屬 ( Xylotrechusspp.)和距步甲屬 ( Zabrusspp.),如玉米距步甲 ( Zabrus tenebrioides); Insects belonging to the order Lepidoptera, for example, Acronicta major , Adoxophyes orana , Aedia leucomelas , Agrotis spp., e.g. common Noctuid ( Agrotis fucosa ), yellow cutworm ( Agrotis segetum ), lesser cutworm ( Agrotis ypsilon ); cotton leaf moth ( Alabama argillacea ), anticarsia gemmatalis , anticarsia spp. , Apple Silver Moth ( Argyresthia conjugella ), Argyrestia conjugella ( Autographa gamma ), Cabbage Spodoptera ( Barathra brassicae ), Cotton Leaf Piercer Moth ( Bucculatrix thurberiella ), Pine Loopworm ( Bupalus piniarius ), Fir Leaf Tortrix ( Cacoecia murinana ), Cacoecia podana , Capua reticulana , Carpocapsa pomonella , Cheimatobia brumata ; Chilo spp., such as Chilo suppressalis ); Choristoneura fumiferana , Choristoneura occidentalis, Cirphis unipuncta , Clysia ambiguella , Cnaphalocerus spp., Apple Cydia pomonella , Dendrolimus pini , Diaphania nitidalis , Diatraea grandiosella , Earias insulana , Elasmopalpus lignosellus ), dried fruit mealworm ( Ephestia cautella ), Mediterranean mealybug borer ( Ephestia kuehniella ), grape and apple leaf roller ( Eupoecilia ambiguell a ), Euproctis chrysorrhoea , Euxoa spp., Evetria bouliana ; Feltia spp., such as Feltia subterranean ; Galleria mellonella , Grapholitha funebrana , Grapholitha molesta ; Helicoverpa spp. such as Helicoverpa armigera , Corn earworm ( Helicoverpa zea ) ; Heliothis spp., such as cotton bollworm ( Heliothis armigera ), tobacco budworm ( Heliothis virescens ), American cotton bollworm ( Heliothis zea ); Moth ( Hibernia defoliaria ), brown weaver moth ( Hofmannophila pseudospretella ), tea tumbler moth ( Homona magnanima ), American white moth (Hyphantria cunea), cherry nest moth ( Hyponomeuta padella ), apple nest moth ( Hyponomeuta malellus ), tomato nest moth ( Keiferia lycopersicella ), Hemlock looper moth ( Lambdina fiscellaria ); Spodoptera ( Laphygma spp.), such as beet armyworm ( Laphygma exigua ); Coffee point leaf miner ( Leucoptera coffeeella ), Spinning miner ( Leucoptera scitella ) , Lithocolletis blancardella , Lithophane antennata , Lobesia botrana , Loxagrotis albicosta , Loxostege sticticalis ; Lymantria spp., such as Lymantria dispar , Lymantria monacha ; Narrow-winged leafminer ( Lyonetia c lerkella ), Malacosoma neustria ; Mamestra spp., such as Mamestra brassicae ; Mocis repanda , Mythimna separata , Mythimna separata ( Orgyia pseudotsugata ); Oria spp.; Ostrinia spp., such as European corn borer ( Ostrinia nubilalis ) ; Oulema oryzae , winter armyworm ( Panolis flammea ); Pectinophora spp., such as Pectinophora gossypiella ; Peridroma saucia , Phalera bucephala ; Phthorimaea spp., such as potato tuber moth ( Phthorimaea operculella ); Phyllocnistis citrella ; Pieris spp., such as Pieris brassicae , Pieris rapae ; Plathypena scabra , Plutella xylostella maculipennis ), Plutella xylostella , Prodenia spp., Pseudaletia spp., Pseudoplusia includens , Corn borer ( Pyrausta nubilalis ), American pine moth ( Rhyacionia frustrana ), potato leafminer ( Scrobipalpula absoluta ), wheat moth ( Sitotroga cerealella ), grape leaf roller moth ( Sparganothis pilleriana ); spodoptera spp., such as Spodoptera frugiperda ), Spodoptera littoralis , Spodoptera litura ; Thaumatopoea pityocampa , Spodoptera littoralis ( Thermesia gemmatalis ), Tinea pellionella , Tineola bisselliella , Tortrix viridana ; Trichoplusia spp. such as Trichoplusia ni ; tomato Liriomyza ( Tuta absoluta ) and spruce leaf tortrix ( Zeiraphera canadensis ); those belonging to the group of beetles (Coleoptera), such as Acanthoscehdes obtectus , Adoretus spp., Poplar beetle ( Agelastica alni ), Pear Narrow Jiding ( Agrilus sinuatus ); Agriotes spp., such as Agriotes fuscicollis , Agriotes lineatus , Agriotes obscurus ; Potato Gill beetle ( Amphimallus solstitialis ), heteromorphic square chest beetle ( Anisandrus dispar ), furniture beetle ( Anobium punctatum ), red copper beetle ( Anomala rufocuprea ); star beetle ( Anoplophora spp.), such as bare-shouldered star beetle ( Anoplophora glabripennis ); Anthonomus spp., such as Anthonomus grandis , Anthonomus pomorum ; Anthrenus spp., Aphthona euphoridae ; Sugarcane scarab ( Apogonia spp .); red-tailed click beetle ( Athous haemorrhoidalis ) ; Aulacophora femoralis ), Blastophagus piniperda , Blitophaga undata , Bruchidius obtectus ; Bruchus sp p.), such as Bruchus lentis , Bruchus pisorum , Bruchus rufimanus ; Byctiscus betulae , Callosobruchus chinensis , Cassida nebulosa , Cerotoma trifurcata , Cetonia aurata ; Ceuthorhynchus spp., such as Ceuthorrhynchus assimilis , Ceuthorrhynchus napi ; ( Chaetocnema tibialis ), Burdock weevil ( Cleonus mendicus ); Broad-breasted click beetle ( Conoderus spp.), such as tobacco wireworm ( Conoderus vespertinus ); Cosmopolites spp., New Zealand grass grub ( Costelytra zealandica ) , Crioceris asparagi , Cryptorhynchus lapathi ; Ctenicera spp., such as Ctenicera destructor ; Curculio spp., stem borer Dectes texanus , Dermestes spp.; Diabrotica spp., such as Diabrotica 12 -punctata , Diabrotica speciosa , Long-horned leaf beetle ( Diabrotica longicornis ), cucumber semipunctata ( Diabrotica semipunctata ), corn root firefly beetle ( Diabrotica virgifera ); herbivorous ladybugs ( Epilachna spp.), such as Mexican bean ladybug ( Epilachna varivestis ), potato ladybug ( Epitrix spp., such as Epitrix hirtipennis ; Eutinobothrus brasilie nsis ), tobacco borer ( Faustinus cubae ), wheat spider beetle ( Gibbium psylloides ), African unicorn ( Heteronychus arator ), excellent beetle ( Hylamorpha elegans ), European pine bark elephant ( Hylobius abietis ), house beetle ( Hylotrupes bajulus ), Egyptian clover leaf elephant ( Hypera brunneipennis ), clover leaf elephant ( Hypera postica ), fruit beetle ( Hypothenemus spp.), spruce eight-toothed beetle ( Ips typographus ), gill horned beetle ( Lachnosterna consanguinea ), Lema bilineata , Lema melanopus ; Leptinotarsa spp., such as Leptinotarsa decemlineata ; Limonius californicus , rice water weevil ( Lissorhoptrus oryzophilus ), rice water weevil ( Lissorhoptrus oryzophilus ), Lixus spp.; Lyctus spp., such as brown beetle ( Lyctus bruneus ) ; corn beetle ( Melanotus communis ); Meligethes spp., such as Meligethes aeneus ; Melolontha hippocastani , Melolontha melolontha , Migdolus spp.; Monochamus spp. spp.), such as Monochamus alternatus ; Naupactus xanthographus , Niptus hololeucus , Oryctes rhinoceros , Oryzaephilus surinamensis , black grape Ear elephant ( Otiorrhynchus sulcatus ), strawberry root weevil ( Otiorrhynchus ovatus ), black grape ear elephant ( Otiorrhynchus sulcatus ), Oulema oryzae , Oxycetonia jucunda , Phaedon cochleariae , Phyllobius pyri , Phyllopertha horticola ; leaf-eating beetle Phyllotreta spp.; Phyllotreta spp ., such as Phyllotreta chrysocephala , Phyllotreta nemorum , and Phyllotreta striolata ; leaf-eating Phyllophaga spp., Phyllopertha horticola , Popillia japonica , Premnotrypes spp., Psylliodes chrysocephala , Ptinus spp.), dusky ladybug ( Rhizobius ventralis ), grain beetle (Rhizopertha dominica), pea leaf elephant ( Sitophilus lineatus ); grain elephant ( Sitophilus spp.), grain elephant ( Sitophilus granaria ), corn elephant ( Sitophilus zeamais ); Sphenophorus spp., such as Sphenophorus levis ; Sternechus spp., such as Sternechus subsignatus ; Symphyletes spp.), Tenebrio molitor ; Tribolium spp., such as Tribolium castaneum ; Trogoderma spp., Tychius spp. , Xylotrechus spp. and Zabrus spp., such as Zabrus tenebrioides ;

蠅、蚊(雙翅目 (Diptera)),例如伊蚊屬 ( Aedesspp.),如埃及伊蚊 ( Aedes aegypti)、白紋伊蚊 ( Aedes albopictus)、剌擾伊蚊 ( Aedes vexans);墨西哥果蠅 ( Anastrepha ludens);按蚊屬 ( Anophelesspp.),如白足按蚊 ( Anopheles albimanus)、災難按蚊 ( Anopheles crucians)、費氏按蚊 ( Anopheles freeborni)、岡比亞按蚊 ( Anopheles gambiae)、白踝按蚊 ( Anopheles leucosphyrus)、五斑按蚊 ( Anopheles maculipennis)、微小按蚊 ( Anopheles minimus)、四斑按蚊 ( Anopheles quadrimaculatus)、中華按蚊 ( Anopheles sinensis);花園毛蚊 ( Bibio hortulanus)、綠頭蠅 ( Calliphora erythrocephala)、紅頭麗蠅 ( Calliphora vicina)、地中海實蠅 ( Cerafitis capitata)、地中海實蠅 ( Ceratitis capitata);金蠅屬 ( Chrysomyiaspp.),如蛆症金蠅 ( Chrysomya bezziana)、螺旋金蠅 ( Chrysomya hominivorax)、腐敗金蠅 ( Chrysomya macellaria);大西洋斑虻 ( Chrysops atlanticus)、鹿蠅 ( Chrysops discalis)、靜斑虻 ( Chrysops silacea);錐蠅屬 ( Cochliomyiaspp.),如螺旋蠅 ( Cochliomyia hominivorax);癭蚊屬 ( Contariniaspp.),如高粱癭蚊 ( Contarinia sorghicola);嗜人瘤蠅蛆 ( Cordylobia anthropophaga);庫蚊屬 ( Culexspp.),如斑蚊 ( Culex nigripalpus)、尖音庫蚊 ( Culex pipiens)、致倦庫蚊 ( Culex quinquefasciatus)、媒斑蚊 ( Culex tarsalis)、三帶喙庫蚊 ( Culex tritaeniorhynchus);狂怒庫蠓 ( Culicoides furens)、無飾脉毛蚊 ( Culiseta inornata)、黑尾脈毛蚊 ( Culiseta melanura)、黃蠅屬 ( Cuterebraspp.)、瓜蠅 ( Dacus cucurbitae)、油橄欖實蠅 ( Dacus oleae)、油菜葉癭蚊 ( Dasineura brassicae);地種蠅屬 ( Deliaspp.),如葱蠅 ( Delia antique)、麥地種蠅 ( Delia coarctata)、灰地種蠅 ( Delia platura)、甘藍地種蠅 ( Delia radicum);人膚皮蠅 ( Dermatobia hominis)、果蠅屬 ( Drosophilaspp.); 廁蠅屬 ( Fanniaspp.),如小毛廁蠅 ( Fannia canicularis);胃蠅屬 ( Gastraphilusspp.),如馬蠅 ( Gasterophilus intestinalis);三點禾蠅 ( Geomyza Tripunctata)、引舌蠅 ( Glossina fuscipes)、刺舌蠅 ( Glossina morsitans)、須舌蠅 ( Glossina palpalis)、膠舌蠅 ( Glossina tachinoides)、擾血蠅 ( Haematobia irritans)、鞍癭癭蚊 ( Haplodiplosis equestris)、潜蠅屬 ( Hippelatesspp.);黑蠅屬 ( Hylemyiaspp.),如花生田灰地種蠅 ( Hylemyia platura);皮蠅屬 ( Hypodermaspp.),如紋皮蠅 ( Hypoderma lineata);蝨蠅屬 ( Hyppoboscaspp.)、急流細蠓 ( Leptoconops torrens);斑潜蠅屬 ( Liriomyzaspp.),如美洲斑潜蠅 (Liriomyza sativae)、美國潜葉蠅 ( Liriomyza trifolii);綠蠅屬 ( Luciliaspp.),如羊綠蠅 ( Lucilia caprina)、銅綠蠅 ( Lucilia cuprina)、絲光綠蠅 ( Lucilia sericata);玉頸洛克蠅 ( Lycoria pectoralis)、曼蚊 ( Mansonia titillanus);癭蚊屬 ( Mayetiolaspp.),如麥癭蚊 ( Mayetiola destructor);家蠅屬 ( Muscaspp.),如秋家蠅 ( Musca autumnalis)、家蠅 ( Musca domestica);廄腐蠅 ( Muscina stabulans)、狂蠅屬 ( Oestrusspp.),如羊狂蠅 ( Oestrus ovis);禾蠅 ( Opomyza florum);麥秆蠅屬 ( Oscinellaspp.),如瑞典麥秆蠅 ( Oscinella frit);天仙子泉蠅 ( Pegomya hysocyami)、銀足白蛉 ( Phlebotomus argentipes);草種蠅屬 ( Phorbiaspp.),如葱蠅 ( Phorbia antiqua)、蘿蔔蠅 ( Phorbia brassicae)、麥地種蠅 ( Phorbia coarctata);混合墨蚊 ( Prosimulium mixtum)、胡蘿蔔莖蠅 ( Psila rosae)、哥倫比亞鱗蚊 ( Psorophora columbiae)、異色鱗蚊 ( Psorophora discolor)、櫻桃實蠅 ( Rhagoletis cerasi)、蘋果實蠅 ( Rhagoletis pomonella);麻蠅屬 ( Sarcophagaspp.),如赤尾麻蠅 ( Sarcophaga haemorrhoidalis);帶蚋 ( Simulium vittatum);螫蠅屬 ( Stomoxysspp.),如廄螫蠅 ( Stomoxys calcitrans);虻屬 ( Tabanusspp.),如北美黑虻 ( Tabanus atratus)、牛虻 ( Tabanus bovinus)、紅色原虻 ( Tabanus lineola)、二毛蟲 ( Tabanus similis);絛蟲屬 ( Tanniaspp.)、沼澤大蚊 ( Tipula oleracea)、歐洲大蚊 ( Tipula paludosa)和污蠅屬 ( Wohlfahrtiaspp.); Flies, mosquitoes (Diptera), e.g. Aedes spp., such as Aedes aegypti , Aedes albopictus , Aedes vexans ; Mexico Drosophila ( Anastrepha ludens ); Anopheles spp., such as Anopheles albimanus , Anopheles crucians , Anopheles freeborni , Anopheles gambiae , Anopheles leucosphyrus , Anopheles maculipennis , Anopheles minimus , Anopheles quadrimaculatus , Anopheles sinensis ; Bibio hortulanus ), blowfly ( Calliphora erythrocephala ), red-headed blowfly ( Calliphora vicina ), Mediterranean fruit fly ( Cerafitis capitata ), Mediterranean fruit fly ( Ceratitis capitata ); Chrysomyia spp. bezziana ), Chrysomya hominivorax , Chrysomya macellaria ; Chrysops atlanticus , Chrysops discalis , Chrysops silacea ; Cochliomyia spp. , such as screwworm ( Cochliomyia hominivorax ); gall midge ( Contarinia spp .), such as sorghum gall midge ( Contarinia sorghicola ); Culex nigripalpus ), Culex pipiens , Culex quinquefasciatus , Culex tarsalis , three Culex tritaeniorhynchus ; Culicoides furens , Culiseta inornata , Culiseta melanura , Cuterebra spp., Dacus cucurbitae ), Dacus oleae , Dasineura brassicae ; Delia spp., such as Delia antique , Delia coarctata , gray field species Delia platura , Delia radicum ; Dermatobia hominis , Drosophila spp.; Fannia spp., such as Fannia canicularis ; Gastraphilus spp., such as Gasterophilus intestinalis ; Geomyza Tripunctata , Glossina fuscipes , Glossina morsitans , Glossina palpalis , Glossina tachinoides , Haematobia irritans , Haplodiplosis equestris , Hippelates spp.; Hylemyia spp., such as peanut field fly ( Hylemyia platura ); Hypoderma spp., such as Hypoderma lineata ; Hyppobosca spp., Leptoconops torrens ; Liriomyza spp., Such as Liriomyza sativae , Liriomyza trifolii ; Lucilia spp., such as Lucilia caprina , Lucilia cuprin a , Lucilia sericata sericata ); ( Lycoria pectoralis ), Mansonia titillanus ; Mayetiola spp., such as Mayetiola destructor ; Musca spp., such as Musca autumnalis , housefly ( Musca domestica ); Muscina stabulans , Oestrus spp., such as Oestrus ovis ; Opomyza florum ; Oscinella spp., such as Sweden Straw fly ( Oscinella frit ); Pegomya hysocyami , silver-footed sandfly ( Phlebotomus argentipes ); Phorbia spp., such as onion fly ( Phorbia antiqua ), turnip fly ( Phorbia brassicae ) , wheat field fly ( Phorbia coarctata ); mixed black mosquito ( Prosimulium mixtum ), carrot stalk fly ( Psila rosae ), Columbia scale mosquito ( Psorophora columbiae ), heterochromatic scale mosquito ( Psorophora discolor ), cherry fruit fly ( Rhagoletis cerasi ), Apple fruit fly ( Rhagoletis pomonella ); Sarcophaga spp., such as Sarcophaga haemorrhoidalis ; Simulium vittatum ; Stomoxys spp., such as Stomoxys calcitrans ; The genus ( Tabanus spp.), such as the black fly ( Tabanus atratus ), the gadfly ( Tabanus bovinus ), the red horsefly ( Tabanus lineola ), the two caterpillars ( Tabanus similis ); oleracea ), Tipula paludosa , and Wohlfahrtia spp.;

薊馬(纓翅目 (Thysanoptera)),例如稻薊馬 ( Baliothrips biformis)、蘭花薊馬 ( Dichromothrips corbetti)、( Dichromothripsssp.)、黃薊馬 ( Enneothrips flavens)、花薊馬屬 ( Frankliniellaspp.),如煙草花薊馬 ( Frankliniella fusca)、西方花薊馬 ( Frankliniella occidentalis)、美東花薊馬 ( Frankliniella tritici);陽薊馬屬 ( Heliothripsspp.)、粟網薊馬 ( Hercinothrips femoralis)、卡薊馬屬 ( Kakothripsspp.)、腹鉤薊馬 ( Rhipiphorothrips cruentatus);硬薊馬屬( Scirtothripsspp.),如桔硬薊馬 ( Scirtothrips citri);荳蔻薊馬 ( Taeniothrips cardamoni);薊馬屬 ( Thripsspp.),如水稻薊馬 ( Thrips oryzae)、棕櫚薊馬 ( Thrips palmi)和蔥薊馬 ( Thrips tabaci); Thrips (Thysanoptera), such as rice thrips ( Baliothrips biformis ), orchid thrips ( Dichromothrips corbetti ), ( Dichromothrips ssp.), yellow thrips ( Enneothrips flavens ), flower thrips ( Frankliniella spp. ), such as Frankliniella fusca , Frankliniella occidentalis , Frankliniella tritici ; Heliothrips spp., Hercinothrips femoralis , Thrips ( Kakothrips spp.), abdominal hook thrips ( Rhipiphorothrips cruentatus ); Scirtothrips spp., such as orange hard thrips ( Scirtothrips citri ); cardamom thrips ( Taeniothrips cardamoni ); Thrips ( Thrips spp.), such as rice thrips ( Thrips oryzae ), palm thrips ( Thrips palmi ) and onion thrips ( Thrips tabaci );

白蟻(等翅目 (Isoptera)),例如乾木白蟻 ( Calotermes flavicollis)、家白蟻 ( Coptotermes formosanus)、南美異白蟻 ( Heterotermes aureus)、長頭異白蟻 ( Heterotermes Iongicep)、甘庶白蟻 ( Heterotermes tenuis)、歐美散白蟻 (Leucotermes flavipes);土白蟻屬 ( Odontotermesspp.);散白蟻屬 ( Reticulitermesspp.),如黃胸散白蟻 ( Reticulitermes speratus)、黃肢散白蟻 ( Reticulitermes flavipes)、格林氏散白蟻 ( Reticulitermes grassei)、南歐網紋白蟻 ( Reticulitermes lucifugus)、桑特散白蟻 ( Reticulitermes santonensis)、南方散白蟻 ( Reticulitermes virginicus)、非洲白蟻 ( Termes natalensis); Termites (Isoptera) such as Calotermes flavicollis , Coptotermes formosanus , Heterotermes aureus , Heterotermes Iongicep , Sugarcane termites ( Heterotermes tenuis ) , Leucotermes flavipes ; Odontotermes spp. ; Reticulitermes spp., such as Reticulitermes speratus , Reticulitermes flavipes , and Green's ( Reticulitermes grassei ), Southern European reticulated termite ( Reticulitermes lucifugus ), Sante termite ( Reticulitermes santonensis ), southern loose termite ( Reticulitermes virginicus ), African termite ( Termes natalensis );

蟑螂(蜚蠊目 (Blattaria)-蜚蠊科 (Blattodea)),例如家蟋蟀 ( Acheta domesticus)、東方蜚蠊 ( Blatta orientalis)、亞洲小蠊 ( Blattella asahinae)、德國小蠊 ( Blattella germanica);螻蛄屬 ( Gryllotalpaspp.);馬得拉蜚蠊 ( Leucophaea maderae);飛蝗屬 ( Locustaspp.);黑蝗屬 ( Melanoplusspp.);美洲大蠊 ( Periplaneta americana)、澳洲大蠊 ( Periplaneta australasiae)、棕色蜚蠊 ( Periplaneta brunnea)、黑胸大蠊 ( Periplaneta fuligginosa)、日本大蠊 ( Periplaneta japonica); Cockroaches (order Blattaria - Blattodea), for example house crickets ( Acheta domesticus ), oriental cockroaches ( Blatta orientalis ), Asian cockroaches ( Blattella asahinae ), German cockroaches ( Blattella germanica ); mole crickets Genus ( Gryllotalpa spp.); Madeira cockroach ( Leucophaea maderae ) ; Migratory locust ( Locusta spp.); Black locust ( Melanoplus spp.); Brown cockroach ( Periplaneta brunnea ), black-breasted cockroach ( Periplaneta fuligginosa ), Japanese cockroach ( Periplaneta japonica );

臭蟲、蚜蟲、葉蟬、粉蝨、蚧殼蟲、蟬(半翅目 (Hemiptera)),例如綠蝽屬 ( Acrosternumspp.),如擬綠蝽 ( Acrosternum hilare);無網長管蚜屬 ( Acyrthosiponspp.),如紅豆草蚜 ( Acyrthosiphon onobrychis)、豌豆蚜 ( Acyrthosiphon pisum);落葉松球蚜 ( Adelges laricis)、沫蜂屬 ( Aeneolamiaspp.)、隆脈木蝨屬( Agonoscenaspp.)、白粉蝨屬 ( Aleurodesspp.)、甘蔗穴粉蝨 ( Aleurolobus barodensis)、絲絨粉蝨屬 ( Aleurothrixusspp.)、小綠葉蟬屬 ( Amrascaspp.)、南瓜緣蝽 ( Anasa tristis)、擬麗蝽屬 ( Antestiopsisspp.)、圓尾蚜 ( Anuraphis cardui)、腎圓盾蚧屬 ( Aonidiellaspp.)、梨瘤蚜 ( Aphanostigma piri)、甘藍蚜 ( Aphidula nasturtii);蚜屬 ( Aphisspp.),如甜菜蚜 ( Aphis fabae)、草莓根蚜 ( Aphis forbesi)、棉蚜 ( Aphis gossypii)、北美茶藨子蚜 ( Aphis grossulariae)、蘋果蚜 ( Aphis pomi)、接骨木蚜 ( Aphis sambuci)、希奈德蚜 ( Aphis schneideri)、卷葉蚜 ( Aphis spiraecola);葡萄阿小葉蟬 ( Arboridia apicalis)、輪背獵蝽 ( Arilus critatus)、小圓盾蚧屬 ( Aspidiellaspp.)、圓盾蚧屬 ( Aspidiotusspp.)、按天蟲屬 ( Atanusspp.)、茄無網蚜 ( Aulacorthum solani);粉蝨屬 ( Bemisiaspp.),如銀葉粉蝨 ( Bemisia argentifolii)、煙粉蝨 ( Bemisia tabaci);土長蝽屬 ( Blissusspp.),如玉米長蝽 ( Blissus leucopterus);飛廉短尾蚜 ( Brachycaudus cardui)、李短尾蚜 ( Brachycaudus helichrysi)、桃短尾蚜 ( Brachycaudus persicae)、櫻桃短尾蚜 ( Brachycaudus prunicola)、微管蚜屬 ( Brachycolusspp.)、甘藍蚜 ( Brevicoryne brassicae)、小褐稻蝨 ( Calligypona marginata)、俊盲蝽屬 ( Calocorisspp.)、斑腿微刺盲蝽 ( Campylomma livida)、角釘毛蚜 ( Capitophorus horni)、黃頭大葉蟬 ( Carneocephala fulgida)、異背長蝽屬 ( Caveleriusspp.)、龜蠟蚧 ( Ceraplastesspp.)、甘蔗綿蚜 ( Ceratovacuna lanigera)、沫蟬科 ( Cercopidae)、棉花方翅網蝽 ( Cerosipha gossypii)、草莓中瘤釘毛蚜 ( Chaetosiphon fragaefolii)、蔗黃雪盾蚧 ( Chionaspis tegalensis)、茶綠葉蟬 ( Chlorita onukii)、核桃黑斑蚜 ( Chromaphis juglandicola)、黑褐圓盾蚧 ( Chrysomphalus ficus)、玉米葉蟬 ( Cicadulina mbila)、臭蟲屬 ( Cimexspp.),如熱帶臭蟲 ( Cimex hemipterus)、溫帶臭蟲 ( Cimex lectularius);介殼蟲 ( Coccomytilus halli)、軟蚧屬 ( Coccusspp.)、盲蝽 ( Creontiades dilutes)、茶藨子隱瘤蚜 ( Cryptomyzus ribis)、茶藨隱瘤蚜 ( Cryptomyzus ribis)、黑斑煙盲蝽 ( Cyrtopeltis notatus)、葉蟬屬 ( Dalbulusspp.)、胡椒緣蝽 ( Dasynus piperis)、粉蝨 ( Dialeuradesspp.)、木蝨屬 ( Diaphorinaspp.)、白背盾蚧屬 ( Diaspisspp.)、二葉喙蝽 ( Dichelops furcatus)、厚氏長棒網蝽 ( Diconocoris hewetti)、棉蚜屬 ( Doralisspp.)、高加索冷杉椎球蚜 ( Dreyfusia nordmannianae)、雲杉椎球蚜 ( Dreyfusia piceae)、履綿蚧屬 ( Drosichaspp.);西圓尾蚜屬 ( Dysaphisspp.),如車前圓尾蚜 ( Dysaphis plantaginea)、梨西圓尾蚜 ( Dysaphis pyri)、居根西圓尾蚜 ( Dysaphis radicola);擬塘鵝蚜 ( Dysaulacorthum pseudosolani);棉紅蝽屬 ( Dysdercusspp.),如棉紅蝽 ( Dysdercus cingulatus)、棉蝽 ( Dysdercus intermedius);灰粉蚧屬 ( Dysmicoccusspp.);小綠葉蟬屬 ( Empoascaspp.),如蠶豆微葉蟬 ( Empoasca fabae)、索拉納小綠葉蝶 ( Empoasca solana);綿蚜屬 ( Eriosomaspp.)、斑葉蟬屬 ( Erythroneuraspp.);扁盾蝽屬 ( Eurygasterspp.),如麥扁盾蝽 ( Eurygaster integriceps);鈍鼻葉蟬 ( Euscelis bilobatus);美洲蝽屬 ( Euschistusspp.),如大豆褐椿 ( Euschistuos heros)、煙草蝽 ( Euschistus impictiventris)、褐臭蝽 ( Euschistus servus);咖啡地粉蚧 ( Geococcus coffeae);茶翅蝽屬 ( Halyomorphaspp.),如茶翅蝽 ( Halyomorpha halys); 角盲椿 ( Heliopeltisspp.)、玻璃葉蟬 ( Homalodisca coagulata)、具凹巨股長蝽 ( Horcias nobilellus)、李大尾蚜 ( Hyalopterus pruni)、茶藨苦菜超瘤蚜 ( Hyperomyzus lactucae)、吹綿蚧屬 ( Iceryaspp.)、片角葉蟬屬 ( Idiocerusspp.)、扁喙葉蟬屬 ( Idioscopusspp.)、灰飛蝨 ( Laodelphax striatellus)、蠟蚧屬 ( Lecaniumspp.)、蠣盾蚧屬 ( Lepidosaphesspp.)、稻緣蝽屬 (Leptocorisa spp.)、棉紅鈴喙緣蝽 ( Leptoglossus phyllopus)、蘿蔔蚜 ( Lipaphis erysimi);草盲蝽屬 ( Lygusspp.),如草盲蝽 ( Lygus hesperus)、美洲牧草盲蝽 ( Lygus lineolaris)、牧草盲蝽 ( Lygus pratensis);蔗黑長蝽 ( Macropes excavatus);長管蚜屬 ( Macrosiphumspp.),如薔薇長管蚜 ( Macrosiphum rosae)、麥長管蚜 ( Macrosiphum avenae)、大戟長管蚜 ( Macrosiphum euphorbiae);泡沫蟲 ( Mahanarva fimbriolata)、篩豆龜蝽 ( Megacopta cribraria)、巢萊修尾蚜 ( Megoura viciae)、高粱蚜 ( Melanaphis pyrarius)、暗圓蚧 ( Melanaphis sacchari)、 Metcafiellaspp.、麥無網蚜 ( Metopolophium dirhodum)、盲蝽科 ( Miridaespp.)、黑緣平翅斑蚜 ( Monellia costalis)、胡桃蚜 ( Monelliopsis pecanis);瘤蚜屬 ( Myzusspp.),如冬葱蚜 ( Myzus ascalonicus)、李瘤蚜 ( Myzus cerasi)、桃蚜 ( Myzus persicae)、黃藥子瘤蚜 ( Myzus varians);黑茶藨子衲長管蚜 ( Nasonovia ribis-nigri);黑尾葉蟬屬 ( Nephotettixspp.),如馬來亞黑尾葉蟬 ( Nephotettix malayanus)、二條黑尾葉蟬 ( Nephotettix nigropictus)、細小黑尾葉蟬 ( Nephotettix parvus)、二點黑尾葉蟬 ( Nephotettix virescens);綠蝽屬 ( Nezaraspp.),如稻綠蝽 ( Nezara viridula);褐飛蝨 ( Nilaparvata lugens)、稻蝽屬 ( Oebalusspp.)、大葉蟬屬 ( Oncometopiaspp.)、旌蚧 ( Orthezia praelonga)、楊梅粉蝨 ( Parabemisia myricae)、木蝨屬 ( Paratriozaspp.)、片盾蚧屬 ( Parlatoriaspp.);癭綿蚜屬 ( Pemphigusspp.),如囊柄癭綿蚜 ( Pemphigus bursarius);烏葉蟬科 ( Pentomidae)、玉米蠟蟬 ( Peregrinus maidis)、蔗飛蝨 ( Perkinsiella saccharicida)、綿粉蚧屬 ( Phenacoccusspp.)、楊平翅綿蚜 ( Phloeomyzus passerinii)、忽布疣蚜 ( Phorodonhumuli)、葡萄根瘤蚜屬 ( Phylloxeraspp.)、甜菜擬網蝽 ( Piesma quadrata);壁蝽屬 ( Piezodorusspp.),如紅蝽 ( Piezodorus guildinii)、蘇鐵褐點並盾蚧 ( Pinnaspis aspidistrae)、臀紋粉蚧屬 ( Planococcusspp.)、梨形原綿蚧 (Protopulvinaria pyriformis)、棉僞斑腿盲蝽 (Psallus seriatus)、波斯小爪蟎 ( Pseudacysta persea)、桑盾蚧 ( Pseudaulacaspis pentagona);粉蚧屬 ( Pseudococcusspp.),如康氏粉蚧 ( Pseudococcus comstocki);木蝨屬 ( Psyllaspp.),如蘋木蝨 ( Psylla mali)、梨木蝨 ( Psylla piri);金小蜂屬 ( Pteromalusspp.)、飛蝨屬 ( Pyrillaspp.)、笠圓盾蚧屬 ( Quadraspidiotusspp.)、楊圓蚧 ( Quesada gigas)、平刺粉蚧屬 ( Rastrococcusspp.)、老獵椿象 ( Reduvius senilis)、紅獵蝽屬 ( Rhodniusspp.)、冬葱瘤蛾蚜 ( Rhopalomyzus ascalonicus);縊管蚜屬 ( Rhopalosiphumspp.),如蘿蔔蚜 ( Rhopalosiphum pseudobrassicas)、蘋草縊管蚜 ( Rhopalosiphum insertum)、玉米蚜 ( Rhopalosiphum maidis)、禾谷縊管蚜 ( Rhopalosiphum padi); Sagatodesspp.、可可褐盲蝽 ( Sahlbergella singularis)、黑盔蚧屬 ( Saissetiaspp.)、梨砧草蚜 ( Sappaphis mala)、蘋紅紮圓尾蚜 ( Sappaphis mali)、葡萄帶葉蟬 ( Scaphoides titanus)、麥二叉蚜 ( Schizaphis graminum)、榆梨棉蚜 ( Schizoneura lanuginose)、稻黑蝽屬 ( Scotinophoraspp.)、刺盾蚧 ( Selenaspidus articulatus)、禾穀網蚜 ( Sitobion avenae)、長唇基飛蝨屬 ( Sogataspp.)、白背飛蝨 ( Sogatella furcifera)、稻蝽 ( Solubea insularis)、梨冠網蝽 ( Stephanitis nashi)、菲惕那沫蟬 ( Stictocephala festina)、馬來蝨 ( Tenalaphara malayensis);肩蝽屬 ( Thyantaspp.),如肩蝽 ( Thyantaperditor);稻莖蝽屬 ( Tibracaspp.)、美洲山核桃長斑蚜 ( Tinocallis caryaefoliae)、廣胸沫蟬屬 ( Tomaspisspp.);聲蚜屬 ( Toxopteraspp.),如桔二叉蚜 ( Toxoptera aurantii);白粉蝨屬 ( Trialeurodesspp.),如白粉蝨 ( Trialeurodes vaporariorum);錐獵蝽屬 ( Triatomaspp.)、個木蝨屬 ( Triozaspp.)、小葉蟬屬 ( Typhlocybaspp.);尖盾蚧屬 ( Unaspisspp.),如矢尖蚧 ( Unaspis yanonensis);和葡萄根瘤蚜 ( Viteus vitifolii); Bedbugs, aphids, leafhoppers, whiteflies, scale insects, cicadas (Hemiptera), for example Acrosternum spp., such as Acrosternum hilare ; Acyrthosipon spp.), such as Acyrthosiphon onobrychis , Acyrthosiphon pisum ; Adelges laricis , Aeneolamia spp., Agonoscena spp., white powder Aleurodes spp., Aleurolobus barodensis , Aleurothrixus spp., Amrasca spp., Anasa tristis , Pseudomonas ( Antestiopsis spp.), Anuraphis cardui , Aonidiella spp., Aphanostigma piri , Aphidula nasturtii ; Aphis spp., such as sugar beet aphid ( Aphis fabae ), strawberry root aphid ( Aphis forbesi ), cotton aphid ( Aphis gossypii ), North American tea currant aphid ( Aphis grossulariae ), apple aphid ( Aphis pomi ), elderberry aphid ( Aphis sambuci ), sineide aphid ( Aphis schneideri ), Aphis spiraecola ; Arboridia apicalis , Arilus critatus , Aspidiella spp., Aspidiotus spp., According to the genus Atanus spp., Aulacorthum solani ; Bemisia spp., such as Bemisia argentifolii , Bemisia tabaci ; Bemisia tabaci ; ( Blissus spp.), such as corn long bug ( Blissus leucopterus ) ; dus helichrysi ), peach aphid ( Brachycaudus persicae ), cherry aphid ( Brachycaudus prunicola ), microtube aphid ( Brachycolus spp.), cabbage aphid ( Brevicoryne brassicae ), small brown rice lice ( Calligypona marginata ), Jun blind Stinkbugs ( Calocoris spp. ), Spot-legged Lygus ( Campylomma livida ), Capitophorus horni ( Capitophorus horni ), Yellow-headed leafhopper ( Carneocephala fulgida ), Cavelerius spp., Turtle wax Scale ( Ceraplastes spp. ), Sugarcane cotton aphid ( Ceratovacuna lanigera ), Cercopidae ( Cercopidae ), Cotton square winged netbug ( Cerosipha gossypii ), Strawberry tuber aphid ( Chaetosiphon fragaefolii ), Cane yellow snow shield scale ( Chionaspis tegalensis ) , tea green leafhopper ( Chlorita onukii ), walnut black spot aphid ( Chromaphis juglandicola ), black and brown round shield scale ( Chrysomphalus ficus ), corn leafhopper ( Cicadulina mbila ), bedbugs ( Cimex spp.), such as tropical bedbugs ( Cimex hemipterus ), temperate bedbug ( Cimex lectularius ); scale insect ( Coccomytilus halli ), soft scale insect ( Coccus spp.), mirid bug ( Creontiades dilutes ), tea currant Cryptomyzus ribis ( Cryptomyzus ribis ), tea currant Cryptomyzus ( Cryptomyzus ribis ), Cyrtopeltis notatus , Dalbulus spp. , Dasynus piperis , Dialeurades spp. , Diaphorina spp. Diaspis spp., Dichelops furcatus , Diconocoris hewetti , Doralis spp., Dreyfusia nordmannianae ), Dreyfusia piceae , Drosicha spp.; Dysaphis spp., such as Dysaphis plantaginea , Dysaphis pyri ), Dysaphis radicola ; Dysaulacorthum pseudosolani ; Dysdercus spp., such as Dysdercus cingulatus , Dysdercus intermedius ; Dysmicoccus spp.; Empoasca spp., such as Empoasca fabae , Empoasca solana ; Eriosoma spp., Leafhopper Erythroneura spp.; Eurygaster spp., such as Eurygaster integriceps ; Euscelis bilobatus ; Euschistus spp., such as soybean brown toon ( Euschistuos heroes ), tobacco bugs ( Euschistus impictiventris ), brown bugs ( Euschistus servus ); coffee ground mealybugs ( Geococcus coffeeae ); Halyomorpha spp., such as Halyomorpha halys ; ( Heliopeltis spp.), Glass Leafhopper ( Homalodisca coagulata ), Horcias nobilellus ( Horcias nobilellus ), Hyalopterus pruni , Hyperomyzus lactucae ( Hyperomyzus lactucae ) ( Icerya spp.), Idiocerus spp., Idioscopus spp., Laodelphax striatellus , Lecanium spp., Oyster shield ( Lepidosaphes spp.), Leptocorisa spp., Cotton red boll Leptoglossus phyllopus , Lipaphis erysimi ; Lygus spp., such as Lygus hesperus , Lygus lineolaris , Lygus pratensis ; Macropes excavatus ; Macrosiphum spp., such as Macrosiphum rosae , Macrosiphum avenae , Macrosiphum euphorbiae ; foam Mahanarva fimbriolata , Megacopta cribraria , Megoura viciae , Melanaphis pyrarius , Melanaphis sacchari , Metcafiella spp., Metopolophium dirhodum ), Miridae spp., Monellia costalis , Monelliopsis pecanis ; Myzus spp., such as Myzus ascalonicus , Myzus ascalonicus Aphids ( Myzus cerasi ), green peach aphids ( Myzus persicae ), xanthophylls ( Myzus variants ); Nephotettix malayanus , Nephotettix nigropictus , Nephotettix parvus , Nephotettix virescens ; Nezara spp. , such as Nezara viridula ; Nilaparvata lugens , Oebalus spp., Oncometopia spp., Orthezia praelonga , Parabemisia myricae ), Paratrioza spp., Parlatoria spp.; Pemphigus spp., such as Pemphigus bursarius ; Pentomidae , Peregrinus maidis , Perkinsiella saccharicida , Phenacoccus spp., Phloeomyzus passerinii , Phorodonhumuli , Phylloxera spp. .), Piesma quadrata ; Piezodorus spp., such as Piezodorus guildinii , Pinnaspis aspidistrae , Planococcus spp. , Protopulvinaria pyriformis, Psallus seriatus, Pseudacysta persea , Pseudaulacaspis pentagona ; Pseudococcus spp. Mealbug ( Pseudococcus comstocki ); Psylla spp., such as Psylla mali , Psylla piri ; Pteromalus spp., Pyrilla spp. , Quadraspidiotus spp., Quesada gigas , Rastrococcus spp., Reduvius senilis , Rhodnius spp., winter Onion aphid ( Rhopalomyzus ascalonicus ); genus Rhopalosiphum spp., such as radish aphid ( Rhopalosiphum pseudobrassicas ), apple grass aphid ( Rhopalosiphum inserttum ), corn aphid ( Rhopalosiphum maidis ), cereal aphid ( Rhopalosiphum padi ); Sa gatodes spp., cocoa brown Lygus ( Sahlbergella singularis ), black helmeted scale ( Saissetia spp.), pear anvil ( Sappaphis mala ), apple red aphid ( Sappaphis mali ), grape leafhopper ( Scaphoides titanus ) , Schizaphis graminum , Schizoneura lanuginose , Scotinophora spp., Selenaspidus articulatus , Sitobion avenae , Schizoneura spp. Sogata spp., Sogatella furcifera , Soluea insularis , Stephanitis nashi , Stictocephala festina , Tenalaphara malayensis ; Thyanta spp., such as Thyantaperditor ; Tibraca spp., Tinocallis caryaefoliae , Tomaspis spp.; Toxoptera spp., such as Toxoptera aurantii ; Trialeurodes spp., such as Trialeurodes vaporariorum ; Triatoma spp., Psyllid ( Trioza spp.), Typhlocyba spp.; Unaspis spp., such as Unaspis yanonensis ; and Viteus vitifolii ;

螞蟻、蜜蜂、黃蜂、鋸蠅(膜翅目 (Hymenoptera))者,例如疆菜葉蜂 ( Athalia rosae)、卡培古魯切葉蟻 ( Atta capiguara)、切葉蟻 ( Atta cephalotes)、切葉蟻 ( Atta cephalotes)、南美切葉蟻 ( Atta laevigata)、強壯切葉蟻 ( Atta robusta)、六孔切葉蟻 ( Atta sexdens)、德州切葉蟻 ( Atta texana)、熊蜂屬 ( Bombusspp.)、佛羅里達弓背蟻 ( Camponotus floridanus)、舉腹蟻屬 ( Crematogasterspp.)、天鵝絨螞蟻 ( Dasymutilla occidentalis)、松葉蜂屬 ( Diprionspp.)、姬胡蜂 ( Dolichovespula maculata);實蜂屬 ( Hoplocampaspp.),如李小葉蜂 ( Hoplocampa minuta)、蘋葉蜂 ( Hoplocampa testudinea);毛蟻屬 ( Lasiusspp.),如黑毛蟻 ( Lasius niger);阿根廷蟻 ( Linepithema humile)、小黃家蟻 ( Monomorium pharaonis)、德國黃胡蜂 ( Paravespula germanica)、樹黃胡蜂 ( Paravespula pennsylvanica)、常見黃胡蜂 ( Paravespula vulgaris)、褐大頭蟻 ( Pheidole megacephala)、紅螞蟻 ( Pogonomyrmex barbatus)、收割機螞蟻 ( Pogonomyrmex californicus)、胡蜂 ( Polistes rubiginosa)、熱帶火蟻 ( Solenopsis geminata)、紅火蟻 ( Solenopsis invicta)、黑火蟻 ( Solenopsis richteri)、南方火蟻 ( Solenopsis xyloni);大胡蜂屬 ( Vespaspp.),如黃邊胡蜂 ( Vespa crabro);和大黃蜂 ( Vespula squamosa);蟋蟀、蚱蜢、蝗蟲(直翅目 (Orthoptera))者,例如居屋艾蟋 ( Acheta domestica)、意大利蝗 ( Calliptamus italicus)、澳洲草栖蝗 ( Chortoicetes terminifera)、摩洛哥戟紋蝗 ( Dociostaurus maroccanus)、非洲螻蛄 ( Gryllotalpa africana)、螻蛄 ( Gryllotalpa gryllotalpa)、非洲蔗蝗 ( Hieroglyphus daganensis)、印度黃檀蝗 ( Kraussaria angulifera)、飛蝗 ( Locusta migratoria)、褐色擬飛蝗 ( Locustana pardalina)、雙紋黑蝗 ( Melanoplus bivittatus)、紅足黑蝗 ( Melanoplus femurrubrum)、墨西哥黑蝗 ( Melanoplus mexicanus)、遷飛黑蝗 ( Melanoplus sanguinipes)、石栖黑蝗 ( Melanoplus spretus)、條紋紅蝗 ( Nomadacris septemfasciata)、塞納加爾小車蝗 ( Oedaleus senegalensis)、美洲沙漠蝗 ( Schistocerca americana)、沙漠蝗 ( Schistocerca gregaria)、庭疾灶螽 ( Tachycines asynamorus)和臭腹腺蝗 ( Zonozerus variegatus); Ants, bees, wasps, sawflies (Hymenoptera) such as Athalia rosae , Atta capiguara , Atta cephalotes , leafcutters Atta cephalotes , Atta laevigata , Atta robusta , Atta sexdens , Atta texana , Bombus spp. , Camponotus floridanus , Crematogaster spp., Dasymutilla occidentalis , Diprion spp., Dolichovespula maculata ; Hoplocampa spp. ), such as Hoplocampa minuta , Hoplocampa testudinea ; Lasius spp., such as Lasius niger ; Linepithema humile , Monomorium pharaonis ), German wasp ( Paravespula germanica ), tree wasp ( Paravespula pennsylvanica ), common wasp ( Paravespula vulgaris ), brown head ant ( Pheidole megacephala ), red ant ( Pogonomyrmex barbatus ), harvester ant ( Pogonomyrmex californicus ), Wasps ( Polistes rubiginosa ), tropical fire ants ( Solenopsis geminata ), red fire ants ( Solenopsis invicta ), black fire ants ( Solenopsis richteri ), southern fire ants ( Solenopsis xyloni ); ( Vespa crabro ); and the bumblebee ( Vespula squamosa ); crickets, grasshoppers, locusts (Orthoptera) such as the house cricket ( Acheta domestica ), the Italian locust ( Cal liptamus italicus ), Chortoicetes terminifera , Dociostaurus maroccanus , Gryllotalpa africana , Gryllotalpa gryllotalpa , Hieroglyphus daganensis , Kraussaria angulifera , Locusta migratoria , Locustana pardalina , Melanoplus bivittatus , Melanoplus femurrubrum , Melanoplus mexicanus , Melanoplus sanguinipes , Black locust ( Melanoplus spretus ), striped red locust ( Nomadacris septemfasciata ), Senegalus senegalensis , American desert locust ( Schistocerca americana ), desert locust ( Schistocerca gregaria ), family disease katydid ( Tachycines aynamorus ) and Smelly locust ( Zonozerus variegatus );

蛛形綱 (Arachnida) 者,如蜱蟎目 (Acari),例如軟蜱科 (Argasidae)、硬蜱科 (Ixodidae) 以及疥蟎科 (Sarcoptidae),例如花蜱屬 ( Amblyommaspp.)(例如長星形壁蝨 ( Amblyomma americanum)、熱帶花蜱 ( Amblyomma variegatum)、斑點鈍眼蜱 ( Amblyomma maculatum))、銳緣蜱屬 (Argas spp.)(例如波斯銳緣蜱 ( Argas persicus))、牛蜱屬 ( Boophilusspp.)(例如牛壁蝨 ( Boophilus annulatus)、消色牛蜱 ( Boophilus decoloratus)、微小牛蜱 ( Boophilus microplus))、森林革蜱 ( Dermacentor silvarum)、安氏革蜱 ( Dermacentor andersoni)、美洲大革蜱 ( Dermacentor variabilis)、璃眼蜱屬 ( Hyalommaspp.)(例如長喙璃眼蜱 ( Hyalomma truncatum))、硬蜱屬 ( Ixodesspp.)(例如蓖子硬蜱 ( Ixodes ricinus)、淺紅硬蜱 ( Ixodes rubicundus)、黑脚硬蜱 ( Ixodes scapularis)、全環硬蜱 ( Ixodes holocyclus)、太平洋硬蜱 ( Ixodes pacificus))、鈍緣蜱屬 ( Ornithodorusspp.)(例如毛白鈍緣蜱 ( Ornithodorus moubata)、赫氏鈍緣蜱 ( Ornithodorus hermsi)、回歸熱蜱 ( Ornithodorus turicata))、柏氏禽刺蟎 ( Ornithonyssus bacoti)、刺耳扁蝨 ( Otobius megnini)、雞皮刺蟎 ( Dermanyssus gallinae)、癢蟎屬 ( Psoroptesspp.)(例如綿羊疥病 ( Psoroptes ovis))、扇頭蜱屬 ( Rhipicephalusspp.)(例如、具尾扇頭蜱 ( Rhipicephalus appendiculatus)、外翻扇頭蜱 ( Rhipicephalus evertsi))、根蟎屬 ( Rhizoglyphusspp.)、疥蟎屬 ( Sarcoptesspp.)(例如人疥蟎 ( Sarcoptes scabiei));和癭蟎科 ( Eriophyidaespp.),如桔瘤節蜱 ( Acaria sheldoni);刺皮節蜱屬 ( Aculopsspp.)(例如桔銹蟎 ( Aculops pelekassi));刺癭蟎屬 ( Aculusspp.)(例如蘋果刺銹蟎 ( Aculus schlechtendali))、棗葉銹蟎 ( Epitrimerus pyri)、桔皺葉刺癭蟎 ( Phyllocoptruta oleivora) 和癭蟎屬 ( Eriophyesspp.)(例如柑橘癭蟎 ( Eriophyes sheldoni));跗線蟎屬 ( Tarsonemidaespp.),如半跗線蟎屬 ( Hemitarsonemusspp.)、仙客來細蟎 ( Phytonemus pallidus) 以及側多食跗線蟎 ( Polyphagotarsonemus latus)、狹跗線蟎屬 ( Stenotarsonemusspp.);細須蟎屬 ( Tenuipalpidaespp.),如短須蟎屬 ( Brevipalpusspp.)(例如紫紅短須蟎 ( Brevipalpus phoenicis));葉蟎屬 ( Tetranychidaespp.),如始葉蟎屬 ( Eotetranychusspp.)、真葉蟎屬 ( Eutetranychusspp.)、小爪蟎屬 ( Oligonychusspp.)、朱砂葉蟎 ( Tetranychus cinnabarinus)、神澤葉蟎 ( Tetranychus kanzawai)、太平洋葉蟎 (Tetranychus pacificus)、棉葉蟎 (Tetranychus telarius)和二點葉蟎 ( Tetranychus urticae);苜蓿苔蟎 ( Bryobia praetiosa)、全爪蟎屬 ( Panonychusspp.)(例如蘋果葉蟎 ( Panonychus ulmi)、橘全爪蟎 ( Panonychus citri))、蛛蟎 ( Metatetranychusspp.) 和小爪蟎屬 ( Oligonychusspp.)(例如草地小爪蟎 ( oligonychus pratensis))、斜背瘤節蜱 ( Vasates lycopersici);蜘蛛目 ( Araneida),例如毒蜘蛛 ( Latrodectus mactans)、褐絲蛛 ( Loxosceles reclusa) 以及粗脚粉蟎 ( Acarus siro)、皮蟎屬 ( Chorioptesspp.)、中東金蝎 ( Scorpio maurus); 跳蚤(蚤目 (Siphonaptera)),例如角葉蚤屬 ( Ceratophyllusspp.)、貓櫛頭蚤 ( Ctenocephalidesfelis)、狗櫛頭蚤 ( Ctenocephalidescanis)、東方鼠蚤 ( Xenopsylla cheopis)、致癢疊 ( Pulex irritans)、穿皮潛疊 ( Tunga penetrans) 以及具帶病蚤 ( Nosopsyllus fasciatus);衣魚、家衣魚(纓尾目 (Thysanura))者,例如西洋衣魚 ( Lepisma saccharina) 和斑衣魚 ( Thermobia domestica);百足蟲 (centipedes)(唇足綱 (Chilopoda)),例如地蜈蚣屬 ( Geophilusspp.)、蚰蜓屬 ( Scutigeraspp.),如蚰蜒 ( Scutigera coleoptrata);千足蟲(倍足綱 (Diplopoda)),例如具斑馬陸 ( Blaniulus guttulatus)、鉤蟲屬 ( Narceusspp.);攫峭(革翅目 (Dermaptera)),例如歐洲球螋 ( forficula auricularia);蝨(蝨毛目 (Phthiraptera)),例如毛蝨屬 ( Damaliniaspp.);人蝨屬 ( Pediculusspp.),頭蝨 ( Pediculus humanus capitis)、人體蝨 ( Pediculus humanus corporis);恥陰蝨 ( Pthirus pubis);血蝨屬 ( Haematop inusspp.),如牛血蝨 ( Haematopinus eurysternus)、豬血蝨 ( Haematopinus suis);長顎蝨屬 ( Linognathusspp.),牛顎蝨 ( Linognathus vituli);牛羽蝨 ( Bovicola bovis)、雞羽蝨 ( Menopon gallinae)、黄體羽蝨 ( Menacanthus stramineus) 以及水牛盲蝨 ( Solenopotes capillatus),嚼蝨屬 ( Trichodectesspp.); 跳蟲(彈尾目 (Collembola)),例如棘跳蟲屬 ( Onychiurusssp.),如棘跳蟲 ( Onychiurus armatus)。 Arachnida, e.g. Acari, e.g. Argasidae, Ixodidae and Sarcoptidae, e.g. Amblyomma spp. (e.g. Amblyomma spp. Star ticks ( Amblyomma americanum ), tropical flower ticks ( Amblyomma variegatum ), spotted ticks ( Amblyomma maculatum ), ticks of the genus Argas spp. (e.g. Argas persicus ), ticks of the bovine tick species ( Boophilus spp.) (eg Boophilus annulatus , Boophilus decoloratus , Boophilus microplus ), Dermacentor silvarum , Dermacentor andersoni , American Dermacentor variabilis , Hyalomma spp. (e.g. Hyalomma truncatum ), Ixodes spp. (e.g. Ixodes ricinus ), superficial Red Ixodes ( Ixodes rubicundus ), Blacklegged Ixodes ( Ixodes scapularis ), Ixodes holocyclus ( Ixodes holocyclus ), Ixodes pacificus ( Ixodes pacificus )), Ornithodorus spp. Ticks ( Ornithodorus moubata ), Ornithodorus hermsi , Recurrent heat ticks ( Ornithodorus turicata ) , Ornithonyssus bacoti , Otobius megnini , Dermanyssus gallinae , Psoroptes spp. (eg Psoroptes ovis ), Rhipicephalus spp. (eg Rhipicephalus appendiculatus ), Rhipicephalus evertsi ), Root mite ( Rhizoglyphus spp.), Sarcoptes spp. (e.g. Sarcoptes spp.); and Eriophyidae spp., such as Acaria sheldoni ; Aculops spp . spp.) (e.g. Aculops pelekassi ); Aculus spp. (e.g. Aculus schlechtendali ), date leaf rust mite ( Epitrimerus pyri ), orange rugose leaf gall mite ( Phyllocoptruta oleivora ) and Eriophyes spp. (eg Eriophyes sheldoni ); Tarsonemidae spp. eg Hemitarsonemus spp., Cyclamen spp. Phytonemus pallidus and Polyphagotarsonemus latus , Stenotarsonemus spp.; Tenuipalpidae spp., such as Brevipalpus spp. (eg Brevipalpus phoenicis ( Brevipalpus phoenicis )); Tetranychidae spp., such as Eotetranychus spp., Eutetranychus spp., Oligonychus spp., Tetranychus cinnabarinus , Tetranychus kanzawai , Tetranychus pacificus , Tetranychus telarius , and Tetranychus urticae ; Bryobia praetiosa , Panonychus spp. (e.g. apple spider mite ( Panonychus ulmi ), orange spider mite ( Panonychus citri )), spider mite ( Metatetranychus spp.) and small claw mite ( Oligonychus spp.) (e.g. Clawed mite ( oligonychus pratensis ), Tumor tick ( Vasates lycopersici ); from the order of the Araneida , such as Latrodectus mactans , Loxosceles reclusa , and Acarus siro , Chorioptes spp., Scorpio maurus Fleas ( Siphonaptera ), such as Ceratophyllus spp., Ctenocephalides felis, Ctenocephalides canis, Xenopsylla cheopis, pruritic fleas ( Pulex irritans ), Tunga penetrans , and Nosopsyllus fasciatus ; silverfish, house silverfish (Thysanura), such as silverfish ( Lepisma saccharina ) and striped fish ( Thermobia domestica ); centipedes (Chilopoda), such as Geophilus spp., Scutigera spp., such as Scutigera coleoptrata ; millipedes ( Scutigera coleoptrata ); Class Diplopoda), such as Blaniulus guttulatus , Narceus spp.; gnats (Dermaptera), such as forficula auricularia ; lice (Phthiraptera )), such as Damalinia spp.; Pediculus spp., Pediculus humanus capitis , Pediculus humanus corporis ; Pthirus pubis ; blood lice ( Haematop inus spp.), such as Haematopinus eurysternus , Haematopinus suis ; Linognathus spp., Linognathus vituli ; Bovicola bovis , chicken Feather lice ( Menopon galli nae ), Menacanthus stramineus and buffalo blind lice ( Solenopotes capillatus ), Trichodectes spp.; Collembola (Collembola), for example Onychiurus ssp., e.g. Springtail ( Onychiurus armatus ).

本案的混合物亦適用於有效控制線蟲:植物寄生性線蟲例如根結線蟲 (root knot nematodes),北方根結線蟲 ( Meloidogyne hapla)、南方根結線蟲 ( Meloidogyne incognita)、爪哇根結線蟲 ( Meloidogyne javanica) 以及其他根結線蟲屬 ( Meloidogynespecies);胞囊線蟲 (cyst-forming nematodes),土豆金線蟲 ( Globodera rostochiensis)和其他球胞囊線蟲屬 (Globodera species);禾穀胞囊線蟲 ( Heterodera avenae)、大豆胞囊線蟲 ( Heterodera glycines)、甜菜胞囊線蟲 ( Heterodera schachtii)、三葉草胞囊線蟲 ( Heterodera trifolii) 和其他胞囊線蟲屬 ( Heteroderaspecies);種子腫癭線蟲 (Seed gall nematodes),粒線蟲屬 ( Anguinaspecies);莖葉線蟲 (Stem and foliar nematodes),滑刃線蟲屬 ( Aphelenchoidesspecies) 如水稻幹尖線蟲 ( Aphelenchoides besseyi);刺線蟲,雜草刺線蟲 ( Belonolaimus longicaudatus)和其他針刺線蟲屬 ( Belonolaimusspecies);松線蟲,松材線蟲 ( Bursaphelenchus lignicolus Mamiya et Kiyohara)、松材線蟲 ( Bursaphelenchus xylophilus)和其他傘滑刃線蟲屬 ( Bursaphelenchusspecies);環形線蟲,環紋線蟲屬 ( Criconemaspecies)、小環線蟲屬 ( Criconemellaspecies)、輪線蟲屬 ( Criconemoidesspecies)、中環線蟲屬 ( Mesocriconemaspecies);球莖線蟲 (Stem and bulb nematodes),腐爛莖線蟲 ( Ditylenchus destructor)、甘薯莖線蟲 ( Ditylenchus dipsaci)和其他莖線蟲屬 ( Ditylenchusspecies);錐線蟲,錐線蟲屬 ( Dolichodorusspecies);螺旋形線蟲,多帶螺旋線蟲 ( Heliocotylenchus multicinctus) 和其他螺旋線蟲屬;鞘線蟲 (Sheath and sheathoid nematodes),鞘線蟲屬 ( Hemicycliophoraspecies)和( Hemicriconemoidesspecies);潛根線蟲屬 ( Hirshmanniellaspecies);冠線蟲 (Lance nematodes),紐帶線蟲屬 ( Hoplolaimusspecies);假根結線蟲 (false rootknot nematodes),真珠線蟲屬 ( Nacobbusspecies);針線蟲,伸展長針線蟲 ( Longidorus elongatus)和其他長針線蟲屬 ( Longidorusspecies);根腐線蟲 (Lesion nematodes),最短尾短體線蟲 ( Pratylenchus brachyurus)、疏忽短體線蟲 ( Pratylenchus neglectus)、穿刺短體線蟲 ( Pratylenchus penetrans)、彎曲短體線蟲 ( Pratylenchus curvitatus)、古迪短體線蟲 ( Pratylenchus goodeyi)和其他短體線蟲屬 ( Pratylenchusspecies);穿孔線蟲 (Burrowing nematodes),香蕉穿孔線蟲 ( Radopholus similis)和其他穿孔線蟲屬 ( Radopholusspecies);腎形線蟲 (Reniform nematodes),盤旋線蟲 ( Rotylenchus robustus)、腎形腎臟線蟲 ( Rotylenchulus reniformis)和其他腎狀線蟲屬 ( Rotylenchulusspecies);盾線蟲屬 ( Scutellonemaspecies);殘根線蟲 ( Stubby root nematodes),原始毛刺線蟲 ( Trichodorus primitivus) 和其他毛刺線蟲屬 ( Trichodorusspecies)、類毛刺屬 ( Paratrichodorusspecies);阻長線蟲 (Stunt nematodes),克萊頓矮化線蟲 ( Tylenchorhynchus claytoni)、不定矮化線蟲 ( Tylenchorhynchus dubius) 以及其他矮化線蟲屬 (Tylenchorhynchus species);柑桔線蟲 (Citrus nematodes),小墊刃線蟲屬 ( Tylenchulusspecies) 如柑桔半穿刺線蟲 ( Tylenchuluss emipenetrans);劍線蟲 (Dagger nematodes),劍線蟲屬 ( Xiphinemaspecies);和其他植物寄生性線蟲種屬。 The mixture in this case is also suitable for effective control of nematodes: plant parasitic nematodes such as root knot nematodes (root knot nematodes), northern root knot nematode ( Meloidogyne hapla ), southern root knot nematode ( Meloidogyne incognita ), java root knot nematode ( Meloidogyne javanica ) and other Meloidogyne species; cyst-forming nematodes, potato golden nematodes ( Globodera rostochie nsis) and other Globodera species; cereal cyst nematodes ( Heterodera avenae ) , Heterodera glycines , Heterodera schachtii , Heterodera trifolii , and other Heterodera species; Seed gall nematodes, nematodes Anguina species; Stem and foliar nematodes, Aphelenchoides species such as Aphelenchoides besseyi ; thorn nematodes, Belonolaimus longicaudatus and other needle-punching nematodes Belonolaimus species; pine nematodes, Bursaphelenchus lignicolus Mamiya et Kiyohara , Bursaphelenchus xylophilus and other Bursaphelenchus species; ringworms, Criconema species , Criconemella species, Criconemoides species, Mesocriconema species; Stem and bulb nematodes, Ditylenchus destructor , Ditylenchus dipsaci and other Ditylenchus species Trypanosomes, Dolichodorus species; Spiral nematodes, Heliocotylenchus multicinctus and other Helicoides species; Sheath and sheathoid nematodes, Hemiccliophora species and Hemicriconemoides species ); Hirshmanniella species; Lance nematodes, Hoplolaimus species; false rootknot nematodes, Nacobbus species; ( Longidorus elongatus ) and other Longidorus species; root rot nematodes ( Lesion nematodes ), short-tailed short-tailed nematodes ( Pratylenchus brachyurus ), negligent short-body nematodes ( Pratylenchus neglectus ), piercing short-body nematodes ( Pratylenchus penetrans ), Pratylenchus curvitatus , Pratylenchus goodeyi and other Pratylenchus species; Burrowing nematodes, Radopholus similis and other Radopholus species); Reniform nematodes, Rotylenchus robustus , Rotylenchulus reniformis and other Rotylenchulus species; Scutellonema species; Stubby root nematodes root nematodes ), Trichodorus primitivus and other Trichodorus species, Paratrichodorus species; Stunt nematodes, Tylenc horhynchus claytoni ), Tylenchorhynchus dubius and other Tylenchorhynchus species; Citrus nematodes, Tylenchulus species such as Tylenchulus emipenetrans ; Dagger nematodes, Xiphinema species; and other plant parasitic nematode species.

可由本案殺蟲混合物來控制之其他害蟲的實例包含:雙殼綱 (Bivalva),例如,飾貝屬 ( Dreissenaspp.);腹足綱 (Gastropoda),例如阿勇蛞蝓屬 ( Arionspp.)、雙臍螺屬 ( Biomphalariaspp.)、小泡螺屬 ( Bulinusspp.)、野蛞蝓屬 ( Derocerasspp.)、土蝸屬 ( Galbaspp.)、椎實螺屬 ( Lymnaeaspp.)、釘螺屬 ( Oncomelaniaspp.)、琥珀螺屬 ( Succineaspp.);蠕蟲綱 (Helminths),例如十二指腸鈎口線蟲 ( Ancylostoma duodenale)、斯裏蘭卡鈎口線蟲 ( Ancylostoma ceylanicum)、巴西鈎口線蟲 ( Acylostoma braziliensis)、鈎口線蟲屬 ( Ancylostomaspp.)、似引蛔線蟲 ( Ascaris lubricoides)、蛔蟲屬 ( Ascarisspp.)、馬來布魯線蟲 ( Brugiamalayi)、帝汶布魯線蟲 ( Brugiatimori)、仰口線蟲屬 ( Bunostomumspp.)、夏伯特線蟲屬 ( Chabertiaspp.)、枝睾吸蟲屬 ( Clonorchisspp.)、古柏線蟲屬 ( Cooperiaspp.)、雙腔吸蟲屬 ( Dicrocoeliumspp.)、絲狀網尾線蟲 ( Dictyocaulus filaria)、闊葉裂頭縧蟲 ( Diphyllobothrium latum)、麥地那龍線蟲 ( Dracunculus medinensis)、細粒棘球縧蟲 ( Echinococcus granulosus)、多房棘球縧蟲 ( Echinococcus multilocularis)、蠕形住腸蟯蟲 ( Enterobius vermicularis)、吸蟲屬 ( Faciolaspp.)、血線蟲屬 ( Haemonchusspp.) 如拈轉血矛線蟲 ( Haemonchus contortus);異刺線蟲屬 ( Heterakisspp.)、短小包膜絛蟲( Hymenolepis nana)、猪圓線蟲屬 ( Hyostrongulusspp.)、羅阿血絲蟲 ( Loa Loa)、細頸線蟲屬 ( Nematodirusspp.)、結節線蟲屬 ( Oesophagostomumspp.)、肝吸蟲屬 ( Opisthorchisspp.)、旋盤尾絲蟲 ( Onchocerca volvulus)、奧斯脫線蟲屬 ( Ostertagiaspp.)、並殖吸蟲屬 ( Paragonimusspp.)、血吸蟲屬 ( Schistosomenspp.)、富氏類圓線蟲 ( Strongyloides fuelleborni)、糞類圓線蟲 ( Strongyloides stercoralis)、糞圓線蟲屬 ( Stronyloidesspp.)、牛帶絛蟲 ( Taeniasaginata)、猪帶絛蟲 ( Taeniasolium)、旋毛形線蟲 ( Trichinella spiralis)、本地毛形線蟲 ( Trichinella nativa)、株布氏旋毛蟲 ( Trichinella britovi)、南方旋毛蟲 ( Trichinella nelsoni)、僞方定毛形線蟲 ( Trichinella pseudopsiralis)、毛圓線蟲屬 ( Trichostrongulusspp.)、毛首鞭形線蟲 ( Trichuris trichuria)、班氏吳策線蟲 ( Wuchereria bancrofti);等足目 (Isopoda),例如鼠婦 ( Armadillidium vulgare)、潮蟲( Oniscus asellus)、球鼠婦 ( Porcellio scaber);結閥目 (Symphyla),例如白松蟲 ( Scutigerella immaculata)。 Examples of other pests that may be controlled by the present pesticidal mixture include: Bivalva, e.g., Dreissena spp.; Gastropoda, e.g., Arion spp., Biomphalaria spp., Bulinus spp., Deroceras spp., Galba spp., Lymnaea spp., Oncomelania ( Oncomelania spp.), Amber snails ( Succinea spp.); Helminths (Helminths), such as Ancylostoma duodenale , Ancylostoma ceylanicum , Ancylostoma ceylanicum braziliensis ), Ancylostoma spp., Ascaris lubr icoides, Ascaris spp., Brugiamalayi , Brugiatimori , Bunostomum spp., Chabertia spp., Clonorchis spp., Cooperia spp., Dicrocoelium spp. ), Dictyocaulus filaria , Diphyllobothrium latum , Dracunculus medinensis , Echinococcus granulosus , Echinococcus multilocularis ), Enterobius vermicularis , Faciola spp., Haemonchus spp. such as Haemonchus contortus ; Heterakis spp . , Hymenolepis nana , Strongulus spp., Loa Loa , Nematodirus spp., Oesophagostomum spp., Opisthorchis spp., Onchocerca volvulus , Ostertagia spp., Paragonimus spp., Schistosomen spp., Strongyloides fueleborni , Strongyloides stercoralis , Stronyloides spp., Taeniasaginata , Taeniasolium , Trichinella spiralis , Trichinella nativa , Trichinella britovi , Trichinella nelsoni , Trichinella pseudopsiralis , Trichinella strongylis Trichostrongulus spp., Trichuris trichuria , Wuchereria bancrofti ; Isopoda, for example, Armadillidium vulgare , Oniscus asellus , Porcellio scaber ; from the order of the Symphyla, for example the white pine worm ( Scutigerella immaculata ).

可由本案的殺蟲混合物來控制之害蟲的其他實例包含:奧地利金龜子 ( Anisoplia austriaca)、竹笋夜蛾屬 ( Apameaspp.)、棉小葉蟬 ( Austroasca viridigrisea)、稻薊馬 ( Baliothrips biformis)、秀麗隱杆線蟲 ( Caenorhabditis elegans)、莖蜂屬 ( Cephusspp.)、甘藍象鼻蟲 ( Ceutorhynchus napi)、麥莖大跳甲 ( Chaetocnema aridula)、臺灣稻螟 ( Chilo auricilius)、三化螟 ( Chilo indicus)、稻多麗螟 ( Chilo polychrysus)、澳大利亞蝗 ( Chortiocetes terminifera)、瘤野螟 ( Cnaphalocrocis medinalis)、縱卷葉野螟屬 ( Cnaphalocrosisspp.)、紋黃豆粉蝶 ( Colias eurytheme)、軟翅花甲屬 ( Collopsspp.)、角象白蟻 ( Cornitermes cumulans)、盲蝽屬 ( Creontiadesspp.)、圓頭金龜屬 ( Cyclocephalaspp.)、玉米葉蟬 ( Dalbulus maidis)、野蛞蝓 ( Deraceras reticulatum)、小蔗螟 ( Diatrea saccharalis)、二葉喙蝽 ( Dichelops furcatus)、稻鐵甲蟲 ( Dicladispa armigera);兜蟲屬 ( Diloboderusspp.),如阿根廷兜蟲 ( Diloboderus abderus);椿象属 ( Edessaspp.)、葉小卷蛾屬 (Epinotia spp.)、蟻科 ( Formicidae)、大眼長蝽屬 ( Geocorisspp.)、黃球白蟻 ( Globitermes sulfureus)、螻蛄科 ( Gryllotalpidae)、紅足海鐮螯蟎 ( Halotydeus destructor)、 Hipnodes bicolor、水稻菲島毛眼水蠅 ( Hydrellia philippina)、馬陸屬 ( Julusspp.)、灰飛蝨屬 ( Laodelphaxspp.)、禾蛛緣椿象 ( Leptocorsia acuta)、大稻緣蝽 ( Leptocorsia oratorius)、( Liogenys fuscus)、綠蠅屬 ( Lucilliaspp.)、( Lyogenys fuscus)、突眼長蝽屬 ( Mahanarvaspp.)、瑪絹金龜 ( Maladera matrida)、刷須野螟屬 ( Marasmiaspp.)、澳白蟻屬 ( Mastotermesspp.)、水蠟蟲 ( Mealybugs)、( Megascelisspp.)、西印度蔗螟 ( Metamasius hemipterus)、微孢子蟲屬( Microthecaspp.)、南美毛脛夜蛾 ( Mocis latipes)、斑色蝽屬 ( Murgantiaspp.)、粘蟲 ( Mythemina separata)、不透明新扭白蟻 ( Neocapritermes opacus)、小體擬新扭白蟻 ( Neocapritermes parvus)、新長緣疇屬 ( Neomegalotomusspp.)、新白蟻屬 ( Neotermesspp.)、稻三點螟 ( Nymphula depunctalis)、美洲稻綠蝽 ( Oebalus pugnax);癭蚊屬 (Orseolia spp.),如稻癭蚊 ( Orseolia oryzae);( Oxycaraenus hyalinipennis)、金翅夜蛾屬 ( Plusiaspp.)、福壽螺 ( Pomacea canaliculata)、原角白蟻屬 ( Procornitermesssp.)、白蟻 ( Procornitermes triacifer)、蚤跳甲屬 ( Psylloidesspp.)、尺蠖屬 ( Rachiplusia spp.)、鑽孔線蟲屬 (Rhodopholus spp.)、栗土蝽 ( Scaptocoris castanea)、土蝽屬 ( Scaptocorisspp.);白禾螟屬 ( Scirpophagaspp.),如三化螟 ( Scirpophaga incertulas)、稻白螟 ( Scirpophaga innotata);黑蝽屬 ( Scotinopharaspp.),如馬來亞稻黑蝽 ( Scotinophara coarctata);蛀莖夜蛾屬 ( Sesamiaspp.),如大螟 ( Sesamia inferens);白背飛蝨 ( Sogaella frucifera)、熱帶火蟻 ( Solenapsis geminata)、膜翅角蟬屬 ( Spissistilusspp.)、條螟 ( Stalk borer)、稻薊馬 ( Stenchaetothrips biformis)、斯氏狹跗線蟎 ( Steneotarsonemus spinki)、棉大卷葉螟 ( Sylepta derogata)、甘蔗大螟 ( Telehin licus)、毛圓線蟲屬 ( Trichostrongylusspp.)。 Other examples of pests that may be controlled by the pesticidal mixtures of the present invention include: Austrian scarab ( Anisoplia austriaca ), bamboo shoot moth ( Apamea spp.), cotton leafhopper ( Austroasca viridigrisea ), rice thrips ( Baliothrips biformis ), Caenopsis Caenorhabditis elegans , Cephus spp., Ceutorhynchus napi , Chaetocnema aridula , Chilo auricilius , Chilo indicus , Chilo polychrysus , Chortiocetes terminifera , Cnaphalocrocis medinalis , Cnaphalocrosis spp. , Colias eurytheme , Colias eurytheme ( Collops spp.), Cornitermes cumulans , Creontiades spp., Cyclocephala spp., Corn leafhopper ( Dalbulus maidis ), Wild slugs ( Deraceras reticulatum ), Small sugarcane borer ( Diatrea saccharalis ), Dichelops furcatus , Dicladispa armigera ; Diloboderus spp., such as Diloboderus abderus ; Stinkbug ( Edessa spp.), leaf roll Epinotia spp., Formicidae, Geocoris spp., Globitermes sulfureus , Gryllotalpidae , Halotydeus destructor , Hipnodes bicolor , Hydrellia philippina , Julus spp., Laodelphax spp., Leptocorsia acuta ), Leptocorsia oratorius , Liogenys fuscus , Lucillia spp. , Lyogenys fuscus , Mahanarva spp. , Maladera matrida , brush Marasmia spp., Mastotermes spp., Mealybugs , Megascelis spp., Metamasius hemipterus , Microtheca spp., Mocis latipes , Murgantia spp., Mythemina separata , Neocapritermes opacus , Neocapritermes parvus , Neocapritermes parvus Neomegalotomus spp., Neotermes spp., Nymphula depunctalis , Oebalus pugnax ; Orseolia spp., such as Orseolia oryzae ); ( Oxycaraenus hyalinipennis ), Spodoptera ( Plusia spp.), apple snail ( Pomacea canaliculata ), Procornitermes ssp., termite ( Procornitermes triacifer ), flea beetle ( Psylloides spp.), Rachiplusia spp. , Rhodopholus spp., Scaptocoris castanea , Scaptocoris spp.; Scirpophaga spp., such as the stem borer ( Scirpophaga incertulas ), Scirpophaga innotata ; Scotinophara spp., such as Scotinophara coarctata ; Sesamia spp., such as Sesamia infer ens ); white-backed planthopper ( Sogaella frucifera ), tropical fire ant ( Solenapsis geminata ), membrane-winged doghopper ( Spissistilus spp.), bar borer ( Stalk borer ), rice thrips ( Stenchaetothrips biformis ), Stenchaetothrips biformis , Stenchaetothrips biformis Steneotarsonemus spinki , Sylepta derogata , Telehin licus , Trichostrongylus spp .

本案之混合物特別適用於控制昆蟲,較佳是吮吸式或刺吸式蟲,如選自種屬纓翅目 ( Thysanoptera)、雙翅目 ( Diptera)和半翅目 ( Hemiptera)的昆蟲;以及嚼咬式害蟲 (chewing-biting pests),如選自種屬鱗翅目 ( Lepidoptera)和鞘翅目 ( Coleoptera)的昆蟲,所述昆蟲特別是如下之種屬:纓翅目 ( Thysanoptera):煙草花薊馬 ( Frankliniella fusca)、西方花薊馬 ( Frankliniella occidentalis)、美東花薊馬 ( Frankliniella tritici)、桔硬薊馬 ( Scirtothrips citri)、水稻薊馬 ( Thrips oryzae)、棕櫚薊馬 ( Thrips palmi)、蔥薊馬 ( Thrips tabaci);雙翅目 ( Diptera),例如埃及伊蚊 ( Aedes aegypti)、白紋伊蚊 ( Aedes albopictus)、剌擾伊蚊 ( Aedes vexans)、墨西哥果蠅 ( Anastrepha ludens)、五斑按蚊 ( Anopheles maculipennis)、災難按蚊 ( Anopheles crucians)、白足按蚊 ( Anopheles albimanus)、岡比亞按蚊 ( Anopheles gambiae)、費氏按蚊 ( Anopheles freeborni)、白踝按蚊 ( Anopheles leucosphyrus)、微小按蚊 ( Anopheles minimus)、四斑按蚊 ( Anopheles quadrimaculatus)、紅頭麗蠅 ( Calliphora vicina)、地中海實蠅 ( Ceratitis capitata)、蛆症金蠅 ( Chrysomya bezziana)、螺旋金蠅 ( Chrysomya hominivorax)、腐敗金蠅 ( Chrysomya macellaria)、靜斑虻 ( Chrysops silacea)、大西洋斑虻 ( Chrysops atlanticus)、螺旋蠅 ( Cochliomyia hominivorax)、高粱癭蚊 ( Contarinia sorghicola)、嗜人瘤蠅蛆 ( Cordylobia anthropophaga)、狂怒庫蠓 ( Culicoides furens)、尖音庫蚊 ( Culex pipiens)、斑蚊 ( Culex nigripalpus)、致倦庫蚊 ( Culex quinquefasciatus)、媒斑蚊 ( Culex tarsalis)、無飾脈毛蚊 ( Culiseta inornata)、黑尾脈毛蚊 ( Culiseta melanura)、瓜蠅 ( Dacus cucurbitae)、油橄欖實蠅 ( Dacus oleae)、油菜葉癭蚊 ( Dasineura brassicae)、葱蠅 ( Delia antique)、麥地種蠅 ( Delia coarctata)、灰地種蠅 ( Delia platura)、甘藍地種蠅 ( Delia radicum)、人膚皮蠅 ( Dermatobia hominis)、小毛廁蠅 ( Fannia canicularis)、三點禾蠅 ( Geomyza Tripunctata)、馬蠅 ( Gasterophilus intestinalis)、刺舌蠅 ( Glossina morsitans)、須舌蠅 ( Glossina palpalis)、引舌蠅 ( Glossina fuscipes)、膠舌蠅 ( Glossina tachinoides)、擾血蠅 ( Haematobia irritans)、鞍癭癭蚊 ( Haplodiplosis equestris)、潜蠅屬 ( Hippelatesspp.)、花生田灰地種蠅 ( Hylemyia platura)、紋皮蠅 ( Hypoderma lineata)、急流細蠓 ( Leptoconops torrens)、美洲斑潜蠅 (Liriomyza sativae)、美國潜葉蠅 ( Liriomyza trifolii)、羊綠蠅 ( Lucilia caprina)、銅綠蠅 ( Lucilia cuprina)、絲光綠蠅 ( Lucilia sericata)、玉頸洛克蠅 ( Lycoria pectoralis)、曼蚊 ( Mansonia titillanus)、麥癭蚊 ( Mayetiola destructor)、秋家蠅 ( Musca autumnalis)、家蠅 ( Musca domestica)、廄腐蠅 ( Muscina stabulans)、羊狂蠅 ( Oestrus ovis)、禾蠅 ( Opomyza florum)、瑞典麥秆蠅 ( Oscinella frit)、天仙子泉蠅 ( Pegomya hysocyami)、葱蠅 ( Phorbia antiqua)、蘿蔔蠅 ( Phorbia brassicae)、麥地種蠅 ( Phorbia coarctata)、銀足白蛉 ( Phlebotomus argentipes)、哥倫比亞鱗蚊 ( Psorophora columbiae)、胡蘿蔔莖蠅 ( Psila rosae)、異色鱗蚊 ( Psorophora discolor)、混合墨蚊 ( Prosimulium mixtum)、櫻桃實蠅 ( Rhagoletis cerasi)、蘋果實蠅 ( Rhagoletis pomonella)、赤尾麻蠅 ( Sarcophaga haemorrhoidalis)、麻蠅屬 ( Sarcophagaspp.)、帶蚋 ( Simulium vittatum)、廄螫蠅 ( Stomoxys calcitrans)、牛虻 ( Tabanus bovinus)、北美黑虻 ( Tabanus atratus)、紅色原虻 ( Tabanus lineola)、二毛蟲 ( Tabanus similis)、沼澤大蚊 ( Tipula oleracea)以及歐洲大蚊 ( Tipula paludosa); The mixture of the present invention is particularly suitable for controlling insects, preferably sucking or piercing insects, such as insects selected from the species Thysanoptera , Diptera and Hemiptera ; and chewing Chewing-biting pests, such as insects selected from the genera Lepidoptera and Coleoptera , in particular the following species: Thysanoptera : Thrips nicotiana ( Frankliniella fusca ), western flower thrips ( Frankliniella occidentalis ), eastern flower thrips ( Frankliniella tritici ), orange hard thrips ( Scirtothrips citri ), rice thrips ( Thrips oryzae ), palm thrips ( Thrips palmi ), onion thrips Horse ( Thrips tabaci ); Diptera ( Diptera ) such as Aedes aegypti , Aedes albopictus , Aedes vexans , Mexican fruit fly ( Anastrepha ludens ), five-spotted Anopheles maculipennis , Anopheles crucians , Anopheles albimanus , Anopheles gambiae , Anopheles freeborni , Anopheles leucosphyrus , Anopheles minimus , Anopheles quadrimaculatus , Calliphora vicina , Ceratitis capitata , Chrysomya bezziana , Chrysomya hominivorax , Chrysomya macellaria , Chrysops silacea , Chrysops atlanticus , Cochliomyia hominivorax , Contarinia sorghicola , Cordylobia a nthropophaga ), Culicoides furens , Culex pipiens , Culex nigripalpus , Culex quinquefasciatus , Culex tarsalis , Veined Mosquito ( Culiseta inornata ), Culiseta melanura , melon fly ( Dacus cucurbitae ), olive fruit fly ( Dacus oleae ), rapeseed leaf gall midge ( Dasineura brassicae ), onion fly ( Delia antique ), wheat field fly ( Delia coarctata ), Delia platura , Delia radicum , Dermatobia hominis , Fannia canicularis , Geomyza tripunctata , horsefly ( Gasterophilus intestinalis ), Glossina morsitans , Glossina palpalis , Glossina fuscipes , Glossina tachinoides , Haematobia irritans , Saddle gall midge ( Haplodiplosis equestris ), Hippelates spp., Hylemyia platura , Hypoderma lineata , Leptoconops torrens , Liriomyza sativae , American Leafminer ( Liriomyza trifolii ), Lucilia caprina , Lucilia cuprin a, Lucilia sericata , Lycoria pectoralis , Mansonia titillanus , wheat gall Mosquito ( Mayetiola destructor ), autumn housefly ( Musca autumnalis ), housefly ( Musca domestica ), rot fly ( Musci na stabulans ), Oestrus ovis , Opomyza florum , Swedish straw fly ( Oscinella frit ), Pegomya hysocyami , onion fly ( Phorbia antiqua ) , turnip fly ( Phorbia brassicae ) , Phorbia coarctata , Phlebotomus argentipes , Psorophora columbiae , Psila rosae , Psorophora discolor , Prosimulium mixtum , Rhagoletis cerasi , Rhagoletis pomonella , Sarcophaga haemorrhoidalis , Sarcophaga spp., Simulium vittatum , Stomoxys calcitrans , Tabanus bovinus ), black fly ( Tabanus atratus ), red fly fly ( Tabanus lineola ), two caterpillars ( Tabanus similis ), swamp mosquito ( Tipula oleracea ) and European giant mosquito ( Tipula paludosa );

半翅目 (Hemiptera),特別是蚜蟲 (aphids):紅豆草蚜 ( Acyrthosiphon onobrychis)、落葉松球蚜 ( Adelges laricis)、甘藍蚜 ( Aphidula nasturtii)、甜菜蚜 ( Aphis fabae)、草莓根蚜 ( Aphis forbesi)、蘋果蚜 (Aphis pomi)、棉蚜 ( Aphis gossypii)、北美茶藨子蚜 ( Aphis grossulariae)、希奈德蚜 ( Aphis schneideri)、卷葉蚜 ( Aphis spiraecola)、接骨木蚜 ( Aphis sambuci)、豌豆蚜 ( Acyrthosiphon pisum)、茄無網蚜 ( Aulacorthum solani)、飛廉短尾蚜 ( Brachycaudus cardui)、李短尾蚜 ( Brachycaudus helichrysi)、桃短尾蚜 ( Brachycaudus persicae)、櫻桃短尾蚜 ( Brachycaudus prunicola)、甘藍蚜 ( Brevicoryne brassicae)、角釘毛蚜 ( Capitophorus horni)、棉花方翅網蝽 ( Cerosipha gossypii)、草莓中瘤釘毛蚜 ( Chaetosiphon fragaefolii)、茶藨子隱瘤蚜 ( Cryptomyzus ribis)、高加索冷杉椎球蚜 ( Dreyfusia nordmannianae)、雲杉椎球蚜 ( Dreyfusia piceae)、居根西圓尾蚜 ( Dysaphis radicola)、擬塘鵝蚜 ( Dysaulacorthum pseudosolani)、車前圓尾蚜 ( Dysaphis plantaginea)、梨西圓尾蚜 ( Dysaphis pyri)、蠶豆微葉蟬 ( Empoasca fabae)、李大尾蚜 ( Hyalopterus pruni)、茶藨苦菜超瘤蚜 ( Hyperomyzus lactucae)、麥長管蚜 ( Macrosiphum avenae)、大戟長管蚜 ( Macrosiphum euphorbiae)、薔薇管蚜 ( Macrosiphon rosae)、巢萊修尾蚜 ( Megoura viciae)、高粱蚜 ( Melanaphis pyrarius)、麥無網蚜 ( Metopolophium dirhodum)、桃蚜 ( Myzodes persicae)、冬葱蚜 ( Myzus ascalonicus)、李瘤蚜 ( Myzus cerasi)、黃藥子瘤蚜 ( Myzus varians)、黑茶藨子衲長管蚜 ( Nasonovia ribis-nigri)、褐飛蝨 ( Nilaparvata lugens)、囊柄癭綿蚜 ( Pemphigus bursarius)、蔗飛蝨 ( Perkinsiella saccharicida)、忽布疣蚜 ( Phorodon humuli)、蘋木蝨 ( Psylla mali)、梨木蝨 ( Psylla piri)、冬葱瘤蛾蚜 ( Rhopalomyzus ascalonicus)、玉米蚜 ( Rhopalosiphum maidis)、禾谷縊管蚜 ( Rhopalosiphum padi)、蘋草縊管蚜 ( Rhopalosiphum insertum)、梨砧草蚜 ( Sappaphis mala)、紅紮圓尾蚜 ( Sappaphis mali)、麥二叉蚜 ( Schizaphis graminum)、榆梨棉蚜 ( Schizoneura lanuginosa)、禾穀網蚜 ( Sitobion avenae)、白粉蝨 ( Trialeurodes vaporariorum)、桔二叉蚜 ( Toxoptera aurantii)以及葡萄根瘤蚜 ( Viteus vitifolii); Hemiptera, especially aphids: Acyrthosiphon onobrychis , Adelges laricis , Aphidula nasturtii , Aphis fabae , Aphis forbesi ), apple aphid (Aphis pomi), cotton aphid ( Aphis gossypii ), North American tea currant aphid ( Aphis grossulariae ), schneideri ( Aphis schneideri ), leaf roller aphid ( Aphis spiraecola ), elderberry aphid ( Aphis sambuci ) , pea aphid ( Acyrthosiphon pisum ), eggplant aphid ( Aulacorthum solani ), flying aphid ( Brachycaudus cardui ), plum aphid ( Brachycaudus helichrysi ), peach aphid ( Brachycaudus persicae ), cherry aphid ( Brachycaudus prunicola ), Brevicoryne brassicae , Capitophorus horni , Cerosipha gossypii , Chaetosiphon fragaefolii , Cryptomyzus ribis ), Dreyfusia nordmannianae , Dreyfusia piceae , Dysaphis radicola , Dysaulacorthum pseudosolani , Dysaphis plantaginea , Dysaphis pyri , Empoasca fabae , Hyalopterus pruni , Hyperomyzus lactucae , Macrosiphum avenae , Euphorbia Macrosiphum euphorbiae , Macrosiphon rosae , Megoura viciae , Melanaph is pyrarius ), Metopolophium dirhodum , Myzodes persicae , Myzus ascalonicus , Myzus cerasi , Myzus variants , black currant Nasonovia ribis-nigri , Nilaparvata lugens , Pemphigus bursarius , Perkinsiella saccharicida , Phorodon humuli , Psylla mali , Psylla piri , Rhopalomyzus ascalonicus , Rhopalosiphum maidis , Rhopalosiphum padi , Rhopalosiphum insertum , Sappaphis mala ), Sappaphis mali , Schizaphis graminum , Schizoneura lanuginosa , Sitobion avenae , Trialeurodes vaporariorum , and Schizaphis graminum ( Toxoptera aurantii ) and grape phylloxera ( Viteus vitifolii );

鱗翅目 (Lepidoptera),特別是:小地老虎 ( Agrotis ypsilon)、黃地老虎 ( Agrotis segetum)、棉葉波紋夜蛾 ( Alabama argillacea)、黎豆夜蛾 ( Anticarsia gemmatalis)、蘋果銀蛾 ( Argyresthia conjugella)、丫紋夜蛾 ( Autographa gamma)、松尺蠖 ( Bupalus piniarius)、樅卷葉蛾 ( Cacoecia murinana)、煙捲葉蛾 ( Capua reticulana)、冬尺蛾 ( Cheimatobia brumata)、雲杉卷葉蛾 ( Choristoneura fumiferana)、雲杉芽卷蛾 (Choristoneura occidentalis)、一星粘蟲 ( Cirphis unipuncta)、蘋果小卷蛾 ( Cydia pomonella)、松毛蟲 ( Dendrolimus pini)、黃瓜絹野螟 ( Diaphania nitidalis)、西南玉米杆草螟 ( Diatraea grandiosella)、埃及鑽夜蛾 ( Earias insulana)、南美玉米苗斑螟 ( Elasmopalpus lignosellus)、葡萄與蘋果捲葉蛾 ( Eupoecilia ambiguella)、歐洲松梢小卷蛾 ( Evetria bouliana)、粒膚地虎 ( Feltia subterranean);蠟螟 ( Galleria mellonella)、李小食心蟲 ( Grapholitha funebrana)、梨小食心蟲 ( Grapholitha molesta)、棉鈴蟲 ( Heliothis armigera)、菸芽夜蛾 ( Heliothis virescens)、美洲棉鈴蟲 (Heliothis zea);菜心野螟 ( Hellula undalis)、灰裙希伯利亞蛾 ( Hibernia defoliaria)、美國白蛾 (Hyphantria cunea)、蘋果巢蛾 ( Hyponomeuta malinellus)、番茄蟲蛾 ( Keiferia lycopersicella)、鐵杉尺蠖蛾 ( Lambdina fiscellaria)、甜菜夜蛾 ( Laphygma exigua)、咖啡點潜葉蛾 ( Leucoptera coffeella)、旋紋潜蛾 ( Leucoptera scitella)、蘋果斑幕潜葉蛾 ( Lithocolletis blancardella)、葡萄漿果小卷蛾 ( Lobesia botrana)、甜菜網螟 ( Loxostege sticticalis)、舞毒蛾 ( Lymantria dispar)、模毒蛾 ( Lymantria monacha);窄翅潛葉蛾 ( Lyonetia clerkella)、黃褐天幕毛蟲 ( Malacosoma neustria)、甘藍夜蛾 ( Mamestra brassicae)、黃杉合毒蛾 ( Orgyia pseudotsugata)、歐洲玉米螟 ( Ostrinia nubilalis)、冬夜蛾 ( Panolis flammea)、棉花紅鈴蟲 ( Pectinophora gossypiella);疆夜蛾 ( Peridroma saucia)、圓掌舟蛾 ( Phalera bucephala)、馬鈴薯塊莖蛾 (Phthorimaea operculella);橘細潛蛾 ( Phyllocnistis citrella)、歐洲粉蝶 ( Pieris brassicae)、苜蓿綠夜蛾 ( Plathypena scabra)、菜蛾 ( Plutella maculipennis)、小菜蛾 ( Plutella xylostella)、大豆夜蛾 ( Pseudoplusia includens)、美松梢小卷蛾 ( Rhyacionia frustrana)、馬鈐薯潛葉蟲 ( Scrobipalpula absoluta)、麥蛾 ( Sitotroga cerealella)、葡萄卷葉蛾 ( Sparganothis pilleriana)、草地夜蛾 ( Spodoptera frugiperda)、海灰翅夜蛾 ( Spodoptera littoralis)、斜紋夜蛾 ( Spodoptera litura);松異周蛾 ( Thaumatopoea pityocampa)、櫟綠卷蛾 ( Tortrix viridana)、粉紋夜蛾 ( Trichoplusia ni)以及雲杉小卷葉蛾 ( Zeiraphera canadensis)。 From the order of the Lepidoptera, especially: Agrotis ypsilon , yellow cutworm ( Agrotis segetum ), cottonleaf moth ( Alabama argillacea ), anticarsia gemmatalis , apple silver moth ( Argyrestia conjugella ), Pine looper ( Bupalus piniarius ), Fir leaf tortrix ( Cacoecia murinana ), Tobacco leaf tortrix ( Capua reticulana ), Chimatobia brumata , Spruce leaf tortrix ( Choristoneura fumiferana ), Choristoneura occidentalis, Cirphis unipuncta , Cydia pomonella , Dendrolimus pini , Diaphania nitidalis , Southwestern corn stalk moth Diatraea grandiosella , Earias insulana , Elasmopalpus lignosellus , Eupoecilia ambiguella , Evetria bouliana , and the cutworm ( Feltia subterranean ); Galleria mellonella , Grapholitha funebrana , Grapholitha molesta , Heliothis armigera , Heliothis virescens , Heliothis zea Cabbage borer ( Hellula undalis ), gray skirt Heberia moth ( Hibernia defoliaria ), American white moth (Hyphantria cunea ), apple nest moth ( Hyponomeuta malellus ), tomato moth ( Keiferia lycopersicella ), hemlock looper moth ( Lambdina fiscellaria ), beet armyworm ( Laphygma exigua ), coffee Leucoptera coffeeella , Leucoptera scitella , Lithocolletis blancardella , Lobesia botrana , Loxostege sticticalis , Gypsy moth ( Lymantria dispar ), mold moth ( Lymantria monacha ); narrow-winged leaf miner ( Lyonetia clerkella ), yellow-brown canopy caterpillar ( Malacosoma neustria ), cabbage moth ( Mamestra brassicae ), Douglas moth ( Orgyia pseudotsugata ), European corn moth Borer ( Ostrinia nubilalis ), Winter Spodoptera ( Panolis flammea ), Cotton Pink Bollworm ( Pectinophora gossypiella ); Spodoptera ( Peridroma saucia ), Phalera bucephala , Potato Tuber Moth (Phthorimaea operculella ); Phyllocnistis citrella , Pieris brassicae , Plathypena scabra , Diamondback moth ( Plutella maculipennis ), Diamondback moth ( Plutella xylostella ), Soy bean moth ( Pseudoplusia includens ), American pine moth Rhyacionia frustrana , Scrobipalpula absoluta , Sitotroga cerealella , Sparganothis pilleriana , Spodoptera frugiperda , Spodoptera littoralis , Spodoptera litura ; Thaumatopoea pityocampa , Tortrix viridana , Trichoplusia ni , and Zeiraphera canadensis .

在一實施例中,本案之混合物特別可用於控制鞘翅目 (Coleoptera)的昆蟲,特別是梨窄吉丁 ( Agrilus sinuatus)、條叩頭蟲 ( Agriotes lineatus)、暗色叩頭蟲 ( Agriotes obscurus)、馬鈴薯鰓金龜 ( Amphimallus solstitialis)、異形方胸材小蠹 ( Anisandrus dispar)、棉鈴象甲 ( Anthonomus grandis)、蘋花象 ( Anthonomus pomorum)、優繭蜂側刺葉蚤 ( Aphthona euphoridae)、紅尾叩頭蟲 ( Athous haemorrhoidalis)、甜菜隱食甲 ( Atomaria linearis)、粗紋小蜂 ( Blitophaga undata)、蠶豆象 ( Bruchus rufimanus)、豌豆象 ( Bruchus pisorum)、歐洲兵豆象 ( Bruchus lentis)、蘋卷象 ( Byctiscus betulae)、甜菜大龜甲 ( Cassida nebulosa)、豆葉甲 ( Cerotoma trifurcata)、金花金龜 ( Cetonia aurata)、白菜籽龜 象 ( Ceuthorrhynchus assimilis)、芫菁龜象 ( Ceuthorrhynchus napi);甜菜脛跳甲 ( Chaetocnema tibialis)、煙草金針蟲 ( Conoderus vespertinus)、石刁柏負 泥蟲 ( Crioceris asparagi)、叩甲屬 ( Cteniceraspp.),長角葉甲 ( Diabrotica longicornis)、黃瓜半星葉甲 ( Diabrotica semipunctata)、黃瓜十二星葉甲 ( Diabrotica12 -punctata)、南美葉甲 ( Diabrotica speciosa)、玉米根螢葉甲 ( Diabrotica virgifera)、墨西哥豆瓢蟲 ( Epilachna varivestis)、煙草跳甲 ( Epitrix hirtipennis);棉灰蒙象變種 ( Eutinobothrus brasiliensis)、歐洲松樹皮象 ( Hylobius abietis)、埃及苜蓿葉象 ( Hypera brunneipennis)、紫苜蓿葉象 ( Hypera postica)、雲杉八齒小蠹 ( Ips typographus)、煙草負泥蟲 ( Lema bilineata)、黑角負泥蟲 ( Lema melanopus)、馬鈴薯葉甲 ( Leptinotarsa decemlineata)、甜菜叩甲 ( Limonius californicus)、稻水象甲 ( Lissorhoptrus oryzophilus)、玉米叩甲蟲 (Melanotus communis)、油菜露尾甲 ( Meligethes aeneus)、大栗鰓金龜 ( Melolontha hippocastani)、五月鰓金龜 ( Melolontha melolontha)、水稻負泥蟲 ( Oulema oryzae)、黑葡萄耳象 ( Otiorrhynchus sulcatus)、草莓根象甲 ( Otiorrhynchus ovatus)、辣根猿葉甲 ( Phaedon cochleariae)、梨樹葉象 ( Phyllobius pyri)、油菜藍跳甲 ( Phyllotreta chrysocephala)、食葉鰓金龜屬 ( Phyllophagaspp.)、庭園發麗金龜 ( Phyllopertha horticola)、大豆淡足跳甲 ( Phyllotreta nemorum)、黃曲條菜跳甲 ( Phyllotreta striolata)、日本大蠊 ( Popillia japonica)、豌豆葉象 ( Sitona lineatus)以及穀象 ( Sitophilus granaria)。 In one embodiment, the mixture of the present invention is particularly useful for controlling insects of the order Coleoptera, especially Agrilus sinuatus , Agriotes lineatus , Agriotes obscurus , potato gills Scarlet tortoise ( Amphimallus solstitialis ), square chest beetle ( Anisandrus dispar ), cotton boll weevil ( Anthonomus grandis ), apple blossom weevil ( Anthonomus pomorum ), Aphthona euphoridae , red-tailed click beetle ( Athous haemorrhoidalis ), Atomaria linearis , Blitophaga undata , Bruchus rufimanus , Bruchus pisorum , Bruchus lentis , Byctiscus betulae ), beet beetle ( Cassida nebulosa ), bean leaf beetle ( Cerotoma trifurcata ), golden beetle beetle ( Cetonia aurata ), cabbage seed tortoise ( Ceuthorrhynchus assimilis ), beet tortoise ( Ceuthorrhynchus napi ); sugar beet flea beetle ( Chaetocnema tibialis ), Conoderus vespertinus , Crioceris asparagi , Ctenicera spp., Diabrotica longicornis , Diabrotica semipunctata , cucumber twelve-star beetle ( Diabrotica 12 -punctata ), South American leaf beetle ( Diabrotica speciosa ), corn root firefly beetle ( Diabrotica virgifera ), Mexican bean lady beetle ( Epilachna varivestis ), tobacco flea beetle ( Epitrix hirtipennis ); Eutinobothrus brasiliensis , European pine bark elephant ( Hylobius abietis ), Egyptian clover leaf elephant ( Hypera br unneipennis ), alfalfa leaf weevil ( Hypera postica ), spruce beetle ( Ips typographus ), tobacco mud worm ( Lema bilineata ), black horned mud worm ( Lema melanopus ), potato leaf beetle ( Leptinotarsa decemlineata ), Beet Weevil ( Limonius californicus ), Rice Water Weevil ( Lissorhoptrus oryzophilus ), Corn Weevil ( Melanotus communis ), Rapeseed Beetle ( Meligethes aeneus ), Chestnut Beetle ( Melolontha hippocastani ), May Beetle ( Melolontha melolontha ) , Rice Negative Mud Worm ( Oulema oryzae ), Black Grape Ear Weevil ( Otiorrhynchus sulcatus ), Strawberry Root Weevil ( Otiorrhynchus ovatus ), Horseradish Root Weevil ( Phaedon cochleariae ), Pear Leaf Weevil ( Phyllobius pyri ), Rapeseed Blue Flea Beetle ( Phyllotreta chrysocephala ), leaf-eating beetle ( Phyllophaga spp. ), garden beetle ( Phyllopertha horticola ), soybean beetle ( Phyllotreta nemorum ), yellow beetle beetle ( Phyllotreta striolata ), Japanese cockroach ( Popillia japonica ), pea leaf elephant ( Sitona lineatus ) and grain elephant ( Sitophilus granaria ).

本案的農業化學組成物特別可用於控制蟎目 ( Acarina)、鞘翅目 ( Coleoptera)、雙翅目 ( Diptera)、膜翅目 ( Hymenoptera)、等翅目 ( Isoptera)、鱗翅目 ( Lepidoptera)、半翅目 ( Hemiptera)、直翅目 ( Orthoptera)和纓翅目 ( Thysanoptera)之昆蟲/蟎類。 The agricultural chemical composition of the present case is particularly useful for controlling mites ( Acarina ), Coleoptera ( Coleoptera ), Diptera ( Diptera ), Hymenoptera ( Hymenoptera ), Isoptera ( Isoptera ), Lepidoptera ( Lepidoptera ), Insects/Acarids of the orders Hemiptera , Orthoptera and Thysanoptera .

在另一實施例中,本案之農業化學組成物尤其適於有效對抗害蟲,例如鱗翅目昆蟲(鱗翅目 ( Lepidoptera))、甲蟲(鞘翅目 ( Coleoptera))、蠅和蚊(雙翅目 ( Dipteran))、薊馬(纓翅目 ( Thysanoptera))、白蟻(等翅目 ( Isoptera))、臭蟲、蚜蟲、葉蟬、粉蝨、蚧殼蟲、蟬(半翅目 ( Hemiptera))、螞蟻、蜜蜂、黃蜂、鋸蠅(膜翅目 ( Hymenoptera))、蟋蟀、蚱蜢、蝗蟲(直翅目 ( Orthoptera))以及蜘蛛亞綱 ( Arachnoidea),如蛛形綱(蜱蟎目 ( Acarina))的昆蟲。 In another embodiment, the agricultural chemical composition of the present invention is especially suitable for effective against pests, such as Lepidoptera insects ( Lepidoptera ), beetles ( Coleoptera ), flies and mosquitoes ( Dipteran )), thrips ( Thysanoptera ), termites ( Isoptera ), bedbugs, aphids, leafhoppers, whiteflies, scale insects, cicadas ( Hemiptera ), ants, Bees, wasps, sawflies ( Hymenoptera ), crickets, grasshoppers, locusts ( Orthoptera ), and insects of the subclass Arachnoidea, such as arachnids (Acarina ) .

本文中所使用的用語「混合物」包含組成物。The term "mixture" as used herein includes compositions.

在一個實施例中,本案還提供了控制昆蟲、蟎、線蟲或植物病原性真菌的方法,所述方法包括使昆蟲、蟎、線蟲或植物病原性真菌,或是將其食物供應、棲息地、繁殖地或它們的存在場所與殺蟲有效劑量的本案混合物接觸。In one embodiment, the present application also provides a method of controlling insects, mites, nematodes or phytopathogenic fungi, said method comprising causing the insects, mites, nematodes or phytopathogenic fungi, or displacing their food supply, habitat, Breeding colonies or their habitats are exposed to insecticidally effective doses of the mixture.

此外,本案亦關於一種保護植物免受昆蟲、蟎類、線蟲或植物病原性真菌侵襲或感染的方法,其包括將植物或植物生長的土壤或水與殺蟲有效劑量的本案混合物接觸。In addition, the present application also relates to a method for protecting plants from attack or infection by insects, acarids, nematodes or phytopathogenic fungi, which comprises contacting the plant or the soil or water where the plant grows with an insecticidally effective dose of the present mixture.

本案還提供了一種保護植物繁殖材料(較佳為種子)免於受土壤昆蟲、以及保護幼苗、根和芽免於受土壤和葉面昆蟲或真菌侵害的方法,該方法包括將植物繁殖材料,例如種子,在播種前及/或預發芽後,與殺蟲有效劑量的本案之混合物接觸。This case also provides a method of protecting plant propagation material (preferably seeds) from soil insects, and protecting seedlings, roots and shoots from soil and foliage insects or fungi, the method comprising plant propagation material, Seeds, for example, are contacted with an insecticidally effective dose of the mixture of the present invention before sowing and/or after pregermination.

本案還提供包含本案混合物的種子。The present invention also provides seeds comprising the present mixture.

本案還提供了殺蟲組合物,其包含液體或固體載體以及本案的殺蟲活性混合物。The present invention also provides an insecticidal composition comprising a liquid or solid carrier and the insecticidally active mixture of the present invention.

本案還涉及殺蟲組合物用於防治昆蟲、蟎類、線蟲或植物病原性真菌的用途。The case also relates to the use of a pesticidal composition for controlling insects, mites, nematodes or phytopathogenic fungi.

可根據本發明進行處理的植物包括:薔薇科 ( Rosaceae sp)(例如梨果類,例如蘋果、梨子、杏桃、櫻桃、杏仁及桃子)、虎耳草科 ( Ribesioidae sp.)、胡桃科 ( Juglandaceae sp.)、樺科 ( Betulaceae sp.)、漆樹科 ( Anacardiaceae sp.)、山毛櫸科 ( Fagaceae sp.)、桑科 ( Moraceae sp.)、木犀科 ( Oleaceae sp.)、獼猴桃科 ( Actinidaceae sp.)、樟科 ( Lauraceae sp.)、芭蕉科 ( Musaceae sp.)(例如香蕉樹及香蕉園)、茜草科 ( Rubiaceae sp.)(例如咖啡)、茶科 (Theaceae sp.)、梧桐科 ( Sterculiceae sp.)、芸香科 ( Rutaceae sp.)(例如檸檬、柳橙及葡萄柚);葡萄科 ( Vitaceae sp.)(例如葡萄);茄科 ( Solanaceae sp.)(例如蕃茄、胡椒)、百合科 ( Liliaceae sp.)、菊科 (Asteraceae sp.)(例如萵苣)、傘形科 ( Umbelliferae sp.)、十字花科 ( Cruciferae sp.)、藜科 ( Chenopodiaceae sp.)、葫蘆科 ( Cucurbitaceae sp.)(例如小黃瓜)、大蒜科 ( Alliaceae sp.)(例如韭菜、洋蔥)、蝶形花科 (Papilionaceae sp.)(例如豌豆);主要作物,諸如禾本科 ( Poaceae/Gramineae sp.)(例如玉米、草坪、穀物(例如小麥、裸麥、稻米、大麥、燕麥及黑小麥))、菊科 ( Asteraceae sp.)(例如向日葵)、十字花科 ( Brassicaceae sp.)(例如白捲心菜、紅捲心菜、青花菜 ( broccoli)、花椰菜 ( cauliflower)、抱子甘藍、小白菜、球莖甘藍、蘿蔔及油菜、芥末、辣根 ( horseradish) 及水芹)、豆科 ( Fabacae sp.)(例如豆子、花生)、蝶形花科 ( Papilinoaceae sp.) (例如大豆)、茄科 (Solanaceae sp.)(例如馬鈴薯)、藜科 ( Chenopodiaceae sp.)(例如糖用甜菜、飼料甜菜、瑞士甜菜、甜菜根);錦葵科 ( Malvaceae)(例如棉花);用於花園及林區的有用植物及觀賞植物;以及每種植物的基因改良品種。 Plants which may be treated according to the invention include: Rosaceae sp . (e.g. pomaceae such as apples, pears, apricots, cherries, almonds and peaches), Saxifrageaceae ( Ribesioidae sp. ), Juglandaceae ( Juglandaceae sp. ), Betuaceae ( Betulaceae sp. ), Anacardiaceae sp. , Fagaceae sp. , Moraceae sp. , Oleaceae sp. , Actinidaceae sp . . ), Lauraceae sp. ), Musaceae sp . Sterculiceae sp. ), Rutaceae sp. (such as lemon, orange, and grapefruit); Vitaceae sp. (such as grapes); Solanaceae sp. (such as tomato, pepper), Lily Liliaceae sp ., Asteraceae sp . (e.g. lettuce), Umbelliferae sp ., Cruciferae sp ., Chenopodiaceae sp ., Cucurbitaceae sp . .) (e.g. gherkins), Alliaceae sp . (e.g. leeks, onions), Papilionaceae sp. (e.g. peas); major crops such as Poaceae/Gramineae sp .) ( eg corn, turf, cereals (eg wheat, rye, rice, barley, oats and triticale), Asteraceae sp . (eg sunflower), Brassicaceae sp . (eg white cabbage, red Cabbage, broccoli, cauliflower , Brussels sprouts, bok choy, kohlrabi, radishes and rapeseed, mustard, horseradish and cress), legumes (Fabacae sp . ) (such as beans, peanut), Papilinoaceae sp . (e.g. soybean), Solanaceae sp. (e.g. potato), Chenopodiaceae sp . (e.g. sugar beet, fodder beet, swede sugar beet, beetroot); the Malvaceae family (such as cotton); useful and ornamental plants for gardens and woodlands; and genetically improved varieties of each.

在一較佳實施例中,可使用本案的農業化學組成物來控制的作物疾病包含:葡萄藤霜黴病(葡萄生單軸黴 ( Plasmopara viticola))、馬鈴薯及蕃茄晚疫病(致病疫黴 ( Phytophthora infestans))、榴蓮/柑橘莖腐病(棕櫚疫黴菌 ( Phytophthora palmivora))、煙草黑柄病(菸草疫黴菌 ( Phytophthora nicotianae))、辣椒脚腐病(辣椒疫黴菌 ( Phytophthora capsici))、葫蘆霜黴病(古巴假霜霉菌 ( Pseudoperonospora cubensis))、啤酒花霜黴病(葎草假霜黴 ( Pseudoperonospora humuli))、洋葱/韭菜/香菜(大蔥霜黴菌 ( peronospora destructor))、白菜霜黴病(寄生霜黴菌 ( Peronospora parasitica))、罌粟霜黴病(樹狀霜黴 ( Peronospora arborescens))、生菜霜黴病(萵苣露菌病 ( bremia lactucae))。 In a preferred embodiment, the crop diseases that can be controlled using the agricultural chemical composition of the present invention include: grapevine downy mildew ( Plasmopara viticola ), potato and tomato late blight (Phytophthora infestans ( Phytophthora infestans ), durian/citrus stem rot ( Phytophthora palmivora ), tobacco black stalk ( Phytophthora nicotianae ), pepper foot rot ( Phytophthora capsici ), Cucurbit downy mildew ( Pseudoperonospora cubensis ), Hop downy mildew ( Pseudoperonospora humuli ), Onion/Leek/cilantro ( Peronospora destructor ), Cabbage downy mildew ( Peronospora parasitica ), poppy downy mildew ( Peronospora arborescens ), lettuce downy mildew ( bremia lactucae ).

可根據本發明處理之植物包括下列主要作物植物:玉米、大豆、苜蓿、棉花、葵花、蕓苔科油菜籽,如:甘藍型油菜 ( Brassica napus)(例如:蕓苔、芥菜)、小松菜 ( Brassica rapa)、葉用芥菜 ( B.juncea)(例如:芥菜)與埃塞俄比亞芥 ( Brassica carinata)、棕櫚 ( Arecaceaesp.)(例如:油棕櫚、椰子)、稻、小麥、甜菜、甘蔗、燕麥、裸麥、大麥、小米與高粱、硬粒小麥、亞麻、堅果、葡萄與籐蔓,及植物分類上之各種水果與蔬菜,如:薔薇科 ( Rosaceae) 屬類(例如:梨果類,如:蘋果與梨,但亦包括核果類,如:杏桃、櫻桃、杏仁、李與桃,及莓果類,如:草莓、覆盆子、紅醋栗與黑醋栗及醋栗)、茶薦子科 ( Ribesioidae)屬類、胡桃科 ( Juglandaceae)屬類、樺木科 ( Betulaceae)屬類、漆樹科 ( Anacardiaceae)屬類、殼斗科 ( Fagaceae)屬類、桑科 ( Moraceae)屬類、木犀科 (Oleaceae)屬類(例如:橄欖樹)、獼猴桃科 ( Actinidaceae)屬類、樟科 ( Lauraceae)屬類(例如:鱷梨、肉桂、樟腦)、芭蕉科 ( Musaceae)屬類(例如:香蕉樹與香蕉園)、茜草科 ( Rubiaceae)屬類(例如:咖啡)、山茶科 ( Theaceae)屬類(例如:茶)、梧桐科 ( Sterculiceae)屬類、芸香科 ( Rutaceae)屬類(例如:檸檬、柳橙、橘子、與葡萄柚);茄科 ( Solanaceae)屬類(例如:番茄、馬鈴薯、青椒、辣椒、茄子、菸草)、百合科 ( Liliaceae)屬類、菊科 ( Compositiae)屬類(例如:萵苣、朝鮮薊與菊苣-包括根用菊苣、菊萵苣或野苦苣)、繖形科 ( Umbelliferae)屬類(例如:胡蘿蔔、荷蘭芹、芹菜與肥根芹菜)、葫蘆科 ( Cucurbitaceae)屬類(例如:胡瓜-包括小黃瓜、南瓜、西瓜、葫蘆與香瓜)、蔥科 ( Alliaceae)屬類(例如:韮菜與洋葱)、十字花科 ( Cruciferae)屬類(例如:白色捲心菜、紅色捲心菜、綠花椰菜、白花椰菜、球芽甘藍、小白菜、大頭菜、蘿蔔、山葵、獨行菜與大白菜)、豆科 ( Leguminosae)屬類(例如:花生、豌豆、扁豆與豆類,如:爬藤豆類與蠶豆)、藜科 ( Chenopodiaceae)屬類(例如:瑞士甜菜、飼料用甜菜、菠菜、甜菜根);亞麻科 ( Linaceae)屬類(例如:麻)、大麻科 ( Cannabeacea)屬類(例如:大麻)、錦葵科 ( Malvaceae)屬類(例如:秋葵、可可)、罌粟科 ( Papaveraceae)屬類(例如:罌粟)、天門冬科 ( Asparagaceae)(例如:蘆筍);花園之有用植物與觀賞植物與木料,包括草坪、草地、牧草與甜菊 ( Stevia rebaudiana);及此等植物之各基因改造態。 Plants that can be treated according to the invention include the following major crop plants: corn, soybean, alfalfa, cotton, sunflower, Brassica rapeseed, such as: Brassica napus (for example: brassica, mustard), komatsuna ( Brassica rapa ), leafy mustard ( B. juncea ) (eg mustard) and Ethiopian mustard ( Brassica carinata ), palm ( Arecaceae sp.) (eg oil palm, coconut), rice, wheat, sugar beet, sugar cane, oats, naked Wheat, barley, millet and sorghum, durum wheat, flax, nuts, grapes and vines, and various fruits and vegetables in plant classification, such as: Rosaceae ( Rosaceae ) genus (for example: pome fruit, such as: apple and Pears, but also stone fruits, such as apricots, cherries, almonds, plums and peaches, and berries, such as strawberries, raspberries, red and black currants and currants), the Ribesioidae genus, Juglandaceae genus, Betulaceae genus, Anacardiaceae genus, Fagaceae genus, Moraceae genus, Oleaceae ) genera (eg: olive tree), Actinidaceae ( Actinidaceae ) genera, Lauraceae (eg: avocado, cinnamon, camphor), Musaceae (eg: banana tree and banana Garden), Rubiaceae ( Rubiaceae ) genera (eg coffee), Theaceae ( Theaceae ) genera (eg: tea), Wutong family ( Sterculiceae ) genera, Rutaceae ( Rutaceae ) genera (eg: lemon, willow oranges, tangerines, and grapefruit); Solanaceae genera (for example: tomato, potato, green pepper, capsicum, eggplant, tobacco), Liliaceae ( Liliaceae ) genera, Compositae (for example: Lettuce, Artichoke, and Endive - including endive, endive, or endive), Umbelliferae genera (such as carrots, parsley, celery, and celery), Cucurbitaceae genera (example: courgettes - including gherkins, pumpkins, watermelons, gourds, and cantaloupes), Alliaceae (ex: leeks and onions), Cruciferae (ex: white cabbage, red cabbage, Broccoli, white cauliflower, Brussels sprouts, bok choy, kohlrabi, radish, horseradish, kale, and Chinese cabbage), Leguminosae (such as peanuts, peas, lentils, and beans, Such as: climbing vine beans and broad beans), Chenopodiaceae genera (such as: Swiss chard, fodder beet, spinach, beetroot); Linaceae ( Linaceae ) genera (such as: hemp), Cannabeaceae ( Cannabeacea ) Genus (e.g. Cannabis ), Malvaceae (e.g. Okra, Cocoa), Papaveraceae (e.g. Poppy), Asparagaceae (e.g. Asparagus); Useful and ornamental plants and timber for gardens, including lawns, grasses, pastures and stevia ( Stevia rebaudiana ); and genetically modified forms of these plants.

特別地,本案之農業化學組成物適於控制以下植物疾病:In particular, the agricultural chemical composition of the present case is suitable for controlling the following plant diseases:

白鏽菌屬 ( Albugospp.)(白銹病),在觀賞性植物、蔬菜(例如白鏽菌 ( A. candida))及向日葵(例如婆羅門參白鏽 ( A. tragopogonis))上;鏈格孢屬 ( Alternariaspp.)(黑斑病),在蔬菜、油菜(芸苔鏈格孢 ( A. brassicola/brassicae))、糖用甜菜(細鏈格孢 ( A. tenuis))、水果、稻穀、大豆、馬鈴薯(例如索蘭尼鏈格孢 ( A. solani)或交錯鏈格孢 ( A. alternata))、蕃茄(例如索蘭尼鏈格孢或交錯鏈格孢)及小麥上;絲囊黴屬 ( Aphanomycesspp.),在糖用甜菜及蔬菜上;穀類及蔬菜上之殼二孢屬 ( Ascochytaspp.),例如小麥上之小麥殼二孢菌 ( A. tritici)(炭疽病)及大麥上之大麥殼二孢菌 ( A. hordei);雙極黴屬 ( Bipolarisspp.) 及德氏黴屬 ( Drechsleraspp.)(有性型:旋孢腔菌屬 ( Cochliobolusspp.)),在玉米(例如玉米德氏黴菌 ( D. maydis))、穀類(例如小麥根腐病菌 ( B. sorokiniana):斑枯)、稻穀(例如稻平臍蠕孢菌 ( B. oryzae))及草皮上;穀類上(例如在小麥或大麥上)之布氏白粉菌 ( Blumeria graminis)(先前稱作白粉菌屬 ( Erysiphe))(白粉病);灰葡萄孢菌 ( Botrytis cinerea)(有性型:富氏葡萄孢菌 ( Botryotinia fuckeliana):灰黴病),在水果及漿果(例如草莓)、蔬菜(例如萵苣、胡蘿蔔、旱芹及甘藍)、油菜、花、藤本植物、林業植物及小麥上;萵苣上之萵苣盤梗黴 ( Bremia lactucae)(霜黴病);長喙殼屬 ( Ceratocystisspp.)(同義詞 Ophiostoma)(腐爛或枯萎),在闊葉樹及常綠樹上,例如榆樹上之榆梢枯長喙黴 ( C. ulmi)(荷蘭榆樹病 ( Dutch elm disease));尾孢屬 ( Cercosporaspp.)(尾孢菌葉斑病),在玉米、稻穀、糖用甜菜(例如甜菜尾孢菌 ( C. beticola))、甘蔗、蔬菜、咖啡、大豆(例如大豆灰斑病菌 ( C. sojina)或大豆紫斑病菌 ( C. kikuchii))及稻穀上;分枝孢子菌屬 ( Cladosporiumspp.),在蕃茄(例如黃枝孢黴 ( C. fulvum):葉黴病)及穀類上,例如小麥上之草本枝孢黴 ( C. herbarum)(黑穗病);穀類上之麥角菌 ( Claviceps purpurea)(麥角症);旋孢腔菌屬(無性型:雙極黴屬之長蠕孢黴 ( Helmin thosporium))(葉斑病),在玉米(玉米圓斑病菌 ( C. carbonum))、穀類(例如禾旋孢腔菌 ( C. sativus),無性型:小麥根腐病菌)及稻穀(例如水稻旋孢腔菌( C. miyabeanus),無性型:水稻長蠕孢屬 ( H. oryzae))上;毛盤孢屬 ( Colletotrichumspp.)(有性型:小叢殼屬 ( Glomerella))(炭疽病),在棉花(例如棉花炭疽病菌 ( C.gossypii))、玉米(例如禾炭疽病菌 ( C. graminicola))、軟果、馬鈴薯(例如辣椒炭疽病菌 ( C. coccodes):黑斑病)、豆類(例如菜豆炭疽病菌 ( C. lindemuthianum))及大豆(例如毛豆炭疽病菌 ( C. truncatum) 或膠孢炭疽病菌 ( C. gloeosporioides))上;伏革菌屬 ( Corticiumspp.),例如稻穀上之稻紋枯病菌 ( C. sasakii)(紋枯病);大豆及觀賞性植物上之多主棒孢菌 ( Corynespora cassiicola)(葉斑病);孔雀斑菌屬 ( Cycloconiumspp.),例如橄欖樹上之油橄欖孔雀斑病 ( C. oleaginum);柱孢屬 ( Cylindrocarponspp.)(例如果樹癌腫病或幼藤衰敗病,有性型:叢赤殼屬( NeotriaNeonectriaspp.)),在果樹、藤本植物(例如鵝掌楸柱孢菌 ( C. liriodendri),有性型:鵝掌楸叢赤殼菌 ( Neonectria liriodendri):烏腳病)及觀賞性植物上;大豆上之白羽紋病 ( Dematophora necatrix)(有性型:白羽紋病 ( Rosellinia))(根莖腐爛);間座殼屬 ( Diaporthespp.),例如大豆上之大豆北方莖潰瘍病菌 ( D. phaseolorum)(猝倒病);德氏黴屬(同義詞:長蠕孢屬,有性型:核腔菌屬 ( Pyrenophora)),在玉米、穀類(例如大麥(例如大麥網斑內臍蠕孢菌 ( D. teres),網斑病)及小麥(例如小麥黃斑葉枯病 ( D. tritici-repentis):褐斑病)、稻穀)及草皮上;藤本植物上之埃斯卡菌 (Esca)(頂梢枯死、中風),由斑褐孔菌 ( Formitiporia punctata)(同義詞:木層孔菌屬 ( Phellinus))、地中海孔菌 ( F. mediterranea)、垣孢伐莫尼亞菌 ( Phaeomoniella chlamydospora)(曾用名 Phaeoacremonium chlamydosporum)、寄生瓶黴菌 ( Phaeoacremonium aleophilum)及/或葡萄座腔菌 ( Botryosphaeria obtusa) 引發;囊腔菌屬 ( Elsinoespp.),在梨果(梨囊腔菌 ( E. pyn))、軟果(樹莓炭疽病菌 ( E. veneta):炭疽病)及藤本植物(葡萄黑痘病 ( E. ampelina):炭疽病)上;稻穀上之稻葉黑粉菌 ( Entyloma oryzae)(葉黑粉病);小麥上之附球菌屬 ( Epicoccumspp.)(黑黴);白粉菌屬 ( Erysiphespp.)(白粉菌),在糖用甜菜(甜菜白粉病 ( E. betae))、蔬菜(例如豌豆白粉病 ( E. pist))上,例如葫蘆(例如瓜類白粉病 ( E. cichoracearum))、甘藍、油菜(例如油菜白粉病 ( E. cruciferarum));葡萄頂枯病 ( Eutypa lata)(葡萄癌腫或頂枯,無性型: Cytosporina lata,同義詞:百簕花盤針孢菌 ( Libertella blepharis)),在果樹、藤本植物及觀賞性喬木上;明臍菌屬 ( Exserohilumspp.)(同義詞:長蠕孢屬),在玉米上(例如玉米大斑病菌 ( E. turcicum));各種植物上之鐮刀菌屬 ( Fusariumspp.)(有性型:赤黴菌 ( Gibberella))(枯萎、根或莖腐爛),例如穀類(例如小麥或大麥)上之禾穀鐮刀菌 ( F. graminearum) 或大刀鐮刀菌 ( F. culmorum)(根腐爛、斑點病或赤黴病)、蕃茄上之尖孢鐮刀菌 ( F. oxysporum)、大豆上之腐皮鐮刀菌 ( F. solani) 及玉米上之輪枝樣鐮刀菌 ( F. verticillioides);穀類(例如小麥或大麥)及玉米上之禾頂囊殼菌 ( Gaeumannomyces graminis)(全蝕病);赤黴菌屬,在穀類(例如玉米赤黴 ( G. zeae))及稻穀(例如弗基克羅赤黴 (G. fujikuroi):稻惡苗病)上;藤本植物、梨果及其他植物上之油茶炭疽病 ( Glomerella cingulata) 及棉花上之棉炭疽病 ( G. gossypii) ;稻穀上之穀粒染色錯合物 (Grainstaining complex);藤本植物上之葡萄球座菌 ( Guignardia bidwellii)(黑腐病);薔薇科植物及杜松屬上之裸孢子囊菌屬 ( Gymnosporangiumspp.),例如梨上之歐洲梨裸孢子囊菌 ( G. sabinae)(銹病);玉米、穀類及稻穀上之長蠕孢屬 ( Helminthosporiumspp.)(同義詞:德氏黴屬 ( Drechslera),有性型:旋孢腔菌 ( Cochliobolus));駝孢鏽菌屬 ( Hemileiaspp.),例如咖啡上之咖啡鏽菌 ( H. vastatrix)(咖啡葉銹病);藤本植物上之褐斑擬棒束孢菌 ( Isariopsis clavispora)(同義詞:葡萄枝孢菌 ( Cladosporium vitis));大豆及棉花上之菜豆殼球孢菌 ( Macrophomina phaseolina)(同義詞:菜豆殼球孢 ( Macrophomina phaseoft))(根莖腐爛);穀類(例如小麥或大麥)上之禾草粉紅雪黴病 ( Microdochium nivale)(同義詞:鐮刀菌)(粉紅雪黴病);大豆上之大豆白粉病 ( Microsphaera diffusa)(白粉菌);褐腐病菌屬 ( Moniliniaspp.),例如核果及其他薔薇科植物上之核果褐腐病 ( M. laxa)、桃褐腐病 ( M. fructicola) 及蘋果褐腐病 ( M. fructigena)(花及嫩枝枯萎、褐腐病);穀類、香蕉、軟果及花生上之球腔菌屬 ( Mycosphaerellaspp.),例如小麥上之小麥殼針孢葉枯病 ( M. graminicola)(無性型:葉枯病 ( Septoria tritici)、斑殼針孢菌 ( Septoria blotch))或香蕉上之香蕉黑條葉斑病菌 ( M. fijiensis)(香蕉葉斑病);斜尖狀孢子菌屬 ( Peronosporaspp.)(霜黴病),在甘藍(例如油菜霜黴病 ( P. brassicae))、油菜(例如寄生霜黴病 ( P. parasitica))、洋蔥(例如洋蔥露菌病 ( P. destructor))、煙草(煙草露菌病 ( P. tabacina))及大豆(例如毛豆露菌病 ( P. manshurica))上;大豆上之大豆銹病 ( Phakopsora pachyrhizi)及山馬蝗層菌 ( P. meibomiae)(大豆銹病);瓶黴屬 ( Phialophoraspp.),例如在藤本植物(例如苜蓿普通葉斑 ( P. tracheiphila) 及四孢瓶黴菌 ( P. tetraspora))及大豆(例如大豆莖褐腐病菌 ( P. gregata):莖腐爛)上;油菜及甘藍上之甘藍黑腳病菌 ( Phoma lingam)(根莖腐爛)及糖用甜菜上之甜菜莖點黴 ( P. betae)(根腐爛、葉斑病及猝倒病);擬莖點黴屬 ( Phomopsisspp.),在向日葵、藤本植物(例如葡萄枝枯病 ( P. viticola):can 及葉斑病 (can and leaf spot))及大豆(例如莖腐病:菜豆疫黴 ( P. phaseoli),有性型:大豆北方莖潰瘍病菌 ( Diaporthe phaseolorum))上;玉米上之玉蜀黍節壺菌 ( Physoderma maydis)(褐斑病);疫黴屬 ( Phytophthoraspp.)(枯萎、根、葉、果實及莖腐爛),在各種植物上,例如在紅辣椒及葫蘆(例如辣椒疫黴 ( P. capsici))、大豆(例如大豆疫黴菌 ( P. megasperma),同義詞:大豆疫黴菌 ( P. sojae))、馬鈴薯及蕃茄(例如馬鈴薯晚疫病 ( P. infestans) :晚疫病)及闊葉樹(例如櫟樹猝死病菌 ( P. ramorum) :櫟樹猝死)上;甘藍、油菜、蘿蔔及其他植物上之十字花科根瘤病菌 ( Plasmodiophora brassicae)(根腫病);單軸黴屬 ( Plasmoparaspp.),例如藤本植物上之葡萄生單軸黴菌 ( P. viticola)(葡萄樹霜黴病)及向日葵上之向日葵霜黴病菌 ( P. halstedii);薔薇科植物、蛇麻草、梨果及軟果上之足球菌屬 ( Podosphaeraspp.)(白粉菌),例如蘋果上之蘋果白粉病 ( P. leucotricha);多黏菌屬 ( Polymyxaspp.),例如在穀類(例如大麥及小麥)(禾穀多黏菌 ( P. graminis))及糖用甜菜(甜菜多黏菌 ( P. betae))上且由此傳播病毒性疾病;穀類(例如小麥或大麥)上之小麥基腐病菌 ( Pseudocercosporella herpotrichoides)(眼斑病,有性型: Tapesia yallundae);各種植物上之擬霜黴菌 ( Pseudoperonospora)(霜黴病),例如葫蘆上之黃瓜擬霜黴菌 ( P. cubensis) 或蛇麻草上之漳草擬霜黴菌 ( P. humili);藤本植物上之葡萄角斑葉焦病菌 ( Pseudopezicula tracheiphila)(葡萄葉斑病或rotbrenner’,無性型:瓶黴屬);柄鏽菌屬 ( Pucciniaspp.)(銹病),在各種植物上,例如穀類(例如小麥、大麥或裸麥)上之小麥葉銹病 ( P. triticina)(褐銹病或葉銹病)、小麥條鏽菌 ( P. striiformis) (條銹病或黃銹病)、大麥柄鏽菌 ( P. hordei)(萎縮銹病)、禾柄鏽菌 ( P. graminis)(莖銹病或黑銹病)或小麥葉銹病 ( P. recondita)(褐銹病或葉銹病),在甘蔗上之屈恩柄銹菌 ( P. kuehnii)(橙銹病)及在蘆筍上之蘆筍銹病 ( P. asparagi);小麥上之黃褐斑核腔菌( Pyrenophora tritici-repentis(無性型:德氏黴菌 ( Drechslera)))(褐斑病)或大麥上之大麥網斑病 ( P. teres)(網斑病);梨孢屬 ( Pyriculariaspp.),例如稻穀上之稻瘟黴菌 ( P. oryzae)(有性型:稻瘟病菌 ( Magnaporthe grisea)、稻瘟病)及草皮及穀類上之稻瘟病菌 ( P. grisea);腐黴菌屬 ( Pythiumspp.)(猝倒病),在草皮、稻穀、玉米、小麥、棉花、油菜、向日葵、大豆、糖用甜菜、蔬菜及各種其他植物上(例如終極腐黴菌 ( P. ultimum) 或瓜果腐黴 ( P. aphanidermatum));柱隔孢屬 ( Ramulariaspp.),例如大麥上之 R. collo-cygni(柱隔孢葉斑病、生理性葉斑病)及糖用甜菜上之甜菜葉斑病 ( R. beticola);絲核菌屬 ( Rhizoctoniaspp.),在棉花、稻穀、馬鈴薯、草皮、玉米、油菜、馬鈴薯、糖用甜菜、蔬菜及各種其他植物上,例如大豆上之立枯絲核菌 ( R. solani)(根莖腐爛)、稻穀上之立枯絲核菌(紋枯病)或小麥或大麥上之禾穀絲核菌 ( R. cerealis)(絲核菌春季枯病);草莓、胡蘿蔔、甘藍、藤本植物及蕃茄上之匍莖根黴菌 ( Rhizopus stolonifer)(黑麯黴、軟腐病);大麥、裸麥及黑小麥上之禾草雲斑病 ( Rhynchosporium secalis)(雲紋病);稻穀上之稻帚枝黴菌 ( Sarocladium oryzae) 及水稻葉鞘腐敗病 ( S. attenuatum)(鞘腐病);核盤菌屬 ( Sclerotiniaspp.)(莖腐病或白黴),在蔬菜及田間作物上,例如油菜、向日葵(例如油菜禾盤菌 ( S. sclerotiorum))及大豆(例如病床白絹病 ( S. rolfsii) 或油菜禾盤菌);各種植物上之殼針孢屬 ( Septoriaspp.),例如大豆上之褐紋病 ( S. glycines)(褐斑病)、小麥上之小麥殼針孢葉枯病 ( S. tritici)(殼針孢葉枯病)及穀類上之狗牙根殼針孢 (S.(同義詞: Stagonosporanodorum)(殼針孢葉枯病 ( Stagonospora blotch));藤本植物上之葡萄鉤絲殼 ( Uncinula(同義詞:白粉菌屬 ( Erysiphe)) necator)(白粉菌,無性型:葡萄粉孢 ( Oidium tucken));在玉米(例如玉米大斑病菌 ( S. turcicum),同義詞:玉米大斑病菌 ( Helminthosporium turcicum))及草皮上之大斑菌屬 ( Setospaeriaspp.)(葉枯病);在玉米(例如玉米絲黑穗病 ( S. reiliana):絲黑穗病)、高粱及甘蔗上之軸黑粉菌屬 ( Sphacelothecaspp.)(黑穗病);葫蘆上之瓜類白粉病 ( Sphaerotheca fuliginea)(白粉菌);馬鈴薯上之馬鈴薯粉狀瘡痂病菌 ( Spongospora subterranea)(白茄病)且由此傳遞病毒性疾病;穀類上之殼多孢菌屬 ( Stagonosporaspp.),例如小麥上之穎枯殼多孢 ( S. nodorum)(殼多孢斑症,有性型:穎枯殼小球腔菌 ( Leptosphaeria[同義詞:葉枯病菌 ( Phaeosphaeria)] nodorum));馬鈴薯上之馬鈴薯癌腫病 ( Synchytrium endobioticum) (馬鈴薯癌腫病);外囊菌屬 ( Taphrinaspp.),例如桃上之桃縮葉病菌 ( T. deformans) (卷葉病)及李子上之李囊果病菌 ( T. pruni)(李縮葉病);煙草、梨果、蔬菜、大豆及棉花上之根串珠黴屬 ( Thielaviopsisspp.)(黑根腐病),例如煙草根腐黴 ( T. basicola)(同義詞:根腐病原菌 ( Chalara elegans));穀物上之腥黑粉菌屬 ( Tilletiaspp.)(光腥黑穗病或腥黑穗病),例如小麥上之小麥腥黑穗病 ( T. tritici) (同義詞: T. caries,小麥腥黑穗病)及小麥矮化腥黑穗病菌 ( T. controversa)(矮化腥黑穗病);大麥或小麥上之麥類雪腐病 ( Typhula incarnata)(灰雪黴病);條黑粉菌屬 ( Urocystisspp.),例如裸麥上之黑麥桿黑穗病菌 ( U. occulta)(杆黑粉病);單胞鏽菌屬 ( Uromycesspp.)(銹病)在蔬菜上,例如豆類(例如疣頂單胞銹菌 ( U. appendiculatus),同義詞:菜豆銹病菌 ( U. phaseoli))及糖用甜菜(例如甜菜銹病 ( U. betae));在穀類(例如麥散黑粉菌 ( U. nuda) 及燕麥散黑穗病 ( U. avaenae))、玉米(例如玉米瘤黑粉病菌 ( U. maydis):玉米黑穗病)及甘蔗上之黑粉菌屬 ( Ustilagospp.)(散黑粉病);在蘋果(例如蘋果黑星菌 ( V. inaequalis))及梨上之黑星菌屬 ( Venturiaspp.)(斑點病);及輪枝孢屬 ( Verticilliumspp.)(枯萎)在各種植物上,例如水果及觀賞性植物、藤本植物、軟果、蔬菜及田間作物,例如草莓、油菜、馬鈴薯及蕃茄上之棉花大麗輪枝菌 ( V. dahliae)。 Albugo spp. (white rust) on ornamental plants, vegetables (such as A. candida ) and sunflowers (such as A. tragopogonis ); Alternaria ( Alternaria spp.) (black spot disease), in vegetables, rapeseed ( A. brassicola/brassicae ), sugar beet ( A. tenuis ), fruit, rice, On soybeans, potatoes (such as A. solani or A. alternata ), tomatoes (such as A. solani or A. alternata ), and wheat; Aphanomyces spp. on sugar beets and vegetables; Ascochyta spp. on cereals and vegetables, e.g. A. tritici (anthracnose) on wheat and barley A. hordei above; Bipolaris spp. and Drechslera spp. (Teletype: Cochliobolus spp.), in on corn (e.g. D. maydis ), cereals (e.g. B. sorokiniana : spot blight), rice (e.g. B. oryzae ) and turf; Blumeria graminis (formerly known as Erysiphe ) (powdery mildew) on cereals (e.g. on wheat or barley); Botrytis ( Botryotinia fuckeliana ): gray mold) on fruits and berries (such as strawberries), vegetables (such as lettuce, carrots, celery, and cabbage), rapeseed, flowers, vines, forestry plants, and wheat; on lettuce Bremia lactucae (downy mildew); Ceratocystis spp. (synonym Ophiostoma ) (rotting or wilting) on deciduous and evergreen trees, e.g. C. ulmi ( Dutch elm disease ); Cercospora spp. (Cercospora leaf spot); C. beticola )), sugar cane, vegetables, coffee, soybeans (such as C. sojina or C. kikuchi i )) and rice; Cladosporium spp., on tomatoes (eg C. fulvum: leaf mold) and cereals, eg Cladosporium ( C. fulvum ): leaf mold on wheat . herbarum ) (smut); Claviceps purpurea (ergot disease) on cereals; Claviceps purpurea (anamorph: Helmin thosporium of the genus Bipolar) ( leaf spot), in maize ( C. carbonum ), cereals (e.g. C. sativus , anamorph: C. sativus) and rice (e.g. C. sativus Miyabeanus ( C. miyabeanus ), anamorphically: H. oryzae ) on; Colletotrichum spp. ( teleotype : Glomerella) (anthracnose) , in cotton (eg C. gossypii ), maize (eg C. graminicola ), soft fruits, potatoes (eg C. coccodes : black spot), beans ( such as C. lindemuthianum ) and soybeans (such as C. truncatum or C. gloeosporioides ); Corticium spp. such as rice on rice C. sasakii (sheath blight); Corynespora cassiicola (leaf spot) on soybeans and ornamentals; Cycloconium spp., e.g. olive trees Olive freckle ( C. oleaginum ) above; Cylindrocarpon spp. (e.g. fruit tree cancerous swelling or young vine rot, sexual type: Neotria or Neonectria spp.), on fruit trees , on vines (such as C. liriodendri ), teletype: Neonectria liriodendri : blackfoot) and ornamental plants; white feather spot on soybeans ( Dematophora necatrix ) (sexual type: Rosellinia ) (root rot); Diaporthe spp., such as D. phaseolorum on soybeans (damp-off); Debrinella (synonym: Helminthias elongatum Genus, sex type: Pyrenophora ( Pyrenophora )), in corn, cereals (such as barley (such as D. teres , net spot disease) and wheat (such as wheat macular D. tritici-repentis : brown spot), rice) and on turf; Esca (apical dieback, stroke) on vines, caused by Formitiporia punctata (synonym : Phellinus ), F. mediterranea , Phaeomoniella chlamydospora (formerly known as Phaeoacremonium chlamydosporum ), Phaeoacremonium aleophilum and/or grape Caused by Botryosphaeria obtusa ; Elsinoe spp. in pome fruit ( E. pyn ), soft fruit ( E. veneta : anthracnose) and vines ( E. ampelina : anthracnose); on rice, Entyloma oryzae (leaf smut); on wheat, Epicoccum spp. (black mildew); Erysiphe spp. ( Erysiphe spp.), on sugar beet (beet powdery mildew ( E. betae )), vegetables (e.g. pea powdery mildew ( E. pist )), e.g. cucurbits (e.g. melon powdery mildew ( E. cichoracearum )), cabbage , rapeseed (e.g. E. cruciferarum ); Libertella blepharis ), on fruit trees, vines, and ornamental trees; Exserohilum spp. (synonym: Helminthes spp.), on maize (eg. ( E. turcicum )); Fusarium spp. (Teotropic: Gibberella ) (blight, root or stem rot) on various plants, such as graminearum on cereals such as wheat or barley F. graminearum or F. culmorum (root rot, spot or scab), F. oxyspora on tomato orum ), F. solani on soybeans and F. verticillioides on corn; Gaeumannomyces graminis on cereals (such as wheat or barley) and corn (take-all disease); Gibberella, on cereals (eg G. zeae ) and rice (eg G. fujikuroi : rice bakanae); vines, pears Camellia anthracnose ( Glomerella cingulata ) on fruit and other plants and cotton anthracnose ( G. gossypii ) on cotton; grain dyeing complex (Grainstaining complex) on rice; staphylococcus ( Guignardia bidwellii ) (black rot); Gymnosporangium spp. on Rosaceae and Juniper, e.g. G. sabinae (rust) on pears; maize, cereals and Helminthosporium spp. (Synonym: Drechslera , teletype: Cochliobolus ) on rice; Hemileia spp., such as coffee H. vastatrix (coffee leaf rust) on vines; Isariopsis clavispora (synonym: Cladosporium vitis ) on vines; bean on soybeans and cotton Macrophomina phaseolina (synonym: Macrophomina phaseoft ) (root rot); Grass pink snow mold ( Microdochium nivale ) (synonym: Fusarium) on cereals such as wheat or barley (pink snow mold); soybean powdery mildew ( Microsphaera diffusa ) (Powdery mildew) on soybeans; brown rot fungus ( Monilinia spp.), such as drupe fruit brown rot ( M. laxa ) on drupes and other Rosaceae plants , peach brown rot ( M. fructicola ) and apple brown rot ( M. fructigena ) (flower and twig wilting, brown rot); cereals, bananas, soft fruits and peanuts Mycosphaerella spp. ), such as Septoria tritici leaf blight ( M. graminicola ) on wheat (anamorph: leaf blight ( Septoria tritici ), Septoria blotch) or M. fijiensis (banana leaf spot) on bananas; Peronospora spp. (downy mildew ), in cabbage (eg P. brassicae ), rape (eg P. parasitica ), onion (eg P. destructor ), tobacco (P. tabacina ) and on soybeans (e.g. P. manshurica ); soybean rust ( Phakopsora pachyrhizi ) and P. meibomiae (soybean rust) on soybeans; bottle mold Phialophora spp., for example in vines (eg P. tracheiphila and P. tetraspora ) and soybeans (eg P. gregata ): stem rot ); Phoma lingam (root rot) on rapeseed and cabbage and Phoma lingam ( P. betae ) on sugar beet (root rot, leaf spot and damping-off); Phomopsis spp., in sunflowers, vines (e.g. P. viticola : can and leaf spot) and soybeans (e.g. stem rot: Phytophthora beanum ( P. phaseoli ), teletype: on soybean northern stem canker ( Diaporthe phaseolorum )); on corn, Physoderma maydis (brown spot); Phytophthora spp. (wilt, root , leaf, fruit and stem rot), on various plants such as red peppers and cucurbits (eg P. capsici ), soybeans (eg P. megasperma ), synonym: Phytophthora sojae ( P. sojae )), potatoes and tomatoes (such as P. infestans : late blight) and broad-leaved trees (such as P. ramorum : sudden death of oak); cabbage, rapeseed, radish and others Plasmodiophora brassicae (Clubroot) on plants; Plasmopara spp., e.g. P. viticola on vines ) (vine downy mildew) and sunflower downy mildew ( P. halstedii ) on sunflowers; Podosphaera spp. (powdery mildew) on roses, hops, pome and soft fruits, such as apples powdery mildew ( P. leucotricha ) on apples; Polymyxa spp., for example on cereals (e.g. barley and wheat) ( P. fungi ( P. betae )) and thus transmit viral diseases; wheat foot rot ( Pseudocercosporella herpotrichoides ) (eye spot, sexual type: Tapesia yallundae ) on cereals (such as wheat or barley); Pseudoperonospora (downy mildew) such as P. cubensis on cucurbits or P. humili on hops; Pseudoperonospora on vines ( Pseudopezicula tracheiphila ) (vine leaf spot or rotbrenner', anamorph: Phalaenopsis); Puccinia spp. (rust disease), on various plants, such as cereals (for example, wheat, barley, or rye ) on wheat leaf rust ( P. triticina ) (brown rust or leaf rust), wheat stripe rust ( P. striiformis ) (stripe rust or yellow rust), barley rust ( P. hordei ) (shrinking rust), P. graminis (stem or black rust) or wheat leaf rust ( P. recondita ) (brown rust or leaf rust), P. kuehnii (orange rust) on sugarcane ) and asparagus rust ( P. asparagi ) on asparagus; Pyrenophora tritici-repentis (anamorph: Drechslera )) on wheat (brown spot) or on barley Barley net spot ( P. teres ) (net spot); Pyricularia spp., e.g. P. oryzae on rice blast) and blast fungus ( P. grisea ) on turf and grain; Pythium spp. beets, vegetables and various other plants (e.g. Pythium ultima ( P. ultimum ) or P. aphanidermatum ( P. aphanidermatum )); Ramularia spp., e.g. R. collo-cygni on barley (P. Beet leaf spot ( R. beticola ) on sugar beet; Rhizoctonia spp. on cotton, rice, potato, turf, corn, rapeseed, potato, sugar beet, vegetables, and various other plants , such as R. solani on soybean (root rot), R. solani on rice (sheath blight) or R. cerealis on wheat or barley ( Rhizoctonia spring blight); Rhizopus stolonifer (Aspergillus niger, soft rot) on strawberries, carrots, cabbage, vines, and tomatoes; grass cloud spot on barley, rye, and triticale ( Rhynchosporium secalis ) (moire disease); Sarocladium oryzae and S. attenuatum (sheath rot) on rice; Sclerotinia spp. (stem rot) or white mildew), on vegetables and field crops such as rapeseed, sunflower (e.g. S. sclerotiorum ) and soybeans (e.g. S. rolfsii or S. sclerotiorum); various plants Septoria spp. on soybeans, such as S. glycines (brown spot) on soybeans, S. tritici on wheat ( S. tritici ) (Septoria leaf blight) blight) and S. bermudagrass (S. (synonym: Stagonospora ) nodorum ) (Septoria blotch ( Stagonospora blotch )) on cereals; Uncinula (synonym: powdery mildew) on vines genus ( Erysiphe )) necator ) (Erysiphe, anamorph: Oidium tucken ); in corn (eg S. turcicum , synonym: Helminthosporium turcicum ) and Setospaeria spp. (leaf blight) on turf; S. reiliana: head smut on maize (e.g. S. reiliana : head smut), sorghum and sugarcane Sphacelotheca spp.) (smut); melon powdery mildew on gourds ( Sphaerot heca fuliginea ) (powdery mildew); Spongospora subterranea (white nightshade) on potatoes and thus transmits viral diseases; Stagonospora spp. on cereals, e.g. on wheat S. nodorum ( S. nodorum ) (S. nodorum, sexual form: Leptosphaeria [synonym: Phaeosphaeria ] nodorum )); potato cancer on potatoes Synchytrium endobioticum (potato cancer); Exocystis ( Taphrina spp.), such as T. deformans (leafroll) on peaches and T. deformans on plums . pruni ) (plum leaf shrinkage); Thielaviopsis spp. (black root rot) on tobacco, pome fruit, vegetables, soybeans, and cotton, e.g. T. basicola (synonym: root rot pathogen ( Chalara elegans )); Tilletia spp. (Tilletia spp.) on cereals, e.g. Tillet smut ( T. tritici ) on wheat ( Synonyms: T. caries , Tillet smut) and T. controversa ( T. controversa ); Typhula incarnata (Ash smut) on barley or wheat snow mold); Urocystis spp., such as U. occulta on rye (rod smut); Uromyces spp. ( rust) on vegetables such as beans (e.g. U. appendiculatus , synonym: U. phaseoli) and sugar beet (e.g. U. betae ); on cereals (such as U. nuda and U. avaenae ), maize (such as U. maydis : maize smut) and smut on sugarcane Ustilago spp. (loose smut); Venturia spp. (spot) on apples (eg V. inaequalis ) and pears; and Verticillium Verticillium spp. (wilted) on various plants such as fruit and ornamentals, vines, Verticillium dahliae ( V. dahliae ) on soft fruits, vegetables and field crops such as strawberries, rapeseed, potatoes and tomatoes.

此外,本案的農業化學組成物可以減少收獲物中以及從其製備的食品和飼料中之黴菌毒素 (mycotoxin)的含量。黴菌毒素尤其包括但並非限於以下:去氧雪腐鐮孢醇 (deoxynivalenol, DON),雪腐鐮孢醇 (nivalenol)、15-Ac-DON、3-Ac-DON、T2-和HT2-毒素、伏馬毒素 (fumonisins)、玉米赤黴烯酮 (zearalenon)、串珠鐮刀菌素 (moniliformin)、鐮菌素 (fusarin)、蛇形菌素 (diaceotoxyscirpenol,DAS)、白僵菌素 (beauvericin)、恩鐮孢菌素 (enniatin),層出鐮孢菌素 (fusaroproliferin)、鐮刀菌醇 (fusarenol)、赭曲毒素 (ochratoxins)、展盤尼西林 (patulin)、麥角類生物鹼 (ergot alkaloids) 和黃曲黴毒素 (aflatoxins),其可例如經由以下的真菌生產:鐮刀菌 ( Fusariumspec.),如銳頂鐮孢菌 ( F. acuminatum)、亞洲鐮刀菌 ( F. asiaticum)、燕麥鐮刀菌 ( F. avenaceum)、克威爾鐮刀菌 ( F. crookwellense)、禾稈鐮孢菌 ( F. culmorum)、禾榖鐮刀菌 ( F. graminearum)(玉米赤霉菌 ( Gibberella zeae))、木賊鐮刀菌 ( F. equiseti)、水稻赤霉菌 ( F. fujikoroi)、香蕉鐮刀菌 ( F. musarum)、尖鐮孢菌 ( F. oxysporum)、串珠鐮刀菌 ( F. proliferatum)、梨孢鐮刀菌 ( F. poae)、小麥冠腐病菌 ( F. pseudograminearum)、接骨木鐮刀菌 ( F. sambucinum)、藨草鐮孢 ( F. scirpi)、半裸镰刀菌 ( F. semitectum)、腐皮镰孢 ( F. solani)、分枝孢鐮孢菌 ( F. sporotrichoides)、燕麥鐮孢 ( F. langsethiae)、膠孢鐮刀菌 ( F. subglutinans)、三線鐮刀菌 ( F. tricinctum)、幹枝鐮刀菌 ( F. verticillioides)等,且還有經由麴菌屬 ( Aspergillusspec.)、如黃麴菌 ( A. flavus)、寄生麴菌 ( A. parasiticus)、麴霉 ( A. nomius)、赭麴菌 ( A. ochraceus)、棒麴霉 ( A. clavatus)、土麴菌 ( A. terreus)、染色麴霉 ( A. versicolor)、青黴菌屬 ( Penicilliumspec. ),如疣孢青黴菌 ( P. verrucosum)、純綠青黴菌 ( P. viridicatum)、橘青黴菌 ( P. citrinum)、擴展青黴菌 ( P. Expansum) 、棒形青霉)、棒形青霉 ( P. claviforme)、婁地青黴菌 ( P. roqueforti)、麥角菌屬 ( Clavicepsspec. ),如黑麥麥角菌 ( C. purpurea)、紡錘麥角菌 ( C. fusiformis)、雀稗麥角菌 ( C. paspali)、非洲麥角菌 ( C. Africana)、葡萄穗黴菌 ( Stachybotrysspec.)及其他菌。 Furthermore, the agrochemical composition of the present invention can reduce the content of mycotoxins in the harvest and in the food and feed prepared therefrom. Mycotoxins especially include but are not limited to the following: deoxynivalenol (DON), nivalenol, 15-Ac-DON, 3-Ac-DON, T2- and HT2-toxins, Fumonisins, zearalenone, moniliformin, fusarin, diaceotoxyscirpenol (DAS), beauvericin, en Enniatin, fusaroproliferin, fusarenol, ochratoxins, patulin, ergot alkaloids and Aspergillus flavus Toxins (aflatoxins), which can be produced, for example, by the following fungi: Fusarium spec., such as F. acuminatum , F. asiaticum , F. avenaceum ), F. crookwellense , F. culmorum, F. graminearum ( Gibberella zeae ), F. equiseti ), Fusarium fujikoroi ( F. fujikoroi ), Fusarium oxysporum ( F. musarum ), Fusarium oxysporum ( F. oxysporum ), Fusarium moniliforme ( F. proliferatum ), Fusarium pirosporum ( F. poae ), wheat Crown rot ( F. pseudograminearum ), elderberry Fusarium ( F. sambucinum ), Fusarium scirpi ( F. scirpi ), F. semimitectum , Fusarium solani ( F. solani ), branching F. sporotrichoides , F. langsethiae , F. subglutinans , F. tricinctum , F. verticillioides , etc., and also Aspergillus spec., such as A. flavus , A. parasiticus , A. nomius , ocher A. ochraceus , A. clavatus , A. terreus , A. versicolor , Penicillium spec. , such as Penicillium verrucosus ( P. verrucosum ), P. viridicatum , P. citrinum , P. Expansum , Penicillium claviforme ), Penicillium claviforme ( P. claviforme ), Lou Penicillium roqueforti , Claviceps spec., such as C. purpurea , C. fusiformis , C. paspali ), C. Africana , Stachybotrys spec. and others.

本案的農業化學組成物亦可用於材料的保護,特別是為了保護工業材料免於受到植物病原性真菌的攻擊和破壞。The agrochemical composition of the present case can also be used for the protection of materials, in particular for the protection of industrial materials from attack and damage by phytopathogenic fungi.

此外,本案的農業化學組成物可單獨或與其他活性成分一起使用作為防污組成物。In addition, the agrochemical composition of the present case can be used alone or in combination with other active ingredients as an antifouling composition.

本案說明書中所述的工業材料應被瞭解為意指被製備成用於工業的無生命材料。例如,欲被保護以防止微生物改變或破壞的工業材料可為黏接劑、膠液、紙、壁紙和夾板/紙板、織物、地毯、皮革、木頭、纖維和組織、塗料和塑膠物件、冷卻潤滑油和其他可能被微生物感染或破壞的材質。生產工廠和建築的組件,例如可能會被微生物的繁生所損壞之冷卻水的管路、冷卻和加熱系統以及通風和空調單元,亦屬於待保護材料的範疇。在本案所述的工業材料中,較佳包括黏接劑、膠水、紙張和卡片、皮革、木頭、油漆、冷卻潤滑油和熱轉移液體,更佳為木頭。Industrial materials mentioned in this case specification should be understood to mean inanimate materials prepared for use in industry. Examples of industrial materials to be protected against microbial alteration or destruction may be adhesives, glues, paper, wallpaper and plywood/cardboard, fabrics, carpets, leather, wood, fibers and tissues, paints and plastic objects, cooling and lubrication Oil and other materials that may be infected or damaged by microorganisms. Components of production plants and buildings, such as pipes for cooling water, cooling and heating systems, and ventilation and air-conditioning units that could be damaged by the growth of microorganisms, also fall within the category of materials to be protected. Among the industrial materials mentioned in this case, preferably include adhesives, glues, paper and cards, leather, wood, paint, cooling lubricants and heat transfer fluids, more preferably wood.

本案的農業化學組成物可防止不利的作用,例如腐爛、侵蝕、變色、脫色或發霉。The agrochemical composition of the present case prevents adverse effects such as rotting, erosion, discoloration, discoloration or mold formation.

在木頭處理的情形中,本案的農業化學組成物亦可用於對抗容易在木材外面或裡面生長的真菌疾病。In the case of wood treatment, the agrochemical compositions of the present invention can also be used to combat fungal diseases that tend to grow on or in wood.

「木材」係表示所有木頭種類,以及表示用在建造的所有形式的木頭加工品,例如實木、高密度木頭,膠合木,以及夾板。此外,本案的農業化學化合物可用於保護與鹽水或味道不佳的水接觸之物件,特別是船殼、屏幕、網子、建築物、繫船設備以及信號設備免於污損。"Wood" refers to all types of wood, and to all forms of processed wood used in construction, such as solid wood, high-density wood, glued wood, and plywood. In addition, the agrochemical compounds of the present case can be used to protect objects that come into contact with salt water or unsavory water, especially ship hulls, screens, nets, buildings, moorings and signaling equipment from fouling.

本案之農業化學組成物亦可用於保護儲存的貨品。儲存的貨品應理解為係表示植物或動物來源的天然物質或其天然來源的加工產品,且需要長期保護者。植物來源的儲存貨品,例如植物或植物的部分,如莖、葉、塊莖、種子、果實、榖粒可被新鮮採收即被保護或在(預先)乾燥、濕潤、研成粉末,磨碾、擠壓或烘焙之加工後被保護。儲存的貨品亦包括木材-未加工的(如建造用的木材、電桿和路障)或加工完成之產品形式(如家具)兩者。The agricultural chemical composition of this case can also be used to protect stored goods. Stored goods are understood to mean natural substances of vegetable or animal origin or processed products of their natural origin and which require long-term conservation. Stored goods of vegetable origin, e.g. plants or plant parts such as stems, leaves, tubers, seeds, fruits, grains may be freshly harvested i.e. preserved or dried, moistened, ground into powder, ground, Protected after extrusion or baking processing. Stored goods also include wood - both in raw (such as construction lumber, poles and barricades) or in finished product form (such as furniture).

動物來源的儲存貨品為例如,獸皮、皮革、毛與髮。本案的農業化學組成物可預防不利的作用,如腐爛、侵蝕、變色、脫色或發霉。Stored goods of animal origin are, for example, hides, hides, hair and hair. The agrochemical composition of the present case prevents adverse effects such as rotting, erosion, discoloration, discoloration or mould.

能造成工業材料分解或變化的微生物包括,例如,真菌。本案的農業化學組成物較佳地作用在對抗真菌,特別是黴菌、使木頭變色和使木頭損壞的真菌(子囊菌 ( Ascomycetes)、擔子菌 ( Basidiomycetes)、半知菌 ( Deuteromycetes)和接合菌 ( Zygomycetes))。 Microorganisms capable of causing decomposition or transformation of industrial materials include, for example, fungi. The agrochemical compositions of the present case preferably act against fungi, especially moulds, wood-staining and wood-damaging fungi ( Ascomycetes , Basidiomycetes , Deuteromycetes and Zygomycetes ( Zygomycetes )).

本案的農業化學組成物會干擾植物的代謝過程因而亦可用作為植物的生長調節劑。植物生長調節劑可施展各種對植物的作用。該物質的作用基本上取決於植物發育階段相關的施用時間,亦取決於施用在植物或其環境之活性成分的用量,並且取決於施用的型式來決定。在每一情形中,生長調節劑對作物植物應具特定所欲的作用,例如:The agricultural chemical composition of the present case interferes with the metabolic process of the plant and thus can also be used as a growth regulator of the plant. Plant growth regulators can exert various effects on plants. The action of the substances depends essentially on the time of application in relation to the developmental stage of the plants, also on the amount of active ingredient applied to the plant or its environment and depends on the type of application. In each case, the growth regulator should have a specific desired effect on the crop plant, for example:

增加的產率係指每公頃的所有生物質量 (total biomass per hectare)、每公頃的產率、穗粒/果實重量、種子大小和/或百升重量以及增進之產品的品質,包括:與以下方面相關之可加工性的提升:大小分佈 (穗粒、果實等)、均質的成熟、穀粒的水分、較佳的研磨、較佳的酒類釀造、較佳的咖啡沖煮、增加的果汁產率、可收穫性、可消化性、沉降值、降落數值、豆莢穩定性、儲存穩定性、改良的纖維長度/強度/一致性、增進青貯料飼養動物的乳汁和/或肉品品質、合適於煎煮;尚包含可販售性的提升,其係關於更佳的果實/穀粒的品質,大小分布 (穗粒、果實等),增進的儲存/擱置壽命/堅硬度/柔軟度/口感 (香氣、質感等),等級 (大小、形狀、莓子的粒數等),每一串的莓子/果實的粒數、脆度、新鮮度,以蠟質包覆,生理病症的頻次、顏色等;尚包含所欲成分的提升,例如:蛋白質含量、脂肪酸、油含量、油品質、胺基酸組成物、糖含量、酸含量 (pH)、糖/酸比率 (Brix)、多酚類、澱粉含量、營養價值、麩質含量/指數、能量含量、口感等;且尚包含降低之不想要的成分,例如:較少黴菌毒素、較少黃麴毒素、土味物質 (geosmin)的量、相苯酚的香氣、漆酶 (lacchase)、多酚氧化酶和過氧化酶、硝酸鹽含量等。Increased yield means total biomass per hectare, yield per hectare, ear/fruit weight, seed size and/or hectare weight and enhanced product quality, including: Aspect-related improvement in processability: size distribution (ears, fruit, etc.), homogeneous ripening, grain moisture, better grinding, better wine brewing, better coffee brewing, increased juice production yield, harvestability, digestibility, sedimentation value, falling number, pod stability, storage stability, improved fiber length/strength/consistency, improved milk and/or meat quality for silage-fed animals, suitable for decoction; also includes marketability enhancements related to better fruit/grain quality, size distribution (ears, fruit, etc.), enhanced storage/shelf life/firmness/softness/mouthfeel ( Aroma, texture, etc.), grade (size, shape, number of berries, etc.), number of berries/fruits per bunch, crispness, freshness, wax coating, frequency and color of physiological symptoms etc.; it also includes the improvement of desired ingredients, such as: protein content, fatty acid, oil content, oil quality, amino acid composition, sugar content, acid content (pH), sugar/acid ratio (Brix), polyphenols, Starch content, nutritional value, gluten content/index, energy content, taste, etc.; and also contains reduced unwanted ingredients, such as: less mycotoxins, less aflatoxin, the amount of earthy substances (geosmin), The aroma of phenol, lacchase (lacchase), polyphenol oxidase and peroxidase, nitrate content, etc.

本案的農業化學組成物也在植物身上展現有效之強化 (strengthening)效果。因此,其可被用於啟動 (mobilize)植物的防禦作用以對抗不想要的微生物。The agricultural chemical composition of this case also exhibits effective strengthening (strengthening) effect on plants. Therefore, it can be used to mobilize the plant's defense against unwanted microorganisms.

植物強化(誘發對抗能力)物質於本文中係指可刺激植物防禦系統的物質,其使處理過的植物在隨後接種到不需要的微生物時,會對這些微生物產生高度的抗性。Plant strengthening (combatability-inducing) substances are used herein to mean substances that stimulate the plant defense system and render the treated plants highly resistant to unwanted microorganisms when subsequently inoculated with these microorganisms.

進一步地,在本案的說明書中,「植物生理作用」包含以下所述:Further, in the description of this case, "physiological effects of plants" includes the following:

「非生物逆境耐受性」包含對高溫或低溫的耐受性、乾旱耐受性和乾旱逆境後的恢復力、水使用效率(與較低的水消耗相關)、水患耐受性、臭氧耐受性、以及UV耐受性、對化學物質像是重金屬、鹽類、殺蟲劑等的耐受性。"Abiotic stress tolerance" includes tolerance to high or low temperature, drought tolerance and resilience after drought stress, water use efficiency (associated with lower water consumption), flood tolerance, ozone tolerance resistance, and UV resistance, resistance to chemicals such as heavy metals, salts, pesticides, etc.

「生物逆境耐受性」包含提升的真菌抵抗力和提升的對於線蟲、病毒和細菌的抵抗力。在本案的內容中,生物逆境耐受性,較佳是包含提升的真菌抵抗力和提升的對於線蟲的抵抗力。"Biological Stress Tolerance" includes increased resistance to fungi and increased resistance to nematodes, viruses and bacteria. In the context of the present case, biological stress tolerance preferably includes increased resistance to fungi and increased resistance to nematodes.

「提升的植物活力」包含植物健康/ 植物的品質以及種子活力、減少無法站立的狀態、改良的外觀、逆境期間之後較佳的恢復力、改良的呈色 (pigmentation)(例如葉綠素含量,保持綠色效果等)以及改良的光合作用效率。"Increased plant vigor" includes plant health/quality of plants and seed vigor, reduced inability to stand, improved appearance, better resilience after periods of stress, improved pigmentation (e.g. chlorophyll content, stay green effects, etc.) and improved photosynthetic efficiency.

本案亦包含種子處理的方法。本案亦關於經前文中所說明的方法之一所處理過的種子。本案所述的種子係用於保護種子免受有害微生物侵害的方法中。在這些方法中,使用了經至少一種本案的農業化學組成物處理過的種子。The case also covers methods of seed treatment. This case also concerns seed treated by one of the methods described above. The seed system described herein is used in a method of protecting seed from harmful microorganisms. In these methods, seeds treated with at least one agrochemical composition of the present invention are used.

本案的農業化學組成物亦適於對種子之處理。有一大部分被有害生物所造成之作物植物的傷害是在保存期間或播種之後,還有在發芽前後的期間被感染所導致的。由於正在生長的植物之根和芽尤其敏感,並且即便是微小的傷害都可能造成植物死亡,故此階段尤其重要。因此,藉由使用合適的組成物來保護種子以及正在發芽的植物受到相當的注目。The agricultural chemical composition of this case is also suitable for the treatment of seeds. A large part of crop plant damage caused by pests is caused by infection during storage or after sowing, and also during the period before and after germination. This stage is especially important since the roots and shoots of growing plants are especially sensitive and even a slight injury can kill the plant. Therefore, the protection of seeds and germinating plants by using suitable compositions has received considerable attention.

長久以來已知利用植物種子處理來控制植物病原性真菌,且其係持續改良的對象。然而,種子處理會導致一系列無法總是以令人滿意的方式解決的問題。舉例而言,希望能開發出一種保護種子和發芽植物的方法,其在種植或植物出苗後能免除或至少顯著減少額外使用作物保護組合物。此外,亦希望將使用的活性成分用量最佳化以對種子和發芽中的植物提供最佳可能的防護,使其免於植物病原性真菌的侵害,但不因所採用的活性成分而損害到植物本身。特別是種子處理方法也應考量基因轉殖植物的內部殺真菌性以在使用最少的作物保護組成物的前提下,達到對種子和發芽中植物的最佳保護。The use of plant seed treatments for the control of phytopathogenic fungi has long been known and is the subject of continuous improvement. However, seed treatment leads to a series of problems which cannot always be solved in a satisfactory manner. For example, it would be desirable to develop a method for protecting seeds and germinating plants which dispenses with, or at least significantly reduces, the additional use of crop protection compositions after planting or plant emergence. Furthermore, it is also desirable to optimize the amount of active ingredient used in order to provide the best possible protection of the seed and the germinating plant against attack by phytopathogenic fungi without damaging the the plant itself. In particular, seed treatment methods should also take into account the internal fungicidal properties of transgenic plants in order to achieve optimum protection of seeds and germinating plants with minimal use of crop protection compositions.

因此,本案亦關於一種藉由將種子以本案之組合物處理後以保護該種子以及發芽中的植物免於植物病原性真菌侵害之方法。本案同樣地關於將本案之組成物用於種子處理以保護該種子和發芽中植物免於植物病原性真菌侵害的用途。本案亦關於已經過本案組成物處理以防止植物病原性真菌侵害的種子。Therefore, the present application also relates to a method for protecting seeds and germinating plants from phytopathogenic fungi by treating the seeds with the composition of the present application. The present case likewise concerns the use of the composition of the present case for the treatment of seeds to protect the seeds and germinating plants from attack by phytopathogenic fungi. The case also relates to seeds which have been treated with the composition of the case for protection against attack by phytopathogenic fungi.

關於在發芽後損害植物的植物病原性真菌之控制,主要是以對土壤和植物的地上部分使用作物保護組成物的方式實行。由於考量到作物保護組成物可能會對環境和人類及動物健康造成影響,因此目前正致力減少活性成分的使用量。The control of phytopathogenic fungi which damage plants after germination is mainly carried out by the application of crop protection compositions to the soil and to the above-ground parts of the plants. Due to the possible impact of crop protection compositions on the environment and human and animal health, efforts are being made to reduce the amount of active ingredients used.

本案的優點之一在於本案新穎之農業化學組成物的特殊內吸性質(systemic properties)不僅保護了種子本身,也保護發芽之後的植物免於植物病原性真菌的侵害。藉此即可免除在播種當下或在其之後短暫的時間內就要立即對作物進行處理的需求。One of the advantages of the present case is that the special systemic properties of the novel agricultural chemical composition of the present case not only protect the seeds themselves, but also protect the germinated plants from phytopathogenic fungi. This eliminates the need to treat the crop immediately at or shortly after sowing.

同樣被認為有助益的是,該新穎農業化學組成物尤其亦可與基因轉殖種子一起使用,在這種情況下,從該種子長出的植物能夠表達出對抗害蟲的蛋白質。藉由將該種子經本案的組合物處理後,僅是表現該蛋白質(例如一種殺昆蟲的蛋白質),即可控制某些害蟲(有害生物)。令人驚訝的是,在此情況下還可發現進一部的協同促進的效果,其額外地增加了對抗有害生物侵害的保護效力。It is also believed to be beneficial that the novel agrochemical compositions may also be used, inter alia, with genetically modified seeds, in which case the plants grown from the seeds are capable of expressing pest-resistant proteins. Certain pests (pests) can be controlled by merely expressing the protein (for example, an insecticidal protein) after the seeds are treated with the composition of the present invention. Surprisingly, a further synergistic effect can also be found in this case, which additionally increases the protective effect against infestation by pests.

本案的新穎農業化學組成物適用於保護用於農業、溫室、森林或園藝及葡萄栽培之任何植物品種的種子。特別是榖物類的種子(如小麥、大麥、裸麥、黑小麥、高粱/小米和燕麥)、玉米、棉花、黃豆、稻米、馬鈴薯、向日葵、四季豆、咖啡、甜菜(例如製糖甜菜和飼料甜菜)、花生、芸苔、罌粟、橄欖、椰子、可可、甘蔗、菸草、蔬菜(如番茄,小黃瓜,洋蔥和包心菜),草皮和裝飾用植物(亦可見後方所述)。其中,穀類(如小麥、大麥、裸麥、黑小麥和燕麥)、玉米及稻米之種子的處理尤其顯著。The novel agricultural chemical composition of the present case is suitable for protecting the seeds of any plant species used in agriculture, greenhouse, forestry or horticulture and viticulture. Especially seeds of cereals (such as wheat, barley, rye, triticale, sorghum/millet and oats), corn, cotton, soybeans, rice, potatoes, sunflowers, green beans, coffee, sugar beets (such as sugar beet and fodder beets), peanuts, brassicas, poppies, olives, coconuts, cocoa, sugar cane, tobacco, vegetables (such as tomatoes, gherkins, onions and cabbages), turf and ornamental plants (see also below). Among them, the treatment of seeds of cereals (such as wheat, barley, rye, triticale and oats), corn and rice is particularly significant.

還有如同本文所述的,使用本案的新穎農業化學組成物處理基因轉殖的種子亦特別顯著。這涉及包含至少一種外源基因的植物種子,該外源基因可表現具有殺蟲功效的多肽或是蛋白質。基因轉殖種子中的外源基因可以源自,例如,芽孢桿菌 ( Bacillus)屬、根瘤菌 ( Rhizobium)屬、假單胞菌 ( Pseudomonas)屬、沙雷氏菌 ( Serratia)屬、木黴 ( Trichoderma)屬、棒桿菌 ( Clavibacter)屬、球囊菌 ( Glomus)屬或膠狀青黴菌 ( Gliocladium)的微生物。該外源基因較佳源自於芽孢桿菌 ( Bacillus)屬,在此種情況下,其基因產物對歐洲玉米螟 (European maize borer)及/或西部玉米根蟲 (western maize rootworm)具有對抗效果。該外源基因更佳可源自於蘇力菌 ( Bacillus thuringiensis) Also, as described herein, the treatment of transgenic seeds with the novel agrochemical composition of the present invention is also particularly significant. This concerns plant seeds comprising at least one exogenous gene expressing a polypeptide or protein with pesticidal activity. The exogenous gene in the gene transgenic seed can be derived from, for example, Bacillus ( Bacillus ) genus, Rhizobium ( Rhizobium ) genus, Pseudomonas ( Pseudomonas ) genus, Serratia ( Serratia ) genus, Trichoderma ( Microorganisms of the genus Trichoderma , Clavibacter, Glomus or Gliocladium . The exogenous gene is preferably derived from the genus Bacillus . In this case, its gene product has an antagonizing effect on European maize borer and/or western maize rootworm. More preferably, the exogenous gene can be derived from Bacillus thuringiensis .

在本發明的說明書中所述的新穎農業化學組成物可單獨或以合適的製劑形式施用於種子。較佳地,種子係在足夠穩定而於處理過程中不發生損害的狀態下進行處理。一般而言,種子可以在收穫和播種之間的任何時間進行處理。習慣上使用從植物中分離出來並去除了穗軸、殼、莖、皮、毛或果肉的種子。例如,可以使用經收穫、清潔和乾燥至水分含量占重量小於15%的種子。或者,也可以使用於乾燥後(例如經過水處理後又乾燥)的種子。The novel agrochemical compositions described in the description of the present invention may be applied to seeds alone or in a suitable formulation. Preferably, the seed is treated in a state sufficiently stable that no damage occurs during handling. In general, seeds can be processed any time between harvest and sowing. It is customary to use the seed separated from the plant and freed of cobs, husks, stems, skins, hairs or pulp. For example, seeds that have been harvested, cleaned and dried to a moisture content of less than 15% by weight may be used. Alternatively, it can also be used on seeds after drying (for example after water treatment and then drying).

當處理種子時,通常必須注意選擇施用於種子的新穎農業化學組成物的量及/或另外的添加劑的量,以使種子的發芽不受到損害,或其長出的植物不受損害。這一點必須牢記,特別是對於在某些施用率下可能具有植物毒性作用之活性成分。When treating seed, care must generally be taken to select the amount of novel agrochemical composition and/or the amount of additional additives applied to the seed so that germination of the seed, or the plant from which it emerges, is not impaired. This must be borne in mind, especially with active ingredients which may have phytotoxic effects at certain application rates.

本案進一步涉及用於控制有害微生物的新穎農業化學組成物。所述農業化學組成物可以施用於微生物及/或它們的棲息地。The case further concerns novel agricultural chemical compositions for the control of harmful microorganisms. The agrochemical compositions may be applied to microorganisms and/or their habitat.

農業化學組成物通常包括至少一種活性化合物組合和至少一種農業上適宜的助劑 (auxiliary),例如一種或多種載體及/或一種或多種表面活性劑。Agrochemical compositions generally comprise at least one active compound combination and at least one agriculturally suitable auxiliary, such as one or more carriers and/or one or more surfactants.

在本案的說明書中,「有害微生物的控制」意指與未經處理的植物相比,對於有害微生物的侵染減少。以殺真菌劑的效力作為測量對象,與未經處理的植物 (100%)相比,較佳是感染降低25-50%;與未經處理的植物 (100%)相比,更佳是將低40-79%;甚至更好地是受有害微生物的感染完全被抑制(抑制程度為70-100%)。所述控制可以是治療性的,即用於處理已經感染的植物,或保護性的,用於保護尚未感染的植物。In the present specification, "control of harmful microorganisms" means a reduction in the infestation of harmful microorganisms compared to untreated plants. The efficacy of the fungicide is measured as a 25-50% reduction in infection compared to untreated plants (100%); more preferably 25-50% reduction in infection compared to untreated plants (100%) 40-79% lower; even better infection by harmful microorganisms is completely inhibited (70-100% inhibition). The control can be curative, ie for the treatment of already infected plants, or protective, for the protection of not yet infected plants.

「有效但無植物毒性的量」係指新穎農業化學組成物的量足以以令人滿意的方式控制植物的真菌病或完全根除真菌病,同時不會引起任何明顯的植物毒性症狀。通常,該施用率可以在相對寬的範圍內變化。其可取決於幾個因素,例如取決於要控制的真菌、植物、氣候條件以及本案組合物的成分。"Effective but non-phytotoxic amount" means an amount of the novel agricultural chemical composition sufficient to control fungal diseases or completely eradicate fungal diseases of plants in a satisfactory manner without causing any overt phytotoxic symptoms. In general, the application rates can be varied within relatively wide ranges. It may depend on several factors, eg on the fungus to be controlled, the plant, the climatic conditions and the ingredients of the present composition.

助劑的選擇與如式 (I)所示之化合物的預期應用方式和/或其物理性質有關。此外,可以選擇助劑以賦予組合物特定的性質(技術、物理和/或生物學上之性質)或使用以此方式製備的劑型。助劑的選擇可讓組成物進行客製化以符合特定需求。The choice of adjuvant is related to the expected application mode and/or its physical properties of the compound represented by formula (I). Furthermore, adjuvants can be chosen in order to impart specific properties (technical, physical and/or biological) to the composition or to use the dosage form prepared in this way. The choice of additives allows the composition to be customized to meet specific needs.

本發明的新穎農業化學組成物可為任何常規劑型,例如溶液(如水溶液)、乳液、可濕性粉劑、水性和油性懸浮液、粉末、粉塵、糊狀物、可溶性粉末、可溶性顆粒、播撒用顆粒物、懸浮乳液濃縮物、浸有農用化學成分天然或合成產品、肥料以及聚合物質中的微膠囊。本案的農業化學組成物可以懸浮、乳化或溶解的形式存在。The novel agrochemical compositions of the present invention may be in any conventional dosage form such as solutions (e.g. aqueous solutions), emulsions, wettable powders, aqueous and oily suspensions, powders, dusts, pastes, soluble powders, soluble granules, Granules, suspoemulsion concentrates, natural or synthetic products impregnated with agrochemical ingredients, fertilizers and microcapsules in polymeric substances. The agricultural chemical composition of the present invention can exist in the form of suspension, emulsification or dissolution.

本案之新穎農業化學組成物可以是以即用製劑的形式提供給終端使用者,即組成物可藉由合適的裝置(例如噴霧或除塵裝置)直接地施用到植物或種子上。或者,組成物可以濃縮物的形式提供給終端使用者,所述組合物在使用前必須先稀釋(較佳為用水稀釋)。The novel agricultural chemical composition of the present application can be provided to end users in the form of a ready-to-use formulation, that is, the composition can be directly applied to plants or seeds by suitable means (such as spraying or dusting devices). Alternatively, the composition may be provided to the end user in the form of a concentrate which must be diluted (preferably with water) before use.

本案的新穎農業化學組成物可以常規方式製備,例如藉由將本案的農業化學組成物與一種或多種合適的助劑(例如前文中所公開的助劑)混合來製備。The novel agrochemical composition of the present invention can be prepared in a conventional manner, for example, by mixing the agrochemical composition of the present invention with one or more suitable adjuvants, such as the adjuvants disclosed above.

本案的新穎農業化學組成物通常包含占總重量之0.01%至99%、0.05%至98%、較佳為0.1%至95%、更佳為0.5%至90%、最佳為10%至70%的本案活性化合物。The novel agricultural chemical composition of the present case usually comprises 0.01% to 99%, 0.05% to 98%, preferably 0.1% to 95%, more preferably 0.5% to 90%, and most preferably 10% to 70% of the total weight % of active compounds in this case.

施用率係在寬廣的範圍內變化,其取決於土壤的性質、施用方法、農作物、要控制的害蟲、主要氣候條件、以及受施用方法、施用時間以及目標作物影響的其他因素。作為一般的原則,化合物的施用率可以為1至2000 L/公頃 (L/ha),特別是10至1000 L/公頃。Application rates vary within wide ranges depending on the nature of the soil, the method of application, the crop, the pests to be controlled, prevailing climatic conditions, and other factors affected by the method of application, the timing of application, and the target crop. As a general rule, the compound can be applied at a rate of 1 to 2000 liters per hectare (L/ha), especially 10 to 1000 L/ha.

本案的新穎農業化學組成物可直接施用,亦即不包含任何其他成分且不需經過稀釋。一般而言,較佳係將該組合物以適當製劑(調配物)的形式施用於種子。用於種子處理之適當製劑和方法是本發明所屬領域具有通常知識者所已知的,並且已在例如以下的文件之中公開:美國專利公告號US4272417、美國專利公告號US4245432、美國專利公告號US4808430、美國專利公告號US5876739、美國專利公告號US20030176428、PCT專利公開號WO2002080675、PCT專利公開號WO2002028186。The novel agricultural chemical composition of the present case can be applied directly, ie does not contain any other ingredients and does not need to be diluted. In general, it is preferred to apply the composition to the seed in a suitable formulation (formulation). Suitable formulations and methods for seed treatment are known to those of ordinary skill in the art to which this invention pertains and are disclosed in, for example, U.S. Patent Publication No. US4272417, U.S. Patent Publication No. US4245432, U.S. Patent Publication No. US4808430, US Patent Publication No. US5876739, US Patent Publication No. US20030176428, PCT Patent Publication No. WO2002080675, PCT Patent Publication No. WO2002028186.

本案使用的新穎農業化學組成物可製成如下所述的製劑形式:粉劑、溶液劑、懸浮劑、粉劑、糊劑、水懸劑 (suspension concentrate, SC)、水分散粒劑 (water dispersible granule, WDG或WG)、片劑 (tablet, TB)、可濕性粉劑 (wettable powder, WP)、水分散性片劑 (water dispersible tablet, WT)、超低容量懸浮劑 (ultra-low volume, ULV)、超低容量液劑 (UL)、超低容量懸浮劑 (ultra-low volume, ULV)、懸浮劑 (suspension, SU)、水溶性粉劑 (water soluble powder, SP)、濃懸乳劑 (suspo-emulsion, SE)、顆粒劑 (granule, GR)、乳粒劑 (emulsifiable granule, EG)、水基乳劑 (oil-in-water emulsion, EW)、乳粒劑 (emulsifiable granule, EG)、油基乳劑 (emulsion oil in water, EO)、乳粉劑 (emulsifiable powder, EP)、種子處理乳液 (emulsion for seed treatment, ES)、種子處理溶液 (solution for seed treatment, LS)、種子處理用水懸劑 (flowable concentrate for seed treatment, FS)、乳劑 (emulsifiable concentrate, EC)、微乳劑 (micro-emulsion, ME)、水基乳劑 (EW)、油溶性可流動濃縮物(油懸劑)(oil miscible flowable concentrate, OF)、油分散性粉劑 (oil dispersible powder, OP)、水分散性油懸劑 (oil dispersion, OD)、膠囊懸著劑 (capsule suspension, CS)、粉劑 (dustable powder, DP)、可溶性濃縮物 (soluble concentrate, SL)、水溶性顆粒 (water soluble granule, SG)、氣霧劑 (aerosol, AE)、膠囊懸著劑 (CS)和水懸劑 (SC)的混合製劑 (ZC)、膠囊懸著劑 (CS)和濃懸乳劑 (SE)的混合製劑 (ZE)或膠囊懸著劑 (CS)和水基乳劑(EW)的混合製劑 (ZW)。The novel agricultural chemical composition used in this case can be made into the following preparation forms: powder, solution, suspension, powder, paste, suspension concentrate (SC), water dispersible granule (water dispersible granule, WDG or WG), tablet (tablet, TB), wettable powder (wettable powder, WP), water dispersible tablet (water dispersible tablet, WT), ultra-low volume suspension (ultra-low volume, ULV) , Ultra-low volume liquid (UL), Ultra-low volume (ULV), Suspension (SU), Water soluble powder (SP), Suspo-emulsion , SE), granule (granule, GR), emulsion (emulsifiable granule, EG), water-based emulsion (oil-in-water emulsion, EW), emulsion (emulsifiable granule, EG), oil-based emulsion ( emulsion oil in water, EO), milk powder (emulsifiable powder, EP), seed treatment emulsion (emulsion for seed treatment, ES), seed treatment solution (solution for seed treatment, LS), seed treatment water suspension (flowable concentrate for seed treatment, FS), emulsion (emulsifiable concentrate, EC), microemulsion (micro-emulsion, ME), water-based emulsion (EW), oil-soluble flowable concentrate (oil suspension) (oil miscible flowable concentrate, OF) , oil dispersible powder (oil dispersible powder, OP), water dispersible oil suspension (oil dispersion, OD), capsule suspension (capsule suspension, CS), powder (dustable powder, DP), soluble concentrate (soluble concentrate, SL), water soluble granule (water soluble granule, SG), aerosol (aerosol, AE), glue Mixed preparation (ZC) of capsule suspension (CS) and water suspension (SC), mixed preparation (ZE) of capsule suspension (CS) and suspoemulsion (SE), or capsule suspension (CS) and Mixed formulations (ZW) of water-based emulsions (EW).

本案使用的新穎農業化學組成物可以製成為常規的拌種製劑 (seed dressing formulation)形式,例如溶液、乳液、懸浮液、粉末、泡沫、漿液或其他種子包衣組合物,以及超低容量溶液。這些製劑可以已知的方式製備—藉由將活性化合物與農用可接受之添加劑混合,農用可接受之添加劑例如常規的增量劑以及溶劑或稀釋劑、染料、潤濕劑、分散劑、乳化劑、防沫劑 (antifoam)、防腐劑、填充劑、增稠劑、黏合劑、赤黴素 (gibberellins)、固體載體、液體載體、氣體載體、表面活性劑、結合劑、崩解劑、pH調節劑、抗結塊劑 (anti-caking agent)、滲透劑、防凍劑、消泡劑 (defoaming agent)、增量劑 (extender)、穩定劑及/或著色劑或前述之組合以及水。The novel agrochemical compositions used in this case can be formulated in conventional seed dressing formulations such as solutions, emulsions, suspensions, powders, foams, slurries or other seed coating compositions, as well as ultra-low volume solutions. These formulations can be prepared in a known manner by mixing the active compounds with agriculturally acceptable additives, such as customary extenders as well as solvents or diluents, dyes, wetting agents, dispersants, emulsifiers , antifoam, preservatives, fillers, thickeners, binders, gibberellins, solid carriers, liquid carriers, gas carriers, surfactants, binders, disintegrants, pH adjustment agent, anti-caking agent, penetrating agent, antifreeze agent, defoaming agent (defoaming agent), extender (extender), stabilizer and/or coloring agent or a combination of the foregoing and water.

染料可以選自包含若丹明B (Rhodamine B)、C.I.顏料紅112 (C.I. Pigment Red 112)以及C.I.溶劑紅1. (C.I. Solvent Red 1)的群組。可用於本案拌種劑中的有用潤濕劑係所有促進潤濕且其通常用於配製活性農業化學成分製劑的物質。較佳係使用烷基萘磺酸烷基酯 (alkyl naphthalenesulphonates),例如二異丙基萘磺酸鈉或二異丁基萘磺酸酯 (diisopropyl or diisobutyl naphthalenesulphonates)。The dye may be selected from the group comprising Rhodamine B, C.I. Pigment Red 112, and C.I. Solvent Red 1. Useful wetting agents which can be used in the seed dressings in this case are all substances which promote wetting and which are usually used in the formulation of active agrochemical ingredients. Preferably, alkyl naphthalenesulphonates, such as diisopropyl or diisobutyl naphthalenesulphonates, are used.

載體係選自包含但不限於通常呈惰性的固體或液體、天然或合成、有機或無機之物質的群組。載體通常用於改善化合物的施用,例如,用於植物、植物部分或種子。合適的 固體載體的實例包括但不限於銨鹽、天然岩石粉(例如高嶺土、黏土、滑石粉、白堊 (chalk)、石英、厄帖浦石 (attapulgite)、蒙脫石和矽藻土)以及合成岩石粉,例如細碎之矽粉、氧化鋁和矽酸鹽。用於製備顆粒的典型可用之固體載體的實例包括但不限於粉碎及分離的天然岩石(例如方解石、大理石、浮石 (pumice)、海泡石 (sepiolite) 和白雲石 (dolomite))、無機和有機粉末的合成顆粒以及有機材料(例如紙、鋸末、椰子殼、玉米棒和煙草秸稈)的顆粒。合適的 液體載體的實例包括但不限於水、有機溶劑及其組合。合適的 溶劑的實例包括極性及非極性之有機化學液體,例如來自芳香族及非芳香族碳氫化合物(例如環己烷、鏈烷烴、烷基苯、二甲苯、甲苯烷基萘、氯化芳烴或氯化脂肪族烴,如氯苯、氯乙烯或亞甲基氯)、醇以及多元醇(其亦可任選地被取代、醚化和/或酯化,例如丁醇或乙二醇)、酮(例如丙酮、甲乙酮、甲基異丁基酮或環己酮)、酯類(包括脂肪和油)和(聚)醚、未被取代和被取代的胺、醯胺(例如二甲基甲醯胺),內醯胺(如N-烷基吡咯烷酮)和內酯、碸和亞碸(如二甲基亞碸)。載體也可以是液化的氣態增量劑,即在標準溫度和標準壓力下為氣態的液體,例如鹵代烴、丁烷、丙烷、氮氣和二氧化碳等氣溶膠推進劑。 The carrier system is selected from the group including, but not limited to, generally inert solid or liquid, natural or synthetic, organic or inorganic substances. Carriers are often used to improve the application of compounds, for example, to plants, plant parts or seeds. Examples of suitable solid carriers include, but are not limited to, ammonium salts, natural rock flours (such as kaolin, clay, talc, chalk, quartz, attapulgite, montmorillonite, and diatomaceous earth), and synthetic rocks Powders such as finely divided silica, alumina and silicates. Examples of typical useful solid carriers for the preparation of particles include, but are not limited to, crushed and isolated natural rocks (such as calcite, marble, pumice, sepiolite, and dolomite), inorganic and organic Synthetic granules of powders and granules of organic materials such as paper, sawdust, coconut shells, corn cobs and tobacco straw. Examples of suitable liquid carriers include, but are not limited to, water, organic solvents, and combinations thereof. Examples of suitable solvents include polar and non-polar organic chemical liquids, such as those derived from aromatic and non-aromatic hydrocarbons (e.g., cyclohexane, paraffins, alkylbenzenes, xylenes, tolylalkylnaphthalenes, or chlorinated aliphatic hydrocarbons such as chlorobenzene, vinyl chloride or methylene chloride), alcohols and polyols (which may also optionally be substituted, etherified and/or esterified, such as butanol or ethylene glycol) , ketones (such as acetone, methyl ethyl ketone, methyl isobutyl ketone or cyclohexanone), esters (including fats and oils) and (poly)ethers, unsubstituted and substituted amines, amides (such as dimethyl formamides), lactams (e.g. N-alkylpyrrolidones) and lactones, thiamines and sulfides (e.g. dimethylsulfide). The carrier may also be a liquefied gaseous extender, ie a liquid which is gaseous at standard temperature and pressure, such as aerosol propellants such as halogenated hydrocarbons, butane, propane, nitrogen and carbon dioxide.

表面活性劑選自包含但不限於以下所述的群組:離子(陽離子或陰離子)或非離子表面活性劑,例如離子或非離子乳化劑、泡沫形成劑、分散劑、潤濕劑及其任何混合物。合適的表面活性劑的實例包含但不限於聚丙烯酸鹽、木質素磺酸鹽 (salts of lignosulphonic acid)、酚磺酸或萘磺酸鹽、乙烯及/或環氧丙烷與脂肪醇、脂肪酸或脂肪胺的縮聚物醚(聚氧乙烯脂肪酸酯、聚氧乙烯脂肪醇,例如烷基醯聚乙二醇醚)、取代酚(較佳為烷基酚或芳基酚)、磺基琥珀酸酯鹽、牛磺酸衍生物(較佳烷基牛磺酸酯)、聚乙氧基化醇或酚的磷酸酯、多元醇脂肪酸酯和含有硫酸鹽、磺酸鹽、磷酸鹽的化合物的衍生物(例如烷基磺酸鹽、烷基硫酸鹽、芳基磺酸鹽)和蛋白質水解物、木質素磺酸鹽廢液和甲基纖維素。表面活性劑通常係在如式 (I)所示之化合物及/或載體的組合物不溶於水、但其施用時需要用到水時使用。然後,表面活性劑的量通常占組成物總重量的5%到40%之間。Surfactants are selected from the group comprising, but not limited to, ionic (cationic or anionic) or nonionic surfactants, such as ionic or nonionic emulsifiers, foam formers, dispersants, wetting agents, and any mixture. Examples of suitable surfactants include, but are not limited to, polyacrylates, salts of lignosulphonic acid, phenolsulfonic acid or naphthalenesulfonate, ethylene and/or propylene oxide with fatty alcohols, fatty acids or fats Polycondensate ethers of amines (polyoxyethylene fatty acid esters, polyoxyethylene fatty alcohols, such as alkylacylpolyglycol ethers), substituted phenols (preferably alkylphenols or arylphenols), sulfosuccinates Derivatization of salts, taurine derivatives (preferably alkyl taurates), phosphate esters of polyethoxylated alcohols or phenols, polyol fatty acid esters and compounds containing sulfates, sulfonates, phosphates products (e.g. alkyl sulfonates, alkyl sulfates, aryl sulfonates) and protein hydrolysates, lignosulfonate waste streams and methyl cellulose. Surfactants are generally used when the composition of the compound represented by formula (I) and/or the carrier is insoluble in water, but water is required for its application. The amount of surfactant is then usually between 5% and 40% by weight of the total composition.

合適的助劑實例選自包含但不限於以下所述的群組:防水劑、乾燥劑、接合劑 (binders)(黏著劑 (adhesive)、增黏劑、例如羧甲基纖維素等固定劑、粉末、顆粒或膠乳形式的天然及合成聚合物,例如阿拉伯膠、聚乙烯醇及聚醋酸乙烯酯、天然磷脂(例如腦磷脂 (cephalins)及卵磷脂)及合成磷脂、聚乙烯吡咯烷酮、聚醋酸乙烯酯、聚乙烯醇和填充體 (tylose))、增稠劑、穩定劑(例如冷穩定劑、防腐劑、抗氧化劑、光穩定劑或其他提高化學和/或物理穩定性的試劑)、染料或顏料(例如無機顏料,例如氧化鐵、氧化鈦和普魯士藍;有機染料,如茜草色素、偶氮和金屬酞菁染料)、消泡劑(例如有機矽消泡劑和硬脂酸鎂)、防腐劑(例如二氯苯酚和苄醇半甲醛)、二次增稠劑(纖維素衍生物、丙烯酸衍生物、黃原膠 (xanthan)、改性黏土和仔細分離的矽粉)、黏著劑 (sticker)、赤黴素和加工助劑、礦物油和植物油、香水、蠟、營養素(包括微量營養素,如鐵鹽、錳鹽、硼鹽、銅鹽、鈷鹽、鉬鹽和鋅鹽)、保護膠體、觸變物質 (thixotropic substance)、滲透劑、螯合劑和配位劑 (complex former)。Examples of suitable auxiliary agents are selected from the group including but not limited to: waterproofing agents, desiccants, binders (adhesives, tackifiers, fixing agents such as carboxymethyl cellulose, Natural and synthetic polymers in powder, granule or latex form, such as gum arabic, polyvinyl alcohol and polyvinyl acetate, natural and synthetic phospholipids (such as cephalins and lecithins), polyvinylpyrrolidone, polyvinyl acetate esters, polyvinyl alcohol and fillers (tylose)), thickeners, stabilizers (such as cold stabilizers, preservatives, antioxidants, light stabilizers or other agents that increase chemical and/or physical stability), dyes or pigments (such as inorganic pigments such as iron oxide, titanium oxide, and Prussian blue; organic dyes such as madder, azo, and metal phthalocyanines), defoamers (such as silicone defoamers and magnesium stearate), preservatives (e.g. dichlorophenol and benzyl alcohol hemiformaldehyde), secondary thickeners (cellulose derivatives, acrylic acid derivatives, xanthan gum (xanthan), modified clays, and finely separated silicon powder), adhesives (stickers) , gibberellins and processing aids, mineral and vegetable oils, perfumes, waxes, nutrients (including micronutrients such as iron, manganese, boron, copper, cobalt, molybdenum and zinc salts), protective colloids, Thixotropic substances, penetrants, chelating agents and complex formers.

分散劑及/或乳化劑選自包含但不限於非離子分散劑或陰離子分散劑,或非離子分散劑之混合物或陰離子分散劑之混合物的群組。合適的非離子分散劑特別是包括環氧乙烷/環氧丙烷嵌段之聚合物、烷基酚聚乙二醇醚和三苯乙烯基酚聚乙二醇醚,及其磷酸化或硫酸化的衍生物。合適的陰離子分散劑特別是木質素磺酸鹽、聚丙烯酸鹽和芳基磺酸鹽/甲醛縮合物。Dispersants and/or emulsifiers are selected from the group comprising, but not limited to, nonionic or anionic dispersants, or mixtures of nonionic or anionic dispersants. Suitable nonionic dispersants are especially polymers comprising ethylene oxide/propylene oxide blocks, alkylphenol polyglycol ethers and tristyrylphenol polyglycol ethers, and their phosphorylated or sulfated Derivatives. Suitable anionic dispersants are especially lignosulfonates, polyacrylates and arylsulfonate/formaldehyde condensates.

防沫劑 (antifoams)選自包含但不限於由有機矽消泡劑以及硬脂酸鎂所組成的群組。防腐劑選自包含但不限於在農業化學組成物中可用於此類目的的所有物質的群組。實例包含二氯苯和苄醇半縮甲醛。Antifoams are selected from the group consisting of, but not limited to, silicone antifoams and magnesium stearate. Preservatives are selected from the group comprising, but not limited to, all substances usable for such purposes in agrochemical compositions. Examples include dichlorobenzene and benzyl alcohol hemiformal.

增稠劑係選自包含但不限於纖維素衍生物、丙烯酸衍生物、黃原膠、改性黏土和矽粉的群組。The thickener is selected from the group including but not limited to cellulose derivatives, acrylic acid derivatives, xanthan gum, modified clays and silica fume.

黏合劑選自包含但不限於聚乙烯吡咯烷酮、聚乙酸乙烯酯、聚乙烯醇和填充體的群組。The binder is selected from the group including but not limited to polyvinylpyrrolidone, polyvinyl acetate, polyvinyl alcohol and fillers.

液體載體選自包含但不限於由以下所組成的群組:水;乙醇、丙醇、丁醇、正辛醇、異丙醇、乙二醇、二甘醇、丙二醇、聚乙二醇、苯甲醇、甘油等醇類;乙二醇單丙醚、二乙二醇單甲醚、二丙二醇二甲醚等多元醇醚;丙酮、甲基乙基酮、甲基異丁基酮、環己酮等酮類;二丙醚、二噁烷、四氫呋喃等醚類;正鏈烷烴、異鏈烷烴、煤油、礦物油等脂肪族烴類;芳香烴如二甲苯、甲苯、環烷烴、溶劑石腦油、C9溶劑、C10溶劑、C12溶劑、芳烴溶劑油solvesso 100、solvesso 150、solvesso 200;氯化脂肪族或芳香族烴,如氯苯、氯乙烯、二氯甲烷;乙酸乙酯、鄰苯二甲酸二異丙酯、己二酸二甲酯、油酸甲酯、牛脂酸甲酯等酯類;內酯如γ-丁內酯、γ-戊內酯、ε-己內酯;二甲基甲醯胺、N-甲基吡咯烷酮、N-辛基吡咯烷酮、N,N-二甲基癸醯胺等醯胺類;乙腈等腈類;二甲基亞碸等有機硫化合物;植物油,如豆油、菜籽油、棉籽油。這些液體載體可以單獨使用或組合使用。The liquid carrier is selected from the group consisting of, but not limited to, water; ethanol, propanol, butanol, n-octanol, isopropanol, ethylene glycol, diethylene glycol, propylene glycol, polyethylene glycol, benzene Methanol, glycerin and other alcohols; ethylene glycol monopropyl ether, diethylene glycol monomethyl ether, dipropylene glycol dimethyl ether and other polyol ethers; acetone, methyl ethyl ketone, methyl isobutyl ketone, cyclohexanone Ketones such as dipropyl ether, dioxane, tetrahydrofuran and other ethers; n-paraffins, isoparaffins, kerosene, mineral oil and other aliphatic hydrocarbons; aromatic hydrocarbons such as xylene, toluene, naphthenes, solvent naphtha , C9 solvent, C10 solvent, C12 solvent, aromatic solvent oil solvesso 100, solvesso 150, solvesso 200; chlorinated aliphatic or aromatic hydrocarbons, such as chlorobenzene, vinyl chloride, methylene chloride; ethyl acetate, phthalic acid Diisopropyl ester, dimethyl adipate, methyl oleate, methyl tallowate and other esters; lactones such as γ-butyrolactone, γ-valerolactone, ε-caprolactone; dimethyl formazan Amides such as amide, N-methylpyrrolidone, N-octylpyrrolidone, N,N-dimethyldecylamide, etc.; nitriles such as acetonitrile; organosulfur compounds such as dimethylsulfoxide; vegetable oils, such as soybean oil, Rapeseed Oil, Cottonseed Oil. These liquid carriers can be used alone or in combination.

氣態載體選自包含但不限於由以下所組成的群組:液化石油氣、空氣、氮氣、二氧化碳及二甲醚。這些氣體載體可以單獨使用或組合使用。The gaseous carrier is selected from the group consisting of, but not limited to, liquefied petroleum gas, air, nitrogen, carbon dioxide, and dimethyl ether. These gas carriers can be used alone or in combination.

表面活性劑可以是非離子或陰離子表面活性劑,或是前述之組合。較佳係使用一種或多於一種的表面活性劑。表面活性劑選自包括但不限於以下所述的組合:糖酯 (sugar ester),如山梨糖醇酐單油酸酯、聚氧乙烯-山梨醇酐單油酸酯;C1-C30烷基羧酸酯、C1-C20羥基烷基羧酸酯、含有具有2至32個碳原子的羧酸酯、芳基羧酸酯、烷基x (alkylx)(例如脂肪族二羧酸及三羧酸酯)的聚合物,例如烏頭酸、己二酸、天冬氨酸、檸檬酸、延胡索酸 (fumaric acid)、半乳糖酸、麩胺酸、戊二酸、氧代戊二酸 (oxoglutaric acid)、馬來酸、蘋果酸、丙二酸、草酸鹽、癸二酸、琥珀酸、酒石酸;烷基多糖苷如癸基葡糖苷;聚氧乙烯烷基醚如聚氧乙烯月桂醚或聚氧乙烯椰子脂肪醇醚;聚氧乙烯炔醚如聚氧乙烯2,4,7,9-四甲基-5-癸炔-4,7-二醇醚 (polyoxyethylene 2,4,7,9-tetramethyl-5-decyn-4,7-diol ether);聚氧乙烯壬基苯基醚 (polyoxyethylene nonylphenyl ether)或聚氧乙烯三苯乙烯基苯基醚 (polyoxyethylene tristyrylphenyl ether)等聚氧乙烯芳基醚 (polyoxyethylene aryl ethers);聚氧乙烯蓖麻油 (polyoxyethylene castor oil)或聚氧乙烯氫化蓖麻油 (polyoxyethylene hydrogenated castor oil)等聚氧乙烯植物油醚 (polyoxyethylene vegetable oil ethers);植物油乙氧基化物;C6-C20直鏈和支鏈醇乙氧基化物 (alcohol ethoxylate)、C6-C20醇丙氧基化物、C6-C20丙氧基化和乙氧基化醇;聚氧乙烯脂肪酸酯如聚氧乙烯單月桂酸酯、聚氧乙烯二硬脂酸酯或聚氧乙烯樹脂酸酯; 聚氧乙烯聚氧丙烯 (EO-PO)嵌段共聚物,例如Pluronic ®;聚氧乙烯聚氧丙烯烷基醚 (polyoxyethylene polyoxypropylene alkyl ether),如聚氧乙烯聚氧丙烯月桂基醚;聚氧乙烯聚氧丙烯芳基醚,如聚氧乙烯聚氧丙烯苯乙烯基苯基醚;改性苯乙烯丙烯酸類聚合物,聚氧乙烯烷基胺,如聚氧乙烯硬脂胺;聚氧乙烯脂肪酸醯胺,如月桂酸二乙醇醯胺等;氟化表面活性劑;烷基硫酸鹽如十二烷基硫酸鈉; 烷基苯磺酸鈉、烷基苯磺酸鈣;聚氧乙烯烷基醚硫酸鹽,如聚氧乙烯十二烷基醚硫酸鈉;聚氧乙烯芳基醚硫酸鹽,如聚氧乙烯壬基苯基醚硫酸鈉或聚氧乙烯三苯乙烯基苯基醚硫酸銨;芳基磺酸鹽,如苯磺酸鈣、十二烷基苯磺酸鈣、萘磺酸鈉、萘磺酸縮合物鈉鹽 (MORWET® D-425)或萘磺酸鈉甲醛縮合物;聚芳基苯基醚硫酸銨鹽;‘α’-烯烴磺酸鹽;月桂醇磺基琥珀酸酯 (lauryl sulfosuccinate)、月桂醇聚醚磺基琥珀酸酯 (laureth sulfosuccinate)、月桂基聚醚-5磺基琥珀酸酯 (Laneth-5 Sulfosuccinate)、蓖麻油醯胺MEA磺基琥珀酸酯 (ricinoleamide MEA sulfosuccinate)、十一碳烯胺MEA磺基琥珀酸酯 (undecylenearnide MEA sulfosuccinate)、磺基琥珀酸二異丁酯 (diisobutyl sulfosuccinate)、磺基琥珀酸二辛酯 (dioctyl sulfosuccinate)、磺基琥珀酸二己基酯 (dihexyl sulfosuccinate)、琥珀磺基琥珀酸二環己基酯 (dicyclohexyl sulfosuccinate)、磺基琥珀酸二異癸酯 (diisodecyl sulfosuccinate)、磺基琥珀酸二異十三烷基酯 (diisotridecyl sulfosuccinate)、磺基琥珀酸二-2-乙基己酯 (di-2-ethylhexyl sulfosuccinate)、磺基琥珀酸二甲基戊酯 (dimethylamyl sulfosuccinate)、磺基琥珀酸二丁基己基酯 (dibutylhexyl sulfosuccinate)、磺基琥珀酸二異辛酯 (diisooctyl sulfosuccinate) 或其鹼金屬鹽、木質素磺酸鈉;聚羧酸鈉鹽;N-甲基脂肪酸肌氨酸鹽 (N-methyl fatty acid sarcosinate);聚氧乙烯烷基醚磷酸酯 (polyoxyethylene alkyl ether phosphate); 聚氧乙烯芳醚磷酸酯 (polyoxyethylene aryl ether phosphates),如聚氧乙烯苯基醚磷酸酯 (polyoxyethylene phenyl ether phosphate);聚氧乙烯烷基苯基醚磷酸酯 (polyoxyethylene alkyl phenyl ether phosphate);接枝共聚物,如聚甲基丙烯酸甲酯-聚乙二醇接枝共聚物 (polymethyl methacrylate-polyethylene glycol graft copolymer)。這些表面活性劑可以單獨使用或組合使用。另一方面,表面活性劑可用作洗滌劑、潤濕劑、乳化劑、發泡劑、分散劑、鋪展劑 (spreader)、增強滲透、耐雨水牢度 (rain fastness)或土壤浸出控制 (soil leaching control)等之助劑。 The surfactant can be a nonionic or anionic surfactant, or a combination of the foregoing. Preferably one or more than one surfactant is used. Surfactant is selected from the combination including but not limited to the following: sugar ester (sugar ester), such as sorbitan monooleate, polyoxyethylene-sorbitan monooleate; C1-C30 alkyl carboxyl Esters, C1-C20 hydroxyalkyl carboxylates, esters containing carboxylates having 2 to 32 carbon atoms, aryl carboxylates, alkylx (alkylx) (e.g. aliphatic dicarboxylic and tricarboxylic acid esters ), such as aconitic acid, adipic acid, aspartic acid, citric acid, fumaric acid, galactobionic acid, glutamic acid, glutaric acid, oxoglutaric acid, horse Malic acid, malic acid, malonic acid, oxalate, sebacic acid, succinic acid, tartaric acid; alkyl polyglycosides such as decyl glucoside; polyoxyethylene alkyl ethers such as polyoxyethylene lauryl ether or polyoxyethylene coco Fatty alcohol ether; polyoxyethylene alkyne ether such as polyoxyethylene 2,4,7,9-tetramethyl-5-decyne-4,7-diol ether (polyoxyethylene 2,4,7,9-tetramethyl-5 -decyn-4,7-diol ether); polyoxyethylene nonylphenyl ether (polyoxyethylene nonylphenyl ether) or polyoxyethylene tristyrylphenyl ether (polyoxyethylene tristyrylphenyl ether) and other polyoxyethylene aryl ether (polyoxyethylene aryl ethers); polyoxyethylene vegetable oil ethers such as polyoxyethylene castor oil or polyoxyethylene hydrogenated castor oil; vegetable oil ethoxylates; C6-C20 straight chain and branched alcohol ethoxylates, C6-C20 alcohol propoxylates, C6-C20 propoxylated and ethoxylated alcohols; polyoxyethylene fatty acid esters such as polyoxyethylene monolaurate , polyoxyethylene distearate or polyoxyethylene resinate; polyoxyethylene polyoxypropylene (EO-PO) block copolymers, such as Pluronic ® ; polyoxyethylene polyoxypropylene alkyl ether (polyoxyethylene polyoxypropylene alkyl ether), such as polyoxyethylene polyoxypropylene lauryl ether; polyoxyethylene polyoxypropylene aryl ether, such as polyoxyethylene polyoxypropylene styryl phenyl ether; modified styrene acrylic polymer, polyoxyethylene Alkylamines, such as polyoxyethylene stearylamine; polyoxyethylene fatty acid amides, such as diethanolamide laurate, etc.; fluorinated surfactants; alkyl sulfates such as sodium lauryl sulfate; Sodium Acid, Calcium Alkylbenzene Sulfonate; Polyoxyethylene Alkyl Ether Sulfate, Such as sodium polyoxyethylene lauryl ether sulfate; polyoxyethylene aryl ether sulfate, such as polyoxyethylene nonylphenyl ether sodium sulfate or polyoxyethylene tristyrylphenyl ether ammonium sulfate; arylsulfonic acid Salts such as calcium benzenesulfonate, calcium dodecylbenzenesulfonate, sodium naphthalenesulfonate, sodium naphthalenesulfonic acid condensate (MORWET® D-425) or sodium naphthalenesulfonate formaldehyde condensate; polyarylphenyl Ammonium ether sulfate; 'alpha'-olefin sulfonate; lauryl sulfosuccinate, laureth sulfosuccinate, laureth-5 sulfosuccinate Ester (Laneth-5 Sulfosuccinate), ricinoleamide MEA sulfosuccinate (ricinoleamide MEA sulfosuccinate), undecylenearnide MEA sulfosuccinate (undecylenearnide MEA sulfosuccinate), diisobutyl sulfosuccinate ( diisobutyl sulfosuccinate), dioctyl sulfosuccinate, dihexyl sulfosuccinate, dicyclohexyl sulfosuccinate, diisodecyl sulfosuccinate (diisodecyl sulfosuccinate), diisotridecyl sulfosuccinate, di-2-ethylhexyl sulfosuccinate, dimethylpentyl sulfosuccinate Dimethylamyl sulfosuccinate, dibutylhexyl sulfosuccinate, diisooctyl sulfosuccinate or their alkali metal salts, sodium lignosulfonate; sodium polycarboxylate; N-methyl fatty acid sarcosinate; polyoxyethylene alkyl ether phosphate; polyoxyethylene aryl ether phosphates, such as polyoxyethylene aryl ether phosphates Polyoxyethylene phenyl ether phosphate; polyoxyethylene alkyl phenyl ether phosphate phosphate); graft copolymers, such as polymethyl methacrylate-polyethylene glycol graft copolymer (polymethyl methacrylate-polyethylene glycol graft copolymer). These surfactants may be used alone or in combination. On the other hand, surfactants can be used as detergents, wetting agents, emulsifiers, foaming agents, dispersants, spreaders, penetration enhancement, rain fastness, or soil leaching control. leaching control) and other additives.

滲透劑選自包含但不限於由以下所述所組成的群組中的一種或多種:醇、乙二醇、乙二醇醚、酯、胺、烷醇胺 (alkanolamine)、氧化胺 (amine oxide)、季銨化合物、甘油三酯、脂肪酸酯、脂肪酸醚、N-甲基吡咯烷酮 (N-methyl pyrrolidone)、二甲基甲醯胺 (dimethylformamide)、二甲基乙醯胺 (dimethyl acetamide)、二甲基亞碸 (dimethyl sulfoxide)、聚氧乙烯三羥甲基丙烷單油酸酯 (polyoxyethylenetrimethylolpropanemonooleate)、聚氧乙烯三羥甲基丙烷二油酸酯 (polyoxyethylenetrimeth ylolpropanedioleate)、聚氧乙烯三羥甲基丙三油酸酯 (polyoxyethylenetrimethylolpropanetrioleate)、聚氧乙烯山梨醇單油酸酯 (polyoxyethylenesorbitanmonooleate)、聚氧乙烯山梨糖醇六油酸酯 (polyoxyethylene sorbitol hexaoleate)和甲基化大豆油 (methylated soybean oil)。然而,本發明所屬技術領域中具有通常知識者可明白,在不逸脫本案範圍的前提下,可使用不同之滲透劑。The penetrant is selected from one or more of the group consisting of, but not limited to: alcohol, ethylene glycol, glycol ether, ester, amine, alkanolamine, amine oxide ), quaternary ammonium compounds, triglycerides, fatty acid esters, fatty acid ethers, N-methyl pyrrolidone, dimethylformamide, dimethyl acetamide, Dimethyl sulfoxide, polyoxyethylenetrimethylolpropanemonooleate, polyoxyethylenetrimethylolpropanemonooleate, polyoxyethylenetrimethylolpropanedioleate, polyoxyethylenetrimethylolpropanedioleate Polyoxyethylenetrimethylolpropanetrioleate, polyoxyethylenesorbitan monooleate, polyoxyethylene sorbitol hexaoleate, and methylated soybean oil. However, those skilled in the art of the present invention can understand that different penetrants can be used without departing from the scope of the present invention.

溶劑可選自包含但不限於由以下所述所組成的群組:一種或多種的乳酸C2-C4烷基酯 (C2-C4-alkyl lactates),特別是三乙酸甘油酯 (glycerin triacetate)、乳酸乙酯 (ethyl lactate)、乳酸正丙酯 (n-propyl lactate)和乳酸異丙酯 (isopropyl lactate)。在一個實施例中,溶劑係選自乳酸C6-C10烷基酯,例如乳酸正己酯 (n-hexyl lactate)、乳酸1-乙基己酯 (1-ethylhexyl lactate)、乳酸1-甲基庚酯 (1-methylhepytyl lactate)、乳酸1,3-二甲基己酯 (1,3-dimethylhexyl lactate)、乳酸2-甲基庚酯 (2-methylheptyl lactate)、2,4-二甲基己基乳酸 (2,4-dimethylhexyllactate)、2,2,4-乳酸三甲基戊酯 (2,2,4-trimethylpentyl lactate)、乳酸正辛酯 (n-octyl lactate)、乳酸2-乙基己酯 (2-ethylhexyl lactate)、乳酸正壬酯 (n-nonyl lactate)、乳酸1-甲基辛酯 (1-methyloctyl lactate)、乳酸2-甲基辛酯 (2-methyloctyl lactate)、乳酸1-甲基壬酯(1-methylnonyl lactate)、乳酸2-丙基庚酯 (2-propylheptyl lactate)和乳酸正癸酯 (n-decyl lactate)、2,2,4-乳酸三甲基戊酯 (2,2,4- trimethylpentyl lactate)、乳酸丁酯 (butyl lactate)、肉荳蔻酸異丙酯 (isopropyl myristate)、己二醇、二噁烷 (dioxane)(或稱二氧陸圜)、d-檸檬烯 (d-limonene)、C l-C l4飽和直鏈醇、異丙醇、2-丁醇、異丁醇、叔丁醇、2-丁氧基乙醇、2-苯基乙醇、雙丙酮醇、γ-丁內酯、硝基甲烷、苯乙酮、三醋精、吡啶、水、甲苯、二甲苯、石油石腦油、農作物油、丙酮、甲乙酮、環己酮、乙酸酐、乙腈、苯乙酮、乙酸戊酯、2-丁酮、氯苯、環己烷、環己醇、乙酸烷基酯、二丙酮醇、1,2-二氯丙烷、二乙醇胺、對二乙苯、松香酸酯、二乙二醇丁醚、二乙二醇乙醚、二乙二醇甲醚、N,N-二甲基甲醯胺、二甲亞碸、1,4-二噁烷、二丙二醇、二丙二醇甲醚、二丙二醇二苯甲酸酯、二吡咯烷酮 (diproxitol)、烷基吡咯烷酮 (alkyl pyrrolidinone)、乙酸乙酯、2-乙基己醇、碳酸亞乙酯 (ethylene carbonate)、1,1,1-三氯乙烷、2-庚酮、α蒎烯 (alpha pinene)、d-檸檬烯、乙二醇、乙二醇丁醚、乙二醇甲醚、γ-丁內酯、甘油、二乙酸甘油酯、單乙酸甘油酯、三乙酸甘油酯、十六烷、己二醇、乙酸異戊酯 (isoamyl acetate)、乙酸異冰片酯 (isobornyl acetate)、異辛烷、異佛爾酮 (isophorone)、異丙苯、肉荳蔻酸異丙酯、乳酸、月桂胺、亞異丙基丙酮 (mesityl oxide)、甲氧基丙醇、甲基異戊酮、甲基異丁基酮、月桂酸甲酯、辛酸甲酯、油酸甲酯、二氯甲烷、間二甲苯、正己烷、正辛胺、十八烷酸、乙酸辛胺、油酸、油胺、鄰二甲苯、苯酚、聚乙二醇 (PEG400)、丙酸、丙二醇、丙二醇單甲醚、對二甲苯、甲苯、磷酸三乙酯、三乙二醇 (triethylene glycol)、二甲苯磺酸 (xylene sulfonic acid)、石蠟、礦物油、三氯乙烯、全氯乙烯、乙酸乙酯、乙酸戊酯、乙酸丁酯、甲醇、乙醇、異丙醇和較高分子量的醇,如戊醇 (amyl alcohol)、四氫呋喃甲醇(tetrahydrofurfuryl alcohol)、己醇、辛醇等、乙二醇、丙二醇、甘油、N-甲基-2-吡咯烷酮 (N-methyl-2- pyrrolidinone)及其類似物。 The solvent may be selected from the group comprising but not limited to: one or more C2-C4-alkyl lactates, especially glycerin triacetate, lactic acid Ethyl lactate, n-propyl lactate and isopropyl lactate. In one embodiment, the solvent is selected from C6-C10 alkyl lactate, such as n-hexyl lactate (n-hexyl lactate), 1-ethylhexyl lactate (1-ethylhexyl lactate), 1-methylheptyl lactate (1-methylhepytyl lactate), 1,3-dimethylhexyl lactate (1,3-dimethylhexyl lactate), 2-methylheptyl lactate (2-methylheptyl lactate), 2,4-dimethylhexyl lactic acid ( 2,4-dimethylhexyllactate), 2,2,4-trimethylpentyl lactate (2,2,4-trimethylpentyl lactate), n-octyl lactate, 2-ethylhexyl lactate (2 -ethylhexyl lactate), n-nonyl lactate, 1-methyloctyl lactate, 2-methyloctyl lactate, 1-methylnonyl lactate ester (1-methylnonyl lactate), 2-propylheptyl lactate (2-propylheptyl lactate) and n-decyl lactate (n-decyl lactate), 2,2,4-trimethylpentyl lactate (2,2, 4-trimethylpentyl lactate), butyl lactate, isopropyl myristate, hexanediol, dioxane (or dioxane), d-limonene (d- limonene), C l -C l4 saturated linear alcohol, isopropanol, 2-butanol, isobutanol, tert-butanol, 2-butoxyethanol, 2-phenylethanol, diacetone alcohol, γ-butanol Lactone, nitromethane, acetophenone, triacetin, pyridine, water, toluene, xylene, petroleum naphtha, crop oil, acetone, methyl ethyl ketone, cyclohexanone, acetic anhydride, acetonitrile, acetophenone, acetic acid Amyl ester, 2-butanone, chlorobenzene, cyclohexane, cyclohexanol, alkyl acetate, diacetone alcohol, 1,2-dichloropropane, diethanolamine, p-diethylbenzene, rosin ester, diethyl Glycol butyl ether, diethylene glycol ethyl ether, diethylene glycol methyl ether, N,N-dimethylformamide, dimethylsulfoxide, 1,4-dioxane, dipropylene glycol, dipropylene glycol methyl ether, Dipropylene glycol dibenzoate, diproxitol, alkyl pyrrolidinone, ethyl acetate, 2-ethylhexanol, ethylene carbonate, 1,1,1-trichloro Ethane, 2-heptanone, alpha pinene, d-limonene, Ethylene glycol, ethylene glycol butyl ether, ethylene glycol methyl ether, γ-butyrolactone, glycerin, diacetin, monoacetin, triacetin, hexadecane, hexanediol, isoamyl acetate Isoamyl acetate, isobornyl acetate, isooctane, isophorone, cumene, isopropyl myristate, lactic acid, laurylamine, mesityl oxide), methoxypropanol, methyl isoamyl ketone, methyl isobutyl ketone, methyl laurate, methyl caprylate, methyl oleate, methylene chloride, m-xylene, n-hexane, n-octylamine , octadecanoic acid, octylamine acetate, oleic acid, oleylamine, o-xylene, phenol, polyethylene glycol (PEG400), propionic acid, propylene glycol, propylene glycol monomethyl ether, p-xylene, toluene, triethyl phosphate , triethylene glycol, xylene sulfonic acid, paraffin, mineral oil, trichloroethylene, perchloroethylene, ethyl acetate, amyl acetate, butyl acetate, methanol, ethanol, iso Propanol and higher molecular weight alcohols, such as amyl alcohol, tetrahydrofurfuryl alcohol, hexanol, octanol, etc., ethylene glycol, propylene glycol, glycerin, N-methyl-2-pyrrolidone (N-methyl -2-pyrrolidinone) and its analogues.

油選自包含但不限於由以下所組成的群組:輕質石蠟油 (paraffin oil)、植物油、礦物油、石油、植物油或動物油或其衍生物或前述之混合物。然而,本發明所屬技術領域中具有通常知識者可明白,在不逸脫本案範圍的前提下,可使用其他不溶於水之溶劑 (water immiscible solvents)。The oil is selected from the group consisting of, but not limited to, paraffin oil, vegetable oil, mineral oil, petroleum, vegetable or animal oil or derivatives thereof or mixtures of the foregoing. However, those skilled in the art of the present invention can understand that other water immiscible solvents can be used without departing from the scope of the present invention.

穩定劑選自包含但不限於由以下所述所組成的群組:乾燥劑,例如沸石 (zeolite)、生石灰或氧化鎂;抗氧化劑,如酚類、胺類、硫類或磷類;紫外線吸收劑,如水楊酸類、二苯甲酮類;甲基化大豆油;過氧化物,如過氧化氫、有機過氧化物;亞硝酸烷基酯,如亞硝酸乙酯;乙醛酸烷基酯,如乙醛酸乙酯;沸石;抗氧化劑,如酚類化合物、磷酸化合物等;紫外線吸收劑,如二苯甲酮化合物或其衍生物。然而,本發明所屬技術領域中具有通常知識者可明白,在不逸脫本案範圍的前提下,可使用其他常規已知之穩定劑。這些穩定劑可以單獨使用或組合使用。Stabilizers are selected from the group consisting of, but not limited to: desiccants such as zeolite, quicklime or magnesium oxide; antioxidants such as phenols, amines, sulfur or phosphorus; UV absorbers Agents, such as salicylic acid, benzophenones; methylated soybean oil; peroxides, such as hydrogen peroxide, organic peroxides; alkyl nitrites, such as ethyl nitrite; alkyl glyoxylates , such as ethyl glyoxylate; zeolite; antioxidants, such as phenolic compounds, phosphoric acid compounds, etc.; ultraviolet absorbers, such as benzophenone compounds or their derivatives. However, those skilled in the art of the present invention can understand that other conventionally known stabilizers can be used without departing from the scope of the present invention. These stabilizers may be used alone or in combination.

若本案組合物中的活性化合物以一定的重量比存在,則其協同作用將特別顯著。然而,於活性化合物之組合中,活性化合物的重量比可以在相對寬廣的範圍內變化。If the active compounds in the composition of the present case exist in a certain weight ratio, the synergistic effect will be particularly significant. In the active compound combinations, however, the weight ratios of the active compounds can be varied within relatively wide ranges.

此外,本案的新穎農業化學組成物之施用率可為每100kg之種子0.1 g至100 kg。In addition, the application rate of the novel agricultural chemical composition of the present invention may be 0.1 g to 100 kg per 100 kg of seeds.

在本案的新穎農業化學組成物中,組分 (1)和組分 (2)係有利地以組分 (1):組分 (2)為10,000:1至1:10,000的協同有效重量比存在,或更佳地以2,000:1至1:2,000的重量比存在,或更佳地以1,000:1至1:1,000的重量比存在。In the novel agricultural chemical composition of the present case, component (1) and component (2) are advantageously present in a synergistic effective weight ratio of component (1):component (2) of 10,000:1 to 1:10,000 , or more preferably present in a weight ratio of 2,000:1 to 1:2,000, or more preferably present in a weight ratio of 1,000:1 to 1:1,000.

在一較佳的實施例中,本案的新穎農業化學組成物中的組分 (1)(一種或多種如式 (I)所示之哌啶噻唑化合物)以及組分 (2)(一種或多種殺真菌活性化合物)之間係有利地以協同有效的重量比500:1至1:5,000的比例存在。較佳地,組分 (1):組分 (2)的重量比範圍為200:1至1:2,000,更佳為100:1至1:1,000,尤其更佳為10:1至1:100、5:1至1:50、2.5:1至1:25、2:1至1:20、1.5:1至1:15、1:1到1:10、1:1到1:5、1:1至1:3、1:1至1:2。In a preferred embodiment, component (1) (one or more piperidinethiazole compounds shown in formula (I)) and component (2) (one or more fungicidally active compounds) are advantageously present in a synergistically effective weight ratio of 500:1 to 1:5,000. Preferably, the weight ratio of component (1):component (2) ranges from 200:1 to 1:2,000, more preferably from 100:1 to 1:1,000, and especially preferably from 10:1 to 1:100 , 5:1 to 1:50, 2.5:1 to 1:25, 2:1 to 1:20, 1.5:1 to 1:15, 1:1 to 1:10, 1:1 to 1:5, 1 :1 to 1:3, 1:1 to 1:2.

本案的拌種 (seed dressing)製劑可以直接或預先用水稀釋後用於處理多種不同的種子,包括基因轉殖植物的種子。在這種情況下,與經表達而形成的物質相互作用也可能產生額外的協同效應。The seed dressing formulation of this case can be used directly or after pre-diluted with water to treat a variety of different seeds, including seeds of transgenic plants. In this case, additional synergistic effects may also result from the interaction with the expressed substance.

對於使用本案的拌種製劑或是藉由將其加水而製得的製劑於種子處理而言,所有通常可用於拌種的混合裝置皆可使用。具體地,拌種的過程是將種子放入混合器中,添加特定所需量的拌種製劑於混合器(直接加入或事先用水稀釋後),並混合所有物質,直到製劑均勻地分佈在種子上。如果合適,隨後進行乾燥程序。For the treatment of seeds using the seed dressing formulations according to the invention or formulations prepared by adding water to them, all mixing devices which are usually used for seed dressing can be used. Specifically, the process of seed dressing is to put the seeds in a mixer, add the specific required amount of the seed dressing preparation to the mixer (directly or after previous dilution with water), and mix everything until the preparation is evenly distributed on the seeds. superior. If appropriate, a drying procedure follows.

本案的新穎農業化學組成物可用於處理種子、基因轉殖植物和基因轉殖植物的種子。The novel agricultural chemical composition of the present case can be used to treat seeds, transgenic plants and seeds of transgenic plants.

此外,本案的新穎農業化學組成物可包含基因轉殖的性狀和非基因轉殖的性狀。In addition, the novel agrochemical composition of the present case may contain genetically modified traits and non-genetically modified traits.

特別地,該新穎農業化學組成物用於葉面施用。In particular, the novel agrochemical compositions are for foliar application.

本案中,用語「組成物(組合物)」代表組分 (1)與組分 (2)的各種混合物或組合,例如以單一「預拌 (ready-mix)」之形式、由各個單一活性化合物的不同配方所形成的組合噴霧混合物(例如「桶混 (tank­mix)」),以及單一活性成分以按順序施用的方式之組合使用(即在相當短的時間內(如幾個小時或幾天)一個接一個地施用)。較佳地,組分 (1)以及組分 (2)的施加順序對於本案的實施而言並非重要的。In this case, the term "composition (composition)" denotes various mixtures or combinations of component (1) and component (2), for example in the form of a single "ready-mix" consisting of each single active compound Combination spray mixtures of different formulations (e.g. "tankmix"), and combinations of single active ingredients in sequential applications (i.e. over a relatively short period of time (e.g. hours or days) applied one after the other). Preferably, the order of application of component (1) and component (2) is not important for the practice of the present case.

在本案中,用語「農業化學組成物」是指至少兩種活性化合物與其他農業上合適的添加劑(如上文所述的溶劑、載體、表面活性劑、填充劑等農業上合適的助劑)的組合或混合物。用語「農用化學組成物」還包括用語「作物保護組成物」和「製劑(配方)」。In this case, the term "agricultural chemical composition" refers to a combination of at least two active compounds and other agriculturally suitable additives (such as solvents, carriers, surfactants, fillers, etc. combination or mixture. The term "agrochemical composition" also includes the terms "crop protection composition" and "preparation (formulation)".

當使用新的農業化學組成物作為殺真菌劑時,施用率可在相對較大的範圍內變化,這取決於施用的方式。在對植物部分(例如葉)進行處理的情況下,施用率的範圍為0.1到10,000 g/公頃(g/ha),較佳為10到大約3,000 g/公頃,更佳為50到1,000 g/公頃,或更佳為80到400 g/公頃(在藉由灌溉或滴灌施用的情況下,還可以降低施用率,特別是當使用岩棉或珍珠岩等惰性基質時);在種子處理的情況下,施用率為每100 kg種子2到200 g,較佳為每100 kg種子10到150 g,更佳為每100 kg種子12到30 g;在土壤處理的情況下,施用率為每公頃0.1到10,000 g,較佳為1到5,000 g。When using novel agrochemical compositions as fungicides, the application rates can vary within a relatively wide range, depending on the mode of application. In the case of treatment of plant parts such as leaves, application rates range from 0.1 to 10,000 g/ha (g/ha), preferably from 10 to about 3,000 g/ha, more preferably from 50 to 1,000 g/ha. hectare, or better 80 to 400 g/ha (in the case of application by irrigation or drip irrigation, it is also possible to reduce the application rate, especially when using inert substrates such as rock wool or perlite); in the case of seed treatments 2 to 200 g per 100 kg of seed, preferably 10 to 150 g per 100 kg of seed, more preferably 12 to 30 g per 100 kg of seed; in the case of soil treatments, the rate of application per hectare 0.1 to 10,000 g, preferably 1 to 5,000 g.

這些施用率僅作為示例,不對本發明產生限制。These application rates are by way of example only and do not limit the invention.

使用者通常可以從預計量裝置、背負式噴霧器、噴霧罐、噴霧飛機或灌溉系統施用本案的新穎農業化學組成物。通常,農業化學組成物用水、緩衝劑和/或其他助劑製成所需的施用濃度,從而獲得本案的即用噴霧液或農業化學組成物。通常,每公頃農業有用面積施用20至2,000升,較佳地使用50至400升的即用噴霧液。Users can generally apply the novel agrochemical compositions of the present invention from pre-metered devices, knapsack sprayers, spray tanks, spray planes or irrigation systems. Usually, the agrochemical composition is made into required application concentration with water, buffer and/or other adjuvants, so as to obtain the ready-to-use spray liquid or agrochemical composition in this case. In general, 20 to 2,000 liters, preferably 50 to 400 liters, of the ready-to-use spray liquor are applied per hectare of agriculturally useful area.

根據一個實施方案,本案的農業化學組成物中的各個成分,例如套組 (kit)的部分或二元或三元混合物的部分,可以由使用者自己在噴霧罐或用於施用的任何其他種類的容器中混合(例如種子處理桶、種子製粒機、背負式噴霧器)。如果合適,亦可以添加其他助劑。According to one embodiment, the individual components of the agrochemical composition of the present case, for example part of a kit or part of a binary or ternary mixture, can be sprayed by the user himself in a spray tank or any other kind for application. mixed in suitable containers (e.g. seed treatment buckets, seed pelletizers, knapsack sprayers). If appropriate, other auxiliaries can also be added.

因此,本發明的一個實施態樣係一種用於製備可用的農業化學組成物的套組,該套組包括:a)一種包含本文所定義的組分 (1)和至少一種助劑的組合物;以及b)一種包含本文定義的組分 (2)和至少一種助劑的組合物;可選地包含c)包含至少一種本文定義的助劑以及可選地包含本文定義之另外的活性組分 (3)的組合物。Accordingly, one embodiment of the present invention is a kit for the preparation of a useful agrochemical composition comprising: a) a composition comprising component (1) as defined herein and at least one adjuvant and b) a composition comprising component (2) as defined herein and at least one adjuvant; optionally comprising c) comprising at least one adjuvant as defined herein and optionally a further active ingredient as defined herein The composition of (3).

根據本案,用語「組分 (3)」亦可指一種或多種殺蟲劑、或殺真菌劑、或殺蟎劑、或殺線蟲劑、或除草劑、或生長調節劑、或生物刺激劑、或肥料或胺基酸化合物、或前述之組合。According to the present case, the term "component (3)" may also refer to one or more insecticides, or fungicides, or acaricides, or nematicides, or herbicides, or growth regulators, or biostimulants, Or fertilizers or amino acid compounds, or a combination of the foregoing.

本案亦關於包含有至少一種如式 (I)所示之化合物作為組分 (1)以及至少一種選自(II-A)至(II-R)的殺真菌活性化合物 (II)/或至少一種選自(III-A)至(III-GG)的殺蟲或殺線蟲活性化合物 (III)作為如上所述可用於植物保護的組分 (2)之混合物的農業化學組成物,所述混合物能選擇性地包含一種合適的溶劑或固體載體。這些混合物特別令人感興趣,因為其中的許多混合物在相同的施用率下,對有害真菌和/或害蟲和蟎蟲表現出更高的效率。This case is also about comprising at least one compound shown in formula (I) as component (1) and at least one fungicidally active compound (II) selected from (II-A) to (II-R)/or at least one Agrochemical compositions of insecticidally or nematicidally active compounds (III) selected from (III-A) to (III-GG) as mixtures of components (2) usable for plant protection as described above, said mixtures capable of Optionally, a suitable solvent or solid carrier is included. These mixtures are of particular interest because many of them exhibit higher efficacy against harmful fungi and/or pests and mites at the same application rate.

此外,以含有如前所述作為組分 (1)之如式 (I)所示化合物以及至少一種選自(II-A)至(II-R)的活性化合物 (II)及/或至少一種選自(III-A)至(III-GG)的殺蟲或殺線蟲活性化合物 (III)作為組分 (2)的混合物來對抗有害真菌,比單獨使用如式 (I)所示之化合物、或是單獨使用選自(II-A)至(II-R)的殺真菌活性化合物 (II)或使用選自(III-A)至(III-GG)的殺蟲或殺線蟲活性化合物 (III)來對抗有害真菌及/或害蟲和蟎蟲,具有更好的功效。藉由將如式 (I)所示之化合物與至少一種選自(II-A)至(II-R)的殺真菌活性化合物 (II)或至少一種選自(III-A)至(III-GG)的殺蟲或殺線蟲活性化合物 (III)同時使用,可獲得協同效應;亦即,所獲得的效果並非僅是單個成分產生的效果簡單相加(協同混合物,synergistic mixtures)。In addition, to contain the compound shown in formula (I) as component (1) and at least one active compound (II) selected from (II-A) to (II-R) and/or at least one The insecticidal or nematicidal active compound (III) selected from (III-A) to (III-GG) is used as a mixture of component (2) to combat harmful fungi, and it is better than using the compound shown in formula (I), Either use the fungicidal active compound (II) selected from (II-A) to (II-R) alone or use the insecticidal or nematicidal active compound (III) selected from (III-A) to (III-GG) ) to fight harmful fungi and/or pests and mites with better efficacy. By combining the compound shown in formula (I) with at least one fungicidally active compound (II) selected from (II-A) to (II-R) or at least one selected from (III-A) to (III- The insecticidal or nematicidal active compounds (III) of GG) can be used at the same time to obtain a synergistic effect; that is, the obtained effect is not simply the sum of the effects produced by the individual components (synergistic mixtures, synergistic mixtures).

所述協同效應可藉由將作為組分 (1)之如式 (I)所示之化合物以及作為組分 (2)之至少一種活性化合物 (II)及/或活性化合物 (III),以及可選地包含作為組分 (3)之另外的活性化合物同時施用獲得,不論是共同地(例如以桶內混合)、分別地或是接連地;其中分別地施用之間的時間間隔之選擇需確保首先施用的活性化合物在其他活性物質施用時,仍然以足夠的量出現在作用部位。施用的順序對於本案的實施而言並非重要的。The synergistic effect can be obtained by using the compound shown in formula (I) as component (1) and at least one active compound (II) and/or active compound (III) as component (2), and can The additional active compounds optionally included as component (3) are obtained by simultaneous application, whether jointly (for example with a tank mix), separately or successively; wherein the time interval between the separate applications is chosen to ensure that The active compound applied first is still present at the site of action in a sufficient amount when the other active substance is applied. The order of administration is immaterial to the practice of the present invention.

當按順序接連地施用作為組分 (1)之如式 (I)所示之化合物以及作為組分 (2)之至少一種活性化合物 (II)及/或活性化合物 (III),以及可選的、作為組分 (3)之另外的活性化合物時,兩次施用之間的時間可以在2小時到7天之間變化。同樣地,更寬的範圍是0.25小時至30天,較佳是0.5小時至14天,特別是1小時至7天或1.5小時至5天,更佳的是2小時至1天。When the compound shown in formula (I) as component (1) and at least one active compound (II) and/or active compound (III) as component (2) are applied sequentially, and optionally . As an additional active compound of component (3), the time between two applications may vary from 2 hours to 7 days. Likewise, a wider range is 0.25 hours to 30 days, preferably 0.5 hours to 14 days, especially 1 hour to 7 days or 1.5 hours to 5 days, more preferably 2 hours to 1 day.

在本案的二元混合物以及組成物中,如式 (I)所示之化合物作為組分 (1)與組分 (2)的重量比通常取決於所用活性組分的性質,一般在1:10,000至10,000:1的範圍內,通常在1:1,000至1,000:1、1:500至500:1或是1:100至100:1的範圍內,經常在1:50至50:1的範圍內,較佳在1:25至25:1或是1:20至20:1的範圍內,更佳地在1:15至15:1或1:10至10:1的範圍內,特別是在1:6至6:1、1:4至4:1、1:2至2:1或1:1至2:1的範圍內。In the binary mixture and composition of this case, the weight ratio of the compound shown in formula (I) as component (1) to component (2) usually depends on the nature of the active component used, generally in the range of 1:10,000 to 10,000:1, usually 1:1,000 to 1,000:1, 1:500 to 500:1 or 1:100 to 100:1, often 1:50 to 50:1 , preferably in the range of 1:25 to 25:1 or 1:20 to 20:1, more preferably in the range of 1:15 to 15:1 or 1:10 to 10:1, especially in 1:6 to 6:1, 1:4 to 4:1, 1:2 to 2:1 or 1:1 to 2:1.

根據二元混合物以及組合物的另一實施例,作為組分 (1)之如式 (I)所示之化合物與組分 (2)間的重量比通常在1:1,000至1:1的範圍內,通常在從1:100到1:1的範圍內,經常在1:50到1:1的範圍內,較佳在1:20到1:1、1:15到1:1的範圍內,且特別是1:10或1:8至1:2的範圍內。According to another embodiment of the binary mixture and composition, the weight ratio between the compound represented by formula (I) as component (1) and component (2) is usually in the range of 1:1,000 to 1:1 Usually in the range from 1:100 to 1:1, often in the range of 1:50 to 1:1, preferably in the range of 1:20 to 1:1, 1:15 to 1:1 , and especially in the range of 1:10 or 1:8 to 1:2.

根據二元混合物以及組合物的另一實施例,作為組分 (1)之如式 (I)所示之化合物與組分 (2)間的重量比通常在1:1至1:1,000的範圍內,通常在從1:1到1:100的範圍內,通常在1:1到1:50的範圍內,較佳在1:1到1:25、1:1到1:20、1:1到1:15的範圍內,更佳地在1:1到1:10的範圍內,特別是在1:1到1:8以及1:1到1:5的範圍內。According to another embodiment of the binary mixture and composition, the weight ratio between the compound represented by formula (I) as component (1) and component (2) is usually in the range of 1:1 to 1:1,000 Within, usually in the range from 1:1 to 1:100, usually in the range of 1:1 to 1:50, preferably in the range of 1:1 to 1:25, 1:1 to 1:20, 1:1 1 to 1:15, more preferably 1:1 to 1:10, especially 1:1 to 1:8 and 1:1 to 1:5.

在另一個實施例中,三元混合物(即包含如式 (I)所示之化合物作為組分 (1)以及如式 (II)所示之化合物及/或如式 (III)所示之化合物作為組分 (2)的混合物)中,組分 (1)與如式 (II)所示之化合物的重量比在1:100至1:1的範圍內,通常在1:50至1:1的範圍內,較佳在1:25至1:1的範圍內,更佳在1:15至1:1的範圍內,特別是在1:5至1:1的範圍內,並且組分 (1)與如式 (III)所示之化合物間的重量比在1:100至1:1的範圍內,通常在1:50至1:1的範圍內,較佳在1:25至1:1的範圍內,更佳在1:10至1:1的範圍內,尤其是在1:5至1:1的範圍內。In another embodiment, the ternary mixture (i.e. comprising the compound shown in formula (I) as component (1) and the compound shown in formula (II) and/or the compound shown in formula (III) As a mixture of component (2), the weight ratio of component (1) to the compound represented by formula (II) is in the range of 1:100 to 1:1, usually 1:50 to 1:1 In the range, preferably in the range of 1:25 to 1:1, more preferably in the range of 1:15 to 1:1, especially in the range of 1:5 to 1:1, and the components ( 1) The weight ratio with the compound shown in formula (III) is in the range of 1:100 to 1:1, usually in the range of 1:50 to 1:1, preferably in the range of 1:25 to 1: 1, more preferably in the range of 1:10 to 1:1, especially in the range of 1:5 to 1:1.

在另一個實施例中,三元混合物(即包含如式 (I)所示之化合物作為組分 (1)以及如式 (II)所示之化合物/如式 (III)所示之化合物作為組分 (2),以及另外的活性化合物作為組分 (3)的混合物)中,組分 (1)與作為組分 (2)的如式 (II)所示之化合物或是如式 (III)所示之化合物的重量比在1:100至1:1的範圍內,通常在1:50至1:1的範圍內,較佳在1:25至1:1的範圍內,更佳在1:15至1:1的範圍內,特別是在1:5至1:1的範圍內,並且組分 (1)與組分 (3)間的重量比在1:100至1:1的範圍內,通常在1:50至1:1的範圍內,較佳在1:25至1:1的範圍內,更佳在1:10至1:1的範圍內,尤其是在1:5至1:1的範圍內。In another embodiment, the ternary mixture (i.e. comprising the compound shown in formula (I) as component (1) and the compound shown in formula (II)/the compound shown in formula (III) as a group (2), and another active compound as a mixture of component (3), component (1) and the compound shown in formula (II) as component (2) or as formula (III) The weight ratio of the compounds shown is in the range of 1:100 to 1:1, usually in the range of 1:50 to 1:1, preferably in the range of 1:25 to 1:1, more preferably in the range of 1 :15 to 1:1, especially in the range of 1:5 to 1:1, and the weight ratio between component (1) and component (3) is in the range of 1:100 to 1:1 Usually within the range of 1:50 to 1:1, preferably in the range of 1:25 to 1:1, more preferably in the range of 1:10 to 1:1, especially in the range of 1:5 to 1:1 range.

較佳地,三元混合物包含彼此獨立地選自(II-A)、(II-B)、(II-C)、(II-D)、(II-D)、(II-E)、(II-F)、(II-G)、(II-H)、(II-I)、(II-J)、(II-K)、(II-L)、(II-M)、(II-N)、(II-O)、(II-P)、(II-Q)及(II-R)的多個殺真菌化合物作為化合物 (II);且其中另外的活性組分 (3)與作為組分 (2)的至少一種殺真菌活性化合物 (II)/至少一種殺蟲或殺線蟲活性化合物 (III)不同。Preferably, the ternary mixture comprises independently selected from (II-A), (II-B), (II-C), (II-D), (II-D), (II-E), ( II-F), (II-G), (II-H), (II-I), (II-J), (II-K), (II-L), (II-M), (II- A plurality of fungicidal compounds of N), (II-O), (II-P), (II-Q) and (II-R) as compound (II); and wherein the additional active component (3) is The at least one fungicidally active compound (II)/at least one insecticidally or nematicidally active compound (III) of component (2) is different.

若有需要,任何另外的活性組分以100:1至1:5的比例添加到作為組分 (1)的如式 (I)所示之化合物。If necessary, any additional active ingredient is added to the compound of formula (I) as component (1) in a ratio of 100:1 to 1:5.

這些比例也適用於種子處理。These ratios also apply to seed treatments.

本案的處理方法還提供了以同時、分開或按順序的方式使用或施用組分 (1)以及組分 (2)。如果單一活性成分按順序接連地施用(即在不同的時間施用),則可以在合理的時期(例如數小時或數天)內,一個接一個地施用它們。較佳地,組分 (1)以及組分 (2)的施加順序對於本案的實施而言並非重要的。The method of treatment of the present case also provides the use or application of component (1) and component (2) in a simultaneous, separate or sequential manner. If the single active ingredients are administered sequentially, ie at different times, they may be administered one after the other within a reasonable period of time, eg hours or days. Preferably, the order of application of component (1) and component (2) is not important for the practice of the present case.

本案所公開的農業化學組成物之較佳製劑可具有以下組成 (weight %):A preferred formulation of the agricultural chemical composition disclosed in this case may have the following composition (weight %):

a)     乳劑 (Emulsifiable concentrates): 活性成分:1至75 %,較佳為5至25 % 表面活性劑:1至30 %,較佳為5至20 % 液體載體:1至80 %,較佳為1至60 % 以下實施例將進一步說明本案,但並非用以對其進行限制。 可用於植物保護的任何所需稀釋度的乳液,可以藉由將該濃縮物經水稀釋獲得。 乳劑    活性成分 10% 烷基聚氧乙烯酯 8% 十二烷基苯磺酸鈣 10% 乙氧基化蓖麻油 (castor oil polyglycol ether) 124% 二甲苯混合物 適量 (quantum sufficit, q.s.) a) Emulsifiable concentrates: Active ingredient: 1 to 75%, preferably 5 to 25% Surfactant: 1 to 30%, preferably 5 to 20% Liquid carrier: 1 to 80%, preferably 1 to 60% The following examples further illustrate the case but are not intended to limit it. Emulsions of any desired dilution useful for plant protection can be obtained by diluting the concentrates with water. emulsion active ingredient 10% Alkyl Polyoxyethylene Ester 8% Calcium dodecylbenzenesulfonate 10% Ethoxylated castor oil (castor oil polyglycol ether) 124% xylene mixture Appropriate amount (quantum sufficient, qs)

b)    粉劑 (Dust): 活性成分:0.1至10 %,較佳為0.1至5 % 固體載體:99.9至90 %,較佳為99.9至99 % 以下實施例將進一步說明本案,但並非用以對其進行限制。 藉由將組合物與載體混合並在合適的研磨機中研磨該混合物以獲得即用型粉劑。這種粉末也可用於種子的乾拌料。 粉劑 a) b) c) 活性成分 5% 6% 4% 滑石粉 (talcum) 95% - - 高嶺土 - 94% - 礦物填料 - - 96% b) Powder (Dust): Active ingredient: 0.1 to 10%, preferably 0.1 to 5% Solid carrier: 99.9 to 90%, preferably 99.9 to 99% The following examples will further illustrate this case, but are not intended to It limits. Ready-to-use powders are obtained by mixing the composition with the carrier and grinding the mixture in a suitable mill. This powder can also be used as a dry mix of seeds. powder a) b) c) active ingredient 5% 6% 4% Talcum powder (talcum) 95% - - Kaolin - 94% - mineral filler - - 96%

c)     水懸劑 (SC): 活性成分:5至75 %,較佳為10至50 % 水:94至24 %,較佳為88至30 % 表面活性劑:1至40 %,較佳為2至30 % 將磨細的混合物與助劑充分混合,得到水懸劑,藉由以水稀釋的方式可以獲得任何所需稀釋度的懸浮液。使用這種稀釋液,可以藉由噴灑、傾倒或浸泡處理活植物以及植物繁殖材料以防止其受微生物侵染。 水懸劑 (SC)    活性成分 40% 丙二醇 10% 壬基酚聚乙氧基醇 (nonylphenol polyethylene glycol ether) (含15 mol之環氧乙烷) 6% 木質素磺酸鈉 10% 羧甲基纖維素 1% 矽油(以75%之水乳液形式) 1% 32% c) Suspension (SC): Active ingredient: 5 to 75%, preferably 10 to 50% Water: 94 to 24%, preferably 88 to 30% Surfactant: 1 to 40%, preferably 2 to 30 % The finely ground mixture is thoroughly mixed with auxiliaries to obtain an aqueous suspension, and any desired dilution of the suspension can be obtained by diluting with water. Using this diluent, living plants and plant propagation material can be treated to protect them from microbial infestation by spraying, pouring or soaking. Suspension (SC) active ingredient 40% Propylene Glycol 10% Nonylphenol polyethylene glycol ether (containing 15 mol of ethylene oxide) 6% Sodium lignosulfonate 10% carboxymethyl cellulose 1% Silicone oil (in the form of 75% water emulsion) 1% water 32%

d)    可濕性粉劑: 活性成分:0.5至90 %,較佳為1至80 % 表面活性劑:0.5至20 %,較佳為1至15 % 固體載體:5至95 %,較佳為15至90 % 以下實施例將進一步說明本案,但並非用以對其進行限制。 將該組合物與助劑充分混合,混合物在合適的研磨機中充分研磨得到可濕性粉劑,其可用水稀釋得到所需濃度的懸浮液。 可濕性粉劑 a) b) c) 活性成分 25% 50% 75% 木質素磺酸鈉 (sodium lignosulfonate) 5% 5% - 月桂基硫酸鈉 (sodium lauryl sulfate) 3% - 5% 二異丁基萘磺酸鈉 (sodium diisobutylnaphthalenesulfonate) - 6% 10% 苯酚聚乙氧基醇 (phenol polyethylene glycol ether) (含7-8 mol環氧乙烷) - 2% - 高分散的矽酸 5% 10% 10% 高嶺土 62% 27% - d) Wettable powder: Active ingredient: 0.5 to 90%, preferably 1 to 80% Surfactant: 0.5 to 20%, preferably 1 to 15% Solid carrier: 5 to 95%, preferably 15% Up to 90% The following examples will further illustrate the case, but are not intended to limit it. The composition is thoroughly mixed with the auxiliaries, and the mixture is thoroughly ground in a suitable mill to obtain a wettable powder, which can be diluted with water to obtain a suspension of the desired concentration. wettable powder a) b) c) active ingredient 25% 50% 75% Sodium lignosulfonate 5% 5% - Sodium lauryl sulfate 3% - 5% Sodium diisobutylnaphthalenesulfonate - 6% 10% Phenol polyethoxy alcohol (phenol polyethylene glycol ether) (containing 7-8 mol ethylene oxide) - 2% - highly dispersed silicic acid 5% 10% 10% Kaolin 62% 27% -

e)     顆粒: 活性成分:0.1至30 %,較佳為0.1至15 % 固體載體:99.5至70 %,較佳為97至85 % 以下實施例將進一步說明本案,但並非用以對其進行限制。 將混合物與助劑混合並研磨,然後用水潤濕混合物。將混合物擠出,然後在空氣流中乾燥。 擠出機顆粒    活性成分 15% 木質素磺酸鈉 2% 羧甲基纖維素 1% 高嶺土 82% 在混合器中,將精細研磨的混合物均勻地施加到用聚乙二醇潤濕的高嶺土上,得到無塵的包覆顆粒 (coated granule)。 包覆顆粒    活性成分 8% 聚乙二醇(分子量200) 3% 高嶺土 89% e) Granules: Active ingredient: 0.1 to 30%, preferably 0.1 to 15% Solid carrier: 99.5 to 70%, preferably 97 to 85% The following examples will further illustrate the case but are not intended to limit it . Mix and grind the mixture with the auxiliaries, then moisten the mixture with water. The mixture is extruded and dried in a stream of air. extruder pellets active ingredient 15% Sodium lignosulfonate 2% carboxymethyl cellulose 1% Kaolin 82% In a mixer, the finely ground mixture is uniformly applied to kaolin moistened with polyethylene glycol to obtain a dust-free coated granule. coated particles active ingredient 8% Polyethylene glycol (molecular weight 200) 3% Kaolin 89%

f)     種子處理成分: 以下實施例將進一步說明本案,但並非用以對其進行限制。 將該組合物與佐劑充分混合,並將混合物在合適的研磨機中充分研磨,得到可直接用於種子處理的粉末。 用於乾種子處理的粉末 a) b) c) 活性成分 25% 50% 75% 聚乙烯醇 5% 5% 5% 高分散的矽酸 5% 5% - 高嶺土 65% 40% - 滑石粉 -    20% 將磨細的混合物與助劑充分混合,得到水懸劑,藉由以水稀釋的方式可以獲得任何所需稀釋度的懸浮液。使用這種稀釋液,可以通過噴灑、傾倒或浸泡處理活植物以及植物繁殖材料以防止其受微生物侵染。 種子處理劑 (concentrate for seed treatment)       活性成分 40% 丙二醇 5% 丁醇環氧丙烷/環氧乙烷共聚物 (copolymer butanol PO/EO) 2% 具有10-20 mol環氧乙烷的三苯乙烯酚 (Tristyrenephenole with 10-20 moles EO) 2% 1,2-苯並異噻唑啉-3-酮 (1,2-benzisothiazolin-3-one) (以20%的水溶液形式) 0.5% 單偶氮顏料鈣鹽 (monoazo-pigment calcium salt) 5% 矽油(以75%之水乳液形式) 0.2% 45.3% f) Seed Treatment Composition: The following examples will further illustrate the case but are not intended to limit it. The composition is thoroughly mixed with the adjuvant and the mixture is thoroughly ground in a suitable grinder to obtain a powder which can be directly used for seed treatment. powder for dry seed treatment a) b) c) active ingredient 25% 50% 75% polyvinyl alcohol 5% 5% 5% highly dispersed silicic acid 5% 5% - Kaolin 65% 40% - talcum powder - 20% The finely ground mixture is thoroughly mixed with auxiliaries to obtain an aqueous suspension, and any desired dilution of the suspension can be obtained by dilution with water. With this dilution, living plants and plant propagation material can be treated by spraying, pouring or soaking to protect them from infestation by microorganisms. Concentrate for seed treatment active ingredient 40% Propylene Glycol 5% Butanol propylene oxide/ethylene oxide copolymer (copolymer butanol PO/EO) 2% Tristyrenephenol with 10-20 moles EO 2% 1,2-Benzisothiazolin-3-one (1,2-benzisothiazolin-3-one) (as a 20% aqueous solution) 0.5% Monoazo-pigment calcium salt 5% Silicone oil (in the form of 75% water emulsion) 0.2% water 45.3%

g)    緩釋膠囊懸浮液 (Slow Release Capsule Suspension):g) Slow Release Capsule Suspension:

將28份組合物與2份芳香族溶劑以及7份甲苯二異氰酸酯 (toluene diisocyanate)/聚亞甲基-聚苯基異氰酸酯 (polymethylene-polyphenylisocyanate)混合物 (8:1)混合。將該混合物在1.2份聚乙烯醇、0.05份消泡劑和51.6份水的混合物中乳化,直到獲得所需的粒度。向該乳液中加入2.8份1,6-二胺基己烷在5.3份水中之混合物。攪拌混合物直至聚合反應完成。藉由於其中加入0.25份增稠劑和3份分散劑來穩定獲得的膠囊懸浮液。膠囊懸浮液製劑中含有28%的活性成分。中等膠囊之直徑為8-15微米。在適於該目的之裝置中,將所得的製劑作為水懸浮液施用於種子。28 parts of the composition were mixed with 2 parts of aromatic solvent and 7 parts of toluene diisocyanate/polymethylene-polyphenylisocyanate mixture (8:1). This mixture was emulsified in a mixture of 1.2 parts polyvinyl alcohol, 0.05 parts antifoam and 51.6 parts water until the desired particle size was obtained. To this emulsion was added a mixture of 2.8 parts of 1,6-diaminohexane in 5.3 parts of water. The mixture was stirred until the polymerization was complete. The capsule suspension obtained is stabilized by adding thereto 0.25 parts of thickener and 3 parts of dispersant. The capsule suspension formulation contains 28% active ingredient. Medium capsules are 8-15 microns in diameter. The resulting formulation is applied to the seeds as an aqueous suspension in a device suitable for the purpose.

包含如式 (I)所示之化合物作為組分 (1)以及組分 (2)之組合物可能表現出協同作用。根據本文所述,當活性化合物之組合物的殺真菌活性,超過其中之各活性化合物單獨施用時之殺菌活性,則協同功效(例如在殺真菌方面)存在。對於給定之兩種活性化合物的組合物(二元混合物)之預期活性,可以藉由使用Colby公式(COLBY, S.R. "Calculating synergistic and antagonistic responses of herbicide combination", Weeds, Vol. 15, pages 20-22; 1967)計算。 Compositions comprising compounds represented by formula (I) as component (1) and component (2) may exhibit a synergistic effect. A synergistic effect (for example in terms of fungicides) is present when, as described herein, the fungicidal activity of the active compound combination exceeds the fungicidal activity of each of the active compounds applied individually. The expected activity of a given combination (binary mixture) of two active compounds can be determined by using the Colby formula (COLBY, SR "Calculating synergistic and antagonistic responses of herbicide combination", Weeds , Vol. 15, pages 20-22 ; 1967) calculations.

Colby’sColby's 公式:formula:

給定之兩種活性化合物的組合物(二元混合物)之預期活性,可以下述方式計算:

Figure 02_image006
其中E代表兩種殺真菌劑在確定劑量下(例如分別等於x和y)的組合物中,對疾病的預期抑制百分比;x是化合物 (1)在給定劑量下觀察到的對該疾病之抑制百分比(等於x),y是化合物 (2)在給定劑量下觀察到的對該疾病之抑制百分比(等於y)。當觀察到的組合物之抑制百分比大於E時,則存在協同作用。 The expected activity of a given combination of two active compounds (binary mixture) can be calculated as follows:
Figure 02_image006
where E represents the expected percent inhibition of disease in a combination of two fungicides at defined doses (e.g. equal to x and y, respectively); x is the observed effect of compound (1) on the disease at a given dose Percent inhibition (equal to x), y is the percent inhibition of the disease (equal to y) observed for compound (2) at a given dose. Synergy exists when the percent inhibition observed for the combination is greater than E.

給定之三種活性化合物的組合物(三元混合物)之預期活性,可以下述方式計算:

Figure 02_image008
X:使用濃度為a的活性化合物 (1)時之功效(以未處理的對照組的百分比表示); Y:使用濃度為b的活性化合物 (2)時之功效(以未處理的對照組的百分比表示); Z:使用濃度為c的活性化合物 (3)時之功效(以未處理的對照組的百分比表示)。 E是活性化合物(1)、(2)和(3)以a、b和c的施用率施用時的功效。 The expected activity of a given combination of three active compounds (ternary mixture) can be calculated in the following way:
Figure 02_image008
X: the efficacy of the active compound (1) at concentration a (expressed as a percentage of the untreated control group); Y: the efficacy of the active compound (2) at the concentration b (expressed as the percentage of the untreated control group) expressed as a percentage); Z: the efficacy (expressed as a percentage of the untreated control group) when using the active compound (3) at a concentration of c. E is the efficacy of the active compounds (1), (2) and (3) when applied at the application rates of a, b and c.

如式 (I)所示之化合物可以藉由類似於PCT專利公開案WO2019048989和PCT專利公開案WO2021094905中所公開的方法以及實施例的多種途徑獲得。The compound represented by formula (I) can be obtained by various methods similar to the methods and examples disclosed in PCT Patent Publication WO2019048989 and PCT Patent Publication WO2021094905.

化學範例:Chemistry example:

以下之範例記載了製備本案化合物之方法以及步驟,但並非對本案作為限制,且所述範例包含發明人為實施本案而設想的最佳模式。The following examples describe the methods and steps for preparing the compounds of the present case, but are not intended to limit the present case, and the examples include the best mode conceived by the inventors for implementing the present case.

範例example 11 : 1-(4-(4-(5-(2-1-(4-(4-(5-(2- chlorine -6--6- 氟苯基Fluorophenyl )-4,5-)-4,5- 二氫異噁唑Dihydroisoxazole -3--3- base )) 噻唑Thiazole -2--2- base )) 哌啶piperidine -1--1- base )-2-((3-()-2-((3-( 三氟甲基Trifluoromethyl )) 吡啶pyridine -2--2- base )) 氧基Oxygen )) Second -1--1- ketone (1-(4-(4-(5-(2-chloro-6-fluorophenyl)-4,5-dihydroisoxazol-3-yl)thiazol-2-yl)piperidin-1-yl)-2-((3-(trifluoromethyl)pyridin-2-yl)oxy)ethan-1-one)(1-(4-(4-(5-(2-chloro-6-fluorophenyl)-4,5-dihydroisoxazol-3-yl)thiazol-2-yl)piperidin-1-yl)-2-((3 -(trifluoromethyl)pyridin-2-yl)oxy)ethan-1-one) 之製備preparation

步驟1:5-(2-氯-6-氟苯基)-3-(2-(哌啶-4-基)噻唑-4-基)-4,5-二氫異噁唑-2,2,2-三氟乙酸酯 (5-(2-chloro-6-fluorophenyl)-3-(2-(piperidin-4-yl)thiazol-4-yl)-4,5-dihydroisoxazole 2,2,2-trifluoroacetate)的製備Step 1: 5-(2-Chloro-6-fluorophenyl)-3-(2-(piperidin-4-yl)thiazol-4-yl)-4,5-dihydroisoxazole-2,2 ,2-Trifluoroacetate (5-(2-chloro-6-fluorophenyl)-3-(2-(piperidin-4-yl)thiazol-4-yl)-4,5-dihydroisoxazole 2,2,2 -trifluoroacetate) preparation

將三氟乙酸 (19.84 mL, 258 mmol)加入至4-(4-(5-(2-氯-6-氟苯基)-4,5-二氫異噁唑-3-基)噻唑-2-基)哌啶-1-羧酸-叔丁基酯 ( tert-butyl 4-(4-(5-(2-chloro-6-fluorophenyl)-4,5-dihydroisoxazol-3-yl)thiazol-2-yl)piperidine-1-carboxylate) (6 g, 12.88 mmol)與二氯甲烷 (64.4 mL)的溶液中。所得混合物在25 oC下攪拌4小時。反應完成後,將反應混合物經減壓濃縮得到產物5-(2-氯-6-氟苯基)-3-(2-(哌啶-4-基)噻唑-4-基)-4,5-二氫異噁唑(4.71 g,12.87 mmol,產率100%)。 Add trifluoroacetic acid (19.84 mL, 258 mmol) to 4-(4-(5-(2-chloro-6-fluorophenyl)-4,5-dihydroisoxazol-3-yl)thiazole-2 -yl)piperidine-1-carboxylic acid-tert-butyl ester ( tert -butyl 4-(4-(5-(2-chloro-6-fluorophenyl)-4,5-dihydroisoxazol-3-yl)thiazol-2 -yl)piperidine-1-carboxylate) (6 g, 12.88 mmol) in dichloromethane (64.4 mL). The resulting mixture was stirred at 25 ° C for 4 hours. After the reaction was complete, the reaction mixture was concentrated under reduced pressure to obtain the product 5-(2-chloro-6-fluorophenyl)-3-(2-(piperidin-4-yl)thiazol-4-yl)-4,5 - Dihydroisoxazole (4.71 g, 12.87 mmol, 100% yield).

步驟2:1-(4-(4-(5-(2-氯-6-氟苯基)-4,5-二氫異噁唑-3-基)噻唑-2-基)哌啶-1-基)-2-((3-(三氟甲基)吡啶-2-基)氧基)乙-1-酮之製備 (1-(4-(4-(5-(2-chloro-6-fluorophenyl)-4,5-dihydroisoxazol-3-yl)thiazol-2-yl)piperidin-1-yl)-2-((3-(trifluoromethyl)pyridin-2-yl)oxy)ethan-1-one)Step 2: 1-(4-(4-(5-(2-Chloro-6-fluorophenyl)-4,5-dihydroisoxazol-3-yl)thiazol-2-yl)piperidine-1 -yl)-2-((3-(trifluoromethyl)pyridin-2-yl)oxy)ethan-1-one preparation (1-(4-(4-(5-(2-chloro-6 -fluorophenyl)-4,5-dihydroisoxazol-3-yl)thiazol-2-yl)piperidin-1-yl)-2-((3-(trifluoromethyl)pyridin-2-yl)oxy)ethan-1-one)

於5-(2-氯-6-氟苯基)-3-(2-(哌啶-4-基)噻唑-4-基)-4,5-二氫異噁唑 (4 g, 10.93 mmol)與二甲基甲醯胺 (100 mL)的攪拌溶液中,添加 N,N-二異丙基乙胺 (13.37 mL, 77 mmol)。在25 oC下,向前述溶液中逐滴加入2-((3-(三氟甲基)吡啶-2-基)氧基)乙酸(2-((3-(trifluoromethyl)pyridin-2-yl)oxy)acetic acid)(2.418 g, 10.93 mmol)和1-[雙(二甲胺基)亞甲基]-1H-1,2,3-三唑並[4,5-b]吡啶鎓3-氧化物六氟磷酸鹽 (1-[Bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]pyridinium 3-oxide hexafluorophosphate, HATU) (6.24 g, 16.40 mmol)。將反應混合物於25 oC下攪拌1小時。反應完成後,用冷水淬滅 (quenched)反應混合物,以冷水 (200 mL)稀釋反應混合物,並用乙酸乙酯 (500 mL × 2)對其萃取。合併的乙酸乙酯層以無水硫酸鈉乾燥、過濾並進行減壓濃縮。粗產物經管柱層析純化得到灰白色固體(off-white solid)之1-(4-(4-(5-(2-氯-6-氟苯基)-4,5-二氫異噁唑-3-基)噻唑-2-基)哌啶-1-基)-2-((3-(三氟甲基)吡啶-2-基)氧基)乙-1-酮(2 g,3.52 mmol,產率32%)。 In 5-(2-chloro-6-fluorophenyl)-3-(2-(piperidin-4-yl)thiazol-4-yl)-4,5-dihydroisoxazole (4 g, 10.93 mmol ) and dimethylformamide (100 mL), N,N -diisopropylethylamine (13.37 mL, 77 mmol) was added. At 25 o C, 2-((3-(trifluoromethyl)pyridin-2-yl)oxy)acetic acid (2-((3-(trifluoromethyl)pyridin-2-yl)pyridin-2-yl) was added dropwise to the aforementioned solution )oxy)acetic acid) (2.418 g, 10.93 mmol) and 1-[bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]pyridinium 3 -Oxide hexafluorophosphate (1-[Bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]pyridinium 3-oxide hexafluorophosphate, HATU) (6.24 g, 16.40 mmol). The reaction mixture was stirred at 25 ° C for 1 hour. After the reaction was completed, the reaction mixture was quenched with cold water, diluted with cold water (200 mL), and extracted with ethyl acetate (500 mL×2). The combined ethyl acetate layers were dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure. The crude product was purified by column chromatography to obtain 1-(4-(4-(5-(2-chloro-6-fluorophenyl)-4,5-dihydroisoxazole- 3-yl)thiazol-2-yl)piperidin-1-yl)-2-((3-(trifluoromethyl)pyridin-2-yl)oxy)ethan-1-one (2 g, 3.52 mmol , yield 32%).

範例example 22 : 1-(4-(4-(5-(2,6-1-(4-(4-(5-(2,6- 二氯苯基Dichlorophenyl )-4,5-)-4,5- 二氫異噁唑Dihydroisoxazole -3--3- base )) 噻唑Thiazole -2--2- base )) 哌啶piperidine -1--1- base )-2-((3-()-2-((3-( 三氟甲基Trifluoromethyl )) 吡嗪pyrazine -2--2- base )) oxygen )) Second -1--1- ketone (1-(4-(4-(5-(2,6-dichlorophenyl)-4,5-dihydroisoxazol-3-yl)thiazol-2-yl)piperidin-1-yl)-2-((3-(trifluoromethyl) pyrazin-2-yl) oxy)ethan-1-one)(1-(4-(4-(5-(2,6-dichlorophenyl)-4,5-dihydroisoxazol-3-yl)thiazol-2-yl)piperidin-1-yl)-2-((3-( trifluoromethyl)pyrazin-2-yl)oxy)ethan-1-one) 之製備preparation

步驟1:5-(2,6-二氯苯基)-3-(2-(哌啶-4-基)噻唑-4-基)-4,5-二氫異噁唑 (5-(2,6-dichlorophenyl)-3-(2-(piperidin-4-yl)thiazol-4-yl)-4,5-dihydroisoxazole)的製備Step 1: 5-(2,6-dichlorophenyl)-3-(2-(piperidin-4-yl)thiazol-4-yl)-4,5-dihydroisoxazole (5-(2 ,6-dichlorophenyl)-3-(2-(piperidin-4-yl)thiazol-4-yl)-4,5-dihydroisoxazole) preparation

將三氟乙酸 (28.7 mL, 373 mmol)加入至4-(4-(5-(2,6-二氯苯基)-4,5-二氫異噁唑-3-基)噻唑-2-基)哌啶-1-羧酸-叔丁基酯 ( tert-butyl 4-(4-(5-(2,6-dichlorophenyl)-4,5-dihydroisoxazol-3-yl)thiazol-2-yl)piperidine-1-carboxylate) (9 g, 18.66 mmol)與二氯甲烷 (65.9 mL)的溶液中。所得混合物在25 oC攪拌4小時。反應完成後,將反應混合物經減壓濃縮得到產物5-(2,6-二氯苯基)-3-(2-(哌啶-4-基)噻唑-4-基)-4,5-二氫異噁唑 (5-(2,6-dichlorophenyl)-3-(2-(piperidin-4-yl)thiazol-4-yl)-4,5-dihydroisoxazole)(7.13 g,18.65 mmol,產率100%)。 Add trifluoroacetic acid (28.7 mL, 373 mmol) to 4-(4-(5-(2,6-dichlorophenyl)-4,5-dihydroisoxazol-3-yl)thiazole-2- Base) piperidine-1-carboxylic acid-tert-butyl ester ( tert -butyl 4-(4-(5-(2,6-dichlorophenyl)-4,5-dihydroisoxazol-3-yl)thiazol-2-yl) piperidine-1-carboxylate) (9 g, 18.66 mmol) and dichloromethane (65.9 mL). The resulting mixture was stirred at 25 ° C for 4 hours. After the reaction was complete, the reaction mixture was concentrated under reduced pressure to obtain the product 5-(2,6-dichlorophenyl)-3-(2-(piperidin-4-yl)thiazol-4-yl)-4,5- Dihydroisoxazole (5-(2,6-dichlorophenyl)-3-(2-(piperidin-4-yl)thiazol-4-yl)-4,5-dihydroisoxazole) (7.13 g, 18.65 mmol, yield 100%).

步驟2:1-(4-(4-(5-(2,6-二氯苯基)-4,5-二氫異噁唑-3-基)噻唑-2-基)哌啶-1-基)-2-((3-(三氟甲基)吡嗪-2-基)氧)乙酮 (1-(4-(4-(5-(2,6-dichlorophenyl)-4,5-dihydroisoxazol-3-yl)thiazol-2-yl)piperidin-1-yl)-2-((3-(trifluoromethyl) pyrazin-2-yl)oxy)ethan-1-one)之製備Step 2: 1-(4-(4-(5-(2,6-dichlorophenyl)-4,5-dihydroisoxazol-3-yl)thiazol-2-yl)piperidine-1- Base)-2-((3-(trifluoromethyl)pyrazin-2-yl)oxy)ethanone (1-(4-(4-(5-(2,6-dichlorophenyl)-4,5- Preparation of dihydroisoxazol-3-yl)thiazol-2-yl)piperidin-1-yl)-2-((3-(trifluoromethyl)pyrazin-2-yl)oxy)ethan-1-one)

於2-((3-(三氟甲基)吡嗪-2-基)氧基)乙酸 (2-((3-(trifluoromethyl)pyrazin-2-yl)oxy)acetic acid) (2.79 g,12.56 mmol)、5-(2,6-二氯苯基)-3-(2-(哌啶-4-基)噻唑-4-基)-4,5-二氫異噁唑 (5-(2,6-dichlorophenyl)-3-(2-(piperidin-4-yl)thiazol-4-yl)-4,5-dihydroisoxazole) (4 g, 10.46 mmol)以及二甲基甲醯胺 (52.3 mL)的溶液中,添加 N,N-二異丙基乙胺 ( N,N-diisopropylethylamine) (10.96 mL, 62.8 mmol)。將反應混合物攪拌5分鐘。於該反應混合物添加 N,N-二異丙基乙胺 (10.96 mL, 62.8 mmol),並將所得混合物在25 oC下攪拌15分鐘。反應完成後,將反應混合物用冷水淬滅;反應混合物用冷水 (200 mL)稀釋並以乙酸乙酯 (500 mL X 2)對其萃取。合併的乙酸乙酯層以無水硫酸鈉乾燥、過濾並進行減壓濃縮。粗產物經管柱層析純化得到1-(4-(4-(5-(2,6-二氯苯基)-4,5-二氫異噁唑-3-基)噻唑-2-基)哌啶-1-基)-2-((3-(三氟甲基)吡嗪-2-基)氧)乙-1-酮(2.15 g,3.67 mmol,產率35%)。 In 2-((3-(trifluoromethyl)pyrazin-2-yl)oxy)acetic acid (2-((3-(trifluoromethyl)pyrazin-2-yl)oxy)acetic acid) (2.79 g, 12.56 mmol), 5-(2,6-dichlorophenyl)-3-(2-(piperidin-4-yl)thiazol-4-yl)-4,5-dihydroisoxazole (5-(2 ,6-dichlorophenyl)-3-(2-(piperidin-4-yl)thiazol-4-yl)-4,5-dihydroisoxazole) (4 g, 10.46 mmol) and dimethylformamide (52.3 mL) To the solution, N,N -diisopropylethylamine ( N,N -diisopropylethylamine) (10.96 mL, 62.8 mmol) was added. The reaction mixture was stirred for 5 minutes. To the reaction mixture was added N,N -diisopropylethylamine (10.96 mL, 62.8 mmol), and the resulting mixture was stirred at 25 ° C. for 15 minutes. After the reaction was complete, the reaction mixture was quenched with cold water; the reaction mixture was diluted with cold water (200 mL) and extracted with ethyl acetate (500 mL X 2). The combined ethyl acetate layers were dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure. The crude product was purified by column chromatography to give 1-(4-(4-(5-(2,6-dichlorophenyl)-4,5-dihydroisoxazol-3-yl)thiazol-2-yl) Piperidin-1-yl)-2-((3-(trifluoromethyl)pyrazin-2-yl)oxy)ethan-1-one (2.15 g, 3.67 mmol, 35% yield).

範例example 33 : 4-(4-(5-(2-4-(4-(5-(2- bromine -6--6- 氟苯基Fluorophenyl )-4,5-)-4,5- 二氫異噁唑Dihydroisoxazole -3--3- base )) 噻唑Thiazole -2--2- base )) 哌啶piperidine -1--1- 羧酸叔丁酯tert-butyl carboxylate (tert-butyl 4-(4-(5-(2-bromo-6-fluorophenyl)-4,5-dihydroisoxazol-3-yl)thiazol-2-yl)piperidine-1-carboxylate)(tert-butyl 4-(4-(5-(2-bromo-6-fluorophenyl)-4,5-dihydroisoxazol-3-yl)thiazol-2-yl)piperidine-1-carboxylate) 之製備preparation

步驟1:1-溴-3-氟-2-乙烯基苯 (1-bromo-3-fluoro-2-vinylbenzene)的製備Step 1: Preparation of 1-bromo-3-fluoro-2-vinylbenzene (1-bromo-3-fluoro-2-vinylbenzene)

於2-溴-6-氟苯甲醛 (5.0 g, 24.63 mmol)、甲基三苯基溴化鏻 (10.56 g, 29.6 mmol)以及四氫呋喃 (100 mL)的攪拌懸浮液中,在0 °C的氮氣環境下,分批地加入氫化鈉 (1.478 g, 36.9 mmol)。將反應溫度升至25 °C並將反應混合物攪拌2小時。反應完成後,將反應混合物用冰淬滅,並以乙酸乙酯 (1L)對其萃取。將乙酸乙酯層以鹽水溶液 (brine solution)洗滌。分離乙酸乙酯層,將其以無水硫酸鈉乾燥、過濾、減壓濃縮後,得到1-溴-3-氟-2-乙烯基苯。In a stirred suspension of 2-bromo-6-fluorobenzaldehyde (5.0 g, 24.63 mmol), methyltriphenylphosphonium bromide (10.56 g, 29.6 mmol) and tetrahydrofuran (100 mL), at 0 °C Under nitrogen, sodium hydride (1.478 g, 36.9 mmol) was added in portions. The reaction temperature was raised to 25 °C and the reaction mixture was stirred for 2 hours. After the reaction was completed, the reaction mixture was quenched with ice, and extracted with ethyl acetate (1 L). The ethyl acetate layer was washed with brine solution. The ethyl acetate layer was separated, dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure to obtain 1-bromo-3-fluoro-2-vinylbenzene.

步驟2:4-(4-((羥基亞胺基)甲基)噻唑-2-基)哌啶-1-羧酸叔丁酯 (tert-butyl 4-(4-((hydroxyimino) methyl) thiazol-2-yl) piperidine-1-carboxylate)的製備Step 2: tert-butyl 4-(4-((hydroxyimino)methyl)thiazol-2-yl)piperidine-1-carboxylate (tert-butyl 4-(4-((hydroxyimino)methyl)thiazol -2-yl) piperidine-1-carboxylate) preparation

於胲鹽酸鹽 (hydroxylamine hydrochloride) (23.43 g, 337 mmol)與乙醇 (500 mL)的攪拌溶液中,加入三乙胺 (94 mL, 674 mmol)。將前述反應混合物攪拌15分鐘。於該反應混合物中,緩慢地加入4-(4-甲醯基噻唑-2-基)哌啶-1-羧酸-叔丁酯 ( tert-butyl 4-(4-formylthiazol-2-yl) piperidine-1-carboxylate) (50 g, 169 mmol)與乙醇 (100 mL)的溶液。添加後,反應混合物進一步攪拌2小時。反應完成後,將反應混合物濃縮,再以1 L水稀釋。所得到的白色沉澱經過濾以及減壓濃縮後,得到4-(4-((羥基亞胺基)甲基)噻唑-2-基)哌啶-1-羧酸叔丁酯(45 g,145 mmol,產率86%)。 To a stirred solution of hydroxylamine hydrochloride (23.43 g, 337 mmol) and ethanol (500 mL) was added triethylamine (94 mL, 674 mmol). The preceding reaction mixture was stirred for 15 minutes. In this reaction mixture, slowly add 4-(4-formylthiazol-2-yl) piperidine-1-carboxylic acid-tert-butyl ester ( tert -butyl 4-(4-formylthiazol-2-yl) piperidine -1-carboxylate) (50 g, 169 mmol) in ethanol (100 mL). After the addition, the reaction mixture was further stirred for 2 hours. After the reaction was complete, the reaction mixture was concentrated and diluted with 1 L of water. The obtained white precipitate was filtered and concentrated under reduced pressure to obtain tert-butyl 4-(4-((hydroxyimino)methyl)thiazol-2-yl)piperidine-1-carboxylate (45 g, 145 mmol, yield 86%).

步驟3:4-(4-(5-(2-溴-6-氟苯基)-4,5-二氫異噁唑-3-基)噻唑-2-基)哌啶-1-羧酸叔丁酯 (tert-butyl 4-(4-(5-(2-bromo-6-fluorophenyl)-4,5-dihydroisoxazol-3-yl)thiazol-2-yl)piperidine-1-carboxylate)之製備Step 3: 4-(4-(5-(2-Bromo-6-fluorophenyl)-4,5-dihydroisoxazol-3-yl)thiazol-2-yl)piperidine-1-carboxylic acid Preparation of tert-butyl ester (tert-butyl 4-(4-(5-(2-bromo-6-fluorophenyl)-4,5-dihydroisoxazol-3-yl)thiazol-2-yl)piperidine-1-carboxylate

在25°C下,於(E)-4-(4-((羥基亞胺基)甲基)噻唑-2-基)哌啶-1-羧酸叔丁酯 ((E)-4-(4-((hydroxyimino)methyl)thiazol-2-yl)piperidine-1-carboxylate) (4.0 g, 12.85 mmol)的攪拌液中,加入1-溴-3-氟-2-乙烯基苯(1-bromo-3-fluoro-2-vinylbenzene) (2.58 g, 12.85 mmol)與乙酸乙酯 (50 mL)的溶液。對該反應混合物添加N-氯代琥珀醯亞胺 ( N-Chlorosuccinimide) (2.57 g, 19.27 mmol)、碳酸氫鈉 (3.24 g, 38.5 mmol)和水 (10 mL)。將反應混合物於60 °C下攪拌2小時。反應完成後,以水 (100 mL)稀釋反應混合物,並以乙酸乙酯 (100 mL × 3)對其萃取。合併的乙酸乙酯層以無水硫酸鈉乾燥、過濾並進行減壓濃縮,以獲得粗產物。粗產物經管柱層析純化,得到4-(4-(5-(2-溴-6-氟苯基)-4,5-二氫異噁唑-3-基)噻唑-2-基)哌啶-1-羧酸叔丁酯(4.5 g,8.82 mmol,產率68.6%)。 At 25°C, in (E)-4-(4-((hydroxyimino)methyl)thiazol-2-yl)piperidine-1-carboxylic acid tert-butyl ester ((E)-4-( Add 1-bromo-3-fluoro-2-vinylbenzene (1-bromo -3-fluoro-2-vinylbenzene) (2.58 g, 12.85 mmol) in ethyl acetate (50 mL). To the reaction mixture were added N -Chlorosuccinimide (2.57 g, 19.27 mmol), sodium bicarbonate (3.24 g, 38.5 mmol) and water (10 mL). The reaction mixture was stirred at 60 °C for 2 hours. After the reaction was completed, the reaction mixture was diluted with water (100 mL), and extracted with ethyl acetate (100 mL×3). The combined ethyl acetate layers were dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure to obtain crude product. The crude product was purified by column chromatography to give 4-(4-(5-(2-bromo-6-fluorophenyl)-4,5-dihydroisoxazol-3-yl)thiazol-2-yl)piper tert-Butyl pyridine-1-carboxylate (4.5 g, 8.82 mmol, 68.6% yield).

生物範例:Biological example:

殺真菌活性:Fungicidal activity:

如本文所述,如式 (I)所示之化合物顯示出對多種攻擊重要農作物的真菌具有殺真菌活性。本案之化合物係藉由下述試驗以評價其活性:As described herein, compounds of formula (I) exhibit fungicidal activity against a variety of fungi that attack important crops. The compound of this case is to evaluate its activity by following test:

生物試驗範例:Examples of biological tests:

範例example 11 :於番茄植物的茄鏈隔孢菌: Alternaria solani on tomato plants ( Alternaria solani) ( Alternaria solani ) 試驗test

將單個化合物或相應的化合物組合溶解在2%的二甲基亞碸/丙酮中,然後在50 mL的校準噴霧體積中與含有乳化劑的水混合至所需的測試濃度。將測試溶液倒入噴霧瓶中用以進一步施用。Individual compounds or corresponding compound combinations are dissolved in 2% dimethyloxide/acetone and then mixed with water containing emulsifier to the desired test concentration in a calibrated spray volume of 50 mL. Pour the test solution into a spray bottle for further application.

為了測試化合物的防病活性,使用空心圓錐噴嘴在噴霧櫃內,向在溫室中培養的健康幼齡番茄以所述的施用率噴灑活性化合物製劑。處理完的隔天,將含有0.24 x 10 6的茄鏈隔孢菌接種體 (inoculum)和2%麥芽糖之孢子懸浮液接種於植物。然後將接種的植物保存在溫度為22-24 ℃、相對濕度為90-95%的溫室中以進行疾病表達。 To test the disease-controlling activity of the compounds, healthy young tomatoes grown in a greenhouse are sprayed with the preparation of active compound at the stated application rates in a spray cabinet using hollow-cone nozzles. The day after the treatment, plants were inoculated with a spore suspension containing 0.24 x 10 6 inoculum (inoculum) of Alternaria solani and 2% maltose. The inoculated plants were then kept in a greenhouse at a temperature of 22-24°C and a relative humidity of 90-95% for disease expression.

藉由在施用後的3、7、10和15天對處理之植物的疾病嚴重程度(0-100%範圍)進行評分,以對單一化合物或化合物的組合物之功效進行視覺評估。單一化合物以及混合物的功效(%控制率)係藉由將治療中的植物的疾病評分與未治療的控制組之疾病評分比較而得。並藉由記錄壞死、萎黃和生長遲緩等症狀,以評估化合物的植物相容性。與化合物 (I-1)有關的結果顯示於表A中。Efficacy of single compounds or combinations of compounds was assessed visually by scoring disease severity (0-100% range) on treated plants at 3, 7, 10 and 15 days after application. Efficacy (% control) of single compounds as well as mixtures was determined by comparing disease scores of treated plants with those of untreated controls. The phytocompatibility of compounds was assessed by recording symptoms such as necrosis, chlorosis and growth retardation. The results related to compound (I-1) are shown in Table A.

令人驚訝的是,下表所示的組合顯示出無法預期的協同效應:Surprisingly, the combinations shown in the table below showed unanticipated synergies:

A 本案的組合物對番茄中的茄鏈格孢菌之協同殺菌活性顯示於下方表中,其中作為組分 (1)之如式 (I)所示之化合物的代表性化合物特別為化合物 (I-1),其他組分 (2)係選自(II-A)至(II-R)各組。 序號 化合物 濃度 (ppm) 比例 觀察到的功效 (%) 預期(或計算出)的功效 協同效應 (Colby’s) 1 化合物 (I-1) 10 20 2 化合物 (I-1) 50 22 3 化合物 (I-1) 100 23 4 安美速 (amisulbrom) 0.05 5 5 安美速 0.1 14 6 亞托敏 (Azoxystrobin) 0.05 33 7 克絕 (cymoxanil) 0.05 7 8 克絕 0.1 12 9 達滅芬 (dimethomorph) 0.05 7 10 達滅芬 0.1 12 11 氟比來 (fluopicolide) 0.1 14 12 唑菌胺酯 (pyraclostrobin) 0.05 21 13 唑菌胺酯 0.1 28 14 免得爛 (metiram) 0.05 26 15 免得爛 0.1 30 16 座賽胺 (zoxamide) 0.05 26 17 座賽胺 0.1 30 18 氟克殺 (fluxapyroxad) 0.1 25 19 化合物 (I-1) + 安美速 (amisulbrom) (50 + 0.1) 500:1 68 33 36 20 化合物 (I-1) + 安美速 (100 + 0.05) 2000:1 71 27 44 21 化合物 (I-1) + 安美速 (100 + 0.1) 1000:1 82 34 48 22 化合物 (I-1) + 亞托敏 (Azoxystrobin) (50 + 0.05) 1000:1 63 48 15 23 化合物 (I-1) + 亞托敏 (100 + 0.05) 2000:1 68 48 20 24 化合物 (I-1) + 克絕 (cymoxanil) (100 + 0.05) 2000:1 40 28 12 25 化合物 (I-1) + 克絕 (100 + 0.1) 1000:1 45 32 13 26 化合物 (I-1) + 達滅芬 (dimethomorph) (100 + 0.05) 2000:1 38 28 10 27 化合物 (I-1) + 達滅芬 (100 + 0.1) 1000:1 45 32 13 28 化合物 (I-1) + 氟比來 (fluopicolide) (100 + 0.1) 1000:1 43 34 9 29 化合物 (I-1) + 唑菌胺酯 (pyraclostrobin) (10 + 0.1) 100:1 59 42 16 30 化合物 (I-1) + 唑菌胺酯 (50 + 0.1) 500:1 71 44 27 31 化合物 (I-1) + 唑菌胺酯 (100 + 0.05) 2000:1 73 39 34 32 化合物 (I-1) + 唑菌胺酯 (100 + 0.1) 1000:1 80 45 36 33 化合物 (I-1) + 免得爛 (100 + 0.05) 2000:1 61 43 18 34 化合物 (I-1) + 免得爛 (100 + 0.1) 1000:1 66 46 20 35 化合物 (I-1) + 座賽胺 (zoxamide) (10 + 0.05) 200:1 73 41 32 36 化合物 (I-1) + 座賽胺 (10 + 0.1) 100:1 83 44 39 37 化合物 (I-1) + 座賽胺 (50 + 0.05) 1000:1 85 42 43 38 化合物 (I-1) + 座賽胺 (50 + 0.1) 500:1 90 45 45 39 化合物 (I-1) + 座賽胺 (100 + 0.05) 2000:1 93 43 50 40 化合物 (I-1) + 座賽胺 (100 + 0.1) 1000:1 95 46 49 41 化合物 (I-1) + 氟克殺 (100 + 0.1) 1000:1 73 42 31 Table A : The synergistic bactericidal activity of the composition of the present case on Alternaria solani in tomato is shown in the table below, wherein the representative compound as the compound shown in formula (I) as component (1) is particularly compound (I-1), other components (2) are selected from the groups (II-A) to (II-R). serial number compound Concentration (ppm) Proportion Observed Efficacy (%) expected (or calculated) power Synergy (Colby's) 1 Compound (I-1) 10 20 2 Compound (I-1) 50 twenty two 3 Compound (I-1) 100 twenty three 4 Amisulbrom 0.05 5 5 Amex 0.1 14 6 Azoxystrobin 0.05 33 7 Cymoxanil 0.05 7 8 Absolutely 0.1 12 9 Dimethomorph 0.05 7 10 Damiphen 0.1 12 11 Fluopicolide 0.1 14 12 pyraclostrobin 0.05 twenty one 13 pyraclostrobin 0.1 28 14 so as not to rot (metiram) 0.05 26 15 so as not to rot 0.1 30 16 Zoxamide 0.05 26 17 Cytamine 0.1 30 18 Fluxapyroxad 0.1 25 19 Compound (I-1) + amisulbrom (50 + 0.1) 500:1 68 33 36 20 Compound (I-1) + Amosox (100 + 0.05) 2000:1 71 27 44 twenty one Compound (I-1) + Amosox (100 + 0.1) 1000:1 82 34 48 twenty two Compound (I-1) + Azoxystrobin (50 + 0.05) 1000:1 63 48 15 twenty three Compound (I-1) + Yatropin (100 + 0.05) 2000:1 68 48 20 twenty four Compound (I-1) + cymoxanil (100 + 0.05) 2000:1 40 28 12 25 Compound (I-1) + g absolute (100 + 0.1) 1000:1 45 32 13 26 Compound (I-1) + Dimethomorph (100 + 0.05) 2000:1 38 28 10 27 Compound (I-1) + Damilfine (100 + 0.1) 1000:1 45 32 13 28 Compound (I-1) + fluopicolide (100 + 0.1) 1000:1 43 34 9 29 Compound (I-1) + pyraclostrobin (10 + 0.1) 100:1 59 42 16 30 Compound (I-1) + pyraclostrobin (50 + 0.1) 500:1 71 44 27 31 Compound (I-1) + pyraclostrobin (100 + 0.05) 2000:1 73 39 34 32 Compound (I-1) + pyraclostrobin (100 + 0.1) 1000:1 80 45 36 33 Compound (I-1) + so as not to rot (100 + 0.05) 2000:1 61 43 18 34 Compound (I-1) + so as not to rot (100 + 0.1) 1000:1 66 46 20 35 Compound (I-1) + zoxamide (10 + 0.05) 200:1 73 41 32 36 Compound (I-1) + Cycloamide (10 + 0.1) 100:1 83 44 39 37 Compound (I-1) + Cycloamide (50 + 0.05) 1000:1 85 42 43 38 Compound (I-1) + Cycloamide (50 + 0.1) 500:1 90 45 45 39 Compound (I-1) + Cycloamide (100 + 0.05) 2000:1 93 43 50 40 Compound (I-1) + Cycloamide (100 + 0.1) 1000:1 95 46 49 41 Compound (I-1) + Fluoxetine (100 + 0.1) 1000:1 73 42 31

範例 2 於番茄植物的致病疫黴 ( Phytophthora infestans)試驗 Example 2 : Experiment with Phytophthora infestans on tomato plants

將單個化合物或相應的化合物組合溶解在2%的二甲基亞碸/丙酮中,然後在50 mL的校準噴霧體積中與含有乳化劑的水混合至所需的測試濃度。將測試溶液倒入噴霧瓶中用以進一步施用。Individual compounds or corresponding compound combinations are dissolved in 2% dimethyloxide/acetone and then mixed with water containing emulsifier to the desired test concentration in a calibrated spray volume of 50 mL. Pour the test solution into a spray bottle for further application.

為了測試化合物的防病活性,使用空心圓錐噴嘴在噴霧櫃內,向在溫室中培養的健康幼齡番茄以所述的施用率噴灑活性化合物製劑。處理後的隔天,以孢子囊懸浮液(含有0.24 x 10 6致病疫黴接種體的無菌冷水)接種於植物。接種後,將植物保存在溫度為15 ℃之暗處24小時、而後將其移至溫度為18 ℃、相對濕度為95-100%的溫室中以進行疾病表達。 To test the disease-controlling activity of the compounds, healthy young tomatoes grown in a greenhouse are sprayed with the preparation of active compound at the stated application rates in a spray cabinet using hollow-cone nozzles. The next day after treatment, the plants were inoculated with a sporangia suspension (0.24 x 106 in sterile cold water containing an inoculum of Phytophthora infestans). After inoculation, plants were kept in the dark at 15°C for 24 hours and then moved to a greenhouse at 18°C and 95-100% relative humidity for disease expression.

藉由在施用後的3、7、10和15天對處理之植物的疾病嚴重程度(0-100%範圍)進行評分,以對單一化合物或化合物的組合物之功效進行視覺評估。化合物的功效(%控制率)係藉由將治療中的植物的疾病評分與未治療的控制組之疾病評分比較而得。並藉由記錄壞死、萎黃和生長遲緩等症狀,以評估化合物的植物相容性。與化合物 (I-1)有關的結果顯示於表B中。Efficacy of single compounds or combinations of compounds was assessed visually by scoring disease severity (0-100% range) on treated plants at 3, 7, 10 and 15 days after application. Compound efficacy (% control) was determined by comparing disease scores of treated plants to disease scores of untreated controls. The phytocompatibility of compounds was assessed by recording symptoms such as necrosis, chlorosis and growth retardation. The results related to compound (I-1) are shown in Table B.

令人驚訝的是,下表所示的組合顯示出無法預期的協同效應:Surprisingly, the combinations shown in the table below showed unanticipated synergies:

B:本案的組合物對於番茄中的致病疫黴之協同殺菌活性顯示於下方表中,其中作為組分 (1)之如式 (I)所示之化合物的代表性化合物特別為化合物 (I-1),其他組分 (2)係選自(II-A)至(II-R)各組。 序號 化合物 濃度 (ppm) 比例 觀察到的功效 (%) 預期(或計算出)的功效 協同效應 (Colby’s) 1 化合物 (I-1) 0.00001 45 2 化合物 (I-1) 0.0001 64 3 安美速 (amisulbrom) 0.05 18 4 安美速 0.02 23 5 安美速 0.1 28 6 亞托敏 (Azoxystrobin) 0.05 13 7 亞托敏 0.02 19 8 亞托敏 0.1 26 9 氟派瑞 (fluopyram) 0.02 9 10 氟派瑞 0.1 11 11 曼普胺 (mandipropamid) 0.05 29 12 曼普胺 0.02 38 13 曼普胺 0.1 45 14 滅芬座 (mefentrifluconazole) 0.05 32 15 滅芬座 0.02 40 16 滅芬座 0.1 47 17 化合物 (I-1) + 安美速 (amisulbrom) (0.00001 + 0.02) 0.0005:1 74 58 16 18 化合物 (I-1) + 安美速 (amisulbrom) (0.00001 + 0.1) 0.0001:1 81 60 21 19 化合物 (I-1) + 安美速 (amisulbrom) (0.0001 + 0.05) 0.002:1 88 70 18 20 化合物 (I-1) + 安美速 (amisulbrom) (0.0001 + 0.02) 0.005:1 90 72 18 21 化合物 (I-1) + 安美速 (amisulbrom) (0.0001 + 0.1) 0.001:1 93 74 19 22 化合物 (I-1) + 亞托敏 (Azoxystrobin) (0.00001 + 0.05) 0.0002:1 69 52 17 23 化合物 (I-1) + 亞托敏 (0.00001 + 0.02) 0.0005:1 76 55 21 24 化合物 (I-1) + 亞托敏 (0.00001 + 0.1) 0.0001:1 81 59 22 25 化合物 (I-1) + 亞托敏 (0.0001 + 0.02) 0.005:1 93 71 22 26 化合物 (I-1) + 亞托敏 (0.0001 + 0.1) 0.001:1 95 73 22 27 化合物 (I-1) + 氟派瑞 (fluopyram) (0.00001 + 0.02) 0.0005:1 71 50 21 28 化合物 (I-1) + 氟派瑞 (0.00001 + 0.1) 0.0001:1 76 51 25 29 化合物 (I-1) + 氟派瑞 (0.0001 + 0.1) 0.001:1 88 68 20 30 化合物 (I-1) + 曼普胺 (mandipropamid) (0.00001 + 0.05) 0.0002:1 73 61 12 31 化合物 (I-1) + 曼普胺 (0.00001 + 0.02) 0.0005:1 80 66 15 32 化合物 (I-1) + 曼普胺 (0.00001 + 0.1) 0.0001:1 85 70 16 33 化合物 (I-1) + 曼普胺 (0.0001 + 0.05) 0.002:1 88 74 13 34 化合物 (I-1) + 曼普胺 (0.0001 + 0.02) 0.005:1 90 78 13 35 化合物 (I-1) + 曼普胺 (0.0001 + 0.1) 0.001:1 93 80 12 36 化合物 (I-1) + 滅芬座 (mefentrifluconazole) (0.00001 + 0.05) 0.0002:1 71 63 8 37 化合物 (I-1) + 滅芬座 (0.00001 + 0.02) 0.0005:1 76 67 9 38 化合物 (I-1) + 滅芬座 (0.00001 + 0.1) 0.0001:1 80 71 10 Table B : The synergistic bactericidal activity of the composition of the present case for Phytophthora infestans in tomato is shown in the table below, wherein the representative compound as the compound shown in formula (I) as component (1) is particularly compound ( I-1), other components (2) are selected from (II-A) to (II-R) each group. serial number compound Concentration (ppm) Proportion Observed Efficacy (%) expected (or calculated) power Synergy (Colby's) 1 Compound (I-1) 0.00001 45 2 Compound (I-1) 0.0001 64 3 Amisulbrom 0.05 18 4 Amex 0.02 twenty three 5 Amex 0.1 28 6 Azoxystrobin 0.05 13 7 Yatomin 0.02 19 8 Yatomin 0.1 26 9 fluopyram 0.02 9 10 Fluperide 0.1 11 11 Mandipropamid 0.05 29 12 Maprotamide 0.02 38 13 Maprotamide 0.1 45 14 Mefentrifluconazole 0.05 32 15 Mephim 0.02 40 16 Mephim 0.1 47 17 Compound (I-1) + amisulbrom (0.00001 + 0.02) 0.0005:1 74 58 16 18 Compound (I-1) + amisulbrom (0.00001 + 0.1) 0.0001:1 81 60 twenty one 19 Compound (I-1) + amisulbrom (0.0001 + 0.05) 0.002:1 88 70 18 20 Compound (I-1) + amisulbrom (0.0001 + 0.02) 0.005:1 90 72 18 twenty one Compound (I-1) + amisulbrom (0.0001 + 0.1) 0.001:1 93 74 19 twenty two Compound (I-1) + Azoxystrobin (0.00001 + 0.05) 0.0002:1 69 52 17 twenty three Compound (I-1) + Yatropin (0.00001 + 0.02) 0.0005:1 76 55 twenty one twenty four Compound (I-1) + Yatropin (0.00001 + 0.1) 0.0001:1 81 59 twenty two 25 Compound (I-1) + Yatropin (0.0001 + 0.02) 0.005:1 93 71 twenty two 26 Compound (I-1) + Yatropin (0.0001 + 0.1) 0.001:1 95 73 twenty two 27 Compound (I-1) + fluopyram (0.00001 + 0.02) 0.0005:1 71 50 twenty one 28 Compound (I-1) + fluperid (0.00001 + 0.1) 0.0001:1 76 51 25 29 Compound (I-1) + fluperid (0.0001 + 0.1) 0.001:1 88 68 20 30 Compound (I-1) + mandipropamid (0.00001 + 0.05) 0.0002:1 73 61 12 31 Compound (I-1) + Maprotamide (0.00001 + 0.02) 0.0005:1 80 66 15 32 Compound (I-1) + Maprotamide (0.00001 + 0.1) 0.0001:1 85 70 16 33 Compound (I-1) + Maprotamide (0.0001 + 0.05) 0.002:1 88 74 13 34 Compound (I-1) + Maprotamide (0.0001 + 0.02) 0.005:1 90 78 13 35 Compound (I-1) + Maprotamide (0.0001 + 0.1) 0.001:1 93 80 12 36 Compound (I-1) + mefentrifluconazole (0.00001 + 0.05) 0.0002:1 71 63 8 37 Compound (I-1) + methphen (0.00001 + 0.02) 0.0005:1 76 67 9 38 Compound (I-1) + methphen (0.00001 + 0.1) 0.0001:1 80 71 10

範例example 33 :於黃瓜植物之瓜類白粉病菌: Melon powdery mildew on cucumber plants ( Erysiphe cichoracearum) ( Erysiphe cichoracearum ) 試驗test

將單個化合物或相應的化合物組合溶解在2%的二甲基亞碸/丙酮中,然後在50 mL的校準噴霧體積中與含有乳化劑的水混合至所需的測試濃度。將測試溶液倒入噴霧瓶中用以進一步施用。Individual compounds or corresponding compound combinations are dissolved in 2% dimethyloxide/acetone and then mixed with water containing emulsifier to the desired test concentration in a calibrated spray volume of 50 mL. Pour the test solution into a spray bottle for further application.

為了測試化合物的防病活性,使用空心圓錐噴嘴在噴霧櫃內,向在溫室中培養的健康幼齡黃瓜以所述的施用率噴灑活性化合物製劑。處理完的隔天,用含有2 x 10 5的瓜類白粉病菌接種體之分生孢子懸浮液接種於植物。然後將接種的植物保存在溫度為22-24 ℃、相對濕度為50-60%的溫室中以進行疾病表達。 To test the disease-controlling activity of the compounds, healthy young cucumbers grown in a greenhouse are sprayed with the preparation of active compound at the stated application rates in a spray cabinet using hollow-cone nozzles. The day after treatment, the plants were inoculated with a conidia suspension containing 2 x 105 inoculum of Powdery mildew cucurbitus. The inoculated plants were then kept in a greenhouse at a temperature of 22-24 °C and a relative humidity of 50-60% for disease expression.

藉由在施用後的3、7、10和15天對處理之植物的疾病嚴重程度(0-100% 範圍)進行評分,以對單一化合物或化合物的組合物之功效進行視覺評估。化合物的功效(%控制率)係藉由將治療中的植物的疾病評分與未治療的控制組之疾病評分比較而得。並藉由記錄壞死、萎黃和生長遲緩等症狀,以評估化合物的植物相容性。與化合物 (I-1)有關的結果顯示於表C中。令人驚訝的是,下表所示的組合顯示出無法預期的協同效應:Efficacy of single compounds or combinations of compounds was assessed visually by scoring disease severity (0-100% range) on treated plants at 3, 7, 10 and 15 days after application. Compound efficacy (% control) was determined by comparing disease scores of treated plants to disease scores of untreated controls. The phytocompatibility of compounds was assessed by recording symptoms such as necrosis, chlorosis and growth retardation. The results related to compound (I-1) are shown in Table C. Surprisingly, the combinations shown in the table below showed unanticipated synergies:

表C:本案的組合物對於黃瓜中之瓜類白粉病菌之協同殺菌活性顯示於下方表中,其中作為組分 (1)之如式 (I)所示之化合物的代表性化合物特別為化合物 (I-1),其他組分 (2)係選自(II-A)至(II-R)各組。 序號 化合物 濃度 (ppm) 比例 觀察到的功效 (%) 預期(或計算出)的功效 協同效應 (Colby’s) 1 化合物 (I-1) 100 58 2 白克列 (boscalid) 0.05 24 3 白克列 0.1 32 4 化合物 (I-1) + 白克列 (100 + 0.05) 2000:1 78 68 10 5 化合物 (I-1) + 白克列 (100 + 0.1) 1000:1 89 71 17 Table C: The synergistic bactericidal activity of the composition of the present case for the cucurbit powdery mildew in cucumber is shown in the following table, wherein as the representative compound of the compound shown in formula (I) as component (1) is particularly compound ( I-1), other components (2) are selected from (II-A) to (II-R) each group. serial number compound Concentration (ppm) Proportion Observed Efficacy (%) expected (or calculated) power Synergy (Colby's) 1 Compound (I-1) 100 58 2 Bekley (boscalid) 0.05 twenty four 3 Bakley 0.1 32 4 Compound (I-1) + Bacrine (100 + 0.05) 2000:1 78 68 10 5 Compound (I-1) + Bacrine (100 + 0.1) 1000:1 89 71 17

範例example 44 :於黃瓜的古巴假霜霉菌: Cuban pseudoperonospora on cucumber ( Pseudoperonospora cubensis) ( Pseudoperonospora cubensis ) 試驗test

將單個化合物或相應的化合物組合溶解在2%的二甲基亞碸/丙酮中,然後在50 mL的校準噴霧體積中與含有乳化劑的水混合至所需的測試濃度。將測試溶液倒入噴霧瓶中用以進一步施用。Individual compounds or corresponding compound combinations are dissolved in 2% dimethyloxide/acetone and then mixed with water containing emulsifier to the desired test concentration in a calibrated spray volume of 50 mL. Pour the test solution into a spray bottle for further application.

為了測試化合物的防病活性,使用空心圓錐噴嘴在噴霧櫃內,向在溫室中培養的健康幼齡黃瓜以所述的施用率噴灑活性化合物製劑。處理完的隔天,用含有2 x 10 4的古巴假霜霉菌接種體之分生孢子懸浮液接種於植物。然後將接種的植物保存在溫度為23 ℃、相對濕度為80-90%的溫室中以進行疾病表達。 To test the disease-controlling activity of the compounds, healthy young cucumbers grown in a greenhouse are sprayed with the preparation of active compound at the stated application rates in a spray cabinet using hollow-cone nozzles. The day after treatment, the plants were inoculated with a conidia suspension containing 2 x 104 inoculum of Pseudomonas cuban. The inoculated plants were then kept in a greenhouse at a temperature of 23 °C and a relative humidity of 80–90% for disease expression.

藉由在施用後的3、7、10和15天對處理之植物的疾病嚴重程度(0-100%範圍)進行評分,以對單一化合物或化合物的組合物之功效進行視覺評估。化合物的功效(%控制率)係藉由將治療中的植物的疾病評分與未治療的控制組之疾病評分比較而得。並藉由記錄壞死、萎黃和生長遲緩等症狀,以評估化合物的植物相容性。與化合物 (I-1)有關的結果顯示於表D1以及表D2中。Efficacy of single compounds or combinations of compounds was assessed visually by scoring disease severity (0-100% range) on treated plants at 3, 7, 10 and 15 days after application. Compound efficacy (% control) was determined by comparing disease scores of treated plants to disease scores of untreated controls. The phytocompatibility of compounds was assessed by recording symptoms such as necrosis, chlorosis and growth retardation. The results related to compound (I-1) are shown in Table D1 and Table D2.

令人驚訝的是,下表所示的組合顯示出無法預期的協同效應:Surprisingly, the combinations shown in the table below showed unanticipated synergies:

D-1:本案的組合物對於黃瓜中的古巴假霜霉菌之協同殺菌活性顯示於下方表中,其中作為組分 (1)之如式 (I)所示之化合物的代表性化合物特別為化合物 (I-1),其他組分 (2)係選自(II-A)至(II-R)各組。 序號 化合物 濃度 (ppm) 比例 觀察到的功效 (%) 預期(或計算出)的功效 協同效應 (Colby’s) 1 化合物 (I-1) 0.00001 10 2 化合物 (I-1) 0.0001 14 3 滅脫定 (ametoctradin) 0.1 40 4 扶吉胺 (fluazinam) 0.05 27 5 扶吉胺 0.02 33 6 扶吉胺 0.1 38 7 氟派瑞 (fluopyram) 0.05 2 8 氟派瑞 0.02 5 9 氟派瑞 0.1 12 10 鋅錳乃浦 (mancozeb) 0.05 2 11 鋅錳乃浦 0.02 3 12 鋅錳乃浦 0.1 5 13 氟克殺 (fluxapyroxad) 0.02 40 14 化合物 (I-1) + 滅脫定 (ametoctradin) (0.0001 + 0.1) 0.001:1 66 48 18 15 化合物 (I-1) + 扶吉胺 (fluazinam) (0.0001 + 0.05) 0.002:1 55 37 18 16 化合物 (I-1) + 扶吉胺 (0.0001 + 0.02) 0.005:1 62 42 20 17 化合物 (I-1) + 扶吉胺 (0.0001 + 0.1) 0.001:1 69 47 22 18 化合物 (I-1) + 氟派瑞 (fluopyram) (0.00001 + 0.1) 0.0001:1 39 21 18 19 化合物 (I-1) + 氟派瑞 (0.0001 + 0.05) 0.002:1 46 16 30 20 化合物 (I-1) + 氟派瑞 (0.0001 + 0.02) 0.005:1 56 18 38 21 化合物 (I-1) + 氟派瑞 (0.0001 + 0.1) 0.001:1 63 24 39 22 化合物 (I-1) + 鋅錳乃浦 (mancozeb) (0.00001 + 0.02) 0.0005:1 24 13 11 23 化合物 (I-1) + 鋅錳乃浦 (0.00001 + 0.1) 0.0001:1 29 15 15 24 化合物 (I-1) + 鋅錳乃浦 (0.0001 + 0.05) 0.002:1 34 16 18 25 化合物 (I-1) + 鋅錳乃浦 (0.0001 + 0.02) 0.005:1 39 17 22 26 化合物 (I-1) + 鋅錳乃浦 (0.0001 + 0.1) 0.001:1 49 18 31 27 化合物 (I-1) + 氟克殺 (0.0001 + 0.02) 0.005:1 57 48 9 Table D-1 : the synergistic bactericidal activity of the composition of this case for the pseudoperonospora cuban in cucumber is shown in the table below, wherein as the representative compound of the compound shown in formula (I) as component (1) is particularly Compound (I-1), other component (2) are selected from each group of (II-A) to (II-R). serial number compound Concentration (ppm) Proportion Observed Efficacy (%) expected (or calculated) power Synergy (Colby's) 1 Compound (I-1) 0.00001 10 2 Compound (I-1) 0.0001 14 3 Ametoctradin 0.1 40 4 Fluazinam 0.05 27 5 Fuguiamine 0.02 33 6 Fuguiamine 0.1 38 7 fluopyram 0.05 2 8 Fluperide 0.02 5 9 Fluperide 0.1 12 10 Zinc manganese Naipu (mancozeb) 0.05 2 11 zinc manganese Naipu 0.02 3 12 zinc manganese Naipu 0.1 5 13 Fluxapyroxad 0.02 40 14 Compound (I-1) + ametoctradin (0.0001 + 0.1) 0.001:1 66 48 18 15 Compound (I-1) + fluazinam (0.0001 + 0.05) 0.002:1 55 37 18 16 Compound (I-1) + Fuguiamine (0.0001 + 0.02) 0.005:1 62 42 20 17 Compound (I-1) + Fuguiamine (0.0001 + 0.1) 0.001:1 69 47 twenty two 18 Compound (I-1) + fluopyram (0.00001 + 0.1) 0.0001:1 39 twenty one 18 19 Compound (I-1) + fluperid (0.0001 + 0.05) 0.002:1 46 16 30 20 Compound (I-1) + fluperid (0.0001 + 0.02) 0.005:1 56 18 38 twenty one Compound (I-1) + fluperid (0.0001 + 0.1) 0.001:1 63 twenty four 39 twenty two Compound (I-1) + zinc manganese Naipur (mancozeb) (0.00001 + 0.02) 0.0005:1 twenty four 13 11 twenty three Compound (I-1) + Zinc Manganese Naipur (0.00001 + 0.1) 0.0001:1 29 15 15 twenty four Compound (I-1) + Zinc Manganese Naipur (0.0001 + 0.05) 0.002:1 34 16 18 25 Compound (I-1) + Zinc Manganese Naipur (0.0001 + 0.02) 0.005:1 39 17 twenty two 26 Compound (I-1) + Zinc Manganese Naipur (0.0001 + 0.1) 0.001:1 49 18 31 27 Compound (I-1) + Fluoxetine (0.0001 + 0.02) 0.005:1 57 48 9

D-2:本案的組合物對於黃瓜中的古巴假霜霉菌之協同殺菌活性顯示於下方表中,其中作為組分(1)之如式(I)所示之化合物的代表性化合物特別為化合物(I-1),其他組分(2)係選自(III-A)至(III-GG)各組。 序號 化合物 濃度 (ppm) 比例 觀察到的功效 (%) 預期(或計算出)的功效 協同效應 (Colby’s) 1 化合物 (I-1) 0.00001 10 2 化合物 (I-1) 0.0001 14 3 噻蟲嗪 (thiamethoxam) 50 23 4 噻蟲嗪 100 25 5 噻蟲嗪 200 30 6 益達胺 (imidacloprid) 50 30 7 益達胺 100 38 8 益達胺 200 43 9 費普尼 (fipronil) 50 30 10 費普尼 100 35 11 費普尼 200 43 12 剋安勃 (chlorantraniliprole) 50 20 13 剋安勃 100 28 14 剋安勃 200 30 15 賽安勃 (cyantraniliprole) 50 28 16 賽安勃 100 30 17 賽安勃 200 38 18 可尼丁(clothianidin) 100 40 19 可尼丁 200 45 20 特安勃 (tetraniliprole) 50 23 21 特安勃 100 30 22 特安勃 200 38 23 化合物 (I-1) + 噻蟲嗪 0.0001+50 0.000002:1 66 34 32 24 化合物 (I-1) + 噻蟲嗪 0.0001+100 0.000001:1 68 36 33 25 化合物 (I-1) + 噻蟲嗪 0.0001+200 0.0000005:1 71 40 31 26 化合物 (I-1) + 益達胺 (imidacloprid) 0.0001+50 0.000002:1 68 40 29 27 化合物 (I-1) + 益達胺 0.0001+100 0.000001:1 71 47 24 28 化合物 (I-1) + 益達胺 0.0001+200 0.0000005:1 79 51 28 29 化合物 (I-1) + 費普尼 (fipronil) 0.0001+50 0.000002:1 63 40 23 30 化合物 (I-1) + 費普尼 0.0001+100 0.000001:1 68 44 24 31 化合物 (I-1) + 費普尼 0.0001+200 0.0000005:1 74 51 23 32 化合物 (I-1) + 剋安勃 (chlorantraniliprole) 0.00001+200 0.00000005:1 63 37 26 33 化合物 (I-1) + 剋安勃 0.0001+50 0.000002:1 66 31 35 34 化合物 (I-1) + 剋安勃 0.0001+100 0.000001:1 71 38 33 35 化合物 (I-1) + 剋安勃 0.0001+200 0.0000005:1 84 40 44 36 化合物 (I-1) + 賽安勃 (cyantraniliprole) 0.0001+50 0.000002:1 68 38 30 37 化合物 (I-1) + 賽安勃 0.0001+100 0.000001:1 79 40 39 38 化合物 (I-1) + 賽安勃 0.0001+200 0.0000005:1 82 47 35 39 化合物 (I-1) + 可尼丁(clothianidin) 0.0001+100 0.000001:1 66 48 17 40 化合物 (I-1) + 可尼丁 0.0001+200 0.0000005:1 74 53 21 41 化合物 (I-1) + 特安勃 (tetraniliprole) 0.0001+50 0.000002:1 63 34 29 42 化合物 (I-1) + 特安勃 0.0001+100 0.000001:1 71 40 31 43 化合物 (I-1) + 特安勃 0.0001+200 0.0000005:1 79 47 32 Table D-2 : the synergistic bactericidal activity of the composition of this case for the pseudoperonospora cuban in cucumber is shown in the table below, wherein as the representative compound of the compound shown in formula (I) as component (1) is particularly Compound (I-1), other component (2) are selected from each group of (III-A) to (III-GG). serial number compound Concentration (ppm) Proportion Observed Efficacy (%) expected (or calculated) power Synergy (Colby's) 1 Compound (I-1) 0.00001 10 2 Compound (I-1) 0.0001 14 3 Thiamethoxam 50 twenty three 4 Thiamethoxam 100 25 5 Thiamethoxam 200 30 6 Imidacloprid 50 30 7 Idamide 100 38 8 Idamide 200 43 9 Fipronil 50 30 10 Fepney 100 35 11 Fepney 200 43 12 Chlorantraniliprole 50 20 13 Amber 100 28 14 Amber 200 30 15 cyantraniliprole 50 28 16 Sai Amber 100 30 17 Sai Amber 200 38 18 Clothianidin 100 40 19 Cornedine 200 45 20 Tetraniliprole 50 twenty three twenty one Amber 100 30 twenty two Amber 200 38 twenty three Compound (I-1) + Thiamethoxam 0.0001+50 0.000002:1 66 34 32 twenty four Compound (I-1) + Thiamethoxam 0.0001+100 0.000001:1 68 36 33 25 Compound (I-1) + Thiamethoxam 0.0001+200 0.0000005:1 71 40 31 26 Compound (I-1) + imidacloprid 0.0001+50 0.000002:1 68 40 29 27 Compound (I-1) + Idamide 0.0001+100 0.000001:1 71 47 twenty four 28 Compound (I-1) + Idamide 0.0001+200 0.0000005:1 79 51 28 29 Compound (I-1) + fipronil 0.0001+50 0.000002:1 63 40 twenty three 30 Compound (I-1) + Fepney 0.0001+100 0.000001:1 68 44 twenty four 31 Compound (I-1) + Fepney 0.0001+200 0.0000005:1 74 51 twenty three 32 Compound (I-1) + chlorantraniliprole 0.00001+200 0.00000005:1 63 37 26 33 Compound (I-1) + gambo 0.0001+50 0.000002:1 66 31 35 34 Compound (I-1) + gambo 0.0001+100 0.000001:1 71 38 33 35 Compound (I-1) + gambo 0.0001+200 0.0000005:1 84 40 44 36 Compound (I-1) + cyantraniliprole 0.0001+50 0.000002:1 68 38 30 37 Compound (I-1) + Cyambo 0.0001+100 0.000001:1 79 40 39 38 Compound (I-1) + Cyambo 0.0001+200 0.0000005:1 82 47 35 39 Compound (I-1) + Clothianidin 0.0001+100 0.000001:1 66 48 17 40 Compound (I-1) + Conitine 0.0001+200 0.0000005:1 74 53 twenty one 41 Compound (I-1) + tetraniliprole 0.0001+50 0.000002:1 63 34 29 42 Compound (I-1) + Tember 0.0001+100 0.000001:1 71 40 31 43 Compound (I-1) + Tember 0.0001+200 0.0000005:1 79 47 32

範例example 55 :於大豆植物之大豆銹病菌: Soybean rust fungus on soybean plants ( Phakopsora pachyrhizi) ( Phakopsora pachyrhizi ) 試驗test

將單個化合物或相應的化合物組合溶解在2%的二甲基亞碸/丙酮中,然後在50 mL的校準噴霧體積中與含有乳化劑的水混合至所需的測試濃度。將測試溶液倒入噴霧瓶中用以進一步施用。Individual compounds or corresponding compound combinations are dissolved in 2% dimethyloxide/acetone and then mixed with water containing emulsifier to the desired test concentration in a calibrated spray volume of 50 mL. Pour the test solution into a spray bottle for further application.

為了測試化合物的防病活性,使用空心圓錐噴嘴在噴霧櫃內,向在溫室中培養的健康幼齡大豆以所述的施用率噴灑活性化合物製劑。處理完的隔天,用含有2 x 10 5的大豆銹病菌分生孢子之懸浮液接種於植物。然後將接種的植物保存在溫度為22-24 ℃、相對濕度為80-90%的溫室中以進行疾病表達。 To test the disease-controlling activity of the compounds, healthy young soybeans grown in a greenhouse are sprayed with the active compound preparations at the stated application rates in a spray cabinet using hollow-cone nozzles. The day after treatment, the plants were inoculated with a suspension containing 2 x 105 conidia of soybean rust. The inoculated plants were then kept in a greenhouse at a temperature of 22-24 °C and a relative humidity of 80-90% for disease expression.

藉由在施用後的3、7、10和15天對處理之植物的疾病嚴重程度(0-100%範圍)進行評分,以對單一化合物或化合物的組合物之功效進行視覺評估。化合物的功效(%控制率)係藉由將治療中的植物的疾病評分與未治療的控制組之疾病評分比較而得。並藉由記錄壞死、萎黃和生長遲緩等症狀,以評估化合物的植物相容性。與化合物(I-1)有關的結果顯示於表E1以及表E2中。Efficacy of single compounds or combinations of compounds was assessed visually by scoring disease severity (0-100% range) on treated plants at 3, 7, 10 and 15 days after application. Compound efficacy (% control) was determined by comparing disease scores of treated plants to disease scores of untreated controls. The phytocompatibility of compounds was assessed by recording symptoms such as necrosis, chlorosis and growth retardation. The results related to compound (I-1) are shown in Table E1 and Table E2.

令人驚訝的是,下表所示的組合顯示出無法預期的協同效應:Surprisingly, the combinations shown in the table below showed unanticipated synergies:

E-1 本案的組合物對於大豆中的大豆銹病菌之協同殺菌活性顯示於下方表中,其中作為組分 (1)之如式 (I)所示之化合物的代表性化合物特別為化合物 (I-1),其他組分 (2)係選自(II-A)至(II-R)各組。 序號 化合物 濃度 (ppm) 比例 觀察到的功效 (%) 預期(或計算出)的功效 協同效應 (Colby’s) 1 化合物 (I-1) 10 25 2 化合物 (I-1) 50 27 3 滅脫定 (ametoctradin) 100 31 4 滅脫定 0.05 22 5 滅脫定 0.1 28 6 亞托敏 (Azoxystrobin) 0.05 15 7 亞托敏 0.1 22 8 白克列 (boscalid) 0.05 27 9 白克列 0.1 32 10 達滅芬 (dimethomorph) 0.05 10 11 噻唑菌胺 (ethaboxam) 0.1 10 12 扶吉胺 (fluazinam) 0.05 2 13 扶吉胺 0.1 10 14 氟比來 (fluopicolide) 0.1 10 15 福爾培 (folpet) 0.05 5 16 福爾培 0.1 12 17 氟派瑞 (fluopyram) 0.05 7 18 氟派瑞 0.1 10 19 鋅錳乃浦 (mancozeb) 0.05 12 20 鋅錳乃浦 0.1 15 21 化合物 (I-1) + 滅脫定 (ametoctradin) (100 + 0.1) 1000:1 68 50 18 22 化合物 (I-1) + 亞托敏 (Azoxystrobin) (100 + 0.05) 2000:1 66 41 24 23 化合物 (I-1) + 亞托敏 (100 + 0.1) 1000:1 74 46 28 24 化合物 (I-1) + 白克列 (boscalid) (100 + 0.05) 2000:1 61 50 11 25 化合物 (I-1) + 白克列 (100 + 0.1) 1000:1 68 53 15 26 化合物 (I-1) + 達滅芬 (dimethomorph) (100 + 0.05) 2000:1 50 38 12 27 化合物 (I-1) + 噻唑菌胺 (ethaboxam) (100 + 0.1) 1000:1 50 38 12 28 化合物 (I-1) + 扶吉胺 (fluazinam) (100 + 0.05) 2000:1 50 32 18 29 化合物 (I-1) + 扶吉胺 (100 + 0.1) 1000:1 56 38 18 30 化合物 (I-1) + 氟比來 (fluopicolide) (100 + 0.1) 1000:1 50 38 12 31 化合物 (I-1) + 福爾培 (folpet) (50 + 0.05) 1000:1 50 31 19 32 化合物 (I-1) + 福爾培 (50 + 0.1) 500:1 47 36 11 33 化合物 (I-1) + 福爾培 (100 + 0.05) 2000:1 56 34 22 34 化合物 (I-1) + 福爾培 (100 + 0.1) 1000:1 59 39 20 35 化合物 (I-1) + 氟派瑞 (10 + 0.05) 200:1 58 30 28 36 化合物 (I-1) + 氟派瑞 (10 + 0.1) 100:1 63 33 31 37 化合物 (I-1) + 氟派瑞 (50 + 0.1) 500:1 74 34 39 38 化合物 (I-1) + 氟派瑞 (100 + 0.05) 2000:1 79 36 43 39 化合物 (I-1) + 氟派瑞 (100 + 0.1) 1000:1 84 38 46 40 化合物 (I-1) + 鋅錳乃浦 (mancozeb) (10 + 0.1) 100:1 58 36 22 41 化合物 (I-1) + 鋅錳乃浦 (50 + 0.1) 500:1 68 38 30 42 化合物 (I-1) + 鋅錳乃浦 (100 + 0.05) 2000:1 71 39 32 43 化合物 (I-1) + 鋅錳乃浦 (100 + 0.1) 1000:1 82 41 40 Table E-1 : The synergistic fungicidal activity of the composition of the present case on soybean rust bacteria in soybeans is shown in the table below, wherein the representative compound as the compound shown in formula (I) as component (1) is particularly compound (I-1), other components (2) are selected from the groups (II-A) to (II-R). serial number compound Concentration (ppm) Proportion Observed Efficacy (%) expected (or calculated) power Synergy (Colby's) 1 Compound (I-1) 10 25 2 Compound (I-1) 50 27 3 Ametoctradin 100 31 4 Methodine 0.05 twenty two 5 Methodine 0.1 28 6 Azoxystrobin 0.05 15 7 Yatomin 0.1 twenty two 8 Bekley (boscalid) 0.05 27 9 Bakley 0.1 32 10 Dimethomorph 0.05 10 11 ethaboxam 0.1 10 12 Fluazinam 0.05 2 13 Fuguiamine 0.1 10 14 Fluopicolide 0.1 10 15 Folpet 0.05 5 16 Folbert 0.1 12 17 fluopyram 0.05 7 18 Fluperide 0.1 10 19 Zinc manganese Naipu (mancozeb) 0.05 12 20 zinc manganese Naipu 0.1 15 twenty one Compound (I-1) + ametoctradin (100 + 0.1) 1000:1 68 50 18 twenty two Compound (I-1) + Azoxystrobin (100 + 0.05) 2000:1 66 41 twenty four twenty three Compound (I-1) + Yatropin (100 + 0.1) 1000:1 74 46 28 twenty four Compound (I-1) + Bacrine (boscalid) (100 + 0.05) 2000:1 61 50 11 25 Compound (I-1) + Bacrine (100 + 0.1) 1000:1 68 53 15 26 Compound (I-1) + Dimethomorph (100 + 0.05) 2000:1 50 38 12 27 Compound (I-1) + ethaboxam (100 + 0.1) 1000:1 50 38 12 28 Compound (I-1) + fluazinam (100 + 0.05) 2000:1 50 32 18 29 Compound (I-1) + Fuguiamine (100 + 0.1) 1000:1 56 38 18 30 Compound (I-1) + fluopicolide (100 + 0.1) 1000:1 50 38 12 31 Compound (I-1) + folpet (50 + 0.05) 1000:1 50 31 19 32 Compound (I-1) + Forbet (50 + 0.1) 500:1 47 36 11 33 Compound (I-1) + Forbet (100 + 0.05) 2000:1 56 34 twenty two 34 Compound (I-1) + Forbet (100 + 0.1) 1000:1 59 39 20 35 Compound (I-1) + fluperid (10 + 0.05) 200:1 58 30 28 36 Compound (I-1) + fluperid (10 + 0.1) 100:1 63 33 31 37 Compound (I-1) + fluperid (50 + 0.1) 500:1 74 34 39 38 Compound (I-1) + fluperid (100 + 0.05) 2000:1 79 36 43 39 Compound (I-1) + fluperid (100 + 0.1) 1000:1 84 38 46 40 Compound (I-1) + zinc manganese Naipur (mancozeb) (10 + 0.1) 100:1 58 36 twenty two 41 Compound (I-1) + Zinc Manganese Naipur (50 + 0.1) 500:1 68 38 30 42 Compound (I-1) + Zinc Manganese Naipur (100 + 0.05) 2000:1 71 39 32 43 Compound (I-1) + Zinc Manganese Naipur (100 + 0.1) 1000:1 82 41 40

E-2 本案的組合物對於大豆中的大豆銹病菌之協同殺菌活性顯示於下方表中,其中作為組分 (1)之如式 (I)所示之化合物的代表性化合物特別為化合物 (I-1),其他組分 (2)係選自(III-A)至(III-GG)各組。 序號 化合物 濃度 (ppm) 比例 觀察到的功效 (%) 預期(或計算出)的功效 協同效應 (Colby’s) 1 化合物 (I-1) 100 31 2 益達胺 (imidacloprid) 50 37 3 益達胺 100 40 4 賽安勃 (cyantraniliprole) 50 43 5 賽安勃 100 53 6 化合物 (I-1) + 益達胺 100+50 2:1 67 57 10 7 化合物 (I-1) + 益達胺 100+100 1:1 73 59 15 8 化合物 (I-1) + 賽安勃 100+50 2:1 67 61 6 9 化合物 (I-1) + 賽安勃 100+100 1:1 73 68 6 Table E-2 : The synergistic fungicidal activity of the composition of the present case on soybean rust bacteria in soybeans is shown in the table below, wherein the representative compound as the compound shown in formula (I) as component (1) is particularly compound (I-1), other components (2) are selected from the groups (III-A) to (III-GG). serial number compound Concentration (ppm) Proportion Observed Efficacy (%) expected (or calculated) power Synergy (Colby's) 1 Compound (I-1) 100 31 2 Imidacloprid 50 37 3 Idamide 100 40 4 cyantraniliprole 50 43 5 Sai Amber 100 53 6 Compound (I-1) + Idamide 100+50 2:1 67 57 10 7 Compound (I-1) + Idamide 100+100 1:1 73 59 15 8 Compound (I-1) + Cyambo 100+50 2:1 67 61 6 9 Compound (I-1) + Cyambo 100+100 1:1 73 68 6

範例example 66 :於水稻植物之立枯絲核菌: Rhizoctonia solani on rice plants ( Rhizoctonia solani) ( Rhizoctonia solani ) 試驗test

將單個化合物或化合物之組合溶解在2%的二甲基亞碸/丙酮中,然後在50 mL的校準噴霧體積中與含有乳化劑的水混合至所需的測試濃度。將測試溶液倒入噴霧瓶中用以進一步施用。Individual compounds or combinations of compounds are dissolved in 2% dimethyloxide/acetone and then mixed with water containing emulsifier to the desired test concentration in a calibrated spray volume of 50 mL. Pour the test solution into a spray bottle for further application.

為了測試化合物的防病活性,使用空心圓錐噴嘴在噴霧櫃內,向在溫室中培養的健康幼齡水稻幼苗/植物以所述的施用率噴灑活性化合物製劑。To test the disease control activity of the compounds, healthy young rice seedlings/plants grown in a greenhouse are sprayed with the active compound preparation at the stated application rates in a spray cabinet using hollow cone nozzles.

處理完的隔天,此些植物以等量之含有立枯絲核菌的受感染米糠進行接種。然後將接種的植物保存在溫度為24-25 ℃、相對濕度為90-95%的溫室中以進行疾病表達。The next day after treatment, the plants were inoculated with an equal amount of infected rice bran containing R. solani. The inoculated plants were then kept in a greenhouse at a temperature of 24-25 °C and a relative humidity of 90-95% for disease expression.

藉由在施用後的3、7、10和15天對處理之植物的疾病嚴重程度(0-100%範圍)進行評分,以對單一化合物或化合物的組合物之功效進行視覺評估。化合物的功效(%控制率)係藉由將治療中的植物的疾病評分與未治療的控制組之疾病評分比較而得。並藉由記錄壞死、萎黃和生長遲緩等症狀,以評估化合物的植物相容性。與化合物 (I-1)有關的結果顯示於表F1以及表F2中。Efficacy of single compounds or combinations of compounds was assessed visually by scoring disease severity (0-100% range) on treated plants at 3, 7, 10 and 15 days after application. Compound efficacy (% control) was determined by comparing disease scores of treated plants to disease scores of untreated controls. The phytocompatibility of compounds was assessed by recording symptoms such as necrosis, chlorosis and growth retardation. The results related to compound (I-1) are shown in Table F1 and Table F2.

令人驚訝的是,下表所示的組合顯示出無法預期的協同效應:Surprisingly, the combinations shown in the table below showed unanticipated synergies:

F-1 本案的組合物對水稻中之立枯絲核菌的協同殺菌活性顯示於下方表中,其中作為組分 (1)之如式 (I)所示之化合物的代表性化合物特別為化合物 (I-1),其他組分 (2)係選自(II-A)至(II-R)各組。 序號 化合物 濃度 (ppm) 比例 觀察到的功效 (%) 預期(或計算出)的功效 協同效應 (Colby’s) 1 化合物 (I-1) 50 17 2 化合物 (I-1) 100 22 4 纈菌胺 (valifenalate) 0.05 12 5 纈菌胺 0.1 17 6 化合物 (I-1) + 纈菌胺 (50 + 0.1) 500:1 43 31 12 7 化合物 (I-1) + 纈菌胺 (100 + 0.05) 2000:1 46 31 15 Table F-1 : the synergistic bactericidal activity of the composition of this case to Rhizoctonia solani in rice is shown in the table below, wherein as the representative compound of the compound shown in formula (I) as component (1) particularly For compound (I-1), other component (2) is selected from each group of (II-A) to (II-R). serial number compound Concentration (ppm) Proportion Observed Efficacy (%) expected (or calculated) power Synergy (Colby's) 1 Compound (I-1) 50 17 2 Compound (I-1) 100 twenty two 4 Valifenalate 0.05 12 5 Valilecin 0.1 17 6 Compound (I-1) + Valerosamine (50 + 0.1) 500:1 43 31 12 7 Compound (I-1) + Valerosamine (100 + 0.05) 2000:1 46 31 15

F-2 本案的組合物對水稻中之立枯絲核菌的協同殺菌活性顯示於下方表中,其中作為組分 (1)之如式 (I)所示之化合物的代表性化合物特別為化合物 (I-1),其他組分 (2)係選自(III-A)至(III-GG)各組。 序號 化合物 濃度 (ppm) 比例 觀察到的功效 (%) 預期(或計算出)的功效 協同效應 (Colby’s) 1 化合物 (I-1) 10 10 2 化合物 (I-1) 50 17 3 化合物 (I-1) 100 22 4 噻蟲嗪 (thiamethoxam) 100 0 5 益達胺 (imidacloprid) 100 0 6 費普尼 (fipronil) 100 0 7 剋安勃 (chlorantraniliprole) 50 0 8 剋安勃 100 0 9 賽安勃 (cyantraniliprole) 100 0 10 可尼丁(clothianidin) 100 0 11 特安勃 (tetraniliprole) 50 0 12 特安勃 100 0 13 PI07364 100 0 14 PI05203 100 0 15 化合物 (I-1) + 噻蟲嗪 100+100 1:1 34 22 12 16 化合物 (I-1) + 益達胺 100+100 1:1 34 22 12 17 化合物 (I-1) + 費普尼 50+100 0.5:1 26 17 9 18 化合物 (I-1) + 費普尼 100+100 1:1 34 22 12 19 化合物 (I-1) + 剋安勃 100+50 2:1 34 22 12 20 化合物 (I-1) + 剋安勃 100+100 1:1 40 22 18 21 化合物 (I-1) + 賽安勃 10+100 0.1:1 19 10 9 22 化合物 (I-1) + 賽安勃 100+100 1:1 31 22 9 23 化合物 (I-1) + 可尼丁 100+100 1:1 31 22 9 24 化合物 (I-1) + 特安勃 10+100 0.1:1 19 10 9 25 化合物 (I-1) + 特安勃 50+50 1:1 26 17 9 26 化合物 (I-1) + 特安勃 50+100 0.5:1 28 17 11 27 化合物 (I-1) + 特安勃 100+50 2:1 34 22 12 28 化合物 (I-1) + 特安勃 100+100 1:1 38 22 16 29 化合物 (I-1) + PI07364 100+100 1:1 40 22 18 30 化合物 (I-1) + PI05203 100+100 1:1 36 22 14 Table F-2 : the synergistic bactericidal activity of the composition of this case to Rhizoctonia solani in rice is shown in the table below, wherein as the representative compound of the compound shown in formula (I) as component (1) particularly For compound (I-1), other component (2) is selected from each group of (III-A) to (III-GG). serial number compound Concentration (ppm) Proportion Observed Efficacy (%) expected (or calculated) power Synergy (Colby's) 1 Compound (I-1) 10 10 2 Compound (I-1) 50 17 3 Compound (I-1) 100 twenty two 4 Thiamethoxam 100 0 5 Imidacloprid 100 0 6 Fipronil 100 0 7 Chlorantraniliprole 50 0 8 Amber 100 0 9 cyantraniliprole 100 0 10 Clothianidin 100 0 11 Tetraniliprole 50 0 12 Amber 100 0 13 PI07364 100 0 14 PI05203 100 0 15 Compound (I-1) + Thiamethoxam 100+100 1:1 34 twenty two 12 16 Compound (I-1) + Idamide 100+100 1:1 34 twenty two 12 17 Compound (I-1) + Fepney 50+100 0.5:1 26 17 9 18 Compound (I-1) + Fepney 100+100 1:1 34 twenty two 12 19 Compound (I-1) + gambo 100+50 2:1 34 twenty two 12 20 Compound (I-1) + gambo 100+100 1:1 40 twenty two 18 twenty one Compound (I-1) + Cyambo 10+100 0.1:1 19 10 9 twenty two Compound (I-1) + Cyambo 100+100 1:1 31 twenty two 9 twenty three Compound (I-1) + Conitine 100+100 1:1 31 twenty two 9 twenty four Compound (I-1) + Tember 10+100 0.1:1 19 10 9 25 Compound (I-1) + Tember 50+50 1:1 26 17 9 26 Compound (I-1) + Tember 50+100 0.5:1 28 17 11 27 Compound (I-1) + Tember 100+50 2:1 34 twenty two 12 28 Compound (I-1) + Tember 100+100 1:1 38 twenty two 16 29 Compound (I-1) + PI07364 100+100 1:1 40 twenty two 18 30 Compound (I-1) + PI05203 100+100 1:1 36 twenty two 14

範例example 77 :於水稻植物之稻梨孢黴: Pyrosporium oryzae in rice plants ( Pyricularia oryzae) ( Pyricularia oryzae ) 試驗test

將單個化合物或相應的化合物組合溶解在2%的二甲基亞碸/丙酮中,然後在50 mL的校準噴霧體積中與含有乳化劑的水混合至所需的測試濃度。將測試溶液倒入噴霧瓶中用以進一步施用。Individual compounds or corresponding compound combinations are dissolved in 2% dimethyloxide/acetone and then mixed with water containing emulsifier to the desired test concentration in a calibrated spray volume of 50 mL. Pour the test solution into a spray bottle for further application.

為了測試化合物的防病活性,使用空心圓錐噴嘴在噴霧櫃內,向在溫室中培養的健康幼齡水稻以所述的施用率噴灑活性化合物製劑。處理完的隔天,用含有1.4 x 10 6的稻梨孢黴 ( Pyricularia oryzae)接種體之孢子懸浮液接種於植物。然後將接種的植物保存在溫度為24 ℃、相對濕度為95%的溫室中以進行疾病表達。 To test the disease-controlling activity of the compounds, young healthy rice plants grown in a greenhouse are sprayed with the active compound preparations at the stated application rates in a spray cabinet using hollow-cone nozzles. The day after the treatment, the plants were inoculated with a spore suspension containing 1.4 x 10 6 inoculum of Pyricularia oryzae . The inoculated plants were then kept in a greenhouse at 24 °C and 95% relative humidity for disease expression.

藉由在施用後的3、7、10和15天對處理之植物的疾病嚴重程度(0-100%範圍)進行評分,以對單一化合物或化合物的組合物之功效進行視覺評估。單一化合物以及組合物的功效(%控制率)係藉由將治療中的植物的疾病評分與未治療的控制組之疾病評分比較而得。並藉由記錄壞死、萎黃和生長遲緩等症狀,以評估化合物的植物相容性。與化合物 (I-1)有關的結果顯示於表G中。Efficacy of single compounds or combinations of compounds was assessed visually by scoring disease severity (0-100% range) on treated plants at 3, 7, 10 and 15 days after application. Efficacy (% control) of individual compounds as well as combinations was determined by comparing disease scores of treated plants to disease scores of untreated controls. The phytocompatibility of compounds was assessed by recording symptoms such as necrosis, chlorosis and growth retardation. The results related to compound (I-1) are shown in Table G.

令人驚訝的是,下表所示的組合顯示出無法預期的協同效應:Surprisingly, the combinations shown in the table below showed unanticipated synergies:

G 本案的組合物對水稻中之稻梨孢黴的協同殺菌活性顯示於下方表中,其中作為組分 (1)之如式 (I)所示之化合物的代表性化合物特別為化合物 (I-1),其他組分 (2)係選自(II-A)至(II-R)各組。 序號 化合物 濃度 (ppm) 比例 觀察到的功效 (%) 預期(或計算出)的功效 協同效應 (Colby’s) 1 化合物 (I-1) 100 34 2 亞托敏 (Azoxystrobin) 0.05 21 3 亞托敏 0.1 26 4 待克利 (difenoconazole) 0.1 26 5 滅達樂 (metalaxyl) 0.05 28 6 滅達樂 0.1 36 7 滅芬座 (mefentrifluconazole) 0.05 21 8 滅芬座 0.1 24 9 普拔克 (propamocarb) 0.1 16 10 三氟敏 (trifloxystrobin) 0.05 24 11 化合物 (I-1) + 亞托敏 (100 + 0.05) 2000:1 72 48 24 12 化合物 (I-1) + 亞托敏 (100 + 0.1) 1000:1 78 51 27 13 化合物 (I-1) + 待克利 (100 + 0.1) 1000:1 57 51 6 14 化合物 (I-1) + 滅達樂 (100 + 0.05) 2000:1 67 52 15 15 化合物 (I-1) + 滅達樂 (100 + 0.1) 1000:1 72 58 14 16 化合物 (I-1) + 滅芬座 (100 + 0.05) 2000:1 61 48 13 17 化合物 (I-1) + 滅芬座 (100 + 0.1) 1000:1 64 50 14 18 化合物 (I-1) + 普拔克 (100 + 0.1) 1000:1 63 45 18 19 化合物 (I-1) + 三氟敏 (100 + 0.05) 2000:1 63 50 13 Table G : the synergistic bactericidal activity of the composition of the present case to Pyricularia oryzae in rice is shown in the table below, wherein the representative compound as the compound shown in formula (I) as component (1) is particularly compound ( I-1), other components (2) are selected from (II-A) to (II-R) each group. serial number compound Concentration (ppm) Proportion Observed Efficacy (%) expected (or calculated) power Synergy (Colby's) 1 Compound (I-1) 100 34 2 Azoxystrobin 0.05 twenty one 3 Yatomin 0.1 26 4 Difenoconazole 0.1 26 5 Metalaxyl 0.05 28 6 Meteor 0.1 36 7 Mefentrifluconazole 0.05 twenty one 8 Mephim 0.1 twenty four 9 propamocarb 0.1 16 10 Trifloxystrobin 0.05 twenty four 11 Compound (I-1) + Yatropin (100 + 0.05) 2000:1 72 48 twenty four 12 Compound (I-1) + Yatropin (100 + 0.1) 1000:1 78 51 27 13 Compound (I-1) + Tiaclyl (100 + 0.1) 1000:1 57 51 6 14 Compound (I-1) + methadrol (100 + 0.05) 2000:1 67 52 15 15 Compound (I-1) + methadrol (100 + 0.1) 1000:1 72 58 14 16 Compound (I-1) + methphen (100 + 0.05) 2000:1 61 48 13 17 Compound (I-1) + methphen (100 + 0.1) 1000:1 64 50 14 18 Compound (I-1) + Probach (100 + 0.1) 1000:1 63 45 18 19 Compound (I-1) + Trifluoromin (100 + 0.05) 2000:1 63 50 13

範例example 88 :於番茄植物之灰葡萄孢菌: Botrytis cinerea on tomato plants ( Botrytis cinerea) ( Botrytis cinerea ) 試驗test

將單個化合物或化合物組合溶解在2%的二甲基亞碸/丙酮中,然後在50 mL的校準噴霧體積中與含有乳化劑的水混合至所需的測試濃度。將測試溶液倒入噴霧瓶中用以進一步施用。Individual compounds or combinations of compounds are dissolved in 2% dimethyloxide/acetone and then mixed with water containing emulsifier to the desired test concentration in a calibrated spray volume of 50 mL. Pour the test solution into a spray bottle for further application.

為了測試化合物的防病活性,使用空心圓錐噴嘴在噴霧櫃內,向在溫室中培養的健康幼齡豆子/辣椒 (bean/chilli)以所述的施用率噴灑活性化合物製劑。處理完的隔天,用含有1.2 x 10 6的灰葡萄孢菌接種體和2%麥芽糖之孢子懸浮液接種植物。然後將接種的植物保存在溫度為18-20 ℃、相對濕度為90-100%的溫室中以進行疾病表達。 To test the disease control activity of the compounds, healthy young beans/chilli grown in a greenhouse are sprayed with the active compound preparations at the stated application rates in a spray cabinet using hollow cone nozzles. The next day after treatment, the plants were inoculated with a spore suspension containing 1.2 x 106 inoculum of Botrytis cinerea and 2 % maltose. The inoculated plants were then kept in a greenhouse at a temperature of 18-20 °C and a relative humidity of 90-100% for disease expression.

藉由在施用後的3、7、10和15天對處理之植物的疾病嚴重程度(0-100%範圍)進行評分,以對單一化合物或化合物的組合物之功效進行視覺評估。化合物的功效(%控制率)係藉由將治療中的植物的疾病評分與未治療的控制組之疾病評分比較而得。並藉由記錄壞死、萎黃和生長遲緩等症狀,以評估化合物的植物相容性。與化合物 (I-1)有關的結果顯示於表H中。Efficacy of single compounds or combinations of compounds was assessed visually by scoring disease severity (0-100% range) on treated plants at 3, 7, 10 and 15 days after application. Compound efficacy (% control) was determined by comparing disease scores of treated plants to disease scores of untreated controls. The phytocompatibility of compounds was assessed by recording symptoms such as necrosis, chlorosis and growth retardation. The results related to compound (I-1) are shown in Table H.

令人驚訝的是,下表所示的組合顯示出無法預期的協同效應:Surprisingly, the combinations shown in the table below showed unanticipated synergies:

H 本案的組合物對番茄中的灰葡萄孢菌之協同殺菌活性顯示於下方表中,其中作為組分 (1)之如式 (I)所示之化合物的代表性化合物特別為化合物 (I-1),其他組分 (2)係選自(II-A)至(II-R)各組。 序號 化合物 濃度 (ppm) 比例 觀察到的功效 (%) 預期(或計算出)的功效 協同效應 (Colby’s) 1 化合物 (I-1) 50 40 2 化合物 (I-1) 100 42 3 安美速 (amisulbrom) 0.1 52 4 亞托敏 (Azoxystrobin) 0.1 45 5 白克列 (boscalid) 0.05 38 6 福爾培 (folpet) 0.05 24 7 福爾培 0.1 38 8 福賽得鋁 (fosetyl­aluminium) 0.05 19 9 福賽得鋁 0.1 26 10 化合物 (I-1) + 安美速 (100 + 0.1) 1000:1 89 72 16 11 化合物 (I-1) + 亞托敏 (100 + 0.1) 1000:1 89 68 20 12 化合物 (I-1) + 白克列 (100 + 0.05) 2000:1 77 64 13 13 化合物 (I-1) + 福爾培 (100 + 0.05) 2000:1 66 56 10 14 化合物 (I-1) + 福爾培 (100 + 0.1) 1000:1 78 64 14 15 化合物 (I-1) + 福賽得鋁 (50 + 0.1) 500:1 66 56 10 16 化合物 (I-1) + 福賽得鋁 (100 + 0.05) 2000:1 76 53 23 17 化合物 (I-1) + 福賽得鋁 (100 + 0.1) 1000:1 83 57 26 Table H : the synergistic bactericidal activity of the composition of the present case to Botrytis cinerea in tomato is shown in the table below, wherein as the representative compound of the compound shown in formula (I) as component (1) is particularly compound ( I-1), other components (2) are selected from (II-A) to (II-R) each group. serial number compound Concentration (ppm) Proportion Observed Efficacy (%) expected (or calculated) power Synergy (Colby's) 1 Compound (I-1) 50 40 2 Compound (I-1) 100 42 3 Amisulbrom 0.1 52 4 Azoxystrobin 0.1 45 5 Bekley (boscalid) 0.05 38 6 Folpet 0.05 twenty four 7 Folbert 0.1 38 8 Fosetylaluminium 0.05 19 9 Forside Aluminum 0.1 26 10 Compound (I-1) + Amosox (100 + 0.1) 1000:1 89 72 16 11 Compound (I-1) + Yatropin (100 + 0.1) 1000:1 89 68 20 12 Compound (I-1) + Bacrine (100 + 0.05) 2000:1 77 64 13 13 Compound (I-1) + Forbet (100 + 0.05) 2000:1 66 56 10 14 Compound (I-1) + Forbet (100 + 0.1) 1000:1 78 64 14 15 Compound (I-1) + Forsaide Aluminum (50 + 0.1) 500:1 66 56 10 16 Compound (I-1) + Forsaide Aluminum (100 + 0.05) 2000:1 76 53 twenty three 17 Compound (I-1) + Forsaide Aluminum (100 + 0.1) 1000:1 83 57 26

範例example 99 :於小麥上之小麥葉枯病菌: Phytophthora tritici on wheat ( Parastagonospora nodorum)/ ( Parastagonospora nodorum )/ 穎枯殼針孢菌Septoria solani ( Septoria nodorum)/ ( Septoria nodorum )/ 小麥殼多孢菌Septoria tritici ( Stagonospora nodorum) ( Stagonospora nodorum ) 試驗test

將單個化合物或化合物組合溶解在2%的二甲基亞碸/丙酮中,然後在50 mL的校準噴霧體積中與含有乳化劑的水混合至所需的測試濃度。將噴灑用溶液倒入噴霧瓶中以進一步施用。Individual compounds or combinations of compounds are dissolved in 2% dimethyloxide/acetone and then mixed with water containing emulsifier to the desired test concentration in a calibrated spray volume of 50 mL. Pour the spray solution into a spray bottle for further application.

為了測試化合物的防病活性,使用空心圓錐噴嘴在噴霧櫃內,向在溫室中培養的健康幼齡小麥以所述的施用率噴灑活性化合物製劑。處理完的隔天,用含有2.8 x 10 6的小麥殼多孢菌 ( Stagonospora nodorum)接種體之懸浮液接種於植物。然後將接種的植物保存在溫度為22-25 °C、相對濕度為90-100%的溫室中以進行疾病表達。 To test the disease-controlling activity of the compounds, healthy young wheat grown in a greenhouse is sprayed with the active compound preparations at the stated application rates in a spray cabinet using hollow-cone nozzles. The day after the treatment, the plants were inoculated with a suspension containing 2.8 x 10 6 inoculum of Stagonospora nodorum . The inoculated plants were then kept in a greenhouse at a temperature of 22-25 °C and a relative humidity of 90-100% for disease expression.

藉由在施用後的3、7和10天對處理之植物的疾病嚴重程度(0-100%範圍)進行評分,以對單一化合物或化合物的組合物之功效進行視覺評估。化合物的功效(%控制率)係藉由將治療中的植物的疾病評分與未治療的控制組之疾病評分比較而得。並藉由記錄壞死、萎黃和生長遲緩等症狀,以評估化合物的植物相容性。與化合物 (I-1)有關的結果顯示於表I1以及表I2中。Efficacy of single compounds or combinations of compounds was assessed visually by scoring disease severity (0-100% range) on treated plants at 3, 7 and 10 days after application. Compound efficacy (% control) was determined by comparing disease scores of treated plants to disease scores of untreated controls. The phytocompatibility of compounds was assessed by recording symptoms such as necrosis, chlorosis and growth retardation. The results related to compound (I-1) are shown in Table I1 and Table I2.

令人驚訝的是,下表所示的組合顯示出無法預期的協同效應:Surprisingly, the combinations shown in the table below showed unanticipated synergies:

I-1 本案的組合物對小麥中之小麥殼多孢菌 ( Septoria nodorum)的協同殺菌活性顯示於下方表中,其中作為組分 (1)之如式 (I)所示之化合物的代表性化合物特別為化合物 (I-1),其他組分 (2)係選自(II-A)至(II-R)各組。 序號 化合物 濃度 (ppm) 比例 觀察到的功效 (%) 預期(或計算出)的功效 協同效應 (Colby’s) 1 化合物 (I-1) 10 18 2 化合物 (I-1) 50 20 3 化合物 (I-1) 100 21 4 賽發滅 (cyazofamid) 0.05 11 5 賽發滅 0.1 21 6 待克利 (difenoconazole) 0.05 21 7 達滅芬 (dimethomorph) 0.05 24 8 腈硫醌 (dithiaonon) 0.05 11 9 腈硫醌 0.1 16 10 噻唑菌胺 (ethaboxam) (0.1 16 11 噻唑菌胺 0.05 24 12 扶吉胺 (fluazinam) 0.1 16 13 扶吉胺 0.05 21 14 氟比來 (fluopicolide) 0.1 26 15 氟比來 0.05 32 16 福爾培 (folpet) 0.1 21 17 滅達樂 (metalaxyl) 0.1 24 18 纈菌胺 (valifenatate) 0.1 3 19 纈菌胺 0.1 5 20 氟克殺 (fluxapyroxad) 0.05 18 21 氟克殺 0.1 29 22 化合物 (I-1) + 賽發滅 (100 + 0.05) 2000:1 49 30 19 23 化合物 (I-1) + 賽發滅 (100 + 0.1) 1000:1 62 38 25 24 化合物 (I-1) + 待克利 (10 + 0.05) 200:1 46 35 11 25 化合物 (I-1) + 達滅芬 (10 + 0.05) 200:1 54 38 16 26 化合物 (I-1) + 腈硫醌 (100 + 0.05) 2000:1 49 30 19 27 化合物 (I-1) + 腈硫醌 (100 + 0.1) 1000:1 62 34 29 28 化合物 (I-1) + 噻唑菌胺 (50 + 0.1) 500:1 50 39 11 29 化合物 (I-1) + 噻唑菌胺 (100 + 0.05) 2000:1 53 34 19 30 化合物 (I-1) + 噻唑菌胺 (100 + 0.1) 1000:1 58 40 18 31 化合物 (I-1) + 扶吉胺 (100 + 0.05) 2000:1 47 34 14 32 化合物 (I-1) + 扶吉胺 (100 + 0.1) 1000:1 53 38 15 33 化合物 (I-1) + 氟比來 (100 + 0.05) 2000:1 53 42 11 34 化合物 (I-1) + 氟比來 (100 + 0.1) 1000:1 55 46 9 35 化合物 (I-1) + 福爾培 (100 + 0.1) 1000:1 53 38 15 36 化合物 (I-1) + 滅達樂 (100 + 0.1) 1000:1 56 40 16 37 化合物 (I-1) + 纈菌胺 (50 + 0.1) 500:1 37 24 13 38 化合物 (I-1) + 纈菌胺 (100 + 0.05) 2000:1 39 23 16 39 化合物 (I-1) + 纈菌胺 (100 + 0.1) 1000:1 47 25 22 40 化合物 (I-1) + 氟克殺 (100 + 0.05) 2000:1 50 35 15 41 化合物 (I-1) + 氟克殺 (100 + 0.1) 1000:1 55 44 11 Table I-1 : the synergistic bactericidal activity of the composition of the present case to Septoria nodorum ( Septoria nodorum ) in wheat is shown in the table below, wherein as the compound shown in formula (I) as component (1) The representative compound is especially compound (I-1), and the other component (2) is selected from each group (II-A) to (II-R). serial number compound Concentration (ppm) Proportion Observed Efficacy (%) expected (or calculated) power Synergy (Colby's) 1 Compound (I-1) 10 18 2 Compound (I-1) 50 20 3 Compound (I-1) 100 twenty one 4 Cyazofamid 0.05 11 5 Saifa off 0.1 twenty one 6 Difenoconazole 0.05 twenty one 7 Dimethomorph 0.05 twenty four 8 Nitrile thioquinone (dithiaonon) 0.05 11 9 Nitrithioquinone 0.1 16 10 ethaboxam (0.1 16 11 ethaboxam 0.05 twenty four 12 Fluazinam 0.1 16 13 Fuguiamine 0.05 twenty one 14 Fluopicolide 0.1 26 15 Fluoridine 0.05 32 16 Folpet 0.1 twenty one 17 Metalaxyl 0.1 twenty four 18 Valifenatate 0.1 3 19 Valilecin 0.1 5 20 Fluxapyroxad 0.05 18 twenty one Fluoxetine 0.1 29 twenty two Compound (I-1) + Sephmet (100 + 0.05) 2000:1 49 30 19 twenty three Compound (I-1) + Sephmet (100 + 0.1) 1000:1 62 38 25 twenty four Compound (I-1) + Tiaclyl (10 + 0.05) 200:1 46 35 11 25 Compound (I-1) + Damilfine (10 + 0.05) 200:1 54 38 16 26 Compound (I-1) + Nitrithioquinone (100 + 0.05) 2000:1 49 30 19 27 Compound (I-1) + Nitrithioquinone (100 + 0.1) 1000:1 62 34 29 28 Compound (I-1) + ethaboxam (50 + 0.1) 500:1 50 39 11 29 Compound (I-1) + ethaboxam (100 + 0.05) 2000:1 53 34 19 30 Compound (I-1) + ethaboxam (100 + 0.1) 1000:1 58 40 18 31 Compound (I-1) + Fuguiamine (100 + 0.05) 2000:1 47 34 14 32 Compound (I-1) + Fuguiamine (100 + 0.1) 1000:1 53 38 15 33 Compound (I-1) + fluridine (100 + 0.05) 2000:1 53 42 11 34 Compound (I-1) + fluridine (100 + 0.1) 1000:1 55 46 9 35 Compound (I-1) + Forbet (100 + 0.1) 1000:1 53 38 15 36 Compound (I-1) + methadrol (100 + 0.1) 1000:1 56 40 16 37 Compound (I-1) + Valerosamine (50 + 0.1) 500:1 37 twenty four 13 38 Compound (I-1) + Valerosamine (100 + 0.05) 2000:1 39 twenty three 16 39 Compound (I-1) + Valerosamine (100 + 0.1) 1000:1 47 25 twenty two 40 Compound (I-1) + Fluoxetine (100 + 0.05) 2000:1 50 35 15 41 Compound (I-1) + Fluoxetine (100 + 0.1) 1000:1 55 44 11

I-2 本案的組合物對小麥中之小麥殼多孢菌 ( Septoria nodorum)的協同殺菌活性顯示於下方表中,其中作為組分 (1)之如式 (I)所示之化合物的代表性化合物特別為化合物 (I-1),其他組分 (2)係選自(III-A)至(III-GG)各組。 序號 化合物 濃度 (ppm) 比例 觀察到的功效 (%) 預期(或計算出)的功效 協同效應 (Colby’s) 1 化合物 (I-1) 100 21 2 噻蟲嗪 (thiamethoxam) 50 12 3 噻蟲嗪 100 19 4 剋安勃 (chlorantraniliprole) 50 19 5 可尼丁(clothianidin) 50 17 6 特安勃 (tetraniliprole) 50 17 7 化合物 (I-1) + 噻蟲嗪 100+50 2:1 45 30 15 8 化合物 (I-1) + 噻蟲嗪 100+100 1:1 50 36 14 9 化合物 (I-1) + 剋安勃 100+50 2:1 43 36 6 10 化合物 (I-1) + 可尼丁 100+50 2:1 40 34 6 11 化合物 (I-1) + 特安勃 100+50 2:1 40 34 6 Table 1-2 : the synergistic bactericidal activity of the composition of this case to Septoria nodorum ( Septoria nodorum ) in wheat is shown in the table below, wherein as the compound shown in formula (I) as component (1) The representative compound is especially compound (I-1), and the other component (2) is selected from the groups (III-A) to (III-GG). serial number compound Concentration (ppm) Proportion Observed Efficacy (%) expected (or calculated) power Synergy (Colby's) 1 Compound (I-1) 100 twenty one 2 Thiamethoxam 50 12 3 Thiamethoxam 100 19 4 Chlorantraniliprole 50 19 5 Clothianidin 50 17 6 Tetraniliprole 50 17 7 Compound (I-1) + Thiamethoxam 100+50 2:1 45 30 15 8 Compound (I-1) + Thiamethoxam 100+100 1:1 50 36 14 9 Compound (I-1) + gambo 100+50 2:1 43 36 6 10 Compound (I-1) + Conitine 100+50 2:1 40 34 6 11 Compound (I-1) + Tember 100+50 2:1 40 34 6

殺蟲活性:Insecticidal activity:

如本文所述,如式 (I)所示之化合物顯示出對多種攻擊重要農作物的害蟲或蟎蟲產生殺蟲活性。本案之化合物係藉由下述試驗以評價其活性:As described herein, compounds represented by formula (I) exhibit insecticidal activity against various pests or mites that attack important agricultural crops. The compound of this case is to evaluate its activity by following test:

範例example AA :於番茄上之番茄夜蛾: Tomato moth on tomato ( Helicoverpa armigera) ( Helicoverpa armigera )

利用葉片藥膜法 (leaf dip method)來進行測試,於該方法中,秤量所需量的化合物或其各自的化合物組合,將其溶解於含有溶劑溶液的試管中。將試管置於2000 rpm的震盪儀 (vortex)上90分鐘以將成分充分混合,然後以0.01%之Triton-X溶液將其稀釋以獲得所需的測試濃度。番茄葉在所述化合物之溶液中浸泡10秒,陰乾20分鐘,然後轉移到生物測定托盤 (bioassay tray)的孔中。於每個孔中放置一隻二齡幼蟲 (second instar larva)後,將蓋子覆蓋於托盤上。然後將該生物測定托盤在實驗室條件下,保持在溫度為25 °C以及相對濕度為70%。在放置後的72小時記錄幼蟲係死亡 (dead)、瀕死 (moribund)或存活 (alive)的觀察結果。藉由將死亡以及瀕死的幼蟲數目相加作為其結果,再將單一化合物之試驗結果以及其各自的化合物組合之試驗結果,與未處理之植物的控制組的試驗結果進行比較,來計算死亡率百分比。與化合物 (I-1)有關的結果顯示於表J中。The test is performed using the leaf dip method, in which the desired amount of the compound or its respective combination of compounds is weighed and dissolved in a test tube containing a solvent solution. The test tube was placed on a vortex at 2000 rpm for 90 minutes to thoroughly mix the components, and then diluted with 0.01% Triton-X solution to obtain the desired test concentration. Tomato leaves were soaked in the compound solution for 10 seconds, dried in the shade for 20 minutes, and then transferred to wells of a bioassay tray. After placing a second instar larva in each well, cover the tray. The bioassay tray was then maintained at a temperature of 25 °C and a relative humidity of 70% under laboratory conditions. Observations of larval lines dead, moribund, or alive were recorded 72 hours after placement. Mortality was calculated by adding the number of dead and moribund larvae as a result and comparing the results for the individual compounds and their respective compound combinations with the results for a control group of untreated plants percentage. The results related to compound (I-1) are shown in Table J.

令人驚訝的是,下表所示的組合顯示出無法預期的協同效應:Surprisingly, the combinations shown in the table below showed unanticipated synergies:

J本案的組合物對番茄上之番茄夜蛾 ( Helicoverpa armigera)的協同殺蟲活性顯示於下方表中,其中作為組分 (1)之如式 (I)所示之化合物的代表性化合物特別為化合物 (I-1),其他組分 (2)係選自(III-A)至(III-GG)各組。 表J :化合物 (I-1) 及其組合物(與殺蟲劑或殺真菌劑)對於番茄夜蛾 ( Helicoverpa armigera) 的評估 化合物 濃度 (ppm) 比例 觀察到的功效 (%) 預期的功效 (%) (Colby’s) 協同效應 (%) 化合物 (I-1) 100 500 0 特安勃 (tetraniliprole) 0.2 ppm 1 0 化合物 (I-1) + 特安勃 500:1 25 0 25 化合物 (I-1) 100 250 0 特安勃 0.4 ppm 1 0 化合物 (I-1) + 特安勃 250:1 25 0 25 化合物 (I-1) 100 2000 0 剋安勃 (chlorantraniliprole) 0.05 ppm 1 0 化合物 (I-1) + 剋安勃 2000:1 12.5 0 12.5 化合物 (I-1) 100 1250 0 剋安勃 0.08 ppm 1 0 化合物 (I-1) + 剋安勃 1250:1 25 0 25 Table J The synergistic insecticidal activity of the composition of this case to the tomato armyworm ( Helicoverpa armigera ) on the tomato is shown in the table below, wherein as the representative compound of the compound shown in formula (I) as component (1) particularly For compound (I-1), other component (2) is selected from each group of (III-A) to (III-GG). Table J : Evaluation of compound (I-1) and its combination (with insecticide or fungicide) against tomato armyworm ( Helicoverpa armigera ) compound Concentration (ppm) Proportion Observed Efficacy (%) Expected Efficacy (%) (Colby's) Synergy (%) Compound (I-1) 100 500 0 Tetraniliprole 0.2ppm 1 0 Compound (I-1) + Tember 500:1 25 0 25 Compound (I-1) 100 250 0 Amber 0.4ppm 1 0 Compound (I-1) + Tember 250:1 25 0 25 Compound (I-1) 100 2000 0 Chlorantraniliprole 0.05ppm 1 0 Compound (I-1) + gambo 2000:1 12.5 0 12.5 Compound (I-1) 100 1250 0 Amber 0.08ppm 1 0 Compound (I-1) + gambo 1250:1 25 0 25

範例example BB :於高麗菜上的小菜蛾: Plutella xylostella on cabbage ( Plutella xylostella) ( Plutella xylostella )

利用葉片藥膜法來進行測試,於該方法中,秤量所需量的化合物或其各自的化合物組合,將其溶解於含有溶劑溶液的試管中。將試管置於2000 rpm的震盪儀 (vortex)上90分鐘以將成分充分混合,然後以0.01%之Triton-X溶液將其稀釋至所需的測試濃度。高麗菜葉在所述化合物之溶液中浸泡10秒,陰乾20分鐘,然後轉移到生物測定托盤的孔中。於每個孔中放置一隻二齡幼蟲 (second instar larva)後,將蓋子覆蓋於托盤上。然後將該生物測定托盤在實驗室條件下,保持在溫度為25 °C以及相對濕度為70%。在放置後的72小時記錄幼蟲係死亡、瀕死或存活的觀察結果。藉由將死亡以及瀕死的幼蟲數目相加作為其試驗結果,再將其各自試驗結果與未處理之植物控制組的試驗結果進行比較,來計算死亡率百分比。與化合物 (I-1)有關的結果顯示於表K中。Testing was performed using the leaf pellicle method, in which the desired amount of the compound or its respective combination of compounds was weighed and dissolved in a test tube containing a solvent solution. Place the test tube on a vortex at 2000 rpm for 90 minutes to mix the components thoroughly, and then dilute it to the required test concentration with 0.01% Triton-X solution. Cabbage leaves were soaked in the compound solution for 10 seconds, dried in the shade for 20 minutes, and then transferred to the wells of the bioassay tray. After placing a second instar larva in each well, cover the tray. The bioassay tray was then maintained at a temperature of 25 °C and a relative humidity of 70% under laboratory conditions. Observations of larval lines dead, moribund or alive were recorded 72 hours after placement. The percent mortality was calculated by adding the number of dead and dying larvae as the test results and comparing their respective test results with the test results of the untreated plant control group. The results related to compound (I-1) are shown in Table K.

令人驚訝的是,下表所示的組合顯示出無法預期的協同效應:Surprisingly, the combinations shown in the table below showed unanticipated synergies:

K 本案的組合物對於小菜蛾 ( Plutella xylostella)之協同殺蟲活性顯示於下方表中,其中作為組分 (1)之如式 (I)所示之化合物的代表性化合物特別為化合物 (I-1),其他組分 (2)係選自(III-A)至(III-GG)各組。 表K :化合物 (I-1) 及其組合物(與殺蟲劑或殺真菌劑)對於小菜蛾 ( Plutella xylostella) 的評估 化合物 濃度 (ppm) 比例 觀察到的功效 (%) 預期的功效 (%) (Colby’s) 協同效應 (%) 化合物 (I-1) 100 2000 0 特安勃 (tetraniliprole) 0.05 ppm 1 0 化合物 (I-1) + 特安勃 2000:1 25 0 25 化合物 (I-1) 100 1000 0 特安勃 0.1 ppm 1 25 化合物 (I-1) + 特安勃 1000:1 50 25 25 剋安勃 (chlorntraniliprole) 0.02 ppm 1 12.5 化合物 (I-1) + 剋安勃 5000:1 25 12.5 12.5 化合物 (I-1) 100 2000 0 剋安勃 0.05 ppm 1 12.5 化合物 (I-1) + 剋安勃 2000:1 25 12.5 12.5 化合物 (I-1) 100 200 0 賽安勃 (cyantraniliprole) 0.5 ppm 1 25 化合物 (I-1) + 賽安勃 200:1 37.5 25 12.5 Table K : The synergistic insecticidal activity of the composition of the present case for diamondback moth ( Plutella xylostella ) is shown in the table below, wherein as the representative compound of the compound shown in formula (I) as component (1) is particularly compound ( I-1), other components (2) are selected from the groups (III-A) to (III-GG). Table K : Evaluation of Compound (I-1) and Compositions (with Insecticides or Fungicides) for Plutella xylostella ( Plutella xylostella ) compound Concentration (ppm) Proportion Observed Efficacy (%) Expected Efficacy (%) (Colby's) Synergy (%) Compound (I-1) 100 2000 0 Tetraniliprole 0.05ppm 1 0 Compound (I-1) + Tember 2000:1 25 0 25 Compound (I-1) 100 1000 0 Amber 0.1 ppm 1 25 Compound (I-1) + Tember 1000:1 50 25 25 Chlorntraniliprole 0.02ppm 1 12.5 Compound (I-1) + gambo 5000:1 25 12.5 12.5 Compound (I-1) 100 2000 0 Amber 0.05ppm 1 12.5 Compound (I-1) + gambo 2000:1 25 12.5 12.5 Compound (I-1) 100 200 0 cyantraniliprole 0.5 ppm 1 25 Compound (I-1) + Cyambo 200:1 37.5 25 12.5

範例example CC :於辣椒: Yu Chili ( capsicum) ( capsicum ) 上之桃蚜Peach Aphid ( Myzus persicae) ( Myzus persicae )

利用葉片藥膜法來進行測試,於該方法中,秤量所需量的單一化合物或其各自的化合物組合,將其溶解於含有溶劑溶液的試管中。將試管置於2000 rpm的震盪儀 (vortex)上90分鐘以將成分充分混合,然後以0.01%之Triton-X溶液將其稀釋至所需的測試濃度。辣椒葉在所述化合物之溶液中浸泡10秒,陰乾20分鐘,然後將辣椒葉以背面朝上的方式放置在含有4 ml固化的1%瓊脂溶液的生物測定托盤的孔中。將已知數量、收集於培養皿中的三齡若蟲 (third instar nymphs)放置到每個具有處理過葉子的孔中,並用多孔蓋覆蓋此些孔以更好地通風。將該托盤保持在溫度為25 °C以及相對濕度為70%的植物生長室中。在放置後的72小時記錄幼蟲係死亡、瀕死或存活的觀察結果。藉由將死亡以及瀕死的若蟲數目相加作為其試驗結果,再將其各自試驗結果與未處理之植物控制組的試驗結果進行比較,來計算死亡率百分比。與化合物 (I-1)有關的結果顯示於表L中。Testing is performed using the leaf pellicle method, in which the desired amount of a single compound or its respective combination of compounds is weighed and dissolved in a test tube containing a solvent solution. Place the test tube on a vortex at 2000 rpm for 90 minutes to mix the components thoroughly, and then dilute it to the required test concentration with 0.01% Triton-X solution. The pepper leaves were soaked in the compound solution for 10 seconds, dried in the shade for 20 minutes, and then the pepper leaves were placed in the wells of the bioassay tray containing 4 ml of solidified 1% agar solution with the back side up. A known number of third instar nymphs collected in petri dishes was placed into each well with the treated leaves and covered with a perforated lid for better ventilation. The tray was kept in a plant growth chamber at a temperature of 25 °C and a relative humidity of 70%. Observations of larval lines dead, moribund or alive were recorded 72 hours after placement. The percent mortality was calculated by adding the number of dead and moribund nymphs to the test results and comparing their respective test results with the test results of the untreated plant control group. The results related to compound (I-1) are shown in Table L.

令人驚訝的是,下表所示的組合顯示出無法預期的協同效應:Surprisingly, the combinations shown in the table below showed unanticipated synergies:

L 本案的組合物對於辣椒上的桃蚜 ( Myzus persicae)之協同殺菌活性顯示於下方表中,其中作為組分 (1)之如式 (I)所示之化合物的代表性化合物特別為化合物 (I-1),其他組分 (2)係選自(III-A)至(III-GG)各組。 表L :化合物 (I-1) 及其組合物(與殺蟲劑或殺真菌劑)對於桃蚜 ( Myzus persicae) 的評估 化合物 濃度 (ppm) 比例 觀察到的功效 (%) 預期的功效 (%) (Colby’s) 協同效應 (%) 化合物 (I-1) 100 200 0.0 益達胺 (imidacloprid) 0.5 ppm 1 0.0 化合物 (I-1) + 益達胺 200:1 53.3 0.0 53.3 化合物 (I-1) 100 50 0.0 可尼丁(clothianidin) 2 ppm 1 0.0 化合物 (I-1) + 可尼丁 50:1 66.7 0.0 66.7 Table L : The synergistic bactericidal activity of the composition of the present case on green peach aphid ( Myzus persicae ) on pepper is shown in the table below, wherein as the representative compound of the compound shown in formula (I) as component (1) is particularly Compound (I-1), other component (2) are selected from each group of (III-A) to (III-GG). Table L : Evaluation of compound (I-1) and its combination (with insecticide or fungicide) against green peach aphid ( Myzus persicae ) compound Concentration (ppm) Proportion Observed Efficacy (%) Expected Efficacy (%) (Colby's) Synergy (%) Compound (I-1) 100 200 0.0 Imidacloprid 0.5 ppm 1 0.0 Compound (I-1) + Idamide 200:1 53.3 0.0 53.3 Compound (I-1) 100 50 0.0 Clothianidin 2 ppm 1 0.0 Compound (I-1) + Conitine 50:1 66.7 0.0 66.7

本案藉由以某些較佳實施例作為參考已描述了所請發明,而藉由考量本案說明書,其他實施例對於本發明所屬領域中具有通常知識者而言將變得顯而易見。對於本發明所屬領域中具有通常知識者而言,可以在不脫離本發明範圍的情況下實施對材料和方法的許多修改。The claimed invention has been described by reference to certain preferred embodiments and other embodiments will become apparent to those of ordinary skill in the art to which this invention pertains from consideration of the present specification. To those skilled in the art to which this invention pertains, many modifications in materials and methods may be made without departing from the scope of the invention.

Figure 110146642-A0101-11-0002-3
Figure 110146642-A0101-11-0002-3

Claims (19)

一種農業化學組成物,包含:如式 (I)所示之活性化合物作為組分 (1)之一混合物:
Figure 03_image001
式 (I) 其中, R 1選自鹵素、腈基、C 1-C 6烷基、C 1-C 6鹵烷基、C 1-C 6烷氧基,C 1-C 6烷硫基以及C 3-C 6環烷基; A係C或N,但不超過兩個A同時為N; G係C(R ) 2或O; 其中R 選自氫、鹵素以及C 1-C 3烷基; R 2選自氫、鹵素、腈基、C 1-C 6烷基、C 1-C 6鹵烷基、C 1-C 6烷氧基,C 3-C 6環烷基以及C 1-C 6烷基磺醯氧基 (alkylsulfonyloxy); n是0-3的整數; 及其鹽類、N-氧化物、金屬錯合物或立體異構物;以及 至少一種殺真菌活性化合物 (II)及/或至少一種殺蟲或殺線蟲活性化合物 (III)作為組分 (2); 其中, 該至少一種殺真菌活性化合物 (II)選自以下(II-A)至(II-R)各組: (II-A) 甾醇生物合成的抑制劑; (II-B) 呼吸鏈複合物I (complex I)或複合物II (complex II)的抑制劑; (II-C) 呼吸鏈複合物III (complex III)的抑制劑; (II-D) 有絲分裂和細胞分裂的抑制劑; (II-E) 可具有多位點作用 (multisite action)的化合物; (II-F) 可誘發宿主防禦之化合物; (II-G) 胺基酸及/或蛋白質生物合成之抑制劑; (II-H) 三磷酸腺苷 (adenosine triphosphate, ATP)產生之抑制劑; (II-I) 細胞壁合成之抑制劑; (II-J) 脂質和膜合成之抑制劑; (II-K) 黑色素 (melanine)生物合成的抑制劑; (II-L) 核酸合成之抑制劑; (II-M) 訊息傳遞之抑制劑; (II-N) 可作為去耦合劑 (uncoupler)之化合物; (II-O) 其他殺真菌劑; (II-P) 組織蛋白去乙醯酶 (Histone deacetylase, HDAC)抑制劑; (II-Q) 可作為保護劑 (safener)的化合物;以及 (II-R) 生物殺真菌劑; 該至少一種殺蟲及/或殺線蟲活性化合物 (III)選自以下(III-A)至(III-GG)各組: (III-A) 乙醯膽鹼酯酶 (Acetylcholinesterase, AChE)抑制劑; (III-B) γ-胺基丁酸閘控氯離子通道阻斷劑 (GABA-gated chloride channel blocker); (III-C) 鈉通道調節劑; (III-D) 菸鹼乙醯膽鹼受體 (Nicotinic acetylcholine receptor, nAChR)競爭性調節劑; (III-E) 菸鹼乙醯膽鹼受體異位調節劑 (allosteric modulator)-位點I; (III-F) 麩胺酸閘控氯通道 (Glutamate-gated chloride channel, GluCl)異位調節劑; (III-G) 青春激素模擬物 (Juvenile hormone mimics); (III-H) 多重非特異性(多位點)抑制劑 (Miscellaneous non-specific (multi-site) inhibitors); (III-I) 弦音器官 (chordotonal organ) TRPV通道調節劑; (III-J) 影響幾丁質合成酶 (chitin synthase 1, CHS1)的蟎生長抑制劑; (III-K) 昆蟲中腸 (midgut)膜的微生物干擾劑; (III-L) 粒線體ATP合成酶之抑制劑; (III-M) 藉由干擾質子梯度而作用之氧化磷酸化 (oxidative phosphorylation)去耦合劑; (III-N) 菸鹼乙醯膽鹼受體 (nAChR)通道阻斷劑; (III-O) 影響CHS1的幾丁質生物合成抑制劑; (III-P) 第1型之幾丁質生物合成抑制劑; (III-Q) 蛻皮干擾劑 (moulting disruptor); (III-R) 蛻皮素 (ecdysone)受體促效劑 (agonists); (III-S) 奧克巴胺 (octopamine)受體促效劑; (III-T) 粒線體複合物III電子傳遞抑制劑; (III-U) 粒線體複合物I電子傳遞抑制劑; (III-V) 電壓依賴性之鈉通道阻斷劑; (III-W) 乙醯輔酶A羧化酶 (acetyl CoA carboxylase)抑制劑; (III-X) 粒線體複合物IV電子傳遞抑制劑; (III-Y) 粒線體複合物II電子傳遞抑制劑; (III-Z) 雷若丁 (Ryanodine)受體調節劑; (III-AA) 弦音器官調節劑; (III-BB) γ-胺基丁酸閘控氯離子通道異位調節劑; (III-CC) 桿狀病毒 (baculoviruses); (III-DD) 菸鹼乙醯膽鹼受體異位調節劑-位點II; (III-EE) 作用方式未知或不確定之殺蟲活性化合物; (III-FF) 生物性殺蟲劑;以及 (III-GG) 具有殺蟲、殺蟎、殺軟體動物 (molluscidal)、費洛蒙 (pheromone)及/或殺線蟲活性的生化殺害蟲劑。
An agricultural chemical composition, comprising: the active compound shown in formula (I) as a mixture of components (1):
Figure 03_image001
Formula (I) wherein, R 1 is selected from halogen, nitrile, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 alkoxy, C 1 -C 6 alkylthio and C 3 -C 6 cycloalkyl; A is C or N, but no more than two A are N at the same time; G is C(R ' ) 2 or O; wherein R ' is selected from hydrogen, halogen and C 1 -C 3 Alkyl; R 2 is selected from hydrogen, halogen, nitrile, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 alkoxy, C 3 -C 6 cycloalkyl and C 1 -C 6 alkylsulfonyloxy (alkylsulfonyloxy); n is an integer of 0-3; and its salts, N-oxides, metal complexes or stereoisomers; and at least one fungicidally active compound ( II) and/or at least one insecticidal or nematicidal active compound (III) as component (2); wherein, the at least one fungicidal active compound (II) is selected from the following (II-A) to (II-R) Groups: (II-A) Inhibitors of sterol biosynthesis; (II-B) Inhibitors of complex I or complex II of the respiratory chain; (II-C) Complexes of the respiratory chain III (complex III) inhibitors; (II-D) inhibitors of mitosis and cell division; (II-E) compounds that may have multisite action; (II-F) compounds that induce host defense Compounds; (II-G) inhibitors of amino acid and/or protein biosynthesis; (II-H) inhibitors of adenosine triphosphate (ATP) production; (II-I) inhibitors of cell wall synthesis; (II-H) inhibitors of adenosine triphosphate (ATP) production; -J) Inhibitors of lipid and membrane synthesis; (II-K) Inhibitors of melanine biosynthesis; (II-L) Inhibitors of nucleic acid synthesis; (II-M) Inhibitors of signal transmission; -N) compounds that can be used as uncouplers; (II-O) other fungicides; (II-P) histone deacetylase (HDAC) inhibitors; (II-Q) can A compound as a protective agent (safener); and (II-R) a biological fungicide; the at least one insecticidal and/or nematicidal active compound (III) is selected from each of the following (III-A) to (III-GG) Groups: (III-A) acetylcholinesterase (Acetylcholinesterase, AChE) inhibitors; (III-B) γ-aminobutyric acid-gated chloride channel blockers (GABA-gated chloride c (III-C) Sodium channel modulator; (III-D) Nicotinic acetylcholine receptor (Nicotinic acetylcholine receptor, nAChR) competitive modulator; (III-E) Nicotinic acetylcholine Allosteric modulator - site I; (III-F) Glutamate-gated chloride channel (GluCl) allosteric modulator; (III-G) youth hormone mimetic (Juvenile hormone mimics); (III-H) Miscellaneous non-specific (multi-site) inhibitors; (III-I) TRPV channel modulator of chordotonal organ ; (III-J) Mite growth inhibitors affecting chitin synthase 1 (CHS1); (III-K) Microbial disruptors of insect midgut membranes; (III-L) Mitochondria Inhibitor of ATP synthase; (III-M) oxidative phosphorylation (oxidative phosphorylation) decoupler acting by interfering with the proton gradient; (III-N) nicotinic acetylcholine receptor (nAChR) channel blocker (III-O) chitin biosynthesis inhibitors affecting CHS1; (III-P) type 1 chitin biosynthesis inhibitors; (III-Q) moulting disruptors; (III -R) ecdysone receptor agonists; (III-S) octopamine receptor agonists; (III-T) mitochondrial complex III electron transport inhibitors (III-U) Mitochondrial complex I electron transport inhibitor; (III-V) Voltage-dependent sodium channel blocker; (III-W) Acetyl CoA carboxylase (acetyl CoA carboxylase) inhibitor (III-X) mitochondrial complex IV electron transport inhibitors; (III-Y) mitochondrial complex II electron transport inhibitors; (III-Z) ryanodine (Ryanodine) receptor modulators; (III-AA) Chord organ modulator; (III-BB) Gamma-aminobutyric acid-gated chloride channel ectopic modulator; (III-CC) baculoviruses; (III-DD) Nicotinic acetylcholine receptor ectopic modulator-site II; (III-EE) insecticidally active compounds with unknown or uncertain mode of action; (III-FF) biological insecticides; and (III-GG ) Biochemical insecticides having insecticidal, acaricidal, molluscidal, pheromone and/or nematicidal activity.
如請求項1所述的農業化學組成物,其中該組分 (2)係至少一種選自如下之(II-A)至(II-R)各組的殺真菌活性化合物 (II): (II-A) 甾醇生物合成的抑制劑:(II-A001) 環克座 (cyproconazole)、(II-A002) 待克利 (difenoconazole)、(II-A003) 依普座 (epoxiconazole)、(II-A004) 環醯菌胺 (fenhexamid)、(II-A005) 苯鏽啶 (fenpropidin)、(II-A006) 芬普福 (fenpropimorph)、(II-A007) 胺苯吡菌酮 (fenpyrazamine)、(II-A008) 氟喹唑 (fluquinconazole)、(II-A009) 護汰芬 (flutriafol)、(II-A010) 依滅列 (imazalil)、(II-A011) 依滅列硫酸鹽 (imazalil sulfate)、(II-A012) 種菌唑 (ipconazole)、(II-A013) 滅特座 (metconazole)、(II-A014) 邁克尼 (myclobutanil)、(II-A015) 巴克素 (paclobutrazol)、(II-A016) 撲克拉 (prochloraz)、(II-A017) 普克利 (propiconazole)、(II-A018) 丙硫菌唑 (prothioconazole)、(II-A019) 啶菌㗁唑 (pyrisoxazole)、(II-A020) 葚孢菌素 (spiroxamine)、(II-A021) 得克利 (tebuconazole)、(II-A022) 四克利 (tetraconazole)、(II-A023) 三泰隆 (triadimenol)、(II-A024) 三得芬 (tridemorph)、(II-A025) 滅菌唑 (triticonazole)、(II-A026) (1R,2S,5S)-5-(4-氯苄基)-2-(氯甲基)-2-甲基-1-(1H-1,2,4-三唑-1-基甲基)環戊醇 ((1R,2S,5S)-5-(4-chlorobenzyl)-2-(chloromethyl)-2-methyl-l-(1H-1,2,4-triazol-1­ylmethyl)cyclopentanol、(II-A027) (1S,2R,5R)-5-(4-氯苄基)-2-(氯甲基)-2-甲基-1-(1H-1,2,4-三唑-1-基甲基)環戊醇 ((1S,2R,5R)-5-(4-chlorobenzyl)-2-(chloromethyl)-2-methyl-1-(1H-1,2,4-triazol-l-ylmethyl)cyclopentanol)、(II-A028) (2R)-2-(1-氯環丙基)-4-[(1R)-2,2-二氯環丙基]-1-(1H-1,2,4-三唑-1-基)丁-2-醇 ((2R)-2-(1-chlorocyclopropyl)-4-[(1R)-2,2-dichlorocyclopropyl]-1-(1H-1,2,4-triazol-1-yl)butan-2-ol)、(II-A029) (2R)-2-(1-氯環丙基)-4-[(1S)-2,2-二氯環丙基]-1-(1H-1,2,4-三唑-1-基)丁-2-醇 ((2R)-2-(1-chlorocyclopropyl)-4-[(1S)-2,2-dichlorocyclopropyl]-1-(1H-1,2,4-triazol-1-yl)butan-2-ol)、(II-A030) (2R)-2-[4-(4-氯苯氧基)-2-(三氟甲基)苯基]-1-(1H-1,2,4-三唑-1-基)丙-2-醇 ((2R)-2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1H-1,2,4-triazol-1-yl)propan-2-ol)、(II-A031) (2S)-2-(1-氯環丙基)-4-[(1R)-2,2-二氯環丙基]-1-(1H-1,2,4-三唑-1-基)丁-2-醇 ((2S)-2-(1-chlorocyclopropyl)-4-[(1R)-2,2-dichlorocyclopropyl]-1-(1H-l,2,4-triazol-1-yl)butan-2-ol)、(II-A032) (2S)-2-(1-氯環丙基)-4-[(1S)-2,2-二氯環丙基]-1-(1H-1,2,4-三唑-1-基)丁-2-醇 ((2S)-2-(1-chlorocyclopropyl)-4-[(1S)-2,2-dichlorocyclopropyl]-1-(1H-1,2,4-triazol-1-yl)butan-2-ol)、(II-A033) (2S)-2-[4-(4-氯苯氧基)-2-(三氟甲基)苯基]-1-(1H-1,2,4-三唑-1-基)丙-2-醇 ((2S)-2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1H-1,2,4-triazol-1-yl)propan-2-ol)、(II-A034) (R)-[3-(4-氯-2-氟苯基)-5-(2,4-二氟苯基)-1,2-噁唑-4-基](吡啶-3-基)甲醇 ((R)-[3-(4-chloro-2-fluorophenyl)-5-(2,4-difluorophenyl)-1,2-oxazol-4-yl](pyridin-3-yl)methanol)、(II-A035) (S)[3-(4-氯-2-氟苯基)-5-(2,4-二氟苯基)-1,2-噁唑-4-基](吡啶-3-基)甲醇 ((S)­[3-(4-chloro-2-fluorophenyl)-5-(2,4-difluorophenyl)-1,2-oxazol-4-yl](pyridin-3-yl)methanol)、(II-A036) [3-(4-氯-2-氟苯基)-5-(2,4-二氟苯基)-1,2-噁唑-4-基](吡啶-3-基)甲醇 ([3-(4-chloro-2-fluorophenyl)-5-(2,4-difluorophenyl)-1,2-oxazol-4-yl](pyridin-3-yl)methanol)、(II-A037) 1-({(2R,4S)-2-[2-氯-4-(4-氯苯氧基)苯基]-4-甲基-1,3-二氧戊環-2-基}甲基)-1H-1,2,4-三唑 (1-({(2R,4S)-2-[2-chloro-4-(4-chlorophenoxy)phenyl]-4-methyl-1,3-dioxolan-2-yl}methyl)-1H-1,2,4-triazole)、(II-A038) 1-({(2S,4S)-2-[2-氯-4-(4-氯苯氧基)苯基]-4-甲基-1,3-二氧戊環-2-基}甲基)-1H-1,2,4-三唑 (1-({(2S,4S)-2-[2-chloro-4-(4-chlorophenoxy)phenyl]-4-methyl-l,3-dioxolan-2-yl}methyl)-1H-1,2,4-triazole)、(II-A039) 1-{[3-(2-氯苯基)-2-(2,4-二氟苯基)環氧乙烷-2-基]甲基}-1H-1,2,4-三唑-5-基硫氰酸酯 (1-{[3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-1H-1,2,4-triazol-5-yl thiocyanate)、(II-A040) 1-{[rel(2R,3R)-3-(2-氯苯基)-2-(2,4-二氟苯基)環氧乙烷-2-基]甲基}-1H-1,2,4-三唑-5-基硫氰酸酯 (1-{[rel(2R,3R)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-1H-1,2,4-triazol-5-yl thiocyanate)、(II-A041) 1-{[rel(2R,3S)-3-(2-氯苯基)-2-(2,4-二氟苯基)環氧乙烷-2-基]甲基}-1H-1,2,4-三唑-5-基硫氰酸酯 (1-{[rel(2R,3S)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-1H-1,2,4-triazol-5-yl thiocyanate)、(II-A042) 2-[(2R,4R,5R)-1-(2,4-二氯苯基)-5-羥基-2,6,6-三甲基庚烷-4-基]-2,4-二氫-3H-1,2,4-三唑-3-硫酮 (2-[(2R,4R,5R)-1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione)、(II-A043) 2-[(2R,4R,5S)-1-(2,4-二氯苯基)-5-羥基-2,6,6-三甲基庚烷-4-基]-2,4-二氫-3H-1,2,4-三唑-3-硫酮 (2-[(2R,4R,5S)-1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione)、(II-A044) 2-[(2R,4S,5R)-1-(2,4-二氯苯基)-5-羥基-2,6,6-三甲基庚烷-4-基]-2,4-二氫-3H-1,2,4-三唑-3-硫酮 (2-[(2R,4S,5R)-l-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione)、(II-A045) 2-[(2R,4S,5S)-1-(2,4-二氯苯基)-5-羥基-2,6,6-三甲基庚烷-4-基]-2,4-二氫-3H-1,2,4-三唑-3-硫酮 (2-[(2R,4S,5S)-l-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione)、(II-A046) 2-[(2S,4R,5R)-1-(2,4-二氯苯基)-5-羥基-2,6,6-三甲基庚烷-4-基]-2,4-二氫-3H-1,2,4-三唑-3-硫酮 (2-[(2S,4R,5R)-1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione)、(II-A047) 2-[(2S,4R,5S)-1-(2,4-二氯苯基)-5-羥基-2,6,6-三甲基庚烷-4-基]-2,4-二氫-3H-1,2,4-三唑-3-硫酮 (2-[(2S,4R,5S)-1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione)、(II-A048) 2-[(2S,4S,5R)-1-(2,4-二氯苯基)-5-羥基-2,6,6-三甲基庚烷-4-基]-2,4-二氫-3H-1,2,4-三唑-3-硫酮 (2-[(2S,4S,5R)-1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione)、(II-A049) 2-[(2S,4S,5S)-1-(2,4-二氯苯基)-5-羥基-2,6,6-三甲基庚烷-4-基]-2,4-二氫-3H-1,2,4-三唑-3-硫酮 (2-[(2S,4S,5S)-l-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione)、(II-A050) 2-[1-(2,4-二氯苯基)-5-羥基-2,6,6-三甲基庚烷-4-基]-2,4-二氫-3H-1,2,4-三唑-3-硫酮 (2-[1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione)、(II-A051) 2-[2-氯-4-(2,4-二氯苯氧基)苯基]-l-(1H-1,2,4-三唑-1-基)丙-2-醇 (2-[2-chloro-4-(2,4-dichlorophenoxy)phenyl]-l-(1H-1,2,4-triazol-1-yl) propan-2-ol)、(II-A052) 2-[2-氯-4-(4-氯苯氧基)苯基]-1-(1H-1,2,4-三唑-1-基)丁-2-醇 (2-[2-chloro-4-(4-chlorophenoxy)phenyl]-1-(1H-1,2,4-triazol-1-yl)butan-2-ol)、(II-A053) 2-[4-(4-氯苯氧基)-2-(三氟甲基)苯基]-1-(1H-1,2,4-三唑-1-基)丁-2-醇 (2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1H-1,2,4-triazol-1-yl)butan-2-ol)、(II-A054) 2-[4-(4-氯苯氧基)-2-(三氟甲基)苯基]-1-(1H-1,2,4-三唑-1-基)戊-2-醇 (2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1H-1,2,4-triazol-l-yl)pentan-2-ol)、(II-A055) 2-[4-(4-氯苯氧基)-2-(三氟甲基)苯基]-1-(1H-1,2,4-三唑-1-基)丙-2-醇 (2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1H-1,2,4-triazol-1-yl)propan-2-ol)、(II-A056) 2-{[3-(2-氯苯基)-2-(2,4-二氟苯基)環氧乙烷-2-基]甲基}-2,4-二氫-3H-1,2,4-三唑-3-硫酮 (2-{[3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-2,4-dihydro-3H-l,2,4-triazole-3-thione)、(II-A057) 2-{[rel(2R,3R)-3-(2-氯苯基)-2-(2,4-二氟苯基)環氧乙烷-2-基]甲基}-2,4-二氫-3H-1,2,4-三唑-3-硫酮 (2-{[rel(2R,3R)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-2,4-dihydro-3H-1,2,4-triazole-3-thione)、(II-A058) 2-{[rel(2R,3S)-3-(2-氯苯基)-2-(2,4-二氟苯基)環氧乙烷-2-基]甲基}-2,4-二氫-3H-l,2,4-三唑-3-硫酮 (2-{[rel(2R,3S)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-2,4-dihydro-3H-l,2,4-triazole-3-thione)、(II-A059) 5-(4-氯芐基)-2-(氯甲基)-2-甲基-1-(1H-1,2,4-三唑-1-基甲基)環戊醇 (5-(4-chlorobenzyl)-2-(chloromethyl)-2-methyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol)、(II-A060) 5-(烯丙基硫基)-1-{[3-(2-氯苯基)-2-(2,4-二氟苯基)環氧乙烷-2-基]甲基}-1H-1,2,4-三唑 (5-(allylsulfanyl)-1-{[3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-1H-1,2,4-triazole)、(II-A061) 5-(烯丙基硫烷基)-1-{[rel(2R,3R)-3-2-氯苯基)-2-(2,4-二氟苯基)環氧乙烷-2-基]甲基}-1H-1,2,4-三唑 (5-(allylsulfanyl)-1-{[rel(2R,3R)-3-2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-1H-1,2,4-triazole)、(II-A062) 5-(烯丙基硫烷基)-1-{[rel(2R,3S)-3-(2-氯苯基)-2-(2,4-二氟苯基)環氧乙烷-2-基]甲基}-1H-1,2,4-三唑 (5-(allylsulfanyl)-1-{[rel(2R,3S)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-1H-1,2,4-triazole)、(II-A063) N’-(2,5-二甲基-4-{[3-(1,1,2,2-四氟乙氧基)苯基]硫基}苯基)-N-乙基-N-甲基亞胺基甲醯胺 (N’-(2,5-dimethyl-4-{[3-(1,1,2,2-tetrafluoroethoxy)phenyl]sulfanyl}phenyl)-N-ethyl-N­methylimidoformamide)、(II-A064) N’-(2,5-二甲基-4-{[3-(2,2,2-三氟乙氧基)苯基]硫基}苯基)N-乙基-N-甲基亞胺基甲醯胺 (N’-(2,5-dimethyl-4-{[3-(2,2,2-trifluoroethoxy)phenyl]sulfanyl}phenyl)­N-ethyl-N-methylimidoformamide)、(II-A065) N’-(2,5-二甲基-4-{[3-(2,2,3,3-四氟丙氧基)苯基]硫基}苯基)-N-乙基-N-甲基亞胺基甲醯胺 (N’-(2,5-dimethyl-4-{[3-(2,2,3,3-tetrafluoropropoxy)phenyl]sulfanyl}phenyl)-N-ethyl-N-methylimidoformamide)、(II-A066) 5-二甲基-4-{[3-(五氟乙氧基)苯基]硫基}苯基)-N-乙基-N-甲基亞胺基甲醯胺 (N’-(2,5-dimethyl-4-{[3-(pentafluoroethoxy)phenyl]sulfanyl}phenyl)-N-ethyl-N-methylimidoformamide)、(II-A067) N’-(2,N’-(2,5-二甲基)-4-{3-[(1,1,2,2-四氟乙基)硫烷基]苯氧基}苯基)-N-乙基-N-甲基亞胺基甲醯胺 (N’-(2,5-dimethyl-4-{3-[(1,l,2,2-tetrafluoroethyl)sulfanyl]phenoxy}phenyl)-N-ethyl-N­methylimidoformamide)、(II-A068) N’-(2,5-二甲基-4-{3-[(2,2,2-三氟乙基)硫烷基]苯氧基}苯基)N-乙基-N-甲基亞胺基甲醯胺 (N’-(2,5-dimethyl-4-{3-[(2,2,2-trifluoroethyl)sulfanyl]phenoxy}phenyl)­N-ethyl-N-methylimidoformamide)、(II-A069) N’-(2,5-二甲基-4-{3-[(2,2,3,3-四氟丙基)硫烷基]苯氧基}苯基)-N-乙基-N-甲基亞胺基甲醯胺 (N’-(2,5-dimethyl-4-{3-[(2,2,3,3-tetrafluoropropyl)sulfanyl]phenoxy}phenyl)-N-ethyl-N-methylimidoformamide、(II-A070) N’-(2,5-二甲基-4-{3-[(五氟乙基)硫烷基]苯氧基}苯基)-N-乙基-N-甲基亞胺基甲醯胺 (N’-(2,5-dimethyl-4-{3-[(pentafluoroethyl)sulfanyl]phenoxy}phenyl)-N-ethyl-N-methylimidoformamide)、(II-A071) N’-(2,5-二甲基-4-苯氧基苯基)-N-乙基-N-甲基亞胺基甲醯胺 (N’-(2,5-dimethyl-4-phenoxyphenyl)-N-ethyl-N-methylimidoformamide)、(II-A072) N’-(4-{[3-(二氟甲氧基)苯基]硫烷基}-2,5-二甲基苯基)-N-乙基-N-甲基亞胺基甲醯胺 (N’-(4-{[3-(difluoromethoxy)phenyl]sulfanyl}-2,5-dimethylphenyl)-N-ethyl-N-methylimidoformamide)、(II-A073) N’(4-{3-[(二氟甲基)硫烷基]苯氧基}-2,5-二甲基苯基)-N-乙基-N-甲基亞胺基甲醯胺 (N’­(4-{3-[(difluoromethyl)sulfanyl]phenoxy}-2,5-dimethylphenyl)-N-ethyl-N-methylimidoformamide)、(II-A074) N’-[5-溴-6-(2,3-二氫-1H-茚-2-氧基)-2-甲基吡啶-3-基]-N-乙基-N-甲基亞胺基甲醯胺 (N’-[5-bromo-6-(2,3-dihydro-1H-inden-2-yloxy)-2-methylpyridin-3-yl]-N-ethyl-N­methylimidoformamide)、(II-A075) N’-{4-[(4,5-二氯-1,3-噻唑-2-基)氧]-2,5-二甲基苯基}-N-乙基-N-甲基亞胺基甲醯胺 (N’-{4-[(4,5-dichloro-1,3-thiazol-2-yl)oxy]-2,5-dimethylphenyl}-N­ethyl-N-methylimidoformamide)、(II-A076) N’-{5-溴-6-[(1R)-1-(3,5-二氟苯基)乙氧基]-2-甲基吡啶-3-基}-N-乙基-N-甲基亞胺基甲醯胺 (N’-{5-bromo-6-[(1R)-1-(3,5-difluorophenyl)ethoxy]-2-methylpyridin-3-yl}-N-ethyl-N-methylimidofonnamide)、(II-A077) N’-{5-溴-6-[(1S)-1-(3,5-二氟苯基)乙氧基]-2-甲基吡啶-3-基}-N-乙基-N-甲基亞胺基甲醯胺 (N’-{5-bromo-6-[(1S)-1-(3,5-difluorophenyl)ethoxy]-2-methylpyridin-3-yl}-N-ethyl-N-methylimidoformamide)、(II-A078) N’-{5-溴-6-[(順式-4-異丙基環己基)氧]-2-甲基吡啶-3-基}-N-乙基-N-甲基亞胺基甲醯胺 (N’-{5-bromo-6-[(cis-4-isopropylcyclohexyl)oxy]-2-methylpyridin-3-yl}-N-ethyl-N-methylimidofornamide)、(II-A079) N’-{5-溴-6-[(反式-4-異丙基環己基)氧]-2-甲基吡啶-3-基}-N-乙基-N-甲基亞胺基甲醯胺 N’-{5-bromo-6-[(trans-4-isopropylcyclohexyl)oxy]-2-methylpyridin-3-yl}-N-ethyl-N­methylimidoformamide)、(II-A080) N’-{5-溴-6-[1-(3,5-二氟苯基)乙氧基]-2-甲基吡啶-3-基}-N-乙基-N-甲基亞胺基甲醯胺 (N’-{5-bromo-6-[1-(3,5-difluorophenyl)ethoxy]-2-methylpyridin-3-yl}­N-ethyl-N-methylimidoformamide)、(II-A081) 滅芬座 (mefentrifluconazole)、(II-A082) 異芬三氟康唑 (ipfentrifluconazole)、(II-A083) 1-(2,4-二氟苯基)-2-(1H-1,2,4-三唑-1-基)-1-[1-(2,6-二氟-4-氯苯氧基)環丙基]乙醇 (1-(2,4-difluorophenyl)-2-(1H-1,2,4-triazol-1-yl)-1-[1-(2,6-difluoro-4-chlorophenoxy)cyclopropyl]ethanol)、(II-A084) 1-[2-(1-氯環丙基)-3-(2-氟苯基)-2-羥丙基]-1H-咪唑-5-腈 (1-[2-(l-chlorocyclopropyl)-3-(2-fluorophenyl)-2-hydroxypropyl]-1H-imidazole-5-carbonitrile)、(II-A085) 特比萘芬 (terbinafine)、(II-A086) 丁硫菌酸鹽 (buthiobate)、(II-A087) 比芬諾 (pyrifenox)、(II-A088) 芬瑞莫 (fenarimol)、(II-A089) 尼瑞莫 (nuarimol)、(II-A090) 嘧菌醇 (triarimol)、(II-A091) 賽福寧 (triforine)、(II-A092) 克黴唑 (clotrimazole)、(II-A093) 益康唑 (econazole)、(II-A094) 異康唑 (isoconazole)、(II-A095) 咪康唑 (miconazole)、(II-A096) 氧唑菌 (oxpoconazole)、(II-A097) 披扶座 (pefurazoate)、(II-A098) 氟蟲唑 (triflumizole)、(II-A099) 氮唑康唑 (azaconazole)、(II-A100) 雙苯三唑醇 (bitertanol)、(II-A101) 溴康唑 (bromuconazole)、(II-A102) 達克利 (diniconazole)、(II-A103) 達克利-M (diniconazole-M)、(II-A104) 乙環唑 (etaconazole)、(II-A105) 芬克座 (fenbuconazole)、(II-A106) 菲克利 (hexaconazole)、(II-A107) 易胺座 (imibenconazole)、(II-A108) 平克座 (penconazole)、(II-A109) 西咪康唑 (simeconazole)、(II-A110) 三泰芬 (triadimefon)、(II-A111) 單克素 (uniconazole)、(II-A112) 稗草畏 (pyributicarb)、(II-A113) 十二嗎啉 (dodemorph)、(II-A114) 歐地莫 (aldimorph)、(II-A115) 三芬醯胺 (trimorphamide)、(II-A116) 粉病靈 (piperalin)、(II-A117) 萘替芬 (naftifine); (II-B) 呼吸鏈複合物I (complex I)或複合物II (complex II)的抑制劑:(II-B001) 苯索伏比 (benzovindiflupyr)、(II-B002) 拜沙芬 (bixafen)、(II-B003) 白克列 (boscalid)、(II-B004) 萎鏽靈 (carboxin)、(II- B005) 氟派瑞 (fluopyram)、(II-B006) 福多寧 (flutolanil)、(II-B007) 氟克殺 (fluxapyroxad)、(II-B008) 福拉比 (furametpyr)、(II-B009) 抑吩滅 (isofetamid)、(II-B010) 亞派占 (isopyrazam)(反差向鏡像異構物 (anti-epimeric enantiomer) 1R,4S,9S)、(II-B011) 亞派占(反差向對映異構物1S,4R,9R)(isopyrazam (anti-epimeric enantiomer 1S,4R,9R))、(II-B012) 亞派占(反差向異構消旋物1RS,4SR,9SR)(isopyrazam (anti-epimeric racemate 1RS,4SR,9SR))、(II-B013) 亞派占(同差向異構消旋物1RS,4SR,9RS與反差向異構消旋物1RS,4SR,9SR之混合物)(isopyrazam (mixture of syn-epimeric racemate 1RS,4SR,9RS and anti-epimeric racemate 1RS,4SR,9SR))、(II-B014) 亞派占(同差向異構消旋物1R,4S,9R) (isopyrazam (syn-epimeric enantiomer 1R,4S,9R))、(II-B015) 亞派占(同差向異構消旋物1S,4R,9S) (isopyrazam (syn-epimeric enantiomer 1S,4R,9S))、(II-B016) 亞派占(同差向異構消旋物1RS,4SR,9RS)(isopyrazam (syn-epimeric racemate 1RS,4SR,9RS))、(II-B017) 本福吩 (penflufen)、(II-B018) 本賽能 (penthiopyrad)、(II-B019) 派滅芬 (pydiflumetofen)、(II-B020) 必福滅 (pyraziflumid)、(II-B021) 速達散 (sedaxane)、(II-B022) 1,3-二甲基-N-(1,1,3-三甲基-2,3-二氫-1H-茚-4-基)-1H-吡唑-4-羧醯胺 (1,3-dimethyl-N-(1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl)-1H-pyrazole-4-carboxamide)、(II-B023) 1,3-二甲基-N-[(3R)-1,1,3-三甲基-2,3-二氫-1H-茚-4-基]-1H-吡唑-4-羧醯胺 (1,3-dimethyl-N-[(3R)-1,l,3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1H-pyrazole-4-carboxamide)、(II-B024) 1,3-二甲基-N-[(3S)-1,1,3-三甲基-2,3-二氫-1H-茚-4-基]-1H-吡唑-4-羧醯胺 (1,3-dimethyl-N-[(3S)-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1H-pyrazole-4-carboxamide)、(II-B025) 1-甲基-3-(三氟甲基)-N-[2’-(三氟甲基)聯苯-2-基]-1H-吡唑-4-羧醯胺 (1-methyl-3-(trifluoromethyl)-N-[2’-(trifluoromethyl)biphenyl-2-yl]-1H-pyrazole-4-carboxamide)、(II-B026) 2-氟-6-(三氟甲基)-N-(1,1,3-三甲基-2,3-二氫-1H-茚-4-基)苯醯胺 (2-fluoro-6-(trifluoromethyl)-N-(1,1,3-trimethyl-2,3-dihydro-1H-inden-4- yl)benzamide)、(II-B027) 3-(二氟甲基)-1-甲基-N-(1,1,3-三甲基-2,3-二氫-1H-茚-4-基)-1H-吡唑-4-羧醯胺 (3-(difluoromethyl)-1-methyl-N-(1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl)-1H­pyrazole-4-carboxamide)、(II-B028) 3-(二氟甲基)-1-甲基-N-[(3R)-1,1,3-三甲基-2,3-二氫-1H-茚-4-基]-1H-吡唑-4-羧醯胺 (3-(difluoromethyl)-1-methyl-N-[(3R)-1,1,3-trimethyl-2,3-dihydro-1H­inden-4-yl]-1H-pyrazole-4-carboxamide)(因吡氟沙,inpyrfluxam)、(II-B029) 3-(二氟甲基)-1-甲基-N-[(3S)-1,1,3-三甲基-2,3-二氫-1H-茚-4-基]-1H-吡唑-4-羧醯胺 (3-(difluoromethyl)-1-methyl-N-[(3S)-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1H-pyrazole-4-carboxamide)、(II-B030) 3-(二氟甲基)-N-(7-氟-1,1,3-三甲基-2,3-二氫-1H-茚-4-基)-1-甲基-1H-吡唑-4-羧醯胺 (3-(difluoromethyl)-N-(7-fluoro-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl)-1-methyl-1H-pyrazole-4- carboxamide)(氟茚唑菌胺,Fluindapyr)、(II-B031) 3-(二氟甲基)-N-[(3R)-7-氟-1,1,3-三甲基-2,3-二氫-1H-茚-4-基]-1-甲基-1H-吡唑-4-羧醯胺 (3-(difluoromethyl)-N-[(3R)-7-fluoro-l,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1-methyl-1H-pyrazole-4-carboxamide)、(II-B032) 3-(二氟甲基)-N-[(3S)-7-氟-1,1,3-三甲基-2,3-二氫-1H-茚-4-基]-1-甲基-1H-吡唑-4-羧醯胺 (3-(difluoromethyl)-N-[(3S)-7-fluoro-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1-methyl-1H-pyrazole-4-carboxamide)、(II-B033) 5,8-二氟-N-[2-(2-氟-4-{[4-(三氟甲基)吡啶-2-基]氧}苯基)乙基]喹唑啉-4-胺 (5,8-difluoro-N-[2-(2-fluoro-4-{[4-(trifluoromethyl)pyridin-2-yl]oxy}phenyl)ethyl]quinazolin-4-amine)、(II-B034) N-(2-環戊基-5-氟苯甲基)-N-環丙基-3-(二氟甲基)-5-氟-1-甲基-1H-吡唑-4-羧醯胺 (N-(2-cyclopentyl-5-fluorobenzyl)-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1-H-pyrazole-4-carboxamide)、(II-B035) N-(2-第三丁基-5-甲基苯甲基)-N-環丙基-3-(二氟甲基)-5-氟-1-甲基-1H-吡唑-4-羧醯胺 (N-(2-tert-butyl-5-methylbenzyl)-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H­pyrazole-4-carboxamide)、(II-B036) N-(2-第三丁基苯甲基)-N-環丙基-3-(二氟甲基)-5-氟-1-甲基-1H-吡唑-4-羧醯胺 (N-(2-tert-butylbenzyl)-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide)、(II-B037) N-(5-氯-2-乙基苯甲基)-N-環丙基-3-(二氟甲基)-5-氟-1-甲基-1H-吡唑-4-羧醯胺 (N-(5-chloro-2-ethylbenzyl)-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide)、(II-B038) N-(5-氯-2-異丙基苯甲基)-N-環丙基-3-(二氟甲基)-5-氟-1-甲基-1H-吡唑-4-羧醯胺 (N-(5-chloro-2-isopropylbenzyl)-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide)(異氟丙啶,isoflucpyram)、(II-B039) N-[(1R,4S)-9-(二氯亞甲基)-1,2,3,4-四氫-1,4-甲撐基萘-5-基]-3-(二氟甲基)-1-甲基-1H-吡唑-4-羧醯胺 (N-[(1R,4S)-9-(dichloromethylene)-1,2,3,4-tetrahydro-1,4-methanonaphthalen-5-yl]-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide)、(II-B040) N-[(1S,4R)-9-(二氯亞甲基)-1,2,3,4-四氫-1,4-甲撐基萘-5-基]-3-(二氟甲基)-1-甲基-1H-吡唑-4-羧醯胺 (N-[(1S,4R)-9-(dichloromethylene)-1,2,3,4-tetrahydro-1,4-methanonaphthalen-5-yl]-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide)、(II-B041) N-[1-(2,4-二氯苯基)-1-甲氧基丙-2-基]-3-(二氟甲基)-1-甲基-1H-吡唑-4-羧醯胺 (N-[1-(2,4-dichlorophenyl)-l-methoxypropan-2-yl]-3-(difluoromethyl)-1-methyl­1H-pyrazole-4-carboxamide)、(II-B042) N-[2-氯-6-(三氟甲基)苯甲基]-N-環丙基-3-(二氟甲基)-5-氟-1-甲基-1H-吡唑-4-羧醯胺 (N-[2-chloro-6-(trifluoromethyl)benzyl]-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide)、(II-B043) N-[3-氯-2-氟-6-(三氟甲基)苯甲基]-N-環丙基-3-(二氟甲基)-5-氟-1-甲基-1H-吡唑-4-羧醯胺 (N-[3-chloro-2-fluoro-6-(trifluoromethyl)benzyl]-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4- carboxamide)、(II-B044) N-[5-氯 -2-(三氟甲基)苯甲基]-N-環丙基-3-(二氟甲基)-5-氟-1-甲基-1H-吡唑-4-羧醯胺 (N-[5-chloro-2-(trifluoromethyl)benzyl]-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide)、(II-B045) N-環丙基-3-(二氟甲基)-5-氟-1-甲基-N-[5-甲基-2-(三氟甲基)苯甲基]-1H-吡唑-4-羧醯胺 (N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-N-[5-methyl-2-(trifluoromethyl)benzyl]-1H-pyrazole-4-carboxamide)、(II-B046) N-環丙基-3-(二氟甲基)-5-氟-N-(2-氟-6-異丙基苯甲基)-1-甲基-1H-吡唑-4-羧醯胺 (N-cyclopropyl-3-(difluoromethyl)-5-fluoro-N-(2-fluoro-6-isopropylbenzyl)-1-methyl-1H-pyrazole-4-carboxamide)、(II-B047) N-環丙基-3-(二氟甲基)-5-氟-N-(2-異丙基-5-甲基苯甲基)-1-甲基-1H-吡唑-4-羧醯胺 (N-cyclopropyl-3-(difluoromethyl)-5-fluoro-N-(2-isopropyl-5-methylbenzyl)-1-methyl-1H­pyrazole-4-carboxamide)、(II-B048) N-環丙基-3-(二氟甲基)-5-氟-N-(2-異丙基苯甲基)-1-甲基-1H-吡唑-4-甲硫醯胺 (N-cyclopropyl-3-(difluoromethyl)-5-fluoro-N-(2-isopropylbenzyl)-1-methyl-1H-pyrazole-4-carbothioamide)、(II-B049) N-環丙基-3-(二氟甲基)-5-氟-N-(2-異丙基苯甲基)-1-甲基-1H-吡唑-4-羧醯胺 (N-cyclopropyl-3-(difluoromethyl)-5-fluoro-N-(2-isopropylbenzyl)-1-methyl-1H-pyrazole-4-carboxamide)、(II-B050) N-環丙基-3-(二氟甲基)-5-氟-N-(5-氟-2-異丙基苯甲基)-1-甲基-1H-吡唑-4-羧醯胺 (N-cyclopropyl-3-(difluoromethyl)-5-fluoro-N-(5-fluoro-2-isopropylbenzyl)-1-methyl-1H-pyrazole-4-carboxamide)、(II-B051) )N-環丙基-3-(二氟甲基)-N-(2-乙基-4,5-二甲基苯甲基)-5-氟-1-甲基-1H-吡唑-4-羧醯胺 (N-cyclopropyl-3-(difluoromethyl)-N-(2-ethyl-4,5-dimethylbenzyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide)、(II-B052) N-環丙基-3-(二氟甲基)-N-(2-乙基-5-氟苯甲基)-5-氟-1-甲基-1H-吡唑-4-羧醯胺 (N-cyclopropyl-3-(difluoromethyl)-N-(2-ethyl-5-fluorobenzyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide)、(II-B053) N-環丙基-3-(二氟甲基)-N-(2-乙基-5-甲基苯甲基)-5-氟-1-甲基-1H-吡唑-4-羧醯胺 (N-cyclopropyl-3-(difluoromethyl)-N-(2-ethyl-5-methylbenzyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide)、(II-B054) N-環丙基-N-(2-環丙基-5-氟苯甲基)-3-(二氟甲基)-5-氟-1-甲基-1H-吡唑-4-羧醯胺 (N-cyclopropyl-N-(2-cyclopropyl-5-fluorobenzyl)-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide)、(II-B055) N-環丙基-N-(2-環丙基-5-甲基苯甲基)-3-(二氟甲基)-5-氟-1-甲基-1H-吡唑-4-羧醯胺 (N-cyclopropyl-N-(2-cyclopropyl-5-methylbenzyl)-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide)、(II-B056) N-環丙基-N-(2-環丙基苯甲基)-3-(二氟甲基)-5-氟-1-甲基-1H-吡唑-4-羧醯胺 (N-cyclopropyl-N-(2-cyclopropylbenzyl)-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide)、(II-B057) 2-(二氟甲基)-N-(1,1-二甲基-3-丙基-2,3-二氫-1H-茚-4-基)煙鹼醯胺 (2-(difluoromethyl)-N-(l,1-dimethyl-3-propyl-2,3-dihydro-1H-inden-4-yl)nicotinamide)、(II-B058) 吡唑甲醯胺類殺菌劑 (pyrapropoyne)、(II-B059) 因吡氟沙 (inpyrfluxam)、(II-B060) 滅普寧 (mepronil)、(II-B061) 異氟丙啶 (isoflucypram)、(II-B062) 嘉保信 (oxycarboxin)、(II-B063) α-(甲氧基亞胺基)-N-甲基-2-[[[1-[3-(三氟甲基)苯基]乙氧基]亞胺基]甲基]苯乙醯胺 (α-(methoxyimino)-N-methyl-2-[[[1-[3-(trifluoromethyl)phenyl]ethoxy]imino]methyl]benzeneacetamide)、(II-B064) 二氟林 (diflumetorim)、(II-B065) 賽氟滅 (thifluzamide)、(II-B066) 甲呋醯胺 (fenfuram)、(II-B067) 麥鏽靈 (benodanil); (II-C) 呼吸鏈複合物 III (complex III)的抑制劑:(II-C001) 辛唑嘧菌胺 (ametoctradin)、(II-C002) 安美速 (amisulbrom)、(II-C003) 亞托敏 (azoxystrobin)、(II-C004) 甲香菌酯 (coumethoxystrobin)、(II-C005) 丁香菌酯 (coumoxystrobin)、(II-C006) 賽發滅 (cyazofamid)、(II-C007) 醚菌胺 (dimoxystrobin)、(II-C008) 烯肟菌酯 (enoxastrobin)、(II-C009) 凡殺同 (famoxadone)、(II-C010) 芬滅酮 (fenamidone)、(II-C011) 吩嘧菌酯 (flufenoxystrobin)、(II-C012) 氟嘧菌酯 (fluoxastrobin)、(II-C013) 克收欣 (kresoxim-methyl)、(II-C014) 氧菌胺 (metominostrobin)、(II-C015) 肟醚菌胺 (orysastrobin)、(II-C016) 啶氧菌酯 (picoxystrobin)、(II-C017) 唑菌胺酯 (pyraclostrobin)、(II-C018) 唑胺菌酯 (pyrametostrobin)、(II-C019) 唑菌酯 (pyraoxystrobin)、(II-C020) 三氟敏 (trifloxystrobin)、(II-C021) (2E)-2-{2-[({[(1E)-1-(3-{[(E)-1-氟-2-苯基乙烯基]氧}苯基)亞乙基]胺基}氧)甲基]苯基}-2-(甲氧基亞胺基)-N-甲基乙醯胺 ((2E)-2-{2-[({[(1E)-1-(3-{[(E)-1-fluoro-2-phenylvinyl]oxy}phenyl)ethylidene]amino}oxy)methyl]phenyl}-2-(methoxyimino)-N-methylacetamide)、(II-C022) (2E,3Z)-5-{[1-(4-氯苯基)-1H-吡唑-3-基]氧}-2-(甲氧基亞胺基)-N,3-二甲基戊-3-烯醯胺 ((2E,3Z)-5-{[1-(4-chlorophenyl)-1H-pyrazol-3-yl]oxy}-2-(methoxyimino)-N,3-dimethylpent-3- enamide)、(II-C023) (2R)-2-{2-[(2,5-二甲基苯氧基)甲基]苯基}-2-甲氧基-N-甲基乙醯胺 ((2R)-2-{2-[(2,5-dimethylphenoxy)methyl]phenyl}-2-methoxy-N- methylacetamide)、(II-C024) (2S)-2-{2-[(2,5-二甲基苯氧基)甲基]苯基}-2-甲氧基-N-甲基乙醯胺 ((2S)-2-{2-[(2,5-dimethylphenoxy)methyl]phenyl}-2-methoxy-N- methylacetamide)、(II-C025) (3S,6S,7R,8R)-8-苄基-3-[({3-[(異丁醯氧基)甲氧基]-4-甲氧基吡啶-2-基}羰基)胺基]-6-甲基-4,9-二氧代-1,5-二氧代-7-基-2-甲基丙酸酯) ((3S,6S,7R,8R)-8-benzyl-3-[({3-[(isobutyryloxy)methoxy]-4-methoxypyridin-2-yl}carbonyl)amino]-6-methyl-4,9-dioxo-1,5-dioxonan-7-yl-2-methylpropanoate)(芬吡沙密,Fenpicoxamid)、(II-C026) 2-{2-[(2,5-二甲基苯氧基)甲基]苯基}-2-甲氧基-N-甲基乙醯胺 (2-{2-[(2,5-dimethylphenoxy)methyl]phenyl}-2-methoxy-N- methylacetamide)(滿得賓,Mandestrobin)、(II-C027) N-(3-乙基-3,5,5-三甲基環己基)-3-甲醯胺基-2-羥基苯醯胺 (N-(3-ethyl-3,5,5-trimethylcyclohexyl)-3-formamido-2-hydroxybenzamide)、(II-C028) (2E,3Z)-5-{[1-(4-氯-2-氟苯基)-1H-吡唑-3-基]氧基}-2-(甲氧基亞胺基)-N,3-二甲基戊-3-烯醯胺 ((2E,3Z)-5-{[1-(4-chloro-2-fluorophenyl)-1H-pyrazol-3-yl]oxy}-2-(methoxyimino)-N,3-dimethylpent-3-enamide)、(II-C029) 甲基{5-[3-(2,4-二甲基苯基)-1H-吡唑-1-基]-2-甲基芐基}胺基甲酸酯 (methyl {5-[3-(2,4-dimethylphenyl)-1H-pyrazol-1-yl]-2-methylbenzyl}carbamate)、(II-C030) 1-(2-{[1-(4-氯苯基)吡唑-3-基]氧基甲基}-3-甲基苯基)-1,4-二氫-4-甲基-5H-四唑-5-酮 (1-(2-{[1-(4-chlorophenyl)pyrazol-3-yl]oxymethyl}-3-methylphenyl)-1,4-dihydro-4-methyl-5H-tetrazol-5-one)(甲基四吡咯,Metyltetraprole)、(II-C031) 氟吡沙胺 (florylpicoxamid)、(II-C032) 吡苯卡 (pyribencarb)、(II-C033) α-(甲氧基亞胺基)-N-甲基-2-[[[1-[3-(三氟甲基)苯基]乙氧基]亞胺基]甲基]苯乙醯胺 (α-(methoxyimino)-N-methyl-2-[[[1-[3-(trifluoromethyl)phenyl]ethoxy]imino]methyl]benzeneacetamide)、(II-C034) metarylpicoxamid; (II-D) 有絲分裂和細胞分裂的抑制劑:(II-D001) 貝芬替 (carbendazim)、(II-D002) 乙黴威 (diethofencarb)、(II-D003) 噻唑菌胺 (ethaboxam)、(II-D004) 氟比來 (fluopicolide)、(II-D005) 賓克隆 (pencycuron)、(II-D006) 腐絕 (thiabendazole)、(II-D007) 甲基硫菌靈 (thiophanate-methyl)、(II-D008) 座賽胺 (zoxamide)、(II-D009) 3-氯-4-(2,6-二氟苯基)-6-甲基-5-苯基噠嗪 (3-chloro-4-(2,6-difluorophenyl)-6-methyl-5- phenylpyridazine)、(II-D010) 3-氯-5-(4-氯苯基)-4-(2,6-二氟苯基)-6-甲基噠嗪 (3-chloro-5-(4-chlorophenyl)-4-(2,6-difluorophenyl)-6-methylpylidazine)、(II-D011) 3-氯-5-(6-氯吡啶-3-基)-6-甲基-4-(2,4,6-三氟苯基)噠嗪 (3-chloro-5-(6-chloropyridin-3-yl)-6-methyl-4-(2,4,6-trifluorophenyl)pyridazine)、(II-D012) 4-(2-溴-4-氟苯基)-N-(2,6-二氟苯基)-1,3-二甲基-1H-吡唑-5-胺 (4-(2-bromo-4-fluorophenyl)-N-(2,6-difluorophenyl)-l,3-dimethyl-1H-pyrazol-5-amine)、(II-D013) 4-(2-溴-4-氟苯基)-N-(2-溴-6-氟苯基)-1,3-二甲基-1H-吡唑-5-胺 (4-(2-bromo-4-fluorophenyl)-N-(2-bromo-6-fluorophenyl)-l,3-dimethyl-1H-pyrazol-5-amine)、(II-D014) 4-(2-溴-4-氟苯基)-N-(2-溴苯基)-1,3-二甲基-1H-吡唑-5-胺 (4-(2-bromo-4-fluorophenyl)-N-(2-bromophenyl)-1,3-dimethyl-1H-pyrazol-5-amine)、(II-D015) 4-(2-溴-4-氟苯基)-N-(2-氯-6-氟苯基)-1,3-二甲基-1H-吡唑-5-胺 (4-(2-bromo-4-fluorophenyl)-N-(2-chloro-6-fluorophenyl)-l,3-dimethyl-1H-pyrazol-5-amine)、(II-D016) 4-(2-溴-4-氟苯基)-N-(2-氯苯基)-1,3-二甲基-1H-吡唑-5-胺 (4-(2-bromo-4-fluorophenyl)-N-(2-chlorophenyl)-l,3-dimethyl-1H-pyrazol-5-amine)、(II-D017) 4-(2-溴-4-氟苯基)-N-(2-氟苯基)-1,3-二甲基-1H-吡唑-5-胺 (4-(2-bromo-4-fluorophenyl)-N-(2-fluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine)、(II-D018) 4-(2-氯-4-氟苯基)-N-(2,6-二氟苯基))-1,3-二甲基-1H-吡唑-5-胺 (4-(2-chloro-4-fluorophenyl)-N-(2,6-difluorophenyl)-l,3-dimethyl-1H-pyrazol-5-amine)、(II-D019) 4-(2-氯-4-氟苯基)-N-(2-氯-6-氟苯基)-1,3-二甲基-1H-吡唑-5-胺 (4-(2-chloro-4-fluorophenyl)-N-(2-chloro-6-fluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine)、(II-D020) 4-(2-氯-4-氟苯基)-N-(2-氯苯基)-1,3-二甲基-1H-吡唑-5-胺 (4-(2-chloro-4-fluorophenyl)-N-(2-chlorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine)、(II-D021) 4-(2-氯-4-氟苯基)-N-(2-氟苯基)-1,3-二甲基-1H-吡唑-5-胺 (4-(2-chloro-4-fluorophenyl)-N-(2-fluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine)、(II-D022) 4-(4-氯苯基)-5-(2,6-二氟苯基)-3,6-二甲基噠嗪 (4-(4-chlorophenyl)-5-(2,6-difluorophenyl)-3,6-dimethylpyridazine)、(II-D023) N-(2-溴-6-氟苯基)-4-(2-氯-4-氟苯基)-l,3-二甲基-1H-吡唑-5-胺 (N-(2-bromo-6-fluorophenyl)-4-(2-chloro-4-fluorophenyl)-l,3-dimethyl-1H-pyrazol-5-amine)、(II-D024) N-(2-溴苯基)-4-(2-氯-4-氟苯基)-1,3-二甲基-1H-吡唑-5-胺 (N-(2-bromophenyl)-4-(2-chloro-4-fluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine)、(II-D025) N-(4-氯-2,6-二氟苯基)-4-(2-氯-4-氟苯基)-1,3-二甲基-1H-吡唑-5-胺 (N-(4-chloro-2,6-difluorophenyl)-4-(2-chloro-4-fluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine)、(II-D026) 免賴得 (benomyl); (II-E) 可具有多位點作用的化合物:(II-E001) 波爾多液 (bordeaux mixture)、(II-E002) 四氯丹 (captafol)、(II-E003) 蓋普丹 (captan)、(II-E004) 四氯異苯腈 (chlorothalonil)、(II-E005) 氫氧化銅、(II-E006) 環烷酸銅 (copper naphthenate)、(II-E007) 氧化銅、(II-E008) 氧氯化銅 (copper oxychloride)、(II-E009) 硫酸銅 (copper sulfate)、(II-E010) 腈硫醌 (dithianon)、(II-E011) 多果定 (dodine)、(II-E012) 福爾培 (folpet)、(II-E013) 鋅錳乃浦 (mancozeb)、(II-E014) 代森猛 (maneb)、(II-E015) 免得爛 (metiram)、(II-E016) 免得爛鋅 (metiram zinc)、(II-E017) 喹啉銅 (oxine-copper)、(II-E018) 甲基鋅乃浦 (propineb)、(II-E019) 硫和硫製備物,例如多硫化鈣 (sulfur and sulfur preparations including calcium polysulfide)、(II-E020) 福美雙 (thiram)、(II-E021) 代森鋅 (zineb)、(II-E022) 福美鋅 (ziram)、(II-E023) 6-乙基-5,7-二氧-6,7-二氫-吡咯並[3’,4’:5,6][1,4]二硫並[2,3-c][1,2]噻唑-3-腈 (6-ethyl-5,7-dioxo-6,7-dihydro-5H­pynolo[3’,4’:5,6][1,4]dithiino[2,3-c] [1,2]thiazole-3-carbonitrile、(II-E024) 富爾邦 (ferbam)、(II-E025) 益發靈 (dichlofluanid)、(II-E026) 甲基益發靈 (tolylfluanid)、(II-E027) 雙胍鹽 (guazatine)、(II-E028) 克熱淨 (iminoctadine)、(II-E029) 敵菌靈 (anilazine)、(II-E030) 滅蟎猛 (quinomethionate); (II-F) 可誘發宿主防禦之化合物:(II-F001) 阿拉酸式苯-S-甲基 (acibenzolar-S-methyl)、(II-F002) 亞汰尼 (isotianil)、(II-F003) 撲殺熱 (probenazole)、(II-F004) 噻醯菌胺 (tiadinil); (II-G) 胺基酸及/或蛋白質生物合成之抑制劑:(II-G001) 賽普洛 (cyprodinil)、(II-G002) 嘉賜黴素 (kasugamycin)、(II-G003) 嘉賜黴素鹽酸鹽水合物 (kasugamycin hydrochloride hydrate)、(II-G004) 土黴素 (oxytetracycline)、(II-G005) 派美尼 (pyrimethanil)、(II-G006) 3-(5-氟-3,3,4,4-四甲基-3,4-二氫異喹啉-1-基)喹啉 (3-(5-fluoro-3,3,4,4-tetramethyl-3,4-dihydroisoquinolin-1-yl)quinoline)、(II-G007) 麥穗寧 (fuberidazole)、(II-G008) 硫菌靈 (thiophanate)、(II-G009) 滅瘟素-S (blasticidin-S)、(II-G010) 鏈黴素 (streptomycin)、(II-G011) 滅派林 (mepanipyrim); (II-H) 三磷酸腺苷 (adenosine triphosphate: ATP)產生之抑制劑:(II-H001) 矽噻菌胺 (silthiofam)、(II-H002) 三苯基乙酸錫 (fentin acetate)、(II-H003) 三苯錫氯 (fentin chloride)、(II-H004) 毒菌錫 (fentin hydroxide); (II-I) 細胞壁合成之抑制劑:(II-I001) 苯噻菌胺 (benthiavalicarb)、(II-I002) 達滅芬 (dimethomorph)、(II-I003) 氟嗎啉 (flumorph)、(II-I004) 丙森鋅 (iprovalicarb)、(II-I005) 曼普胺 (mandipropamid)、(II-I006) 丁吡嗎啉 (pyrimorph)、(II-I007) 纈菌胺 (valifenalate)、(II-I008) (2E)-3-(4-叔丁基苯基)-3-(2-氯吡啶-4-基)-1-(嗎啉-4-基)丙-2-烯-1-酮 ((2E)-3-(4-tert-butylphenyl)-3-(2-chloropyridin-4-yl)-l-(morpholin-4-yl)prop-2-en-1-one)、(II-I009) (2Z)-3-(4-叔丁基苯基)-3-(2-氯吡啶-4-基)-1-(嗎啉-4-基)丙-2-烯-1-酮 ((2Z)-3-(4-tert-butylphenyl)-3-(2-chloropyridin-4-yl)-1-(morpholin-4-yl)prop-2-en-1-one)、(II-I010) 苯噻菌胺-異丙基 (benthiavalicarb-isopropyl)、(II-I011) 保粒黴素 (polyoxins)、(II-I012) N-[2-[4-[[3-(4-氯苯基)-2-丙炔-1-基]氧基]-3-(N-[2-[4-[[3-(4-chlorophenyl)-2-propyn-1-yl]oxy]-3-)、(II-I013) 甲氧基苯基]乙基]-3-甲基-2-[(甲基磺醯基)-胺基]丁醯胺 (methoxyphenyl]ethyl]-3-methyl-2-[(methylsulfonyl)-amino]butanamide)、(II-I014) N-[2-[4-[[3-(4-氯苯基)-2-丙炔-1-基]氧基]-3-甲氧基苯基]-乙基]-3-甲基-2-[(乙基磺醯基)胺基]丁醯胺 (N-[2-[4-[[3-(4-chlorophenyl)-2-propyn-1-yl]oxy]-3-methoxyphenyl]-ethyl]-3-methyl-2-[(ethylsulfonyl)amino]butanamide); (II-J) 脂質和膜合成之抑制劑:(II-J001) 普拔克 (propamocarb)、(II-J002) 普拔克鹽酸鹽 (propamocarb hydrochloride)、(II-J003) 脫克松 (tolclofos-methyl)、(II-J004) 雙硫磷 (difenphos)、(II- J005) 愛得寶 (iodocarb)、(II-J006) 硫菌威 (prothiocarb)、(II-J007) 護粒松 (edifenphos)、(II-J008) 丙基喜樂松 (iprobenfos)、(II-J009) 白粉松 (pyrazophos)、(II-J010) 亞賜圃 (isoprothiolane)、(II-J011) 依得利 (etridiazole)、(II-J012) 聯苯 (biphenyl)、(II-J013) 地茂丹 (chloroneb)、(II-J014) 大克爛 (dicloran)、(II-J015) 喹啉 (quintozene)、(II-J016) 四氯硝基苯 (tecnazene); (II-K) 黑色素生物合成抑制劑:(II-K001) 三環唑 (tricyclazole)、(II-K002) 2,2,2-三氟乙基{3-甲基-1-[(4-甲基苯甲醯基)胺基]丁烷-2-基}胺基甲酸酯 (2,2,2-trifluoroethyl {3-methyl-1-[(4-methylbenzoyl)amino]butan-2-yl}carbamate)、(II-K003) 加普胺 (carpropamid)、(II-K004) 雙氯氰菊酯 (diclocymet)、(II-K005) 芬諾尼 (fenoxanil)、(II-K006) 熱必斯 (fthalide)、(II-K007) 百快隆 (pyroquilon); (II-L) 核酸合成抑制劑:(II-L001) 本達樂 (benalaxyl)、(II-L002) 右本達樂 (benalaxyl-M (kiralaxyl))、(II-L003) 滅達樂 (metalaxyl)、(II-L004) 右滅達樂 (metalaxyl-M)(甲芬沙姆,mefenoxam)、(II-L005) 依瑞莫 (ethirimol)、(II-L006) 呋霜靈 (furalaxyl)、(II-L007) 呋醯胺 (ofurace)、(II-L008) 歐索林酸 (oxolinic acid)、(II-L009) 殺紋寧 (hymexazole)、(II-L010) 辛噻酮 (octhilinone)、(II-L011) 布瑞莫 (bupirimate)、(II-L012) 二甲嘧酚 (dimethirimol); (II-M) 訊息傳遞之抑制劑:(II-M001) 護汰寧 (fludioxonil)、(II-M002) 依普同 (iprodione)、(II-M003) 撲滅寧 (procymidone)、(II-M004) 普快淨 (proquinazid)、(II-M005) 快諾芬 (quinoxyfen)、(II-M006) 免克寧(vinclozolin)、(II-M007) 克氯得 (chlozolinate)、(II-M008) 拌種咯 (fenpiclonil)、(II-M009) 普快淨 (proquinazid)、(II-M010) 2-丁氧基-6-碘-3-丙基-4H-1-苯並吡喃-4-酮 (2-butoxy-6-iodo-3-propyl-4H-1-benzopyran-one); (II-N) 可作為去偶合劑之化合物:(II-N001) 扶吉胺 (fluazinam)、(II-N002) 甲基敵蟎普 (meptyldinocap)、(II-N003) 百蟎克 (binapacryl)、(II-N004) 敵蟎普 (dinocap); (II-O) 其他殺真菌劑:(II-O001) 離層酸 (abscisic acid)、(II-O002) 本噻唑 (benthiazole)、(II-O003) 貝梭沙今 (bethoxazin)、(II-O004) 卡普黴素 (capsimycin)、(II-O005) 卡吩 (carvone)、(II-O006) 蟎離丹 (chinomethionat)、(II-O007) 庫發尼 (cufraneb)、(II-O008) 賽芬胺 (cyflufenamid)、(II-O009) 克絕 (cymoxanil)、(II-O010) 環丙磺草胺 (cyprosulfamide)、(II-O011) 噻菌淨 (flutianil)、(II-O012) 福賽得鋁 (fosetyl­aluminium)、(II-O013) 福賽得鈣 (fosetyl-calcium)、(II-O014) 福賽得鈉 (fosetyl-sodium)、(II-O015) 異硫氰酸甲酯 (methyl isothiocyanate)、(II-O016) 滅芬農 (metrafenone)、(II-O017) 米德黴 (mildiomycin)、(II-O018) 納坦黴素 (natamycin)、(II-O019) 二甲基二硫代胺甲酸鎳 (nickel dimethyldithiocarbamate)、(II-O020) 硝基太-異丙基 (nitrothal-isopropyl)、(II-O021) 歐賽保 (oxamocarb)、(II-O022) 氧硫普靈 (oxathiapiprolin)、(II-O023) 歐芬汀 (oxyfenthiin)、(II-O024) 五氯酚及其鹽類 (pentachlorophenol and salts)、(II-O025) 膦酸及其鹽類 (phosphorous acid and its salts)、(II-O026) 霜黴威乙膦酸鹽 (propamocarb-fosetylate)、(II-O027) 必伏農 (pyriofenone)(克吩農,chlazafenone)、(II-O028) 特伏克 (tebufloquin)、(II-O029) 特伏爛 (tecloftalam)、(II-O030) 特利吩 (tolnifanide)、(I-O031) 1-(4-{4-[(5R)-5-(2,6-二氟苯基)-4,5-二氫-1,2-唑-3-基]-1,3-噻唑-2-基}哌啶-1-基)-2-[5-甲基-3-(三氟甲基)-1H-吡唑-1-基]乙酮 (1-(4-{4-[(5R)-5-(2,6-difluorophenyl)-4,5-dihydro-1,2-oxazol-3-yl]-1,3-thiazol-2-yl}piperidin-1-yl)-2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]ethanone)、(II-O032) 1-(4-{4-[(5S)-5-(2,6-二氟苯基)-4,5-二氫-1,2-唑-3-基]-1,3-噻唑-2-基}哌啶-1-基)-2-[5-甲基-3-(三氟甲基)-1H-吡唑-1-基]乙酮 (1-(4-{4-[(5S)-5-(2,6-difluorophenyl)-4,5-dihydro-1,2-oxazol-3-yl]-l,3-thiazol-2-yl}piperidin-1-yl)-2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]ethanone)、(II-O033) 2-(6-苯甲基吡啶-2-基)喹唑啉 (2-(6-benzylpyridin-2-yl)quinazoline)、(II-O034) 2,6-二甲基-1H,5H-[1,4]二硫雜環己烯並[2,3-c:5,6-c’]二吡咯-1,3,5,7(2H,6H)-四酮 (2,6-dimethyl-1H,5H-[1,4]dithiino[2,3-c:5,6-c’]dipyrrole-1,3,5,7(2H,6H)-tetrone)、(II-O035) 2-[3,5-雙(二氟甲基)-1H-吡唑-1-基]-1-[4-(4-{5-[2-(丙-2-炔-1-基氧)苯基]-4,5-二氫-1,2-唑-3-基}-1,3-噻唑-2-基)哌啶-1-基]乙酮 (2-[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]-1-[4-(4-{5-[2-(prop-2-yn-1-yloxy)phenyl]-4,5-dihydro-l,2-oxazol-3-yl}-l,3-thiazol-2-yl)piperidin-1-yl]ethanone)、(II-O036) 2-[3,5-雙(二氟甲基)-1H-吡唑-1-基]-1-[4-(4-{5-[2-氯-6-(丙-2-炔-1-基氧)苯基]-4,5-二氫-1,2-唑-3-基}-1,3-噻唑-2-基)哌啶-1-基]乙酮 (2-[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]-1-[4-(4-{5-[2-chloro-6-(prop-2-yn-1-yloxy)phenyl]-4,5-dihydro-1,2-oxazol-3-yl}-1,3-thiazol-2-yl)piperidin-1-yl]ethanone)、(II-O037) 2-[3,5-雙(二氟甲基)-1H-吡唑-1-基]-1-[4-(4-{5-[2-氟-6-(丙-2-炔-1-基氧)苯基]-4,5-二氫-1,2-唑-3-基}-1,3-噻唑-2-基)哌啶-1-基]乙酮 (2-[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]-1-[4-(4-{5-[2-fluoro-6-(prop-2-yn-1-yloxy)phenyl]-4,5-dihydro-l,2-oxazol-3-yl}-l,3-thiazol-2- yl)piperidin-1-yl]ethanone)、(II-O038) 2-[6-(3-氟-4-甲氧基苯基)-5-甲基吡啶-2-基]喹唑啉 (2-[6-(3-fluoro-4-methoxyphenyl)-5-methylpyridin-2-yl]quinazoline)、(II-O039) 2-{(5R)-3-[2-(1-{[3,5-雙(二氟甲基)-1H-吡唑-1-基]乙醯基}哌啶-4-基)-1,3-噻唑-4-基]-4,5-二氫-1,2-唑-5-基}-3-氯苯基甲磺酸酯 (2-{(5R)-3-[2-(1-{[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1,3-thiazol-4-yl]-4,5-dihydro-l,2-oxazol-5-yl}-3-chlorophenyl methanesulfonate)、(II-O040) 2-{(5S)-3-[2-(1-{[3,5-雙(二氟甲基)-1H-吡唑-1-基]乙醯基}哌啶-4-基)-1,3-噻唑-4-基]-4,5-二氫-1,2-唑-5-基}-3-氯苯基甲磺酸酯 (2-{(5S)-3-[2-(1-{[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1,3-thiazol-4-yl]-4,5-dihydro-1,2-oxazol-5-yl}-3-chlorophenyl methanesulfonate)、(II-O041) 2-{2-[(7,8-二氟-2-甲基喹啉-3-基)氧]-6-氟苯基}丙-2-醇 (2-{2-[(7,8-difluoro-2-methylquinolin-3-yl)oxy]-6-fluorophenyl}propan-2-ol)、(II-O042) 2-{2-氟-6-[(8-氟-2-甲基喹啉-3-基)氧]苯基}丙-2-醇 (2-{2-fluoro-6-[(8-fluoro-2-methylquinolin-3-yl)oxy]phenyl}propan-2-ol)、(II-O043) 2-{3-[2-(1-{[3,5-雙(二氟甲基)-1H-吡唑-1-基]乙醯基}哌啶-4-基)-1,3-噻唑-4-基]-4,5-二氫-1,2-唑-5-基}-3-氯苯基甲磺酸酯 (2-{3-[2-(1-{[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1,3-thiazol-4-yl]-4,5-dihydro-1,2-oxazol-5-yl}-3-chlorophenyl methanesulfonate)(氟醚菌醯胺,fluoxapiprolin)、(II-O044) 2-{3-[2-(1-{[3,5-雙(二氟甲基)-1H-吡唑-1-基]乙醯基}哌啶-4-基)-1,3-噻唑-4-基]-4,5-二氫-1,2-唑-5-基}苯基甲磺酸酯 (2-{3-[2-(1-{[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1,3-thiazol-4-yl]-4,5-dihydro-1,2-oxazol-5-yl}phenyl methanesulfonate)、(II-O045) 2-苯基酚及其鹽類 (2-phenylphenol and salts)、(II-O046) 3-(4,4,5-三氟-3,3-二甲基-3,4-二氫異喹啉-1-基)喹啉 (3-(4,4,5-trifluoro-3,3-dimethyl-3,4-dihydroisoquinolin-1-yl)quinoline)、(II-O047) 3-(4,4-二氟-3,3-二甲基-3,4-二氫異喹啉-1-基)喹啉 (3-(4,4-difluoro-3,3-dimethyl-3,4-dihydroisoquinolin-1-yl)quinoline)(喹富美林,Quinofumelin)、(II-O048) 4-胺基-5-氟嘧啶-2-醇(互變異構形:4-胺基-5-氟嘧啶-2(1H)-酮)(4-amino-5-fluoropyrimidin-2-ol (tautomeric form: 4-amino-5- fluoropyrimidin-2(1H)-one))、(II-O049) 4-側氧基-4-[(2-苯基乙基)胺基]丁酸 (4-oxo-4-[(2-phenylethyl)amino]butanoic acid)、(II-O050) 5-胺基-1,3,4-噻二唑-2-硫醇 (5-amino-1,3,4-thiadiazole-2-thiol)、(II-O051) 5-氯-N’’-苯基-N’-(丙-2-炔-1-基)噻吩-2-磺醯基醯肼 (5-chloro-N’-phenyl-N’-(prop-2-yn-1-yl)thiophene-2-sulfonohydrazide)、(II-O052) 5-氟-2-[(4-氟苯甲基)氧]嘧啶-4-胺 (5-fluoro-2-[(4-fluorobenzyl)oxy]pyrimidin-4-amine)、(II-O053) 5-氟-2-[(4-甲基苯甲基)氧]嘧啶-4-胺 (5-fluoro-2-[(4-methylbenzyl)oxy]pyrimidin-4-amine)、(II-O054) 9-氟-2,2-二甲基-5-(喹啉-3-基)-2,3-二氫-1,4-並苯並氮平 (9-fluoro-2,2-dimethyl-5-(quinolin-3-yl)-2,3-dihydro-1,4-benzoxazepine)、(II-O055) {6-[({[(Z)-(1-甲基-1H-四唑-5-基)(苯基)亞甲基]胺基}氧)甲基]吡啶-2-基}胺甲酸丁-3-炔-1-基酯 (but-3-yn-1-yl{6-[({[(Z)-(l-methyl-1H-tetrazol-5-yl)(phenyl)methylene]amino}oxy)methyl]pyridin-2-yl}carbamate)、(II-O056) (2Z)-3-胺基-2-腈基-3-苯基丙烯酸乙酯 (ethyl(2Z)-3-amino-2-cyano-3-phenylacrylate)、(II-O057) 吩-1-羧酸 (phenazine-1-carboxylic acid)、(II-O058) 3,4,5-三羥基苯甲酸丙酯 (propyl 3,4,5-trihydroxybenzoate)、(II-O059) 喹啉-8-醇 (quinolin-8-ol)、(II-O060) 喹啉-8-醇硫酸鹽 (2:1) (quinolin-8-ol sulfate (2:1))、(II-O061) {6-[({[(1-甲基-1H-四唑-5-基)(苯基)亞甲基]胺基}氧)甲基]吡啶-2-基}胺甲酸第三丁酯 (tert-butyl {6-[({[(1-methyl-1H-tetrazol-5-yl)(phenyl)methylene]amino}oxy)methyl]pyridin-2-yl}carbamate)、(II-O062) 5‑氟‑4‑亞胺基‑3‑甲基‑1‑[(4‑甲基苯基)磺醯基]‑3,4‑二氫嘧啶‑2(1H)‑酮 (5-fluoro-4-imino-3-methyl-1-[(4-methylphenyl)sulfonyl]-3,4-dihydropyrimidin-2(1H)-one)、(II-O063) 吡啶氯甲基 (pyridachlometyl)、(II-O064) 伊匹芬喹 (ipflufenoquin)、(II-O065) 氯胺吡啶芬 (aminopyrifen)、(II-O066) N-[[(環丙基-甲氧基)胺基][6-(二氟甲氧基)-2,3-二氟苯基]-亞甲基]苯乙醯胺 (N-[[(cyclopropyl-methoxy)amino][6-(difluoromethoxy)-2,3-difluorophenyl]-methylene]benzeneacetamide)、(II-O067) 滅速克 (methasulfocarb)、(II-O068) 代森鈉 (nabam)、(II-O069) 萬得寧 (oxine copper)、(II-O070) 滅菌磷 (ditalimfos)、(II-O071) 敵菌酮 (drazoxolon)、(II-O072) 甲苯氟磺胺 (tolyfluanide)、(II-O073) 苄氯三唑醇 (diclobutrazol)、(II-O074) 酯菌胺 (cyprofuram)、(II-O075) 磷酸及其鹽類 (phophorous acid and salts)、(II-O076) 富米綜 (ferimzone)、(II-O077) pyrrolnitrin、(II-O078) 咪唑嗪 (triazoxide)、(II-O079) 氟硫滅 (flusulfamide)、(II-O080) 達滅淨 (diclomezine)、(II-O081) 礦物油 (mineral oils)、(II-O082) 有機油 (organic oils)、(II-O083) 無機油 (inorganic oils)、(II-O084) 碳酸氫鉀 (potassium bicarbonate)、(II-O085) 甲磺酸鐵 (ferric methanearsonate)、(II-O086) 4-氟苯基-N-[1-[[[[1-(4-腈基苯基)乙基]磺醯基]甲基]丙基]胺基甲酸酯 (4-fluorophenyl-N-[1-[[[1-(4-cyanophenyl)ethyl]sulfonyl]msethyl]propyl]carbamate)、(II-O087) 5-氯-6-(2,4,6-三氟苯基)-7-(4-甲基哌啶-1-基)[1,2,4]三唑並[1,5-a]嘧啶 (5-chloro-6-(2,4,6-trifluorophenyl)-7-(4-methylpiperidin-1-yl)[1,2,4]triazolo[1,5-a]pyrimidine)、(II-O088) N-[4-[4-氯-3-(三氟甲基)苯氧基]-2,5-二甲基苯基]-N-乙基-N-甲基甲亞胺 (N-[4-[4-chloro-3-(trifluoromethyl)phenoxy]-2,5-dimethylphenyl]-N- ethyl-N-methylmethanimidamide); (II-P) HDAC抑制劑:(II-P001) N-(1-乙基環丙基)-4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯醯胺 (N-(1-ethylcyclopropyl)-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl] benzamide)、(II-P002) N-(2-異丙基環丙基)-4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯醯胺 (N-(2-isopropylcyclopropyl)-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide)、(II-P003) N-(2-甲基環丙基)-4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯醯胺 (N-(2-methylcyclopropyl)-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide)、(II-P004) N-(1-甲基環丙基)-4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯醯胺 (N-(1-methylcyclopropyl)-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide)、(II-P005) N-(2-乙基環丙基)-4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯醯胺 (N-(2-ethylcyclopropyl)-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide)、(II-P006) N-(2,4-二氟苯基)-4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯醯胺 (N-(2,4-difluorophenyl)-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide)、(II-P007) 5-(三氟甲基)-3-[4-[[3-(三氟甲基)-1,2,4-三唑-1-基]甲基]苯基]-1,2,4-噁二唑 (5-(trifluoromethyl)-3-[4-[[3-(trifluoromethyl)-1,2,4triazol-1-yl]methyl]phenyl]-1,2,4-oxadiazole)、(II-P008) 2-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]-1,2,4-三唑-3-腈 (2-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-triazole-3-carbonitrile)、(II-P009) 1-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]吡唑-4-羧酸乙酯 (ethyl 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylate)、(II-P010) N-環丙基-1-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]吡唑-4-羧醯胺 (N-cyclopropyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxamide)、(II-P011) N,N-二甲基-1-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]吡唑-4-羧醯胺 (N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxamide)、(II-P012) N-甲基-1-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]吡唑-4-羧醯胺 (N-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxamide)、(II-P013) N,N,-二甲基-H[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]-1,2,4-三唑-3-胺 (N,N,-dimethyl-H[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-triazol-3-amine)、(II-P014) 3-[4-[(5-乙基磺醯基-1,2,4-三唑-1-基)甲基]苯基]-5-(三氟甲基)-1,2,4-噁二唑 (3-[4-[(5-ethylsulfanyl-1,2,4-triazol-1-yl)methyl]phenyl]-5­(trifluoromethyl)-1,2,4-oxadiazole)、(II-P015) 3-[4-(三唑[4,5-b]吡啶-1-基甲基)苯基]-5-(三氟甲基)-1,2,4-噁二唑 (3-[4-(triazolo[4,5-b]pyridin-1-ylmethyl)phenyl]-5-(trifluoromethyl)-1,2,4-oxadiazole)、(II-P016) 3-[4-(三唑[4,5-b]吡啶-2-基甲基)苯基]-5-(三氟甲基)-1,2,4-噁二唑 (3-[4-(triazolo[4,5-b]pyridin-2-ylmethyl)phenyl]-5-(trifluoromethyl)-1,2,4-oxadiazole)、(II-P017) 3-[4-(三唑[4,5-b]吡啶-3-基甲基)苯基]-5-(三氟甲基)-1,2,4-噁二唑 (3-[4-(triazolo[4,5-b]pyridin-3-ylmethyl)phenyl]-5-(trifluoromethyl)-1,2,4-oxadiazole)、(II-P018) 甲基1-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]吡唑-4-羧酸酯 (methyl 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylate)、(II-P019) 乙基1-[[3-氟-4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]吡唑-4-羧酸乙酯 (ethyl 1-[[3-fluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylate)、(II-P020) N,N-二乙基-1-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]吡唑-4-羧醯胺 (N,N-diethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxamide)、(II-P021) N-甲氧基-N -甲基-1-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]吡唑-4-羧醯胺 (N-methoxy-N-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxamide)、(II-P022) 丙基1-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]吡唑-4-羧酸酯 (propyl 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylate)、(II-P023) N-甲氧基-1-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]吡唑-4-羧醯胺 (N-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxamide)、(II-P024) N-乙基-1-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]吡唑-4-羧醯胺 (N-ethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxamide)、(II-P025) 1-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]吡唑-4-羧醯胺 (1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxamide)、(II-P026) N-甲氧基-1-[1-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]吡唑-4-基]亞胺 (N-methoxy-1-[1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl] methyl]pyrazol-4-yl]methanimine)、(II-P027) 乙基1-[1-[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]乙基]吡唑-4-羧酸酯 (ethyl 1-[1-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]ethyl]pyrazole-4-carboxylate)、(II-P028) 1-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]吡咯烷-2-酮 (1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrrolidin-2-one)、(II-P029) 1-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]哌啶-2-酮 (1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]piperidin-2-one)、(II-P030) 4-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]嗎啉-3-酮 (4-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]morpholin-3-one)、(II-P031) 4,4-二甲基-2-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]異噁唑啉-3-酮 (4,4-dimethyl-2-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl] methyl]isoxazolidin-3-one)、(II-P032) 2-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]異噁唑啉-3-酮 (2-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl] isoxazolidin-3-one)、(II-P033) 5,5-二甲基-2-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]異噁唑啉-3-酮 (5,5-dimethyl-2-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]isoxazolidin-3-one)、(II-P034) 3,3-二甲基-1[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]哌啶-2-酮 (3,3-dimethyl-1[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]piperidin-2-one)、(II-P035) 1-[[2-氟-4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]吡咯烷-2-酮 (1-[[2-fluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrrolidin-2-one)、(II-P036) 1-[[2-氟-4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]哌啶-2-酮 (1-[[2-fluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]piperidin-2-one)、(II-P037) 2-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]噁嗪-3-酮 (2-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]oxazinan-3-one)、(II-P038) 1-[[3-氟-4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]哌啶-2-酮 (1-[[3-fluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]piperidin-2-one)、(II-P039) 3-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]唑烷-2-酮 (3-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]oxazolidin-2-one)、(II-P040) 1-甲基-3-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]咪唑啉啶-2-酮 (1-methyl-3-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]imidazolidin-2-one)、(II-P041) 1-[[3-氟-4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]-3,3-二甲基-哌啶-2-酮 (1-[[3-fluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-3,3-dimethyl-piperidin-2-one)、(II-P042) 1-[[3-氟-4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]吡咯烷-2-酮 (1-[[3-fluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrrolidin-2-one)、(II-P043) 2-[[3-氟-4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]-4,4-二甲基-異噁唑啉-3-酮 (2-[[3-fluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-4,4-dimethyl-isoxazolidin-3-one)、(II-P044) 2-[[2,3-二氟-4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]異噁唑啉-3-酮 (2-[[2,3-difluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]isoxazolidin-3-one)、(II-P045) 2-[[3-氟-4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]異噁唑啉-3-酮 (2-[[3-fluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]isoxazolidin-3-one)、(II-P046) 1-[[3-氟-4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]氮雜烷-2-酮 (1-[[3-fluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]azepan-2-one)、(II-P047) N-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]丙醯胺 (N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide)、(II-P048) 2,2-二甲基-N-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]丁基-3-炔醯胺 (2,2-dimethyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl] methyl]but-3-ynamide)、(II-P049) N-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]丁醯胺 (N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl] butanamide)、(II-P050) 3-甲基-N-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]丁醯胺 (3-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl] methyl]butanamide)、(II-P051) 2-甲基-N-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]丙基-2-烯胺 (2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]prop-2-enamide)、(II-P052) 2-甲基-N-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]丁醯胺 (2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]butanamide)、(II-P053) 2-甲氧基-N-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基] (2-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl])、(II-P054) 3,3,3-三氟-N-[[3-氟-4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]丙醯胺 (3,3,3-trifluoro-N-[[3-fluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide)、(II-P055) 3,3,3-三氟-N-[[2-氟-4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]丙醯胺 (3,3,3-trifluoro-N-[[2-fluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide)、(II-P056) N-[[2,3-二氟-4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]丁醯胺 (N-[[2,3-difluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]butanamide)、(II-P057) N-[[2,3-二氟-4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]-3,3,3-三氟-丙醯胺 (N-[[2,3-difluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-3,3,3-trifluoro-propanamide)、(II-P058) 2-(二氟甲氧基)-N-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]乙醯胺 (2-(difluoromethoxy)-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]acetamide)、(II-P059) 2-甲氧基-2-甲基-N-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]丙醯胺 (2-methoxy-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide)、(II-P060) 1-甲基-3-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]脲 (1-methyl-3-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea)、(II-P061) 1-乙基-1-甲基-3-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]脲 (1-ethyl-1-methyl-3-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea)、(II-P062) 1-乙氧基-3-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]脲 (1-ethoxy-3-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea)、(II-P063) 1-甲氧基-1-甲基-3-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基] (1-methoxy-1-methyl-3-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl])、(II-P064) 1,1-二乙基-3-[[4-[5-(三氟甲基)-1 ,2,4-噁二唑-3-基]苯基]甲基]脲 (1,1-diethyl-3-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea)、(II-P065) N-甲氧基-N-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]環丙烷羧醯胺 (N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl] methyl]cyclopropanecarboxamide)、(II-P066) N-甲氧基-N-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]戊基-4-炔醯胺 (N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pent-4-ynamide)、(II-P067) N-甲氧基-2-甲基-N-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]丙基-2-烯胺 (N-methoxy-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]prop-2-enamide)、(II-P068) N,2-二甲氧基-N-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]丙醯胺 (N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide)、(II-P069) N-環丙基-3,3,3-三氟-N-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]丙醯胺 (N-cyclopropyl-3,3,3-trifluoro-N-[[4-[5-(trifluoromethyl)-1,2,4- oxadiazol-3-yl]phenyl]methyl]propanamide)、(II-P070) 2,2-二氟-N-(2-甲氧基乙基)-N-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]環丙烷羧醯胺 (2,2-difluoro-N-(2-methoxyethyl)-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclo propanecarboxamide)、(II-P071) N-乙基-2-甲基-N-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]丙醯胺 (N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide)、(II-P072) N-[[3-氟-4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]-N-甲氧基-丙醯胺 (N-[[3-fluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-N-methoxy-propanamide)、(II-P073) 2-甲氧基-N-(2,2,2-三氟乙基)-N-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]乙醯胺 (2-methoxy-N-(2,2,2-trifluoroethyl)-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl] acetamide)、(II-P074) N-[[2,3-二氟-4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]-N-甲氧基-環丙烷羧醯胺 (N-[[2,3-difluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-N-methoxy-cyclopropane carboxamide)、(II-P075) 2-(二氟甲氧基)-N-甲基-N-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]乙醯胺 (2-(difluoromethoxy)-N-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]acetamide)、(II-P076) N-乙氧基-2-甲氧基-N-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]丙醯胺 (N-ethoxy-2-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide)、(II-P077) N-異丙基-N-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]四氫呋喃-2-羧醯胺 (N-isopropyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]tetrahydrofuran-2-carboxamide)、(II-P078) 1-甲氧基-3-甲基-1-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]脲 (1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea)、(II-P079) 3-環丙基-1-甲氧基-1-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]脲 (3-cyclopropyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea)、(II-P080) 3-乙氧基-1-甲氧基-1-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]脲 (3-ethoxy-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea)、(II-P081) 3-烯丙基-1-甲氧基-1-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]脲 (3-allyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea)、(II-P082) 1-環丙基-3-甲氧基-3-甲基-1-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]脲 (1-cyclopropyl-3-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea)、(II-P083) 3-異丙基-1-甲氧基-1-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]脲 (3-isopropyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea)、(II-P084) 1-甲氧基-3-丙基-2-炔基-1-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]脲 (1-methoxy-3-prop-2-ynyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea)、(II-P085) 1-[[3-氟-4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]-1-甲氧基-3-甲基-脲 (1-[[3-fluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1-methoxy-3-methyl-urea)、(II-P086) 3-(環丙基甲基)-1-甲基-1-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]脲 (3-(cyclopropylmethyl)-1-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea)、(II-P087) 1-乙基-3-(2,2,2-三氟乙基)-1-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3- 基]苯基]甲基]脲 (1-ethyl-3-(2,2,2-trifluoroethyl)-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea)、(II-P088) 1,3-二甲氧基-1-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]脲 (1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea)、(II-P089) 3-乙基-1-甲氧基-1-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]脲 (3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea)、(II-P090) N-甲基-4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯醯胺 (N-methyl-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide)、(II-P091) N-[(E)-甲氧基亞胺基甲基]-4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯醯胺 (N-[(E)-methoxyiminomethyl]-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide)、(II-P092) N-[(Z)-甲氧基亞胺基甲基]-4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯醯胺 (N-[(Z)-methoxyiminomethyl]-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide)、(II-P093) N-[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]環丙烷羧醯胺 (N-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]cyclopropanecarboxamide)、(II-P094) N-(2-氟苯基)-4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯醯胺 (N-(2-fluorophenyl)-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide)、(II-P095) 2,2-二氟-N-甲基-2-[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]乙醯胺 (2,2-difluoro-N-methyl-2-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]acetamide)、(II-P096) N-烯丙基-N-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]乙醯胺 (N-allyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]acetamide)、(II-P097) N-[(E)-N-甲氧基-C-甲基-亞胺亞甲基]-4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯醯胺 (N-[(E)-N-methoxy-C-methyl-carbonimidoyl]-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide)、(II-P098) N-[(Z)-N-甲氧基-C-甲基-亞胺亞甲基]-4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯醯胺 (N-[(Z)-N-methoxy-C-methyl-carbonimidoyl]-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide)、(II-P100) N-烯丙基-N-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]丙醯胺 (N-allyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide)、(II-P101) 4,4-二甲基-1-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]吡咯烷-2-酮 (4,4-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrrolidin-2-one)、(II-P102) N-甲基-4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯甲硫醯胺 (N-methyl-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzenecarbothioamide)、(II-P103) 5-甲基-1-[[4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯基]甲基]吡咯烷-2-酮 (5-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrrolidin-2-one)、(II-P104) N-甲基-4-[5-(三氟甲基)-1,2,4-噁二唑-3-基]苯甲羧醯胺 (N-methyl-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzenecarboxamide)、(II-P105) N1-甲基-N2-(4-(5-(三氟甲基)-1,2,4-噁二唑-3-基)苄基)草醯胺 (N1-methyl-N2-(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl) oxalamide); (II-Q) 可作為保護劑的化合物:(II-Q001) 1-(2,4-二氯苯基)-5-(乙氧基羰基)-5-甲基-2-吡唑啉-3-羧酸 (1-(2,4-dichlorophenyl)-5-(ethoxycarbonyl)-5-methyl-2-pyrazoline-3-carboxylic acid)、(II-Q002) 1-(2,4-二氯苯基)-5-(乙氧基羰基)-5-甲基-2-吡唑啉-3-羧酸乙酯 (ethyl 1-(2,4-dichlorophenyl)-5-(ethoxycarbonyl)-5-methyl-2-pyrazoline-3-carboxylate)(mefenpyr(-diethyl))、(II-Q003) 苯諾沙克 (benoxacor)、(II-Q004) 解毒喹 (cloquintocet-mexyl)、(II-Q005) 枯草隆 (cumyluron)、(II-Q006) 解草胺腈 (cymetrinil)、(II-Q007) 殺草隆 (daimuron)、(II-Q008) 二氯丙烯胺 (dichlormid)、(II-Q009) 大賽克農 (dicyclonon)、(II-Q010) 增效磷 (dietholate)、(II-Q011) 哌草丹 (dimepiperate)、(II-Q012) 解草唑 (fenchlorazole-ethyl)、(II-Q013) 解草啶 (fenclorim)、(II-Q014) 解草胺 (flurazole)、(II-Q015) 氟草肟 (fluxofenim)、II-Q016) 解草噁唑 (furilazole)、(II-Q017) 雙苯噁唑酸 (isoxadifen-ethyl)、(II-Q018) 唑解草酯 (mefenpyr-diethyl)、(II-Q019) 梅芬內 (mephenate)、(II-Q020) 苯草酮 (methoxyphenone)、(II-Q021) 萘二甲酸酐 (naphthalic anhydride)、(II-Q022) 解草腈 (oxabetrinil)、(II-Q023) AD-67、(II-Q024) 環丙磺醯胺 (cyprosulfamide)、(II-Q025) 呋喃解草唑及其相應的R異構物 (furilazole and the corresponding R isomer)、(II-Q026) 雙苯噁唑酸乙酯 (isoxadifenethyl)、(II-Q027) N-(胺基羰基)-2-甲苯磺醯胺 (N-(aminocarbonyl)-2-methylbenzenesulfonamide)、(II-Q028) N-(胺基-羰基)-2-氟苯磺醯胺 (N-(aminocarbonyl)-2-fluorobenzenesulfonamide)、(II-Q029) 1-溴-4-[(氯甲基)磺醯基]苯 (1-bromo-4-[(chloromethyl)sulfonyl]benzene)、(II-Q030) 2-(二氯甲基)-2-甲基-1,3-二氧五環烷 (2-(dichloromethyl)-2-methyl-1,3-dioxolane) (MG 191)、(II-Q031) 4-(二氯乙醯基)-1-氧雜-4-偶氮螺[4.5]癸烷 (4-(dichloroacetyl)-1-oxa-4-azospiro-[4.5]decane) (MON 4660)、(II-Q032) 2,2-二氯-1-(2,2,5-三甲基-3-噁唑烷基)-乙酮 (2,2-dichloro-1-(2,2,5-trimethyl-3-oxazolidinyl)-ethanone)、(II-Q033) 2-甲氧基-N-[[4-[[(甲胺基)羰基]胺基]苯基]磺醯基]-苯醯胺 (2-methoxy-N-[[4-[[(methylamino)carbonyl]amino]phenyl]sulfonyl]-benzamide)、(II-Q034) 2-甲氧基-N-[[4-[[(甲胺基)羰基]胺基]苯基]磺醯基]-苯醯胺 (2-methoxy-N-[[4-[[(methylamino)carbonyl]amino]-phenyl]sulfonyl]-benzamide);以及 (II-R) 生物殺真菌劑:(II-R001) 枯草芽孢桿菌合成 ( Bacillus subtilis syn.)、(II-R002) 枯草芽孢桿菌QST713株 ( Bacillus subtilisstrain QST713)、(II-R003) 枯草芽孢桿菌BU1814株 ( Bacillus subtilisstrain BU1814)、(II-R004) 枯草桿菌變種解澱粉芽孢桿菌 ( Bacillus subtilis var. amyloliquefaciens) 菌株FZB24 (strain FZB24)、(II-R005) 解澱粉芽孢桿菌 ( Bacillus amyloliquefaciens) 菌株MBI 600 (strain MBI600)、(II-R006) 解澱粉芽孢桿菌菌株D747 ( Bacillus amyloliquefaciensstrain D747)、(II-R007) 解澱粉芽孢桿菌 ( Bacillus amyloliquefaciens) 菌株D727 (strain D727)、(II-R008) 解澱粉芽孢桿菌 ( Bacillus amyloliquefaciens)菌株ENV503 (strain ENV503)、(II-R009) 深綠木黴菌 ( Tricoderma atroviride) 菌株SC1 (strain SC1)、(II-R010) 蕈狀芽孢桿菌分離物 (Bacillus mycoidesisolate)、(II-R011) 綠針假單胞菌菌株 AFS009 ( Pseudomonas chlororaphisstrain AFS009)、(II-R012) 利迪鏈黴菌 WYEC 108 ( Streptomyces lydicusstrain WYEC108)、(II-R013) 出芽短梗黴菌菌株DSM14940及DSM14941之混合物 ( Aureobasidium pullulansstrain DSM 14940 + Pullulansstrain DSM 14941)、(II-R014) 茶樹 ( Melameuca alternifolia) 萃取物、(II-R015) 菲律賓木桔萃取物 ( Swinglea glutinosaextract)、(II-R016) 磷酸鈣鹽/亞磷酸鈣 (calcium salt of phosphorus acid/calcium phosphite)、(II-R017) 吸水鏈黴菌 ( Streptomyces hygroscopicus)(維利黴素,validamycin)、(II-R018) 高地芽孢桿菌 ( Bacillus altudinis)、(II-R019) 解澱粉芽孢桿菌 ( Bacillus amyloliquefaciens)、(II-R020) 解澱粉芽孢桿菌植物亞種MBI 600 ( Bacillus amyloliquefaciens ssp. plantarumMBI 600) (II-27)、(II-R021) 解澱粉芽孢桿菌植物亞種D747 ( Bacillus amyloliquefaciens ssp. plantarumD747)、(II-R022) 巨大芽孢桿菌 ( Bacillus megaterium)、(II-R023) 莫哈韋芽孢桿菌 ( Bacillus mojavensis) (II-28)、(II-R024) 蕈狀芽孢桿菌 ( Bacillus mycoides)、(II-R025) 短小芽孢桿菌 ( Bacillus pumilus)INR-7 (II-29)、(II-R026) 短小芽抱桿菌 ( Bacillus pumilus)GHA 180、(II-R027) 簡單芽孢桿菌 ( Bacillus simplex) (II-30)、(II-R028) 索立思芽孢桿菌 ( Bacillus solisalsi) (II-31)、(II-R029) 伯克霍爾德氏菌屬 ( Burkholderia sp.)、(II-R030) 密執安棍狀桿菌 ( Clavibacter michiganensis)(噬菌體,bacteriophages) (II-32)、(II-R031) 粉紅膠黴菌 ( Gliocladium roseum) (II-33)、(II-R032) 赫色小球殼孢菌 ( Microsphaeropsis ochracea)、(II-R033) 白色產氣黴 ( Muscodor albus)、(II-R034) 蜂房類芽孢桿菌 ( Paenibacillus alvei)、(II-R035) 多黏類芽孢桿菌 ( Paenibacillus polymyxa) (II-34)、(II-R036) 成團泛菌 (Pantoea agglomerans)(II-35)、(II-R037) 泛菌 ( Pantoea vagans)、(II-R038) 拜萊青黴菌 ( Penicillium bilaiae)、(II-R039) 假單胞菌屬 ( Pseudomonas sp.) (II-R040) 綠針假單胞菌 ( Pseudomonas chloraphis)、(II-R041) 螢光假單胞菌 ( Pseudomonas fluorescens)、(II-R042) 菌寄生球殼菌 ( Sphaerodes mycoparasitica) (II-36)、(II-R043) 紫黑鏈黴菌 ( Streptomyces violaceusniger) (II-38)、(II-R044) 頂孢木黴 JM41R ( Trichoderma fertileJM41R) (II-39), (II-R045) 同擔子菌 ( Typhula phacorrhiza) (II-40)、(II-R046) 大麗輪枝菌 ( Verticillium dahlia) (II-42)、(II-R047) 矮南瓜黃化嵌紋病毒 (zucchini yellow mosaic virus)(無毒菌株,avirulent strain);及/或 至少一種殺蟲及/或殺線蟲活性化合物 (III) 選自如下所述各組: (III-A) 乙醯膽鹼酯酶 (AChE)抑制劑,選自以下各類: (III-A1) 胺基甲酸酯:(III-A1001) 棉靈威 (alanycarb)、(III-A1002) 得滅克 (aldicarb)、(III-A1003) 免敵克 (bendiocarb)、(III-A1004) 免扶克 (benfuracarb)、(III-A1005) 佈嘉信 (butocarboxim)、(III-A1006) 丁酮碸威 (butoxycarboxim)、(III-A1007) 加保利 (carbaryl)、(III-A1008) 加保扶 (carbofuran)、(III-A1009) 丁基加保扶 (carbosulfan)、(III-A1010) 殺蟲丹 (ethiofencarb)、(III-A1011) 丁基滅必蝨 (fenobucarb)、(III-A1012) 複滅蟎 (formetanate)、(III-A1013) 呋線威 (furathiocarb)、(III-A1014) 滅必蝨 (isoprocarb)、(III-A1015) 滅賜克 (methiocarb)、(III-A1016) 納乃得 (methomyl)、(III-A1017) 治滅蝨 (metolcarb)、(III-A1018) 歐殺滅 (oxamyl)、(III-A1019) 比加普 (pirimicarb)、(III-A1020) 安丹 (propoxur)、(III-A1021) 硫敵克 (thiodicarb)、(III-A1022) 硫伐隆 (thiofanox)、(III-A1023) 唑蚜威 (triazamate)、(III-A1024) 混滅威 (trimethacarb)、(III-A1025) 滅克蝨 (XMC)、(III-A1026) 滅殺威 (xylylcarb); (III-A2) 機磷酸酯:(III-A2001) 歐殺松 (acephate)、(III-A2002) 亞滅松 (azamethiphos)、(III-A2003) 穀速松-乙酯 (azinphos-ethyl)、(III-A2004) 穀速松-甲酯 (azinphos-methyl)、(III-A2005) 硫線磷 (cadusafos)、(III-A2006) 氯氧磷 (chlorethoxyfos)、(III-A2007) 氯芬松 (chlorfenvinphos)、(III-A2008) 氯甲磷 (chlormephos)、(III-A2009) 陶斯松 (chlorpyrifos)、(III-A2010) 陶斯松-甲酯 (chlorpyrifos-methyl)、(III-A2011) 蠅毒磷 (coumaphos)、(III-A2012) 氰乃松 (cyanophos)、(III-A2013) 甲基硫代內吸磷 (demeton-S-methyl)、(III-A2014) 大利松 (diazinon)、(III-A2015) 二氯松 (dichlorvos, DDVP)、(III-A2016) 雙特松 (dicrotophos)、(III-A2017) 大滅松 (dimethoate)、(III-A2018) 甲基毒蟲畏 (dimethylvinphos)、(III-A2019) 二硫松 (disulfoton)、(III-A2020) 一品松 (O-Ehtyl-O-pnitrophenyl thionobenzenephosphonate, EPN)、(III-A2021) 愛殺松 (ethion)、(III-A2022) 普伏松 (ethoprophos)、(III-A2023) 胺磺磷 (famphur)、(III-A2024) 芬滅松 (fenamiphos)、(III-A2025) 撲滅松 (fenitrothion)、(III-A2026) 芬殺松 (fenthion)、(III-A2027) 福賽絕 (fosthiazate)、(III-A2028) 飛達松 (heptenophos)、(III-A2029) 新煙磷 (imicyafos)、(III-A2030) 亞芬松 (isofenphos)、(III-A2031) O-(甲氧基胺基硫基-磷醯基)水楊酸異丙酯 (isopropyl o-(methoxyaminothio-phosphoryl) salicylate)、(III-A2032) 加福松 (isoxathion)、(III-A2033) 馬拉硫磷 (malathion)、(III-A2034) 滅加松 (mecarbam)、(III-A2035) 達馬松 (methamidophos)、(III-A2036) 滅大松 (methidathion)、(III-A2037) 美文松 (mevinphos)、(III-A2038) 亞素靈 (monocrotophos)、(III-A2039) 乃力松 (naled)、(III-A2040) 毆滅松 (omethoate)、(III-A2041) 甲基滅多松 (oxydemeton-methyl)、(III-A2042) 巴拉松 (parathion)、(III-A2043) 甲基巴拉松 (parathion-methyl)、(III-A2044) 賽達松 (phenthoate)、(III-A2045) 福瑞松 (phorate)、(III-A2046) 裕必松 (phosalone)、(III-A2047) 益滅松 (phosmet)、(III-A2048) 福賜米松 (phosphamidon)、(III-A2049) 巴賽松 (phoxim)、(III-A2050) 亞特松-甲酯 (pirimiphos-methyl)、(III-A2051) 布飛松 (profenofos)、(III-A2052) 撲達松 (propetamphos)、(III-A2053) 普硫松 (prothiofos)、(III-A2054) 白克松 (pyraclofos)、(III-A2055) 必芬松 (pyridaphenthion)、(III-A2056) 拜裕松 (quinalphos)、(III-A2057) 治螟磷 (sulfotep)、(III-A2058) 丁基嘧啶磷 (tebupirimfos)、(III-A2059) 雙硫磷 (temephos)、(III-A2060) 託福松 (terbufos)、(III-A2061) 樂本松 (tetrachlorvinphos)、(III-A2062) 硫滅松 (thiometon)、(III-A2063) 三落松 (triazophos)、(III-A2064) 三氯松 (triclorfon)、(III-A2065) 繁米松 (vamidothion); (III-B) γ-胺基丁酸 (GABA)閘控氯離子通道阻斷劑,選自以下各類: (III-B1) 環戊二烯-有機氯:(III-B1001) 可氯丹 (chlordane)、(III-B1002) 安殺番 (endosulfan); (III-B2) 苯基吡唑(非潑羅,fiproles):(III-B2001) 益斯普 (ethiprole)、(III-B2002) 費普尼 (fipronil)、(III-B2003) 丁烯氟蟲腈 (flufiprole)、(III-B2004) 啶吡唑蟲胺 (pyrafluprole)、(III-B2005) 吡唑蟲啶 (pyriprole); (III-C) 鈉通道調節劑,選自以下各類: (III-C1) 除蟲菊精和類除蟲菊精類:(III-C1001) 阿納寧 (acrinathrin)、(III-C1002) 亞烈寧 (allethrin)、(III-C1003) d-順式反式亞烈寧 (d-cis-trans allethrin)、(III-C1004) d-反式亞烈寧 (d-trans-allethrin)、(III-C1005) 畢芬寧 (bifenthrin)、(III-C1006) 拜烈寧 (bioallethrin)、(III-C1007) S-環戊烯基拜烈寧異構物 (bioallethrin s-cyclopentenyl isomer)、(III-C1008) 苄呋菊脂 (bioresmethrin)、(III-C1009) 賽保寧 (cycloprothrin)、(III-C1010) 賽扶寧 (cyfluthrin)、(III-C1011) β-賽扶寧、(III-C1012) 賽洛寧 (cyhalothrin)、(III-C1013) λ-賽洛寧、(III-C1014) γ-賽洛寧、(III-C1015) 賽滅寧 (cypermethrin)、(III-C1016) α-賽滅寧、(III-C1017) β-賽滅寧、(III-C1018) θ-賽滅寧、(III-C1019) ξ-賽滅寧、(III-C1020) 賽酚寧、(III-C1021) [(1R)-反式異構物]、(III-C1022) 第滅寧 (deltamethrin)、(III-C1023) 烯炔菊酯[(EZ)-(1R)-異構物]、(III-C1024) 益化利 (esfenvalerate)、(III-C1025) 依芬寧 (etofenprox)、(III-C1026) 芬普寧 (fenpropathrin)、(III-C1027) 芬化利 (fenvalerate)、(III-C1028) 護賽寧 (flucythrinate)、(III-C1029) 福滅寧 (flumethrin)、(III-C1030) τ-福化利 (tau-fluvalinate)、(III-C1031) 合芬寧 (halfenprox)、(III-C1032) 依普寧 (imiprothrin)、(III-C1033) 氯氟醚菊酯 (meperfluthrin)、(III-C1034) 美特寧 (metofluthrin)、(III-C1035) 滅伏靈 (momfluorothrin)、(III-C1036) 剋特寧 (kadethrin)、(III-C1037) 百滅寧 (permethrin)、(III-C1038) 苯醚菊酯[(1R)-反式異構物] (phenothrin [(1R)-trans-isomer])、(III-C1039) 普亞列寧 (prallethrin)、(III-C1040) 丙氟菊酯 (profluthrin)、(III-C1041) 除蟲菊素 (pyrethrins) (除蟲菊,pyrethrum)、(III-C1042) 苄呋菊脂 (resmethrin)、(III-C1043) 矽護芬 (silafluofen)、(III-C1044) 汰福寧 (tefluthrin)、(III-C1045) 四氟醚菊酯 (tetramethylfluthrin)、(III-C1046) 治滅寧 (tetramethrin)、(III-C1047) 治滅寧 [(1R)-異構物] (tetramethrin [(1R)-isomers])、(III-C1048) 泰滅寧 (tralomethrin)、(III-C1049) 拜富寧 (transfluthrin); (III-C2) 有機氯類:(III-C2001) 滴滴涕 (DDT)、(III-C2002) 甲氧基氯 (methoxychlor); (III-D) 菸鹼乙醯膽鹼受體 (nAChR)競爭性調節劑,選自以下各類: (III-D1) 新菸鹼類似物:(III-D1001) 亞滅培 (acetamiprid)、(III-D1002) 可尼丁(clothianidin)、(III-D1003) 達特南 (dinotefuran)、(III-D1004) 益達胺 (imidacloprid)、(III-D1005) 烯啶蟲胺 (nitenpyram)、(III-D1006) 噻蟲啉 (thiacloprid)、(III-D1007) 噻蟲嗪 (thiamethoxam)、(III-D1008) 1-[(6-氯-3-吡啶基)甲基]-2,3,5,6,7,8-六氫-9-硝基-(5S,8R)-5,8-環氧-H-咪唑並[1,2-a]氮呯 (1-[(6-chloro-3-pyridinyl)methyl]-2,3,5,6,7,8-hexahydro-9-nitro-(5S,8R)-5,8-epoxy-H-imidazo[1,2-a]azepine)、(III-D1009) (1-[(6-氯-3-吡啶基)甲基]-2-硝基-1-[(E)-亞戊基胺基]胍 (1-[(6-chloro-3-pyridyl)methyl]-2-nitro-1-[(E)-pentylideneamino]guanidine、(III-D1010) 1-[(6-氯-3-吡啶基)甲基]-7-甲基-8-硝基-5-丙氧基-3,5,6,7-四氫-2H-咪唑並[1,2-a]吡啶 (1-[(6-chloro-3-pyridyl)methyl]-7-methyl-8-nitro-5-propoxy-3,5,6,7-tetrahydro-2H-imidazo[1,2-a]pyridine); (III-D2001) 菸鹼; (III-D3) 甲硫胺酸磺醯亞胺 (sulfoximines):(III-D3001) 速殺氟 (sulfoxaflor); (III-D4) 丁烯羥酸內酯 (butenolides):(III-D4001) 氟吡呋喃酮 (flupyradifurone); (III-D5) 中離子化合物 (mesoionics):(III-D5001) 氟美派 (triflumezopyrim)、(III-D5002) 二氯滅座替 (dichloromezotiaze); (III-D6) 伸二氫吡啶基化合物 (pyridylidenes):(III-D6001) 氟必靈 (flupyrimin); (III-E) 菸鹼乙醯膽鹼 (nAChR)受體異位調節劑-位點I,選自以下各類: (III-E1) 賜諾殺類 (spinosyns):(III-E1001) 賜諾特 (spinetoram)、(III-E1002) 賜諾殺 (spinosad); (III-F) 麩胺酸閘控氯通道 (GluCl)異位調節劑,選自以下各類: (III-F1) 阿維菌素類 (avermectin)/米爾倍黴素類 (milbemycin):(III-F1001) 阿巴汀 (abamectin)、(III-F1002) 因滅汀苯甲酸酯 (emamectin benzoate)、(III-F1003) 雷匹美汀 (lepimectin)、(III-F1004) 密滅汀 (milbemectin); (III-G) 青春激素模擬物,選自以下各類: (III-G1) 青少年激素類似物:(III-G1001) 烯蟲乙酯 (hydroprene)、(III-G1002) 烯蟲炔酯 (kinoprene)、(III-G1003) 美賜平 (methoprene); (III-G2001) 芬諾克 (fenoxycarb); (III-G3001) 百利普芬 (pyriproxyfen); (III-H) 多重非特異性(多位點)抑制劑,選自以下各類: (III-H1) 烷基鹵化物:(III-H1001) 溴化甲烷、(III-H1002) 其他烷基鹵化物; (III-H2001) 氯化苦 (chloropicrin); (III-H3) 氟化物:(III-H3001) 冰晶石 (cryolite)(氟鋁化鈉,sodium aluminium fluoride)、(III-H3002) 磺醯氟 (sulfuryl fluoride); (III-H4) 硼酸鹽 (borates):(III-H4001) 硼砂、(III-H4002) 硼酸、(III-H4003) 八硼酸二鈉、(III-H4004) 硼酸鈉 (sodium borate)、(III-H4005) 偏硼酸鈉; (III-H5001) 酒石酸銻鉀; (III-H6) 異氰酸甲酯產生劑:(III-H6001) 必速滅 (diazomet)、(III-H6002) 威百畝 (metam); (III-I) 弦音器官TRPV通道調節劑,選自以下各類: (III-I1) 吡啶偶氮甲鹼衍生物 (pyridine azomethine derivatives):(III-I1001) 派滅淨 (pymetrozine)、(III-I1002) 氟蟲吡喹 (pyrifluquinazon); (III-I2001) 啶喃環丙蟲酯 (afidopyropen); (III-J) 影響CHS1的蟎生長抑制劑,選自以下各類: (III-J1) 克芬蟎 (clofentezine)、氟蟎嗪 (diflovidazin)、合賽多 (hexythiazox) :(III-J1001) 克芬蟎、(III-J1002) 合賽多、(III-J1003) 氟蟎嗪; (III-J2003) 依殺蟎 (etoxazole); (III-K) 昆蟲中腸膜的微生物干擾劑,選自以下各類: (III-K1) 蘇力菌 ( Bacillus thuringiensis) 及其產生的殺蟲蛋白:(III-K1001) 蘇力菌 ( Bacillus thuringiensis)、(III-K1002) 蘇力菌以色列變種 ( Bacillus thuringiensisvar. israelensis)、(III-K1003) 蘇力菌亞莎華變種 ( Bacillus thuringiensisvar. aizawai)、(III-K1004) 蘇力菌庫斯塔克變種 ( Bacillus thuringiensisvar. kurstaki)、(III-K1005) 蘇力菌坦尼布列翁斯變種 ( Bacillus thuringiensisvar. tenebrionis)、(III-K1006) Cry1Ab,、(III-K1007) Cry1Ac、(III-K1008) Cry1Fa、(III-K1009) Cry1A.105、(III-K1010) Cry2Ab、(III-K1011) Vip3A、(III-K1012) mCry3A、(III-K1013) Cry3Ab、(III-K1014) Cry3Bb、(III-K1015) Cry34/35Ab1; (III-K2001) 圓形芽孢桿菌 ( Bacillus sphaericus); (III-L) 粒線體ATP合成酶之抑制劑,選自以下各類: (III-L1001) 汰芬諾克 (diafenthiuron); (III-L2) 有機錫殺蟎劑:(III-L2001) 三唑錫 (azocyclotin)、(III-L2002) 錫蟎丹 (cyhexatin)、(III-L2003) 芬布錫 (fenbutatin oxide); (III-L3001) 毆蟎多 (propargite); (III-L4001) 得脫蟎 (tetradifon); (III-M) 藉由干擾質子梯度而作用之氧化磷酸化去耦合劑,選自以下各類: (III-M1) 吡咯 (pyrroles):(III-M1001) 克凡派 (chlorfenapyr); (III-M2) 二硝基苯酚:(III-M2001) 二硝基甲酚 (dinitro-ortho-cresol, DNOC); (III-M3001) 氟蟲胺 (sulfluramid); (III-N) 菸鹼乙醯膽鹼受體 (nAChR)通道阻斷劑,選自以下各類: (III-N1) 沙蠶毒素類似物 (nereistoxin analogues):(III-N1001) 免速達 (bensultap)、(III-N1002) 培丹鹽酸鹽 (cartap hydrochloride)、(III-N1003) 硫賜安 (thiocylam)、(III-N1004) 殺蟲雙鈉 (thiosultap-sodium); (III-O) 影響CHS1的幾丁質生物合成抑制劑,選自以下各類: (III-O1) 苯甲醯脲 (benzoylureas):(III-O1001) 雙三氟蟲脲 (bistrifluron)、(III-O1002) 克福隆 (chlorfluazuron)、(III-O1003) 二福隆 (diflubenzuron)、(III-O1004) 氟環脲 (flucycloxuron)、(III-O1005) 氟芬隆 (flufenoxuron)、(III-O1006) 六伏隆 (hexaflumuron)、(III-O1007) 祿芬隆 (lufenuron)、(III-O1008) 諾伐隆 (novaluron)、(III-O1009) 多氟脲 (noviflumuron)、(III-O1010) 得福隆 (teflubenzuron)、(III-O1011) 三福隆 (triflumuron); (III-P) 第1型之幾丁質生物合成抑制劑:(III-P1001) 布芬淨 (buprofezin); (III-Q) 蛻皮干擾劑,選自以下各類: (III-Q1) 用於雙翅目 (Dipteran)之干擾劑:(III-Q1001) 賽滅淨 (cyromazine); (III-R) 蛻皮素受體促效劑,選自以下各類: (III-R1) 二醯基聯胺類 (diacylhydrazines):(III-R1001) 滅芬諾 (methoxyfenozide)、(III-R1002) 得芬諾 (tebufenozide)、(III-R1003) 合芬隆 (halofenozide)、(III-R1004) 呋喃蟲醯肼 (fufenozide)、(III-R1005) 可芬諾 (chromafenozide); (III-S) 奧克巴胺受體促效劑:(III-S1001) 三亞蟎 (amitraz); (III-T) 粒線體複合物III電子傳遞抑制劑:(III-T1001) 愛美松 (hydramethylnone)、(III-T2001) 亞醌蟎 (acequinocyl)、(III-T3001) 嘧蟎酯 (fluacrypyrim)、(III-T4001) 畢芬載 (Bifenazate); (III-U) 粒線體複合物I電子傳遞抑制劑,選自以下各類: (III-U1) 電子傳遞抑制劑 (METI)之殺蟎劑和殺蟲劑:(III-U1001) 芬殺蟎 (fenazaquin)、(III-U1002) 芬普蟎 (fenpyroximate)、(III-U1003) 嘧蟎醚 (pyrimidifen)、(III-U1004) 畢達本 (pyridaben)、(III-U1005) 得芬瑞 (tebufenpyrad)、(III-U1006) 脫芬瑞 (tolfenpyrad); (III-U2001) 魚藤精 (rotenone); (III-V) 電壓依賴性之鈉通道阻斷劑,選自以下各類: (III-V1) 噁二嗪 (oxadiazines):(III-V1001) 因得克 (indoxacarb); (III-V2) 縮胺脲 (semicarbazones):(III-V2001) 美氟綜 (metaflumizone); (III-V3001) 1-[(E)-[2-(4-腈基苯基)-1-[3-(三氟甲基)苯基]亞乙基]胺基]-3-[4-(二氟甲氧基)苯基]脲 (1-[(E)-[2-(4-cyanophenyl)-1-[3-(trifluoromethyl)phenyl]ethylidene]amino]-3-[4-(difluoromethoxy)phenyl]urea); (III-V4001) 2-[3-(乙磺醯基)吡啶-2-基]-5-[三氟(甲磺醯基)]-1,3-苯並噁唑 (2-[3-(ethanesulfonyl)pyridin-2-yl]-5-[trifluoro(methanesulfonyl)]-1,3-benzoxazole (oxazosulfyl))(歐賽菲,oxazosulfyl); (III-W) 乙醯輔酶A羧化酶抑制劑,選自以下各類: (III-W1) 特窗酸 (tetronic acid)以及特特拉姆酸 (tetramic acid)之衍生物:(III-W1001) 賜派芬 (spirodiclofen)、(III-W1002) 賜滅芬 (spiromesifen)、(III-W1003) 賜派酮 (spiropidion)、(III-W1004) 賜派滅 (spirotetramat); (III-X) 粒線體複合物IV電子傳遞抑制劑,選自以下各類: (III-X1001) 磷化物 (phosphides):(III-X1001) 磷化鋁、(III-X1002) 磷化鈣、(III-X1003) 膦 (phosphine)、(III-X1004) 磷化鋅; (III-X2) 氰化物:(III-X2001) 氰化鈣、(III-X2002) 氰化鉀、(III-X2003) 氰化鈉; (III-Y) 粒線體複合物II電子傳遞抑制劑,選自以下各類: (III-Y1001) β-酮腈 (beta-ketonitrile)衍生物:(III-Y1001) 賽派芬 (cyenopyrafen)、(III-Y1002) 賽芬蟎 (cyflumetofen); (III-Y2) 苯胺基甲醯 (carboxanilides):(III-Y2001) 派氟丁胺 (pyflubumide); (III-Z) 雷若丁受體調節劑,選自以下各類: (III-Z1) 二醯胺類 (diamides):(III-Z1001) 氟大滅 (flubendiamide)、(III-Z1002) 剋安勃 (chlorantraniliprole) (Rynaxypyr®)、(III-Z1003) 賽安勃 (cyantraniliprole) (Rynaxypyr®)、(III-Z1004) 環溴蟲醯胺 (cyclaniliprole)、(III-Z1005) 四唑蟲醯胺 (tetraniliprole)、(III-Z1006) 四氯蟲醯胺 (tetra-chlorantraniliprole)、(III-Z1007) (R)-3-氯-N1-{2-甲基-4-[1,2,2,2-四氟-1-(三氟甲基)乙基]苯基}-N2-(1-甲基-2-甲基磺醯基乙基)鄰苯二甲醯胺 ((R)-3-Chlor-N1-{2-methyl-4-[1,2,2,2-tetrafluor-1-(trifluormethyl)ethyl]phenyl}-N2-(1-methyl-2-methylsulfonylethyl)phthalamid)、(III-Z1008) (S)-3-氯-N1-{2-甲基-4-[1,2,2,2-四氟-1-(三氟甲基)乙基]苯基}-N2-(1-甲基-2-甲基磺醯基乙基)鄰苯二甲醯胺 ((S)-3-Chlor-N1-{2-methyl-4-[1,2,2,2-tetrafluor-1-(trifluormethyl)ethyl]phenyl}-N2-(1-methyl-2-methylsulfonylethyl)phthalamid)、(III-Z1009) 甲基-2-[3,5-二溴-2-({[3-溴-1-(3-氯吡啶-2-基)-1H-吡唑-5-基]羰基}胺基)苯甲醯基]-1,2-二甲基肼羧酸 (methyl-2-[3,5-dibromo-2-({[3-bromo-1-(3-chlorpyridin-2-yl)-1H-pyrazol-5-yl]carbonyl}amino)benzoyl]-1,2-dimethylhydrazinecarboxylate)、(III-Z1010) N-[2-(5-胺基-1,3,4-噻二唑-2-基)-4-氯-6-甲基-苯基]-5-溴-2-(3-氯-2-吡啶基)吡唑-3-羧醯胺 (N-[2-(5-amino-1,3,4-thiadiazol-2-yl)-4-chloro-6-methyl-phenyl]-5-bromo-2-(3-chloro-2-pyridyl)pyrazole-3-carboxamide)、(III-Z1011) 5-氯-2-(3-氯-2-吡啶基)-N-[2,4-二氯-6-[(1-腈基-1-甲基-乙基)胺基甲醯基]苯基]吡唑-3-羧醯胺 (5-chloro-2-(3-chloro-2-pyridyl)-N-[2,4-dichloro-6-[(1-cyano-1-methyl-ethyl)carbamoyl]phenyl]pyrazole-3-carboxamide)、(III-Z1012) 5-溴-N-[2,4-二氯-6-(甲基胺基甲醯基)苯基]-2-(3,5-二氯-2-吡啶基)吡唑-3-羧醯胺 5-bromo-N-[2,4-dichloro-6-(methylcarbamoyl)phenyl]-2-(3,5-dichloro-2-pyridyl)pyrazole-3-carboxamide、(III-Z1013) N-[2-(叔丁基胺基甲醯基)-4-氯-6-甲基-苯基]-2-(3-氯-2-吡啶基)-5-(氟甲氧基)吡唑-3-羧醯胺 (N-[2-(tert-butylcarbamoyl)-4-chloro-6-methyl-phenyl]-2-(3-chloro-2-pyridyl)-5-(fluoromethoxy)pyrazole-3-carboxamide)、(III-Z1014) N2-(1-腈基-1-甲基-乙基)-N1-(2,4-二甲基苯基)-3-碘-鄰苯二甲醯胺 (N2-(1-cyano-1-methyl-ethyl)-N1-(2,4-dimethylphenyl)-3-iodo-phthalamide)、3-氯-N2-(1-腈基-1-甲基-乙基)-N1-(2,4-二甲基苯基)鄰苯二甲醯胺 (3-chloro-N2-(1-cyano-1-methyl-ethyl)-N1-(2,4-dimethylphenyl)phthalamide); (III-AA) 弦音器官調節劑-未定義的目標位點:(III-AA1001) 氟尼胺 (flonicamid); (III-BB) γ-胺基丁酸 (GABA)閘控氯離子通道調節劑,選自以下各類: (III-BB1) 間二醯胺 (meta-diamides):溴蟲氟苯雙醯胺 (broflanilide); (III-BB2) 異噁唑啉:(III-BB2001) 氣釀醯胺 (fluxametamide)、(III-BB2002) 抑克斯能 (isocycloseram); (III-CC) 桿狀病毒,選自以下各類: (III-CC1) 顆粒體病毒 (Granuloviruses, GVs):(III-CC1001) 蘋果蠹蛾 ( Cydia pomonella) GV、(III-CC1002) 偽蘋果蠹蛾 ( Thaumatotibia leucotreta) GV; (III-CC2001) 核多角體病毒 (nucleopolyhedroviruses, NPVs):黎豆夜蛾 ( Anticarsia gemmatalis)之繁殼核多角體病毒 (Multi-nucleocapsid nucleopolyhedroviruses, MNPV)、(III-CC2002) 棉鈴實夜蛾 ( Helicoverpa armigera)之核多角體病毒; (III-DD) 菸鹼乙醯膽鹼受體異位調節劑-位點II;(III-DD1001) GS-ω/κ HXTX-Hv1a胜肽; (III-EE) 作用方式未知或不確定之殺蟲活性化合物:(III-EE1001) 艾特本 (afidopyropen)、(III-EE1002) 印楝素 (azadirachtin)、(III-EE1003) 磺胺蟎酯 (amidoflumet)、(III-EE1004) 苯賽滅 (benzoximate)、(III-EE1005) 苯吡莫賽 (benzpyrimoxan)、(III-EE1006) 必芬賽 (bifenazate)、(III-EE1007) 新殺蟎 (bromopropylate)、(III-EE1008) 滅蟎猛 (chinomethionat)、(III-EE1009) 克利得 (cryolite)、(III-EE1010) 大克蟎 (dicofol)、(III-EE1011) 伏吩靈 (flufenerim)、(III-EE1012) 氟喹啉 (flometoquin)、(III-EE1013) 氟赫吩 (fluhexafon)、(III-EE1014) 氟速吩 (fluensulfone)、(III-EE1015) 伏達隆 (flupyradifurone)、(III-EE1016) 石灰硫黃合劑 (lime sulphur)、(III-EE1017) 鋅錳乃浦 (mancozeb)、(III-EE1018) 協力精 (piperonyl butoxide)、(III-EE1019) 吡啶蟲丙醚 (pyridalyl)、(III-EE1020) 必伏松 (pyrifluquinazon)、(III-EE1021) 碸蟲啶 (sulfoxaflor)、(III-EE1022) 硫、(III-EE1023) 4-[5-(3,5-二氯-苯基)-5-三氟甲基-4,5-二氫-異噁唑-3-基]-2-甲基-N-[(2,2,2-三氟-乙基胺基甲醯基)-甲基]-苯醯胺 (4-[5-(3,5-Dichloro-phenyl)-5-trifluoromethyl-4,5-dihydro-isoxazol-3-yl]-2-methyl-N-[(2,2,2-trifluoro-ethylcarbamoyl)-methyl]-benzamide)、(III-EE1024) 環丙基乙酸 (cyclopropaneacetic acid)、(III-EE1025) 1,1’-[(3S,4R,4aR,6S,6aS,12R,12aS,12bS)-4-[[(2-環丙基乙醯基)氧基]甲基]-1,3,4,4a,5,6,6a,12,12a,12b-十氫-12-羥基-4,6a,12b-三甲基-11-氧代-9-(3-吡啶基)-2H,11H-萘並[2,1-b]吡喃[3,4-e]吡喃-3,6-二基]酯 (1,1’-[(3S,4R,4aR,6S,6aS,12R,12aS,12bS)-4-[[(2-cyclopropylacetyl)oxy]methyl]-1,3,4,4a,5,6,6a,12,12a,12b-decahydro-12-hydroxy-4,6a,12b-trimethyl-11-oxo-9-(3-pyridinyl)-2H,11H-naphtho[2,1-b]pyrano[3,4-e]pyran-3,6-diyl]ester、(III-EE1026) 11-(4-氯-2,6-二甲基苯基)-12-羥基-1,4-二氧-9-氮雜二螺[4.2.4.2]-十四碳-11-烯-10-酮 (11-(4-chloro-2,6-dimethylphenyl)-12-hydroxy-1,4-dioxa-9-azadispiro[4.2.4.2]-tetradec-11-en-10-one)、(III-EE1027) 4,3-(4’-氟-2,4-二甲基聯苯-3-基)-4-羥基-8-氧杂-1-氮雜螺[4.5]-十烷-3-烯-2-酮 (4,3-(4’-fluoro-2,4-dimethylbiphenyl-3-yl)-4-hydroxy-8-oxa-1-azaspiro[4.5]dec-3-en-2-one、(III-EE1028) 1-[2-氟-4-甲基-5-[(2,2,2-三氟乙基)亞磺醯基]苯基]-3-(三氟甲基)-1H-1,2,4-三唑-5-胺 (1-[2-fluoro-4-methyl-5-[(2,2,2-trifluoroethyl)sulfinyl]phenyl]-3-(trifluoromethyl)-1H-1,2,4-triazole-5-amine)、(III-EE1029) 基於強固芽胞桿菌之活性劑 (actives on basis of bacillus firmus(Votivo), II-1582)、(III-EE1030) (E/Z)-N-[1-[(6-氯-3-吡啶基)甲基]-2-吡啶基]-2,2,2-三氟-乙醯胺 ((E/Z)-N-[1-[(6-chloro-3-pyridyl)methyl]-2-pyridylidene]-2,2,2-trifluoro-acetamide)、(III-EE1031) (E/Z)-N-[1-[(6-氯-5-氟-3-吡啶基)甲基]-2-吡啶亞基]-2,2,2-三氟-乙醯胺 ((E/Z)-N-[1-[(6-chloro-5-fluoro-3-pyridyl)methyl]-2-pyridylidene]-2,2,2-trifluoro-acetamide)、(III-EE1032) (E/Z)-2,2,2-三氟-N-[1-[(6-氟-3-吡啶基)甲基]-2-吡啶基]乙醯胺 ((E/Z)-2,2,2-trifluoro-N-[1-[(6-fluoro-3-pyridyl)methyl]-2-pyridylidene]acetamide)、(III-EE1033) (E/Z)-N-[1-[(6-氟-3-吡啶基)甲基]-2-吡啶基]-2,2,2-三氟-乙醯胺 ((E/Z)-N-[1-[(6-bromo-3-pyridyl)methyl]-2-pyridylidene]-2,2,2-trifluoro-acetamide)、(III-EE1034) (E/Z)-N-[1-[1-[(6-氯-3-吡啶基)乙基]-2-吡啶基]-2,2,2-三氟-乙醯胺 ((E/Z)-N-[1-[1-(6-chloro-3-pyridyl)ethyl]-2-pyridylidene]-2,2,2-trifluoro-acetamide)、(III-EE1035) (E/Z)-N-[1-[(6-氯-3-吡啶基)甲基]-2-吡啶基]-2,2-二氟-乙醯胺 ((E/Z)-N-[1-[(6-chloro-3-pyridyl)methyl]-2-pyridylidene]-2,2-difluoro-acetamide)、(III-EE1036) (E/Z)-2-氯-N-[1-[(6-氯-3-吡啶基)甲基]-2-吡啶基]-2,2-二氟-乙醯胺 ((E/Z)-2-chloro-N-[1-[(6-chloro-3-pyridyl)methyl]-2-pyridylidene]-2,2-difluoro-acetamide)、(III-EE1037) (E/Z)-N-[1-[(2-氯嘧啶-5-基)甲基]-2-亞吡啶]-2,2,2-三氟乙醯胺 ((E/Z)-N-[1-[(2-chloropyrimidin-5-yl)methyl]-2-pyridylidene]-2,2,2-trifluoro-acetamide)、(III-EE1038) (E/Z)-N-[1-[(6-氯-3-吡啶基)甲基]-2-吡啶基]-2,2,3,3,3-五氟丙醯胺 ((E/Z)-N-[1-[(6-chloro-3-pyridyl)methyl]-2-pyridylidene]-2,2,3,3,3-pentafluoro-propanamide)、(III-EE1039) 氟美派 (triflumezopyrim)、(III-EE1040) 4-[5-[3-氯-5-(三氟甲基)苯基]-5-(三氟甲基)-4H-異噁唑-3-基]-N-[2-氧代-2-(2,2,2-三氟乙胺基)乙基]萘-1-羧醯胺 (4-[5-[3-chloro-5-(trifluoromethyl)phenyl]-5-(trifluoromethyl)-4H-isoxazol-3-yl]-N-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]naphthalene-1-carboxamide)、(III-EE1041) 3-[3-氯-5-(三氟甲基)苯基]-4-氧代-1-(嘧啶-5-基甲基)吡啶並[1,2-a]嘧啶鎓-2-油酸鹽 (3-[3-chloro-5-(trifluoromethyl)phenyl]-4-oxo-1-(pyrimidin-5-ylmethyl) pyrido[1,2-a]pyrimidin-1-ium-2-olate)、(III-EE1042) 8-氯-N-[2-氯-5-甲氧基苯基)磺醯基]-6-三氟甲基)-咪唑並[1,2-a]吡啶-2-羧醯胺 (8-chloro-N-[2-chloro-5-methoxyphenyl)sulfonyl]-6-trifluoromethyl)-imidazo[1,2-a]pyridine-2-carboxamide)、(III-EE1043) 4-[5-(3,5-二氯苯基)-5-(三氟甲基)-4H-異噁唑-3-基]-2-甲基-N-(1-側氧基硫雜環丁烷-3-基)苯醯胺 (4-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4H-isoxazol-3-yl]-2-methyl-N-(1-oxothietan-3-yl)benzamide)、(III-EE1044) 5-[3-[2,6-二氯-4-(3,3-二氯烯丙氧基)苯氧基]丙氧基]-1H-吡唑 (5-[3-[2,6-dichloro-4-(3,3-dichloroallyloxyl)phenoxy]propoxy]-1H-pyrazole)、(III-EE1045) 吡蟲啉 (dimpropyridaz)、(III-EE1046) 吡啶菌醯胺 (tyclopyrazoflor)、(III-EE1047) 尼可氟酮 (nicofluprole)、(III-EE1048) 阿西諾吡 (acynonapyr); (III-FF) 生物性殺蟲劑,選自以下各類: (III-FF1) 微生物殺蟲劑 (Microbial pesticides):(III-FF1001) 強固芽胞桿菌 ( Bacillus firmus)、(III-FF1002) 蘇力菌醋螟亞種 ( Bacillus thuringiensissubsp. galleriae)、(III-FF1003) 蘇力菌庫斯塔克亞種 ( Bacillus thuringiensissubsp. kurstaki)、(III-FF1004) 白殭菌 ( Beauveria bassiana)、(III-FF1005) 伯克霍爾德菌屬 ( Burkholderiasp.)、(III-FF1006) 鐵杉紫色桿菌 ( Chromobacterium subtsugae)、(III-FF1007) 鐵杉紫色桿菌新種 ( Chromobacterium subtsugaesp. nov.)、(III-FF1008) 玫煙色擬青黴 ( Isaria fumosorosea)、(III-FF1009) 長孢輪枝菌 ( Lecanicillium longisporum)、(III-FF1010) 蠟蚧輪枝菌 ( Lecanicillium muscarium)(原為 Verticillium lecanii)、(III-FF1011) 黑殭菌 ( Metarhizium anisopliae)、(III-FF1012) 黃綠綠僵菌 ( Metarhizium anisopliaevar. acridum)、(III-FF1013) 玫煙色擬青黴阿波普卡菌株97 ( Paecilomyces fumosoroseusApopka strain 97)、(III-FF1014) 淡紫紫孢菌 ( Purpureocillium lilacinus)、(III-FF1015) 金龜子類芽孢桿菌 ( Paenibacillus popilliae)、(III-FF1016) 巴斯德菌屬 ( Pasteuriaspp.)、(III-FF1017) 擬斯紮瓦巴氏桿菌 ( Pasteuria nishizawae)、(III-FF1018) 腎形巴氏桿菌 ( Pasteuria reneformis)、(III-FF1019) usgae巴氏桿菌 ( Pasteuria usagae)、(III-FF1020) 螢光假單胞菌 ( Pseudomonas fluorescens)、(III-FF1021) 夜蛾斯氏線蟲 ( Steinernema feltiae)、(III-FF1022) Streptomces galbus、(III-FF1023) 沃巴赫氏菌 ( Wolbachia pipientis(Zap));以及 (III-GG) 具有殺蟲、殺蟎、殺軟體動物 (molluscidal)、費洛蒙 (pheromone)及/或殺線蟲活性的生化殺害蟲劑:(III-GG1001) L-香芹酮 (L-carvone)、(III-GG1002) 檸檬醛 (citral)、(III-GG1003) (E,Z)-7,9-十二碳二烯-1-基乙酸酯 ((E,Z)-7,9-dodecadien-1-yl acetate)、(III-GG1004) 甲酸乙酯 (ethyl formate)、(III-GG1005) (E,Z)-癸二烯酸(E,Z)-2,4-乙酯(梨酯) ((E,Z)-2,4-ethyl decadienoate (pear ester))、(III-GG1006) (Z,Z,E)-7,11,13-十六碳三烯醛 ((Z,Z,E)-7,11,13-hexadecatrienal)、(III-GG1007) 丁酸庚酯 (heptyl butyrate)、(III-GG1008) 肉豆蔻酸異丙酯 (isopropyl myristate)、(III-GG1009) 異戊烯酸熏衣草酯 (lavanulyl senecioate)、(III-GG1010) 2-甲基1-丁醇、(III-GG1011) 甲基丁香酚 (methyl eugenol)、(III-GG1012) 茉莉酸甲酯 (methyl jasmonate)、(III-GG1013) (E,Z)-2,13-十八碳二烯-1-醇 ((E,Z)-2,13-octadecadien-1-ol)、(III-GG1014) (E,Z)-2,13-十八碳二烯-1-醇乙酸酯 ((E,Z)-2,13-octadecadien-1-ol acetate)、(III-GG1015) (E,Z)-3,13-十八碳二烯-1-醇 ((E,Z)-3,13-octadecadien-1-ol)、(III-GG1016) R-1-辛烯-3-醇 (R-1-octen-3-ol)、(III-GG1017) 噴他特馬農 (pentatermanone)、(III-GG1018) 矽酸鉀 (potassium silicate)、(III-GG1019) 山梨糖醇辛酸酯 (sorbitol actanoate)、(III-GG1020) 乙酸(E,Z,Z)-3,8,11-十四碳三烯酯 ((E,Z,Z)-3,8,11-tetradecatrienyl acetate)、(III-GG1021) 乙酸(Z,E)-9,12-十四烷二烯-1-基酯 ((Z,E)-9,12-tetradecadien-1-yl acetate)、(III-GG1022) Z-7-十四碳烯-2-酮 (Z-7-tetradecen-2-one)、Z-9-十四碳烯-1-基乙酸酯 (Z-9-tetradecen-1-yl acetate)、(III-GG1023) Z-11-十四烯醛 (Z-11-tetradecenal)、(III-GG1024) Z-11-十四碳烯-1-醇 (Z-11-tetradecen-1-ol)、(III-GG1025) 黑綠荊樹 ( Acacia negra) 萃取物、(III-GG1026) 葡萄柚籽及果肉萃取物、(III-GG1027) 土荊芥 ( Chenopodium ambrosiodae) 萃取物、(III-GG1028) 脂肪酸與甘油或丙二醇的單酯 (fatty acid monoester with glycerol or propanediol)、(III-GG1029) 貓薄荷油 (catnip oil)、(III-GG1030) 苦楝油 (neem oil)、(III-GG1031) 皂萃取物 (quillay extract)、(III-GG1032) 萬壽菊油 (tagetes oil)。 The agricultural chemical composition as claimed in claim 1, wherein the component (2) is at least one fungicidally active compound (II) selected from the following groups (II-A) to (II-R): (II -A) Inhibitors of sterol biosynthesis: (II-A001) cyproconazole, (II-A002) difenoconazole, (II-A003) epoxiconazole, (II-A004) Fenhexamid, (II-A005) Fenpropidin, (II-A006) Fenpropimorph, (II-A007) Fenpyrazamine, (II-A008 ) Fluquinconazole, (II-A009) Flutriafol, (II-A010) Imazalil, (II-A011) Imazalil sulfate, (II- A012) ipconazole, (II-A013) metconazole, (II-A014) myclobutanil, (II-A015) paclobutrazol, (II-A016) pokera ( prochloraz), (II-A017) propiconazole, (II-A018) prothioconazole, (II-A019) pyrisoxazole, (II-A020) morphosporin ( spiroxamine), (II-A021) tebuconazole, (II-A022) tetraconazole, (II-A023) triadimenol, (II-A024) tridemorph, (II -A025) triticonazole, (II-A026) (1R,2S,5S)-5-(4-chlorobenzyl)-2-(chloromethyl)-2-methyl-1-(1H- 1,2,4-triazol-1-ylmethyl)cyclopentanol ((1R,2S,5S)-5-(4-chlorobenzyl)-2-(chloromethyl)-2-methyl-l-(1H- 1,2,4-triazol-1ylmethyl)cyclopentanol, (II-A027) (1S,2R,5R)-5-(4-chlorobenzyl)-2-(chloromethyl) -2-Methyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol ((1S,2R,5R)-5-(4-chlorobenzyl)-2-(chloromethyl )-2-methyl-1-(1H-1,2,4-triazol-l-ylmethyl)cyclopentanol), (II-A028) (2R)-2-(1-chlorocyclopropyl)-4-[( 1R)-2,2-dichlorocyclopropyl]-1-(1H-1,2,4-triazol-1-yl)butan-2-ol ((2R)-2-(1-chlorocyclopropyl)- 4-[(1R)-2,2-dichlorocyclopropyl]-1-(1H-1,2,4-triazol-1-yl)butan-2-ol), (II-A029) (2R)-2-( 1-chlorocyclopropyl)-4-[(1S)-2,2-dichlorocyclopropyl]-1-(1H-1,2,4-triazol-1-yl)butan-2-ol ( (2R)-2-(1-chlorocyclopropyl)-4-[(1S)-2,2-dichlorocyclopropyl]-1-(1H-1,2,4-triazol-1-yl)butan-2-ol), (II-A030) (2R)-2-[4-(4-Chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1H-1,2,4-triazole-1 -yl)propan-2-ol ((2R)-2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1H-1,2,4-triazol-1-yl)propan -2-ol), (II-A031) (2S)-2-(1-chlorocyclopropyl)-4-[(1R)-2,2-dichlorocyclopropyl]-1-(1H-1 ,2,4-triazol-1-yl)butan-2-ol ((2S)-2-(1-chlorocyclopropyl)-4-[(1R)-2,2-dichlorocyclopropyl]-1-(1H-l ,2,4-triazol-1-yl)butan-2-ol), (II-A032) (2S)-2-(1-chlorocyclopropyl)-4-[(1S)-2,2-two Chlorocyclopropyl]-1-(1H-1,2,4-triazol-1-yl)butan-2-ol ((2S)-2-(1-chlorocyclopropyl)-4-[(1S)-2 ,2-dichlorocyclopropyl]-1-(1H-1,2,4-triazol-1-yl)butan-2-ol), (II-A033) (2S)-2-[4-(4-chlorophenoxy base)-2-( Trifluoromethyl)phenyl]-1-(1H-1,2,4-triazol-1-yl)propan-2-ol ((2S)-2-[4-(4-chlorophenoxy)-2- (trifluoromethyl)phenyl]-1-(1H-1,2,4-triazol-1-yl)propan-2-ol), (II-A034) (R)-[3-(4-chloro-2-fluoro Phenyl)-5-(2,4-difluorophenyl)-1,2-oxazol-4-yl](pyridin-3-yl)methanol ((R)-[3-(4-chloro-2 -fluorophenyl)-5-(2,4-difluorophenyl)-1,2-oxazol-4-yl](pyridin-3-yl)methanol), (II-A035) (S)[3-(4-chloro- 2-fluorophenyl)-5-(2,4-difluorophenyl)-1,2-oxazol-4-yl](pyridin-3-yl)methanol ((S)[3-(4-chloro -2-fluorophenyl)-5-(2,4-difluorophenyl)-1,2-oxazol-4-yl](pyridin-3-yl)methanol), (II-A036) [3-(4-chloro-2 -Fluorophenyl)-5-(2,4-difluorophenyl)-1,2-oxazol-4-yl](pyridin-3-yl)methanol ([3-(4-chloro-2-fluorophenyl )-5-(2,4-difluorophenyl)-1,2-oxazol-4-yl](pyridin-3-yl)methanol), (II-A037) 1-({(2R,4S)-2-[ 2-Chloro-4-(4-chlorophenoxy)phenyl]-4-methyl-1,3-dioxolan-2-yl}methyl)-1H-1,2,4-triazole (1-({(2R,4S)-2-[2-chloro-4-(4-chlorophenoxy)phenyl]-4-methyl-1,3-dioxolan-2-yl}methyl)-1H-1,2 ,4-triazole), (II-A038) 1-({(2S,4S)-2-[2-chloro-4-(4-chlorophenoxy)phenyl]-4-methyl-1,3 -Dioxolan-2-yl}methyl)-1H-1,2,4-triazole (1-({(2S,4S)-2-[2-chloro-4-(4-chlorophenoxy)phenyl ]-4-methyl-l,3-dioxolan-2-yl}methyl)-1H-1,2,4-triazole), (II-A039) 1-{[3-(2-chlorophenyl)-2 -(2,4-Difluorophenyl)oxirane Alk-2-yl]methyl}-1H-1,2,4-triazol-5-ylthiocyanate (1-{[3-(2-chlorophenyl)-2-(2,4-difluorophenyl) oxiran-2-yl]methyl}-1H-1,2,4-triazol-5-yl thiocyanate), (II-A040) 1-{[rel(2R,3R)-3-(2-chlorophenyl) -2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-1H-1,2,4-triazol-5-ylthiocyanate (1-{[rel (2R,3R)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-1H-1,2,4-triazol-5-yl thiocyanate), (II -A041) 1-{[rel(2R,3S)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxirane-2-yl]methyl}-1H -1,2,4-triazol-5-ylthiocyanate (1-{[rel(2R,3S)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2- yl]methyl}-1H-1,2,4-triazol-5-yl thiocyanate), (II-A042) 2-[(2R,4R,5R)-1-(2,4-dichlorophenyl)- 5-Hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione (2-[(2R, 4R,5R)-1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3- thione), (II-A043) 2-[(2R,4R,5S)-1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptane-4- Base]-2,4-dihydro-3H-1,2,4-triazole-3-thione (2-[(2R,4R,5S)-1-(2,4-dichlorophenyl)-5-hydroxy -2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione), (II-A044) 2-[(2R,4S,5R) -1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4- Triazole-3-thione (2-[(2R,4S ,5R)-l-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione ), (II-A045) 2-[(2R,4S,5S)-1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl ]-2,4-dihydro-3H-1,2,4-triazole-3-thione (2-[(2R,4S,5S)-l-(2,4-dichlorophenyl)-5-hydroxy- 2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione), (II-A046) 2-[(2S,4R,5R)- 1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-tri Azole-3-thione (2-[(2S,4R,5R)-1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro -3H-1,2,4-triazole-3-thione), (II-A047) 2-[(2S,4R,5S)-1-(2,4-dichlorophenyl)-5-hydroxy-2 ,6,6-trimethylheptane-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione (2-[(2S,4R,5S)- 1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione), (II -A048) 2-[(2S,4S,5R)-1-(2,4-dichlorophenyl)-5-hydroxyl-2,6,6-trimethylheptane-4-yl]-2, 4-Dihydro-3H-1,2,4-triazole-3-thione (2-[(2S,4S,5R)-1-(2,4-dichlorophenyl)-5-hydroxy-2,6, 6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione), (II-A049) 2-[(2S,4S,5S)-1-(2 ,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3- Thione (2-[(2S,4S,5S)-l-(2, 4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione), (II-A050) 2- [1-(2,4-Dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4- Triazole-3-thione (2-[1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2, 4-triazole-3-thione), (II-A051) 2-[2-chloro-4-(2,4-dichlorophenoxy)phenyl]-l-(1H-1,2,4-tri Azol-1-yl) propan-2-ol (2-[2-chloro-4-(2,4-dichlorophenoxy)phenyl]-l-(1H-1,2,4-triazol-1-yl) propan- 2-ol), (II-A052) 2-[2-Chloro-4-(4-chlorophenoxy)phenyl]-1-(1H-1,2,4-triazol-1-yl)butyl -2-alcohol (2-[2-chloro-4-(4-chlorophenoxy)phenyl]-1-(1H-1,2,4-triazol-1-yl)butan-2-ol), (II-A053 ) 2-[4-(4-Chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1H-1,2,4-triazol-1-yl)butan-2-ol (2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1H-1,2,4-triazol-1-yl)butan-2-ol), (II-A054) 2 -[4-(4-Chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1H-1,2,4-triazol-1-yl)pentan-2-ol (2 -[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1H-1,2,4-triazol-l-yl)pentan-2-ol), (II-A055) 2-[ 4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1H-1,2,4-triazol-1-yl)propan-2-ol (2-[ 4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1H-1,2,4-triazol-1-yl)propan-2-ol), (II-A056) 2-{[3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-2,4-dihydro-3H-1, 2,4-triazole-3-thione (2-{[3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-2,4-dihydro-3H- l,2,4-triazole-3-thione), (II-A057) 2-{[rel(2R,3R)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl )Oxirane-2-yl]methyl}-2,4-dihydro-3H-1,2,4-triazole-3-thione (2-{[rel(2R,3R)-3- (2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-2,4-dihydro-3H-1,2,4-triazole-3-thione), (II-A058) 2-{[rel(2R,3S)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-2,4- Dihydro-3H-l,2,4-triazole-3-thione (2-{[rel(2R,3S)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2 -yl]methyl}-2,4-dihydro-3H-l,2,4-triazole-3-thione), (II-A059) 5-(4-chlorobenzyl)-2-(chloromethyl)- 2-Methyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol (5-(4-chlorobenzyl)-2-(chloromethyl)-2-methyl-1-( 1H-1,2,4-triazol-1-ylmethyl)cyclopentanol), (II-A060) 5-(allylthio)-1-{[3-(2-chlorophenyl)-2-(2 ,4-Difluorophenyl)oxiran-2-yl]methyl}-1H-1,2,4-triazole(5-(allylsulfanyl)-1-{[3-(2-chlorophenyl)- 2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-1H-1,2,4-triazole), (II-A061) 5-(allylsulfanyl)-1-{[rel (2R,3R)-3-2-Chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-1H-1,2,4-triazole (5-(allylsulfanyl)-1-{[rel(2 R,3R)-3-2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-1H-1,2,4-triazole), (II-A062) 5-(ene Propylsulfanyl)-1-{[rel(2R,3S)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxirane-2-yl]methanol Base}-1H-1,2,4-triazole(5-(allylsulfanyl)-1-{[rel(2R,3S)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran- 2-yl]methyl}-1H-1,2,4-triazole), (II-A063) N'-(2,5-dimethyl-4-{[3-(1,1,2,2- Tetrafluoroethoxy)phenyl]thio}phenyl)-N-ethyl-N-methyliminoformamide (N'-(2,5-dimethyl-4-{[3-(1 ,1,2,2-tetrafluoroethoxy)phenyl]sulfanyl}phenyl)-N-ethyl-Nmethylimidoformamide), (II-A064) N'-(2,5-dimethyl-4-{[3-(2,2 ,2-trifluoroethoxy)phenyl]thio}phenyl)N-ethyl-N-methyliminoformamide (N'-(2,5-dimethyl-4-{[3- (2,2,2-trifluoroethoxy)phenyl]sulfanyl}phenyl)N-ethyl-N-methylimidoformamide), (II-A065) N'-(2,5-dimethyl-4-{[3-(2, 2,3,3-Tetrafluoropropoxy)phenyl]thio}phenyl)-N-ethyl-N-methyliminoformamide (N'-(2,5-dimethyl-4- {[3-(2,2,3,3-tetrafluoropropoxy)phenyl]sulfanyl}phenyl)-N-ethyl-N-methylimidoformamide), (II-A066) 5-dimethyl-4-{[3-(five Fluoroethoxy)phenyl]thio}phenyl)-N-ethyl-N-methyliminoformamide (N'-(2,5-dimethyl-4-{[3-(pentafluoroethoxy) phenyl]sulfanyl}phenyl)-N-ethyl-N-methylimidoformamide), (II-A067) N'-(2,N'-(2,5-dimethyl)-4-{3-[(1,1 ,2,2-Tetrafluoroethyl) Sulfuryl]phenoxy}phenyl)-N-ethyl-N-methyliminoformamide (N'-(2,5-dimethyl-4-{3-[(1,l,2 ,2-tetrafluoroethyl)sulfanyl]phenoxy}phenyl)-N-ethyl-Nmethylimidoformamide), (II-A068) N'-(2,5-dimethyl-4-{3-[(2,2,2-three Fluoroethyl)sulfanyl]phenoxy}phenyl)N-ethyl-N-methyliminoformamide (N'-(2,5-dimethyl-4-{3-[(2, 2,2-trifluoroethyl)sulfanyl]phenoxy}phenyl)N-ethyl-N-methylimidoformamide), (II-A069) N'-(2,5-dimethyl-4-{3-[(2,2,3 ,3-tetrafluoropropyl)sulfanyl]phenoxy}phenyl)-N-ethyl-N-methyliminoformamide (N'-(2,5-dimethyl-4-{3 -[(2,2,3,3-tetrafluoropropyl)sulfanyl]phenoxy}phenyl)-N-ethyl-N-methylimidoformamide, (II-A070) N'-(2,5-dimethyl-4-{3- [(Pentafluoroethyl)sulfanyl]phenoxy}phenyl)-N-ethyl-N-methyliminoformamide (N'-(2,5-dimethyl-4-{3- [(pentafluoroethyl)sulfanyl]phenoxy}phenyl)-N-ethyl-N-methylimidoformamide), (II-A071) N'-(2,5-dimethyl-4-phenoxyphenyl)-N-ethyl -N-methyliminoformamide (N'-(2,5-dimethyl-4-phenoxyphenyl)-N-ethyl-N-methylimidoformamide), (II-A072) N'-(4-{[3 -(Difluoromethoxy)phenyl]sulfanyl}-2,5-dimethylphenyl)-N-ethyl-N-methyliminoformamide (N'-(4-{ [3-(difluoromethoxy)phenyl]sulfanyl}-2,5-dimethylphenyl)-N-ethyl-N-methylimidoformamide), (II-A073) N'(4-{3-[(difluoromethyl)sulfanyl ]phenoxy}-2,5-dimethylphenyl)-N-ethyl-N-methyliminoformamide (N'(4-{3-[(difluoromethyl)sulfan yl]phenoxy}-2,5-dimethylphenyl)-N-ethyl-N-methylimidoformamide), (II-A074) N'-[5-bromo-6-(2,3-dihydro-1H-indene-2- Oxy)-2-methylpyridin-3-yl]-N-ethyl-N-methyliminoformamide (N'-[5-bromo-6-(2,3-dihydro-1H- inden-2-yloxy)-2-methylpyridin-3-yl]-N-ethyl-Nmethylimidoformamide), (II-A075) N'-{4-[(4,5-dichloro-1,3-thiazole-2 -yl)oxy]-2,5-dimethylphenyl}-N-ethyl-N-methyliminoformamide (N'-{4-[(4,5-dichloro-1,3 -thiazol-2-yl)oxy]-2,5-dimethylphenyl}-Nethyl-N-methylimidoformamide), (II-A076) N'-{5-bromo-6-[(1R)-1-(3,5 -Difluorophenyl)ethoxy]-2-methylpyridin-3-yl}-N-ethyl-N-methyliminoformamide (N'-{5-bromo-6-[( 1R)-1-(3,5-difluorophenyl)ethoxy]-2-methylpyridin-3-yl}-N-ethyl-N-methylimidofonnamide), (II-A077) N'-{5-bromo-6-[( 1S)-1-(3,5-difluorophenyl)ethoxy]-2-methylpyridin-3-yl}-N-ethyl-N-methyliminoformamide (N'- {5-bromo-6-[(1S)-1-(3,5-difluorophenyl)ethoxy]-2-methylpyridin-3-yl}-N-ethyl-N-methylimidoformamide), (II-A078) N'- {5-bromo-6-[(cis-4-isopropylcyclohexyl)oxy]-2-methylpyridin-3-yl}-N-ethyl-N-methyliminoformamide ( N'-{5-bromo-6-[(cis-4-isopropylcyclohexyl)oxy]-2-methylpyridin-3-yl}-N-ethyl-N-methylimidofornamide), (II-A079) N'-{5- Bromo-6-[(trans-4-isopropylcyclohexyl)oxy]-2-methylpyridin-3-yl}-N-ethyl-N-methyliminoformamide N'-{ 5-bromo-6-[(trans-4-isoprop ylcyclohexyl)oxy]-2-methylpyridin-3-yl}-N-ethyl-Nmethylimidoformamide), (II-A080) N'-{5-bromo-6-[1-(3,5-difluorophenyl) ethyl Oxy]-2-methylpyridin-3-yl}-N-ethyl-N-methyliminoformamide (N'-{5-bromo-6-[1-(3,5-difluorophenyl )ethoxy]-2-methylpyridin-3-yl}N-ethyl-N-methylimidoformamide), (II-A081) mefentrifluconazole, (II-A082) isofen trifluconazole (ipfentrifluconazole), (II -A083) 1-(2,4-difluorophenyl)-2-(1H-1,2,4-triazol-1-yl)-1-[1-(2,6-difluoro-4- Chlorophenoxy)cyclopropyl]ethanol (1-(2,4-difluorophenyl)-2-(1H-1,2,4-triazol-1-yl)-1-[1-(2,6-difluoro -4-chlorophenoxy)cyclopropyl]ethanol), (II-A084) 1-[2-(1-chlorocyclopropyl)-3-(2-fluorophenyl)-2-hydroxypropyl]-1H-imidazole- 5-carbonitrile (1-[2-(l-chlorocyclopropyl)-3-(2-fluorophenyl)-2-hydroxypropyl]-1H-imidazole-5-carbonitrile), (II-A085) terbinafine, (II-A086) buthiobate, (II-A087) pyrifenox, (II-A088) fenarimol, (II-A089) nuarimol, (II-A090) triarimol, (II-A091) triforine, (II-A092) clotrimazole, (II-A093) econazole, (II -A094) Isoconazole, (II-A095) Miconazole, (II-A096) Oxpoconazole, (II-A097) Pefurazoate, (II-A098 ) Triflumizole, (II-A 099) Azaconazole, (II-A100) Bitertanol, (II-A101) Bromuconazole, (II-A102) Diniconazole, (II-A102) A103) Dakley-M (diniconazole-M), (II-A104) etaconazole, (II-A105) Fenke block (fenbuconazole), (II-A106) Fickley (hexaconazole), (II- A107) Imibenconazole, (II-A108) Penconazole, (II-A109) Simeconazole, (II-A110) Triadimefon, (II-A111 ) Uniconazole, (II-A112) pyributicarb, (II-A113) dodemorph, (II-A114) aldimorph, (II-A115) Trimorphamide, (II-A116) piperalin, (II-A117) naftifine; (II-B) Respiratory chain complex I (complex I) or complex II Inhibitors of (complex II): (II-B001) benzovindiflupyr, (II-B002) bixafen, (II-B003) boscalid, (II-B004) Carboxin, (II-B005) Fluopyram, (II-B006) Flutolanil, (II-B007) Fluxapyroxad, (II-B008) Fula Furametpyr, (II-B009) isofetamid, (II-B010) isopyrazam (anti-epimeric enantiomer 1R, 4S, 9S), (II -B011) (isopyrazam (anti-epimeric enantiomer 1S,4R,9R)), (II-B012) 1RS, 4SR, 9SR) (iso pyrazam (anti-epimeric racemate 1RS, 4SR, 9SR)), (II-B013) Mixture) (isopyrazam (mixture of syn-epimeric racemate 1RS, 4SR, 9RS and anti-epimeric racemate 1RS, 4SR, 9SR)), (II-B014) 9R) (isopyrazam (syn-epimeric enantiomer 1R,4S,9R)), (II-B015) ,9S)), (II-B016) sub-epimeric racemate 1RS, 4SR, 9RS) (isopyrazam (syn-epimeric racemate 1RS, 4SR, 9RS)), (II-B017) Benfu Penflufen, (II-B018) Penthiopyrad, (II-B019) pydiflumetofen, (II-B020) pyraziflumid, (II-B021) sedaxane ), (II-B022) 1,3-Dimethyl-N-(1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl)-1H-pyrazole-4 -Carboxamide (1,3-dimethyl-N-(1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl)-1H-pyrazole-4-carboxamide), (II-B023 ) 1,3-Dimethyl-N-[(3R)-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1H-pyrazole-4-carboxy Amide (1,3-dimethyl-N-[(3R)-1,l,3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1H-pyrazole-4-carboxamide), (II -B024) 1,3-Dimethyl-N-[(3S)-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1H-pyrazole-4 -Carboxamide (1,3-dimethyl-N-[(3S)-1,1,3-trimethyl-2,3-dihydro-1H- inden-4-yl]-1H-pyrazole-4-carboxamide), (II-B025) 1-methyl-3-(trifluoromethyl)-N-[2'-(trifluoromethyl)biphenyl- 2-yl]-1H-pyrazole-4-carboxamide (1-methyl-3-(trifluoromethyl)-N-[2'-(trifluoromethyl)biphenyl-2-yl]-1H-pyrazole-4-carboxamide) 、(II-B026) 2-fluoro-6-(trifluoromethyl)-N-(1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl)benzamide (2-fluoro-6-(trifluoromethyl)-N-(1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl)benzamide), (II-B027) 3-(difluoromethyl Base)-1-methyl-N-(1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl)-1H-pyrazole-4-carboxamide (3- (difluoromethyl)-1-methyl-N-(1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl)-1Hpyrazole-4-carboxamide), (II-B028) 3-(two Fluoromethyl)-1-methyl-N-[(3R)-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1H-pyrazole-4- Carboxamide (3-(difluoromethyl)-1-methyl-N-[(3R)-1,1,3-trimethyl-2,3-dihydro-1Hinden-4-yl]-1H-pyrazole-4-carboxamide) (Inpyrfluxam, inpyrfluxam), (II-B029) 3-(Difluoromethyl)-1-methyl-N-[(3S)-1,1,3-trimethyl-2,3-di Hydrogen-1H-inden-4-yl]-1H-pyrazole-4-carboxamide (3-(difluoromethyl)-1-methyl-N-[(3S)-1,1,3-trimethyl-2,3 -dihydro-1H-inden-4-yl]-1H-pyrazole-4-carboxamide), (II-B030) 3-(difluoromethyl)-N-(7-fluoro-1,1,3-trimethyl Base-2,3-dihydro-1H-inden-4-yl)-1-methyl-1H-pyrazole-4-carboxamide (3-(difluoromethyl)-N-(7-fluoro-1,1 ,3-trimethyl-2,3-dihydro-1H- inden-4-yl)-1-methyl-1H-pyrazole-4-carboxamide) (fluindapyr, Fluindapyr), (II-B031) 3-(difluoromethyl)-N-[(3R)- 7-fluoro-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1-methyl-1H-pyrazole-4-carboxamide (3-(difluoromethyl )-N-[(3R)-7-fluoro-l,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1-methyl-1H-pyrazole-4-carboxamide), ( II-B032) 3-(Difluoromethyl)-N-[(3S)-7-fluoro-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl]- 1-Methyl-1H-pyrazole-4-carboxamide (3-(difluoromethyl)-N-[(3S)-7-fluoro-1,1,3-trimethyl-2,3-dihydro-1H-inden -4-yl]-1-methyl-1H-pyrazole-4-carboxamide), (II-B033) 5,8-difluoro-N-[2-(2-fluoro-4-{[4-(trifluoro Methyl)pyridin-2-yl]oxy}phenyl)ethyl]quinazolin-4-amine (5,8-difluoro-N-[2-(2-fluoro-4-{[4-(trifluoromethyl) pyridin-2-yl]oxy}phenyl)ethyl]quinazolin-4-amine), (II-B034) N-(2-cyclopentyl-5-fluorobenzyl)-N-cyclopropyl-3-( Difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide (N-(2-cyclopentyl-5-fluorobenzyl)-N-cyclopropyl-3-(difluoromethyl)-5- fluoro-1-methyl-1-H-pyrazole-4-carboxamide), (II-B035) N-(2-tert-butyl-5-methylbenzyl)-N-cyclopropyl-3-( Difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide (N-(2-tert-butyl-5-methylbenzyl)-N-cyclopropyl-3-(difluoromethyl)- 5-fluoro-1-methyl-1Hpyrazole-4-carboxamide), (II-B036) N-(2-tert-butylbenzyl)-N-cyclopropyl-3-(difluoromethyl)-5 - Fluoro-1-methyl-1H-pyrazole-4-carboxamide (N-(2-tert-butylbenzyl)-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole- 4-carboxamide), (II-B037) N-(5-chloro-2-ethylbenzyl)-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl- 1H-pyrazole-4-carboxamide (N-(5-chloro-2-ethylbenzyl)-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide), (II-B038) N-(5-Chloro-2-isopropylbenzyl)-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole -4-Carboxamide (N-(5-chloro-2-isopropylbenzyl)-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide) (isofluoropropidine , isoflucpyram), (II-B039) N-[(1R,4S)-9-(dichloromethylene)-1,2,3,4-tetrahydro-1,4-methylenenaphthalene-5- Base]-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide (N-[(1R,4S)-9-(dichloromethylene)-1,2,3,4 -tetrahydro-1,4-methanonaphthalen-5-yl]-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide), (II-B040) N-[(1S,4R)-9-( Dichloromethylene)-1,2,3,4-tetrahydro-1,4-methylenenaphthalen-5-yl]-3-(difluoromethyl)-1-methyl-1H-pyrazole -4-Carboxamide (N-[(1S,4R)-9-(dichloromethylene)-1,2,3,4-tetrahydro-1,4-methanonaphthalen-5-yl]-3-(difluoromethyl)-1 -methyl-1H-pyrazole-4-carboxamide), (II-B041) N-[1-(2,4-dichlorophenyl)-1-methoxypropan-2-yl]-3-(difluoro Methyl)-1-methyl-1H-pyrazole-4-carboxamide (N-[1-(2,4-dichlorophenyl )-l-methoxypropan-2-yl]-3-(difluoromethyl)-1-methyl1H-pyrazole-4-carboxamide), (II-B042) N-[2-chloro-6-(trifluoromethyl)benzene Base]-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide (N-[2-chloro-6-(trifluoromethyl) benzyl]-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide), (II-B043) N-[3-chloro-2-fluoro-6-(three Fluoromethyl)benzyl]-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide (N-[3-chloro -2-fluoro-6-(trifluoromethyl)benzyl]-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide), (II-B044) N-[5- Chloro-2-(trifluoromethyl)benzyl]-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide ( N-[5-chloro-2-(trifluoromethyl)benzyl]-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide), (II-B045) N-cyclo Propyl-3-(difluoromethyl)-5-fluoro-1-methyl-N-[5-methyl-2-(trifluoromethyl)benzyl]-1H-pyrazole-4-carboxy Amide (N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-N-[5-methyl-2-(trifluoromethyl)benzyl]-1H-pyrazole-4-carboxamide), (II-B046) N-cyclopropyl-3-(difluoromethyl)-5-fluoro-N-(2-fluoro-6-isopropylbenzyl)-1-methyl-1H-pyrazole-4-carboxylate Amine (N-cyclopropyl-3-(difluoromethyl)-5-fluoro-N-(2-fluoro-6-isopropylbenzyl)-1-methyl-1H-pyrazole-4-carboxamide), (II -B047) N-cyclopropyl-3-(difluoromethyl)-5-fluoro-N-(2-isopropyl-5-methylbenzyl)-1-methyl-1H-pyrazole- 4-Carboxamide (N-cyclopropyl-3-(difluoromethyl)-5-fluoro-N-(2-isopropyl-5-methylbenzyl)-1-methyl-1Hpyrazole-4-carboxamide), (II-B048) N- Cyclopropyl-3-(difluoromethyl)-5-fluoro-N-(2-isopropylbenzyl)-1-methyl-1H-pyrazole-4-methionamide (N-cyclopropyl -3-(difluoromethyl)-5-fluoro-N-(2-isopropylbenzyl)-1-methyl-1H-pyrazole-4-carbothioamide), (II-B049) N-cyclopropyl-3-(difluoromethyl )-5-fluoro-N-(2-isopropylbenzyl)-1-methyl-1H-pyrazole-4-carboxamide (N-cyclopropyl-3-(difluoromethyl)-5-fluoro-N -(2-isopropylbenzyl)-1-methyl-1H-pyrazole-4-carboxamide), (II-B050) N-cyclopropyl-3-(difluoromethyl)-5-fluoro-N-(5-fluoro -2-isopropylbenzyl)-1-methyl-1H-pyrazole-4-carboxamide (N-cyclopropyl-3-(difluoromethyl)-5-fluoro-N-(5-fluoro-2- isopropylbenzyl)-1-methyl-1H-pyrazole-4-carboxamide), (II-B051) ) N-cyclopropyl-3-(difluoromethyl)-N-(2-ethyl-4,5-di Methylbenzyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide (N-cyclopropyl-3-(difluoromethyl)-N-(2-ethyl-4,5-dimethylbenzyl) -5-fluoro-1-methyl-1H-pyrazole-4-carboxamide), (II-B052) N-cyclopropyl-3-(difluoromethyl)-N-(2-ethyl-5-fluorobenzene Methyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide (N-cyclopropyl-3-(difluoromethyl)-N-(2-ethyl-5-fluorobenzyl)-5-fluoro- 1-methyl-1H-pyrazole-4-carboxa mide), (II-B053) N-cyclopropyl-3-(difluoromethyl)-N-(2-ethyl-5-methylbenzyl)-5-fluoro-1-methyl-1H -pyrazole-4-carboxamide (N-cyclopropyl-3-(difluoromethyl)-N-(2-ethyl-5-methylbenzyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide), ( II-B054) N-cyclopropyl-N-(2-cyclopropyl-5-fluorobenzyl)-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole- 4-Carboxamide (N-cyclopropyl-N-(2-cyclopropyl-5-fluorobenzyl)-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide), (II-B055) N-cyclopropyl-N-(2-cyclopropyl-5-methylbenzyl)-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxy Amide (N-cyclopropyl-N-(2-cyclopropyl-5-methylbenzyl)-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide), (II-B056) N-cyclo Propyl-N-(2-cyclopropylbenzyl)-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide (N-cyclopropyl-N -(2-cyclopropylbenzyl)-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide), (II-B057) 2-(difluoromethyl)-N-(1,1 -Dimethyl-3-propyl-2,3-dihydro-1H-inden-4-yl)nicotinamide (2-(difluoromethyl)-N-(l,1-dimethyl-3-propyl-2 ,3-dihydro-1H-inden-4-yl)nicotinamide), (II-B058) pyrapropoyne, (II-B059) inpyrfluxam, (II-B060 ) Mepronil, (II-B061) isoflucypram, (II-B062) oxycarboxin, (II-B063) α-(methoxyimino)-N-methyl base-2-[[[1-[ 3-(trifluoromethyl)phenyl]ethoxy]imino]methyl]phenylacetamide (α-(methoxyimino)-N-methyl-2-[[[1-[3-(trifluoromethyl) phenyl]ethoxy]imino]methyl]benzeneacetamide), (II-B064) diflumetorim, (II-B065) thifluzamide, (II-B066) fenfuram, (II -B067) benodanil; (II-C) Inhibitors of respiratory chain complex III (complex III): (II-C001) ametoctradin, (II-C002) Amethoxam ( amisulbrom), (II-C003) azoxystrobin, (II-C004) coumethoxystrobin, (II-C005) coumoxystrobin, (II-C006) cyazofamid ), (II-C007) dimoxystrobin, (II-C008) enoxastrobin, (II-C009) famoxadone, (II-C010) fenamidone , (II-C011) flufenoxystrobin, (II-C012) fluoxastrobin, (II-C013) kresoxim-methyl, (II-C014) oxastrobin ( metominostrobin), (II-C015) orysastrobin, (II-C016) picoxystrobin, (II-C017) pyraclostrobin, (II-C018) pyraclostrobin Esters (pyrametostrobin), (II-C019) pyraoxystrobin (pyraoxystrobin), (II-C020) trifluorosensitivity (trifloxystrobin), (II-C021) (2E)-2-{2-[({[(1E) -1-(3-{[(E)-1-fluoro-2-phenylvinyl]oxy}phenyl)ethylene]amino}oxy)methyl]phenyl}-2-(methoxy Imino)-N-methylacetamide ((2E)-2-{2-[({[(1E)-1-(3-{[(E)-1-fluoro-2-phenylv inyl]oxy}phenyl)ethylene]amino}oxy)methyl]phenyl}-2-(methoxyimino)-N-methylacetamide), (II-C022) (2E,3Z)-5-{[1-(4-chlorobenzene Base)-1H-pyrazol-3-yl]oxy}-2-(methoxyimino)-N,3-dimethylpent-3-enamide ((2E,3Z)-5-{ [1-(4-chlorophenyl)-1H-pyrazol-3-yl]oxy}-2-(methoxyimino)-N,3-dimethylpent-3-enamide), (II-C023) (2R)-2-{2 -[(2,5-Dimethylphenoxy)methyl]phenyl}-2-methoxy-N-methylacetamide ((2R)-2-{2-[(2,5- dimethylphenoxy)methyl]phenyl}-2-methoxy-N- methylacetamide), (II-C024) (2S)-2-{2-[(2,5-dimethylphenoxy)methyl]phenyl}- 2-Methoxy-N-methylacetamide ((2S)-2-{2-[(2,5-dimethylphenoxy)methyl]phenyl}-2-methoxy-N-methylacetamide), (II-C025) (3S,6S,7R,8R)-8-Benzyl-3-[({3-[(isobutyryloxy)methoxy]-4-methoxypyridin-2-yl}carbonyl)amino ]-6-methyl-4,9-dioxo-1,5-dioxo-7-yl-2-methylpropionate) ((3S,6S,7R,8R)-8-benzyl- 3-[({3-[(isobutyryloxy)methoxy]-4-methoxypyridin-2-yl}carbonyl)amino]-6-methyl-4,9-dioxo-1,5-dioxonan-7-yl-2-methylpropanoate ) (Fenpicoxamid, Fenpicoxamid), (II-C026) 2-{2-[(2,5-Dimethylphenoxy)methyl]phenyl}-2-methoxy-N-methyl Acetamide (2-{2-[(2,5-dimethylphenoxy)methyl]phenyl}-2-methoxy-N-methylacetamide) (Mandestrobin), (II-C027) N-(3-ethyl -3,5,5-trimethylcyclohexyl)-3-formamido-2-hydroxybenzamide (N-(3-ethyl-3,5,5-trimet hylcyclohexyl)-3-formamido-2-hydroxybenzamide), (II-C028) (2E,3Z)-5-{[1-(4-chloro-2-fluorophenyl)-1H-pyrazol-3-yl] Oxy}-2-(methoxyimino)-N,3-dimethylpent-3-enamide ((2E,3Z)-5-{[1-(4-chloro-2-fluorophenyl )-1H-pyrazol-3-yl]oxy}-2-(methoxyimino)-N,3-dimethylpent-3-enamide), (II-C029) methyl{5-[3-(2,4-dimethyl phenyl)-1H-pyrazol-1-yl]-2-methylbenzyl}carbamate (methyl {5-[3-(2,4-dimethylphenyl)-1H-pyrazol-1-yl ]-2-methylbenzyl}carbamate), (II-C030) 1-(2-{[1-(4-chlorophenyl)pyrazol-3-yl]oxymethyl}-3-methylphenyl) -1,4-Dihydro-4-methyl-5H-tetrazol-5-one (1-(2-{[1-(4-chlorophenyl)pyrazol-3-yl]oxymethyl}-3-methylphenyl)- 1,4-dihydro-4-methyl-5H-tetrazol-5-one) (Methyltetraprole), (II-C031) florylpicoxamid, (II-C032) pyribencarb ), (II-C033) α-(methoxyimino)-N-methyl-2-[[[1-[3-(trifluoromethyl)phenyl]ethoxy]imino] ( II-D) Inhibitors of mitosis and cell division: (II-D001) carbendazim, (II-D002) diethofencarb, (II-D003) ethaboxam, (II -D004) fluopicolide, (II-D005) pencycuron, (II-D006) thiabendazole, (II-D007) methyl Thiophanate-methyl, (II-D008) zoxamide, (II-D009) 3-chloro-4-(2,6-difluorophenyl)-6-methyl-5- Phenylpyridazine (3-chloro-4-(2,6-difluorophenyl)-6-methyl-5-phenylpyridazine), (II-D010) 3-chloro-5-(4-chlorophenyl)-4-( 2,6-difluorophenyl)-6-methylpyridazine (3-chloro-5-(4-chlorophenyl)-4-(2,6-difluorophenyl)-6-methylpyridazine), (II-D011) 3 -Chloro-5-(6-chloropyridin-3-yl)-6-methyl-4-(2,4,6-trifluorophenyl)pyridazine (3-chloro-5-(6-chloropyridin-3 -yl)-6-methyl-4-(2,4,6-trifluorophenyl)pyridazine), (II-D012) 4-(2-bromo-4-fluorophenyl)-N-(2,6-difluoro Phenyl)-1,3-dimethyl-1H-pyrazol-5-amine (4-(2-bromo-4-fluorophenyl)-N-(2,6-difluorophenyl)-l,3-dimethyl-1H -pyrazol-5-amine), (II-D013) 4-(2-bromo-4-fluorophenyl)-N-(2-bromo-6-fluorophenyl)-1,3-dimethyl-1H -pyrazol-5-amine (4-(2-bromo-4-fluorophenyl)-N-(2-bromo-6-fluorophenyl)-l,3-dimethyl-1H-pyrazol-5-amine), (II- D014) 4-(2-bromo-4-fluorophenyl)-N-(2-bromophenyl)-1,3-dimethyl-1H-pyrazole-5-amine (4-(2-bromo- 4-fluorophenyl)-N-(2-bromophenyl)-1,3-dimethyl-1H-pyrazol-5-amine), (II-D015) 4-(2-bromo-4-fluorophenyl)-N-( 2-Chloro-6-fluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine (4-(2-bromo-4-fluorophenyl)-N-(2-chloro-6-fluorophenyl )-l,3-dimethyl-1H-pyrazol-5-amine), (II-D016) 4-(2-bromo-4-fluorophenyl)-N-(2-chlorophenyl)-1,3- Dimethyl-1H-pyrazol-5-amine (4-(2-bromo-4-fluorophenyl)-N-(2-chlorophenyl)-l,3-dimethyl-1H-pyrazol-5-amine), (II-D017) 4-(2-bromo-4- Fluorophenyl)-N-(2-fluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine (4-(2-bromo-4-fluorophenyl)-N-(2-fluorophenyl )-1,3-dimethyl-1H-pyrazol-5-amine), (II-D018) 4-(2-chloro-4-fluorophenyl)-N-(2,6-difluorophenyl))- 1,3-Dimethyl-1H-pyrazol-5-amine (4-(2-chloro-4-fluorophenyl)-N-(2,6-difluorophenyl)-l,3-dimethyl-1H-pyrazol-5 -amine), (II-D019) 4-(2-chloro-4-fluorophenyl)-N-(2-chloro-6-fluorophenyl)-1,3-dimethyl-1H-pyrazole- 5-amine (4-(2-chloro-4-fluorophenyl)-N-(2-chloro-6-fluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine), (II-D020) 4- (2-Chloro-4-fluorophenyl)-N-(2-chlorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine (4-(2-chloro-4-fluorophenyl) -N-(2-chlorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine), (II-D021) 4-(2-chloro-4-fluorophenyl)-N-(2-fluorobenzene Base)-1,3-dimethyl-1H-pyrazol-5-amine (4-(2-chloro-4-fluorophenyl)-N-(2-fluorophenyl)-1,3-dimethyl-1H-pyrazol- 5-amine), (II-D022) 4-(4-chlorophenyl)-5-(2,6-difluorophenyl)-3,6-dimethylpyridazine (4-(4-chlorophenyl) -5-(2,6-difluorophenyl)-3,6-dimethylpyridazine), (II-D023) N-(2-bromo-6-fluorophenyl)-4-(2-chloro-4-fluorophenyl) -l,3-Dimethyl-1H-pyrazol-5-amine (N-(2-bromo-6-fluorophenyl)-4-(2-chloro-4-fluorophenyl)-l,3-dimethyl-1H- pyra zol-5-amine), (II-D024) N-(2-bromophenyl)-4-(2-chloro-4-fluorophenyl)-1,3-dimethyl-1H-pyrazole-5 -Amine (N-(2-bromophenyl)-4-(2-chloro-4-fluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine), (II-D025) N-(4-chloro- 2,6-difluorophenyl)-4-(2-chloro-4-fluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine (N-(4-chloro-2, 6-difluorophenyl)-4-(2-chloro-4-fluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine), (II-D026) Benomyl; (II-E) can Compounds with multi-site action: (II-E001) Bordeaux mixture, (II-E002) captafol, (II-E003) captan, (II-E004) IV Chlorothalonil, (II-E005) copper hydroxide, (II-E006) copper naphthenate, (II-E007) copper oxide, (II-E008) copper oxychloride (copper oxychloride), (II-E009) copper sulfate, (II-E010) dithianon, (II-E011) dodine, (II-E012) folpet , (II-E013) mancozeb (mancozeb), (II-E014) maneb, (II-E015) metiram, (II-E016) metiram zinc, (II-E017) Oxine-copper, (II-E018) Propineb, (II-E019) Sulfur and sulfur preparations, such as sulfur and sulfur preparations including calcium polysulfide polysulfide), (II-E020) thiram, (II-E021) zineb, (II-E022) ziram, (II-E023) 6-ethyl-5,7 -Dioxy-6,7-dihydro-pyrrolo[3',4':5,6][1,4]di Thio[2,3-c][1,2]thiazole-3-carbonitrile (6-ethyl-5,7-dioxo-6,7-dihydro-5Hpynolo[3',4':5,6][1 ,4]dithiino[2,3-c] [1,2]thiazole-3-carbonitrile, (II-E024) Ferbam, (II-E025) dichlofluanid, (II-E026) Tolylfluanid, (II-E027) Guazatine, (II-E028) iminoctadine, (II-E029) anilazine, (II-E030) Acaricide Quinomethionate; (II-F) Compounds that induce host defense: (II-F001) acibenzolar-S-methyl, (II-F002) isotianil , (II-F003) probenazole, (II-F004) tiadinil; (II-G) inhibitors of amino acid and/or protein biosynthesis: (II-G001) Saipu Cyprodinil, (II-G002) kasugamycin, (II-G003) kasugamycin hydrochloride hydrate, (II-G004) oxytetracycline, ( II-G005) pyrimethanil, (II-G006) 3-(5-fluoro-3,3,4,4-tetramethyl-3,4-dihydroisoquinolin-1-yl)quinone (3-(5-fluoro-3,3,4,4-tetramethyl-3,4-dihydroisoquinolin-1-yl)quinoline), (II-G007) fuberidazole, (II-G008) sulfur (thiophanate), (II-G009) blasticidin-S (blasticidin-S), (II-G010) streptomycin (streptomycin), (II-G011) mepanipyrim; (II-H ) Inhibitors of adenosine triphosphate (ATP) production: (II-H001) silthiofam, (II-H002) triphenyltin acetate (fen tin acetate), (II-H003) fentin chloride, (II-H004) fentin hydroxide; (II-I) inhibitor of cell wall synthesis: (II-I001) phenthiazium Amines (benthiavalicarb), (II-I002) Dimethomorph, (II-I003) Flumorph (flumorph), (II-I004) Provalicarb, (II-I005) Manpramide ( mandipropamid), (II-I006) pyrimorph, (II-I007) valifenalate, (II-I008) (2E)-3-(4-tert-butylphenyl)-3 -(2-Chloropyridin-4-yl)-1-(morpholin-4-yl)prop-2-en-1-one ((2E)-3-(4-tert-butylphenyl)-3-(2 -chloropyridin-4-yl)-l-(morpholin-4-yl)prop-2-en-1-one), (II-I009) (2Z)-3-(4-tert-butylphenyl)-3 -(2-Chloropyridin-4-yl)-1-(morpholin-4-yl)prop-2-en-1-one ((2Z)-3-(4-tert-butylphenyl)-3-(2 -chloropyridin-4-yl)-1-(morpholin-4-yl)prop-2-en-1-one), (II-I010) benthiavalicarb-isopropyl, (II- I011) Paulomycin (polyoxins), (II-I012) N-[2-[4-[[3-(4-chlorophenyl)-2-propyn-1-yl]oxyl]-3- (N-[2-[4-[[3-(4-chlorophenyl)-2-propyn-1-yl]oxy]-3-), (II-I013)methoxyphenyl]ethyl]-3 -Methyl-2-[(methylsulfonyl)-amino]butanamide (methoxyphenyl]ethyl]-3-methyl-2-[(methylsulfonyl)-amino]butanamide), (II-I014) N- [2-[4-[[3-(4-Chlorophenyl)-2-propyn-1-yl]oxy]-3-methoxyphenyl]-ethyl]-3-methyl-2 -[(Ethylsulfonyl)amino]butyramide (N-[2-[4-[[3-(4-chlorophenyl)-2-propyn-1-yl]oxy]-3-met hoxyphenyl]-ethyl]-3-methyl-2-[(ethylsulfonyl)amino]butanamide); (II-J) Inhibitors of lipid and membrane synthesis: (II-J001) propamocarb, (II-J002 ) propamocarb hydrochloride, (II-J003) tolclofos-methyl, (II-J004) difenphos, (II-J005) iodocarb, (II-J006) Prothiocarb, (II-J007) Edifenphos, (II-J008) Propyl pine (iprobenfos), (II-J009) Pyrazophos, (II -J010) isoprothiolane, (II-J011) etridiazole, (II-J012) biphenyl, (II-J013) chloroneb, (II-J014) Dicloran, (II-J015) quintozene, (II-J016) tecnazene; (II-K) melanin biosynthesis inhibitor: (II-K001) tricyclic Tricyclazole, (II-K002) 2,2,2-trifluoroethyl{3-methyl-1-[(4-methylbenzoyl)amino]butan-2-yl}amine Carbamate (2,2,2-trifluoroethyl {3-methyl-1-[(4-methylbenzoyl)amino]butan-2-yl}carbamate), (II-K003) carpropamid, (II -K004) diclocymet, (II-K005) fenoxanil, (II-K006) fthalide, (II-K007) pyroquilon; (II-L) Nucleic acid synthesis inhibitors: (II-L001) Benalaxyl (benalaxyl), (II-L002) Right Benalaxyl (benalaxyl-M (kiralaxyl)), (II-L003) Metaxyl (metalaxyl), (II- L004) Dextromethorphan (metalaxyl-M) (Mefenoxam, mefenoxam), (II-L005) Iremo (e thirimol), (II-L006) furalaxyl, (II-L007) ofurace, (II-L008) oxolinic acid, (II-L009) oxolinic acid ( hymexazole), (II-L010) octhilinone, (II-L011) bupirimate, (II-L012) dimethirimol; (II-M) Inhibitor of signal transmission : (II-M001) fludioxonil, (II-M002) iprodione, (II-M003) procymidone, (II-M004) proquinazid, (II -M005) Quinoxyfen, (II-M006) Vinclozolin, (II-M007) Chlozolinate, (II-M008) Fenpiclonil, (II-M009) Proquinazid, (II-M010) 2-butoxy-6-iodo-3-propyl-4H-1-benzopyran-4-one (2-butoxy-6-iodo-3- propyl-4H-1-benzopyran-one); (II-N) Compounds that can be used as decoupling agents: (II-N001) fluazinam, (II-N002) meptyldinocap, (II-N003) binapacryl, (II-N004) dinocap; (II-O) other fungicides: (II-O001) abscisic acid, (II- O002) Benthiazole, (II-O003) Bethoxazin, (II-O004) Capsimycin, (II-O005) Carvone, (II-O006) Chinomethionat, (II-O007) cufraneb, (II-O008) cyflufenamid, (II-O009) cymoxanil, (II-O010) cyprosulfone Cyprosulfamide, (II-O011) flutianil, (II-O012) fosetylalum inium), (II-O013) fosetyl-calcium, (II-O014) fosetyl-sodium, (II-O015) methyl isothiocyanate, ( II-O016) Metrafenone, (II-O017) Mildiomycin, (II-O018) Natamycin, (II-O019) Nickel Dimethyldithiocarbamate (nickel dimethyldithiocarbamate), (II-O020) nitrothal-isopropyl, (II-O021) oxamocarb, (II-O022) oxathiapiprolin, (II -O023) Oxyfenthiin, (II-O024) Pentachlorophenol and salts, (II-O025) Phosphorous acid and its salts, (II- O026) propamocarb-fosetylate, (II-O027) pyriofenone (chlazafenone), (II-O028) tebufloquin, (II-O029 ) tecloftalam, (II-O030) tolnifanide, (I-O031) 1-(4-{4-[(5R)-5-(2,6-difluorophenyl) -4,5-dihydro-1,2-oxazol-3-yl]-1,3-thiazol-2-yl}piperidin-1-yl)-2-[5-methyl-3-(trifluoro Methyl)-1H-pyrazol-1-yl]ethanone (1-(4-{4-[(5R)-5-(2,6-difluorophenyl)-4,5-dihydro-1,2-oxazol -3-yl]-1,3-thiazol-2-yl}piperidin-1-yl)-2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]ethanone), (II- O032) 1-(4-{4-[(5S)-5-(2,6-difluorophenyl)-4,5-dihydro-1,2-oxazol-3-yl]-1,3- Thiazol-2-yl}piperidin-1-yl)-2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]ethanone (1-(4-{ 4-[(5S)-5-(2,6-difluorophenyl)-4,5-dihydro-1,2-oxazol-3-yl]-l,3-thiazol-2-yl}piperidin-1-yl) -2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]ethanone), (II-O033) 2-(6-benzylpyridin-2-yl)quinazoline (2- (6-benzylpyridin-2-yl)quinazoline), (II-O034) 2,6-dimethyl-1H,5H-[1,4]dithieno[2,3-c:5, 6-c']dipyrrole-1,3,5,7(2H,6H)-tetraketone (2,6-dimethyl-1H,5H-[1,4]dithiino[2,3-c:5,6 -c']dipyrrole-1,3,5,7(2H,6H)-tetrone), (II-O035) 2-[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl ]-1-[4-(4-{5-[2-(prop-2-yn-1-yloxy)phenyl]-4,5-dihydro-1,2-oxazol-3-yl}- 1,3-thiazol-2-yl)piperidin-1-yl]ethanone (2-[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]-1-[4-(4-{ 5-[2-(prop-2-yn-1-yloxy)phenyl]-4,5-dihydro-l,2-oxazol-3-yl}-l,3-thiazol-2-yl)piperidin-1- yl]ethanone), (II-O036) 2-[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]-1-[4-(4-{5-[2-chloro -6-(prop-2-yn-1-yloxy)phenyl]-4,5-dihydro-1,2-oxazol-3-yl}-1,3-thiazol-2-yl)piperidine- 1-yl]ethanone (2-[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]-1-[4-(4-{5-[2-chloro-6-(prop-2 -yn-1-yloxy)phenyl]-4,5-dihydro-1,2-oxazol-3-yl}-1,3-thiazol-2-yl)piperidin-1-yl]ethanone), (II-O037 ) 2-[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]-1-[4-(4-{5-[2-fluoro-6-(prop-2-yne -1-yloxy)phenyl]-4,5-dihydro-1,2-oxazol-3-yl}-1,3-thiazole-2 -yl)piperidin-1-yl]ethanone (2-[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]-1-[4-(4-{5-[2-fluoro- 6-(prop-2-yn-1-yloxy)phenyl]-4,5-dihydro-l,2-oxazol-3-yl}-l,3-thiazol-2-yl)piperidin-1-yl]ethanone ), (II-O038) 2-[6-(3-fluoro-4-methoxyphenyl)-5-methylpyridin-2-yl]quinazoline (2-[6-(3-fluoro- 4-methoxyphenyl)-5-methylpyridin-2-yl]quinazoline), (II-O039) 2-{(5R)-3-[2-(1-{[3,5-bis(difluoromethyl)- 1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1,3-thiazol-4-yl]-4,5-dihydro-1,2-oxazol-5-yl}- 3-Chlorophenyl mesylate (2-{(5R)-3-[2-(1-{[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4- yl)-1,3-thiazol-4-yl]-4,5-dihydro-l,2-oxazol-5-yl}-3-chlorophenyl methanesulfonate), (II-O040) 2-{(5S)-3 -[2-(1-{[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1,3-thiazole-4- Base]-4,5-dihydro-1,2-oxazol-5-yl}-3-chlorophenyl mesylate (2-{(5S)-3-[2-(1-{[3, 5-bis(difluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1,3-thiazol-4-yl]-4,5-dihydro-1,2-oxazol-5-yl }-3-chlorophenylmethanesulfonate), (II-O041) 2-{2-[(7,8-difluoro-2-methylquinolin-3-yl)oxy]-6-fluorophenyl}propan-2 -alcohol (2-{2-[(7,8-difluoro-2-methylquinolin-3-yl)oxy]-6-fluorophenyl}propan-2-ol), (II-O042) 2-{2-fluoro- 6-[(8-fluoro-2-methylquinolin-3-yl)oxy]phenyl}propan-2-ol (2-{2-fluoro-6 -[(8-fluoro-2-methylquinolin-3-yl)oxy]phenyl}propan-2-ol), (II-O043) 2-{3-[2-(1-{[3,5-double( Difluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1,3-thiazol-4-yl]-4,5-dihydro-1,2-oxazole -5-yl}-3-chlorophenyl mesylate (2-{3-[2-(1-{[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin- 4-yl)-1,3-thiazol-4-yl]-4,5-dihydro-1,2-oxazol-5-yl}-3-chlorophenyl methanesulfonate) (fluoxapiprolin), (II -O044) 2-{3-[2-(1-{[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1 ,3-Thiazol-4-yl]-4,5-dihydro-1,2-oxazol-5-yl}phenyl methanesulfonate (2-{3-[2-(1-{[3,5 -bis(difluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1,3-thiazol-4-yl]-4,5-dihydro-1,2-oxazol-5-yl} phenylmethanesulfonate), (II-O045) 2-phenylphenol and salts (2-phenylphenol and salts), (II-O046) 3-(4,4,5-trifluoro-3,3-dimethyl -3,4-dihydroisoquinolin-1-yl)quinoline (3-(4,4,5-trifluoro-3,3-dimethyl-3,4-dihydroisoquinolin-1-yl)quinoline), (II -O047) 3-(4,4-difluoro-3,3-dimethyl-3,4-dihydroisoquinolin-1-yl)quinoline (3-(4,4-difluoro-3,3 -dimethyl-3,4-dihydroisoquinolin-1-yl)quinoline) (Quinofumelin, Quinofumelin), (II-O048) 4-amino-5-fluoropyrimidin-2-ol (tautomeric form: 4-amine base-5-fluoropyrimidin-2(1H)-one) (4-amino-5-fluoropyrimidin-2-ol (tautomeric form: 4-amino-5-fluoropyrimidin-2(1H )-one)), (II-O049) 4-oxo-4-[(2-phenylethyl)amino]butanoic acid (4-oxo-4-[(2-phenylethyl)amino]butanoic acid ), (II-O050) 5-amino-1,3,4-thiadiazole-2-thiol (5-amino-1,3,4-thiadiazole-2-thiol), (II-O051) 5 -Chloro-N''-phenyl-N'-(prop-2-yn-1-yl)thiophene-2-sulfonylhydrazine (5-chloro-N'-phenyl-N'-(prop-2 -yn-1-yl)thiophene-2-sulfonohydrazide), (II-O052) 5-fluoro-2-[(4-fluorobenzyl)oxy]pyrimidin-4-amine (5-fluoro-2-[( 4-fluorobenzyl)oxy]pyrimidin-4-amine), (II-O053) 5-fluoro-2-[(4-methylbenzyl)oxy]pyrimidin-4-amine (5-fluoro-2-[( 4-methylbenzyl)oxy]pyrimidin-4-amine), (II-O054) 9-fluoro-2,2-dimethyl-5-(quinolin-3-yl)-2,3-dihydro-1, 4-benzoxazepine (9-fluoro-2,2-dimethyl-5-(quinolin-3-yl)-2,3-dihydro-1,4-benzoxazepine), (II-O055) {6-[ ({[(Z)-(1-Methyl-1H-tetrazol-5-yl)(phenyl)methylene]amino}oxy)methyl]pyridin-2-yl}carbamic acid butyl-3- Alkyn-1-yl ester (but-3-yn-1-yl{6-[({[(Z)-(l-methyl-1H-tetrazol-5-yl)(phenyl)methylene]amino}oxy)methyl ]pyridin-2-yl}carbamate), (II-O056) (2Z)-3-amino-2-cyano-3-phenylacrylate ethyl ester (ethyl(2Z)-3-amino-2-cyano- 3-phenylacrylate), (II-O057) phenazine-1-carboxylic acid (phenazine-1-carboxylic acid), (II-O058) 3,4,5-trihydroxybenzoic acid propyl ester (propyl 3,4,5- trihydroxybenzoate), (II-O059) quinolin-8-ol (quinolin-8-ol), (II-O060) quinolin-8-ol sulfate (2:1) (quinolin-8-ol sulfate ate (2:1)), (II-O061) {6-[({[(1-methyl-1H-tetrazol-5-yl)(phenyl)methylene]amino}oxy)methyl ]pyridin-2-yl}carbamic acid tert-butyl ester (tert-butyl {6-[({[(1-methyl-1H-tetrazol-5-yl)(phenyl)methylene]amino}oxy)methyl]pyridin- 2-yl}carbamate), (II-O062) 5‑fluoro‑4‑imino‑3‑methyl‑1‑[(4‑methylphenyl)sulfonyl]‑3,4‑dihydropyrimidine ‑2(1H)‑ketone (5-fluoro-4-imino-3-methyl-1-[(4-methylphenyl)sulfonyl]-3,4-dihydropyrimidin-2(1H)-one), (II-O063) pyridachlometyl, (II-O064) ipflufenoquin, (II-O065) aminopyrifen, (II-O066) N-[[(cyclopropyl-methoxy Base) amino][6-(difluoromethoxy)-2,3-difluorophenyl]-methylene]phenylacetamide (N-[[(cyclopropyl-methoxy)amino][6-( difluoromethoxy)-2,3-difluorophenyl]-methylene]benzeneacetamide), (II-O067) methasulfocarb, (II-O068) nabam, (II-O069) oxine copper ), (II-O070) ditalimfos, (II-O071) drazoxolon, (II-O072) tolyfluanide, (II-O073) diclobutrazol , (II-O074) cyprofuram, (II-O075) phosphate and its salts (phophorous acid and salts), (II-O076) rich rice comprehensive (ferimzone), (II-O077) pyrrolnitrin, ( II-O078) Triazoxide, (II-O079) Flusulfamide, (II-O080) Diclomezine, (II-O081) Mineral oils, (II-O082 ) Organic oils, (II-O083) Inorganic oils, (II-O084) Potassium bicarbonate, (II-O085) Ferric methanesulfonate, (II- O086) 4-fluorophenyl-N-[1-[[[[1-(4-cyanophenyl) ethyl] sulfonyl] methyl] propyl] carbamate (4-fluorophenyl- N-[1-[[[1-(4-cyanophenyl)ethyl]sulfonyl]msethyl]propyl]carbamate), (II-O087) 5-chloro-6-(2,4,6-trifluorophenyl)- 7-(4-Methylpiperidin-1-yl)[1,2,4]triazolo[1,5-a]pyrimidine (5-chloro-6-(2,4,6-trifluorophenyl)-7 -(4-methylpiperidin-1-yl)[1,2,4]triazolo[1,5-a]pyrimidine), (II-O088) N-[4-[4-chloro-3-(trifluoromethyl )phenoxy]-2,5-dimethylphenyl]-N-ethyl-N-methylimine (N-[4-[4-chloro-3-(trifluoromethyl)phenoxy]-2, 5-dimethylphenyl]-N-ethyl-N-methylmethanimidamide); (II-P) HDAC inhibitors: (II-P001) N-(1-ethylcyclopropyl)-4-[5-(trifluoromethyl )-1,2,4-oxadiazol-3-yl]benzamide ), (II-P002) N-(2-isopropylcyclopropyl)-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide ( N-(2-isopropylcyclopropyl)-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide), (II-P003) N-(2-methylcyclopropyl)-4 -[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide (N-(2-methylcyclopropyl)-4-[5-(trifluoromethyl)-1,2, 4-oxadiazol-3-yl]benzamide), (II-P004) N-( 1-methylcyclopropyl)-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide (N-(1-methylcyclopropyl)-4-[ 5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide), (II-P005) N-(2-ethylcyclopropyl)-4-[5-(trifluoromethyl)- 1,2,4-Oxadiazol-3-yl]benzamide (N-(2-ethylcyclopropyl)-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide), (II-P006) N-(2,4-difluorophenyl)-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide (N- (2,4-difluorophenyl)-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide), (II-P007) 5-(trifluoromethyl)-3-[4 -[[3-(trifluoromethyl)-1,2,4-triazol-1-yl]methyl]phenyl]-1,2,4-oxadiazole(5-(trifluoromethyl)-3- [4-[[3-(trifluoromethyl)-1,2,4triazol-1-yl]methyl]phenyl]-1,2,4-oxadiazole), (II-P008) 2-[[4-[5-( Trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-triazole-3-carbonitrile (2-[[4-[5-( trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-triazole-3-carbonitrile), (II-P009) 1-[[4-[5-(trifluoro Methyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester (ethyl 1-[[4-[5-(trifluoromethyl)-1, 2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylate), (II-P010) N-cyclopropyl-1-[[4-[5-(trifluoromethyl)-1, 2,4-Oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxamide (N-cyclopropyl-1-[[4-[5-(trifluoromethyl)-1,2,4- oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxam ide), (II-P011) N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methanol Base]pyrazole-4-carboxamide (N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4- carboxamide), (II-P012) N-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyridine Azole-4-carboxamide (N-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxamide), (II -P013) N,N,-Dimethyl-H[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2 ,4-triazol-3-amine (N,N,-dimethyl-H[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4 -triazol-3-amine), (II-P014) 3-[4-[(5-Ethylsulfonyl-1,2,4-triazol-1-yl)methyl]phenyl]-5- (Trifluoromethyl)-1,2,4-oxadiazole (3-[4-[(5-ethylsulfanyl-1,2,4-triazol-1-yl)methyl]phenyl]-5(trifluoromethyl)- 1,2,4-oxadiazole), (II-P015) 3-[4-(triazol[4,5-b]pyridin-1-ylmethyl)phenyl]-5-(trifluoromethyl)- 1,2,4-Oxadiazole (3-[4-(triazolo[4,5-b]pyridin-1-ylmethyl)phenyl]-5-(trifluoromethyl)-1,2,4-oxadiazole), (II -P016) 3-[4-(triazol[4,5-b]pyridin-2-ylmethyl)phenyl]-5-(trifluoromethyl)-1,2,4-oxadiazole (3 -[4-(triazolo[4,5-b]pyridin-2-ylmethyl)phenyl]-5-(trifluoromethyl)-1,2,4-oxadiazole), (II-P017) 3-[4-(triazole [4,5-b]pyridin-3-ylmethyl)phenyl]-5-(trifluoromethyl)-1,2,4-oxadiazole (3-[4-(triazo lo[4,5-b]pyridin-3-ylmethyl)phenyl]-5-(trifluoromethyl)-1,2,4-oxadiazole), (II-P018) methyl 1-[[4-[5-(trifluoromethyl) Fluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylate (methyl 1-[[4-[5-(trifluoromethyl)-1, 2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylate), (II-P019) ethyl 1-[[3-fluoro-4-[5-(trifluoromethyl)-1, 2,4-Oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester (ethyl 1-[[3-fluoro-4-[5-(trifluoromethyl)-1,2, 4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylate), (II-P020) N,N-diethyl-1-[[4-[5-(trifluoromethyl)-1, 2,4-Oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxamide (N,N-diethyl-1-[[4-[5-(trifluoromethyl)-1,2, 4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxamide), (II-P021) N-methoxy-N-methyl-1-[[4-[5-(trifluoromethyl) -1,2,4-Oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxamide (N-methoxy-N-methyl-1-[[4-[5-(trifluoromethyl) -1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxamide), (II-P022) Propyl 1-[[4-[5-(trifluoromethyl)-1,2 ,4-Oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylate (propyl 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl]phenyl]methyl]pyrazole-4-carboxylate), (II-P023) N-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazole- 3-yl]phenyl]methyl]pyrazole-4-carboxamide (N-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl] meth yl]pyrazole-4-carboxamide), (II-P024) N-ethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzene Base]methyl]pyrazole-4-carboxamide (N-ethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4 -carboxamide), (II-P025) 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4- Carboxamide (1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxamide), (II-P026) N-methoxy -1-[1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazol-4-yl]imine ( N-methoxy-1-[1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazol-4-yl]methanimine), (II-P027) Ethyl 1-[1-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]ethyl]pyrazole-4-carboxylate (ethyl 1-[1-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]ethyl]pyrazole-4-carboxylate), (II-P028) 1-[[4-[ 5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrrolidin-2-one (1-[[4-[5-(trifluoromethyl)-1 ,2,4-oxadiazol-3-yl]phenyl]methyl]pyrrolidin-2-one), (II-P029) 1-[[4-[5-(trifluoromethyl)-1,2,4-oxa Oxadiazol-3-yl]phenyl]methyl]piperidin-2-one (1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]piperidin -2-one), (II-P030) 4-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]morpholine- 3-keto (4-[[4-[5-(trifluoromethyl)-1,2,4-oxadiaz ol-3-yl]phenyl]methyl]morpholin-3-one), (II-P031) 4,4-dimethyl-2-[[4-[5-(trifluoromethyl)-1,2, 4-Oxadiazol-3-yl]phenyl]methyl]isoxazolin-3-one (4,4-dimethyl-2-[[4-[5-(trifluoromethyl)-1,2,4- oxadiazol-3-yl]phenyl]methyl]isoxazolidin-3-one), (II-P032) 2-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazole-3- Base] phenyl] methyl] isoxazolidin-3-one (2-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl] isoxazolidin-3- one), (II-P033) 5,5-Dimethyl-2-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methanol Base] isoxazolin-3-one (5,5-dimethyl-2-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]isoxazolidin-3- one), (II-P034) 3,3-Dimethyl-1[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl] Piperidin-2-one (3,3-dimethyl-1[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]piperidin-2-one), (II- P035) 1-[[2-fluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrrolidin-2-one (1 -[[2-fluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrrolidin-2-one), (II-P036) 1-[[2- Fluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]piperidin-2-one (1-[[2-fluoro-4 -[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]piperidin-2-one), (II-P037) 2-[[4-[5-(trifluoromethyl )-1,2,4-oxadiazol-3-yl]phenyl]methyl]oxazin-3-one (2-[[4-[5-(tr ifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]oxazinan-3-one), (II-P038) 1-[[3-fluoro-4-[5-(trifluoromethyl) -1,2,4-Oxadiazol-3-yl]phenyl]methyl]piperidin-2-one (1-[[3-fluoro-4-[5-(trifluoromethyl)-1,2,4 -oxadiazol-3-yl]phenyl]methyl]piperidin-2-one), (II-P039) 3-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazole-3 -yl]phenyl]methyl]oxazolidin-2-one (3-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]oxazolidin-2-one ), (II-P040) 1-methyl-3-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]imidazoline Pyridin-2-one (1-methyl-3-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]imidazolidin-2-one), (II-P041 ) 1-[[3-fluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-3,3-dimethyl- Piperidin-2-one (1-[[3-fluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-3,3-dimethyl-piperidin-2 -one), (II-P042) 1-[[3-fluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrrole Alkan-2-one (1-[[3-fluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrrolidin-2-one), (II-P043 ) 2-[[3-fluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-4,4-dimethyl- Isoxazolin-3-one (2-[[3-fluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-4,4-dimethyl-isoxazolidin -3-one), (II-P044) 2-[[2,3 -Difluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]isoxazolin-3-one (2-[[2 ,3-difluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]isoxazolidin-3-one), (II-P045) 2-[[3-fluoro- 4-[5-(Trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]isoxazolin-3-one (2-[[3-fluoro-4 -[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]isoxazolidin-3-one), (II-P046) 1-[[3-fluoro-4-[5-( Trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]azepine-2-one (1-[[3-fluoro-4-[5-(trifluoromethyl) -1,2,4-oxadiazol-3-yl]phenyl]methyl]azepan-2-one), (II-P047) N-[[4-[5-(trifluoromethyl)-1,2,4 -oxadiazol-3-yl]phenyl]methyl]propanamide , (II-P048) 2,2-Dimethyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl] Butyl-3-ynamide (2,2-dimethyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]but-3-ynamide) , (II-P049) N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]butyramide (N-[[ 4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl] butanamide), (II-P050) 3-methyl-N-[[4-[5-(trifluoro Methyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]butyramide (3-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4 -oxadiazol-3-yl]phenyl]methyl]butanamide), (II-P051) 2-methyl-N-[[4-[5- (Trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propyl-2-enamine (2-methyl-N-[[4-[5-(trifluoromethyl )-1,2,4-oxadiazol-3-yl]phenyl]methyl]prop-2-enamide), (II-P052) 2-methyl-N-[[4-[5-(trifluoromethyl) -1,2,4-Oxadiazol-3-yl]phenyl]methyl]butyramide (2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol- 3-yl]phenyl]methyl]butanamide), (II-P053) 2-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazole-3- base]phenyl]methyl](2-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]), (II-P054) 3 ,3,3-Trifluoro-N-[[3-fluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionyl Amine (3,3,3-trifluoro-N-[[3-fluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide), (II-P055 ) 3,3,3-Trifluoro-N-[[2-fluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl] Propanamide (3,3,3-trifluoro-N-[[2-fluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide), (II -P056) N-[[2,3-difluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]butyramide ( N-[[2,3-difluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]butanamide), (II-P057) N-[[2,3 -Difluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-3,3,3-trifluoro-propionamide ( N-[[2,3-difluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl] -3,3,3-trifluoro-propanamide), (II-P058) 2-(difluoromethoxy)-N-[[4-[5-(trifluoromethyl)-1,2,4-oxa Diazol-3-yl]phenyl]methyl]acetamide (2-(difluoromethoxy)-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl] methyl]acetamide), (II-P059) 2-methoxy-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl ]phenyl]methyl]propanamide , (II-P060) 1-methyl-3-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea (1 -methyl-3-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea), (II-P061) 1-ethyl-1-methyl- 3-[[4-[5-(Trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea (1-ethyl-1-methyl-3-[[ 4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea), (II-P062) 1-ethoxy-3-[[4-[5-(three Fluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea (1-ethoxy-3-[[4-[5-(trifluoromethyl)-1,2,4- oxadiazol-3-yl]phenyl]methyl]urea), (II-P063) 1-methoxy-1-methyl-3-[[4-[5-(trifluoromethyl)-1,2,4 -oxadiazol-3-yl]phenyl]methyl](1-methoxy-1-methyl-3-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl ]methyl]), (II-P064) 1,1-diethyl-3-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl ]methyl]urea (1,1-diethyl-3-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl ]phenyl]methyl]urea), (II-P065) N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzene Base] methyl] cyclopropanecarboxamide (N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropanecarboxamide), (II- P066) N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pentyl-4-yne Amide (N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pent-4-ynamide), (II-P067) N- Methoxy-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propyl-2- Enamine (N-methoxy-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]prop-2-enamide), (II- P068) N,2-Dimethoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide (N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide), (II-P069) N-cyclopropyl- 3,3,3-Trifluoro-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide (N -cyclopropyl-3,3,3-trifluoro-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide), (II-P070) 2, 2-Difluoro-N-(2-methoxyethyl)-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl] Methyl]cyclopropanecarboxamide (2,2-difluoro-N-(2-methoxyethyl)-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl] methyl]cyclopropanecarboxamide), (II-P071) N-Ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl ]propanamide (N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide), (II-P072) N-[[3-fluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-N-methoxy-propionamide (N-[[3-fluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-N-methoxy-propanamide), (II-P073) 2-methoxy-propanamide Oxygen-N-(2,2,2-trifluoroethyl)-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl ]methyl]acetamide (2-methoxy-N-(2,2,2-trifluoroethyl)-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl ]methyl] acetamide), (II-P074) N-[[2,3-difluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl ]methyl]-N-methoxy-cyclopropanecarboxamide (N-[[2,3-difluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl] methyl]-N-methoxy-cyclopropane carboxamide), (II-P075) 2-(difluoromethoxy)-N-methyl-N-[[4-[5-(trifluoromethyl)-1,2 ,4-Oxadiazol-3-yl]phenyl]methyl]acetamide (2-(difluoromethoxy)-N-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4- oxadiazol-3-yl]phenyl]methyl]acetamide), (II-P076) N-ethoxy-2-methoxy-N-[[4-[5-(trifluoromethyl)-1,2, 4-oxadiazol-3-yl]phenyl]methyl]propionamide (N-ethoxy-2-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3 -yl]phenyl]methyl]propanamide), (II-P077) N-isopropyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]tetrahydrofuran-2-carboxamide ( N-isopropyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]tetrahydrofuran-2-carboxamide), (II-P078) 1-methoxy -3-Methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea (1-methoxy-3- methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea), (II-P079) 3-cyclopropyl-1-methoxy -1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea (3-cyclopropyl-1-methoxy-1-[ [4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea), (II-P080) 3-ethoxy-1-methoxy-1-[[ 4-[5-(Trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea (3-ethoxy-1-methoxy-1-[[4-[5 -(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea), (II-P081) 3-allyl-1-methoxy-1-[[4-[5- (Trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea (3-allyl-1-methoxy-1-[[4-[5-(trifluoromethyl)- 1,2,4-oxadiazol-3-yl]phenyl]methyl]urea), (II-P082) 1-cyclopropyl-3-methoxy-3-methyl-1-[[4-[5- (Trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea (1-cyclopropyl-3-methoxy-3-methyl-1-[[4-[5- (trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea), (II-P083) 3-isopropyl-1-methoxy-1-[[4-[5-( Trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea (3-isopropyl-1-methoxy-1-[ [4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea), (II-P084) 1-methoxy-3-propyl-2-ynyl- 1-[[4-[5-(Trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea (1-methoxy-3-prop-2-ynyl- 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea), (II-P085) 1-[[3-fluoro-4-[5- (Trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1-methoxy-3-methyl-urea (1-[[3-fluoro-4 -[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1-methoxy-3-methyl-urea), (II-P086) 3-(cyclopropylmethyl) -1-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea (3-(cyclopropylmethyl)- 1-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea), (II-P087) 1-ethyl-3-(2 ,2,2-trifluoroethyl)-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea (1 -ethyl-3-(2,2,2-trifluoroethyl)-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea), (II- P088) 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea (1 ,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea), (II-P089) 3-ethyl-1-methyl Oxygen-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea (3-ethyl-1-methoxy-1 -[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea), (I I-P090) N-methyl-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide (N-methyl-4-[5-(trifluoromethyl )-1,2,4-oxadiazol-3-yl]benzamide), (II-P091) N-[(E)-methoxyiminomethyl]-4-[5-(trifluoromethyl) -1,2,4-oxadiazol-3-yl]benzamide (N-[(E)-methoxyiminomethyl]-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl] benzamide), (II-P092) N-[(Z)-methoxyiminomethyl]-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl ]benzamide (N-[(Z)-methoxyiminomethyl]-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide), (II-P093) N-[4-[ 5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]cyclopropanecarboxamide (N-[4-[5-(trifluoromethyl)-1,2,4- oxadiazol-3-yl]phenyl]cyclopropanecarboxamide), (II-P094) N-(2-fluorophenyl)-4-[5-(trifluoromethyl)-1,2,4-oxadiazole-3- Base] benzamide (N-(2-fluorophenyl)-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide), (II-P095) 2,2-difluoro- N-methyl-2-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]acetamide (2,2-difluoro-N-methyl -2-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]acetamide), (II-P096) N-allyl-N-[[4-[5- (Trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]acetamide (N-allyl-N-[[4-[5-(trifluoromethyl)-1, 2,4-oxadiazol-3-yl]phenyl]methyl]acetamide), (II-P097) N-[(E)-N-methoxy-C-methyl-iminomethylene]-4-[ 5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide (N-[(E)-N-methoxy -C-methyl-carbonimidoyl]-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide), (II-P098) N-[(Z)-N-methoxy- C-methyl-iminomethylene]-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide (N-[(Z)-N -methoxy-C-methyl-carbonimidoyl]-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide), (II-P100) N-allyl-N-[[4 -[5-(Trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide (N-allyl-N-[[4-[5-(trifluoromethyl )-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide), (II-P101) 4,4-dimethyl-1-[[4-[5-(trifluoromethyl)- 1,2,4-Oxadiazol-3-yl]phenyl]methyl]pyrrolidin-2-one (4,4-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2, 4-oxadiazol-3-yl]phenyl]methyl]pyrrolidin-2-one), (II-P102) N-methyl-4-[5-(trifluoromethyl)-1,2,4-oxadiazole -3-yl]benzonecarbothioamide (N-methyl-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzenecarbothioamide), (II-P103) 5-methyl-1 -[[4-[5-(Trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrrolidin-2-one (5-methyl-1-[[ 4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrrolidin-2-one), (II-P104) N-methyl-4-[5-(trifluoro N-methyl-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzenecarboxamide ), (II-P105) N1-methyl-N2-(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl)oxamide (N1- methyl-N2-(4-(5-(t rifluoromethyl)-1,2,4-oxadiazol-3-yl)benzyl) oxalamide); (II-Q) Compounds that can be used as protective agents: (II-Q001) 1-(2,4-Dichlorophenyl)- 5-(ethoxycarbonyl)-5-methyl-2-pyrazoline-3-carboxylic acid (1-(2,4-dichlorophenyl)-5-(ethoxycarbonyl)-5-methyl-2-pyrazoline-3 -carboxylic acid), (II-Q002) 1-(2,4-dichlorophenyl)-5-(ethoxycarbonyl)-5-methyl-2-pyrazoline-3-carboxylic acid ethyl ester ( ethyl 1-(2,4-dichlorophenyl)-5-(ethoxycarbonyl)-5-methyl-2-pyrazoline-3-carboxylate)(mefenpyr(-diethyl)), (II-Q003) benoxacor, (II-Q004) Cloquintocet-mexyl, (II-Q005) Cumyluron, (II-Q006) Cymetrinil, (II-Q007) Daimuron, ( II-Q008) dichlormid, (II-Q009) dicyclonon, (II-Q010) dietholate, (II-Q011) dimepiperate, (II -Q012) Fenchlorazole-ethyl, (II-Q013) Fenclorim, (II-Q014) Flurazole, (II-Q015) Fluxofenim, II- Q016) furilazole, (II-Q017) isoxadifen-ethyl, (II-Q018) mefenpyr-diethyl, (II-Q019) mefenene ( mephenate), (II-Q020) methoxyphenone, (II-Q021) naphthalic anhydride, (II-Q022) oxabetrinil, (II-Q023) AD-67, (II-Q024) cyprosulfamide (cyprosulfamide), (II-Q025) fenoxazole and their corresponding R isomer (furilazole and the corresponding R isomer), (II-Q026) isoxadifenethyl, (II-Q027) N-(aminocarbonyl)-2-toluenesulfonamide (N -(aminocarbonyl)-2-methylbenzenesulfonamide), (II-Q028) N-(amino-carbonyl)-2-fluorobenzenesulfonamide (N-(aminocarbonyl)-2-fluorobenzenesulfonamide), (II-Q029) 1- Bromo-4-[(chloromethyl)sulfonyl]benzene (1-bromo-4-[(chloromethyl)sulfonyl]benzene), (II-Q030) 2-(dichloromethyl)-2-methyl- 1,3-Dichloropentane (2-(dichloromethyl)-2-methyl-1,3-dioxolane) (MG 191), (II-Q031) 4-(dichloroacetyl)-1-oxa -4-Azospiro[4.5]decane (4-(dichloroacetyl)-1-oxa-4-azospiro-[4.5]decane) (MON 4660), (II-Q032) 2,2-Dichloro-1- (2,2,5-trimethyl-3-oxazolidinyl)-ethanone (2,2-dichloro-1-(2,2,5-trimethyl-3-oxazolidinyl)-ethanone), (II- Q033) 2-methoxy-N-[[4-[[(methylamino)carbonyl]amino]phenyl]sulfonyl]-benzamide (2-methoxy-N-[[4-[[ (methylamino)carbonyl]amino]phenyl]sulfonyl]-benzamide), (II-Q034) 2-methoxy-N-[[4-[[(methylamino)carbonyl]amino]phenyl]sulfonyl ]-benzamide (2-methoxy-N-[[4-[[(methylamino)carbonyl]amino]-phenyl]sulfonyl]-benzamide); and (II-R) Biofungicides: (II-R001) Bacillus subtilis syn ., (II-R002) Bacillus subtilis strain QST713 ( Bacillus subtilis strain QST713), (II-R003) Bacillus subtilis strain BU1814 ( Bacillus subtilis strain BU18 14), (II-R004) Bacillus subtilis var. amyloliquefaciens strain FZB24 (strain FZB24), (II-R005) Bacillus amyloliquefaciens strain MBI 600 (strain MBI600), (II-R006) Bacillus amyloliquefaciens strain D747, (II-R007) Bacillus amyloliquefaciens strain D727 (strain D727), (II-R008) Bacillus amyloliquefaciens ) strain ENV503 (strain ENV503), (II-R009) Tricoderma atroviride ) strain SC1 (strain SC1), (II-R010) Bacillus mycoides isolate, (II-R011) Pseudomonas chlororaphis strain AFS009 ( Pseudomonas chlororaphis strain AFS009), (II-R012) Streptomyces lydicus strain WYEC 108 ( Streptomyces lydicus strain WYEC108), (II-R013) Aureobasidium pullulans strain DSM14940 and a mixture of DSM14941 ( Aureobasidium pullulans strain DSM 14940 + Pullulans strain DSM 14941), (II-R014) tea tree ( Melameuca alternifolia ) extract, (II-R015) Philippine orange extract ( Swinglea glutinosa extract), (II-R016) calcium phosphate salt/ Calcium salt of phosphorus acid/calcium phosphite, (II-R017) Streptomyces hygroscopicus (Vilimycin, validamycin), (II-R018) Bacillus altudinis , (II- R019) solution Bacillus amyloliquefaciens ( Bacillus amyloliquefaciens ), (II-R020) Bacillus amyloliquefaciens ssp. plantarum MBI 600 ( Bacillus amyloliquefaciens ssp. plantarum MBI 600) (II-27), (II-R021) Bacillus amyloliquefaciens subsp. D747 ( Bacillus amyloliquefaciens ssp. plantarum D747), (II-R022) Bacillus megaterium , (II-R023) Bacillus mojavensis (II-28), (II-R024) Bacillus mycoides Bacillus mycoides , (II-R025) Bacillus pumilus INR-7 (II-29), (II-R026) Bacillus pumilus GHA 180, (II-R027) Simple spores Bacillus simplex (II-30), (II-R028) Bacillus solisalsi (II-31), (II-R029) Burkholderia sp. , (II-R030) Clavibacter michiganensis (bacteriophages) (II-32), (II-R031) Gliocladium roseum (II-33), (II-R032) Microsphaeropsis ochracea , (II-R033) Muscodor albus , (II-R034) Paenibacillus alvei , (II-R035) Paenibacillus polymyxa ( Paenibacillus polymyxa ) (II-34), (II-R036) Pantoea agglomerans (II-35), (II-R037) Pantoea vagans ), (II-R038) Penicillium bayley ( Penicillium bilaiae ), (II-R039) Pseudomonas sp. , (II-R040) Pseudomonas chloraphis , (II-R041) Pseudomonas fluorescens , (II-R042) Sphaerodes mycoparasitica (II- 36), (II-R043) Streptomyces violaceusniger (II-38), (II-R044) Trichoderma fertile JM41R ( Trichoderma fertile JM41R) (II-39), (II-R045) Basidiomycetes Typhula phacorrhiza (II-40), (II-R046) Verticillium dahlia (II-42), (II-R047) zucchini yellow mosaic virus ( avirulent strain); and/or at least one insecticidal and/or nematicidal active compound (III) selected from the following groups: (III-A) acetylcholinesterase (AChE) inhibitors, selected From the following categories: (III-A1) Carbamates: (III-A1001) alanycarb, (III-A1002) aldicarb, (III-A1003) bendiocarb ), (III-A1004) benfuracarb, (III-A1005) butocarboxim, (III-A1006) butoxycarboxim, (III-A1007) carbaryl, ( III-A1008) carbofuran, (III-A1009) butyl carbosulfan, (III-A1010) ethiofencarb, (III-A1011) butyl fenobucarb , (III-A1012) formetanate, (III-A1013) furathiocarb, (III-A1014) isoprocarb, (III-A1015) methiocarb, ( III-A1016) Nanoide (methomyl), (III-A1017) Metolcarb, (III-A101 8) Oxamyl, (III-A1019) pirimicarb, (III-A1020) propoxur, (III-A1021) thiodicarb, (III-A1022) sulfur Thiofanox, (III-A1023) Triazamate, (III-A1024) Trimethacarb, (III-A1025) XMC, (III-A1026) Methacarb (xylylcarb); (III-A2) organophosphates: (III-A2001) acephate, (III-A2002) azamethiphos, (III-A2003) azinphos -ethyl), (III-A2004) azinphos-methyl, (III-A2005) cadusafos, (III-A2006) chlorethoxyfos, (III-A2007) Chlorfenvinphos, (III-A2008) Chlormephos, (III-A2009) Chlorpyrifos, (III-A2010) Chlorpyrifos-methyl, (III-A2011) Fly Coumaphos, (III-A2012) cyanophos, (III-A2013) demeton-S-methyl, (III-A2014) diazinon, ( III-A2015) Dichlorvos (DDVP), (III-A2016) Dicrotophos, (III-A2017) Dimethoate, (III-A2018) Dimethylvinphos , (III-A2019) Disulfoton (disulfoton), (III-A2020) Yipinsong (O-Ehtyl-O-pnitrophenyl thionobenzenephosphonate, EPN), (III-A2021) Aisha pine (ethion), (III-A2022) Provosone (ethoprophos), (III-A2023) amisulfonate (famphur), (III-A2024) fenmetazone (fe namiphos), (III-A2025) fenitrothion, (III-A2026) fenthion, (III-A2027) fosthiazate, (III-A2028) heptenophos, (III-A2029) imicyafos, (III-A2030) isofenphos, (III-A2031) isopropyl O-(methoxyaminothio-phosphoryl)salicylate (isopropyl o-(methoxyaminothio-phosphoryl) salicylate), (III-A2032) isoxathion, (III-A2033) malathion, (III-A2034) mecarbam, (III -A2035) methamidophos, (III-A2036) methidathion, (III-A2037) mevinphos, (III-A2038) monocrotophos, (III-A2039) Naled, (III-A2040) Omethoate, (III-A2041) Oxydemeton-methyl, (III-A2042) Parathion, (III-A2043) Parathion-methyl, (III-A2044) phenthoate, (III-A2045) phorate, (III-A2046) phosalone, (III-A2047 ) phosmet, (III-A2048) phosphamidon, (III-A2049) phoxim, (III-A2050) pirimiphos-methyl, ( III-A2051) profenofos, (III-A2052) propetamphos, (III-A2053) prothiofos, (III-A2054) pyraclofos, (III-A2055) must Fensong (pyridaphenthion), (III-A2056) Baiyusong (quinalphos), (III-A205 7) Sulfotep, (III-A2058) tebupirimfos, (III-A2059) temephos, (III-A2060) terbufos, (III-A2061) Tetrachlorvinphos, (III-A2062) thiometon, (III-A2063) triazophos, (III-A2064) triclorfon, (III-A2065) pine (vamidothion); (III-B) gamma-aminobutyric acid (GABA) gated chloride channel blockers selected from the following classes: (III-B1) cyclopentadiene-organochlorine: (III-B1001 ) chlordane, (III-B1002) endosulfan; (III-B2) phenylpyrazoles (fiproles): (III-B2001) ethiprole, ( III-B2002) fipronil, (III-B2003) butene fipronil (flufiprole), (III-B2004) pyrafluprole, (III-B2005) pyriprole ); (III-C) Sodium channel modulators selected from the following classes: (III-C1) Pyrethrins and pyrethrins: (III-C1001) Acrinathrin, (III-C1002 ) Allethrin, (III-C1003) d-cis-trans allethrin, (III-C1004) d-trans allethrin , (III-C1005) Bifenning (bifenthrin), (III-C1006) Bailiening (bioallethrin), (III-C1007) S-cyclopentenyl Bailiening isomer (bioallethrin s-cyclopentenyl isomer), (III -C1008) Bioresmethrin, (III-C1009) Cycloprothrin, (III-C1010) Cyfluthrin, (III-C1011) β-Sai Funing, (III-C1012 ) Xeronine (cyhalothrin), (III-C1013) λ-xeronine, (III-C 1014) γ-cypermethrin, (III-C1015) cypermethrin, (III-C1016) α-cypermethrin, (III-C1017) β-cypermethrin, (III-C1018) θ-cypermethrin (III-C1019) ξ-safenin, (III-C1020) saphenin, (III-C1021) [(1R)-trans isomer], (III-C1022) deltamethrin ), (III-C1023) ethynthrin [(EZ)-(1R)-isomer], (III-C1024) esfenvalerate, (III-C1025) etofenprox, ( III-C1026) Fenpropathrin, (III-C1027) Fenvalerate, (III-C1028) Flucythrinate, (III-C1029) Flumethrin, (III-C1030 ) τ-Fuhuali (tau-fluvalinate), (III-C1031) Hefenning (halfenprox), (III-C1032) Yipuning (imiprothrin), (III-C1033) Meperfluthrin (meperfluthrin), ( III-C1034) metofluthrin, (III-C1035) momfluorothrin, (III-C1036) kadethrin, (III-C1037) permethrin, (III- C1038) Phenothrin [(1R)-trans-isomer] (phenothrin [(1R)-trans-isomer]), (III-C1039) prallethrin, (III-C1040) Profluthrin Esters (profluthrin), (III-C1041) pyrethrins (pyrethrum, pyrethrum), (III-C1042) resmethrin, (III-C1043) silafluofen, (III-C1044) Tefithrin, (III-C1045) Tetramethylfluthrin, (III-C1046) Tetramethrin, (III-C1047) Tetramethrin [(1R) -isomers] (tetramethrin [(1 R)-isomers]), (III-C1048) tralomethrin, (III-C1049) transfluthrin; (III-C2) organochlorines: (III-C2001) DDT, (III-C2002) Methoxychlor; (III-D) Nicotinic acetylcholine receptor (nAChR) competitive modulators selected from the group consisting of: (III-D1) Neonicotinoid analogues : (III-D1001) Acetamiprid, (III-D1002) Clothianidin, (III-D1003) Dinotefuran, (III-D1004) Imidacloprid, ( III-D1005) nitenpyram, (III-D1006) thiacloprid, (III-D1007) thiamethoxam, (III-D1008) 1-[(6-chloro-3 -pyridyl)methyl]-2,3,5,6,7,8-hexahydro-9-nitro-(5S,8R)-5,8-epoxy-H-imidazo[1,2- a] Nitrogen (1-[(6-chloro-3-pyridinyl)methyl]-2,3,5,6,7,8-hexahydro-9-nitro-(5S,8R)-5,8-epoxy- H-imidazo[1,2-a]azepine), (III-D1009) (1-[(6-chloro-3-pyridyl)methyl]-2-nitro-1-[(E)-pentylidene Baseamino]guanidine (1-[(6-chloro-3-pyridyl)methyl]-2-nitro-1-[(E)-pentylideneamino]guanidine, (III-D1010) 1-[(6-chloro-3 -pyridyl)methyl]-7-methyl-8-nitro-5-propoxy-3,5,6,7-tetrahydro-2H-imidazo[1,2-a]pyridine (1- [(6-chloro-3-pyridyl)methyl]-7-methyl-8-nitro-5-propoxy-3,5,6,7-tetrahydro-2H-imidazo[1,2-a]pyridine); (III -D2001) Nicotine; (III-D3) Methionine sulfoximines: (III-D3001) Sulfoxaflor; (III-D4) Butenolides: (III -D4001) flupyradifurone (flupyradifurone); (III-D5) mesoionics: (III-D5001) triflumezopyrim, (III-D5002) dichloromezotiaze; ( III-D6) Pyridylidenes: (III-D6001) Flupyrimin; (III-E) Nicotinic acetylcholine (nAChR) receptor ectopic modulator-site I, Selected from the following categories: (III-E1) spinosyns: (III-E1001) spinetoram, (III-E1002) spinosad; (III-F) glutamine Acid-gated chloride channel (GluCl) ectopic modulators selected from the following classes: (III-F1) avermectins/milbemycins: (III-F1001) abatine (abamectin), (III-F1002) emamectin benzoate, (III-F1003) rapimectin, (III-F1004) milbemectin; (III-G ) youth hormone mimetics, selected from the following classes: (III-G1) Juvenile hormone analogues: (III-G1001) hydroprene, (III-G1002) kinoprene, (III -G1003) methoprene; (III-G2001) fenoxycarb; (III-G3001) pyriproxyfen; (III-H) multiple non-specific (multi-site) inhibition (III-H1) Alkyl halides: (III-H1001) Methyl bromide, (III-H1002) Other alkyl halides; (III-H2001) Chloropicrin; (III-H3) fluoride: (III-H3001) cryolite (cryolite) (sodium aluminum fluoride, sodium aluminum fluoride), (III-H3002) sulfonyl fluoride (sulfuryl fluoride); (III-H4) borate ( borates): (III-H4001) borax, (III-H4002) boric acid, (III-H4003) eight Disodium borate, (III-H4004) sodium borate (sodium borate), (III-H4005) sodium metaborate; (III-H5001) antimony potassium tartrate; (III-H6) methyl isocyanate generator: (III- H6001) diazomet, (III-H6002) metam; (III-I) string organ TRPV channel modulators selected from the following classes: (III-I1) pyridine azomethine derivatives Pyridine azomethine derivatives: (III-I1001) pymetrozine, (III-I1002) pyrifluquinazon; (III-I2001) afidopyropen; (III- J) Mite growth inhibitors affecting CHS1 selected from the following classes: (III-J1) clofentezine, diflovidazin, hexythiazox: (III-J1001) clofentezine , (III-J1002) Hesedo, (III-J1003) Flufenazine; (III-J2003) Etoxazole; (III-K) Microbial disruptors of insect midgut membranes, selected from the following categories : (III-K1) Bacillus thuringiensis and its insecticidal protein: (III-K1001) Bacillus thuringiensis , (III-K1002) Bacillus thuringiensis var. israelensis ), (III-K1003) Bacillus thuringiensis var. aizawai ), (III-K1004) Bacillus thuringiensis var. kurstaki , (III-K1005) Bacillus thuringiensis Bacillus thuringiensis var. tenebrionis , (III-K1006) Cry1Ab, (III-K1007) Cry1Ac, (III-K1008) Cry1Fa, (III-K1009) Cry1A.105, (III-K1009) Cry1A.105, (III- K1010) Cry2Ab, (III-K1011) Vip3A, (III-K1012) mCry3A, (III-K1013) Cry3Ab, (III-K1014) Cry3Bb, (III-K1015) Cry34/35Ab1; (III-K2001) Bacillus sphaericus ; (III-L) Inhibition of mitochondrial ATP synthase (III-L1001) diafenthiuron; (III-L2) organotin acaricides: (III-L2001) azocyclotin, (III-L2002) tin Cyhexatin, (III-L2003) fenbutatin oxide; (III-L3001) propargite; (III-L4001) tetradifon; (III-M) by Oxidative phosphorylation decouplers acting by interfering with the proton gradient, selected from the following classes: (III-M1) pyrroles: (III-M1001) chlorfenapyr; (III-M2) dinitrophenol : (III-M2001) dinitro-ortho-cresol (DNOC); (III-M3001) sulfluramid (sulfluramid); (III-N) nicotinic acetylcholine receptor (nAChR) channel Blocking agent, selected from the following classes: (III-N1) Nereistoxin analogues: (III-N1001) bensultap, (III-N1002) cartap hydrochloride , (III-N1003) thiocylam, (III-N1004) thiosultap-sodium; (III-O) chitin biosynthesis inhibitors affecting CHS1, selected from the following classes: (III-O1) Benzoylureas: (III-O1001) bistrifluron, (III-O1002) chlorfluazuron, (III-O1003) diflubenzuron , (III-O1004) Flucycloxuron, (III-O1005) Flufenoxuron, (III-O1006) Hexaflumuron, (III-O1007) Lufenuron, (III-O1008) Novaluron (novaluron), (III-O1009) Polyfluorourea (noviflumuron), (III-O1010) Teflubenzuron (Teflubenzuron), (III-O1011) Triflumuron (triflumuron); (III -P) Type 1 chitin biosynthesis inhibitors: (III-P1001) buprofezin; (III-Q) moulting disruptors selected from the following categories: (III-Q1) for dual Interfering agents of the order Dipteran: (III-Q1001) cyromazine; (III-R) Ecdysone receptor agonists selected from the following classes: (III-R1) Diacylhydrazine Diacylhydrazines: (III-R1001) methoxyfenozide, (III-R1002) tebufenozide, (III-R1003) halofenozide, (III-R1004) furofenozide (fufenozide), (III-R1005) chromafenozide; (III-S) octopamine receptor agonists: (III-S1001) amitraz; (III-T) mitochondria Complex III electron transport inhibitors: (III-T1001) hydramethylnone, (III-T2001) acequinocyl, (III-T3001) fluacrypyrim, (III-T4001) Biffin (Bifenazate); (III-U) Mitochondrial complex I electron transport inhibitors, selected from the following classes: (III-U1) Acaricides and insecticides of electron transport inhibitors (METI): (III -U1001) fenazaquin, (III-U1002) fenpyroximate, (III-U1003) pyrimidifen, (III-U1004) pyridaben, (III-U1005 ) tebufenpyrad, (III-U1006) tolfenpyrad; (III-U2001) rotenone; (III-V) voltage-dependent sodium channel blocker selected from the following Classes: (III-V1) Oxadiazines: (III-V1001) Indoxacarb ); (III-V2) semicarbazones: (III-V2001) metaflumizone; (III-V3001) 1-[(E)-[2-(4-cyanophenyl)- 1-[3-(trifluoromethyl)phenyl]ethylene]amino]-3-[4-(difluoromethoxy)phenyl]urea (1-[(E)-[2-( 4-cyanophenyl)-1-[3-(trifluoromethyl)phenyl]ethylene]amino]-3-[4-(difluoromethoxy)phenyl]urea); (III-V4001) 2-[3-(Ethylsulfonyl)pyridine -2-yl]-5-[trifluoro(methylsulfonyl)]-1,3-benzoxazole(2-[3-(ethanesulfonyl)pyridin-2-yl]-5-[trifluoro(methanesulfonyl) ]-1,3-benzoxazole (oxazosulfyl)) (Ocean, oxazosulfyl); (III-W) Acetyl-CoA carboxylase inhibitors, selected from the following classes: (III-W1) Tetronic acid (tetronic acid) and derivatives of tetramic acid: (III-W1001) spirodiclofen, (III-W1002) spiromesifen, (III-W1003) spiropidion ), (III-W1004) spirotetramat (spirotetramat); (III-X) mitochondrial complex IV electron transport inhibitors, selected from the following classes: (III-X1001) phosphides (phosphides): (III- X1001) Aluminum phosphide, (III-X1002) Calcium phosphide, (III-X1003) Phosphine, (III-X1004) Zinc phosphide; (III-X2) Cyanide: (III-X2001) Calcium cyanide , (III-X2002) potassium cyanide, (III-X2003) sodium cyanide; (III-Y) mitochondrial complex II electron transport inhibitors, selected from the following classes: (III-Y1001) β-ketonitrile (beta-ketonitrile) derivatives: (III-Y1001) cyenopyrafen, (III-Y1002) cyflumetofen; (III-Y2) carboxanilides: (III-Y2001) Pyflubumid (pyflubumid e); (III-Z) radine receptor modulators, selected from the following categories: (III-Z1) diamides (diamides): (III-Z1001) flubendiamide (flubendiamide), (III- Z1002) chlorantraniliprole (Rynaxypyr®), (III-Z1003) cyantraniliprole (Rynaxypyr®), (III-Z1004) cyclaniliprole, (III-Z1005) tetrazole Tetraniliprole, (III-Z1006) Tetra-chlorantraniliprole, (III-Z1007) (R)-3-chloro-N1-{2-methyl-4-[1,2 ,2,2-Tetrafluoro-1-(trifluoromethyl)ethyl]phenyl}-N2-(1-methyl-2-methylsulfonylethyl)phthalamide ((R )-3-Chlor-N1-{2-methyl-4-[1,2,2,2-tetrafluor-1-(trifluormethyl)ethyl]phenyl}-N2-(1-methyl-2-methylsulfonylethyl)phthalamid), (III-Z1008) (S)-3-chloro-N1-{2-methyl-4-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]phenyl}- N2-(1-methyl-2-methylsulfonylethyl)phthalamide ((S)-3-Chlor-N1-{2-methyl-4-[1,2,2,2 -tetrafluor-1-(trifluormethyl)ethyl]phenyl}-N2-(1-methyl-2-methylsulfonylethyl)phthalamid), (III-Z1009) methyl-2-[3,5-dibromo-2-({[ 3-Bromo-1-(3-chloropyridin-2-yl)-1H-pyrazol-5-yl]carbonyl}amino)benzoyl]-1,2-dimethylhydrazinecarboxylic acid (methyl- 2-[3,5-dibromo-2-({[3-bromo-1-(3-chlorpyridin-2-yl)-1H-pyrazol-5-yl]carbonyl}amino)benzoyl]-1,2-dimethylhydrazinecarboxylate ), (III-Z1010) N-[2-(5-amino-1,3,4-thiadiazol-2-yl)-4-chloro-6-methyl-phenyl]-5-bromo- 2-(3-Chloro-2-pyridyl)pyrazole-3 -Carboxamide (N-[2-(5-amino-1,3,4-thiadiazol-2-yl)-4-chloro-6-methyl-phenyl]-5-bromo-2-(3-chloro- 2-pyridyl)pyrazole-3-carboxamide), (III-Z1011) 5-chloro-2-(3-chloro-2-pyridyl)-N-[2,4-dichloro-6-[(1-carbonitrile Base-1-methyl-ethyl)aminoformyl]phenyl]pyrazole-3-carboxamide (5-chloro-2-(3-chloro-2-pyridyl)-N-[2,4 -dichloro-6-[(1-cyano-1-methyl-ethyl)carbamoyl]phenyl]pyrazole-3-carboxamide), (III-Z1012) 5-bromo-N-[2,4-dichloro-6-( Methylaminoformyl)phenyl]-2-(3,5-dichloro-2-pyridyl)pyrazole-3-carboxamide 5-bromo-N-[2,4-dichloro-6- (methylcarbamoyl)phenyl]-2-(3,5-dichloro-2-pyridyl)pyrazole-3-carboxamide, (III-Z1013) N-[2-(tert-butylaminoformyl)-4-chloro- 6-methyl-phenyl]-2-(3-chloro-2-pyridyl)-5-(fluoromethoxy)pyrazole-3-carboxamide (N-[2-(tert-butylcarbamoyl)- 4-chloro-6-methyl-phenyl]-2-(3-chloro-2-pyridyl)-5-(fluoromethoxy)pyrazole-3-carboxamide), (III-Z1014) N2-(1-cyano-1- Methyl-ethyl)-N1-(2,4-dimethylphenyl)-3-iodo-phthalamide (N2-(1-cyano-1-methyl-ethyl)-N1-(2 ,4-dimethylphenyl)-3-iodo-phthalamide), 3-chloro-N2-(1-cyano-1-methyl-ethyl)-N1-(2,4-dimethylphenyl)phthalamide Formamide (3-chloro-N2-(1-cyano-1-methyl-ethyl)-N1-(2,4-dimethylphenyl)phthalamide); (III-AA) String organ modulator - undefined target site : (III-AA1001) flonicamid; (III-BB) gamma-aminobutyric acid (GABA) gated chloride ion channel modulator, Selected from the following categories: (III-BB1) meta-diamides: broflanilide; (III-BB2) isoxazolines: (III-BB2001) aerosol Amines (fluxametamide), (III-BB2002) isocycloseram; (III-CC) Baculoviruses, selected from the following classes: (III-CC1) Granuloviruses (GVs): (III- CC1001) Cydia pomonella GV, (III-CC1002) Thaumatotibia leucotreta GV; (III-CC2001) Nucleopolyhedroviruses (NPVs): of Anticarsia gemmatalis Multi-nucleocapsid nucleopolyhedroviruses (MNPV), (III-CC2002) nuclear polyhedroviruses of Helicoverpa armigera ; (III-DD) ectopic regulation of nicotinic acetylcholine receptors Agent-site II; (III-DD1001) GS-ω/κ HXTX-Hv1a peptide; (III-EE) Insecticidal active compound with unknown or uncertain mode of action: (III-EE1001) afidopyropen , (III-EE1002) azadirachtin, (III-EE1003) amidoflumet, (III-EE1004) benzoximate, (III-EE1005) benzpyrimoxan, (III-EE1006) bifenazate, (III-EE1007) bromopropylate, (III-EE1008) chinomethionat, (III-EE1009) cryolite, (III- EE1010) Dicofol, (III-EE1011) Flufenerim, (III-EE1012) Flumetoquin, (III-EE1013) Fluhexafon, (III-EE1014) Fluosulfone (fluensulfone), (III-E E1015) Flupyradifurone, (III-EE1016) lime sulfur, (III-EE1017) mancozeb, (III-EE1018) piperonyl butoxide, (III -EE1019) pyridalyl, (III-EE1020) pyrifluquinazon, (III-EE1021) sulfoxaflor, (III-EE1022) sulfur, (III-EE1023) 4-[ 5-(3,5-Dichloro-phenyl)-5-trifluoromethyl-4,5-dihydro-isoxazol-3-yl]-2-methyl-N-[(2,2, 2-Trifluoro-ethylaminoformyl)-methyl]-benzamide (4-[5-(3,5-Dichloro-phenyl)-5-trifluoromethyl-4,5-dihydro-isoxazol-3 -yl]-2-methyl-N-[(2,2,2-trifluoro-ethylcarbamoyl)-methyl]-benzamide), (III-EE1024) cyclopropaneacetic acid, (III-EE1025) 1, 1'-[(3S,4R,4aR,6S,6aS,12R,12aS,12bS)-4-[[(2-cyclopropylacetyl)oxy]methyl]-1,3,4,4a ,5,6,6a,12,12a,12b-decahydro-12-hydroxy-4,6a,12b-trimethyl-11-oxo-9-(3-pyridyl)-2H,11H-naphtho [2,1-b]pyran[3,4-e]pyran-3,6-diyl]ester (1,1'-[(3S,4R,4aR,6S,6aS,12R,12aS,12bS )-4-[[(2-cyclopropylacetyl)oxy]methyl]-1,3,4,4a,5,6,6a,12,12a,12b-decahydro-12-hydroxy-4,6a,12b-trimethyl- 11-oxo-9-(3-pyridinyl)-2H,11H-naphtho[2,1-b]pyrano[3,4-e]pyran-3,6-diyl]ester, (III-EE1026) 11-( 4-Chloro-2,6-dimethylphenyl)-12-hydroxy-1,4-dioxo-9-azadispiro[4.2.4.2]-tetradec-11-en-10-one ( 11-(4-chloro-2,6-dimethyl phenyl)-12-hydroxy-1,4-dioxa-9-azadispiro[4.2.4.2]-tetradec-11-en-10-one), (III-EE1027) 4,3-(4'-fluoro-2, 4-Dimethylbiphenyl-3-yl)-4-hydroxy-8-oxa-1-azaspiro[4.5]-decane-3-en-2-one (4,3-(4'- fluoro-2,4-dimethylbiphenyl-3-yl)-4-hydroxy-8-oxa-1-azaspiro[4.5]dec-3-en-2-one, (III-EE1028) 1-[2-fluoro-4 -Methyl-5-[(2,2,2-trifluoroethyl)sulfinyl]phenyl]-3-(trifluoromethyl)-1H-1,2,4-triazole-5- Amine (1-[2-fluoro-4-methyl-5-[(2,2,2-trifluoroethyl)sulfinyl]phenyl]-3-(trifluoromethyl)-1H-1,2,4-triazole-5-amine) 、(III-EE1029) Actives on basis of bacillus firmus (Votivo), II-1582、(III-EE1030) (E/Z)-N-[1-[(6-chloro -3-pyridyl)methyl]-2-pyridyl]-2,2,2-trifluoro-acetamide ((E/Z)-N-[1-[(6-chloro-3-pyridyl) methyl]-2-pyridylidene]-2,2,2-trifluoro-acetamide), (III-EE1031) (E/Z)-N-[1-[(6-chloro-5-fluoro-3-pyridyl) Methyl]-2-pyridylidene]-2,2,2-trifluoro-acetamide ((E/Z)-N-[1-[(6-chloro-5-fluoro-3-pyridyl)methyl ]-2-pyridylidene]-2,2,2-trifluoro-acetamide), (III-EE1032) (E/Z)-2,2,2-trifluoro-N-[1-[(6-fluoro-3 -pyridyl)methyl]-2-pyridyl]acetamide ((E/Z)-2,2,2-trifluoro-N-[1-[(6-fluoro-3-pyridyl)methyl]-2 -pyridylidene]acetamide), (III-EE1033) (E/Z)-N-[1-[(6-fluoro-3-pyridyl)methyl]-2-pyridyl]-2,2,2-tri Fluoro-acetamide ((E /Z)-N-[1-[(6-bromo-3-pyridyl)methyl]-2-pyridylidene]-2,2,2-trifluoro-acetamide), (III-EE1034) (E/Z)-N -[1-[1-[(6-Chloro-3-pyridyl)ethyl]-2-pyridyl]-2,2,2-trifluoro-acetamide ((E/Z)-N-[ 1-[1-(6-chloro-3-pyridyl)ethyl]-2-pyridylidene]-2,2,2-trifluoro-acetamide), (III-EE1035) (E/Z)-N-[1-[ (6-Chloro-3-pyridyl)methyl]-2-pyridyl]-2,2-difluoro-acetamide ((E/Z)-N-[1-[(6-chloro-3- pyridyl)methyl]-2-pyridylidene]-2,2-difluoro-acetamide), (III-EE1036) (E/Z)-2-chloro-N-[1-[(6-chloro-3-pyridyl) Methyl]-2-pyridyl]-2,2-difluoro-acetamide ((E/Z)-2-chloro-N-[1-[(6-chloro-3-pyridyl)methyl]-2 -pyridylidene]-2,2-difluoro-acetamide), (III-EE1037) (E/Z)-N-[1-[(2-chloropyrimidin-5-yl)methyl]-2-pyridine]- 2,2,2-Trifluoroacetamide ((E/Z)-N-[1-[(2-chloropyrimidin-5-yl)methyl]-2-pyridylidene]-2,2,2-trifluoro-acetamide ), (III-EE1038) (E/Z)-N-[1-[(6-chloro-3-pyridyl)methyl]-2-pyridyl]-2,2,3,3,3-penta Fluoropropanamide ((E/Z)-N-[1-[(6-chloro-3-pyridyl)methyl]-2-pyridylidene]-2,2,3,3,3-pentafluoro-propanamide), ( III-EE1039) Triflumezopyrim, (III-EE1040) 4-[5-[3-chloro-5-(trifluoromethyl)phenyl]-5-(trifluoromethyl)-4H-iso Oxazol-3-yl]-N-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]naphthalene-1-carboxamide (4-[5-[3- chloro-5-(trifluoromethyl)phenyl]-5-(trifluoromethyl )-4H-isoxazol-3-yl]-N-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]naphthalene-1-carboxamide), (III-EE1041) 3-[3-chloro- 5-(trifluoromethyl)phenyl]-4-oxo-1-(pyrimidin-5-ylmethyl)pyrido[1,2-a]pyrimidinium-2-oleate (3-[3 -chloro-5-(trifluoromethyl)phenyl]-4-oxo-1-(pyrimidin-5-ylmethyl)pyrido[1,2-a]pyrimidin-1-ium-2-olate), (III-EE1042) 8- Chloro-N-[2-chloro-5-methoxyphenyl)sulfonyl]-6-trifluoromethyl)-imidazo[1,2-a]pyridine-2-carboxamide (8-chloro -N-[2-chloro-5-methoxyphenyl)sulfonyl]-6-trifluoromethyl)-imidazo[1,2-a]pyridine-2-carboxamide), (III-EE1043) 4-[5-(3,5- Dichlorophenyl)-5-(trifluoromethyl)-4H-isoxazol-3-yl]-2-methyl-N-(1-oxothietane-3-yl)benzene Amide (4-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4H-isoxazol-3-yl]-2-methyl-N-(1-oxothietan-3-yl)benzamide), ( III-EE1044) 5-[3-[2,6-dichloro-4-(3,3-dichloroallyloxy)phenoxy]propoxy]-1H-pyrazole (5-[3- [2,6-dichloro-4-(3,3-dichloroallyloxyl)phenoxy]propoxy]-1H-pyrazole), (III-EE1045) imidacloprid (dimpropyridaz), (III-EE1046) pyridine amide (tyclopyrazoflor), ( III-EE1047) Nicofluprole, (III-EE1048) Acynonapyr; (III-FF) Biological insecticides selected from the following classes: (III-FF1) Microbial insecticides Microbial pesticides: (III-FF1001) Bacillus firmus , (III-FF1002) Bacillus thaliana subsp. ( Bacillus thuringiensis subsp. galleriae ), (III-FF1003) Bacillus thuringiensis subsp. kurstaki ), (III-FF1004) Beauveria bassiana , (III-FF1005) Burke Burkholderia sp., (III-FF1006) Chromobacterium subtsugae , (III-FF1007) Chromobacterium subtsugae sp. nov., (III-FF1008) Rose Paecilomyces fumosorosea ( Isaria fumosorosea ), (III-FF1009) Lecanicillium longisporum (III-FF1010) Lecanicillium muscarium (formerly Verticillium lecanii ), (III-FF1011) (III-FF1012) Metarhizium anisopliae var. acridum (III-FF1013) Paecilomyces fumosoroseus Apopka strain 97 (III-FF1012) -FF1014) Purpureocillium lilacinus , (III-FF1015) Paenibacillus popilliae , (III-FF1016) Pasteuria spp., (III-FF1017) Neres Pasteuria nishizawae , (III-FF1018) Pasteuria reneformis , (III-FF1019) Pasteuria usagae , (III-FF1020) Pseudomonas fluorescens ( Pseudomonas fluorescens ), (III-FF1021) Steinernema feltiae , (III-FF1022) Streptomces galbus , (III-FF1023) Wolbachia pipientis (Zap); and (III-GG) have insecticidal, acaricidal, molluscidal, pheromone and/or Nematode active biochemical insecticides: (III-GG1001) L-carvone (L-carvone), (III-GG1002) citral, (III-GG1003) (E,Z)-7,9- Dodecadien-1-yl acetate ((E,Z)-7,9-dodecadien-1-yl acetate), (III-GG1004) ethyl formate, (III-GG1005) ( E,Z)-(E,Z)-2,4-ethyl decadienoate (pear ester) ((E,Z)-2,4-ethyl decadienoate (pear ester)), (III-GG1006) ( Z,Z,E)-7,11,13-hexadecatrienal ((Z,Z,E)-7,11,13-hexadecatrienal), (III-GG1007) heptyl butyrate , (III-GG1008) isopropyl myristate (isopropyl myristate), (III-GG1009) lavanulyl senecioate (III-GG1010) 2-methyl 1-butanol, ( III-GG1011) methyl eugenol, (III-GG1012) methyl jasmonate, (III-GG1013) (E,Z)-2,13-octadecadiene-1- Alcohol ((E,Z)-2,13-octadecadien-1-ol), (III-GG1014) (E,Z)-2,13-octadecadien-1-ol acetate ((E, Z)-2,13-octadecadien-1-ol acetate), (III-GG1015) (E,Z)-3,13-octadecadien-1-ol ((E,Z)-3,13- octadecadien-1-ol), (III-GG1016) R-1-octen-3-ol (R-1-octen-3-ol), (III-GG1017) pentatermanone (pentatermanone), (III -GG1018) potassium silicate (potassium silicate), (III-GG1019) sorbitol caprylate (s orbitol actanoate), (III-GG1020) (E,Z,Z)-3,8,11-tetradecatrienyl acetate ((E,Z,Z)-3,8,11-tetradecatrienyl acetate), ( III-GG1021) (Z,E)-9,12-tetradecadien-1-yl acetate ((Z,E)-9,12-tetradecadien-1-yl acetate), (III-GG1022) Z -7-tetradecen-2-one (Z-7-tetradecen-2-one), Z-9-tetradecen-1-yl acetate (Z-9-tetradecen-1-yl acetate) , (III-GG1023) Z-11-tetradecenal (Z-11-tetradecenal), (III-GG1024) Z-11-tetradecen-1-ol (Z-11-tetradecen-1-ol) , (III-GG1025) Black Nepeta ( Acacia negra ) Extract, (III-GG1026) Grapefruit Seed and Pulp Extract, (III-GG1027) Nepeta ( Chenopodium ambrosiodae ) Extract, (III-GG1028) Fatty Acid Fatty acid monoester with glycerol or propanediol, (III-GG1029) catnip oil, (III-GG1030) neem oil, (III-GG1031) soap extract (quillay extract), (III-GG1032) Tagetes oil. 如請求項1所述的農業化學組成物,其中該組分 (2)係至少一種選自下述各組之殺真菌活性化合物 (II): (II-A) 甾醇生物合成的抑制劑; (II-B) 呼吸鏈複合物I (complex I)或複合物II (complex II)的抑制劑; (II-C) 呼吸鏈複合物III (complex III)的抑制劑; (II-D) 有絲分裂和細胞分裂的抑制劑; (II-E) 可具有多位點作用的化合物; (II-I) 細胞壁合成之抑制劑; (II-J) 脂質和膜合成之抑制劑; (II-L) 核酸合成之抑制劑; (II-N) 可作為去耦合劑 (uncoupler)之化合物; (II-O) 其他殺真菌劑; (II-P) 組織蛋白去乙醯酶 (HDAC)抑制劑;或 (II-R) 生物殺真菌劑。 The agricultural chemical composition as claimed in claim 1, wherein the component (2) is at least one fungicidally active compound (II) selected from the following groups: (II-A) Inhibitors of sterol biosynthesis; (II-B) Inhibitors of respiratory chain complex I (complex I) or complex II (complex II); (II-C) Inhibitors of respiratory chain complex III (complex III); (II-D) Inhibitors of mitosis and cell division; (II-E) Compounds that may have multiple sites of action; (II-I) Inhibitors of cell wall synthesis; (II-J) Inhibitors of lipid and membrane synthesis; (II-L) Inhibitors of nucleic acid synthesis; (II-N) Compounds that can be used as uncouplers; (II-O) Other fungicides; (II-P) Histone deacetylase (HDAC) inhibitors; or (II-R) Biofungicides. 如請求項1所述的農業化學組成物,其中該組分 (2)係至少一種選自以下各組的殺蟲或殺線蟲活性化合物 (II): (III-B) γ-胺基丁酸閘控氯離子通道阻斷劑; (III-C) 鈉通道調節劑; (III-D) 菸鹼乙醯膽鹼受體競爭性調節劑; (III-E) 菸鹼乙醯膽鹼受體異位調節劑-位點I; (III-F) 麩胺酸閘控氯通道異位調節劑; (III-G) 青春激素模擬物; (III-I) 弦音器官TRPV通道調節劑; (III-K) 昆蟲中腸膜的微生物干擾劑; (III-M) 藉由干擾質子梯度而作用之氧化磷酸化去耦合劑; (III-V) 電壓依賴性之鈉通道阻斷劑; (III-Z) 雷若丁受體調節劑; (III-BB) γ-胺基丁酸閘控氯離子通道異位調節劑;或 (III-EE) 作用方式未知或不確定之殺蟲活性化合物。 The agricultural chemical composition as claimed in item 1, wherein the component (2) is at least one insecticidal or nematicidal active compound (II) selected from the following groups: (III-B) GABA-gated chloride channel blockers; (III-C) Sodium channel modulators; (III-D) Nicotinic acetylcholine receptor competitive modulators; (III-E) Nicotinic acetylcholine receptor ectopic modulator-site I; (III-F) Glutamine-gated chloride channel ectopic modulators; (III-G) Mimetics of youth hormones; (III-I) string organ TRPV channel modulator; (III-K) Microbial disruptors of insect midgut membranes; (III-M) Oxidative phosphorylation decouplers that act by interfering with the proton gradient; (III-V) Voltage-dependent sodium channel blockers; (III-Z) Ranerodine receptor modulators; (III-BB) GABA-gated chloride channel ectopic modulators; or (III-EE) Pesticidally active compounds with unknown or uncertain mode of action. 如請求項1所述的農業化學組成物,其中作為組分 (1)之該如式 (I)所示之化合物或其鹽類、N-氧化物、金屬錯合物或立體異構物係選自: (I-1) 1-(4-(4-(5-(2,6-二氯苯基)-4,5-二氫異噁唑-3-基)噻唑-2-基)哌啶-1-基)-2-((3-(三氟甲基)吡嗪-2-基)氧)乙-1-酮 (1-(4-(4-(5-(2,6-dichlorophenyl)-4,5-dihydroisoxazol-3-yl)thiazol-2-yl)piperidin-1-yl)-2-((3-(trifluoromethyl) pyrazin-2-yl) oxy)ethan-1-one); (I-2) 1-(4-(4-(5-(2-氯-6-氟苯基)-4,5-二氫異噁唑-3-基)噻唑-2-基)哌啶-1-基)-2-((3-(三氟甲基)吡啶-2-基)氧基)乙-1-酮 (1-(4-(4-(5-(2-chloro-6-fluorophenyl)-4,5-dihydroisoxazol-3-yl)thiazol-2-yl)piperidin-1-yl)-2-((3-(trifluoromethyl) pyridin-2-yl) oxy)ethan-1-one);或 (I-3) 4-(4-(5-(2-溴-6-氟苯基)-4,5-二氫異噁唑-3-基)噻唑-2-基)哌啶-1-羧酸叔丁酯 (tert-butyl 4-(4-(5-(2-bromo-6-fluorophenyl)-4,5-dihydroisoxazol-3-yl) thiazol-2-yl)piperidine-1-carboxylate)。 The agricultural chemical composition as described in claim 1, wherein the compound represented by formula (I) or its salts, N-oxides, metal complexes or stereoisomers as component (1) selected from: (I-1) 1-(4-(4-(5-(2,6-dichlorophenyl)-4,5-dihydroisoxazol-3-yl)thiazol-2-yl)piperidine- 1-yl)-2-((3-(trifluoromethyl)pyrazin-2-yl)oxy)ethan-1-one (1-(4-(4-(5-(2,6-dichlorophenyl) -4,5-dihydroisoxazol-3-yl)thiazol-2-yl)piperidin-1-yl)-2-((3-(trifluoromethyl)pyrazin-2-yl)oxy)ethan-1-one); (I-2) 1-(4-(4-(5-(2-chloro-6-fluorophenyl)-4,5-dihydroisoxazol-3-yl)thiazol-2-yl)piperidine -1-yl)-2-((3-(trifluoromethyl)pyridin-2-yl)oxy)ethan-1-one (1-(4-(4-(5-(2-chloro-6 -fluorophenyl)-4,5-dihydroisoxazol-3-yl)thiazol-2-yl)piperidin-1-yl)-2-((3-(trifluoromethyl)pyridin-2-yl)oxy)ethan-1-one) ;or (I-3) 4-(4-(5-(2-bromo-6-fluorophenyl)-4,5-dihydroisoxazol-3-yl)thiazol-2-yl)piperidine-1- Tert-butyl carboxylate (tert-butyl 4-(4-(5-(2-bromo-6-fluorophenyl)-4,5-dihydroisoxazol-3-yl) thiazol-2-yl)piperidine-1-carboxylate). 如請求項1所述的農業化學組成物,其中該組分 (2)係至少一種選自下述各組之殺真菌活性化合物 (II)及/或至少一種選自下述各組之殺蟲或殺線蟲活性化合物 (III): (II-A) 甾醇生物合成的抑制劑;(II-A002) 待克利 (difenoconazole)、(II-A021) 得克利 (tebuconazole)、(II-A081) 滅芬座 (mefentrifluconazole); (II-B) 呼吸鏈複合物I (complex I)或複合物II (complex II)的抑制劑:(II-B001) 苯索伏比 (benzovindiflupyr)、(II-B003) 白克列 (boscalid)、(II- B005) 氟派瑞 (fluopyram)、(II-B007) 氟克殺 (fluxapyroxad); (II-C) 呼吸鏈複合物III (complex III)的抑制劑:(II-C001) 辛唑嘧菌胺 (ametoctradin)、(II-C002) 安美速 (amisulbrom)、(II-C003) 亞托敏 (azoxystrobin)、(II-C006) 賽發滅 (cyazofamid)、(II-C009) 凡殺同 (famoxadone)、(II-C010) 芬滅酮 (fenamidone)、(II-C016) 啶氧菌酯 (picoxystrobin)、(II-C017) 唑菌胺酯 (pyraclostrobin)、(II-C020) 三氟敏 (trifloxystrobin)、(II-C030) 甲基四吡咯 (Metyltetraprole); (II-D) 有絲分裂和細胞分裂的抑制劑:(II-D003) 噻唑菌胺 (ethaboxam)、(II-D004) 氟比來 (fluopicolide)、(II-D008) 座賽胺 (zoxamide); (II-E) 可具有多位點作用的化合物:(II-E004) 四氯異苯腈 (chlorothalonil)、(II-E005) 氫氧化銅、(II-E008) 氧氯化銅 (copper oxychloride)、(II-E009) 硫酸銅 (copper sulfate)、(II-E010) 腈硫醌 (dithianon)、(II-E012) 福爾培 (folpet)、(II-E013) 鋅錳乃浦 (mancozeb)、(II-E015) 免得爛 (metiram)、(II-E018) 甲基鋅乃浦 (propineb); (II-I) 細胞壁合成之抑制劑:(II-I001) 苯噻菌胺 (benthiavalicarb)、(II-I002) 達滅芬 (dimethomorph)、(II-I004) 丙森鋅 (iprovalicarb)、(II-I005) 曼普胺 (mandipropamid)、(II-I007) 纈菌胺 (valifenalate); (II-J) 脂質和膜合成之抑制劑:(II-J001) 普拔克 (propamocarb); (II-L) 核酸合成之抑制劑:(II-L004) 甲芬沙姆 (mefenoxam); (II-N) 可作為去耦合劑 (uncoupler)之化合物:(II-N001) 扶吉胺 (fluazinam); (II-O) 其他殺真菌劑:(II-O009) 克絕 (cymoxanil)、(II-O012) 福賽得鋁 (fosetyl­aluminium); (III-B) γ-胺基丁酸 (GABA)閘控氯離子通道阻斷劑,選自以下各類: (III-B2) 苯基吡唑(非潑羅,fiproles):(III-B2002) 費普尼 (fipronil); (III-D) 菸鹼乙醯膽鹼受體 (nAChR)競爭性調節劑,選自以下各類: (III-D1) 新菸鹼類似物:(III-D1002) 可尼丁(clothianidin)、(III-D1004) 益達胺 (imidacloprid)、(III-D1007) 噻蟲嗪 (thiamethoxam);以及 (III-Z) 雷若丁受體調節劑,選自以下各類: (III-Z1) 二醯胺類:(III-Z1002) 氯蟲苯醯胺 (chlorantraniliprole)、(III-Z1003) 氰強尼普羅 (cyantraniliprole)、(III-Z1005) 四硝基吡咯 (tetraniliprole)。 The agricultural chemical composition as claimed in claim 1, wherein the component (2) is at least one fungicidal active compound (II) selected from the following groups and/or at least one insecticidal compound selected from the following groups or nematicide active compound (III): (II-A) Inhibitors of sterol biosynthesis; (II-A002) difenoconazole, (II-A021) tebuconazole, (II-A081) mefentrifluconazole; (II-B) Inhibitors of complex I or complex II of the respiratory chain: (II-B001) benzovindiflupyr, (II-B003) boscalid , (II-B005) fluopyram (fluopyram), (II-B007) fluoxad (fluxapyroxad); (II-C) Inhibitors of respiratory chain complex III: (II-C001) ametoctradin, (II-C002) amisulbrom, (II-C003) yator Azoxystrobin, (II-C006) cyazofamid, (II-C009) famoxadone, (II-C010) fenamidone, (II-C016) picoxystrobin (picoxystrobin), (II-C017) pyraclostrobin (pyraclostrobin), (II-C020) trifluorinated (trifloxystrobin), (II-C030) methyl tetrapyrrole (Metyltetraprole); (II-D) Inhibitors of mitosis and cell division: (II-D003) ethaboxam, (II-D004) fluopicolide, (II-D008) zoxamide; (II-E) Compounds that may have multisite effects: (II-E004) chlorothalonil, (II-E005) copper hydroxide, (II-E008) copper oxychloride , (II-E009) copper sulfate (copper sulfate), (II-E010) dithianon (dithianon), (II-E012) folpet (II-E013) zinc manganese Naipu (mancozeb), (II-E015) lest rotten (metiram), (II-E018) methyl zinc Naipu (propineb); (II-I) Inhibitors of cell wall synthesis: (II-I001) benthiavalicarb, (II-I002) dimethomorph, (II-I004) iprovalicarb, (II -I005) mandipropamid, (II-I007) valifenalate; (II-J) Inhibitors of lipid and membrane synthesis: (II-J001) propamocarb; (II-L) Inhibitors of nucleic acid synthesis: (II-L004) Mefenoxam; (II-N) Compounds that can be used as uncouplers: (II-N001) fluazinam; (II-O) Other fungicides: (II-O009) cymoxanil, (II-O012) fosetylaluminium; (III-B) Gamma-aminobutyric acid (GABA)-gated chloride channel blockers selected from the group consisting of: (III-B2) Phenylpyrazoles (fiproles): (III-B2002) Fipronil; (III-D) Nicotinic acetylcholine receptor (nAChR) competitive modulators selected from the group consisting of: (III-D1) Neonicotinoid analogues: (III-D1002) clothianidin, (III-D1004) imidacloprid, (III-D1007) thiamethoxam; and (III-Z) Ranerodine receptor modulators selected from the group consisting of: (III-Z1) Diamides: (III-Z1002) Chlorantraniliprole, (III-Z1003) cyantraniliprole, (III-Z1005) Tetraniliprole. 如請求項1所述的農業化學組成物,其中該組分 (1)與組分 (2)之間的重量比為100:1至1:100。The agricultural chemical composition according to claim 1, wherein the weight ratio between the component (1) and the component (2) is 100:1 to 1:100. 如請求項1所述的農業化學組成物,其中該組分 (1)與組分 (2)之間的重量比為10:1至1:10。The agricultural chemical composition according to claim 1, wherein the weight ratio between the component (1) and the component (2) is 10:1 to 1:10. 一種農業化學組成物,其包含一有效劑量之如請求項1至8中任一項所述的組成物,以及一農用可接受之添加劑。An agricultural chemical composition, which comprises an effective dose of the composition according to any one of claims 1 to 8, and an agriculturally acceptable additive. 如請求項9所述的農業化學組成物,其中該農用可接受之添加劑係選自由以下所組成的群組:溶劑或稀釋劑、染料、潤濕劑、分散劑、乳化劑、消泡劑、防腐劑、填充劑、增稠劑、黏合劑、赤黴素、固體載體、液體載體、氣體載體、表面活性劑、結合劑、崩解劑、pH調節劑、抗結塊劑、防凍劑、消泡劑、增量劑、穩定劑及/或著色劑或前述之組合。The agricultural chemical composition as described in claim 9, wherein the agriculturally acceptable additive is selected from the group consisting of: solvent or diluent, dye, wetting agent, dispersant, emulsifier, defoamer, Preservatives, fillers, thickeners, binders, gibberellins, solid carriers, liquid carriers, gas carriers, surfactants, binders, disintegrants, pH regulators, anti-caking agents, antifreeze, disinfectants Foaming agent, bulking agent, stabilizer and/or coloring agent or a combination of the foregoing. 如請求項1至10中任一項所述的農業化學組成物,其係用於控制或預防植物病原性真菌與細菌及/或害蟲與蟎蟲。The agricultural chemical composition according to any one of claims 1 to 10, which is used for controlling or preventing phytopathogenic fungi and bacteria and/or pests and mites. 一種將如請求項1至10中任一項所述的農業化學組成物用於控制或預防農作物及/或園藝作物上由植物病原性真菌造成之疾病的用途。A use of the agricultural chemical composition according to any one of claims 1 to 10 for controlling or preventing diseases caused by phytopathogenic fungi on crops and/or horticultural crops. 如請求項12所述的農業化學組成物的用途,其中該植物病原性真菌係鏈格孢屬 ( Alternariaspp.)、葡萄孢屬 ( Botrytisspp)、刺盤孢屬 ( Colletotrichumspp.)、白粉菌屬 ( Erysiphespp.)、鐮菌屬 ( Fusariumspp.)、駝孢鏽菌屬 ( Hemileiaspp.)、層鏽菌屬 ( Phakopsoraceaespp .)、霜黴菌屬 ( Pseudoperonosporaspp.)、單軸黴屬 ( Plasmoparaspp.)、疫病菌屬 ( Phytophthoraspp.)、核腔菌屬 ( Pyrenophoraspp.)、腐霉屬 ( Pythiumspp.)、梨孢黴屬 ( Pyriculariaspp.)、絲核菌屬 ( Rhizoctoniaspp.)、殼針孢菌屬 ( Septoriaspp.)、柄鏽菌屬 ( Pucciniaspp.)、或單胞銹菌屬 ( Uromycesspp.)。 The use of the agricultural chemical composition as claimed in item 12, wherein the phytopathogenic fungus is Alternaria spp., Botrytis spp, Colletotrichum spp., Alternaria spp. Erysiphe spp., Fusarium spp., Hemileia spp., Phakopsoraceae spp . , Pseudoperonospora spp., Plasmodium Plasmopara spp., Phytophthora spp., Pyrenophora spp., Pythium spp., Pyricularia spp., Rhizoctonia ( Rhizoctonia spp.), Septoria spp., Puccinia spp., or Uromyces spp. 一種將如請求項1-10所述的農業化學組成物用於控制或預防農作物及/或園藝作物上由卵菌綱 (Oomycetes)造成的疾病的用途。A use of the agricultural chemical composition as described in Claims 1-10 for controlling or preventing diseases caused by Oomycetes on crops and/or horticultural crops. 如請求項14所述的農業化學組成物之用途,其中該卵菌綱之病原體係選自致病疫黴 ( Phytophthora infestans)、大豆疫黴菌 ( Phytophthora megasperma)、煙草黑脛病菌 ( Phytophthora parasitica)、樟疫黴 ( Phytophthora cinnamomi)、辣椒疫黴菌 ( Phytophthora capsici)、菸草疫黴菌 ( Phytophthora nicotianae)、棕櫚疫病菌 ( Phytophthora palmivora)、瓜果腐黴 ( Pythium aphanidermatum)、葡萄生單軸黴 ( Plasmopara viticola)、霜黴病菌 ( Peronospora tabacina)、寄生霜黴菌 ( Peronospora parasitica)、大蔥霜黴菌 ( Peronospora destructor)、樹狀霜黴 ( Peronospora arborescens)、古巴假霜黴菌 ( Pseudoperonospora cubensis)、葎草假霜黴 ( Pseudoperonospora humuli)、以及萵苣露菌病 ( Bremia lactucae)。 The use of the agricultural chemical composition as described in claim 14, wherein the pathogenic system of the Oomycetes is selected from the group consisting of Phytophthora infestans , Phytophthora megasperma , Phytophthora parasitica , Phytophthora cinnamomi , Phytophthora capsici , Phytophthora nicotianae , Phytophthora palmivora , Pythium aphanidermatum , Plasmopara viticola , Peronospora tabacina , Peronospora parasitica , Peronospora destructor , Peronospora arborescens , Pseudoperonospora cubensis , Pseudoperonospora humuli ), and Bremia lactucae . 如請求項11所述的農業化學組成物之用途,其係用以控制蟎目、鞘翅目、雙翅目、膜翅目、等翅目、鱗翅目、半翅目、直翅目及纓翅目之昆蟲/蟎類。The use of the agricultural chemical composition as described in claim 11, which is used to control Acarina, Coleoptera, Diptera, Hymenoptera, Isoptera, Lepidoptera, Hemiptera, Orthoptera and Thysanoptera Insects/Acarids. 如請求項1至10中任一項所述的農業化學組成物,其係用於處理種子、基因轉殖植物的種子以及基因改造植物的種子。The agricultural chemical composition according to any one of claims 1 to 10, which is used for treating seeds, seeds of genetically modified plants, and seeds of genetically modified plants. 一種包含如請求項1-10中任一項所述的農業化學組成物的種子,其中該農業化學組成物的施用率為每100 kg種子0.1 g至100 kg。A seed comprising the agrochemical composition according to any one of claims 1-10, wherein the agrochemical composition is applied at a rate of 0.1 g to 100 kg per 100 kg of seeds. 一種控制或預防植物病原性真菌侵染農作物及/或園藝作物中有用植物的方法,其包含將如請求項1-10中任一項所述的農業化學組成物施用於該植物、該植物之部分或該植物之所在地。A method for controlling or preventing phytopathogenic fungi from infecting crops and/or useful plants in horticultural crops, comprising applying the agricultural chemical composition as described in any one of claims 1-10 to the plant, the plant part or locus of the plant.
TW110146642A 2020-12-15 2021-12-13 Novel agrochemical composition comprising piperidine thiazole compounds TW202236965A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN202011054441 2020-12-15
IN202011054441 2020-12-15

Publications (1)

Publication Number Publication Date
TW202236965A true TW202236965A (en) 2022-10-01

Family

ID=79602093

Family Applications (1)

Application Number Title Priority Date Filing Date
TW110146642A TW202236965A (en) 2020-12-15 2021-12-13 Novel agrochemical composition comprising piperidine thiazole compounds

Country Status (4)

Country Link
AR (1) AR124364A1 (en)
TW (1) TW202236965A (en)
UY (1) UY39563A (en)
WO (1) WO2022130188A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025031845A1 (en) 2023-08-09 2025-02-13 Basf Se Fungicidal compositions comprising 5-fluoro-4-imino-3-methyl-1-(p-tolylsulfonyl)pyrimidin-2-one
WO2025031846A1 (en) 2023-08-09 2025-02-13 Basf Se Fungicidal ternary mixtures comprising 5-fluoro-4-imino-3-methyl-1-(p-tolylsulfonyl)pyrimidin-2-one
CN117089547B (en) * 2023-08-25 2024-01-30 青岛农业大学 Application of dsRNA in preventing and controlling cyantraniliprole-resistant bemisia tabaci
WO2025195883A1 (en) 2024-03-21 2025-09-25 Basf Se Fungicidal compositions comprising oxathiapiprolin derivatives
WO2025195881A1 (en) 2024-03-21 2025-09-25 Basf Se Fungicidal compositions comprising strobilurine derivatives
WO2025195882A1 (en) 2024-03-21 2025-09-25 Basf Se Fungicidal compositions comprising strobilurine derivatives
WO2025223904A1 (en) 2024-04-24 2025-10-30 Basf Se Mixtures of strobilurin type compounds for combating phytopathogenic fungi containing an amino acid substitution f129l in the mitochondrial cytochrome b protein conferring resistance to qo inhibitors with at least one further pesticide i
EP4640052A1 (en) 2024-04-24 2025-10-29 Basf Se Mixtures of strobilurin type compounds for combating phytopathogenic fungi containing an amino acid substitution f129l in the mitochondrial cytochrome b protein conferring resistance to qo inhibitors with at least one further pesticide i

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4272417A (en) 1979-05-22 1981-06-09 Cargill, Incorporated Stable protective seed coating
US4245432A (en) 1979-07-25 1981-01-20 Eastman Kodak Company Seed coatings
US4808430A (en) 1987-02-27 1989-02-28 Yazaki Corporation Method of applying gel coating to plant seeds
US5876739A (en) 1996-06-13 1999-03-02 Novartis Ag Insecticidal seed coating
US6503904B2 (en) 1998-11-16 2003-01-07 Syngenta Crop Protection, Inc. Pesticidal composition for seed treatment
US6660690B2 (en) 2000-10-06 2003-12-09 Monsanto Technology, L.L.C. Seed treatment with combinations of insecticides
US20020134012A1 (en) 2001-03-21 2002-09-26 Monsanto Technology, L.L.C. Method of controlling the release of agricultural active ingredients from treated plant seeds
WO2008013622A2 (en) 2006-07-27 2008-01-31 E. I. Du Pont De Nemours And Company Fungicidal azocyclic amides
TWI428091B (en) 2007-10-23 2014-03-01 Du Pont Fungicide mixture
CN101970432B (en) 2008-01-25 2014-05-28 杜邦公司 fungicidal heterocyclic compounds
JP5535941B2 (en) 2008-01-25 2014-07-02 イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニー Bactericidal amide
MX2012007200A (en) 2009-12-21 2012-07-10 Bayer Cropscience Ag Bis(difluormethyl)pyrazoles used as fungicides.
JP5959646B2 (en) 2011-09-15 2016-08-02 バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングBayer Intellectual Property GmbH Piperidine pyrazoles as fungicides
BR122019010638B1 (en) 2012-02-27 2020-12-29 Bayer Intellectual Property Gmbh combination, method to control harmful phytopathogenic fungi and use of said combination
CN108601353B (en) 2016-02-08 2024-04-05 高文作物保护公司 Bactericidal composition
TW201838974A (en) 2017-04-19 2018-11-01 印度商Pi工業公司 Heterocyclic compounds with microbicidal properties
WO2019048988A1 (en) 2017-09-08 2019-03-14 Pi Industries Ltd. NOVEL FUNGICIDE HETEROCYCLIC COMPOUNDS
MX2020002449A (en) 2017-09-08 2020-11-06 Pi Industries Ltd Novel fungicidal heterocyclic compounds.
AR120376A1 (en) 2019-11-11 2022-02-09 Pi Industries Ltd SUBSTITUTED HETEROARYL PIPERIDINILETHANONES WITH FUNGICIDAL ACTIVITY

Also Published As

Publication number Publication date
WO2022130188A1 (en) 2022-06-23
AR124364A1 (en) 2023-03-22
UY39563A (en) 2022-07-29

Similar Documents

Publication Publication Date Title
WO2022243810A1 (en) Novel agrochemical composition comprising piperidine thiazole compounds
JP7027329B2 (en) Bicyclic compound
TW202236965A (en) Novel agrochemical composition comprising piperidine thiazole compounds
RU2731150C2 (en) Pesticide compositions containing a triazole compound
CN116234444A (en) Insecticidally active mixtures containing thietaneoxy compounds, their oxides or their salts
BR112017015061B1 (en) PESTICIDE MIXTURE COMPRISING AN ACTIVE COMPOUND OF FORMULA IA AND BROFLANILIDE
JP2015530414A (en) Pesticide active mixture containing anthranilamido compound
KR102727205B1 (en) Mixtures containing benzpyrimoxane and oxazosulpirin, uses thereof and methods of application thereof
AU2017250534B2 (en) Pesticidally active mixtures of tioxazafen
WO2016079043A1 (en) Pesticidal compositions comprising a triazole compound
WO2017153218A1 (en) Method for controlling pests of plants
EP3628157A1 (en) Method of controlling insecticide resistant insects and virus transmission to plants
JP2023535465A (en) Pesticidal active mixtures containing pyrazolopyridine anthranilamide compounds, oxides or salts thereof
CN109068655B (en) Pesticidal active mixtures of tioxazafen
KR20170043606A (en) Pesticidal mixtures of chlorfenapyr of chlorfenapyr and teflubenzuron, and their separate applications